Basket Home Your Account Contact/Consultation

Market Surveys Globaldata Pharmaceuticals Health

TitleYearPrice

Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q4 2011

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q4 2011” report is an esse
2012 1.500,00$

Canada Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “Canada Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound
2012 2.500,00$

Operating Room Solutions Market - An Overview

Introduction / / GlobalData’s report, “Operating Room Solutions Market - An Overview” provides information and analysis on the gl
2012 500,00$

Middle East and Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Middle East and Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Resp
2011 3.500,00$

New Zealand Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “New Zealand Wound Care Management Market Outlook to 2017 - Advanced Wound Management,
2012 2.500,00$

Saudi Arabia Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “Saudi Arabia Wound Care Management Market Outlook to 2017 - Advanced Wound Management,
2012 2.500,00$

Belgium Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “Belgium Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Woun
2012 2.500,00$

Argentina Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “Argentina Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wo
2012 2.500,00$

Taiwan Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “Taiwan Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound
2012 2.500,00$

Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ankylosing Spondylitis Therapeutics
2012 3.995,00$

Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peptic Ulcer Therapeutics- Pipeline
2012 3.995,00$

Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myasthenia Gravis Therapeutics - Pip
2012 3.995,00$

Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012" p
2012 1.000,00$

Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012" provides da
2012 1.000,00$

Ewing Sarcoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H1, 2012" provides data on the
2012 1.000,00$

Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012" provi
2012 1.000,00$

Neutropenia Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H1, 2012" provides data on the N
2012 1.000,00$

Inflammatory Bowel Disease Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, H1, 2012" provide
2012 1.000,00$

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012" provides da
2012 1.000,00$

Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012" provides da
2012 1.000,00$

Plasma Cell Neoplasm Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Plasma Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides dat
2012 1.000,00$

Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data
2012 1.000,00$

B-Cell Lymphomas Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on
2012 1.000,00$

Dental Plaque Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Dental Plaque Global Clinical Trials Review, H1, 2012" provides data on the
2012 1.000,00$

Venous Thromboembolism Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012" provides da
2012 1.000,00$

Vulvar Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H1, 2012" provides data on the
2012 1.000,00$

T-Cell Leukemia Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H1, 2012" provides data on t
2012 1.000,00$

Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012" provides data on
2012 1.000,00$

Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides d
2012 1.000,00$

T-Cell Lymphomas Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on
2012 1.000,00$

Throat Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Throat Cancer Global Clinical Trials Review, H1, 2012" provides data on the
2012 1.000,00$

Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Vitiligo Therapeutics - Pipeline Ass
2012 3.995,00$

Atrial Fibrillation Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H1, 2012" provides data
2012 1.000,00$

Oligodendroglioma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2012" provides data on
2012 1.000,00$

Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012" provides data
2012 1.000,00$

Tinnitus Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, H1, 2012" provides data on the Tinn
2012 1.000,00$

Tuberculosis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2012" provides data on the
2012 1.000,00$

Depression Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Depression Global Clinical Trials Review, H1, 2012" provides data on the De
2012 1.000,00$

Diabetic Macular Edema Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Diabetic Macular Edema Global Clinical Trials Review, H1, 2012" provides da
2012 1.000,00$

Follicular Lymphoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2012" provides data
2012 1.000,00$

Gall Stone Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Gall Stone Global Clinical Trials Review, H1, 2012" provides data on the Ga
2012 1.000,00$

Gingivitis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Gingivitis Global Clinical Trials Review, H1, 2012" provides data on the Gi
2012 1.000,00$

Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020” provides D
2012 2.000,00$

Anemia Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Anemia Global Clinical Trials Review, H1, 2012" provides data on the Anemia
2012 1.000,00$

Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012" provides data
2012 1.000,00$

Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides
2012 1.000,00$

Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides d
2012 1.000,00$

Pruritus Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Pruritus Global Clinical Trials Review, H1, 2012" provides data on the Prur
2012 1.000,00$

Pulmonary Hypertension Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H1, 2012" provides da
2012 1.000,00$

Abraxane (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Abraxane (Breast Cancer) – Analysis and Forecasts to 2020” provides Abraxa
2011 2.000,00$

Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gallbladder Cancer Therapeutics - Pi
2012 3.995,00$

Saudi Arabia In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Saudi Arabia In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic
2012 2.500,00$

New Zealand In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “New Zealand In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic T
2012 2.500,00$

Sweden In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Sweden In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin
2012 2.500,00$

Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Ge
2012 2.500,00$

Israel In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Israel In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin
2012 2.500,00$

Brazil In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Brazil In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin
2012 2.500,00$

Canada In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin
2012 2.500,00$

United States In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “United States In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic
2012 2.500,00$

Brazil Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “Brazil Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound
2012 2.500,00$

Spain Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “Spain Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound
2012 2.500,00$

China Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “China Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound
2012 2.500,00$

United Kingdom Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “United Kingdom Wound Care Management Market Outlook to 2017 - Advanced Wound Managemen
2012 2.500,00$

United States Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s new report, “United States Wound Care Management Market Outlook to 2017 - Advanced Wound Management
2012 2.500,00$

Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa)
2012 2.500,00$

Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China,
2012 2.500,00$

Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Afri
2012 2.500,00$

Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market
2012 3.995,00$

North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic
2012 3.500,00$

Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecast
2012 3.995,00$

Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2011"
2012 1.000,00$

Tonsillitis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Tonsillitis Global Clinical Trials Review, H2, 2011" provides data on the T
2012 1.000,00$

Tetanus Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Tetanus Global Clinical Trials Review, H2, 2011" provides data on the Tetan
2012 1.000,00$

Solid Tumor Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Solid Tumor Global Clinical Trials Review, H2, 2011" provides data on the S
2012 1.000,00$

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Small Cell Lung Cancer Global Clinical Trials Review, H2, 2011" provides da
2012 1.000,00$

Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011" prov
2012 1.000,00$

Pulmonary Fibrosis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, H2, 2011" provides data o
2012 1.000,00$

Pneumonia Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Pneumonia Global Clinical Trials Review, H2, 2011" provides data on the Pne
2012 1.000,00$

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2011" provide
2012 1.000,00$

Myocardial Infarction Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Myocardial Infarction Global Clinical Trials Review, H2, 2011" provides dat
2012 1.000,00$

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 20
2012 1.000,00$

Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Gastrointestinal Hemorrhage Global Clinical Trials Review, H2, 2011" provid
2012 1.000,00$

Gastritis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Gastritis Global Clinical Trials Review, H2, 2011" provides data on the Gas
2012 1.000,00$

Esophagitis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Esophagitis Global Clinical Trials Review, H2, 2011" provides data on the E
2012 1.000,00$

Enterocolitis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Enterocolitis Global Clinical Trials Review, H2, 2011" provides data on the
2012 1.000,00$

Dyspnea Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, H2, 2011" provides data on the Dyspn
2012 1.000,00$

Cough Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Cough Global Clinical Trials Review, H2, 2011" provides data on the Cough c
2012 1.000,00$

Chicken Pox Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Chicken Pox Global Clinical Trials Review, H2, 2011" provides data on the C
2012 1.000,00$

Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Revi
2012 1.000,00$

Aspergillosis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, H2, 2011" provides data on the
2012 1.000,00$

Baxter Acquires Synovis - To Consolidate its Position in the Soft Tissue Repair Market - Deal Analysis from GlobalData

Introduction / / GlobalData’s “Baxter Acquires Synovis - To Consolidate its Position in the Soft Tissue Repair Market” provides k
2012 500,00$

C. R. Bard Acquires Lutonix - Set to Gain from a New Technology - Deal Analysis from GlobalData

Introduction / / GlobalData’s report, “C. R. Bard Acquires Lutonix - Set to Gain from a New Technology” provides key information
2012 500,00$

Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, C
2012 2.500,00$

Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive Blood Pressure Cuffs and Patient Monitoring Temperature Probes) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive
2012 2.500,00$

Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) t
2012 2.500,00$

Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Af
2012 2.500,00$

Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Afr
2012 2.500,00$

Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Afri
2012 2.500,00$

Europe In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Europe In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing
2012 3.500,00$

Middle East and Africa In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Middle East and Africa In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistr
2012 3.500,00$

South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemis
2012 3.500,00$

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive La
2012 3.995,00$

Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape an
2012 3.995,00$

Wire Sutures - A Market Snapshot

Introduction / / GlobalData’s report, “Wire Sutures - A Market Snapshot” provides information and analysis on the global wire sut
2012 500,00$

Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Co
2012 3.995,00$

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market
2012 3.995,00$

Oral Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Oral Cancer Global Clinical Trials Review, H2, 2011" provides data on the O
2011 1.000,00$

Pancreatic Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Smallpox Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Smallpox Global Clinical Trials Review, H2, 2011" provides data on the Smal
2011 1.000,00$

Peritoneal Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" p
2012 1.000,00$

Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2011" provid
2012 1.000,00$

Liver Transplantation Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, H2, 2011" provides dat
2012 1.000,00$

Iliac Aneurysms Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Iliac Aneurysms Global Clinical Trials Review, H2, 2011" provides data on t
2012 1.000,00$

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2011" provide
2012 1.000,00$

Pompe Disease Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H2, 2011" provides data on the
2012 1.000,00$

Filariasis Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H2, 2011" provides data on the Fi
2012 1.000,00$

Friedreich Ataxia Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H2, 2011" provides data on
2012 1.000,00$

Cerebral Aneurysms Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H2, 2011" provides data o
2012 1.000,00$

Arteriosclerosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Arteriosclerosis Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2012

Introduction / / GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H2, 2011" provides
2012 1.000,00$

Argentina In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Test
2011 2.500,00$

Belgium In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin
2011 2.500,00$

Netherlands In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Netherlands In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Te
2011 2.500,00$

Australia In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Australia In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Test
2011 2.500,00$

Spain In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Spain In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing,
2011 2.500,00$

Italy In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Italy In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing,
2011 2.500,00$

France In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “France In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing
2011 2.500,00$

Germany In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Germany In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin
2011 2.500,00$

China In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing,
2011 2.500,00$

India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing,
2011 2.500,00$

Japan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Japan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing,
2011 2.500,00$

United Kingdom In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “United Kingdom In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic
2011 2.500,00$

Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline An
2012 3.995,00$

Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forec
2012 3.500,00$

Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market
2012 3.500,00$

Republic of Korea In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Republic of Korea In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Gene
2011 2.500,00$

Airway and Anesthesia Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Airway and Anesthesia Devices Market Outlook in BRICS (Brazil, Russia, India, China, S
2011 2.500,00$

Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Fo
2012 3.500,00$

Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Marke
2012 3.500,00$

Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Lands
2012 3.500,00$

Hospital Wireless Patient Monitoring Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Hospital Wireless Patient Monitoring Devices - Global Opportunity Assessment, Competit
2011 3.500,00$

Regional Anesthesia Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Regional Anesthesia Disposables Market Outlook in BRICS (Brazil, Russia, India, China,
2011 2.500,00$

Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South A
2011 2.500,00$

Insulin Delivery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Insulin Delivery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa)
2011 2.500,00$

Multiparameter Patient Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Multiparameter Patient Monitoring Market Outlook in BRICS (Brazil, Russia, India, Chin
2011 2.500,00$

Magnetic Resonance Imaging (MRI) Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Magnetic Resonance Imaging (MRI) Systems Market Outlook in BRICS (Brazil, Russia, Indi
2011 2.500,00$

Asia-Pacific In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Asia-Pacific In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic T
2011 3.500,00$

Mexico In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Mexico In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing
2011 2.500,00$

Taiwan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing
2011 2.500,00$

South Africa In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic T
2011 2.500,00$

Austria In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Austria In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin
2011 2.500,00$

Czech Republic In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Czech Republic In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic
2011 2.500,00$

Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Introduction / / GlobalData’s new report, “Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin
2011 2.500,00$

Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B Vaccines - Pipeline Asse
2011 3.500,00$

Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Fibromyalgia Therapeutics - Pipeline
2011 3.500,00$

Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Eczema Therapeutics - Pipeline Asses
2012 3.500,00$

Acute Coronary Syndrome (ACS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report “Acute Coronary Syndrome (ACS) Therape
2011 3.500,00$

Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Addiction Control Therapeutics - Pip
2011 3.500,00$

Thalassemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Thalassemia Therapeutics - Pipeline
2011 3.500,00$

Lip and Oral Cavity Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Lip and Oral Cavity Cancer Therapeut
2011 3.500,00$

Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Graft Versus Host Disease (GVHD) T
2012 3.995,00$

Anorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anorexia Nervosa Therapeutics - Pipe
2011 3.500,00$

Kawasaki Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Kawasaki Disease Therapeutics - Pipe
2011 3.500,00$

Testicular Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2
2011 1.000,00$

Polio Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Polio Global Clinical Trials Review, H2, 2011" provides data on the Polio c
2011 1.000,00$

Phlebitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Phlebitis Global Clinical Trials Review, H2, 2011" provides data on the Phl
2011 1.000,00$

Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Hemostasis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H2, 2011" provides data on the He
2011 1.000,00$

Dengue Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Dengue Global Clinical Trials Review, H2, 2011" provides data on the Dengue
2011 1.000,00$

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review,
2011 1.000,00$

Asthma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H2, 2011" provides data on the Asthma
2011 1.000,00$

Angina (Angina Pectoris) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Angina (Angina Pectoris) Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis (OA) Therapeutics - P
2011 3.500,00$

Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bronchitis Therapeutics - Pipeline A
2011 3.500,00$

Huntington’s Disease (HD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Huntington’s Disease (HD) Therapeuti
2011 3.500,00$

Generalized Anxiety Disorders (GAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Generalized Anxiety Disorders (GAD)
2011 3.500,00$

Male Hypogonadism Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Male Hypogonadism Therapeutics - Pip
2011 3.500,00$

Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Atherosclerosis or Coronary Artery D
2012 3.500,00$

Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gaucher’s Disease Therapeutics - Pip
2012 3.500,00$

Myocardial Infarction (MI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myocardial Infarction (MI) Therapeut
2011 3.500,00$

Dyskinesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dyskinesia Therapeutics - Pipeline A
2011 3.500,00$

Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Overactive Bladder (OAB) Therapeut
2012 3.995,00$

Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism (VTE) Thera
2012 3.995,00$

Thyroid Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Rectal Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Peripheral Arterial Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Peripheral Arterial Disease Global Clinical Trials Review, H2, 2011" provid
2011 1.000,00$

Ovarian Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Meningitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Meningitis Global Clinical Trials Review, H2, 2011" provides data on the Me
2011 1.000,00$

Insomnia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, H2, 2011" provides data on the Inso
2011 1.000,00$

Hepatic Tumor Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatic Tumor Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Glioma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Glioma Global Clinical Trials Review, H2, 2011" provides data on the Glioma
2011 1.000,00$

Gallbladder Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Burns Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Burns Global Clinical Trials Review, H2, 2011" provides data on the Burns c
2011 1.000,00$

Allergic Rhinitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2017

Introduction / / GlobalData’s new report, “Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fore
2011 3.500,00$

Rigid Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Rigid Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecast
2011 3.500,00$

Dysmenorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dysmenorrhea Therapeutics - Pipeline
2011 3.500,00$

Radiological Society of North America (RSNA) Conference 2011 - Review and Analysis

Introduction / / GlobalData’s report, “Radiological Society of North America (RSNA) Conference 2011 - Review and Analysis” provid
2011 1.000,00$

Hospital Information Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Hospital Information Systems Market Outlook in BRICS (Brazil, Russia, India, China, So
2011 2.500,00$

Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa
2011 2.500,00$

Anesthesia Machines in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Anesthesia Machines Market Outlook in BRICS (Brazil, Russia, India, China, South Afric
2011 2.500,00$

Sleep Apnea Diagnostic Systems in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Sleep Apnea Diagnostic Systems Market Outlook in BRICS (Brazil, Russia, India, China,
2011 2.500,00$

North America Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “North America Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory D
2011 3.500,00$

Europe Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Europe Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 3.500,00$

Asia-Pacific Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Asia-Pacific Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory De
2011 3.500,00$

South and Central America Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Othe

Introduction / / GlobalData’s new report, “South and Central America Anesthesia and Respiratory Devices Market Outlook to 2017- R
2011 3.500,00$

North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Ins
2011 3.500,00$

Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 3.500,00$

Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insu
2011 3.500,00$

Middle East and Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Middle East and Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitorin
2011 3.500,00$

South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monito
2011 3.500,00$

Sleep Apnea Diagnostic Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Sleep Apnea Diagnostic Systems - Global Pipeline Analysis, Competitive Landscape and M
2011 3.500,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, December 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, December 2011” report is an
2011 1.000,00$

United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Ins
2011 2.500,00$

United Kingdom Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “United Kingdom Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and In
2011 2.500,00$

Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del
2011 2.500,00$

India Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “India Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del
2011 2.500,00$

China Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “China Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del
2011 2.500,00$

Canada Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Canada Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

Germany Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Germany Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D
2011 2.500,00$

France Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “France Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

Italy Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Italy Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

Spain Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Spain Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del
2011 2.500,00$

Australia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Australia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin
2011 2.500,00$

Brazil Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Brazil Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

Netherlands Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Netherlands Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insul
2011 2.500,00$

Belgium Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Belgium Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D
2011 2.500,00$

Argentina Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Argentina Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin
2011 2.500,00$

Mexico Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Mexico Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and
2011 2.500,00$

Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

South Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “South Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insu
2011 2.500,00$

Israel Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Israel Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

India Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “India Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

France Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “France Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

Italy Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Italy Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

Brazil Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Brazil Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

Argentina Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Argentina Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devic
2011 2.500,00$

Mexico Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Mexico Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2017- Respirato
2011 2.500,00$

Taiwan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Taiwan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

South Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “South Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory De
2011 2.500,00$

Israel Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Israel Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

New Zealand Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “New Zealand Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Dev
2011 2.500,00$

Saudi Arabia Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Saudi Arabia Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory De
2011 2.500,00$

Compression Hosiery Stockings - A Market Snapshot

Introduction / / GlobalData’s report, “Compression Hosiery Stockings - A Market Snapshot” provides key data, information and anal
2011 500,00$

US Surgical Booms Market - An Overview

Introduction / / GlobalData’s report, “US Surgical Booms Market - An Overview” provides key data, information and analysis on the
2011 500,00$

European Debt Crisis - Impact on Healthcare Industry

Introduction / / GlobalData’s report, “European Debt Crisis - Impact on Healthcare Industry” provides key information and analysi
2011 500,00$

New Zealand Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “New Zealand Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insul
2011 2.500,00$

Saudi Arabia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Saudi Arabia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insu
2011 2.500,00$

Sweden Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Sweden Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De
2011 2.500,00$

Austria Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Austria Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D
2011 2.500,00$

Denmark Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Denmark Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D
2011 2.500,00$

Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring an
2011 2.500,00$

Czech Republic Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction / / GlobalData’s new report, “Czech Republic Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and In
2011 2.500,00$

Czech Republic Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Czech Republic Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory
2011 2.500,00$

Austria Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Austria Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices
2011 2.500,00$

Sweden Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Sweden Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoporosis Therapeutics - Pipeline
2011 3.500,00$

Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Epilepsy Therapeutics - Pipeline Ass
2011 3.500,00$

Crohn’s Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Crohn’s Disease (CD) Therapeutics -
2011 3.500,00$

NovoLog (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “NovoLog (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides NovoL
2011 2.000,00$

Candidiasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Candidiasis Therapeutics - Pipeline
2011 3.500,00$

Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cervical Cancer Therapeutics - Pipel
2011 3.500,00$

Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dystonia Therapeutics - Pipeline Ass
2011 3.500,00$

Sickle Cell Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Sickle Cell Anemia Therapeutics - Pi
2011 3.500,00$

Fabry’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Fabry’s Disease Therapeutics - Pipel
2011 3.500,00$

Paget’s Disease of Bone (PDB) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Paget’s Disease of Bone (PDB) Therap
2011 3.500,00$

Ovarian Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Ovarian Disease Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H2,
2011 1.000,00$

Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011
2011 1.000,00$

Fragile X Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Fragile X Syndrome Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Amblyopia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Amblyopia Global Clinical Trials Review, H2, 2011" provides data on the Amb
2011 1.000,00$

Iliac Aneurysms Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Iliac Aneurysms Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Dermatitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, H2, 2011" provides data on the De
2011 1.000,00$

Stomatitis (Sore Mouth) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Stomatitis (Sore Mouth) Global Clinical Trials Review, H2, 2011" provides d
2011 1.000,00$

Aphasia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Aphasia Global Clinical Trials Review, H2, 2011" provides data on the Aphas
2011 1.000,00$

Psoriatic Arthritis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Biliary Tract Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Biliary Tract Disease Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2
2011 1.000,00$

Anal Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, H2, 2011" provides data on the A
2011 1.000,00$

Astrocytoma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Astrocytoma Global Clinical Trials Review, H2, 2011" provides data on the A
2011 1.000,00$

Osteosarcoma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Osteosarcoma Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Staphylococcal Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Staphylococcal Infections Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Kidney Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Kidney Cancer Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Opium Addiction Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Opium Addiction Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Subarachnoid Hemorrhage Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Subarachnoid Hemorrhage Global Clinical Trials Review, H2, 2011" provides d
2011 1.000,00$

Laryngeal Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Lung Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Lung Cancer Global Clinical Trials Review, H2, 2011" provides data on the L
2011 1.000,00$

Acute Coronary Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2011" provides d
2011 1.000,00$

Leukemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Leukemia Global Clinical Trials Review, H2, 2011" provides data on the Leuk
2011 1.000,00$

Head and Neck Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Head and Neck Cancer Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Global Clinic
2011 1.000,00$

Endometrial Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011" p
2011 1.000,00$

Esophageal Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Fallopian Tube Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Prostate Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Prostate Cancer Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

HIV / AIDS Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “HIV / AIDS Global Clinical Trials Review, H2, 2011" provides data on the HI
2011 1.000,00$

Colorectal Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Colorectal Cancer Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011”
2011 1.000,00$

BioClinica (BIOC) - Financial and Strategic SWOT Analysis Review

BioClinica is a health information technology company, which provides clinical research services in health industry. The company i
2011 125,00$

Kawasumi Laboratories, Inc. (7703) - Financial and Strategic SWOT Analysis Review

Kawasumi Laboratories, Inc. (Kawasumi) is a medical device company engaged in the blood purifying business. The company develops a
2011 125,00$

Calypte Biomedical Corporation (CBMC) - Financial and Strategic SWOT Analysis Review

Calypte Biomedical Corporation (Calypte) is a diagnostic company engaged in the development, manufacture and marketing of in-vitro
2011 125,00$

CAS Medical Systems, Inc. (CASM) - Financial and Strategic SWOT Analysis Review

CAS Medical Systems, Inc. (CASMED) is a medical device company engaged in designing, developing, manufacturing and marketing of in
2011 125,00$

Imaging Diagnostic Systems, Inc. (IMDS) - Financial and Strategic SWOT Analysis Review

Imaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company, which commercializes medical imaging eq
2011 125,00$

International Isotopes Inc. (INIS) - Financial and Strategic SWOT Analysis Review

International Isotopes Inc. (INIS) is a holding company engaged in the development and manufacture of nuclear medicine calibration
2011 125,00$

PC Group, Inc. (PCGR) - Financial and Strategic SWOT Analysis Review

PC Group, Inc. (PC Group) formerly Langer, Inc., is engaged in the design, manufacture and distribution of medical products and se
2011 125,00$

Arrhythmia Research Technology, Inc. (HRT) - Financial and Strategic SWOT Analysis Review

Arrhythmia Research Technology ( ART ) is a medical technology company. It is principally engaged in delivering state-of-the-art s
2011 250,00$

Biohit Oyj (BIOBV) - Financial and Strategic SWOT Analysis Review

Biohit Oyj (Biohit), is engaged in the manufacturing, developing and marketing of liquid handling products and accessories. The co
2011 250,00$

Corin Group PLC (CRG) - Financial and Strategic SWOT Analysis Review

Corin Group plc (Corin Group) is a medical device company engaged in the development, manufacture and sale of a wide variety of pr
2011 125,00$

Del Global Technologies Corp. (DGTC) - Financial and Strategic SWOT Analysis Review

Del Global Technologies Corp. (Del Global Technologies) is a medical device company engaged in the design, manufacture and marketi
2011 125,00$

Digirad Corporation (DRAD) - Financial and Strategic SWOT Analysis Review

Digirad Corporation (Digirad) is a medical technology company that is engaged in the research, development and manufacture of soli
2011 125,00$

Fonar Corporation (FONR) - Financial and Strategic SWOT Analysis Review

Fonar Corporation (Fonar) is a medical device company engaged in the development, production and marketing of medical scanning equ
2011 125,00$

Hemagen Diagnostics, Inc. (HMGN) - Financial and Strategic SWOT Analysis Review

Hemagen Diagnostics, Inc. (Hemagen) is a biotechnology company engaged in the research, development, production and marketing of m
2011 250,00$

MTS Systems Corporation (MTSC) - Financial and Strategic SWOT Analysis Review

MTS Systems Corporation (MTS) is a supplier of mechanical testing systems and industrial position sensors. The company carries out
2011 250,00$

NeuroMetrix, Inc. (NURO) - Financial and Strategic SWOT Analysis Review

NeuroMetrix, Inc. (NeuroMetrix) is a science-based medical device company. It is engaged in the design, development and commercial
2011 250,00$

Ophthalmic Imaging Systems Inc. (OISI) - Financial and Strategic SWOT Analysis Review

Ophthalmic Imaging Systems Inc. (Ophthalmic Imaging) is a division of MediVision Medical Imaging Ltd. The company is engaged in th
2011 250,00$

Retractable Technologies, Inc. (RVP) - Financial and Strategic SWOT Analysis Review

Retractable Technologies, Inc. (Retractable) is a medical devices company. It is involved in the design, develop, manufacture and
2011 250,00$

The Spectranetics Corporation (SPNC) - Financial and Strategic SWOT Analysis Review

The Spectranetics Corporation (Spectranetics) is engaged in the marketing of Excimer Laser System used in minimally invasive inter
2011 250,00$

AtCor Medical Holdings Limited (ACG) - Financial and Strategic SWOT Analysis Review

AtCor Medical Holdings Limited (AtCor Medical) is a medical device company, engaged in the design, manufacture and marketing of me
2011 125,00$

MacKay Life Sciences, Inc. (BZEC) - Financial and Strategic SWOT Analysis Review

MacKay Life Sciences, Inc. (MLS) is formerly known as Biofield. The company is a US based, listed corporation which develops, manu
2011 250,00$

Conceptus, Inc. (CPTS) - Financial and Strategic SWOT Analysis Review

Conceptus, Inc. (Conceptus) is a medical device company engaged in developing, manufacturing and marketing medical devices and pro
2011 125,00$

Lombard Medical Technologies PLC (LMT) - Financial and Strategic SWOT Analysis Review

Lombard Medical Technologies PLC (LMT) is a medical equipment company engaged in the discovery, manufacture and marketing of speci
2011 125,00$

Magna-Lab Inc. (MAGAA) - Financial and Strategic SWOT Analysis Review

Magna-Lab is a medical device company which is focused on the development and commercialization of disposable medical devices. The
2011 125,00$

MedTox Scientific, Inc. (MTOX) - Financial and Strategic SWOT Analysis Review

MEDTOX Scientific, Inc. (MedTox) is medical device company that is engaged in providing forensic and laboratory services to corp
2011 125,00$

Akers Biosciences, Inc. (AKR) - Financial and Strategic SWOT Analysis Review

Akers Biosciences, Inc. (ABI) is engaged in the development, manufacture and supply of rapid point care screening and testing prod
2011 125,00$

Ametek, Inc. (AME) - Financial and Strategic SWOT Analysis Review

Ametek, Inc. (Ametek) is a one of the largest manufacturer of electronic instruments and electromechanical devices company. The co
2011 250,00$

AMICAS, Inc. (AMCS) - Financial and Strategic SWOT Analysis Review

Amicas, Inc. (Amicas) is engaged in providing radiology, medical image and information management solutions. The company's product
2011 125,00$

Angeion Corporation (ANGN) - Financial and Strategic SWOT Analysis Review

Angeion Corporation (Angeion) is engaged in the design, development, manufacture and distribution of cardiorespiratory diagnostic
2011 250,00$

Biotel Incorporated (BTEL) - Financial and Strategic SWOT Analysis Review

Biotel Incorporated (Biotel) is engaged in the design, manufacture and marketing of patient-worn diagnostic electrocardiology devi
2011 250,00$

Cardima, Inc. (CADMQ) - Financial and Strategic SWOT Analysis Review

Cardima, Inc. (Cardima) designs, develops, manufactures and markets minimally invasive, single-use, micro-catheter systems for the
2011 250,00$

AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

AdvanSource Biomaterials Corporation (AdvanSource) is engaged in developing polymer based materials for the medical and pharmaceut
2011 125,00$

China Medical Technologies, Inc. (CMED) - Financial and Strategic SWOT Analysis Review

China Medical Technologies, (China Medical) is engaged in the development, manufacture and marketing of in-vitro diagnostics (IVD)
2011 250,00$

Chindex International, Inc. (CHDX) - Financial and Strategic SWOT Analysis Review

Chindex International, Inc. (Chindex) is a healthcare service and medical equipment company, is focused on providing healthcare se
2011 250,00$

Hamamatsu Photonics K.K. (6965) - Financial and Strategic SWOT Analysis Review

Hamamatsu Photonics K.K. (Hamamatsu) is an optical electronic devices manufacturing company. It is principally engaged in the desi
2011 125,00$

HEI, Inc. (HEII) - Financial and Strategic SWOT Analysis Review

HEI Inc., an electronic device and medical equipment manufacturer, focuses on specialized services in Electronic Manufacturing Ser
2011 250,00$

Hydromer, Inc. (HYDI) - Financial and Strategic SWOT Analysis Review

Hydromer, Inc. (Hydromer) is a biotechnology company engaged in developing, patenting, licensing, manufacture and commercializing
2011 250,00$

IntegraMed America, Inc. (INMD) - Financial and Strategic SWOT Analysis Review

IntegraMed America, Inc. (IntegraMed) is a specialty healthcare service company focused in providing products and services in the
2011 250,00$

International Brachytherapy S.A. (EZBG) - Financial and Strategic SWOT Analysis Review

International Brachytherapy S.A. (IBT Bebig) is a Europe-based medical device company, focusing on cancer treatment by radiation t
2011 250,00$

IRIDEX Corporation (IRIX) - Financial and Strategic SWOT Analysis Review

IRIDEX Corporation (IRIDEX) is a medical devices company. It is engaged in development, manufacture, marketing and sale of medical
2011 250,00$

Landauer, Inc. (LDR) - Financial and Strategic SWOT Analysis Review

Landauer, Inc. (Landauer) is a medical device company focused on providing analytical services to determine the exposure of enviro
2011 250,00$

MedMira Inc. (MIR) - Financial and Strategic SWOT Analysis Review

MedMira, Inc (MedMira) is a diagnostic company principally engaged in the developing, manufacturing and commercializing of rapid d
2011 250,00$

Capstone Therapeutics Corp. (CAPS) - Financial and Strategic SWOT Analysis Review

Capstone Therapeutics Corp. (Capstone) formerly known as OrthoLogic Corp. is a biotechnology company engaged in the development an
2011 250,00$

PhotoMedex, Inc. (PHMD) - Financial and Strategic SWOT Analysis Review

PhotoMedex, Inc. (PhotoMedex) is engaged in the development, manufacture and marketing of proprietary laser and fiber optic system
2011 250,00$

Somanetics Corporation (SMTS) - Financial and Strategic SWOT Analysis Review

Somanetics Corporation (Somanetics) is a medical device company principally engaged in the development, manufacture and marketing
2011 250,00$

ALR Technologies Inc. (ALRT) - Financial and Strategic SWOT Analysis Review

ALR Technologies Inc. (ALRT), formerly Mo Betta Corp. is a medical device company engaged in the business of designing, marketing,
2011 125,00$

CompuMed, Inc. (CMPD) - Financial and Strategic SWOT Analysis Review

CompuMed, Inc. (CompuMed) is a medical diagnostics equipment company. It is engaged in developing and marketing products and servi
2011 125,00$

MediVision Medical Imaging Ltd. (MEDV) - Financial and Strategic SWOT Analysis Review

MediVision Medical Imaging (MediVision) is a medical device company engaged in manufacturing clinically advanced digital imaging
2011 125,00$

Micrus Endovascular Corporation - Financial and Strategic SWOT Analysis Review

Micrus Endovascular Corporation (Mircus) engaged in the developing, manufacturing and marketing of implantable and disposable medi
2011 250,00$

NxStage Medical, Inc. (NXTM) - Financial and Strategic SWOT Analysis Review

NxStage Medical, Inc. (NxStage) is a medical device company engaged in the design, development, manufacture and commercialization
2011 250,00$

STAAR Surgical Company (YORW) - Financial and Strategic SWOT Analysis Review

STAAR Surgical Company (STAAR Surgical) is a medical devices company. It is principally engaged in developing, manufacturing and c
2011 250,00$

Synovis Life Technologies, Inc. (SYNO) - Financial and Strategic SWOT Analysis Review

Synovis Life Technologies, Inc. (Synovis) is a diversified medical device company. It is engaged in the development, manufacture a
2011 125,00$

Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial company principally e
2011 250,00$

Utah Medical Products, Inc. (UTMD) - Financial and Strategic SWOT Analysis Review

Utah Medical Products, Inc. (Utah Medical) is engaged in the development, manufacture and marketing of disposable and reusable spe
2011 250,00$

biolitec AG (BIB) - Financial and Strategic SWOT Analysis Review

Biolitec AG (Biolitec) is a medical device company, engaged in the research, development, production and marketing of medical las
2011 125,00$

Medisana AG (MHH) - Financial and Strategic SWOT Analysis Review

Medisana AG (Medisana) is engaged in the development, manufacture and marketing of home care products for the healthcare markets.
2011 250,00$

Ortivus AB (ORTI B) - Financial and Strategic SWOT Analysis Review

Ortivus AB (Ortivus) is a medical technology company which is involved in providing information and tech device which give decisi
2011 125,00$

Apex Medical Corporation (4106) - Financial and Strategic SWOT Analysis Review

Apex Medical Corporation (Apex Medical) is engaged in providing medical device manufacturing services for the OEM and healthcare i
2011 250,00$

American Bio Medica Corporation (ABMC) - Financial and Strategic SWOT Analysis Review

American Bio Medica Corporation (ABMC) is a biotechnology company engaged in the development, manufacturing and marketing of immu
2011 125,00$

SHOFU INC. (7979) - Financial and Strategic SWOT Analysis Review

SHOFU INC. (SHOFU) is a medical device company which is mainly into manufacturing and marketing of dental materials and equipments
2011 125,00$

RTI Biologics, Inc. (RTIX) - Financial and Strategic SWOT Analysis Review

RTI Biologics, Inc. (RTI) provides tissue-based solutions to repair and promote the natural healing of human bone and other human
2011 125,00$

United-Guardian, Inc. (UG) - Financial and Strategic SWOT Analysis Review

United-Guardian, Inc. (United-Guardian) is a diversified company engaged in the manufacture and distribution of pharmaceuticals, c
2011 250,00$

TearLab Corporation (TEAR) - Financial and Strategic SWOT Analysis Review

TearLab Corporation (TearLab) formerly OccuLogix, Inc., is an in-vitro diagnostic company, engaged in the development and marketin
2011 125,00$

Prism Medical Ltd. (PM) - Financial and Strategic SWOT Analysis Review

Prism Medical Ltd. (Prism) is engaged in providing durable medical equipment and related services to the mobility disadvantaged pe
2011 125,00$

Pro-Dex, Inc. (PDEX) - Financial and Strategic SWOT Analysis Review

Pro-Dex, Inc. (Pro-Dex) is engaged in the design, development, manufacture and marketing of rotary drive systems which are used in
2011 125,00$

Synergy Health plc (SYR) - Financial and Strategic SWOT Analysis Review

Synergy Health plc (Synergy Health) is a medical equipment company, engaged in providing healthcare support services. The company
2011 125,00$

Cyberonics, Inc. (CYBX) - Financial and Strategic SWOT Analysis Review

Cyberonics, Inc. (Cyberonics) is a neuromodulation company that designs, develops and markets medical devices for the treatment of
2011 125,00$

LiDCO Group Plc (LID) - Financial and Strategic SWOT Analysis Review

LiDCO Group Plc (LiDCO) is a medical device company, engaged in research, development and manufacture and marketing of medical dev
2011 125,00$

Mesa Laboratories, Inc. (MLAB) - Financial and Strategic SWOT Analysis Review

Mesa Laboratories, Inc. (Mesa) is engaged in the development, manufacture and marketing of electronic instruments and disposable p
2011 125,00$

Signature Eyewear, Inc. (SEYE) - Financial and Strategic SWOT Analysis Review

Signature Eyewear, Inc. (Signature) is a eyewear company, engaged in the design, marketing and distribution of prescription eyegla
2011 125,00$

CTS Corporation (CTS) - Financial and Strategic SWOT Analysis Review

CTS Corporation (CTS) is engaged in the design, manufacture and sale of electronic components, sensors and actuators. It operates
2011 125,00$

Cynosure, Inc. (CYNO) - Financial and Strategic SWOT Analysis Review

Cynosure, Inc. (Cynosure) is a medical device company engaged in the development, manufacture and distribution of lasers and light
2011 125,00$

Encision Inc. (ECIA) - Financial and Strategic SWOT Analysis Review

Encision Inc.(Encision) is a medical device company engaged in designing, developing, manufacturing and marketing patented surgica
2011 125,00$

Hypertension Diagnostics, Inc. (HDII) - Financial and Strategic SWOT Analysis Review

Hypertension Diagnostics, Inc. (Hypertension) is engaged in the design, development, manufacture and marketing of proprietary devi
2011 125,00$

Neovasc Inc. (NVC) - Financial and Strategic SWOT Analysis Review

Neovasc Inc. (Neovasc), formerly known as Medical Ventures Corp., is a medical device company engaged in the development and manuf
2011 125,00$

Apogee Technology, Inc. (ATCS) - Financial and Strategic SWOT Analysis Review

Apogee Technology, Inc. (Apogee) is a biotechnology company, engaged in the development of advanced vaccine delivery systems. The
2011 125,00$

BSD Medical Corporation (BSDM) - Financial and Strategic SWOT Analysis Review

BSD Medical Corporation (BSD) is engaged in the development, manufacture and marketing of treatment systems, which are used for t
2011 125,00$

ASAHI INTECC CO., LTD. (7747) - Financial and Strategic SWOT Analysis Review

ASAHI INTECC CO., LTD. (ASAHI) is engaged in the development, manufacture and supply of medical devices, OEM products, percutaneou
2011 125,00$

Astro-Med, Inc. (ALOT) - Financial and Strategic SWOT Analysis Review

Astro-Med, Inc. (Astro-Med) is engaged in the design, development, manufacture and marketing of printers and data acquisition and
2011 125,00$

Artimplant AB (ARTI B) - Financial and Strategic SWOT Analysis Review

Artimplant AB (Artimplant) is a biomaterials company providing solutions for the treatment of orthopedic, reconstructive surgery a
2011 125,00$

Medical Action Industries, Inc. (MDCI) - Financial and Strategic SWOT Analysis Review

Medical Action Industries, Inc. (Medical Action) is a manufacturer of medical products in the US. The company is principally engag
2011 125,00$

AGA Medical Holdings, Inc. - Financial and Strategic SWOT Analysis Review

AGA Medical Holdings, Inc. (AGA Medical), a medical device company, is engaged in the designing, development, manufacturing and ma
2011 125,00$

Cardiogenesis Corporation (CGCP) - Financial and Strategic SWOT Analysis Review

Cardiogenesis Corporation (Cardiogenesis) is engaged in the development, design and distribution of laser-based surgical products
2011 250,00$

BIONIME Corporation (4737) - Financial and Strategic SWOT Analysis Review

BIONIME Corporation (BIONIME), a privately-held medical testing company. The company is principally engaged in the design, manufac
2011 250,00$

Dynatronics Corporation (DYNT) - Financial and Strategic SWOT Analysis Review

Dynatronics Corporation (Dynatronics) is engaged in the manufacture and distribution of broad line therapy devices, medical suppli
2011 250,00$

Exactech, Inc. (EXAC) - Financial and Strategic SWOT Analysis Review

Exactech, Inc. (Exactech) is engaged in the development, manufacture, marketing and distribution of orthopedic implant devices, su
2011 125,00$

Japan Medical Dynamic Marketing, INC. (7600) - Financial and Strategic SWOT Analysis Review

Japan Medical Dynamic Marketing, INC. (Japan MDM) is a medical device company, engaged in developing, manufacturing and marketing
2011 125,00$

DiaSorin S.p.A (DIA) - Financial and Strategic SWOT Analysis Review

DiaSorin S.p.A. (DiaSorin) is a medical device company, engaged in the manufacture and development of reagents pertaining to in-vi
2011 125,00$

AcuNetx, Inc. (ANTX) - Financial and Strategic SWOT Analysis Review

AcuNetx, Inc. (AcuNetx) is a medical device company that provides products and services for the three broad markets, namely, Medic
2011 250,00$

aap Implantate AG (AAQ) - Financial and Strategic SWOT Analysis Review

aap Implantate AG (aap) is a medical technology company principally engaged in the development, manufacture and distribution of jo
2011 125,00$

Anteo Diagnostics Limited (ADO) - Financial and Strategic SWOT Analysis Review

Anteo Diagnostics Limited (Anteo) formerly known as BioLayer Corporation Limited has developed a platform for the rapid design of
2011 125,00$

Hansen Medical, Inc. (HNSN) - Financial and Strategic SWOT Analysis Review

Hansen Medical, Inc. (Hansen Medical), formerly Autocath, Inc. is a medical technology company engages principally in the design,
2011 125,00$

HORIBA, Ltd. (6856) - Financial and Strategic SWOT Analysis Review

HORIBA, Ltd. (HORIBA) is a medical device manufacturing company, engaged in the manufacture and sale of measuring equipment. It op
2011 250,00$

Imaging Dynamics Company, Ltd. (IDL) - Financial and Strategic SWOT Analysis Review

Imaging Dynamics Company, Ltd. (IDC) is a medical technology services provider, engaged in the manufacture of Digital Radiography
2011 250,00$

Cellestis Limited (CST) - Financial and Strategic SWOT Analysis Review

Cellestis Limited (Cellestis) is engaged in the development, manufacture and marketing of medical diagnostic products. The company
2011 250,00$

DiagnoCure Inc. (CUR) - Financial and Strategic SWOT Analysis Review

DiagnoCure Inc. (DiagnoCure) is engaged in the development, production and commercialization of immunoassay and molecular tests fo
2011 250,00$

Montvale Technologies, Inc. (IVVI) - Financial and Strategic SWOT Analysis Review

Montvale Technologies, Inc. (Montvale Technologies) formerly known as Ivivi Technologies, Inc., an early-stage medical technology
2011 250,00$

MAKO Surgical Corp. (MAKO) - Financial and Strategic SWOT Analysis Review

MAKO Surgical Corp. (MAKO Surgical) is a medical device company, based in the US. The company is engaged in the development of adv
2011 250,00$

Pyng Medical Corporation (PYT) - Financial and Strategic SWOT Analysis Review

Pyng Medical Corp. (Pyng) is engaged in the production and sale of the FAST1 Intraosseous Infusion System, TPOD Pelvic Stabilizer,
2011 250,00$

SQI Diagnostics Inc. (SQD) - Financial and Strategic SWOT Analysis Review

SQI Diagnostics Inc. (SQI) is a privately-held medical device company engaged in the development and marketing of immunoassay syst
2011 250,00$

Cardiovascular Systems, Inc. (CSII) - Financial and Strategic SWOT Analysis Review

Cardiovascular Systems, Inc. (CSI) is an independent medical device organization. It is engaged in the designing, development and
2011 250,00$

Medgenics Inc. (MEDG) - Financial and Strategic SWOT Analysis Review

Medgenics Inc. (Medgenics) is a clinical-stage biopharmaceutical company, engaged in developing ultra sustained action protein dru
2011 250,00$

Medicsight PLC (MDST) - Financial and Strategic SWOT Analysis Review

Medicsight PLC (Medicsight) is engaged in the development of Computer Aided Detection (CAD) and image analysis software . by using
2011 250,00$

NuSep Ltd (NSP) - Financial and Strategic SWOT Analysis Review

NuSep Ltd (NuSep) is a Life Science Separations company. It is engaged in producing precast gels and laboratory separation process
2011 250,00$

American Homepatient, Inc. (AHOM) - Financial and Strategic SWOT Analysis Review

American HomePatient, Inc. (American HomePatient) is a medical device company. The company along with its subsidiaries, engaged in
2011 125,00$

Uroplasty, Inc. (UPI) - Financial and Strategic SWOT Analysis Review

Uroplasty, Inc. (Uroplasty), a medical device company, is engaged in the development, manufacturing and marketing of innovative pr
2011 250,00$

Vision-Sciences, Inc. (VSCI) - Financial and Strategic SWOT Analysis Review

Vision-Sciences, Inc. (Vision-Sciences) is a medical device company engaged in the development, manufacturing and marketing of inn
2011 250,00$

CardioNet, Inc. (BEAT) - Financial and Strategic SWOT Analysis Review

CardioNet, Inc, (CardioNet) is a medical device company which deals with the development and marketing of mobile cardiac outpatien
2011 125,00$

GSI Group Inc. (GSIGQ) - Financial and Strategic SWOT Analysis Review

GSI Group Inc. (GSI) is a provider of precision technology components, lasers and laser-based advanced manufacturing systems to th
2011 125,00$

Non-Invasive Monitoring Systems, Inc. (NIMU) - Financial and Strategic SWOT Analysis Review

Non-Invasive Monitoring Systems, Inc. (NIMS) is engaged in the research, development, manufactureand marketing of non-invasive, wh
2011 125,00$

Merge Healthcare Incorporated (MRGE) - Financial and Strategic SWOT Analysis Review

Merge Healthcare Incorporated (Merge Healthcare) is a market leading company, which engages in the development of medical imaging
2011 250,00$

pSivida Corp. (PSDV) - Financial and Strategic SWOT Analysis Review

pSivida Limited (pSivida) is engaged in the manufacture and development of drug delivery products for the healthcare markets. It d
2011 125,00$

Seikagaku Corporation (4548) - Financial and Strategic SWOT Analysis Review

Seikagaku Corporation (Seikagaku), is principally engaged in the development and manufacturing of medical devices and pharmaceutic
2011 125,00$

MAZOR Surgical Technologies Ltd. (MZOR) - Financial and Strategic SWOT Analysis Review

MAZOR Surgical Technologies Ltd. (MAZOR) is engaged in the development and marketing of surgical positioning systems for the spina
2011 250,00$

Greatbatch, Inc. (GB) - Financial and Strategic SWOT Analysis Review

Greatbatch, Inc. (GB) is a medical device company that designs, develops and manufactures various systems, components and devices
2011 125,00$

Beijing Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic SWOT Analysis Review

Beijing Wandong Medical Equipment Co., Ltd. (Wandong Medical) is a Chinese medical equipment company. The company develops, manufa
2011 125,00$

Compumedics Limited (CMP) - Financial and Strategic SWOT Analysis Review

Compumedics Limited (Compumedics) is a medical diagnostic technology company, engaged in the designing, development and marketing
2011 125,00$

Paradigm Medical Industries, Inc. (PDMI) - Financial and Strategic SWOT Analysis Review

Paradigm Medical Industries, Inc. (Paradigm Medical) is a medical device company engaged in the development, manufacture and marke
2011 125,00$

Acme United Corporation (ACU) - Financial and Strategic SWOT Analysis Review

Acme United Corporation (AUC) is a supplier of products used for cutting, measuring and safety to school, home, office and industr
2011 250,00$

Sunshine Heart Company, Pty. Ltd. (SHC) - Financial and Strategic SWOT Analysis Review

Sunshine Heart Company, Pty. Ltd. (Sunshine Heart) is engaged in the design, development and marketing of medical devices for the
2011 250,00$

BioCurex, Inc. (BOCX) - Financial and Strategic SWOT Analysis Review

BioCurex, Inc. (BioCurex) is a biotechnology company, principally engaged in the development and marketing of cancer diagnostic te
2011 250,00$

Urologix Inc. (ULGX) - Financial and Strategic SWOT Analysis Review

Urologix, Inc. (Urologix) is engaged in the research, development, manufacture and marketing of catheter based therapies. The comp
2011 125,00$

Milestone Scientific Inc. (MLSS) - Financial and Strategic SWOT Analysis Review

Milestone Scientific Inc. (Milestone Scientific) is engaged in the development, manufacture and distribution of proprietary, compu
2011 250,00$

Deltex Medical Group plc (DEMG) - Financial and Strategic SWOT Analysis Review

Deltex Medical Group plc (Deltex) is a medical device company, manufacturing and selling of oesophageal Doppler monitor. The compa
2011 125,00$

Goodman Co., Ltd. (7535) - Financial and Strategic SWOT Analysis Review

Goodman Co., Ltd. (Goodman) is a medical device company engaged in the development, manufacture and selling of cardiology products
2011 250,00$

JMS CO., LTD. (7702) - Financial and Strategic SWOT Analysis Review

JMS CO., LTD. (JMS) is engaged in the research, development, manufacture and distribution of medical equipments and pharmaceutical
2011 125,00$

Medikit Co., Ltd. (7749) - Financial and Strategic SWOT Analysis Review

Medikit Co., Ltd. (Medikit) is a global technology and product development company. It is engaged in manufacturing and marketing o
2011 250,00$

Itamar Medical Ltd. (ITMR) - Financial and Strategic SWOT Analysis Review

Itamar Medical Ltd. (Itamar Medical) is a medical technology company. It is engaged in the development and marketing of cardio mon
2011 250,00$

Bovie Medical Corporation (BVX) - Financial and Strategic SWOT Analysis Review

Bovie Medical Corporation (Bovie Medical) is a medical device company principally engaged in the development, manufacture and dist
2011 125,00$

Medical Australia Limited (MLA) - Financial and Strategic SWOT Analysis Review

Medical Australia Limited (Medical Australia) formerly BMDi TUTA Healthcare is a medical device company, engaged in the developmen
2011 125,00$

BIOQUELL (BQE) - Financial and Strategic SWOT Analysis Review

BIOQUELL is a privately-held medical device company, engaged in the development of biodecontamination systems for the life science
2011 250,00$

Neogen Corporation (NEOG) - Financial and Strategic SWOT Analysis Review

Neogen Corporation (Neogen) is a medical device company engaged in the development, manufacture, and marketing of diverse line of
2011 125,00$

BIOTEQUE CORPORATION (4107) - Financial and Strategic SWOT Analysis Review

Bioteque Corporation (Bioteque) is a privately held medical device company. The company is engaged in the development, manufacture
2011 250,00$

Cutera, Inc. (CUTR) - Financial and Strategic SWOT Analysis Review

Cutera, Inc. (Cutera) engages in the designing, manufacturing and marketing of laser and other light-based aesthetics systems for
2011 125,00$

OSSTEM IMPLANT Co., Ltd. (048260) - Financial and Strategic SWOT Analysis Review

OSSTEM IMPLANT Co., Ltd. (Osstem) is a medical equipment company specialized in the designing, manufacturing and marketing of dent
2011 250,00$

RION Co., Ltd. (6823) - Financial and Strategic SWOT Analysis Review

RION Co., Ltd. (Rion) is engaged in the development and marketing of products that are used in government institutions, schools an
2011 250,00$

DexCom, Inc. (DXCM) - Financial and Strategic SWOT Analysis Review

DexCom, Inc. (DexCom) is a medical device company engaged in the development, manufacture, and distribution of continuous glucose
2011 125,00$

Biological Signal Processing Ltd. (BSP) - Financial and Strategic SWOT Analysis Review

Biological Signal Processing Ltd. (BSP) is engaged in the development of innovative non-invasive solution for the diagnosis and mo
2011 250,00$

VirtualScopics, Inc. (VSCP) - Financial and Strategic SWOT Analysis Review

VirtualScopics, Inc. (VirtualScopics) is a service provider company engaged in offering central reads and quantitative imaging sol
2011 125,00$

Holista CollTech Limited (HCT) - Financial and Strategic SWOT Analysis Review

Holista CollTech Limited (Holista CollTech) is a biotechnology and a medical equipment company, which is engaged in the developmen
2011 125,00$

ContextVision AB (COV) - Financial and Strategic SWOT Analysis Review

ContextVision AB (ContextVision) is a medical technology company engaged in the development and marketing of imaging devices and r
2011 125,00$

Oncoprobe Biotech Inc. (4113) - Financial and Strategic SWOT Analysis Review

Oncoprobe Biotech Inc. (Oncoprobe) is a public company which is a distributor of medical devices and test reagents. The company is
2011 250,00$

CardioComm Solutions, Inc. (EKG) - Financial and Strategic SWOT Analysis Review

CardioComm Solutions, Inc. (CardioComm) is a medical software company, which is engaged in the development and marketing of advanc
2011 125,00$

National Dentex Corporation - Financial and Strategic SWOT Analysis Review

National Dentex Corporation (National Dentex) is a dental devices company engaged in the design, fabrication and marketing of cust
2011 125,00$

Tyrian Diagnostics Limited (TDX) - Financial and Strategic SWOT Analysis Review

Tyrian Diagnostics Limited (Tyrian) is a diagnostics company, which is engaged in the manufacture, development and distribution of
2011 125,00$

CarePayment Technologies, Inc. (CPYT) - Financial and Strategic SWOT Analysis Review

CarePayment Technologies, Inc., formerly, Microhelix, Inc. (Microhelix) is a public company that is engaged in the design, manufac
2011 250,00$

Helicos BioSciences Corporation (HLCS) - Financial and Strategic SWOT Analysis Review

Helicos BioSciences Corporation (Helicos) is a life sciences company focused on developing genetic analysis technologies for the r
2011 125,00$

NISSAN MEDICAL INDUSTRIES LTD. (NISA) - Financial and Strategic SWOT Analysis Review

NISSAN MEDICAL INDUSTRIES LTD. (NISSAN MEDICAL) is engaged in the development and manufacture of surgical dressing products for wo
2011 250,00$

United Orthopedic Corporation (4129) - Financial and Strategic SWOT Analysis Review

United Orthopedic Corporation (UOC) is a medical device company, it manufactures, develops and distributes medical equipments such
2011 125,00$

MEDICREA INTERNATIONAL (ALMED) - Financial and Strategic SWOT Analysis Review

MEDICREA INTERNATIONAL (Medicrea) is a medical device company, engaged in the design, manufacturing and distribution of implant sy
2011 250,00$

Solco Biomedical Co., Ltd. (043100) - Financial and Strategic SWOT Analysis Review

Solco Biomedical Co., Ltd. (Solco) is a medical device company engaged in the development and marketing of medical appliances for
2011 125,00$

Biocoral, Inc. (BCRA) - Financial and Strategic SWOT Analysis Review

Biocoral, Inc. (Biocoral) is a medical device company, engaged in the design, research, development, commercialization and manufac
2011 250,00$

Applied NeuroSolutions, Inc. (APSN) - Financial and Strategic SWOT Analysis Review

Applied NeuroSolutions, Inc. (APNS) is a development stage biopharmaceutical company engaged in the research and development of pr
2011 125,00$

ZoomMed Inc. (ZMD) - Financial and Strategic SWOT Analysis Review

ZoomMed Inc. (ZoomMed) is engaged in the development of paramedical equipments for the healthcare industry. The company has come u
2011 250,00$

MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Financial and Strategic SWOT Analysis Review

MCS Medical Compression Systems (DBN) Ltd. (MCS Medical) is engaged in the development, manufacture and marketing of non-invasive
2011 250,00$

NorDiag ASA (NORD) - Financial and Strategic SWOT Analysis Review

NorDiag ASA (NorDiag) is a biotechnology company engages in the development, manufacture and marketing of automated nucleic acid p
2011 125,00$

Noveko International Inc. (EKO) - Financial and Strategic SWOT Analysis Review

Noveko International Inc. (Noveko) is engaged in the design, development and distribution of ultrasound products and medical devic
2011 250,00$

Fermiscan Holdings Limited (FER) - Financial and Strategic SWOT Analysis Review

Fermiscan Holdings Limited (Fermiscan) is a medical device company engaged in the development of products and technology for use i
2011 125,00$

Amplifon S.p.A. (AMP) - Financial and Strategic SWOT Analysis Review

Amplifon S.p.A. (Amplifon) is a multinational company based in Italy. The company is engaged in the distribution and application o
2011 125,00$

Topspin Medical Inc. (TOPMD) - Financial and Strategic SWOT Analysis Review

Topspin Medical Inc. (TopSpin) is a medical device company that is engaged in the development of medical devices for the cardiovas
2011 250,00$

Applied Visual Sciences, Inc. (APVS) - Financial and Strategic SWOT Analysis Review

Applied Visual Sciences, Inc. (Formerly known as Guardian Technologies International, Inc.) is a technology company engaged in the
2011 125,00$

Cosmo Bio Co., Ltd. (3386) - Financial and Strategic SWOT Analysis Review

Cosmo Bio Co., Ltd. (Cosmo Bio) is engaged in the development and marketing of products for the in-vitro diagnostic markets. The c
2011 250,00$

Exonhit S.A. (ALEHT) - Financial and Strategic SWOT Analysis Review

ExonHit is a medical diagnostic company. It is engaged in development and marketing of genomic profiling technology, diagnostic so
2011 250,00$

European Institute of Science AB (EURI B) - Financial and Strategic SWOT Analysis Review

European Institute of Science AB (European Institute) is an investment company, engaged in biotechnological and medical research,
2011 250,00$

LifeAssays AB (LIFE B) - Financial and Strategic SWOT Analysis Review

LifeAssays AB (LifeAssays) is a diagnostic company, engaged in the development, manufacture and marketing of in-vitro diagnostic p
2011 250,00$

MagForce Nanotechnologies AG (MF6) - Financial and Strategic SWOT Analysis Review

MagForce Nanotechnologies AG (MagForce) is a medical device company principally engaged in providing niche technologies to the dru
2011 250,00$

CytoSorbents Corporation (CTSO) - Financial and Strategic SWOT Analysis Review

CytoSorbents Corporation(CytoSorbents) is a medical device company engaged in design and developing hemoperfusion technology to th
2011 250,00$

CRH Medical Corporation (CRM) - Financial and Strategic SWOT Analysis Review

CRH Medical Corporation (CRH Medical) is a medical device technology company principally engaged in the development of medical dev
2011 250,00$

Precision Optics Corporation, Inc. (PEYE) - Financial and Strategic SWOT Analysis Review

Precision Optics Corporation, Inc. (Precision Optics) is engaged in the design, development, manufacture and distribution of optic
2011 250,00$

Rossmax International Ltd. (4121) - Financial and Strategic SWOT Analysis Review

Rossmax International Ltd. (Rossmax International) is a medical device manufacturing company principally engaged in the manufactur
2011 250,00$

Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Financial and Strategic SWOT Analysis Review

Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a producer of radioactive components. The company is engage
2011 125,00$

OPTOPOL Technology S.A. (OPL) - Financial and Strategic SWOT Analysis Review

OPTOPOL Technology S.A (OPTOPOL) is a medical device company, engaged in the development, production and distribution of medical d
2011 250,00$

Medtechnica Ltd. (MEDI) - Financial and Strategic SWOT Analysis Review

Medtechnica Ltd. (Medtechnica) is a medical device company engaged in the distribution of medical equipments for the health care m
2011 250,00$

Elbit Imaging Ltd. (EMITF) - Financial and Strategic SWOT Analysis Review

Elbit Imaging Ltd. (Elbit) is a diversified company. It is engaged in the initiation, construction, operation, management, and sal
2011 125,00$

Global Health Limited (GLH) - Financial and Strategic SWOT Analysis Review

Global Health Pty Ltd (Global Health) is an information technology company engaged in providing e-health solutions to the healthca
2011 125,00$

Nightingale Informatix Corporation (NGH) - Financial and Strategic SWOT Analysis Review

Nightingale Informatix Corporation (Nightingale) is a healthcare IT company engaged in the developing, marketing and licensing of
2011 125,00$

CompuGroup Medical AG. (COP) - Financial and Strategic SWOT Analysis Review

CompuGroup Medical AG (CompuGROUP Medical), formerly CompuGROUP Holding AG, is a medical device company that is engaged in the dev
2011 125,00$

CathRx Ltd (CXD) - Financial and Strategic SWOT Analysis Review

CathRx Ltd (CathRx) is a medical device company engaged in the research, development and commercialization of a wide range of card
2011 125,00$

Nanosphere, Inc. (NSPH) - Financial and Strategic SWOT Analysis Review

Nanosphere, Inc. (Nanosphere) is a nanotechnology-based molecular diagnostics company, offering proprietary breakthrough technolog
2011 250,00$

AuthentiDate Holding Corporation (ADAT) - Financial and Strategic SWOT Analysis Review

Authentidate Holding Corporation (Authentidate) is a provider of secure enterprise workflow management applications and related ad
2011 250,00$

Matrix I.T. Ltd. (MTRX) - Financial and Strategic SWOT Analysis Review

Matrix I.T. Ltd. (Matrix I.T) is a medical device company engaged in the design and distribution of information technology (IT) se
2011 125,00$

Advanced Micronic Devices Limited (517552) - Financial and Strategic SWOT Analysis Review

Advanced Micronic Devices Limited (AMDL) is engaged in the development, manufacture and marketing of the healthcare products. The
2011 250,00$

Elk Corporation (9833) - Financial and Strategic SWOT Analysis Review

Elk Corporation (Elk) is a medical device company engaged in offering autoclaves, bone densitometers, X-ray protective aprons, X-r
2011 250,00$

Hogy Medical Co., Ltd. (3593) - Financial and Strategic SWOT Analysis Review

Hogy Medical Co., Ltd. (Hogy) is a medical device manufacturing company, which operates through a single wholly-owned subsidiary;
2011 125,00$

CustomVis Plc (CUS) - Financial and Strategic SWOT Analysis Review

CustomVis Plc (CustomVis) is a medical technology company. It is engaged in the research, design, development, manufacture and sal
2011 125,00$

HTL-STREFA S.A. (HTL) - Financial and Strategic SWOT Analysis Review

HTL-STREFA S.A (HTL) is engaged in the development, manufacture and marketing of medical disposable products for the healthcare ma
2011 250,00$

Japan Lifeline Co., Ltd. (7575) - Financial and Strategic SWOT Analysis Review

Japan Lifeline Co., Ltd. (Japan Lifeline) is a medical device distributor engaged in providing cardiovascular devices. Japan Lifel
2011 125,00$

Kawamoto Corporation (3604) - Financial and Strategic SWOT Analysis Review

Kawamoto Corporation (Kawamoto) is a Japan based company principally engaged in the development, manufacture, marketing and sale o
2011 125,00$

Mochida Pharmaceutical Co., Ltd. (4534) - Financial and Strategic SWOT Analysis Review

Mochida Pharmaceutical Co., Ltd (Mochida) is a Japan- based healthcare company. The company principally manufactures and sells pha
2011 125,00$

Noritake Co., Limited (5331) - Financial and Strategic SWOT Analysis Review

Noritake Co., Limited (Noritake) is a medical device company engaged in manufacture and distribution of medical devices for the de
2011 250,00$

Response Biomedical Corporation (RBM) - Financial and Strategic SWOT Analysis Review

Response Biomedical Corporation (Response Biomedical) is a Canadian company, which is engaged in the research, development, manufa
2011 125,00$

IVAX Diagnostics, Inc. (IVD) - Financial and Strategic SWOT Analysis Review

IVAX Diagnostics, Inc. (IVAX), is a medical device company engaged in develops, manufactures and markets diagnostic test kits, or
2011 250,00$

Vitrolife AB (VITR) - Financial and Strategic SWOT Analysis Review

Vitrolife AB (Vitrolife) is a public limited company, which is engaged in the development, production and sale of superior quality
2011 125,00$

EnteroMedics Inc. (ETRM) - Financial and Strategic SWOT Analysis Review

EnteroMedics Inc. (Enteromedics) is a medical device company. It is engaged in the design and development of medical devices for t
2011 250,00$

Shandong Weigao Group Medical Polymer Company Limited (8199) - Financial and Strategic SWOT Analysis Review

Shandong Weigao Group Medical Polymer Co.,Ltd. ( Weigao) is principally engaged in the research and development, production and sa
2011 125,00$

Ahlstrom Corporation (AHL1V) - Financial and Strategic SWOT Analysis Review

Ahlstrom Corporation (Ahlstrom) is one of the leading companies in Finland fiber industry. The company, along with its subsidiarie
2011 125,00$

Medi-Stim ASA (MEDI) - Financial and Strategic SWOT Analysis Review

Medi-Stim ASA (Medi-Stim) is a medical device company principally engaged in the development, manufacture, distribution and sale o
2011 125,00$

Pacific Hospital Supply Co., Ltd. (4126) - Financial and Strategic SWOT Analysis Review

Pacific Hospital Supply Co., Ltd. (PAHSCO) is a medical equipment manufacturer. It is engaged in the manufacture, processing and s
2011 125,00$

Quick-Med Technologies, Inc. (QMDT) - Financial and Strategic SWOT Analysis Review

Quick-Med Technologies, Inc. (Quick-Med) is a publicly traded life sciences company, which is engaged in the research, development
2011 125,00$

PuriCore plc (PURI) - Financial and Strategic SWOT Analysis Review

PuriCore plc (PuriCore) is a medical device company principally engaged in the research, development, marketing and sale of propri
2011 125,00$

Imaging3, Inc. (IMGG) - Financial and Strategic SWOT Analysis Review

Imaging3, Inc. (Imaging3) is a medical device company, based in the US. The company is engaged in manufacturing medical imaging de
2011 250,00$

BioPorto Diagnostics A/S (BIOPOR) - Financial and Strategic SWOT Analysis Review

BioPorto Diagnostics A/S (BioPorto Diagnostics) is a biotechnology company engaged in developing and marketing antibodies and anti
2011 250,00$

DiaGenic ASA (DIAG) - Financial and Strategic SWOT Analysis Review

DiaGenic ASA (DiaGenic) is a life sciences company, primarily engaged in research, development and sale of modern and user friendl
2011 125,00$

Nyer Medical Group, Inc. (NYER) - Financial and Strategic SWOT Analysis Review

Nyer Medical Group, Inc. (Nyer Medical Group) is engaged in the development of medical supplies for the healthcare markets. It ope
2011 250,00$

SPO Medical Inc. (SPOM) - Financial and Strategic SWOT Analysis Review

SPO Medical Inc. (SPO Medical) is a medical device company, engaged in the development and marketing of the non-invasive monitorin
2011 250,00$

Power3 Medical Products, Inc. (PWRM) - Financial and Strategic SWOT Analysis Review

Power3 Medical Products, Inc. (Power3 Medical) is a biotechnology company engaged in the detection, monitoring, and targeting of d
2011 125,00$

Optiscan Imaging Limited (OIL) - Financial and Strategic SWOT Analysis Review

Optiscan Imaging Limited (Optiscan Imaging) is a medical device company, which is engaged in the development, manufacture and sale
2011 250,00$

Zecotek Photonics Inc. (ZMS) - Financial and Strategic SWOT Analysis Review

Zecotek Photonics Inc. (Zecotek Photonics) is a photonics technology company, engaged in development and sales of advanced technol
2011 125,00$

InfoLogix, Inc. (IFLG) - Financial and Strategic SWOT Analysis Review

InfoLogix, Inc. (InfoLogix) is a mobility solution company, engaged in the development, sales and marketing of mobile intelligence
2011 125,00$

Ceragenix Pharmaceuticals, Inc. (CGXP) - Financial and Strategic SWOT Analysis Review

Ceragenix Pharmaceuticals, Inc. (Ceragenix) is a medical device company engaged in discovery, development and commercialization of
2011 250,00$

Exiqon A/S (EXQ) - Financial and Strategic SWOT Analysis Review

Exiqon A/S (Exiqon) is a biotechnology company principally engaged in the development, manufacture and distribution of products fo
2011 125,00$

Rosetta Genomics, Ltd. (ROSG) - Financial and Strategic SWOT Analysis Review

Rosetta Genomics, Ltd. (RGL) is a medical device company engaged in the development and commercialization of new diagnostic and th
2011 250,00$

Eizo Nanao Corporation (6737) - Financial and Strategic SWOT Analysis Review

Eizo Nanao Corporation (Eizo) is engaged in the design, development, manufacture and marketing of monitors and peripherals, amusem
2011 250,00$

QuantRx Biomedical Corporation (QTXB) - Financial and Strategic SWOT Analysis Review

QuantRx Biomedical Corporation (QuantRx Biomedical) is a medical device company engaged in the development of products for advance
2011 250,00$

BioView Ltd. (BIOV) - Financial and Strategic SWOT Analysis Review

BioView Ltd. (BioView) is a medical diagnostics company, based in Israel. The company is engaged in development, manufacturing, ma
2011 250,00$

Response Genetics, Inc. (RGDX) - Financial and Strategic SWOT Analysis Review

Response Genetics, Inc. (RGI) is engaged in the research and development of pharmacogenomic cancer diagnostic tests. The company u
2011 250,00$

HealthLinx Limited (HTX) - Financial and Strategic SWOT Analysis Review

HealthLinx Limited (HealthLinx) is a developing biomarker and diagnostic company with an integrated platform in biomarker and bioa
2011 125,00$

Avacta Group PLC (AVCT) - Financial and Strategic SWOT Analysis Review

Avacta Group PLC (Avacta) is a biophysics company specializing in solving high value problems. It was formed in 2004, as a spin-ou
2011 250,00$

Medical International Technology, Inc. (MDLH) - Financial and Strategic SWOT Analysis Review

Medical International Technology Inc. (MIT) is a Canada based medical devices company. It is specialized in the research, developm
2011 250,00$

DVx, Inc. (3079) - Financial and Strategic SWOT Analysis Review

DVx Inc. (DVx) is a medical device company, which is engaged in the development and marketing of medical devices for the cardiovas
2011 250,00$

Nephros, Inc. (NEPH) - Financial and Strategic SWOT Analysis Review

Nephros, Inc. (Nephros) is US-based medical device company, engaged in developing and marketing of filtration products for therape
2011 250,00$

Scivanta Medical Corporation (SCVM) - Financial and Strategic SWOT Analysis Review

Scivanta Medical Corporation (Scivanta Medical) formerlly known as Medi-Hut Co. is a medical device company, focuses on the acquis
2011 125,00$

Moria SA (MLMOR) - Financial and Strategic SWOT Analysis Review

Moria SA (Moria) is a medical device company engaged in designing, manufacturing and marketing of instruments and equipment for op
2011 250,00$

Eiken Chemical Co.,Ltd. (4549) - Financial and Strategic SWOT Analysis Review

Eiken Chemical Co., Ltd (Eiken Chemical) is a diagnostic company engaged in the development, manufacture and distribution of clini
2011 250,00$

Accelerator Nordic AB (ACCE B) - Financial and Strategic SWOT Analysis Review

Accelerator Nordic AB (Accelerator) is a group of Life Science companies, focuses on pharmaceutical drug development and medical
2011 125,00$

Advanced Integrated Manufacturing Corp. Ltd (A54) - Financial and Strategic SWOT Analysis Review

Advanced Integrated Manufacturing Corp. Ltd. (AIM) is a Singapore based company. It is a holding company of an integrated group of
2011 125,00$

Arkimedica S.P.A (AKM) - Financial and Strategic SWOT Analysis Review

Arkimedica S.P.A (Arkimedica) is a medical device company, engaged in the manufacture and distribution of medical products, hospit
2011 125,00$

Beijing Aerospace Changfeng Co., Ltd (600855) - Financial and Strategic SWOT Analysis Review

Beijing Aerospace Changfeng Co. Ltd. (Aerospace Changfeng) is a medical device company principally engaged in the development, man
2011 250,00$

Biospace Co.,Ltd. (041830) - Financial and Strategic SWOT Analysis Review

Biospace Co., Ltd. (Biospace) is a medical device company engaged in providing body composition analyzers for the healthcare marke
2011 250,00$

Cogstate Limited (CGS) - Financial and Strategic SWOT Analysis Review

CogState Limited (CogState) is engaged in providing cognitive testing products and services. The company operates its business in
2011 250,00$

Create Medic Co., Ltd. (5187) - Financial and Strategic SWOT Analysis Review

Create Medic Co., Ltd. (CMCL) is a medical equipment company which is engaged in the production and distribution of medical equipm
2011 250,00$

Diagnostic Medical Systems (DGM) - Financial and Strategic SWOT Analysis Review

Diagnostic Medical Systems (DMS) is a medical device company, engaged in designing, manufacturing and distribution of imaging syst
2011 250,00$

Eastland Medical Systems Limited (EMS) - Financial and Strategic SWOT Analysis Review

Eastland Medical Systems Ltd (Eastland Medical) is a health care company engaged in the research, development and manufacture of p
2011 125,00$

elexxion AG (E8X) - Financial and Strategic SWOT Analysis Review

elexxion AG (elexxion) is engaged in the design, manufacture and distribution of dental laser systems. The company uses latest and
2011 250,00$

EXCELSIOR MEDICAL CO.,LTD (4104) - Financial and Strategic SWOT Analysis Review

EXCELSIOR MEDICAL CO.,LTD (Excelsior) formerly Enfield Medical Co., Ltd., is a medical device company engaged in the distribution
2011 250,00$

Etropal Ad (5EO) - Financial and Strategic SWOT Analysis Review

Etropal Ad (Etropal) is a medical device company based in Bulgaria. It specializes in the scientific research, experimental and de
2011 250,00$

Geratherm Medical AG (GME) - Financial and Strategic SWOT Analysis Review

Geratherm Medical AG (Geratherm) is an internationally aligned medical technology company, which is engaged in the manufacturing a
2011 250,00$

Golden Meditech Holdings Limited (0801) - Financial and Strategic SWOT Analysis Review

Golden Meditech Holdings Limited (Golden Meditech), formerly Golden Meditech Company Limited is a leading integrated medical devic
2011 250,00$

Hamilton Thorne Ltd. (HTL) - Financial and Strategic SWOT Analysis Review

Hamilton Thorne Ltd. (Hamilton Thorne) is a provider of advanced laser systems and instruments. The company is engaged in the prov
2011 250,00$

Health & Life Co., Ltd. (1781) - Financial and Strategic SWOT Analysis Review

Health & Life Co., Ltd. (H&L) is a medical device company that is engaged in the manufacture and marketing of medical equipments f
2011 125,00$

Hi-Clearance Inc. (1788) - Financial and Strategic SWOT Analysis Review

Hi-Clearance Inc. (HCI) is a medical device company engaged in providing medical apparatus and medical materials for the nephrolog
2011 250,00$

Infopia Co., Ltd. (036220) - Financial and Strategic SWOT Analysis Review

Infopia Co., Ltd. (Infopia) is engaged in the design, development and distribution of high performance blood glucose monitoring sy
2011 250,00$

Medigard Limited (MGZ) - Financial and Strategic SWOT Analysis Review

Medigard Limited (Medigard) is engaged in the design, development and marketing of safety engineered medical devices for the healt
2011 250,00$

Medivac Limited (MDV) - Financial and Strategic SWOT Analysis Review

MediVac Limited (MediVac), formerly Nautilis Australia is a biomedical waste management company engaged in offering healthcare sol
2011 250,00$

Microlife Corporation (4103) - Financial and Strategic SWOT Analysis Review

Microlife Corporation (Microlife) is a medical equipment company, it designs, develops, manufactures and distributes medical diag
2011 125,00$

Palomar Medical Technologies, Inc. (PMTI) - Financial and Strategic SWOT Analysis Review

Palomar Medical Technologies, Inc. (PMTI) is engaged in the research and development of advanced laser and light based systems for
2011 250,00$

Precision System Science Co., Ltd. (7707) - Financial and Strategic SWOT Analysis Review

Precision System Science Co., Ltd. (PSS) is engaged in the biotechnology related business. The company is engaged in the developme
2011 250,00$

Radiant Innovation Inc. (3373) - Financial and Strategic SWOT Analysis Review

Radiant Innovation Inc. (Radiant) is a medical device company engaged in the design and development of Infrared technology product
2011 250,00$

Sonomax Technologies Inc (SHH) - Financial and Strategic SWOT Analysis Review

Sonomax Technologies Inc (Sonomax) is a medical device company engaged in the research, development and manufacturing of intra-ear
2011 250,00$

STRATEC Biomedical Systems AG (SBS) - Financial and Strategic SWOT Analysis Review

STRATEC Biomedical Systems AG (STRATEC Biomedical Systems) is a medical device company. It is principally engaged in the design, d
2011 250,00$

Morepen Laboratories Limited (MOREPENLAB) - Financial and Strategic SWOT Analysis Review

Morepen Laboratories Limited (Morepen Laboratories) is a publically held company based in India. The company is primarily engaged
2011 250,00$

Luna Innovations Incorporated (LUNA) - Financial and Strategic SWOT Analysis Review

Luna Innovations Incorporated (Luna Innovations) is engaged in the research, development and commercialization of new-generation p
2011 250,00$

NewCardio, Inc. (NWCI) - Financial and Strategic SWOT Analysis Review

NewCardio, Inc. (NewCardio) is a medical technology company. It is primarily engaged in design, development and commercializing a
2011 250,00$

Remedent, Inc. (REMI) - Financial and Strategic SWOT Analysis Review

Remedent, Inc. (Remedent), formerly Remedent USA, Inc. is a company that provides solutions for dentistry. It is principally engag
2011 250,00$

HARBIN PHARMACEUTICAL GROUP CO., LTD. (600664) - Financial and Strategic SWOT Analysis Review

HARBIN PHARMACEUTICAL GROUP CO., LTD. (Harbin Pharmaceutical Group) is a healthcare company engaged in the research, development a
2011 250,00$

ProUroCare Medical Inc. (PUMD) - Financial and Strategic SWOT Analysis Review

ProUroCare Medical, Inc. (ProUroCare) is a medical device company. The company is engaged in developing diagnostic and imaging tec
2011 250,00$

Opto Circuits India Limited (OPTOCIRCUI) - Financial and Strategic SWOT Analysis Review

Opto Circuits India Limited (OCI) is a India-based technology company engaged in the design, development, manufacturing, marketing
2011 125,00$

Tyson Bioresearch, Inc. (4134) - Financial and Strategic SWOT Analysis Review

Tyson Bioresearch, Inc., (Tyson) is an innovative medical diagnostic manufacturing company, principally engaged in manufacturing a
2011 250,00$

Vatech Co., Ltd. (043150) - Financial and Strategic SWOT Analysis Review

Vatech Co., Ltd. (Vatech) is a medical equipment company. It is engaged in research and development of novel technologies in the f
2011 250,00$

Bio-Light - Israeli Life Sciences Investments Ltd. (BOLT) - Financial and Strategic SWOT Analysis Review

Bio-Light - Israeli Life Sciences Investments Ltd. (Bio-Light) is engaged in the development of life science technology. The produ
2011 250,00$

IPSOGEN SA (ALIPS) - Financial and Strategic SWOT Analysis Review

IPSOGEN SA (Ipsogen) is an immunodiagnostic company engaged in designing, manufacturing and distributing of molecular diagnostic t
2011 250,00$

Patni Computer Systems Ltd. (PATNI) - Financial and Strategic SWOT Analysis Review

Patni Computer Systems Ltd. (Patni) is an Indian based IT consulting and software services provider that is principally engaged in
2011 125,00$

IDEX Corporation (IEX) - Financial and Strategic SWOT Analysis Review

IDEX Corporation (IDEX) is engaged in design and distributing of fluid and metering technologies systems for fluid-handling applic
2011 250,00$

MedX Health Corp. (MDX) - Financial and Strategic SWOT Analysis Review

MedX Health Corp. (MedX) is a medical device company engaged in designing, manufacturing and distributing of low level laser and l
2011 250,00$

GeneNews Limited (GEN) - Financial and Strategic SWOT Analysis Review

GeneNews Limited (GeneNews) is a Canada based molecular diagnostics company. Through its subsidiaries, it is principally engaged i
2011 250,00$

Competitive Technologies, Inc. (CTT) - Financial and Strategic SWOT Analysis Review

Competitive Technologies, Inc., (CTT) is engaged in identifying, developing, and commercializing innovative products technologies
2011 250,00$

Occupational & Medical Innovations Limited (OMI) - Financial and Strategic SWOT Analysis Review

Occupational & Medical Innovations Limited (OMI) is a medical device company, based in Australia. The company is principally engag
2011 250,00$

TTK Healthcare Limited (TTKHEALTH) - Financial and Strategic SWOT Analysis Review

TTK Healthcare Limited (TTK Healthcare) is an Indian-based company engaged in providing innovative pharmaceutical and consumer sol
2011 250,00$

AMERIGROUP Corporation (AGP) - Financial and Strategic SWOT Analysis Review

AMERIGROUP Corporation (AMERIGROUP) is a multi-state managed healthcare company. The company principally concentrates on serving p
2011 125,00$

SafeStitch Medical, Inc. (SFES) - Financial and Strategic SWOT Analysis Review

SafeStitch Medical, Inc. (SafeStitch) formerly known as Cellular Technical Services Company, Inc., a shell company, is a developme
2011 250,00$

Vision Eye Institute Limited (VEI) - Financial and Strategic SWOT Analysis Review

Vision Group Holdings Limited (Vision Group) is engaged in providing ophthalmic care services. The company operates 29 dedicated o
2011 250,00$

Tiger X Medical, Inc. (CDOM) - Financial and Strategic SWOT Analysis Review

Tiger X Medical, Inc. (Tiger X) formerly Cardo Medical, Inc., is an development-stage orthopedic medical device company. It engage
2011 250,00$

Daiken Medical Co., Ltd. (7775) - Financial and Strategic SWOT Analysis Review

Daiken Medical Co., Ltd. (Daiken Medical) is a medical equipment company. It is engaged in the manufacturing and distribution of m
2011 250,00$

Kelyniam Global, Inc. (KLYG) - Financial and Strategic SWOT Analysis Review

Kelyniam Global, Inc (Kelyniam) is an engineering consulting services company. The company is engaged in providing services in the
2011 250,00$

Human Care HC AB (HUMA) - Financial and Strategic SWOT Analysis Review

Human Care HC AB (Human Care) is a medical device company engaged in the manufacture and marketing of medical aid devices for the
2011 250,00$

INVO Bioscience, Inc. (IVOB) - Financial and Strategic SWOT Analysis Review

INVO Bioscience, Inc. (INVO) is a US based medical device company. The company was formerly known as Bio X Cell, Inc. Moreover, it
2011 250,00$

MabCure Inc. (MBCI) - Financial and Strategic SWOT Analysis Review

MabCure Inc. (MabCure), formerly Smartec Holdings Inc. is a development stage medical device company engaged in the development of
2011 250,00$

Qatari German Company for Medical Devices (QGMD) - Financial and Strategic SWOT Analysis Review

Qatari German Company for Medical Devices (QGMD) is a medical device company engaged in the manufacturing and distribution of medi
2011 250,00$

Gerresheimer AG (GXI) - Financial and Strategic SWOT Analysis Review

Gerresheimer AG (Gerresheimer) is a publicly held Germany-based company engaged in manufacture and supply of specialty glass and p
2011 250,00$

BioMedical Technology Solutions Holdings, Inc. (BMTL) - Financial and Strategic SWOT Analysis Review

BioMedical Technology Solutions Holdings, Inc. (Biomedical) is principally engaged in providing economic and environment friendly
2011 250,00$

Arcam AB (ARCM) - Financial and Strategic SWOT Analysis Review

Arcam AB (Arcam) is engaged in providing machines for direct manufacturing of fully dense parts from metal powder by utilizing its
2011 250,00$

Elder Pharmaceuticals Ltd. (ELDERPHARM) - Financial and Strategic SWOT Analysis Review

Elder Pharmaceuticals Ltd. (Elder) is a publically held company based in India. The company is primarily engaged in the manufactur
2011 250,00$

Harvard Bioscience, Inc. (HBIO) - Financial and Strategic SWOT Analysis Review

Harvard Bioscience, Inc. (HBIO) is engaged in development, manufacture and distributing apparatus and scientific instruments. The
2011 250,00$

SXC Health Solutions Corp. (SXC) - Financial and Strategic SWOT Analysis Review

SXC Health Solutions Corp. (SXC) is a leading provider of pharmacy benefit management services and healthcare information technolo
2011 125,00$

Ceradyne, Inc. (CRDN) - Financial and Strategic SWOT Analysis Review

Ceradyne, Inc. (Ceradyne) is an integrated developer and manufacturer of advanced technical ceramic products and components for us
2011 125,00$

PAION AG (PA8) - Financial and Strategic SWOT Analysis Review

PAION AG (PAION) is a biopharmaceutical holding company. It develops and commercializes drugs for the hospital-based treatment of
2011 250,00$

Medy-Tox Inc. (086900) - Financial and Strategic SWOT Analysis Review

Medy-tox Inc. (Medy-tox) is a privately-held biopharmaceutical manufacturing company. The company is principally engaged in the re
2011 250,00$

Transcu Group Limited (E15) - Financial and Strategic SWOT Analysis Review

Transcu Group Limited (TGL) is a life sciences company that is engaged in the research, development and commercialization of trans
2011 250,00$

Visiodent SA (SDT) - Financial and Strategic SWOT Analysis Review

Visiodent SA (Visiodent) is a medical technology company that specializes in the development and marketing of software solutions f
2011 125,00$

CDEX, Inc. (CEXI) - Financial and Strategic SWOT Analysis Review

CDEX, Inc. (CDEX) is a technology development company. It is engaged in applying its patented and patents pending chemical detecti
2011 250,00$

Da An Gene Co., Ltd. (002030) - Financial and Strategic SWOT Analysis Review

Da An Gene Co., Ltd. (Da An Gene) is a medical company engaged in the research, development, manufacture and marketing of biomedic
2011 250,00$

Jiangsu Yuyue Medical Equipment Inc. (002223) - Financial and Strategic SWOT Analysis Review

Jiangsu Yuyue Medical Equipment Inc. (Jiangsu Yuyue Medical) is a medical equipment manufacturing company principally engaged in t
2011 250,00$

Shinva Medical Instrument Co., Ltd. (600587) - Financial and Strategic SWOT Analysis Review

Shinva Medical Instrument Co., Ltd. (Shinva Medical) is a medical device company engaged in the manufacture and marketing of medic
2011 250,00$

Huiheng Medical, Inc. (HHGM) - Financial and Strategic SWOT Analysis Review

Huiheng Medical, Inc. (Huiheng Medical) is engaged in the design, development, manufacture and marketing of radiation therapy syst
2011 250,00$

Elegance International Holdings Ltd (0907) - Financial and Strategic SWOT Analysis Review

Elegance International Holdings Ltd (Elegance International) is a medical device company engaged in the design, manufacture and sa
2011 250,00$

Medidata Solutions, Inc. (MDSO) - Financial and Strategic SWOT Analysis Review

Medidata Solutions, Inc. (Medidata) is a global provider of software as a service based clincal technology solutions. It provides
2011 250,00$

Sirtex Medical Limited (SRX) - Financial and Strategic SWOT Analysis Review

Sirtex Medical Limited (Sirtex), a biotechnology and medical device company is engaged in the developing, manufacturing and market
2011 250,00$

KM Corporation (083550) - Financial and Strategic SWOT Analysis Review

KM Corporation (KM) is a health care company, offering medical equipments. The company is specialized in equipment for clean rooms
2011 250,00$

Ergoresearch Ltd. (ERG) - Financial and Strategic SWOT Analysis Review

Ergoresearch Ltd. (Ergoresearch) is a Canada-based company that specializes in research and alleviating foot pain. The company, th
2011 250,00$

Streamline Health Solutions, Inc. (STRM) - Financial and Strategic SWOT Analysis Review

Streamline Health Solutions, Inc. (Streamline) is a provider of workflow and document management tools, applications and services
2011 250,00$

Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review

Nolato AB (Nolato) is a pharmaceutical company, principally engaged in the development and manufacture of polymer components and p
2011 250,00$

Hamai Industries Ltd. (6497) - Financial and Strategic SWOT Analysis Review

Hamai Industries Ltd. (Hamai) is a Japan based company. It is engaged in manufacture and marketing of precision machine equipment,
2011 250,00$

OmniComm Systems, Inc. (OMCM) - Financial and Strategic SWOT Analysis Review

OmniComm Systems, Inc., (OmniComm) is a healthcare service provider company, based in the US. The company is engaged in providing
2011 125,00$

Flexpoint Sensor Systems, Inc. (FLXT) - Financial and Strategic SWOT Analysis Review

Flexpoint Sensor Systems, Inc. (FLXT) is the US based thin film sensing technology supplying company. It is engaged in supplying t
2011 250,00$

D. Medical Industries Limited (DMDC) - Financial and Strategic SWOT Analysis Review

D. Medical Industries Limited (D. Medical) is a medical devices holding company operating through its subsidiaries in the product
2011 250,00$

Craneware plc (CRW) - Financial and Strategic SWOT Analysis Review

Craneware plc is a supplier of business intelligence and revenue cycle software that provides clients with chargemaster management
2011 125,00$

VentriPoint Diagnostics Ltd. (VPT) - Financial and Strategic SWOT Analysis Review

VentriPoint Diagnostics, Ltd. (Ventripoint) is a medical device company engaged in the development of diagnostic tools to monitor
2011 250,00$

GEOMC Co., Ltd. (033030) - Financial and Strategic SWOT Analysis Review

GEOMC Co, Ltd. (GEOMC) is engaged in manufacturing and marketing technology devices. The company is formerly known as Daeyang E&C,
2011 250,00$

Wound Management Technologies, Inc. (WNDM) - Financial and Strategic SWOT Analysis Review

Wound Management Technologies, Inc. (WMT) is a medical device company, engaged in marketing and distributing products for the woun
2011 250,00$

Bioland co., Ltd (052260) - Financial and Strategic SWOT Analysis Review

Bioland co., Ltd (Bioland) is a privately held company engaged in providing natural products, tissue engineering solutions and dia
2011 250,00$

Medtronic CryoCath, LP. - Strategic SWOT Analysis Review

Medtronic CryoCath, LP. (Medtronic CryoCath), formerly CryoCath Technologies Inc. is a medical device company engaged in developin
2011 125,00$

Alertis Medical AS - Strategic SWOT Analysis Review

Alertis Medical AS (Alertis) is a Norwegian specialty medical devices company, engaged in the development of new technologies for
2011 125,00$

Blood Cell Storage, Inc. - Strategic SWOT Analysis Review

Blood Cell Storage, Inc. (BCS) is a Netherland-based medical device company. It engages in the development and manufacturing of pr
2011 125,00$

MicroMed Cardiovascular, Inc. (MMCO) - Strategic SWOT Analysis Review

MicroMed Cardiovascular ( MicroMed ) is a medical device company engaged in development of medical products for the cardiovascular
2011 250,00$

Miraculins Inc. (MOM) - Strategic SWOT Analysis Review

Miraculins Inc (Miraculins) is a research and development company engaged in the discovery and validation of cancer biomarkers, wh
2011 250,00$

Spacelabs Healthcare, Inc. - Strategic SWOT Analysis Review

Spacelabs Healthcare, Inc. (Spacelabs Healthcare) is a medical device company engaged in the development, manufacturing and sellin
2011 125,00$

CIBA Vision Corporation - Strategic SWOT Analysis Review

CIBA Vision Corporation (CIBA) is an ophthalmic device company engaged in the research, development and manufacturing of optical p
2011 125,00$

Planmeca Oy - Strategic SWOT Analysis Review

Planmeca Oy (Planmeca) is a medical device company engaged in the design, manufacturing and marketing of high-tech dental equipmen
2011 125,00$

AMG Medical Inc. - Strategic SWOT Analysis Review

AMG Medical Inc. (AMG), formerly AMG Sales Agency Inc. is a medical device company engaged in the development, manufacture and dis
2011 125,00$

CooperVision, Inc. - Strategic SWOT Analysis Review

CooperVision, Inc. (CVI) is a medical device company principally engaged in the development, manufacturing and marketing of contac
2011 125,00$

Johnson & Johnson Vision Care, Inc. - Strategic SWOT Analysis Review

Johnson & Johnson Vision Care, Inc. (J&J Vision Care) is a opthalmic device company principally engaged in the design and manufact
2011 125,00$

GE Measurement & Control Solutions - Strategic SWOT Analysis Review

GE Measurement & Control Solutions is a technology instruments company, engaged in the design, manufacture and sale of the advance
2011 125,00$

Glidewell Dental Laboratories - Strategic SWOT Analysis Review

Glidewell Dental Laboratories (Glidewell) is a dental company principally engaged in the development, manufacturing and marketing
2011 125,00$

Sunrise Medical, Inc. - Strategic SWOT Analysis Review

Sunrise Medical, Inc. (Sunrise Medical) is a medical device company principally engaged in the design, manufacture, distribution a
2011 125,00$

DeRoyal Industries, Inc. - Strategic SWOT Analysis Review

DeRoyal Industries, Inc. (DeRoyal) is engaged in the manufacture and distribution of medical products and services for the healthc
2011 125,00$

TORNIER, Inc. - Strategic SWOT Analysis Review

TORNIER, Inc. (Tornier) is a medical device company, principally engaged in the design, development, manufacture and sale of ortho
2011 125,00$

Ventana Medical Systems, Inc. - Strategic SWOT Analysis Review

Ventana Medical Systems, Inc. (Ventana Medical) is engaged in the development, manufacture and marketing of medical diagnostic ins
2011 125,00$

Atritech, Inc. - Strategic SWOT Analysis Review

Atritech, Inc. (Atritech) is a clinical stage medical device company engaged in the development, manufacture and sales of medical
2011 125,00$

Medikro Oy. - Strategic SWOT Analysis Review

Medikro Oy. (Medikro) is a medical equipment manufacturing company. The company is engaged in the development, manufacture and mar
2011 125,00$

KaVo Dental Corporation - Strategic SWOT Analysis Review

KaVo Dental Corporation (KaVo Dental) is a dental equipments manufacturing company, which is engaged in the design, manufacture an
2011 125,00$

A-dec Inc. - Strategic SWOT Analysis Review

A-dec Inc. (A-dec) is a dental equipment manufacturing company engaged in the design, development, production and sales of dental
2011 125,00$

Ortho-Clinical Diagnostics Inc. - Strategic SWOT Analysis Review

Ortho-Clinical Diagnostics, Inc., (Ortho-Clinical) is a subsidiary of Johnson & Johnson company. The company principally engages i
2011 125,00$

Gendex Dental Systems - Strategic SWOT Analysis Review

Gendex Dental Systems (Gendex) is a dental X-ray equipment company engaged in the research and development, manufacture and distri
2011 125,00$

Mennen Medical Ltd. - Strategic SWOT Analysis Review

Mennen Medical Ltd. (Mennen Medical) is a global medical device company principally engaged in the design, development and marketi
2011 125,00$

Hollister Incorporated - Strategic SWOT Analysis Review

Hollister Incorporated (Hollister), formerly JDS Printer Craftsman, Inc. is a specialty medical products company. It is engaged in
2011 125,00$

Microtek Medical Holdings, Inc. - Strategic SWOT Analysis Review

Microtek Medical Holdings, Inc. (Microtek Medical) is involved in the design, manufacture and marketing of a wide range of infecti
2011 125,00$

Esaote North America, Inc. - Strategic SWOT Analysis Review

Esaote North America, Inc. (Esaote NA) formerlly Biosound Esaote, Inc., is a medical device company engaged in developing advanced
2011 125,00$

Excel-Tech Ltd. - Strategic SWOT Analysis Review

Excel-Tech Ltd. is a medical technology company that designs, develops and sells proprietary medical devices, based in Canada. The
2011 250,00$

Inovise Medical, Inc. - Strategic SWOT Analysis Review

Inovise Medical, Inc. (Inovise Medical) is a cardiac diagnostic medical technology company engaged in the development of portable
2011 125,00$

ADInstruments Pty Ltd - Strategic SWOT Analysis Review

ADInstruments Pty Ltd (ADI) is a medical equipment company, provides computer-based data acquisition and analysis systems for life
2011 125,00$

ALung Technologies, Inc. - Strategic SWOT Analysis Review

ALung Technologies, Inc. (ALung) is an US-based company. It is a pioneer in the development of respiratory assist technologies whi
2011 125,00$

Amedica Corporation - Strategic SWOT Analysis Review

Amedica Corporation (Amedica) is a medical device company, operates as a orthopedic implant and spine company, engaged in the deve
2011 125,00$

LifeWatch Corp. - Strategic SWOT Analysis Review

LifeWatch Corp. (LWC) is an ambulatory health monitoring solutions provider principally engaged in the development, marketing and
2011 125,00$

Integra Spine - Strategic SWOT Analysis Review

Integra Spine formerly Theken Spine, LLC is a medical device company engaged in the design, development, manufacture and sale of s
2011 125,00$

IMPAC Medical Systems, Inc. - Strategic SWOT Analysis Review

IMPAC Medical Systems, Inc. (IMPAC) is engaged in providing oncology charting, practice management, clinical laboratory, anatomic
2011 125,00$

Mercury Medical, Inc. - Strategic SWOT Analysis Review

Mercury Medical, Inc. (Mercury Medical) is a privately-held medical device company, engaged in the development, manufacture and ma
2011 125,00$

American Diagnostic Corporation - Strategic SWOT Analysis Review

American Diagnostic Corporation (ADC), a medical device company, is engaged in the development, manufacturing and marketing of dia
2011 125,00$

Advanced Bionics, LLC - Strategic SWOT Analysis Review

Advanced Bionics, LLC (Advanced Bionics) is engaged in the development, manufacture and marketing of bionic technologies and impla
2011 125,00$

Showa Best Glove, Inc. - Strategic SWOT Analysis Review

Showa Best Glove, Inc (Showa Best) is engaged in the design, development, manufacture and marketing of hand protection for industr
2011 125,00$

ViOptix Inc. - Strategic SWOT Analysis Review

ViOptix Inc. (ViOptix) is engaged in the design, development, manufacture and marketing of non-invasive local tissue oxygen measur
2011 125,00$

Universal Medical Technologies Inc. - Strategic SWOT Analysis Review

Universal Medical Technologies Inc., (Universal Medical) is engaged in the design, manufacture and development of intravenous (IV)
2011 125,00$

Kibow Biotech Inc. - Strategic SWOT Analysis Review

Kibow Biotech Inc. (Kibow) is a biotechnology company. It engages in the development and commercialization of scientifically-formu
2011 125,00$

Alara, Inc. - Strategic SWOT Analysis Review

Alara, Inc. (Alara) is engaged in the design, development, manufacture and marketing of high quality imaging products based on Co
2011 125,00$

ApaTech Limited - Strategic SWOT Analysis Review

ApaTech Limited (ApaTech) is an orthobiologics company, which is engaged in the manufacture and development of synthetic bone graf
2011 125,00$

HydroCision, Inc. - Strategic SWOT Analysis Review

HydroCision, Inc. (HydroCision) is a medical device company engaged in the development, manufacturing and marketing of surgical pr
2011 125,00$

Current Technology Corporation - Strategic SWOT Analysis Review

Current Technology Corporation (CTC) is a medical device company engaged in the development, manufacture and marketing of electrot
2011 250,00$

Fallbrook Engineering, Inc. - Strategic SWOT Analysis Review

Fallbrook Engineering, Inc. (Fallbrook Engineering) is engaged in providing consulting services related to contract product develo
2011 125,00$

InfraReDx, Inc. - Strategic SWOT Analysis Review

InfraReDx, Inc. (InfraReDx) is an US based medical device company. It develops and commercializes imaging technologies for the d
2011 125,00$

Tyco Healthcare/Kendall - Strategic SWOT Analysis Review

Tyco Healthcare/Kendall (Kendall) is a medical device company principally engaged in the manufacture, development, distribution an
2011 125,00$

Nexgen Spine Inc. - Strategic SWOT Analysis Review

Nexgen Spine Inc. (Nexgen) is a privately held medical device company engaged in the design; development and manufacturing of adva
2011 125,00$

Larsen & Toubro Medical Equipment & Systems - Strategic SWOT Analysis Review

Larsen & Toubro Medical Equipment and Systems (L&T Medical), a sub-division of Larsen & Toubro Limited’s Electrical & Electronics
2011 125,00$

Aniara Corporation - Strategic SWOT Analysis Review

Aniara Corporation (Aniara) is an invitro diagnostics company engaged in the manufacture marketing and distribution of screening t
2011 125,00$

Aperio Technologies, Inc. - Strategic SWOT Analysis Review

Aperio Technologies, Inc. (Aperio) is engaged in the design, development, manufacture and sale of systems and services pertaining
2011 125,00$

Applied Spectral Imaging, Ltd. - Strategic SWOT Analysis Review

Applied Spectral Imaging, Ltd. (ASI), is engaged in the design, manufacture and marketing of various healthcare imaging and data m
2011 125,00$

ERBLAN Surgical, Inc. - Strategic SWOT Analysis Review

ERBLAN Surgical, Inc. (ERBLAN Surgical) is engaged in the design, development and commercialization of medical devices and surgica
2011 125,00$

LifeSync Corporation - Strategic SWOT Analysis Review

LifeSync Corporation (LifeSync) is a privately owned medical device company engaged in the development and sale of its flagship pr
2011 125,00$

HD Medical Group Limited - Strategic SWOT Analysis Review

HD Medical Group Limited (HD Medical) is principally engaged in the development of proprietary and patented heart sound technology
2011 125,00$

Sensors for Medicine and Science, Inc. - Strategic SWOT Analysis Review

Sensors for Medicine and Science, Inc. (SMSI), is a medical technology company engaged in the research, development and commercial
2011 125,00$

NsGene A/S - Strategic SWOT Analysis Review

NsGene A/S (NsGene) is a Danish biotech company, engaged in providing biological products for the treatment of neurological diseas
2011 125,00$

NovoSci Corporation - Strategic SWOT Analysis Review

NovoSci Corporation (NovoSci) is a medical device company engaged in the development and manufacture of products that are used by
2011 125,00$

Access Bio, Inc. - Strategic SWOT Analysis Review

Access Bio, Inc. (Access Bio) is a medical technology company. It is engaged in the development, manufacture and marketing of In-V
2011 125,00$

Active Implants Corporation - Strategic SWOT Analysis Review

Active Implants Corporation (AIC) is an orthopedic medical device company engaged in the development of advanced polymer orthopedi
2011 125,00$

Medtrode Inc. - Strategic SWOT Analysis Review

Medtrode Inc. (Medtrode) is a medical device company, engaged in the development of neuromodulation therapy for cognitive and memo
2011 125,00$

Valleylab, Inc. - Strategic SWOT Analysis Review

Valleylab, Inc. (Valleylab) is engaged in the design, manufacture and marketing of electrosurgery systems for the surgical markets
2011 125,00$

Bone Biologics, Inc. - Strategic SWOT Analysis Review

Bone Biologics, Inc. (Bone Biologics) is an US-based biotechnology company. It develops and manufactures bone regeneration techno
2011 125,00$

BoneSupport AB - Strategic SWOT Analysis Review

BoneSupport AB (BoneSupport) is a Swedish medical technology company. It engages in the development of bone substitute products fo
2011 125,00$

Boule Diagnostics International AB - Strategic SWOT Analysis Review

Boule Diagnostics International AB (Boule Diagnostics) is a diagnostic company, engaged in the development and marketing of in pro
2011 125,00$

Dornier MedTech GmbH - Strategic SWOT Analysis Review

Dornier MedTech GmbH (Dornier MedTech) is a privately held medical device company, principally engaged in the development, manufac
2011 125,00$

PENTAX of America, Inc. - Strategic SWOT Analysis Review

PENTAX of America, Inc. (PENTAX) operates in two business divisions, namely, PENTAX Medical Company and PENTAX Imaging Company. It
2011 125,00$

Ethicon Endo-Surgery, Inc. - Strategic SWOT Analysis Review

Ethicon Endo-Surgery, Inc. (EES) is a medical device company engaged in the development and distribution of advanced medical devic
2011 125,00$

Berlin Heart GmbH - Strategic SWOT Analysis Review

Berlin Heart GmbH (Berlin Heart) is engaged in development, manufacture, sale and commercialization of cardiovascular devices. The
2011 125,00$

Kuros Biosurgery AG - Strategic SWOT Analysis Review

Kuros Biosurgery AG (Kuros) is a biomedical company engaged in the development of biomaterial products. It develops a broad range
2011 125,00$

Planmed Oy - Strategic SWOT Analysis Review

Planmed Oy (Planmed) is a Finnish medical equipment manufacturer. The company is engaged in the research and development of novel
2011 125,00$

m2m Imaging Corporation - Strategic SWOT Analysis Review

m2m Imaging Corporation (m2m Imaging) is engaged in the manufacture and development of magnetic resonance imaging (MRI) coils and
2011 125,00$

Oxford Immunotec Limited - Strategic SWOT Analysis Review

Oxford Immunotec Limited (Oxford Immunotec) is an international T cell measurement company engaged in the development and commerci
2011 125,00$

Oxford Biomedical Research, Inc. - Strategic SWOT Analysis Review

Oxford Biomedical Research, Inc. (OBR) is engaged in the development and manufacture of immunoassay products, such as ELISA kits f
2011 125,00$

Optovue, Inc. - Strategic SWOT Analysis Review

Optovue, Inc. (Optovue) is an ophthalmic device company engaged in the development, designing, production, marketing and commercia
2011 125,00$

Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review

Otto Bock HealthCare GmbH (Otto Bock) is a medical device company engaged in the production and distribution of prosthetic and ort
2011 125,00$

FASgen, Inc. - Strategic SWOT Analysis Review

FASgen, Inc. (FASgen) is a medical company principally engaged in the manufacturing and development of new drugs and therapeutic p
2011 125,00$

Finsbury Orthopaedics Limited - Strategic SWOT Analysis Review

Finsbury Orthopedic Limited (Finsbury) is a medical device company, engaged in the design, development, manufacture and supply of
2011 125,00$

TeraRecon, Inc. - Strategic SWOT Analysis Review

TeraRecon, Inc. (TeraRecon) is a provider of technological solutions for professional imaging applications with a focus on medical
2011 125,00$

Hai Kang Life Corporation Limited - Strategic SWOT Analysis Review

Hai Kang Life Corporation Limited (Hai Kang Life) is a biotechnology company engaged in the research, development and manufacture
2011 125,00$

ARKRAY, Inc. - Strategic SWOT Analysis Review

ARKRAY, Inc. (ARKRAY) formerlly known as KDK Corporation is medical equipment company, engaged in the development and manufacture
2011 125,00$

Globus Medical, Inc. - Strategic SWOT Analysis Review

Globus Medical, Inc. (Globus Medical) is a privately-held medical device company, which is principally engaged in the research and
2011 125,00$

Evolved Digital Systems Inc. (EVD) - Strategic SWOT Analysis Review

Evolved Digital Systems Inc. (Evolved Digital) is a healthcare technology solutions company, which specializes in delivering manag
2011 125,00$

Coherex Medical, Inc. - Strategic SWOT Analysis Review

Coherex Medical, Inc. (Coherex) is a medical device company engaged in the development of innovative medical devices for the cardi
2011 125,00$

Deep Breeze Ltd. - Strategic SWOT Analysis Review

Deep Breeze Ltd. (Deep Breeze) is a privately owned medical device company engaged in the development, manufacturing and distribut
2011 125,00$

Hemosystem - Strategic SWOT Analysis Review

Hemosystem is a French based biotechnology company, which is principally engaged in the development of solutions that improves saf
2011 125,00$

Kyungwon Medical Co., Ltd. - Strategic SWOT Analysis Review

Kyungwon Medical Co., Ltd. (Kyungwon Medical) is a medical device company principally engaged in the manufacture and distribution
2011 125,00$

dbMotion Inc. - Strategic SWOT Analysis Review

dbMotion Inc. (dbMotion) is a privately-held healthcare information technology company that provides clinical information integrat
2011 125,00$

Doxa AB - Strategic SWOT Analysis Review

Doxa AB (Doxa) is a dental device company engaged in the manufacture and development of bioceramic dental products. Their products
2011 125,00$

Gene Express, Inc. - Strategic SWOT Analysis Review

Gene Express, Inc. (Gene Express) is principally engaged in the development and marketing of molecular diagnostic products and sta
2011 125,00$

Integrated Sensing Systems, Inc. - Strategic SWOT Analysis Review

Integrated Sensing Systems, Inc. (ISSYS) is engaged in the design, manufacture, development and distribution of microelectromechan
2011 125,00$

Intelligent Medical Devices, Inc. - Strategic SWOT Analysis Review

Intelligent Medical Devices, Inc. (Intelligent Medical) is a molecular diagnostics company, engaged in the design, development and
2011 125,00$

Scanlan International, Inc. - Strategic SWOT Analysis Review

Scanlan International (Scanlan) is a medical device company principally engaged in the design, development, manufacture and distri
2011 125,00$

Boss Instruments, Ltd. - Strategic SWOT Analysis Review

Boss Instruments, Ltd. (Boss Instruments) is a privately-held medical device company engaged in the development, manufacture and m
2011 125,00$

InterGenetics Incorporated - Strategic SWOT Analysis Review

InterGenetics Incorporated (InterGenetics) is a biotechnology company engaged in the development and manufacture of genetic medici
2011 125,00$

MEDICON eG - Strategic SWOT Analysis Review

MEDICON eG (MEDICON) is a medical device company principally engaged in the design, manufacture and distribution of surgical produ
2011 125,00$

ESAOTE S.p.A. - Strategic SWOT Analysis Review

ESAOTE S.p.A. (Esaote) is a medical device company engaged in the manufacturing of the non-invasive diagnostic equipment and syste
2011 125,00$

Bayer MaterialScience AG - Strategic SWOT Analysis Review

Bayer MaterialScience AG (BMS) is a material science company, primarily engaged in the development and production of polymer and p
2011 125,00$

Prosonic Co., Ltd. - Strategic SWOT Analysis Review

Prosonic Co., Ltd. (Prosonic) is a medical equipment company, engaged in providing equipments and accessories manufacturing servic
2011 125,00$

Shofu Dental Corporation (7979) - Strategic SWOT Analysis Review

Shofu Dental Corporation (Shofu) is a medical device company principally engaged in manufacturing of dental materials and equipmen
2011 250,00$

LipoScience, Inc. - Strategic SWOT Analysis Review

LipoSceince, Inc. (LipoScience) is a medical technology company engaged in the research, development and marketing of clinical dia
2011 125,00$

ADVANCE CO., LTD. - Strategic SWOT Analysis Review

ADVANCE CO., LTD. (Advance) is a medical device company, engaged in the development, manufacture, sale and import and export of me
2011 125,00$

Healthnostics, Inc. (HNSS) - Strategic SWOT Analysis Review

Healthnostics, Inc. (Healthnostics) is a medical and biotechnology analytics company which is principally engaged in providing pat
2011 250,00$

iSOFT Group PLC - Strategic SWOT Analysis Review

iSOFT Group plc (iSOFT) is a Healthcare Information Technology company engages in the design, development and marketing of advanc
2011 125,00$

CLINICARE Corporation - Strategic SWOT Analysis Review

CLINICARE Corporation (CLINICARE) is a healthcare IT company, engaged in the development, marketing and providing computerized inf
2011 125,00$

VEPRO AG - Strategic SWOT Analysis Review

VEPRO AG (VEPRO) is healthcare company that is engaged in the development, manufacture and distribution of storage and communicati
2011 125,00$

Healthphone Solutions Limited - Strategic SWOT Analysis Review

Healthphone Solutions Limited (Healthphone Solutions) is a healthcare IT company, which is principally engaged in the development,
2011 125,00$

Spinal Restoration, Inc. - Strategic SWOT Analysis Review

Spinal Restoration, Inc. (Spinal Restoration) is a medical device company principally engaged in the development, manufacture and
2011 125,00$

ATMOS MedizinTechnik GmbH & Co. KG - Strategic SWOT Analysis Review

ATMOS MedizinTechnik GmbH & Co. KG (ATMOS) is a medical devices company that principally specializes in the development and manufa
2011 125,00$

Spine Smith, LP - Strategic SWOT Analysis Review

Spine Smith, LP (SpineSmith) is a medical device company, which is engaged in the design, manufacture and marketing of surgical im
2011 125,00$

BioTex, Inc. - Strategic SWOT Analysis Review

BioTex, Inc. (BioTex) is engaged in the research, development and marketing of novel optical solutions and technologies for medica
2011 125,00$

Focal Corporation - Strategic SWOT Analysis Review

Focal Corporation (Focal) is engaged in the supply of medical products for the healthcare industry to its overseas customers. The
2011 125,00$

Lantis Laser, Inc. (LLSR) - Strategic SWOT Analysis Review

Lantis Laser Inc. (Lantis Laser) is a medical device company, engaged in the development, manufacture and distribution of dental t
2011 250,00$

IDMoS plc - Strategic SWOT Analysis Review

IDMoS plc (IDMoS) is a medical technology company, which is engaged in the development and providing of innovative technologies an
2011 125,00$

SOLOS Endoscopy, Inc. (SNDY) - Strategic SWOT Analysis Review

SOLOS Endoscopy, Inc. (SOLOS) is a medical technology company, engaged in development and marketing of medical devices and technol
2011 250,00$

Leonhard Lang GmbH - Strategic SWOT Analysis Review

Leonhard Lang GmbH (Leonhard) is a privately held medical device company that is engaged in the design, manufacture and distributi
2011 125,00$

Alltracel Pharmaceuticals plc - Strategic SWOT Analysis Review

Alltracel Pharmaceuticals plc (Alltracel) is a medical technology company, which is principally engaged in the manufacture, distri
2011 250,00$

Visicu, Inc. - Strategic SWOT Analysis Review

VISICU, Inc. (VISICU) is a Healthcare Information Technology company principally engaged in the development, marketing and sale of
2011 125,00$

XTend Medical Corporation - Strategic SWOT Analysis Review

XTend Medical Corporation (XTend Medical) is a healthcare IT company, which is engaged in the development, manufacturing and distr
2011 250,00$

Glide Pharmaceutical Technologies Limited - Strategic SWOT Analysis Review

Glide Pharmaceutical Technologies Limited (Glide Pharma) formerly Caretek Medical Ltd. is a specialty pharmaceutical company, whic
2011 125,00$

Aquamatrix, Inc. (AQMT) - Strategic SWOT Analysis Review

Aquamatrix, Inc. (formerly known as Nesco Industries, Inc.) is a medical device company, which is engaged in developing, manufactu
2011 250,00$

Sorin Group USA Inc. - Strategic SWOT Analysis Review

Sorin Group USA, Inc. (Sorin USA) formerly COBE Cardiovascular, Inc. is the US-based company. It develops, manufactures and marke
2011 125,00$

Transasia Bio-Medicals Ltd. - Strategic SWOT Analysis Review

Transasia Bio-Medicals Ltd. (Transasia) is a medical device company, engaged in the designing, manufacturing and distribution of i
2011 125,00$

Teijin Pharma Limited - Strategic SWOT Analysis Review

Teijin Pharma Limited (Teijin Pharma) is engaged in the manufacturing and marketing of pharmaceuticals and medical devices. Teijin
2011 125,00$

Shree Pacetronix Ltd. (527005) - Strategic SWOT Analysis Review

Shree Pacetronix Ltd. (Pacetronix) is a medical device company engaged in the designing, development and manufacturing of quality
2011 250,00$

PulmoBioTech Inc (PLMO) - Strategic SWOT Analysis Review

PulmoBioTech Inc (Pulmo) is engaged in designing, development and distributing of medial technology for diagnostic and research ap
2011 250,00$

SIGVARIS MANAGEMENT AG - Strategic SWOT Analysis Review

SIGVARIS MANAGEMENT AG (SIGVARIS) previously called GANZONI MANAGEMENT AG is part of the medical device manufacturing company, kno
2011 125,00$

OrthoPediatrics Corp. - Strategic SWOT Analysis Review

OrthoPediatrics Corp. (OrthoPediatrics) is a medical device company, engaged in inventing, designing and distributing anatomically
2011 125,00$

OsteoRad, Co., Ltd. - Strategic SWOT Analysis Review

Shan Xiao Rui Biological Material Co., Ltd. (Shan Xiao Rui) which was previously called OsteoRad, Co., Ltd. is a medical device co
2011 125,00$

HoMedics, Inc. - Strategic SWOT Analysis Review

HoMedics, Inc. (HoMedics) is a US-based company, which is engaged in providing health and care services also provides a diverse ra
2011 125,00$

BREG Incorporated - Strategic SWOT Analysis Review

BREG Incorporated (BREG) is a medical device company engaged in the designing, manufacturing and distribution of orthopedic, recon
2011 125,00$

Aspect Imaging - Strategic SWOT Analysis Review

Aspect Imaging (Aspect), formerlly known as Aspect Magnet Technologies Ltd. is a medical device company. It is engaged in designin
2011 125,00$

Biomagnetics Diagnostics Corporation (BMGP) - Strategic SWOT Analysis Review

Biomagnetics Diagnostics Corporation (Biomagnetics Diagnostics) is a medical devices company that is principally engaged in provid
2011 250,00$

Sialo Technology Ltd. (SALO) - Strategic SWOT Analysis Review

Sialo Technology Ltd. (Sialo Technology) is a developer of medical devices for the treatment of temporomandibular joint (TMJ) synd
2011 250,00$

Julius Zorn, Inc. - Strategic SWOT Analysis Review

Julius Zorn, Inc. (Juzo) is a healthcare company engaged in the manufacture of medical compression and support therapy garments. T
2011 125,00$

Bauerfeind USA, Inc. - Strategic SWOT Analysis Review

Bauerfeind USA, Inc. (Bauerfeind USA) is an US-based company manufacturing orthopedic supports and orthoses. The company is a spec
2011 125,00$

Kronos Incorporated - Strategic SWOT Analysis Review

Kronos Incorporated (Kronos) is a privately-held technology company engaged in providing human capital management solutions. The c
2011 125,00$

Unomedical Inc. - Strategic SWOT Analysis Review

Unomedical Inc. (Unomedical), is a medical device company engaged in the manufacture and distribution of single use respiratory an
2011 125,00$

Diagnostic Imaging International Corp. (DIIG) - Strategic SWOT Analysis Review

Diagnostic Imaging International Corp. (DIIC) is a US based medical device company. The company was formerly known as Galloway Inv
2011 250,00$

Xion GmbH - Strategic SWOT Analysis Review

Xion GmbH (Xion) is a German-based privately held medical devices company engaged in the developing, manufacturing and sales of v
2011 125,00$

ChromoCure, Inc. (KKUR) - Strategic SWOT Analysis Review

ChromoCure, Inc.,(ChromoCure) formerly known as Cyberhand Technologies International, Inc., is engaged in developing and providing
2011 250,00$

Allocade, Inc. - Strategic SWOT Analysis Review

Allocade, Inc. (Allocade) is a privately owned software technology company, which focuses on the development and marketing of capa
2011 125,00$

InStar Systems International, LLC - Strategic SWOT Analysis Review

InStar Systems International, LLC (InStar Systems) is a privately-held company, which is engaged in providing a wide range of radi
2011 125,00$

eClinicalWorks, LLC - Strategic SWOT Analysis Review

eClinicalWorks, LLC (eClinicalWorks) is a US-based privately-held healthcare IT company. The company is engaged in providing the t
2011 125,00$

Materialise NV - Strategic SWOT Analysis Review

The Materialise NV(Materialise) is a privately held diversified business company. It is engaged in providing innovative software s
2011 125,00$

Medixsysteme - Strategic SWOT Analysis Review

Medixsysteme is a medical device company, which is engaged in the development, manufacture and sales of medical equipments related
2011 125,00$

Healthpoint Biotherapeutics - Strategic SWOT Analysis Review

Healthpoint Biotherapeutics (Healthpoint) is an US-based biopharmaceutical company. It engages in development and marketing of pha
2011 125,00$

JN-International Medical Corporation - Strategic SWOT Analysis Review

JN-International Medical Corporation (JNI Medical) is a biopharmaceutical corporation engaged in developing vaccines for infectiou
2011 125,00$

American Scientific Resources, Inc. (ASFX) - Strategic SWOT Analysis Review

American Scientific Resources, Inc. (ASR) is a provider of medical products and healthcare supplements through retail drug chains,
2011 250,00$

Barco Medical Imaging - Strategic SWOT Analysis Review

Barco Medical Imaging (Barco Medical) is engaged in the design, development, manufacture and supply of visualization products for
2011 125,00$

Dr. Langer Medical GmbH - Strategic SWOT Analysis Review

Dr. Langer Medical GmbH (Langer Medical) is engaged in the design and development of devices for intraoperative neurological monit
2011 125,00$

ATEK Medical, LLC - Strategic SWOT Analysis Review

ATEK Medical, LLC (ATEK Medical) is a privately-owned contract manufacturer of medical devices. The company offers complete produc
2011 125,00$

Nobel Biocare AB - Strategic SWOT Analysis Review

Nobel Biocare AB (Nobel Biocare) is a medical device company engaged in the production of pioneer dental solutions using CAD (comp
2011 250,00$

Bederra Corporation (ZICX) - Strategic SWOT Analysis Review

Bederra Corporation is a diversified medical services provider and is engaged in financing of equipment and other assets to doctor
2011 250,00$

Metiscan, Inc. (MTIZ) - Strategic SWOT Analysis Review

Metiscan, Inc. (Metiscan) is a public company that is focused on healthcare related businesses. The company is a provider of web-b
2011 250,00$

Capsule Technologie S.A. - Strategic SWOT Analysis Review

Capsule Technologie S.A. (Capsule) is a medical device company, provides Enterprise Medical Device Connectivity solutions. It offe
2011 125,00$

Dimensional Insight, Inc. - Strategic SWOT Analysis Review

Dimensional Insight, Inc. (DI) is specialty service providing company that specializes in the development and marketing of multidi
2011 125,00$

Peter-Brehm GMBH - Strategic SWOT Analysis Review

Peter-Brehm GMBH (Peter-Brehm) is engaged in the research, development, manufacture, marketing and export of medical devices for t
2011 125,00$

Futuremed Health Care Products L.P. - Strategic SWOT Analysis Review

Futuremed Health Care Products L.P. (Futuremed) is a privately-held medical devices company, based in Canada. It is engaged in the
2011 250,00$

Sonic Innovations, Inc. - Strategic SWOT Analysis Review

Sonic Innovations, Inc. (Sonic) is a hearing aid company, which is engaged in the design, development, manufacture and marketing o
2011 125,00$

Arthro Kinetics plc - Strategic SWOT Analysis Review

Arthro Kinetics plc (Arthro Kinetics) is an orthopedic company engaged in the development and commercialization of biological cart
2011 125,00$

ESTECH - Strategic SWOT Analysis Review

ESTECH is a medical device company engaged in the manufacture and distribution of least invasive products for cardiac surgery. The
2011 250,00$

Atto Corporation - Strategic SWOT Analysis Review

Atto Corporation (Atto) is a medical device manufacturing company principally engaged in developing, manufacturing and marketing o
2011 250,00$

Health Science Products, Inc. - Strategic SWOT Analysis Review

Health Science Products Inc.( Health Science Products Inc.) is a US Based Dental equipment manufacturer company, that design and
2011 250,00$

DOBI Medical International, Inc. - Strategic SWOT Analysis Review

DOBI Medical International, Inc. (DOBI Medical) is an independent medical equipment company. The company is engaged in developing
2011 250,00$

The Medical House PLC (MLH) - Strategic SWOT Analysis Review

The Medical House PLC (TMH) is engaged in the development and supply of innovative delivery systems for injectable drugs. Its prod
2011 250,00$

Healthcare Integrated Services, Inc. - Strategic SWOT Analysis Review

Healthcare Integrated Services, Inc. is engaged in manufacture and sale of medical devices Relating to Diagnostic Imaging and Also
2011 250,00$

National Quality Care, Inc. (NQCI) - Strategic SWOT Analysis Review

National Quality Care, Inc provides wearable artificial kidney for dialysis and other medical applications. / / This comprehensiv
2011 250,00$

HealtheTech, Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of HealtheTech, Inc. provides you with an in-depth strategic analysis of the company's businesses
2011 250,00$

Cell Robotics International, Inc. (CRII) - Strategic SWOT Analysis Review

Cell Robotics International, Inc. manufactures, markets and sells laser-based medical devices and scientific research instruments.
2011 250,00$

Ichimaru Sangyo Co., Ltd. - Strategic SWOT Analysis Review

Ichimaru Sangyo Co., Ltd. is Japan-based medical device company that engages in offering Formalin gas sterilizers, vacuum steriliz
2011 250,00$

SurgiLight, Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of SurgiLight, Inc. provides you with an in-depth strategic analysis of the company's businesses a
2011 250,00$

InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis Review

InforMedix Holdings, Inc. is engaged in the development, patenting and integrating of Med-eXpert system, an integrated Internet-ba
2011 250,00$

Synbiotics Corporation - Strategic SWOT Analysis Review

Synbiotics Corporation, based in Kansas City,United States, is a developer, manufacturer and marketer of diagnostic products dedi
2011 250,00$

Bb Medtech Ag - Strategic SWOT Analysis Review

BB MEDTECH AG is an investment company. The company participates in companies in the growth market of medical technology. / / Thi
2011 250,00$

Biomerge Industries Ltd. (BIL.H) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Biomerge Industries Ltd. provides you with an in-depth strategic analysis of the company's busi
2011 250,00$

Cul 2 Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Cul 2 Inc. provides you with an in-depth strategic analysis of the company's businesses and ope
2011 250,00$

Egm International, Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Egm International, Inc. provides you with an in-depth strategic analysis of the company's busin
2011 250,00$

Jawon Medical Co.,Ltd. - Strategic SWOT Analysis Review

Jawon Medical Co.,Ltd. (Jawon Medical) is a Korea based medical equipment company, engaged in the designing, development, manufact
2011 250,00$

Kmh Co Ltd - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Kmh Co Ltd provides you with an in-depth strategic analysis of the company's businesses and ope
2011 250,00$

Liberating Technologies Inc - Strategic SWOT Analysis Review

Liberating Technologies Inc is a manufacturer and distributor of upper-limb prosthetic devices for adult and children. The company
2011 250,00$

Lifeport, Inc - Strategic SWOT Analysis Review

Lifeport, Inc is a company engaged in the manufacture and supply of general hospital supplies like Whell chairs ,Tables,Stetchers
2011 250,00$

Medical Resources - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Medical Resources provides you with an in-depth strategic analysis of the company's businesses
2011 250,00$

Monogen, Inc. - Strategic SWOT Analysis Review

Monogen, Inc. (Monogen) is a medical devices and diagnostics company that offers cytological screening and diagnostic products for
2011 250,00$

Oculus Innovative Sciences Netherlands B.V. - Strategic SWOT Analysis Review

Oculus Innovative Sciences Netherlands B.V. is a wholly owned subsidiary of Oculus Innovative Sciences, Inc. was founded at the en
2011 250,00$

Polartechnics Limited - Strategic SWOT Analysis Review

Polartechnics Limited is a life sciences company involved in the research, development, manufacture and marketing of innovative me
2011 125,00$

Roesch Ag Medizintechnik - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Roesch Ag Medizintechnik provides you with an in-depth strategic analysis of the company's busi
2011 250,00$

Scantek Medical, Inc. - Strategic SWOT Analysis Review

Scantek Medical, Inc. (Scantek) is engaged in the design and marketing of BreastCare Differential Temperature Sensor (DTS). The pr
2011 250,00$

Shanghai Pudong Jinhuan Medical Products Co., Ltd. - Strategic SWOT Analysis Review

Shanghai Pudong Jinhuan Medical Products Co., Ltd. (Jinhuan) is engaged in manufacturing and marketing of single use medical instr
2011 250,00$

Sound Health Solutions Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Sound Health Solutions Inc. provides you with an in-depth strategic analysis of the company's b
2011 250,00$

CLX Medical, Inc. (CLXM) - Strategic SWOT Analysis Review

CLX Medical, Inc. is engaged in the distribution of medical diagnostic testing products. The company is headquartered in Californi
2011 250,00$

American HealthChoice, Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of American HealthChoice, Inc. provides you with an in-depth strategic analysis of the company's b
2011 250,00$

Advanced Optics Electronics Inc. (ADOT) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Advanced Optics Electronics Inc. provides you with an in-depth strategic analysis of the compan
2011 250,00$

American Biomed, Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of American Biomed, Inc. provides you with an in-depth strategic analysis of the company's busines
2011 250,00$

Electronic Sensor Technology (ESNR) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Electronic Sensor Technology provides you with an in-depth strategic analysis of the company's
2011 250,00$

MDwerks, Inc. (MDWK) - Strategic SWOT Analysis Review

MDwerks, Inc. provides healthcare professionals with automated electronic insurance claims management solutions and advance fundin
2011 250,00$

Invivosense ASA (INVIVO) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Invivosense ASA provides you with an in-depth strategic analysis of the company's businesses an
2011 250,00$

Cryonic Medical SA (MLCRY) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Cryonic Medical SA provides you with an in-depth strategic analysis of the company's businesses
2011 250,00$

Pharma Plast Co. S.A.E - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Pharma Plast Co. S.A.E provides you with an in-depth strategic analysis of the company's busine
2011 250,00$

EchoCath, Inc. (ECHTA) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of EchoCath, Inc. provides you with an in-depth strategic analysis of the company's businesses and
2011 250,00$

Photoelectron Corporation (PECN) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Photoelectron Corporation provides you with an in-depth strategic analysis of the company's bus
2011 250,00$

MZT Holdings, Inc. (MZT) - Strategic SWOT Analysis Review

MZT Holdings, Inc. (formerly Matritech, Inc.), is engaged in development of proteomics-based diagnostic products for the early det
2011 250,00$

DATATRAK International, Inc. (DATA) - Financial and Strategic SWOT Analysis Review

DATATRAK International, Inc. (DATATRAK International, Inc.) is engaged in the Electronic Data Capture industry. It operates as a w
2011 250,00$

CPC of America, Inc. (CPCF) - Financial and Strategic SWOT Analysis Review

CPC of America, Inc. (CPC of America, Inc.) is a development stage company in the medical device and healthcare sector. It engages
2011 250,00$

Vyteris, Inc. (VYTR) - Financial and Strategic SWOT Analysis Review

Vyteris, Inc. (Vyteris) is a publicly held research focused biotechnology company that is engaged in the research and development
2011 250,00$

Norwood Abbey Limited (SLE) - Financial and Strategic SWOT Analysis Review

Norwood Abbey Limited (Norwood Abbey) is a publicly held pharmaceuticals and health care company. It is principally engaged in the
2011 250,00$

Viralytics Ltd. (VLA) - Financial and Strategic SWOT Analysis Review

Viralytics Ltd. (Viralytics), formerly Psiron Limited, is a publicly held anti-cancer biotechnology company. The company is princi
2011 250,00$

Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic SWOT Analysis Review

Questcor Pharmaceuticals, Inc. (Questcor Pharma) is a publicly held bio pharmaceutical company. It is specialized in the provision
2011 250,00$

Cambrex Corporation (CBM) - Financial and Strategic SWOT Analysis Review

Cambrex Corporation (Cambrex) is a US based life sciences company. Cambrex is principally engaged in providing a range of products
2011 125,00$

Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic SWOT Analysis Review

Biotec Pharmacon ASA (Biotec Pharmacon) is a publicly held Norway-based bio-pharmaceutical company. The company is principally eng
2011 250,00$

Herbalife Ltd. (HLF) - Financial and Strategic SWOT Analysis Review

Herbalife Ltd. (Herbalife) is a health care related products manufacturer and supplier company. The product portfolio of the compa
2011 125,00$

Bavarian Nordic A/S (BAVA) - Financial and Strategic SWOT Analysis Review

Bavarian Nordic A/S (Bavarian Nordic) is a publicly held bio pharmaceutical company engaged in developing and producing vaccines f
2011 250,00$

GUIDED THERAPEUTICS, INC. (GTHP) - Financial and Strategic SWOT Analysis Review

Guided Therapeutics, Inc. (GTI) is a publicly held medical technology company that is engaged in developing and marketing of produ
2011 250,00$

Urodynamix Technologies Ltd. (VVV) - Financial and Strategic SWOT Analysis Review

Urodynamix Technologies Ltd. (Urodynamix) is a publicly held Canadian based medical device company that ie engaged in developing a
2011 250,00$

Hiran Orgochem Ltd. (506170) - Financial and Strategic SWOT Analysis Review

Hiran Orgochem Ltd. (Hiran), is a publicly held India-based company. The company is principally engaged in the production and sale
2011 250,00$

PULSION Medical Systems AG (PUS) - Financial and Strategic SWOT Analysis Review

PULSION Medical Systems AG (Pulsion) is a publicly held biotechnology company that is engaged in the development, manufacture, and
2011 250,00$

NovaMed, Inc. (NOVA) - Financial and Strategic SWOT Analysis Review

NovaMed, Inc. (NovaMed) is a publicly held US-based healthcare services company. The company is principally engaged in the ownersh
2011 250,00$

HealthSouth Corporation (HLS) - Financial and Strategic SWOT Analysis Review

HealthSouth Corporation (HealthSouth) is an US based healthcare company. HealthSouth is principally engaged in providing inpatient
2011 125,00$

Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic SWOT Analysis Review

Santen Pharmaceutical Co., Ltd. (Santen) is a pharmaceutical company based in Japan. The company together with its subsidiaries en
2011 125,00$

Taisho Pharmaceutical Co., Ltd. (4535) - Financial and Strategic SWOT Analysis Review

Taisho Pharmaceutical Co., Ltd. (Taisho) is a Japan-based pharmaceutical company that is engaged in the manufacturing and selling
2011 125,00$

Dechra Pharmaceuticals plc (DPH) - Financial and Strategic SWOT Analysis Review

Dechra Pharmaceuticals PLC (Dechra) is engaged in the manufacture and distribution of veterinary medicines. It also sells various
2011 125,00$

Cangene Corporation (CNJ) - Financial and Strategic SWOT Analysis Review

Cangene Corporation (Cangene) is a biopharmaceutical company. It is engaged in the development, manufacture, and marketing of spec
2011 125,00$

NeoGenomics, Inc. (NGNM) - Financial and Strategic SWOT Analysis Review

NeoGenomics, Inc., (NeoGenomics) is a publicly held pharmaceutical company. It is principally engaged in providing cancer-related
2011 250,00$

Covalon Technologies Ltd. (COV) - Financial and Strategic SWOT Analysis Review

Covalon Technologies, Ltd. (Covalon) is a publicly held Canada-based advanced medical products company. The company is principally
2011 250,00$

Span-America Medical Systems, Inc. (SPAN) - Financial and Strategic SWOT Analysis Review

Span-America Medical Systems, Inc. (Span America) is a publicly held US-based pharmaceutical company. The company is primarily eng
2011 250,00$

Jilin Leading Technology Development Co (000669) - Financial and Strategic SWOT Analysis Review

Jilin Leading Technology Development Co., Ltd. (Jilin Leading) is a healthcare product and machinery manufacturing and distributio
2011 250,00$

ICON plc (ICON) - Financial and Strategic SWOT Analysis Review

ICON plc (ICON) is a contract research organization that is engaged in offering outsourced development services to the biotechnolo
2011 125,00$

YM BioSciences Inc. (YM) - Financial and Strategic SWOT Analysis Review

YM BioSciences Inc. (YM BioSciences) is a life sciences product development company. The company currently has three late-stage pr
2011 250,00$

Kaigen Co., Ltd. (8000) - Financial and Strategic SWOT Analysis Review

Kaigen Co., Ltd. (Kaigen) is a pharmaceutical drug distribution company. It has products in the areas of OTC, diagnostic drugs for
2011 250,00$

Quality Systems, Inc. (QSII) - Financial and Strategic SWOT Analysis Review

Quality Systems, Inc. (QSI) is a publicly held US-based company. The company is principally engaged in the development and marketi
2011 125,00$

ULURU Inc. (ULU) - Financial and Strategic SWOT Analysis Review

Uluru Inc. (Uluru) is a publicly held specialty pharmaceutical company that is engaged in the research, development and commercial
2011 250,00$

Oculus Innovative Sciences, Inc. (OCLS) - Financial and Strategic SWOT Analysis Review

Oculus Innovative Sciences, Inc. (Oculus), formerly Micromed Laboratories, Inc. is a publicly held bio-pharmaceutical company. It
2011 250,00$

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

Tissue Therapies Limited (TTL) is a publicly held Australian based biotechnology company. The company is principally involved in t
2011 250,00$

Vermillion, Inc. (VRML) - Financial and Strategic SWOT Analysis Review

Vermillion, Inc. (VRML) is a pharmaceutical company that discovers, develops and commercializes diagnostic tests to improve patien
2011 125,00$

Fuso Pharmaceutical Industries, Ltd. (4538) - Financial and Strategic SWOT Analysis Review

Fuso Pharmaceutical Industries, Ltd. (Fuso Pharmaceutical Industries, Ltd.) is an independent research and biotechnology organizat
2011 250,00$

Piramal Healthcare Limited (PIRHEALTH) - Financial and Strategic SWOT Analysis Review

Piramal Healthcare Limited (PHL) is an integrated healthcare company engaged in providing products for unmet medical needs across
2011 125,00$

Bio-Path Holdings, Inc. (BPTH) - Financial and Strategic SWOT Analysis Review

Bio-Path Holdings, Inc. (Bio-Path) is a publicly held biotechnology company. It is engaged in financing and facilitating the devel
2011 250,00$

Ilex Medical Ltd. (ILX) - Financial and Strategic SWOT Analysis Review

Ilex Medical Ltd. (Ilex Medical Ltd.) is an independent health care pharmaceutical industry. Ilex Medical is involved in supplying
2011 250,00$

Biolife Solutions, Inc. (BLFS) - Financial and Strategic SWOT Analysis Review

BioLife Solutions, Inc. (BioLife Solutions, Inc.) is an independent biopharmaceutical organization in the US. The company is invol
2011 250,00$

Eau Technologies, Inc. (EAUI) - Financial and Strategic SWOT Analysis Review

Eau Technologies, Inc. (Eau Technologies, Inc.) is a United State’s largest pharmaceutical company. The company is involved in sup
2011 125,00$

Mts Medication Technologies, Inc. (MTSI) - Financial and Strategic SWOT Analysis Review

MTS Medication Technologies, Inc. (MTS) is a publicly held US-based medical device company. The company is principally engaged in
2011 250,00$

PTS, Inc. (PTSH) - Financial and Strategic SWOT Analysis Review

PTS, Inc. (PTS) is a publicly held consulting company that is engaged in offering consulting services and automated software to bo
2011 250,00$

Repro-Med Systems, Inc. (REPR) - Financial and Strategic SWOT Analysis Review

Repro-Med Systems, Inc. (RMS) is a publicly held US-based traded medical device company. The company is principally engaged in pro
2011 250,00$

WeiDa Medical Applied Technology Co., Ltd (000603) - Financial and Strategic SWOT Analysis Review

WeiDa Medical Applied Technology Co., Ltd. (WeiDa) is a publicly held China-based company. The company is principally engaged in t
2011 250,00$

Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review

Biofrontera AG (Biofrontera) is a publicly held pharmaceutical company, engaged in the development of drugs for the treatment of d
2011 250,00$

TiGenix NV (TIG) - Financial and Strategic SWOT Analysis Review

TiGenix NV (TiGenix) is a publicly held Belgium-based biomedical company. TiGenix is engaged in the development of innovative loca
2011 125,00$

Medial Saude S.A. (MEDI3) - Financial and Strategic SWOT Analysis Review

Medial Saude S.A.(Medial) is a health insurance company engaged in providing health insurance services. The company offers its hea
2011 125,00$

ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic SWOT Analysis Review

ZIOPHARM Oncology, Inc. (ZIOPHARM Oncology) is an independent health care pharmaceutical organization. The company is mainly invol
2011 250,00$

Sun Healthcare Group, Inc. (SUNH) - Financial and Strategic SWOT Analysis Review

Sun Healthcare Group, Inc. (Sun Healthcare) is a healthcare company based in the US. Sun Healthcare is principally engaged in prov
2011 125,00$

Cipher Pharmaceuticals Inc. (DND) - Financial and Strategic SWOT Analysis Review

Cipher Pharmaceuticals Inc. (v Cipher Pharmaceuticals Inc.) is Canada’s largest pharmaceutical organization. The company is involv
2011 250,00$

Neptune Technologies & Bioressources Inc. (NTB) - Financial and Strategic SWOT Analysis Review

Neptune Technologies & Bioressources Inc. (Neptune) is a publicly held research focused company that is engaged in the development
2011 250,00$

Universal Health Services, Inc. (UHS) - Financial and Strategic SWOT Analysis Review

Universal Health Services, Inc. (UHS) is a publicly held US-based traded specialty health care organization. It is principally eng
2011 125,00$

Southern Petrochemical Industries Corporation Ltd. (SPIC) - Financial and Strategic SWOT Analysis Review

Southern Petrochemical Industries Corporation Ltd. (SPIC) is a bio-pharmaceutical company that operates its businesses in four seg
2011 125,00$

Health Discovery Corporation (HDVY) - Financial and Strategic SWOT Analysis Review

Health Discovery Corporation (HDC) is a publicly held company specialized in medicine and biomarker discovery. The company mainly
2011 250,00$

American Oriental Bioengineering, Inc. (AOB) - Financial and Strategic SWOT Analysis Review

American Oriental Bioengineering, Inc. (American Oriental Bioengineering, Inc.) is china based independent health care pharmaceuti
2011 125,00$

Standard Diagnostics, Inc. (066930) - Financial and Strategic SWOT Analysis Review

Standard Diagnostics Incorporation (SD) is a publicly held diagnostic services company. It is engaged in the manufacture and distr
2011 250,00$

A&D Pharma Holdings N.V. (ADPH) - Financial and Strategic SWOT Analysis Review

A&D Pharma Holdings N.V. (A&D Pharma Holdings) is the Dutch holding company of A&D Pharma Holdings S.R.L., a pharmaceutical wholes
2011 125,00$

AIN Pharmaciez Inc. (9627) - Financial and Strategic SWOT Analysis Review

AIN Pharmaciez Inc. (AIN Pharmaciez) is a Japan-based company, which is engaged in the management and franchising of pharmacies an
2011 125,00$

Alfresa Holdings Corporation (2784) - Financial and Strategic SWOT Analysis Review

Alfresa Holdings Corporation (Alfresa) is a Japan-based holding company. It is principally engaged in the field of medical and nur
2011 125,00$

Allied Healthcare International, Inc. (AHCI) - Financial and Strategic SWOT Analysis Review

Allied Healthcare International Inc. (Allied Healthcare) is one of the leading providers of flexible healthcare staffing to the he
2011 125,00$

Amedisys, Inc. (AMED) - Financial and Strategic SWOT Analysis Review

Amedisys Inc. (Amedisys) is one of the leading provider of home health care and hospice service in the US and Puerto Rico. The com
2011 125,00$

AmSurg Corp. (AMSG) - Financial and Strategic SWOT Analysis Review

Amsurg Corp. (AmSurg) is the operator of single specialty surgery centers in the US. Through its subsidiaries, the company is enga
2011 125,00$

Andreae-Noris Zahn AG (ANZ) - Financial and Strategic SWOT Analysis Review

Andreae-Noris Zahn AG (Anzag) is a German pharmaceutical wholesaler. It is principaly engaged in production, processing and distri
2011 125,00$

Arseus NV (RCUS) - Financial and Strategic SWOT Analysis Review

Arseus NV (Arseus) offers a range of health care products and services to the healthcare professionals and institutions based in E
2011 125,00$

ASKA Pharmaceutical Co., Ltd (4514) - Financial and Strategic SWOT Analysis Review

ASKA Pharmaceutical Co., Ltd. (ASKA Pharmaceutical) is engaged in manufacturing medicines for human and animal health. ASKA Pharma
2011 125,00$

Assisted Living Concepts, Inc. (ALC) - Financial and Strategic SWOT Analysis Review

Assisted Living Concepts, Inc. (Assisted Living Concepts) is a US based assisted living facilities provider. It operates assisted
2011 125,00$

Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review

Aurobindo Pharma Limited (Aurobindo Pharma) is a pharmaceutical company. The company is engaged in manufacturing active pharmaceut
2011 125,00$

BB BIOTECH AG (BION) - Financial and Strategic SWOT Analysis Review

BB BIOTECH AG (BB BIOTECH) is an investment company, principally engaged in investing in biotech companies related to oncology, ca
2011 125,00$

BML Inc. (4694) - Financial and Strategic SWOT Analysis Review

BML, INC. is a Japan-based company engaged in improving medical services and health through modern technologies, systems, and serv
2011 125,00$

Bruker Corporation (BRKR) - Financial and Strategic SWOT Analysis Review

Bruker Corporation (Bruker) is one of the leading suppliers of life science and materials research systems across the world. It is
2011 125,00$

Caraco Pharmaceutical Laboratories, Ltd. (CPD) - Financial and Strategic SWOT Analysis Review

Caraco Pharmaceutical Laboratories, Ltd. (Caraco) is one of the fastest growing companies in the generic pharmaceutical industry.
2011 125,00$

Care UK plc (CUK) - Financial and Strategic SWOT Analysis Review

Care UK Plc is an Independent provider of health and social care. It works with partner companies such as local authorities, PCTs
2011 125,00$

Chemed Corporation (CHE) - Financial and Strategic SWOT Analysis Review

Chemed Corporation (formerly known as Roto-Rooter, Inc.) is a diversified US based pharmaceutical company, engaged in providing of
2011 125,00$

China HealthCare Holdings Limited (0673) - Financial and Strategic SWOT Analysis Review

China HealthCare Holdings Limited (CHHL) is a provider of healthcare and consumer services. It operates through its subsidiaries a
2011 125,00$

China Pharmaceutical Group Limited (1093) - Financial and Strategic SWOT Analysis Review

China Pharmaceutical Group Limited (China Pharm) is engaged in the manufacture and distribution of bulk drug products and antibiot
2011 125,00$

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

Cipla Ltd. (Cipla) is a pharmaceutical company. The company offers various drugs and healthcare products. The company manufactures
2011 125,00$

Corporativo Fragua S.A.B. de C.V. (FRAGUAB) - Financial and Strategic SWOT Analysis Review

Corporativo Fragua S.A.B. de C.V. (Corporativo Fragua) is a Mexico based Pharmaceutical company. The company operates a chain of p
2011 125,00$

Curanum AG (BHS) - Financial and Strategic SWOT Analysis Review

Curanum AG (Curanum) is a Germany based company operator of care homes. The company is engaged in the development and operation of
2011 125,00$

Diagnosticos da America S.A. (DASA3) - Financial and Strategic SWOT Analysis Review

Diagnosticos da America S.A. (DASA) is a private medical diagnostics company. The company is the largest provider of diagnostic me
2011 125,00$

Dksh Holdings (Malaysia) Berhad (DITHELM) - Financial and Strategic SWOT Analysis Review

DKSH Holdings (Malaysia) Berhad (DKSH(M)) operates as a subsidiary of DKSH Group of Switzerland. The company offers services such
2011 125,00$

Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review

Dr. Reddy's Laboratories Limited (RL) is a pharmaceutical company engaged in offering pharmaceutical services and developing activ
2011 125,00$

Drogasil S.A. (DROG3) - Financial and Strategic SWOT Analysis Review

Drogasil S.A (Drogasil) is a Brazil based retail drugstore company. The company is principally engaged in the retail sale of pharm
2011 125,00$

Emergency Medical Services Corporation (EMS) - Financial and Strategic SWOT Analysis Review

Emergency Medical Services Corporation (EMS) is a US based company, engaged in providing of emergency medical services. The compan
2011 125,00$

Emeritus Corp. (ESC) - Financial and Strategic SWOT Analysis Review

Emeritus Corporation (Emeritus) is largest operators of assisted living and Alzheimer’s care residential communities in the US. Th
2011 125,00$

PT Enseval Putera Megatrading Tbk (EPMT) - Financial and Strategic SWOT Analysis Review

PT Enseval Putera Megatrading Tbk (Enseval) is an Indonesia-based trading and distribution company. The company is a part of Kalbe
2011 125,00$

Euromedica SA (EUROM) - Financial and Strategic SWOT Analysis Review

Euromedica SA (Euromedica) is one of the largest providers of primary and secondary health care services in Greece. Its range of a
2011 125,00$

Fosun International Limited (0656) - Financial and Strategic SWOT Analysis Review

Fosun International Limited (Fosun) is a Hong Kong based conglomerate, operating in pharmaceuticals, property development, steel,
2011 125,00$

Galenica Ltd. (GALN) - Financial and Strategic SWOT Analysis Review

Galenica Ltd (Galenica) is a diversified healthcare company engaged in the development, manufacture and marketing of pharmaceutica
2011 125,00$

Generale de Sante (GDS) - Financial and Strategic SWOT Analysis Review

Generale de Sante is a French healthcare system. The company principally operates in France and Europe. It is engaged in providing
2011 125,00$

Gentiva Health Services, Inc. (GTIV) - Financial and Strategic SWOT Analysis Review

Gentiva Health Services, Inc. (Gentiva) is a US based health care services provider. The company offers various healthcare service
2011 125,00$

Genus plc (GNS) - Financial and Strategic SWOT Analysis Review

Genus plc (Genus) is a global company engaged in the application of quantitative genetics and biotechnology to animal breeding in
2011 125,00$

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial and Strategic SWOT Analysis Review

Glenmark Pharmaceuticals Limited (Glenmark Pharmaceuticals) is an integrated pharmaceutical company. The company is engaged in man
2011 125,00$

Ship Healthcare Holdings, Inc. (3360) - Financial and Strategic SWOT Analysis Review

Ship Healthcare Holdings, Inc. (Ship Healthcare), formerly Green Hospital Supply, Inc., is engaged in marketing of medical instrum
2011 125,00$

Hanmi Holdings Co., Ltd. (008930) - Financial and Strategic SWOT Analysis Review

Hanmi Holdings Co., Ltd. (Hanmi) is a manufacturer and supplier of pharmaceuticals. It was formerly known as Hanmi Pharmaceutical
2011 125,00$

Healthcare Services Group, Inc. (HCSG) - Financial and Strategic SWOT Analysis Review

Healthcare Services Group, Inc. (Healthcare Services Group) is a Pennsylvania based corporation, engaged in providing on-site mana
2011 125,00$

Catalyst Health Solutions, Inc. (CHSI) - Financial and Strategic SWOT Analysis Review

Catalyst Health Solutions, Inc (Catalyst Health Solutions) was formerly known as HelathExtras, Inc. is a full-service pharmacy ben
2011 125,00$

HealthSpring, Inc. (HS) - Financial and Strategic SWOT Analysis Review

HealthSpring, Inc. (HealthSpring) is a US-based managed care organization. The company offers commercial health plans to employer
2011 125,00$

Hooper Holmes, Inc. (HH) - Financial and Strategic SWOT Analysis Review

Hooper Holmes, Inc. (Hooper Holmes) is one of the leading providers of risk assessment services for the insurance industry. The co
2011 125,00$

Ildong Pharmaceutical Co., Ltd. (000230) - Financial and Strategic SWOT Analysis Review

Ildong Pharmaceutical Co., Ltd. (Ildong Pharmaceutical) is a Korea-based pharmaceutical company engaged in the production of pharm
2011 125,00$

Integrated Healthcare Holdings Inc. (IHCH) - Financial and Strategic SWOT Analysis Review

Integrated Healthcare Holdings Inc. (Integrated Healthcare Holdings) is a US-based hospital management company which operates gene
2011 125,00$

Inter Parfums, Inc. (IPAR) - Financial and Strategic SWOT Analysis Review

Inter Parfums, Inc (Inter Parfums), together with its subsidiaries develops, manufactures, markets and distributes fragrances, pre
2011 125,00$

inVentiv Health, Inc - Financial and Strategic SWOT Analysis Review

inVentiv Health, Inc (inVentiv Health) is one of the leading providers of value-added services to the pharmaceutical, life science
2011 125,00$

Iwaki & Co. Ltd. (8095) - Financial and Strategic SWOT Analysis Review

IWAKI & CO., LTD. (Iwaki & Co) is a Japan-based company principally engaged in the manufacture trade and wholesale of pharmaceutic
2011 125,00$

Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis Review

Jeil Pharmaceutical Co., Ltd (Jeil Pharmaceutical Co) is a Korea-based company. It is involved in the manufacture and sale of phar
2011 125,00$

Jenburkt Pharmaceuticals Limited (524731) - Financial and Strategic SWOT Analysis Review

Jenburkt Pharmaceuticals Limited (JPL) is an India based pharmaceutical company. The company is principally engaged in the manufac
2011 125,00$

Kawanishi Holdings, Inc. (2689) - Financial and Strategic SWOT Analysis Review

Kawanishi Holdings, Inc. (Kawanishi) is a Japan-based holding company. It is engaged in the wholesale distribution of medical diag
2011 125,00$

KPJ Healthcare Berhad (KPJ) - Financial and Strategic SWOT Analysis Review

KPJ Healthcare Berhad (KPJ Healthcare) is a private healthcare providers in Malaysia. The company has its network in the region wi
2011 125,00$

LHC Group, Inc. (LHCG) - Financial and Strategic SWOT Analysis Review

LHC Group, Inc. (LHC Group) provides post-acute healthcare services principally to Medicare beneficiaries in rural markets in the
2011 125,00$

Mannatech, Incorporated (MTEX) - Financial and Strategic SWOT Analysis Review

Mannatech, Incorporated (Mannatech) is a global wellness solution provider. The company develops and sells a range of nutritional
2011 125,00$

Marseille-Kliniken AG (MKA) - Financial and Strategic SWOT Analysis Review

Marseille-Kliniken AG (Marseille-Kliniken) is a German-based healthcare service provider engaged in the provision of nursing care
2011 125,00$

Mylan Laboratories Limited (524794) - Financial and Strategic SWOT Analysis Review

Mylan Laboratories Limited (Mylan Laboratories) is an India-based company. The company is engaged in the manufacture of Active Pha
2011 125,00$

Meda AB (MEDA A) - Financial and Strategic SWOT Analysis Review

Meda AB (Meda) is a Sweden-based specialty pharmaceutical company. Its operations concentrate on offering cost-effective pharmaceu
2011 125,00$

Medical Staffing Network Holdings, Inc. (MSNWQ) - Financial and Strategic SWOT Analysis Review

Medical Staffing Network Holdings Inc (MSN) is an US based temporary healthcare staffing company. The company principally provides
2011 125,00$

MediPal Holdings Corporation (7459) - Financial and Strategic SWOT Analysis Review

MediPal Holdings Corporation (MediPal Holdings), formerly Mediceo Paltac Holdings Co., Ltd is the Japan based pharmaceutical compa
2011 125,00$

Mediclin AG (MED) - Financial and Strategic SWOT Analysis Review

Mediclin AG (Mediclin) is a German medical services company. Mediclin is principally engaged in the provision of medical rehabilit
2011 125,00$

Medi-Clinic Corporation Limited (MDC) - Financial and Strategic SWOT Analysis Review

Medi-Clinic Corporation Limited (Medi-Clinic Corporation) engages in the operation of multi-disciplinary private hospitals. The co
2011 125,00$

Metropolitan Health Networks, Inc. (MDF) - Financial and Strategic SWOT Analysis Review

Metropolitan Health Networks, Inc (MHN) is a US- based health care service provider. Through provider service network (PSN), the c
2011 125,00$

Mettler-Toledo International Inc (MTD) - Financial and Strategic SWOT Analysis Review

Mettler-Toledo International Inc (MTI) engages in supplying of precision instruments and services. The company principally provide
2011 125,00$

National HealthCare Corporation (NHC) - Financial and Strategic SWOT Analysis Review

National HealthCare Corporation (NHC) is an US based long-term health care service provider, principally engaged in the operation
2011 125,00$

Netcare Limited (NTC) - Financial and Strategic SWOT Analysis Review

Netcare Limited (Netcare) is an investment holding company. The company with its subsidiaries operates as a private health care pr
2011 125,00$

Nichii Gakkan Co., Inc. (9792) - Financial and Strategic SWOT Analysis Review

Nichii Gakkan Co., Inc. (Nichii Gakkan) is a Japanese health care company. The company is principally engaged in offering medical
2011 125,00$

Noevir Co., Ltd. (4916) - Financial and Strategic SWOT Analysis Review

Noevir Co., Ltd. (Noevir) is Japan based company principally engaged in developing, manufacturing and marketing of pharmaceuticals
2011 125,00$

Odyssey HealthCare, Inc. (ODSY) - Financial and Strategic SWOT Analysis Review

Odyssey HealthCare, Inc. (Odyssey) is one of the largest hospice providers in the US. The company offers Medicare-certified hospic
2011 125,00$

Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review

Pharmaniaga Berhad (Pharmaniaga) is an integrated healthcare company in Malaysia. The company's principal activities include manuf
2011 125,00$

PIGEON CORPORATION (7956) - Financial and Strategic SWOT Analysis Review

Pigeon Corporation (Pigeon) is a Japan-based pharmaceutical company, principally engaged in the manufacturing, sales, import and e
2011 125,00$

Podravka d.d. (PODR-R-A) - Financial and Strategic SWOT Analysis Review

Podravka d.d. is involved in providing food products, medicines, pharmaceutical and cosmetic products to its customers across Croa
2011 125,00$

Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review

Primary Health Care Limited (PHC) is an Australia based healthcare service provider, primary engaged in offering medical-related s
2011 125,00$

Psychiatric Solutions, Inc. (PSYS) - Financial and Strategic SWOT Analysis Review

Psychiatric Solutions, Inc. (PSI) is an US based inpatient behavioral health care service and treatment centre provider. The compa
2011 125,00$

Recordati S.p.A. (REC) - Financial and Strategic SWOT Analysis Review

Recordati S.p.A (Recordati) is an Italy-based European pharmaceutical group engaged in the research, manufacturing, development an
2011 125,00$

Rhon-Klinikum AG (RHK) - Financial and Strategic SWOT Analysis Review

Rhon-Klinikum AG (Rhon-Klinikum) is a healthcare company based in Germany. Rhon-Klinikum, together with its subsidiaries, is princ
2011 125,00$

Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review

Sartorius AG (Sartorius) is a German company which is principally engaged in manufacturing, distribution and sale of laboratory an
2011 125,00$

Sino Biopharmaceutical Limited (1177) - Financial and Strategic SWOT Analysis Review

Sino Biopharmaceutical Limited (Sino) is a pharmaceutical company engaged in the development, manufacturing and marketing of Chine
2011 125,00$

Sonic Healthcare Limited (SHL) - Financial and Strategic SWOT Analysis Review

Sonic Healthcare Limited (Sonic Healthcare) is an Australian medical diagnostics company. The company together with its subsidiari
2011 125,00$

Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

Strides Arcolab Limited (Strides Arcolab) is an Indian pharmaceutical company, engaged in the manufacturing and export of finished
2011 125,00$

Sud-Chemie AG (SUC) - Financial and Strategic SWOT Analysis Review

Sud-Chemie AG (Sud-Chemie) is one of the Germany’s leading manufacturers of chemicals. The company is principally engaged in the f
2011 125,00$

Sunrise Senior Living, Inc. (SRZ) - Financial and Strategic SWOT Analysis Review

Sunrise Senior Living, Inc. (Sunrise) is a healthcare company based in the US, principally engaged in the provision of senior livi
2011 125,00$

Suzuken Co., Ltd. (9987) - Financial and Strategic SWOT Analysis Review

Suzuken Co., Ltd. (Suzuken) is a Japanese pharmaceutical and healthcare company, engaged in the manufacturing, distribution and sa
2011 125,00$

Taro Pharmaceuticals Industries Ltd. (TAROF) - Financial and Strategic SWOT Analysis Review

Taro Pharmaceutical Industries Ltd. (Taro) is a pharmaceutical company. It involves in developing, manufacturing and marketing of
2011 125,00$

Tecan Group Ltd (TECN) - Financial and Strategic SWOT Analysis Review

Tecan Group Ltd (Tecan) is engaged in the development, manufacturing and distribution of automation solutions for life science lab
2011 125,00$

Tiger Brands Limited (TBS) - Financial and Strategic SWOT Analysis Review

Tiger Brands Limited (Tiger) is engaged in providing branded consumer packaged goods to its customers. The company operates throug
2011 125,00$

USANA Health Sciences, Inc. (USNA) - Financial and Strategic SWOT Analysis Review

USANA Health Sciences, Inc. (USANA) is a personal care products manufacturing company. The company is principally engaged in the d
2011 125,00$

WellCare Health Plans, Inc (WCG) - Financial and Strategic SWOT Analysis Review

WellCare Health Plans, Inc. (WellCare) is a provider of managed care services to government sponsored healthcare programs. The com
2011 125,00$

Wockhardt Limited (WOCKPHARMA) - Financial and Strategic SWOT Analysis Review

Wockhardt Limited (Wockhardt) is an Indian-based pharmaceutical and biotechnology company. The company is principally engaged in r
2011 125,00$

Zynex Medical, Inc. (ZYXI) - Financial and Strategic SWOT Analysis Review

Zynex Medical, Inc. (Zynex) is a medical device company that is engaged in developing, distributing and marketing of pain manageme
2011 250,00$

YaSheng Group Ltd. (YHGG) - Financial and Strategic SWOT Analysis Review

YaSheng Group Ltd. (YaSheng) is a US based holding company, engaged in agricultural operations in China. The company is one of the
2011 125,00$

Zeria Pharmaceutical Co Ltd (4559) - Financial and Strategic SWOT Analysis Review

Zeria pharmceutical co., Ltd. (Zeria) is a pharmaceutical services provider to its customers across Japan. The company operates th
2011 125,00$

Zydus Cadila Healthcare Limited (CADILAHC) - Financial and Strategic SWOT Analysis Review

Zydus Cadila Healthcare Limited (Zydus Cadila) is a Indian-based integrated healthcare company. It engages in discovery, developme
2011 125,00$

Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review

Kobayashi Pharmaceutical Co Ltd (Kobayashi Pharmaceutical) is a Japan-based company engaged in the manufacture and sale of pharmac
2011 125,00$

ROHTO Pharmaceutical Co.,Ltd. (4527) - Financial and Strategic SWOT Analysis Review

ROHTO Pharmaceutical Co., Ltd. (ROHTO Pharmaceutical) is a manufacturer of ophthalmic medicines in Japan. The company engages in m
2011 125,00$

InSight Health Services Holdings Corp. (ISGTQ) - Financial and Strategic SWOT Analysis Review

InSight Health Services Holdings Corp (InSight Imaging) is a diagnostic imaging services provider, primarily in California. The co
2011 125,00$

Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic SWOT Analysis Review

Chemical Company of Malaysia Berhad (CCM) manufacture and markets and supplies fertilizers, chemicals and pharmaceutical products.
2011 125,00$

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (Sun Pharma) is an Indian pharmaceutical company. Sun Pharma, together with its subsidiaries
2011 125,00$

Apollo Hospitals Enterprise Limited (508869) - Financial and Strategic SWOT Analysis Review

Apollo Hospitals Enterprise Limited (Apollo Hospitals) is one of the leading healthcare groups in Asia. The company provides a ran
2011 125,00$

Stone Group Holdings Limited (0409) - Financial and Strategic SWOT Analysis Review

Stone Group Holdings Limited (Stone Group) is a publicly held Hong Kong-based investment holding company. The company is principal
2011 250,00$

Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review

Eurofins Scientific SE (ES) is a France based pharmaceutical company engaged in providing bioanalytical testing of drugs, food and
2011 125,00$

Lavipharm Group (LAVI) - Financial and Strategic SWOT Analysis Review

Lavipharm Group (Lavipharm) is a Greek Group of companies, engaged in developement, manufacturing, marketing and distribution of p
2011 125,00$

Axon Holdings S.A. (AXON) - Financial and Strategic SWOT Analysis Review

Axon Holdings S.A (Axon) is a Greece-based holding company engaged in the healthcare, technology, financial services and real esta
2011 125,00$

Guangzhou Pharmaceutical Company Limited (600332) - Financial and Strategic SWOT Analysis Review

Guangzhou Pharmaceutical Company Limited (Guangzhou Pharmaceutical Company) is a China based pharmaceutical company. It is princip
2011 125,00$

Albert David Limited (524075) - Financial and Strategic SWOT Analysis Review

Albert David Limited (Albert David Limited) is an independent health care pharmaceutical company in India. The company is involved
2011 250,00$

Parenteral Drug India Ltd. (524689) - Financial and Strategic SWOT Analysis Review

Parenteral Drug India Ltd. (PDPL) is a publicly held India-based pharmaceutical company. The company is principally engaged in the
2011 250,00$

Dharamsi Morarji Chemical Co Ltd (506405) - Financial and Strategic SWOT Analysis Review

Dharamsi Morarji Chemical Co Ltd (Dharamsi Morarji Chemical Co Ltd) is Mumbai based a publicly held Indian based company. Dharamsi
2011 250,00$

Venus Remedies Limited (VENUSREM) - Financial and Strategic SWOT Analysis Review

Venus Remedies Limited (Venus) is a publicly held Indian based pharmaceutical company. It is primarily focused on the business of
2011 250,00$

Neuland Laboratories Limited (524558) - Financial and Strategic SWOT Analysis Review

Neuland Laboratories Limited (Neuland) is a publicly held Indian based company. The company is principally engaged in the producti
2011 250,00$

Trimeris, Inc. (TRMS) - Financial and Strategic SWOT Analysis Review

Trimeris, Inc. (Trimeris) is a publicly held biopharmaceutical company engaged in the research against human immunodeficiency viru
2011 250,00$

Nanosonics Limited (NAN) - Financial and Strategic SWOT Analysis Review

Nanosonics Limited (Nanosonics) is a publicly held company, specialized in developing infection control solutions for the global h
2011 250,00$

Talecris Biotherapeutics Holdings Corp (TLCR) - Financial and Strategic SWOT Analysis Review

Talecris Biotherapeutics Holdings Corp (Talecris) is a US-based publicly held pharmaceutical company. It engages in development, p
2011 125,00$

Silence Therapeutics plc (SLN) - Financial and Strategic SWOT Analysis Review

Silence Therapeutics plc. (Silence Therapeutics) is a biotechnology company. The company is involved in discovering and developing
2011 250,00$

Optimer Pharmaceuticals, Inc. (OPTR) - Financial and Strategic SWOT Analysis Review

Optimer Pharmaceuticals, Inc. (Optimer) is a publicly held US-based biopharmaceutical company. The company is principally engaged
2011 250,00$

Sangui BioTech International, Inc. (SGBI) - Financial and Strategic SWOT Analysis Review

Sangui Biotech International, Inc. (SGBI) is a publicly held company engaged in the development of pharmaceutical, medical and cos
2011 250,00$

Cyclacel Pharmaceuticals Inc. (CYCC) - Financial and Strategic SWOT Analysis Review

Cyclacel Pharmaceuticals, Inc. (Cyclacel Pharmaceuticals) is an independent biotechnology pharmaceutical organization. The company
2011 250,00$

United American Healthcare Corporation (UAHC) - Financial and Strategic SWOT Analysis Review

United American Healthcare Corporation,( UAHC) is a publicly held US-based company. The company is principally engaged in providin
2011 250,00$

AES Chemunex SA (AESCH) - Financial and Strategic SWOT Analysis Review

AES Chemunex SA (AES Chemunex SA) is an independent pharmaceutical laboratories company in France. The company is engaged manufact
2011 250,00$

Arvind Remedies Ltd (ARL) - Financial and Strategic SWOT Analysis Review

Arvind Remedies Ltd (Arvind Remedies Ltd) is an independent health care pharmaceutical organization. The company is involved in de
2011 250,00$

OPKO Health, Inc. (OPK) - Financial and Strategic SWOT Analysis Review

OPKO Health, Inc. (OPKO) is a publicly held US-based specialty healthcare company. The company is principally engaged in the disc
2011 250,00$

BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic SWOT Analysis Review

BrainStorm Cell Therapeutics Inc. (BrainStorm Cell Therapeutics Inc.) is an independent biotechnology company. The company is invo
2011 250,00$

XTL Biopharmaceuticals Ltd. (XTLBY) - Financial and Strategic SWOT Analysis Review

XTL Biopharmaceuticals Ltd. (XTL) is a publicly held engaged in the acquisition, development and commercialization of therapeutics
2011 250,00$

Healthscreen Solutions Inc. (MDU) - Financial and Strategic SWOT Analysis Review

Healthscreen Solutions Inc. (Healthscreen) is a publicly held Canada-based healthcare company. The company is principally engaged
2011 250,00$

Alembic Limited (ALEMBICLTD) - Financial and Strategic SWOT Analysis Review

Alembic Limited (Alembic Limited) is an Indian based pharmaceutical company engaged in manufacturing of fermentation and chemistry
2011 125,00$

Transcat, Inc. (TRNS) - Financial and Strategic SWOT Analysis Review

Transcat, Inc. (Transcat) is a publicly held US-based company. The company is principally engaged in distribution of calibrators,
2011 250,00$

Bone Medical Limited (BNE) - Financial and Strategic SWOT Analysis Review

Bone Medical Limited (Bone Medical) is a publicly held US-based bio pharmaceutical development stage company. The company is princ
2011 250,00$

Transgenomic, Inc. (TBIO) - Financial and Strategic SWOT Analysis Review

Transgenomic, Inc.(Transgenomic) is a publicly held US-based biotechnology company. The company is principally engaged in providin
2011 250,00$

ALDA Pharmaceuticals Corp. (APH) - Financial and Strategic SWOT Analysis Review

ALDA Pharmaceuticals Corp. (ALDA) is a British Columbia based disinfectant manufacturing company. It focuses on the production and
2011 125,00$

Genera Biosystems Limited (GBI) - Financial and Strategic SWOT Analysis Review

Genera Biosystems Limited (Genera) is an Australia-based company. It is engaged in development and commercialization of multiplexe
2011 125,00$

Genesis Research and Development Corporation Ltd. (GEN) - Financial and Strategic SWOT Analysis Review

Genesis Research and Development Corporation Ltd. (Genesis) is a publicly held NewZealand-based biotechnology company. The company
2011 250,00$

Genoptix, Inc. (GXDX) - Financial and Strategic SWOT Analysis Review

Genoptix, Inc (Genoptix) is a specialized laboratory service provider engaged in delivering personalized and comprehensive diagnos
2011 125,00$

HearUSA, Inc. (HEARQ) - Financial and Strategic SWOT Analysis Review

HearUSA, Inc. (HearUSA, Inc.) is an independent diagnostic organization. The company is involved in providing hearing care product
2011 250,00$

Advitech Inc. (AVI) - Financial and Strategic SWOT Analysis Review

Advitech Inc. (Advitech) is a publicly held pharmaceutical company that is engaged in research, development and marketing of natur
2011 250,00$

IBEX Technologies Inc. (IBT) - Financial and Strategic SWOT Analysis Review

IBEX Technologies, Inc. (IBEX Technologies, Inc.) is a Canada based pharmaceutical organization. The company is mainly involved in
2011 250,00$

iCo Therapeutics Inc. (ICO) - Financial and Strategic SWOT Analysis Review

iCo Therapeutics Inc. (iCo) is a biotechnology company engaged in developing and commercializing drug candidates for treating ocul
2011 250,00$

Nutex Plc (NUTEX) - Financial and Strategic SWOT Analysis Review

Nutex Plc (Nutex) formerly known as Humet Nyrt. is a privately held specialty pharmaceutical company that is engaged in research,
2011 250,00$

Pressure BioSciences, Inc. (PBIO) - Financial and Strategic SWOT Analysis Review

Pressure BioSciences, Inc. (PBI) is a publicly held life sciences company. It is engaged in the development and commercialization
2011 250,00$

ValiRx Plc (VAL) - Financial and Strategic SWOT Analysis Review

ValiRx Plc (ValiRx) is a publicly held biopharmaceutical company engaged in the development of novel technologies and products for
2011 250,00$

Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis Review

Neuralstem, Inc. (Neuralstem) is a publicly held research focused biotechnology company, engaged in research, development and comm
2011 250,00$

IMMUNOSYN CORPORATION (IMYN) - Financial and Strategic SWOT Analysis Review

Immunosyn Corporation (Immunosyn) is a publicly held company that is engaged in marketing and distributng pharmaceuticals. The com
2011 250,00$

Integrated BioPharma, Inc. (INBP) - Financial and Strategic SWOT Analysis Review

Integrated BioPharma, Inc. (Integrated BioPharma) is a publicly held US-based bio pharmaceutical company. The company is principal
2011 250,00$

IntelGenx Corp. (IGXT) - Financial and Strategic SWOT Analysis Review

IntelGenx Corp. (IntelGenx) is a publicly held drug delivery company. It is engaged in the development of therapeutics using orall
2011 125,00$

Genfit (ALGFT) - Financial and Strategic SWOT Analysis Review

Genfit (Genfit) is a publicly held biopharmaceutical company specialized in developing medicines for the early prevention and trea
2011 250,00$

Antibiotice SA (ATB) - Financial and Strategic SWOT Analysis Review

Antibiotice SA (Antibiotice SA) is an independent health care pharmaceutical organization. The industry is mainly involved in manu
2011 250,00$

Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review

Apex Healthcare Berhad (APEX) is a publicly held Malaysia-based pharmaceutical company. The company is principally engaged in manu
2011 250,00$

Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic SWOT Analysis Review

Can-Fite BioPharma Ltd.(Can-Fite) is a publicly held biopharmaceutical company engaged in development of molecule-based drugs for
2011 250,00$

Ascent Pharmahealth Limited (APH) - Financial and Strategic SWOT Analysis Review

Ascent Pharmahealth Limited (Ascent Pharmahealth Limited) is an independent health care pharmaceutical organization. This organiza
2011 250,00$

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (International Stem Cell) is a publicly held biotechnology company. It is focused on developin
2011 250,00$

IsoRay, Inc. (ISR) - Financial and Strategic SWOT Analysis Review

IsoRay, Inc., (IsoRay) is a publicly traded US-based pharmaceutical company. The company is principally engaged in producing thera
2011 250,00$

Arrowhead Research Corporation (ARWR) - Financial and Strategic SWOT Analysis Review

Arrowhead Research Corporation (Arrowhead) is a public nanotechnology company. It is principally focusing on the development, comm
2011 250,00$

Krka d.d. Novo Mesto (KRKG) - Financial and Strategic SWOT Analysis Review

Krka d.d. Novo Mesto (Krka) is a Slovenia-based pharmaceutical company. It engages in the development, production, sale and distri
2011 125,00$

LAB Research Inc (LRI) - Financial and Strategic SWOT Analysis Review

LAB Research Inc. (LAB Research) is a publicly held Canadian, in-vivo nonclinical contract research organization. The company has
2011 250,00$

Livzon Pharmaceutical Group Inc. (200513) - Financial and Strategic SWOT Analysis Review

Livzon Pharmaceutical Group Inc. (Livzon) is a publicly held China-based company. The company is principally engaged in the develo
2011 125,00$

Marshall Edwards, Inc. (MSHL) - Financial and Strategic SWOT Analysis Review

Marshall Edwards Inc. (MEI) is a publicly held Australian-based pharmaceutical company. The company is principally involved in th
2011 250,00$

Medicure Inc. (MPH) - Financial and Strategic SWOT Analysis Review

Medicure Inc. (Medicure), is a publicly held bio-pharmaceutical company. It is involved in research, development and commercializa
2011 250,00$

Basilea Pharmaceutica Ltd. (BSLN) - Financial and Strategic SWOT Analysis Review

Basilea Pharmaceutica Ltd. (Basilea) is a publicly held Switzerland-based pharmaceutical company. The company is principally engag
2011 250,00$

Medivir AB (MVIRB) - Financial and Strategic SWOT Analysis Review

Medivir AB (Medivir) is a research focused pharmaceuticals company engaged in the development of products for high-value treatment
2011 125,00$

Benda Pharmaceutical, Inc. (BPMA) - Financial and Strategic SWOT Analysis Review

Benda Pharmaceutical, Inc. (Benda Pharmaceutical, Inc) is an independent China based health care pharmaceutical organization. The
2011 250,00$

Calzada Limited (CZD) - Financial and Strategic SWOT Analysis Review

Calzada Limited (Calzada), formerly Metabolic Pharmaceuticals Limited is an Australian based biotechnology company which developed
2011 125,00$

Microbix Biosystems Inc. (MBX) - Financial and Strategic SWOT Analysis Review

Microbix Biosystems Inc. (Microbix) is a biotechnology company engaged in the development, manufacturing and distribution of cell-
2011 125,00$

Medwell Capital Corp. (MWC) - Financial and Strategic SWOT Analysis Review

Medwell Capital Corp. (Medwell) is a publicly held biotechnology company. It is engaged in the development and commercialization o
2011 250,00$

Bionomics Limited (BNO) - Financial and Strategic SWOT Analysis Review

Bionomics Limited is a pharmaceuticals company engaged in research and development of innovative therapeutics for cancer and disea
2011 125,00$

Biosignal Limited (BOSDA) - Financial and Strategic SWOT Analysis Review

Biosignal Limited (Biosignal) is a publicly held Australia-based biotechnology company. The company primarily focused on research
2011 250,00$

BIOTON S.A. (BIO) - Financial and Strategic SWOT Analysis Review

BIOTON S.A.(BIOTON) is a publicly held biotechnological company engaged in the manufacture and distribution of pharmaceutical prod
2011 250,00$

BMP Sunstone Corp. (BJGP) - Financial and Strategic SWOT Analysis Review

BMP Sunstone Corp. (BMP Sunstone) is a publicly held US-based pharmaceutical company. The company is principally engaged in the ma
2011 250,00$

Neurobiological Technologies, Inc. (NTII) - Financial and Strategic SWOT Analysis Review

Neurobiological Technologies, Inc. (NTI) is a publicly held US-based drug development company. The company is principally engaged
2011 250,00$

NeuroDiscovery Ltd (NDL) - Financial and Strategic SWOT Analysis Review

NeuroDiscovery Ltd (NeuroDiscovery) is a publicly held Australian-based pharmaceutical company. The company is principally engaged
2011 250,00$

NeurogesX, Inc. (NGSX) - Financial and Strategic SWOT Analysis Review

NeurogesX, Inc. (NeurogesX) is a publicly held US-based bio-pharmaceutical company. The company is principally engaged in the deve
2011 250,00$

NicOx SA (COX) - Financial and Strategic SWOT Analysis Review

NicOx SA (NicOx) is an independent one of the largest pharmaceutical company of the France. The company is mainly involved in the
2011 250,00$

Northstar Healthcare Inc. (NHC) - Financial and Strategic SWOT Analysis Review

Northstar Healthcare Inc. (Northstar Healthcare) is a publicly held US-based full-scale ASC development and management company. Th
2011 250,00$

NovaBay Pharmaceuticals, Inc. (NBY) - Financial and Strategic SWOT Analysis Review

NovaBay Pharmaceuticals, Inc. (NovaBay) is a publicly held biopharmaceutical company. It is focused on developing innovative produ
2011 250,00$

ChemGenex Pharmaceuticals Limited (CXS) - Financial and Strategic SWOT Analysis Review

ChemGenex Pharmaceuticals Limited (ChemGenex Pharmaceuticals) is an Australia based genomics-driven pharmaceutical development com
2011 250,00$

Chengzhi Co., Ltd (000990) - Financial and Strategic SWOT Analysis Review

Chengzhi Co., Ltd (Chengzhi) is a pharmaceutical company based in China. The company is involved in offering biological products a
2011 125,00$

Nuvo Research Inc. (NRI) - Financial and Strategic SWOT Analysis Review

Nuvo Research Inc. (Nuvo Research) is a publicly held pharmaceutical company. It is engaged in the research and development(R&D) o
2011 250,00$

Chongqing Huapont Pharm. Co., Ltd. (002004) - Financial and Strategic SWOT Analysis Review

Chongqing Huapont Pharm. Co., Ltd. (Chongqing Huapont) is a publicly held China-based pharmaceutical company. The company is princ
2011 250,00$

Circadian Technologies Limited (CIR) - Financial and Strategic SWOT Analysis Review

Circadian Technologies Limited (Circadian Technologies Limited) is an independent united based pharmaceutical organization. The co
2011 250,00$

Cleveland BioLabs, Inc. (CBLI) - Financial and Strategic SWOT Analysis Review

Cleveland BioLabs, Inc. (Cleveland) is a publicly held research based biotechnology company. It is engaged in the development of i
2011 250,00$

Omega Pharma NV (OME) - Financial and Strategic SWOT Analysis Review

Omega Pharma NV (Omega Pharma) is a Belgium based healthcare products and services provider engaged mainly in OTC and personal car
2011 125,00$

Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis Review

Oncothyreon Inc. (Oncothyreon) is a publicly held clinical-stage biopharmaceutical company. It is principally engaged in the devel
2011 250,00$

Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic SWOT Analysis Review

Opexa Therapeutics, Inc. (Opexa) is a publicly held pharmaceutical company. It is engaged in the development of autologous cellula
2011 250,00$

Compugen Ltd. (CGEN) - Financial and Strategic SWOT Analysis Review

Compugen, Ltd. (Compugen) is a biotechnology company based in Israel. The company is involved in developing, producing and marketi
2011 250,00$

OPMEDIC Group Inc. (OMG) - Financial and Strategic SWOT Analysis Review

OPMEDIC Group Inc. (OPMEDIC Group) is a publicly held Canada-based healthcare services company. The company is principally engaged
2011 250,00$

Ore Pharmaceuticals Inc (ORXE) - Financial and Strategic SWOT Analysis Review

Ore Pharmaceuticals Inc (Ore Pharmaceuticals) is a US-based public drug development company. The company engages in development of
2011 250,00$

Osta Biotechnologies Inc. (OBI) - Financial and Strategic SWOT Analysis Review

Osta Biotechnologies Inc. (Osta) is a publicly held biopharmaceutical company. It is engaged in the research and development work
2011 250,00$

OXiGENE, Inc. (OXGN) - Financial and Strategic SWOT Analysis Review

OXiGENE, Inc. (OXiGENE) is a US-based biopharmaceutical company. It engages in development of therapeutics to treat cancer and e
2011 250,00$

Pacgen Biopharmaceuticals Corporation (PGA) - Financial and Strategic SWOT Analysis Review

Pacgen Biopharmaceuticals Corporation (Pacgen) is Canada-based life science company. It is engages in developing therapeutics wh
2011 250,00$

Pacific Biomarkers, Inc. (PBMC) - Financial and Strategic SWOT Analysis Review

Pacific Biomarkers, Inc. (PBI) is a publicly held US-based healthcare service provider company. The company is principally engaged
2011 250,00$

Patrys Limited (PAB) - Financial and Strategic SWOT Analysis Review

Patrys Limited (Patrys) is a publicly held Australia-based company. The company is principally engaged in the commercialization of
2011 250,00$

ConjuChem Biotechnologies Inc. (CJB) - Financial and Strategic SWOT Analysis Review

ConjuChem Biotechnologies Inc. (ConjuChem) is a publicly held Canada-based biotechnology company. The company is principally engag
2011 250,00$

Medigen Biotechnology Corp. (3176) - Financial and Strategic SWOT Analysis Review

Medigen Biotechnology Corp. (MBC) is a publicly held pharmaceutical company. It is engaged in the research and development of new
2011 250,00$

Cosmo Pharmaceuticals S.p.A (CQ1) - Financial and Strategic SWOT Analysis Review

Cosmo Pharmaceuticals S.p.A (Cosmo) is a publicly held speciality pharmaceutical company engaged in developing therapies for selec
2011 250,00$

Peregrine Pharmaceuticals, Inc. (PPHM) - Financial and Strategic SWOT Analysis Review

Peregrine Pharmaceuticals, Inc. (Peregrine) is a publicly held pharmaceutical company. It is engaged in the development and manufa
2011 250,00$

Critical Outcome Technologies Inc. (COT) - Financial and Strategic SWOT Analysis Review

Critical Outcome Technologies Inc. (Critical Outcome Technologies) is Canada-based pharmaceutical biotechnology industry. The comp
2011 250,00$

Pharmanet Group Ltd (PNO) - Financial and Strategic SWOT Analysis Review

Pharmanet Group Limited (Pharmanet) is a biotechnology and pharmaceutical company which is principally engaged in research, develo
2011 250,00$

Pharmasset, Inc (VRUS) - Financial and Strategic SWOT Analysis Review

Pharmasset, Inc. (Pharmasset.) is a health care pharmaceutical company. The company is engaged in discovering, producing and comme
2011 250,00$

PharmAthene, Inc. (PIP) - Financial and Strategic SWOT Analysis Review

PharmAthene, Inc. (PharmAthene), was formerly known as Healthcare Acquisition Corp. It is a bio-defense company. It deals with the
2011 250,00$

PharmAust Limited (PAA) - Financial and Strategic SWOT Analysis Review

PharmAust Limited (PharmAust) is an Australia-based biopharmaceutical company that is engaged in the development of drug discovery
2011 125,00$

Cytopia Limited (CYT) - Financial and Strategic SWOT Analysis Review

Cytopia Limited (Cytopia) is principally engaged in the development of targeted small molecule therapeutics for cancer. In additio
2011 250,00$

Pharmaxis Ltd. (PXS) - Financial and Strategic SWOT Analysis Review

Pharmaxis Ltd. (Pharmaxis) is a publicly held Australian-based pharmaceutical company. The company is principally engaged in the d
2011 250,00$

Symyx Technologies, Inc. (SMMX) - Financial and Strategic SWOT Analysis Review

Symyx Technologies, Inc. (Symyx) is a public scientific company. The company's product portfolio comprises of software, databases,
2011 250,00$

Transcept Pharmaceuticals, Inc. (TSPT) - Financial and Strategic SWOT Analysis Review

Transcept Pharmaceuticals, Inc. (Transcept) is a publicly held US based specialty pharmaceutical company. The company deals with t
2011 250,00$

Stellar Pharmaceuticals Inc. (SLXCF) - Financial and Strategic SWOT Analysis Review

Stellar Pharmaceuticals Inc. (Stellar) is a publicly held Canadian based health care company. It is engaged in the development of
2011 250,00$

Gujarat Themis Biosyn Ltd. (506879) - Financial and Strategic SWOT Analysis Review

Gujarat Themis Biosyn Ltd. (Gujarat Themis Biosyn Ltd.) is an independent pharmaceutical heath care industry. The industry is prin
2011 250,00$

TopoTarget A/S (TOPO) - Financial and Strategic SWOT Analysis Review

TopoTarget A/S (TopoTarget) is a biotechnology company engaged in the discovery, development and commercialization of treatments f
2011 250,00$

Phase Forward Incorporated (PFWD) - Financial and Strategic SWOT Analysis Review

Phase Forward Incorporated (Phase Forward) is a publicly held US-based company. The company is principally engaged in providing i
2011 125,00$

Shandong Donge E-jiao Co.,Ltd (000423) - Financial and Strategic SWOT Analysis Review

Shandong Donge E-jiao Co.,Ltd (Shandong) is a publicly held China based pharmaceutical company. It is engaged in the production of
2011 125,00$

Hubei Guangji Pharmaceutical Co.,Ltd. (000952) - Financial and Strategic SWOT Analysis Review

Hubei Guangji Pharmaceutical Co., Ltd. (Hubei Guangji Pharmaceutical Co., Ltd.) is an independent health cared pharmaceutical indu
2011 250,00$

Somaxon Pharmaceuticals, Inc. (SOMX) - Financial and Strategic SWOT Analysis Review

Somaxon Pharmaceuticals, Inc. (Somaxon) is a publicly held research focused specialty pharmaceutical company. It is engaged in res
2011 250,00$

XELR8, Inc (XELR) - Financial and Strategic SWOT Analysis Review

XELR8, Inc (XELR8) is a publicly held US based pharmaceutical company. It is engaged delivering products related to nutritional su
2011 250,00$

Senetek PLC (SNKTY) - Financial and Strategic SWOT Analysis Review

Senetek PLC (Senetek) is a public biotechnology company. It is engaged in the development of technologies, targeting skin care an
2011 250,00$

Puleva Biotech S.A. (BIO) - Financial and Strategic SWOT Analysis Review

Puleva Biotech S.A. (Puleva) is a publicly held Spain based pharmaceutical company engaged in production of functional foods. The
2011 250,00$

Orient Europharma Co., Ltd. (4120) - Financial and Strategic SWOT Analysis Review

Orient Europharma Co., Ltd. (Orient Europharma) is a publicly held Taiwan-based company. It engages in the production of pharmaceu
2011 250,00$

Quality Healthcare Asia Limited (0593) - Financial and Strategic SWOT Analysis Review

Quality Healthcare Asia Limited (Quality HealthCare) is a publicly held company that is engaged in providing healthcare services,
2011 250,00$

China Yongxin Pharmaceuticals Inc. (CYXN) - Financial and Strategic SWOT Analysis Review

China Yongxin Pharmaceuticals Inc (China Yongxin) also known as Changchun Yongxin Dirui Medical Company is a publicly held Chinese
2011 250,00$

Lend Lease Primelife Group (LLP) - Financial and Strategic SWOT Analysis Review

Lend Lease Primelife Group (LLPG) is a publicy held company which was formerly known as Babcock & Brown Communities Limited is eng
2011 250,00$

Zhejiang NHU Company Ltd. (002001) - Financial and Strategic SWOT Analysis Review

Zhejiang Nhu Company Ltd. (NHU), is a publicly held pharmaceutical company that is engaged in production and distribution of natur
2011 125,00$

Vinati Organics Limited (VINATIORGA) - Financial and Strategic SWOT Analysis Review

Vinati Organics Ltd. (VOL) is publicly held company engaged in manufacturing organic intermediates, monomers and polymers and othe
2011 250,00$

Shanghai RAAS Blood Products Co., Ltd. (002252) - Financial and Strategic SWOT Analysis Review

Shanghai RAAS Blood Products Co., Ltd (Shanghai RAAS) is a publicly held biotechnology company. It is engaged in the production of
2011 250,00$

RehabCare Group, Inc. (RHB) - Financial and Strategic SWOT Analysis Review

RehabCare Group, Inc. (RehabCare) is one of the leading providers of physical rehabilitation program management services in the US
2011 125,00$

Longlife Group Holdings Limited (8037) - Financial and Strategic SWOT Analysis Review

Longlife Group Holdings Limited (LGH) is a publicly held company engaged in manufacturing, distributing, research and development
2011 250,00$

The Ensign Group, Inc. (ENSG) - Financial and Strategic SWOT Analysis Review

The Ensign Group, Inc. (Ensign Group) is a public company that is engaged in providing health care facility and long-term care. Th
2011 125,00$

Nestor Healthcare Group plc (NSR) - Financial and Strategic SWOT Analysis Review

Nestor Healthcare Group plc (Nestor) is an UK based holding company. The company principally provides managed services for health
2011 125,00$

Aceto Corporation (ACET) - Financial and Strategic SWOT Analysis Review

Aceto Corporation (Aceto) is a pharmaceutical company engaged in sourcing, quality assurance, regulatory support, marketing and di
2011 125,00$

Yungjin Pharm Ind. Co., Ltd. (003520) - Financial and Strategic SWOT Analysis Review

Yungjin Pharm Ind. Co., Ltd. (Yungjin) is a publicly held pharmaceutical company that is engaged in developing, manufacturing and
2011 250,00$

Yuyu Pharma, Inc. (000220) - Financial and Strategic SWOT Analysis Review

Yuyu Pharma, Inc. (Yuyu) is a publicly held research focused pharmaceuticals company engaged in manufacturing of pharmaceuticals.
2011 250,00$

Zentiva S.A. (SCD) - Financial and Strategic SWOT Analysis Review

Zentiva S.A. (Zentiva) is a publicly held pharmaceutical company that is engaged in developing, manufacturing and commercializatio
2011 250,00$

Toho Holdings Company Ltd. (8129) - Financial and Strategic SWOT Analysis Review

Toho Holdings Company Ltd. (Toho Pharmaceutical) is a pharmaceutical wholesaler, operating as a subsidiary of the Kyoso Mirai Grou
2011 125,00$

Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic SWOT Analysis Review

Sogo Clinical Holdings Co., Ltd. (Sogo) is a Japan-based pharmaceutical company. It engages in providing clinical trials to hospit
2011 250,00$

Bioanalytical Systems, Inc. (BASI) - Financial and Strategic SWOT Analysis Review

Bioanalytical Systems, Inc. (Bioanalytical Systems, Inc.) is an independent biomedical pharmaceutical industry. The company is eng
2011 250,00$

Health Management International Ltd. (588) - Financial and Strategic SWOT Analysis Review

Health Management International Ltd. (HMI) is public company that is principally engaged in providing healthcare and educational s
2011 250,00$

Procter & Gamble Hygiene & Health Care Limited (500459) - Financial and Strategic SWOT Analysis Review

Procter & Gamble Hygiene & Health Care Limited (PGHHCL) is a public company that is engaged in providing consumer goods (FMCG) in
2011 125,00$

Wanbury Limited (524212) - Financial and Strategic SWOT Analysis Review

Wanbury Limited (Wanbury) is a publicly held pharmaceutical company that offers domestic branded drugs and pharmaceuticals as well
2011 250,00$

Kilitch Drugs (India) Ltd. (KILITCH) - Financial and Strategic SWOT Analysis Review

Kilitch Drugs (India) Ltd. (Kilitch) is a publicly held pharmaceutical company engaged in manufacturing and marketing of various r
2011 250,00$

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

Vita 34 International AG (Vita 34) is a publicly held biotechnology company. It operates as a umbilical cord blood bank. The compa
2011 250,00$

Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic SWOT Analysis Review

Wakamoto Pharmaceutical Co., Ltd. (Wakamoto) is a publicly held pharmaceutical company that is engaged in manufacturing of over th
2011 250,00$

Dishman Pharmaceuticals & Chemicals Ltd. (532526) - Financial and Strategic SWOT Analysis Review

Dishman Pharmaceuticals & Chemicals Ltd. (Dishman) is a public company that is engaged in manufacturing and commercialization of b
2011 125,00$

William Ransom & Son PLC (RNSM) - Financial and Strategic SWOT Analysis Review

William Ransom & Son PLC (William Ransom) is publicly held company engaged in supply of branded medicines, vitamins, and food supp
2011 250,00$

Goldshield Group plc (GSD) - Financial and Strategic SWOT Analysis Review

Goldshield Group Plc (Goldshield Group Plc.) is UK based pharmaceutical industry. The company is involved in development and comme
2011 125,00$

Sinclair Pharma Plc (SPH) - Financial and Strategic SWOT Analysis Review

Sinclair Pharma Plc (Sinclair) is a public company operating as a global specialty pharmaceutical company that focuses on developi
2011 250,00$

Yamane Medical Co., Ltd. (2144) - Financial and Strategic SWOT Analysis Review

Yamane Medical Co., Ltd. (Yamane Medical) is a publicly held company providing services in nursing and home care. The company oper
2011 250,00$

PT Bristol-Myers Squibb Indonesia Tbk (SQBB) - Financial and Strategic SWOT Analysis Review

PT Bristol-Myers Squibb Indonesia Tbk (PT Bristol) is a publicly held Indonesia based pharmaceutical company. It is engaged in th
2011 250,00$

Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review

Y.S.P. Southeast Asia Holding Berhad (Y.S.P SAH) is a pharmaceutical company, which is engaged in producing, importing, exporting
2011 250,00$

Dynacq Healthcare, Inc. (DYII) - Financial and Strategic SWOT Analysis Review

Dynacq Healthcare, Inc. (DHI) is a US based public company. The company is involved in the development, management of general acut
2011 250,00$

HYGEIA Hospital S.A. (HYGEIA) - Financial and Strategic SWOT Analysis Review

HYGEIA Hospital S.A. (Hygeia) is a Greece based hospital involved in offering healthcare services. The hospital offers a range of
2011 125,00$

Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (000522) - Financial and Strategic SWOT Analysis Review

Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (BYS) is a biopharmaceutical company. The company is involved in the research and de
2011 125,00$

Manchester International Hlgs Unltd Corp (MIHB) - Financial and Strategic SWOT Analysis Review

Manchester International Holdings Unlimited Corporation (Manchester International) is a publicly held Philippines-based pharmaceut
2011 250,00$

EASY BIO System, Inc. (035810) - Financial and Strategic SWOT Analysis Review

EASY BIO System, Inc. (EASY BIO System) is a fully integrated biotechnology company. The company is involved in the research and d
2011 125,00$

OAO VEROPHARM (VRPH) - Financial and Strategic SWOT Analysis Review

OAO VEROPHARM (Verofarm) is a publicly held Russia based generic pharmaceutical company. It is engaged in the development and manu
2011 125,00$

WhanIn Pharmaceutical Co., Ltd. (016580) - Financial and Strategic SWOT Analysis Review

WhanIn Pharmaceutical Co., Ltd. (WhanIn) is a publicly held Korea based pharmaceutical company. It is engaged in the development,
2011 250,00$

Wooridul Life Sciences Ltd (118000) - Financial and Strategic SWOT Analysis Review

Wooridul Life Sciences Ltd (Wooridul Life) is a publicly held Korean based pharmaceutical company. It is engaged in manufacturing
2011 250,00$

Cipla Medpro South Africa Limited (CMP) - Financial and Strategic SWOT Analysis Review

Cipla Medpro South Africa Limited (Cipla Medpro) is a pharmaceutical company. It is engaged in the manufacturing, marketing and su
2011 250,00$

Midelfart Sonesson AB (MSON B) - Financial and Strategic SWOT Analysis Review

Midelfart Sonesson AB (Midelfart Sonesson) is a publicly held Swedan based pharmaceutical company. It is engaged in the developme
2011 125,00$

Krungdhon Hospital Public Company Ltd. (KDH) - Financial and Strategic SWOT Analysis Review

Krungdhon Hospital Public Company Ltd. (KDH) is a publicly held healthcare services company. The company operates two general hosp
2011 250,00$

Wattana Karnpaet PCL (NEW) - Financial and Strategic SWOT Analysis Review

Wattana Karnpaet PCL (Wattana) is a publicly held Thailand based pharmaceutical company. It is engaged in providing health care fa
2011 250,00$

Vibhavadi Medical Center Public Co. Ltd. (VIBHA) - Financial and Strategic SWOT Analysis Review

Vibhavadi Medical Center Public Co. Ltd. (Vibhavadi) is a publicly held Thailand based hospital, engaged in providing health care
2011 250,00$

Ramkhamhaeng Hospital (RAM) - Financial and Strategic SWOT Analysis Review

Ramkhamhaeng Hospital (Ramkhamhaeng) is publicly held hospital providing specialty healthcare services. The hospital offers specia
2011 250,00$

Nonthavej Hospital Public Company Ltd. (NTV) - Financial and Strategic SWOT Analysis Review

Nonthavej Hospital Public Company Ltd. (Nonthavej Hospital) is a publicly held hospital that is engaged in providing a broad range
2011 250,00$

TECHNE Corporation (TECH) - Financial and Strategic SWOT Analysis Review

TECHNE Corporation (TECHNE) is a holding company engaged in the development, production and sale of biotechnology products and hem
2011 125,00$

Medical Care Service Company Inc. (2494) - Financial and Strategic SWOT Analysis Review

Medical Care Service Company Inc. (MCSC) is a publicly held long term care service provider company that operates assisted living
2011 250,00$

J. Bridge Corp. (9318) - Financial and Strategic SWOT Analysis Review

J. Bridge Corp. (J. Bridge) is a Japan based publicly held company that is engaged in providing outsourcing services to medical an
2011 250,00$

Khimiko-farmatsevticheskiy kombinat Akrikhin OAO (AKPH) - Financial and Strategic SWOT Analysis Review

Khimiko-farmatsevticheskiy kombinat Akrikhin OAO (Akrikhin) is a publicly held Russia based company. It is engaged in the developm
2011 250,00$

Selcuk Ecza Deposu Ticaret ve Sanayi A.S (SELEC) - Financial and Strategic SWOT Analysis Review

Selcuk Ecza Deposu Ticaret ve Sanayi A.S (Selcuk Ecza) is a public company that operates as a distribution channel between drug ma
2011 125,00$

HemaCare Corporation (HEMA) - Financial and Strategic SWOT Analysis Review

HemaCare Corporation (HemaCare) is a public company based in the US. The company in mainly focusing in offering blood related prod
2011 250,00$

Igene Biotechnology, Inc. (IGNE) - Financial and Strategic SWOT Analysis Review

Igene Biotechnology, Inc. (Igene) is a biotechnology company based in the US. The company is involved in developing and commercial
2011 250,00$

IGI Laboratories, Inc. (IG) - Financial and Strategic SWOT Analysis Review

IGI Laboratories, Inc. (IGI) is a pharmacuetical company. The company is involved in developing, manufacturing, filling and packag
2011 250,00$

Natural Alternatives International, Inc. (NAII) - Financial and Strategic SWOT Analysis Review

Natural Alternatives International, Inc. (NAI) is a publicly held company engaged in formulation and manufacturing of customized n
2011 250,00$

Poniard Pharmaceuticals, Inc. (PARD) - Financial and Strategic SWOT Analysis Review

Poniard Pharmaceuticals, Inc. (Poniard) is a publicly held bio-pharmaceutical company engaged in developing and commercializing ca
2011 250,00$

Psychemedics Corporation (PMD) - Financial and Strategic SWOT Analysis Review

Psychemedics Corporation (Psychemedics) engages in providing drug testing services for the identification of abused substances by
2011 125,00$

Repligen Corporation (RGEN) - Financial and Strategic SWOT Analysis Review

Repligen Corporation (Repligen) is a US-based research focused bio pharmaceutical company. The company is engaged in developing i
2011 250,00$

HST Global Inc. (HSTC) - Financial and Strategic SWOT Analysis Review

HST Global, Inc. (HST Global) is public healthcare services company. It is primarily involved in the acquisition, development and
2011 250,00$

Champions Biotechnology, Inc. (CSBR) - Financial and Strategic SWOT Analysis Review

Champions Biotechnology, Inc. (Champions Biotechnology) is a biotechnology company. It is involved in developing potential drugs.
2011 250,00$

U.S. Physical Therapy, Inc. (USPH) - Financial and Strategic SWOT Analysis Review

U.S. Physical Therapy, Inc. (USPh) is a publicly held pharmaceutical company engaged in providing physical and occupational therap
2011 125,00$

Repros Therapeutics Inc. (RPRX) - Financial and Strategic SWOT Analysis Review

Repros Therapeutics, Inc., (Repros) is US- based public biopharmaceutical company. The company is involved in the development of m
2011 250,00$

Advocat Inc. (AVCA) - Financial and Strategic SWOT Analysis Review

Advocat Inc. (Advocat) is a public company offering a wide range of long-term care services to nursing home patients. Advocat is o
2011 125,00$

NeoStem, Inc. (NBS) - Financial and Strategic SWOT Analysis Review

NeoStem, Inc. (NeoStem), is a US based company acts as a adult stem cell bank. It is formerly known as Phase III Medical, Inc. Th
2011 250,00$

Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic SWOT Analysis Review

Oncogenex Pharmaceuticals, Inc. (OncoGenex) is involved in developing research focused biopharmaceutical products. It is involved
2011 250,00$

Conmed Healthcare Management, Inc. (CONM) - Financial and Strategic SWOT Analysis Review

Conmed Healthcare Management, Inc. (Conmed) is a US based healthcare services provider. The company is engaged in offering healthc
2011 250,00$

Cadus Corporation (KDUS) - Financial and Strategic SWOT Analysis Review

Cadus Corporation (Cadus) is the US based pharmaceutical pharmaceutical company develop products related using genetically enginee
2011 250,00$

PHC, Inc. (PHC) - Financial and Strategic SWOT Analysis Review

PHC, Inc., (Pioneer Behavioral Health) is a healthcare company that is engaged in offering behavioral healthcare services to its c
2011 250,00$

Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic SWOT Analysis Review

Titan Pharmaceuticals, Inc. (Titan Pharmaceuticals) is a US based biopharmaceutical company. The company is engaged in the develop
2011 250,00$

Continucare Corporation (CNU) - Financial and Strategic SWOT Analysis Review

Continucare Corporation (Continucare) is a publicly held company that is engaged in providing primary care physician services. It
2011 125,00$

Symbollon Pharmaceuticals, Inc. (SYMBA) - Financial and Strategic SWOT Analysis Review

Symbollon Pharmaceuticals, Inc. (Symbollon) is a pharmaceutical company that is focused on the development and commercialization o
2011 250,00$

UCI Medical Affiliates, Inc. (UCIA) - Financial and Strategic SWOT Analysis Review

UCI Medical Affiliates, Inc. (UCI Medical) is a publicly traded specialty pharmaceutical company. This company is engaged in prov
2011 250,00$

Encorium Group, Inc. (ENCO) - Financial and Strategic SWOT Analysis Review

Encorium Group, Inc. (Encorium) is a US based service contract research organization. Encorium has specialization in the therapeut
2011 250,00$

Capital Senior Living Corporation (CSU) - Financial and Strategic SWOT Analysis Review

Capital Senior Living Corporation (Capital Senior Living) is a US based service providing company. It is involved in offering livi
2011 125,00$

SIGA Technologies, Inc. (SIGA) - Financial and Strategic SWOT Analysis Review

SIGA Technologies, Inc. (SIGA) is a US- based public company. The company engages in research, development and commercialization o
2011 250,00$

Sanguine Corporation (SGUI) - Financial and Strategic SWOT Analysis Review

Sanguine Corporation (Sanguine) is a pharmaceutical company, engaged in the development of oxygen carriers used by the medical pro
2011 250,00$

CRYO-CELL International, Inc. (CCEL) - Financial and Strategic SWOT Analysis Review

Cryo-Cell International, Inc. (Cryo-Cell) is a public trade biotechnology company. It is involved in cellular processing and cryop
2011 250,00$

Birner Dental Management Services, Inc. (BDMS) - Financial and Strategic SWOT Analysis Review

Birner Dental Management Services, Inc. (BDMS) is a US based medical device company. It is involved in providing common dentistry
2011 250,00$

Mera Pharmaceuticals, Inc. (MRPI) - Financial and Strategic SWOT Analysis Review

Mera Pharmaceuticals, Inc. (Mera) is a publicly held biotechnology company involved in developing natural astaxanthin derived from
2011 250,00$

Proteonomix, Inc. (PROT) - Financial and Strategic SWOT Analysis Review

Proteonomix, Inc. (Proteonomix) is a start-up stage biotechnology company engaged in providing regenerative stem cell therapies an
2011 250,00$

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

Protalix BioTherapeutics, Inc. (Protalix) is a Israel-basedpublic biopharmaceutical company. The company is engages in developin
2011 250,00$

PhytoMedical Technologies, Inc. (PYTO) - Financial and Strategic SWOT Analysis Review

PhytoMedical Technologies, Inc. (PhytoMedical) is a publicly held biopharmaceutical company. It is engaged in discovery, acquisiti
2011 250,00$

Sharps Compliance Corp. (SMED) - Financial and Strategic SWOT Analysis Review

Sharps Compliance Corp. (Sharps) is engaged in developing and providing medical disposal solutions to diverse customers. The compa
2011 250,00$

U.S. Neurosurgical, Inc. (USNU) - Financial and Strategic SWOT Analysis Review

U.S. NeuroSurgical, Inc., (USN) is a medical service provider based in the US. The company owns and operates a stereotactic radios
2011 250,00$

Deltagen, Inc. (DGEN) - Financial and Strategic SWOT Analysis Review

Deltagen, Inc. (Deltagen, Inc.) is a biopharmaceutical company which provides drug discovery tools and services to the biopharmace
2011 250,00$

Tikcro Technologies, Ltd. (TIKRF) - Financial and Strategic SWOT Analysis Review

Tikcro Technologies Ltd. (Tikcro) is developmental stage company engaged in the process of acquiring or merging a domestic/foreign
2011 250,00$

China Botanic Pharmaceutical Inc. (CBP) - Financial and Strategic SWOT Analysis Review

China Botanic Pharmaceutical Inc. (China Botanic Pharmaceutical Inc.) is a pharmaceutical company engaged in the development, manu
2011 250,00$

Dynavax Technologies Corporation (DVAX) - Financial and Strategic SWOT Analysis Review

Dynavax Technologies Corporation (Dynavax Technologies) is a US-based biopharmaceutical company. The company engages in discoverin
2011 250,00$

Senomyx, Inc. (SNMX) - Financial and Strategic SWOT Analysis Review

Senomyx, Inc. (Senomyx) is a publicly traded chemical company, engaged in discovering and developing novel flavor ingredients. It
2011 250,00$

Epicore BioNetworks Inc. (EBN) - Financial and Strategic SWOT Analysis Review

Epicore BioNetworks Inc. (Epicore BioNetworks Inc.) is a New Jersey based company engaged in the development, manufacture, and mar
2011 250,00$

ProMetic Life Sciences Inc. (PLI) - Financial and Strategic SWOT Analysis Review

ProMetic Life Sciences Inc. (ProMetic Life Sciences) a Canada based biopharmaceutical company. It engages in the research, develop
2011 250,00$

Phytopharm Plc (PYM) - Financial and Strategic SWOT Analysis Review

Phytopharm Plc (Phytopharm) a U.K based pharmaceutical company,. The company is engaged in developing novel treatments targeting d
2011 250,00$

Indo Internacional SA (IDO) - Financial and Strategic SWOT Analysis Review

Indo Internacional, S.A. (Indo Internacional) is a Spain based company engaged in manufacturing and retailing lenses, ophthalmic e
2011 250,00$

Source BioScience Plc (SBS) - Financial and Strategic SWOT Analysis Review

Source BioScience Plc. (Source BioScience) is a healthcare and biotechnology company that operates businesses in three sectors nam
2011 250,00$

Reliance GeneMedix Plc (GMX) - Financial and Strategic SWOT Analysis Review

Reliance GeneMedix Plc (Reliance GeneMedix), formerly GeneMedix plc is a publicly held biopharmaceutical company. It is involved i
2011 125,00$

FuturaGene, Plc (FGN) - Financial and Strategic SWOT Analysis Review

FuturaGene, Plc. (Futuragene) is a UK based biotechnology research and development company, engaged in plant genetic research and
2011 250,00$

Fulcrum Pharma plc (FUL) - Financial and Strategic SWOT Analysis Review

Fulcrum Pharma plc (Fulcrum Pharma) is a service provider to pharmaceutical company. Fulcrum Pharma offers a range of drug develop
2011 250,00$

LVL Medical Groupe SA (LVL) - Financial and Strategic SWOT Analysis Review

LVL Medical Groupe SA (LVL Medical) is a healthcare services company, engaged in providing home-based medical assistance services.
2011 125,00$

Semperit AG Holding (SEM) - Financial and Strategic SWOT Analysis Review

Semperit AG Holding is a holding company, operating through its subsidiaries. The company is engaged in the manufacturing of indus
2011 125,00$

Audika SA (ADI) - Financial and Strategic SWOT Analysis Review

Audika SA (Audika SA) is a France based company which offers hearing correction solutions. The company also engaged in the sale an
2011 250,00$

MorphoSys AG (MOR) - Financial and Strategic SWOT Analysis Review

MorphoSys AG (MorphoSys) is a Germany based biotechnology company. The company engages in developing antibodies for therapeutic, d
2011 250,00$

Aker BioMarine ASA (AKBM) - Financial and Strategic SWOT Analysis Review

Aker BioMarine ASA (Aker BioMarine ASA) a Norway based marine biotechnology company, engaged in the manufacture and sale of biomar
2011 250,00$

Fornix BioSciences N.V. (FORBI) - Financial and Strategic SWOT Analysis Review

Fornix BioSciences N.V. (Fornix BioSciences N.V.) is engaged in the research and development, production, marketing and sale relat
2011 250,00$

Athens Medical C.S.A. (IATR) - Financial and Strategic SWOT Analysis Review

Athens Medical C.S.A. (Athens Medical C.S.A.) is a Greece based pharmaceutical company engaged in the provision of healthcare serv
2011 125,00$

IASO S.A. (IASO) - Financial and Strategic SWOT Analysis Review

IASO S.A. (IASO S.A.) is a Greece based pharmaceutical company which provides various health care services. The company offers a r
2011 125,00$

Green Cross Holdings Corporation (005250) - Financial and Strategic SWOT Analysis Review

Green Cross Holdings Corporation (Green Cross) is a biotechnology company engaged in the development of ethical drugs in the field
2011 125,00$

Eu Yan Sang International Ltd. (E02) - Financial and Strategic SWOT Analysis Review

Eu Yan Sang International Ltd. (Eu Yan Sang International Ltd.) is a Singapore based investment holding company, engages in the ma
2011 250,00$

Kwang Dong Pharmaceutical Co., Ltd. (009290) - Financial and Strategic SWOT Analysis Review

Kwang Dong Pharmaceutical Co., Ltd. (Kwang Dong), is a Korean based health care company. It is involved in the production of orien
2011 125,00$

PT Tempo Scan Pacific Tbk. (TSPC) - Financial and Strategic SWOT Analysis Review

PT Tempo Scan Pacific Tbk (TSP), formerly PT Scanchemie, is a pharmaceutical company that manufactures generic and specialty produ
2011 125,00$

Macrogen Incorporation (038290) - Financial and Strategic SWOT Analysis Review

Macrogen Incorporation (Macrogen) is engaged in providing customized transgenic and other services in the biomedical research. The
2011 250,00$

EXCON Co.,Ltd. (038120) - Financial and Strategic SWOT Analysis Review

EXCON Co., Ltd., (EXCON) previously known as RINOCELL Co., Ltd. is a medical equipment company engaged in the manufacture and dist
2011 250,00$

Hepahope Korea, Inc. (039350) - Financial and Strategic SWOT Analysis Review

Hepahope Korea, Inc. (Hepahope) is a biotechnology company, principally engaged in the development of products pertaining to the b
2011 250,00$

Ryman Healthcare Ltd. (RYM) - Financial and Strategic SWOT Analysis Review

Ryman Healthcare Ltd. (Ryman Healthcare) is a healthcare service provider engaged in the development and operating of retirement
2011 250,00$

Transgene SA (TNG) - Financial and Strategic SWOT Analysis Review

Transgene SA (Transgene) is a France based biopharmaceutical company. The company engages in the discovery and development of gene
2011 250,00$

SYGNIS Pharma AG (LIOK) - Financial and Strategic SWOT Analysis Review

SYGNIS Pharma AG (SYGNIS Pharma) is a Germany based pharmaceutical company. The company engates in research, development and mark
2011 250,00$

Senesco Technologies, Inc. (SNT) - Financial and Strategic SWOT Analysis Review

Senesco Technologies, Inc. (Senesco) is a bio-pharmaceutical company that is engaged in the research and development of genetic te
2011 250,00$

China Agrotech Holdings Limited (1073) - Financial and Strategic SWOT Analysis Review

China Agrotech Holdings Limited (China Agrotech Holdings Limited) is an investment holding company that trades in fertilizers, pes
2011 125,00$

Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review

Prana Biotechnology Limited (Prana Biotechnology) is a publicly held company engaged in development of stage biotechnology, resear
2011 250,00$

Sawai Pharmaceutical Co., Ltd. (4555) - Financial and Strategic SWOT Analysis Review

Sawai Pharmaceutical Co., Ltd. (Sawai Pharmaceutical) is a publicly held pharmaceutical company that is engaged in the manufacture
2011 125,00$

Feelgood Svenska AB (FEEL) - Financial and Strategic SWOT Analysis Review

Feelgood Svenska AB (Feelgood Svenska AB) is a Sweden based healthcare service provider. It provides healthcare services to busine
2011 250,00$

Forest Place Group Limited (FPG) - Financial and Strategic SWOT Analysis Review

Forest Place Group Limited (Forest Place Group Limited) owns, develops and operates retirement villages and an aged care facility
2011 250,00$

Prima BioMed Limited (PRR) - Financial and Strategic SWOT Analysis Review

Prima BioMed Limited (Prima) is a publicly held biomedical company. It is engaged in the development of anti-cancer therapeutics b
2011 250,00$

Oral Hammaslaakarit Oyj (ORA1V) - Financial and Strategic SWOT Analysis Review

Oral Hammaslaakarit Oyj (Oral Hammaslaakarit) is engaged in providing dental care related services. The company offers a range of
2011 250,00$

Dragon Pharmaceuticals Inc. (DDD) - Financial and Strategic SWOT Analysis Review

Dragon Pharmaceuticals Inc. (Dragon Pharmaceuticals Inc.) was acquired by Oriental Wave Holding Ltd., in a reverse merger transact
2011 250,00$

Immuron Limited (IMC) - Financial and Strategic SWOT Analysis Review

Immuron Limited (Immuron Limited) operates in the biopharmaceutical sector and focuses on the research and development of polyclon
2011 125,00$

Nissui Pharmaceutical Co., Ltd. (4550) - Financial and Strategic SWOT Analysis Review

Nissui Pharmaceutical Co., Ltd. (Nissui Pharmaceutical) is a publicly held pharmaceutical company. It is engaged in the developmen
2011 250,00$

MATERNUS Kliniken AG (MAK) - Financial and Strategic SWOT Analysis Review

MATERNUS Kliniken AG (MATERNUS) is a German based company involved in the operations of care centers for senior citizens and long-
2011 250,00$

Nippon Chemiphar Co., Ltd. (4539) - Financial and Strategic SWOT Analysis Review

Nippon Chemiphar Co., Ltd. (Nippon Chemiphar) is a publicly held company engaged in manufacture and marketing of pharmaceuticals,
2011 125,00$

Eifelhoehen-Klinik AG (EIF) - Financial and Strategic SWOT Analysis Review

Eifelhoehen-Klinik AG (Eifelhoehen-Klinik AG) operates rehabilitation and outpatient medical care centers primarily for elderly pe
2011 250,00$

Prim S.A. (PRIM) - Financial and Strategic SWOT Analysis Review

Prim S.A. (Prim) is a pharmaceutical provider services company engaged in manufacturing and commercializing hospital supplies and
2011 250,00$

Kopran Limited (KOPRAN) - Financial and Strategic SWOT Analysis Review

Kopran Limited (Kopran) is a group company of Parijat Enterprises. Kopran is an integrated pharmaceutical company engaged in the r
2011 250,00$

Pfizer Limited (PFIZER) - Financial and Strategic SWOT Analysis Review

Pfizer Limited (Pfizer) is a research based pharmaceutical company. It engages in the research and development of medicines for hu
2011 250,00$

Tokiwa Yakuhin Co., Ltd. (7644) - Financial and Strategic SWOT Analysis Review

Tokiwa Yakuhin Co., Ltd. (Tokiwa Yakuhin) is principally engaged in the wholesale of pharmaceuticals to hospitals, medical practi
2011 125,00$

Fulford (India) Limited (506803) - Financial and Strategic SWOT Analysis Review

Fulford (India) Limited (Fulford) is a publicly held research focused biotechnology company. It is engaged in research, developmen
2011 250,00$

Lyka Labs Limited (LYKALABS) - Financial and Strategic SWOT Analysis Review

Lyka Labs Limited (Lyka Labs), a publicly-held healthcare company engaged in the manufacturing, marketing, and exports of pharmace
2011 250,00$

JAPAN CARE SERVICE GROUP CORPORATION (7566) - Financial and Strategic SWOT Analysis Review

Japan Care Service Group Corporation (Japan Care Service) is a holding company, engaged in the provision of nursing and residentia
2011 125,00$

Unichem Laboratories Ltd. (UNICHEMLAB) - Financial and Strategic SWOT Analysis Review

Unichem Laboratories Limited (Unichem) is a publicly held pharmaceutical company engaged in the manufacture and sale of formulatio
2011 250,00$

Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis Review

Torrent Pharmaceuticals Limited (Torrent) is a public company engaged in the research, development and marketing of active pharmac
2011 125,00$

Merck Limited (MERCK) - Financial and Strategic SWOT Analysis Review

Merck Limited (formerly E. Merck Limited) is a publicly held company engaged in the manufacture of pharmaceuticals and chemicals.
2011 250,00$

Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis Review

Progen Pharmaceuticals Limited (Progen Pharmaceuticals) is an Australian based pharmaceutical company. The company engages in clin
2011 250,00$

Metlifecare Limited (MET) - Financial and Strategic SWOT Analysis Review

Metlifecare Limited (Metlifecare) is a healthcare services provider, principally engaged in operating lifestyle retirement village
2011 250,00$

FDC Limited (FDC) - Financial and Strategic SWOT Analysis Review

FDC Limited (FDC Limited) is an Indian based pharmaceutical company. It pioneered the manufacture of specialized ophthalmic formul
2011 250,00$

Katakura Industries Co., Ltd. (3001) - Financial and Strategic SWOT Analysis Review

Katakura Industries Co., Ltd. (Katakura) is a research institute of biological science, operates through its business segment. The
2011 125,00$

IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

IPCA Laboratories Limited (IPCA) is a publicly held pharmaceutical company. It is engaged in the development and manufacture of ac
2011 125,00$

Novartis India Limited (500672) - Financial and Strategic SWOT Analysis Review

Novartis India Limited (Novartis India) is a pharmaceutical company. It is a 51% subsidiary of Novartis AG, Switzerland. The compa
2011 250,00$

MATSUDA SANGYO Co., Ltd. (7456) - Financial and Strategic SWOT Analysis Review

Matsuda Sangyo Co., Ltd. (Matsuda) is a publicly held company. It is principally engaged in the Metals and Food Product segments r
2011 125,00$

Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

Xenetic Biosciences plc (Xenetic), formerly Lipoxen PLC is a UK-based bio-pharmaceutical company. It engages in the development of
2011 250,00$

Extrawell Pharmaceutical Holdings Limited (0858) - Financial and Strategic SWOT Analysis Review

Extrawell Pharmaceutical Holdings Limited (Extrawell) is an investment holding company that operates through four business segment
2011 250,00$

Torii Pharmaceutical Co., Ltd. (4551) - Financial and Strategic SWOT Analysis Review

Torii Pharmaceutical Co., Ltd. (Torii), is a publicly held Japan based company and formerly known as Torii Shoten K.K.,. The compa
2011 125,00$

Telesso Technologies Limited (TEO) - Financial and Strategic SWOT Analysis Review

Telesso Technologies Limited (Telesso Technologies) is a publicly traded biotechnology company, engaged in providing research and
2011 250,00$

Daewoong Co., Ltd. (003090) - Financial and Strategic SWOT Analysis Review

Daewoong Co., Ltd. (Daewoong Co., Ltd.) is a Korea based company which operates as an industrial corporation offering diversified
2011 125,00$

Biotika, a.s. (1BSL01A) - Financial and Strategic SWOT Analysis Review

Biotika, a.s. (Biotika) is a pharmaceutical company that is engaged in the biotechnological production of substances of penicillin
2011 250,00$

Bukwang Pharmaceutical Co., Ltd. (003000) - Financial and Strategic SWOT Analysis Review

Bukwang Pharmaceutical Co., Ltd. (Bukwang Pharmaceutical Co., Ltd.) is engaged as a manufacturer of pharmaceutical products. The p
2011 250,00$

TapImmune Inc. (TPIV) - Financial and Strategic SWOT Analysis Review

TapImmune Inc. (Taplummune) is engaged in the development of vaccines and therapeutics pertaining to the areas of oncology and inf
2011 250,00$

BIOFERMIN PHARMACEUTICAL CO., LTD. (4517) - Financial and Strategic SWOT Analysis Review

BIOFERMIN PHARMACEUTICAL CO., LTD. (Biofermin Pharmaceutical) is an independent pharmaceutical health care industry. The industry
2011 250,00$

JW Pharmaceutical (001060) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of JW Pharmaceutical provides you an in-depth strategic analysis of the company’s businesses and
2011 125,00$

HANDOK Pharmaceuticals Co., Ltd. (002390) - Financial and Strategic SWOT Analysis Review

HANDOK Pharmaceuticals Co., Ltd. (HANDOK Pharmaceuticals Co., Ltd) is a South Korea based pharmaceutical industry.The company is i
2011 125,00$

ILSUNG PHARMACEUTICAL CO.,LTD (003120) - Financial and Strategic SWOT Analysis Review

ILSUNG PHARMACEUTICAL CO., LTD (ILSUNG PHARMACEUTICAL) is an independent publicly held health care pharmaceutical industry. Its ma
2011 250,00$

Dongwha Pharm Co., Ltd. (000020) - Financial and Strategic SWOT Analysis Review

Dongwha Pharm Co., Ltd. (Dongwha Pharm) is a South Korea based health care pharmaceutical industry. The company is engages in the
2011 125,00$

Boryung Pharmaceutical Co., Ltd. (003850) - Financial and Strategic SWOT Analysis Review

Boryung Pharmaceutical Co., Ltd. (Boryung Pharmaceutical Co., Ltd.) is a South Korea based health care pharmaceutical industry.
2011 250,00$

Samil Pharmaceutical Co., Ltd. (000520) - Financial and Strategic SWOT Analysis Review

Samil Pharmaceutical Co., Ltd. (Samil Pharmaceutical) is a publicly held pharmaceutical company. It is engaged in the discovery an
2011 250,00$

Samjin Pharmaceutical Co., Ltd. (005500) - Financial and Strategic SWOT Analysis Review

Samjin Pharmaceutical Co., Ltd. (Samjin) is a publicly held Korean based pharmaceutical company. It is engaged in research and dev
2011 250,00$

Fuji Pharma Co., Ltd. (4554) - Financial and Strategic SWOT Analysis Review

Fuji Pharma Co., Ltd. (Fuji Pharma) is a publicly held pharmaceutical company. It is engaged in the development, manufacture and m
2011 125,00$

IVF Hartmann Holding AG (VBSN) - Financial and Strategic SWOT Analysis Review

IVF Hartmann Holding AG (IVF) is a Switzerland-based company. It is engaged in the development, production, and marketing of medic
2011 250,00$

Sun Biomedical Limited (SBN) - Financial and Strategic SWOT Analysis Review

Sun Biomedical Limited (Sun Biomedical) is a publicly held Australia-based pharmaceutical company. The company through its subsidi
2011 250,00$

KunWha Pharmaceutical Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review

KunWha Pharmaceutical Co., Ltd. (KunWha) is a publicly held Korean based company, that is involved in the production of pharmaceut
2011 250,00$

Ilyang Pharmaceutical Co., Ltd (007570) - Financial and Strategic SWOT Analysis Review

Ilyang Pharmaceutical Co., Ltd (Ilyang Pharmaceutical Co., Ltd.) is a Korea based heath care pharmaceutical company. It is engaged
2011 250,00$

Miraca Holdings Inc. (4544) - Financial and Strategic SWOT Analysis Review

Miraca Holdings Inc. (Miraca Holdings) is a Japan based health care pharmaceutical industry. The company operates through its sub
2011 125,00$

J. B. Chemicals & Pharmaceuticals Ltd. (506943) - Financial and Strategic SWOT Analysis Review

J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is a pharmaceutical company that is engaged in the manufacture and marketing of var
2011 125,00$

IMI Co., Ltd. (7503) - Financial and Strategic SWOT Analysis Review

IMI Co., Ltd. (IMI Co., Ltd.) is a Japan based pharmaceutical company which imports, sells, rents, and maintains medical equipment
2011 250,00$

Solvay Pharma India Ltd. (532447) - Financial and Strategic SWOT Analysis Review

Solvay Pharma India Ltd. (Solvay), an India-based public shareholding company. It is engaged in the production and sale of pharmac
2011 250,00$

Shinpoong Pharmaceutical Co., Ltd. (019170) - Financial and Strategic SWOT Analysis Review

Shinpoong Pharmaceutical Co., Ltd. (Shinpoong) is a pharmaceutical company that is principally engaged in the manufacture of phar
2011 125,00$

Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis Review

Green Cross Corporation (Green Cross) is a Korean pharmaceutical company. Its activities include research, development, productio
2011 125,00$

Pacific Pharmaceutical Co., Ltd. (016570) - Financial and Strategic SWOT Analysis Review

Pacific Pharmaceutical Co., Ltd. (PPCL) is a publicly held pharmaceutical company. It is engaged in the development and manufactur
2011 250,00$

HanAll Biopharma Co., Ltd. (009420) - Financial and Strategic SWOT Analysis Review

Hanall Pharmaceutical Co., Ltd. (HanAll), is a public shareholder company. It is engaged in the production and sale of pharmaceuti
2011 250,00$

KAINOS Laboratories, Inc. (4556) - Financial and Strategic SWOT Analysis Review

Kainos Laboratories, Inc. (Kainos), is a publicly held Japan based company. It is involved in developing, manufacturing, marketing
2011 250,00$

Shenzhen Accord Pharmaceutical Co., Ltd. (200028) - Financial and Strategic SWOT Analysis Review

Shenzhen Accord Pharmaceutical Co., Ltd. (Shenzhen Accord) is a publicly held pharmaceutical company that is engaged in the resear
2011 125,00$

Samsung Pharmaceutical Industry Corporation Limited (001360) - Financial and Strategic SWOT Analysis Review

Samsung Pharmaceutical Industry Corporation Limited. (SPICO) is a publicly held pharmaceutical manufacturing company. It is engage
2011 250,00$

Kukje Pharmaceutical Industry Co., Ltd. (002720) - Financial and Strategic SWOT Analysis Review

Kukje Pharmaceutical Industry Co., Ltd. (Kukje) is a publicly held Korean based company. It is involved in the production, sale an
2011 250,00$

Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

Galectin Therapeutics, Inc. (Galectin Therapeutics) is a pharmaceutical company that is engaged discovering, developing and commer
2011 250,00$

MOLOGEN AG (MGN) - Financial and Strategic SWOT Analysis Review

MOLOGEN AG (Mologen) a German based bio-pharmaceutical company which specializes in the research and development of innovative med
2011 250,00$

Searainbow Holding Co., Ltd (000503) - Financial and Strategic SWOT Analysis Review

Searainbow Holding Co., Ltd (Searainbow) is a provider services company engaged in three major businesses namely, medical e-commer
2011 250,00$

TOWA PHARMACEUTICAL CO., LTD. (4553) - Financial and Strategic SWOT Analysis Review

Towa Pharmaceutical Co. Ltd (Towa) is a publicly held pharmaceutical company. It is involved in the development and distribution o
2011 125,00$

Nanoen Tek, Inc. (039860) - Financial and Strategic SWOT Analysis Review

Nanoen Tek, Inc. (Nanoen Tek) is a publicly traded nano-biotechnology company. It is principally engaged in the realization of Na
2011 250,00$

Kyung Dong Pharmaceutical Co., Ltd. (011040) - Financial and Strategic SWOT Analysis Review

Kyung Dong Pharmaceutical Co., Ltd. (Kyung Dong) is a publicly held pharmaceutical company. It is engaged in the development of ra
2011 250,00$

Ahn-Gook Pharmaceutical Co., Ltd. (001540) - Financial and Strategic SWOT Analysis Review

Ahn-Gook Pharmaceutical Co., Ltd. (Ahn-Gook Pharmaceutical) is a publicly held pharmaceutical company. It specializes in the produ
2011 250,00$

Nichi-Iko Pharmaceutical Co., Ltd. (4541) - Financial and Strategic SWOT Analysis Review

Nichi-Iko Pharmaceutical Co., Ltd. (Nichi-Iko) is a publicly held pharmaceutical company. It is focused on the manufacture and mar
2011 125,00$

PT Indofarma (Persero) Tbk (INAF) - Financial and Strategic SWOT Analysis Review

Pt Indofarma (Persero) Tbk (Indofarma), a medical equipment and pharmaceutical company, that is engaged in the manufacture, market
2011 250,00$

PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic SWOT Analysis Review

PT Kimia Farma Tbk (Kimia Farma) is pharmaceutical company that is engaged in the manufacture, development and sale of chemical an
2011 125,00$

TTY Biopharm Company Limited (4105) - Financial and Strategic SWOT Analysis Review

TTY Biopharm Company Limited (TTY) is a Taiwan based bio-pharmaceutical company, engaged in research and development of drugs for
2011 250,00$

Standard Chemical & Pharmaceutical Co. (1720) - Financial and Strategic SWOT Analysis Review

Standard Chemical & Pharmaceutical Co. (Standard Chemical) is engaged in the activities including product innovation, manufacturin
2011 250,00$

PhytoHealth Corporation (4108) - Financial and Strategic SWOT Analysis Review

PhytoHealth Corporation (PhytoHealth) is a pharmaceutical company engaged in developing, manufacturing and commercializing drugs f
2011 250,00$

Pihsiang Machinery Mfg. Co., Ltd. (1729) - Financial and Strategic SWOT Analysis Review

Pihsiang Machinery Mfg. Co., Ltd. (Pihsiang Machinery) is a public limited company principally engaged in the research, developmen
2011 250,00$

Hyundai Pharmaceutical Co., Ltd. (004310) - Financial and Strategic SWOT Analysis Review

Hyundai Pharmaceutical Co., Ltd. (Hyundai Pharma) is publically held pharmaceutical company. The company is involved in manufactur
2011 250,00$

Chi Sheng Chemical Corporation (4111) - Financial and Strategic SWOT Analysis Review

Chi Sheng Chemical Corporation (Chi Sheng) is a publicly held healthcare company. The company is involved in manufacturing and dis
2011 250,00$

LG Life Sciences, Ltd (068870) - Financial and Strategic SWOT Analysis Review

LG Life Sciences, Ltd. (LGLS) engages in the development and marketing of pharmaceutical products. The operational business of the
2011 250,00$

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

CCM Duopharma Biotech Bhd. (CCM Duopharma) is a publicly held investment holding company. The company is involved in manufacturing
2011 250,00$

China Chemical & Pharmaceutical Co. Ltd. (1701) - Financial and Strategic SWOT Analysis Review

China Chemical & Pharmaceutical Co. Ltd. (China Chemical) is publically held pharmaceutical company. The company is involved in in
2011 250,00$

Pelion SA (PGF) - Financial and Strategic SWOT Analysis Review

Pelion SA (Pelion), formerly Polska Grupa Farmaceutyczna S.A., is a publicly held healthcare company. It is engaged in the distrib
2011 125,00$

CMIC Co., Ltd. (2309) - Financial and Strategic SWOT Analysis Review

CMIC Co., Ltd. (CMIC) is a publicly held healthcare company. The company is involved in providing services related to pharmaceutic
2011 125,00$

Ohki Co., Ltd. (8120) - Financial and Strategic SWOT Analysis Review

Ohki Co Ltd. (Ohki) is a publicly held pharmaceutical company. It is principally engaged in the wholesale distribution of pharmace
2011 125,00$

Shigematsu Works Co., Ltd. (7980) - Financial and Strategic SWOT Analysis Review

Shigematsu Works Co., Ltd. (Shigematsu) is a publicly held respiratory device company. It is, principally involved in the producti
2011 250,00$

Hua Han Bio-Pharmaceutical Holdings Ltd. (587) - Financial and Strategic SWOT Analysis Review

Hua Han Bio-Pharmaceutical Holdings Ltd. (Hua Han) is a Hong Kong based public share holding company. It is engaged in the manufac
2011 250,00$

Tong Ren Tang Technologies Co., Ltd. (1666) - Financial and Strategic SWOT Analysis Review

Tong Ren Tang Technologies Co., Ltd. (TRTT) is a publicly held pharmaceutical company. It is engaged in the development, productio
2011 125,00$

Deva Holding A.S. (DEVA) - Financial and Strategic SWOT Analysis Review

Deva Holding A.S. (Deva) is a pharmaceutical company. The company is involved in manufacturing and marketing of branded generic ph
2011 125,00$

PT Darya-Varia Laboratoria Tbk (DVLA) - Financial and Strategic SWOT Analysis Review

Pt Darya-Varia Laboratoria Tbk (Darya-Varia), an Indonesia-based pharmaceutical company. It is engaged in the manufacture, trade a
2011 250,00$

LONGLIFE HOLDING Co., Ltd. (4355) - Financial and Strategic SWOT Analysis Review

LONGLIFE HOLDING Co., Ltd. (LHCL) is a provider of nursing care services. It is principally engaged in operating nursing home and
2011 250,00$

Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic SWOT Analysis Review

Sapporo Clinical Laboratory Inc. (Sapporo) is a publicly held pharmaceutical research company. It is engaged in public health and
2011 250,00$

Medical System Network Co., Ltd. (4350) - Financial and Strategic SWOT Analysis Review

Medical System Network Co., Ltd. (MSNW) is a publicly held Japan based pharmaceutical company. It is engaged in the pharmaceutical
2011 125,00$

Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis Review

Biotie Therapies Corp. (Biotie) is a biotechnology company, engaged in the discovery and development of therapeutics for the treat
2011 250,00$

Abano Healthcare Group Limited (ABA) - Financial and Strategic SWOT Analysis Review

Abano Healthcare Group Limited (Abano Healthcare) is publicly held healthcare and medical services provider. The company operates
2011 250,00$

Euro-Med Laboratories Phil., Inc. (EURO) - Financial and Strategic SWOT Analysis Review

Euro-Med Laboratories Phil., Inc. (Euro-Med) is publicly held bio Technology Company. The company is involved in manufacturing and
2011 250,00$

ALKALOID AD - Skopje (ALK) - Financial and Strategic SWOT Analysis Review

ALKALOID AD Skopje (ALKALOID) is a pharmaceutical company involved in the production of drugs, cosmetics and chemical products, as
2011 250,00$

Sam Chun Dang Pharm Co., Ltd. (000250) - Financial and Strategic SWOT Analysis Review

Sam Chun Dang Pharm Co., Ltd. (Sam Chun) is a Korea-based pharmaceutical company. The company is engaged in the so engaged in the
2011 250,00$

Schnell Biopharmaceuticals, Inc. (003060) - Financial and Strategic SWOT Analysis Review

Schnell Biopharmaceuticals, Inc. (Schnell) is a publicly held pharmaceutical product manufacturing company. It is engaged in the p
2011 250,00$

Daewon Pharmaceutical Co., Ltd. (003220) - Financial and Strategic SWOT Analysis Review

Daewon Pharmaceutical Co., Ltd. (Daewon) is a korea based pharmaceutical company and involved in the development, production and
2011 250,00$

Les Trois Chenes SA (MLTRC) - Financial and Strategic SWOT Analysis Review

Les Trois Chenes SA (Les Trois) is a France-based food supplements and cosmetic products manufacturing company. The company is pri
2011 250,00$

Innocell Corporation (031390) - Financial and Strategic SWOT Analysis Review

Innocell Corporation (Innocell) operates as a biotechnology company. The company is involved in the development of immune cell tre
2011 250,00$

BLIS Technologies Ltd (BLT) - Financial and Strategic SWOT Analysis Review

BLIS Technologies Ltd (BLIS) is pharmaceutical company involved in oral health care market. The service portfolio includes develop
2011 250,00$

Botry-Zen Limited (BOZ) - Financial and Strategic SWOT Analysis Review

Botry-Zen Limited (Botry-Zen) is a biotechnology company engaged in developing and commercializing biological control agents that
2011 250,00$

BioPhausia AB (BIOP) - Financial and Strategic SWOT Analysis Review

BioPhausia AB (BioPhausia) operates as a Sweden based pharmaceutical company. The company is involved in the provision of cost-eff
2011 250,00$

Komipharm International Co., Ltd. (041960) - Financial and Strategic SWOT Analysis Review

Komipharm International Co., Ltd. (Komipharm) is a publicly held pharmaceutical company. It is engaged in manufacturing veterinary
2011 250,00$

Jin Yang Pharmaceutical Co., Ltd. (007370) - Financial and Strategic SWOT Analysis Review

Jin Yang Pharmaceutical Co., Ltd. (Jin Yang) is a pharmaceutical company engaged in the development and production of pharmaceutic
2011 250,00$

PharmswellBio Co., Ltd. (043090) - Financial and Strategic SWOT Analysis Review

PharmswellBio Co., Ltd. (PharmswellBio) is a publicly held company that is largely focused on bioengineering industry. The company
2011 250,00$

F. Reichelt AG (RCH) - Financial and Strategic SWOT Analysis Review

F. Reichelt AG (Reichelt) is involved in distribution of pharmaceutical products. The company is engaged in supplying of drugs, me
2011 250,00$

Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review

Korea United Pharm, Inc., is a South Korean based company which is involved in the production, marketing, selling and distributing
2011 250,00$

Sam-A Pharm. Co., Ltd. (009300) - Financial and Strategic SWOT Analysis Review

Sam-A Pharm. Co., Ltd. (Sam-A) is principally engaged in the manufacture and sale of pharmaceuticals. The company has recently com
2011 250,00$

Eagle Veterinary Technology Co., Ltd. (044960) - Financial and Strategic SWOT Analysis Review

Eagle Veterinary Technology Co., Ltd. (Eagle Vet) is involved in exporting and manufacturing of veterinary health care products.Th
2011 250,00$

CHO-A PHARM.Co.,LTD. (034940) - Financial and Strategic SWOT Analysis Review

CHO-A PHARM.Co., LTD. (CHO-A) is a public pharmaceutical company, that is involved in distribution and manufacturing of pharmaceut
2011 250,00$

Medica Sur SAB de CV (MEDICAB) - Financial and Strategic SWOT Analysis Review

Medica Sur SAB de CV (Medica) is a non-governmental institution, engaged in healthcare sector. Medica operates its own clinic comp
2011 250,00$

Supermax Corporation Berhad (SUPERMX) - Financial and Strategic SWOT Analysis Review

Supermax Corporation Berhad (Supermax Corp) is a publicly held medical appliance provider, principally engaged in the manufacturin
2011 125,00$

Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic SWOT Analysis Review

Dawnrays Pharmaceutical (Holdings) Limited (Dawnrays) is a pharmaceutical company, that engaged in the development, manufacturing
2011 250,00$

MEDINET Co., Ltd. (2370) - Financial and Strategic SWOT Analysis Review

MEDINET Co., Ltd. (Medinet) is a publicly held research focused biotechnology company that is engaged in developing immuno cell th
2011 250,00$

AquaCarotene Limited (AQL) - Financial and Strategic SWOT Analysis Review

AquaCarotene Limited (AquaCarotene) is engaged in growing and commercializing natural micro algae products. The company is princip
2011 250,00$

Daesung Microbiological Labs, Co., Ltd. (036480) - Financial and Strategic SWOT Analysis Review

Daesung Microbiological Labs, Co., Ltd., (Daesung Microbiological) is an animal pharmaceuticals product development and manufactur
2011 250,00$

Cheil Bio Co., Ltd. (052670) - Financial and Strategic SWOT Analysis Review

Cheil Bio Co., Ltd.(Cheil Bio) is health care company, principally engaged in the manufacture and marketing of veterinary products
2011 250,00$

Daehan New Pharm Co., Ltd. (054670) - Financial and Strategic SWOT Analysis Review

Daehan New Pharm Co., Ltd. (Daehan New Pharm) is a South Korea based pharmaceutical health care industry. The company is involved
2011 250,00$

CTCBIO INC. (060590) - Financial and Strategic SWOT Analysis Review

CTCBIO INC (CTCBIO) is a South Korea based health care organization. The company is involved in the provision of pharmaceuticals,
2011 250,00$

Skynewpharm Inc. (058820) - Financial and Strategic SWOT Analysis Review

Skynewpharm Inc. (Skynewpharm) is a pharmaceutical company engaged in drug manufacturing and research activities. The product port
2011 250,00$

CKD Bio Corporation (063160) - Financial and Strategic SWOT Analysis Review

CKD Bio Corporation (CKD Bio Corporation) is a health care pharmaceutical organization in Korea. The company is engaged in the dev
2011 250,00$

Daihan Pharmaceutical Co., Ltd. (023910) - Financial and Strategic SWOT Analysis Review

Dai Han Pharmaceutical Co., Ltd., (Dai Han) is a Korea based medical terminology pharmaceutical organization. The company is invol
2011 250,00$

Hwail Pharma Co., Ltd. (061250) - Financial and Strategic SWOT Analysis Review

Hwail Pharma Co., Ltd. (Hwail Pharma Co., Ltd.) is Korea based medical terminology pharmaceutical organization. The company is inv
2011 250,00$

DAE HWA Pharm Co., Ltd. (067080) - Financial and Strategic SWOT Analysis Review

DAE HWA Pharm. Co., Ltd. (DAE HWA) is a South Korea based medical health care pharmaceutical organization. The company is involved
2011 250,00$

Kyung Nam Pharm. Co., Ltd. (053950) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Kyung Nam Pharm. Co., Ltd. provides you an in-depth strategic analysis of the company’s busine
2011 250,00$

Soiken Holdings Inc. (2385) - Financial and Strategic SWOT Analysis Review

Soiken Holdings Inc. (Soiken Holdings) is a publicly held biotechnology company that operates its businesses in four segments name
2011 250,00$

Shinil Pharmaceutical Co., Ltd. (012790) - Financial and Strategic SWOT Analysis Review

Shinil Pharmaceutical Co., Ltd., is a publicly held South Korea based pharmaceutical company. It is engaged in the production and
2011 250,00$

Seoul Pharma Co., Ltd. (018680) - Financial and Strategic SWOT Analysis Review

Seoul Pharma Co., Ltd. (Seoul Pharma) is a pharmaceutical company engaged in the manufacture and sale of pharmaceutical formulatio
2011 250,00$

Korean Drug Co., Ltd. (014570) - Financial and Strategic SWOT Analysis Review

Korean Drug Co., Ltd. (KDC) is pharmaceutical products manufacturer company. The company is engaged in manufacturing over the co
2011 250,00$

OncoTherapy Science, Inc. (4564) - Financial and Strategic SWOT Analysis Review

OncoTherapy Science, Inc. (OncoTherapy Science) is a Japan-based health care biotechnology organization. The company engages in th
2011 250,00$

Goldis Berhad (GOLDIS) - Financial and Strategic SWOT Analysis Review

Goldis Berhad (Goldis) is a publicly held investment holding company. It focuses on the fields of life sciences, information commu
2011 250,00$

Joincare Pharmaceutical Group Industry Co., Ltd. (600380) - Financial and Strategic SWOT Analysis Review

Joincare Pharmaceutical Group Industry Co., Ltd. (Joincare) is a publicly held pharmaceutical company engaged in the manufacture
2011 125,00$

Stirling Products Limited (STI) - Financial and Strategic SWOT Analysis Review

Stirling Products Limited (Stirling) is a publicly held pharmaceutical company. It focuses on the development and commercializati
2011 250,00$

EstechPharma Co., Ltd. (041910) - Financial and Strategic SWOT Analysis Review

EstechPharma Co., Ltd. (EstechPharma) is a pharmaceutical company that is engaged in manufacturing and supplying active pharmaceut
2011 250,00$

Select Vaccines Limited (SLT) - Financial and Strategic SWOT Analysis Review

Select Vaccines Limited (SVL) is a publicly held pharmaceutical company, engaged in the development of vaccines based on its virus
2011 250,00$

SciGen Limited (SIE) - Financial and Strategic SWOT Analysis Review

SciGen Limited (SciGen) is a bio-pharmaceutical company engaged in the development, manufacturing and marketing of recombinant hum
2011 250,00$

Transition Therapeutics Inc. (TTH) - Financial and Strategic SWOT Analysis Review

Transition Therapeutics Inc. (Transition Therapeutics) is Canada based health care biopharmaceutical company. The organization i
2011 250,00$

Beijing Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic SWOT Analysis Review

Beijing Double-Crane Pharmaceutical Co., Ltd.(Beijing Double-Crane Pharmaceutical Co., Ltd.) is China based pharmaceutical organiz
2011 125,00$

Bio-Treat Technology Ltd. (B22) - Financial and Strategic SWOT Analysis Review

Bio-Treat Technology Ltd. (Bio-Treat) is engaged in the development and application of biotechnology for the treatment of waste an
2011 250,00$

DNA Chip Research Inc. (2397) - Financial and Strategic SWOT Analysis Review

DNA Chip Research Inc. (DNA Chip Research Inc.) is a Japan based medical research organization. The company is involved in manufac
2011 250,00$

ChoongAng Vaccine Laboratory (072020) - Financial and Strategic SWOT Analysis Review

ChoongAng Vaccine Laboratory (ChoongAng Vaccine Laboratory) is a South Korea based pharmaceutical research Laboratory. The company
2011 250,00$

GuiZhou YiBai Pharmaceutical Co., Ltd. (600594) - Financial and Strategic SWOT Analysis Review

GuiZhou YiBai Pharmaceutical Co., Ltd. (GuiZhou YiBai Pharmaceutical Co., Ltd.) is China based pharmaceutical company. The company
2011 125,00$

PharmaGap Inc. (GAP) - Financial and Strategic SWOT Analysis Review

Pharmagap Inc. (Pharmagap) is biotechnology company, that is engaged in clinical development of innovative therapeutics for severa
2011 250,00$

DR. Chip Biotech Inc. (4131) - Financial and Strategic SWOT Analysis Review

Dr. Chip Biotechnology, Inc. (Dr. Chip Biotechnology, Inc.) is a Taiwan based biotechnology organization. The company is involved
2011 250,00$

TSUKUI CORPORATION (2398) - Financial and Strategic SWOT Analysis Review

Tsukui Corporation (Tsukui) is a publicly held, Japan based health care services company. It is engaged in providing broad range o
2011 125,00$

Catasys, Inc. (CATS) - Financial and Strategic SWOT Analysis Review

Catasys, Inc. (Catasys) is a managed healthcare services organization engaged in providing health care plans and rehabilitation se
2011 250,00$

Allon Therapeutics Inc. (NPC) - Financial and Strategic SWOT Analysis Review

Allon Therapeutics Inc. (Allon), formerly Neuro Discovery Inc. is a clinical-stage biotechnology company, engaged in the developme
2011 250,00$

Medtecs International Corporation Limited (546) - Financial and Strategic SWOT Analysis Review

MEDTECS INTERNATIONAL CORPORATION LIMITED (Medtecs) is a publicly held medical device company. It is engaged in providing integrat
2011 250,00$

Sopharma AD Sofia (3JR) - Financial and Strategic SWOT Analysis Review

Sopharma AD Sofia (Sopharma), is a public share holding company. It is engaged in the manufacture and trade of active substances a
2011 125,00$

AS Olainfarm (OLF1R) - Financial and Strategic SWOT Analysis Review

AS Olainfarm (AS Olainfarm) is a health care pharmaceutical joint stock organization. The company is involved in the developmentof
2011 250,00$

Bangkok Dusit Medical Services PCL (BGH) - Financial and Strategic SWOT Analysis Review

Bangkok Dusit Medical Services PCL (BDMS) is a publicly held health care services company. The hospital network consists of over 7
2011 125,00$

Prasit Patana Public Company Limited (PYT) - Financial and Strategic SWOT Analysis Review

Prasit Patana Public Company Limited (Prasit Patana) is a pharmaceutical provider service company engaged into hospital business u
2011 250,00$

Samitivej PCL (SVH) - Financial and Strategic SWOT Analysis Review

Samitivej PCL (Samitivej) is a publicly held health care services company.It is engaged in providing integrated medical services i
2011 250,00$

Sikarin PCL (SKR) - Financial and Strategic SWOT Analysis Review

Sikarin PCL (Sikarin) is a publicly held healthcare service provider company owned by Sikarin Public Company limited. It is engage
2011 250,00$

Jinling Pharmaceutical Co., Ltd. (000919) - Financial and Strategic SWOT Analysis Review

Jinling Pharmaceutical Co., Ltd. (Jinling) is a pharmaceutical company engaged in the research, development, manufacture and sale
2011 125,00$

Medical Facilities Corporation (DR) - Financial and Strategic SWOT Analysis Review

Medical Facilities Corporation (MFC) is a publicly held hospital that operates four specialty surgical hospitals (SSHs) located in
2011 125,00$

Message Co., Ltd. (2400) - Financial and Strategic SWOT Analysis Review

Message Co., Ltd. (Message Co.) is a health care company, engaged in providing nursing care services to old people. It operates el
2011 125,00$

Chiang Mai Ram Medical Business PCL (CMR) - Financial and Strategic SWOT Analysis Review

Chiang Mai Ram Medical Business PCL (Chiang Mai Ram Medical Business PCL) is one of the largest medical health care services provi
2011 250,00$

Quest PharmaTech Inc. (QPT) - Financial and Strategic SWOT Analysis Review

Quest PharmaTech Inc. (Quest) is a Canada based company which is involved in discovering, developing and commercializing pharmaceu
2011 250,00$

Imagin Molecular Corporation (IMGM) - Financial and Strategic SWOT Analysis Review

Imagin Molecular Corporation (Imagin) is a medical devices company engaged in the manufacture of positron emission tomography (PET
2011 250,00$

MaYinglong Pharmaceutical Group Co., Ltd (600993) - Financial and Strategic SWOT Analysis Review

MaYinglong Pharmaceutical Group Co., Ltd (MaYinglong Pharmaceutical) is china based pharmaceutical company. It is engaged in the
2011 250,00$

PT Merck Tbk (MERK) - Financial and Strategic SWOT Analysis Review

PT Merck Tbk (Merck Tbk) is engaged in the manufacture of prescriptions drugs and over-the-counter products. The numerous products
2011 250,00$

Pluristem Therapeutics Inc. (PSTI) - Financial and Strategic SWOT Analysis Review

Pluristem Therapeutics Inc. (Pluristem Therapeutics Inc.) is a Israel based bio-therapeutics organization. The company is involved
2011 250,00$

PT Schering Plough Indonesia Tbk (SCPI) - Financial and Strategic SWOT Analysis Review

PT Schering Plough Indonesia Tbk (PT Schering) is an outsourcing company engaged in activities like processing and marketing of ph
2011 250,00$

Mahachai Hospital Public Company Limited (M-CHAI) - Financial and Strategic SWOT Analysis Review

Mahachai Hospital Public Company Limited (Mahachai) is a public listed health care company that is engaged in providing health car
2011 250,00$

Gesundheitswelt Chiemgau AG (JTH) - Financial and Strategic SWOT Analysis Review

Gesundheitswelt Chiemgau AG (Gesundheitswelt Chiemgau AG) is Germany based health resorts and Clinics Company. The company is main
2011 250,00$

Theravance, Inc. (THRX) - Financial and Strategic SWOT Analysis Review

Theravance, Inc. (Theravance) formerly known as Advanced Medicine, Inc. is a US-based health care pharmaceutical company. The comp
2011 250,00$

Resverlogix Corp. (RVX) - Financial and Strategic SWOT Analysis Review

Resverlogix Corp. (Resverlogix Corp.) is Canada based clinical biotechnology organization. The company is involved in the developm
2011 250,00$

Ondine Biopharma Corporation (OBP) - Financial and Strategic SWOT Analysis Review

Ondine Biopharma Corporation (now known as Ondine Biomedical Inc.) is a biotechnology company, that is engaged on the development
2011 250,00$

Aikchol Hospital Public Company Limited (AHC) - Financial and Strategic SWOT Analysis Review

Aikchol Hospital Public Company Limited (Aikchol Hospital Public Company Limited) is Thailand based health care services Provider
2011 250,00$

Propharex (PROP) - Financial and Strategic SWOT Analysis Review

Propharex is a specialty pharmaceutical company specialized in the conception, the construction, the delivery and the assembly of
2011 125,00$

LTT Bio-Pharma Co., Ltd. (4566) - Financial and Strategic SWOT Analysis Review

LTT Bio-Pharma Co., Ltd. (LTT Bio-Pharma) is a biotech company, engaged in research and development of drugs and new technologies.
2011 250,00$

Care Service Co., Ltd. (2425) - Financial and Strategic SWOT Analysis Review

Care Service Co., Ltd. (Care Service Co., Ltd.) is Japan based healthcare Services industry. The company is involved in the condit
2011 250,00$

Takara Bio Inc. (4974) - Financial and Strategic SWOT Analysis Review

Takara Bio Inc. (Takara) is a biotechnological company which is focused on developing genomics and biotechnology research reagents
2011 125,00$

Henan Topfond Pharmaceutical Co., Ltd (600253) - Financial and Strategic SWOT Analysis Review

Henan Topfond Pharmaceutical Co., Ltd (Henan Topfond Pharmaceutical Co., Ltd) is China based pharmaceutical company. The company w
2011 125,00$

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu Hengrui) is a biopharmaceutical company engaged in the manufacturing and distribution
2011 125,00$

Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic SWOT Analysis Review

Threshold Pharmaceuticals, Inc.(Threshold Pharmaceuticals) is a biotechnology company, engaged in the discovery and development of
2011 250,00$

Provectus Pharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Pharmaceuticals, Inc. (Provectus) is a biotechnology company, that is engaged in the development of oncology and dermato
2011 250,00$

Tianjin Tianyao Pharmaceutical Co., Ltd (600488) - Financial and Strategic SWOT Analysis Review

Tianjin Tianyao Pharmaceutical Co., Ltd. (TJPC) is a pharmaceutical company, engaged in the development and production of pharmace
2011 250,00$

JiLin AoDong Medicine Industry Group Co., Ltd. (000623) - Financial and Strategic SWOT Analysis Review

JiLin AoDong Medicine Industry Group Co., Ltd. (Jilin Aodong) is a pharmaceutical company engaged, that is engaged in the manufact
2011 250,00$

Guangxi Beisheng Pharmaceutical Co., Ltd (600556) - Financial and Strategic SWOT Analysis Review

Guangxi Beisheng Pharmaceutical Co., Ltd (Guangxi Beisheng Pharmaceutical Co., Ltd.) is China medicine manufacturing organization.
2011 250,00$

Care Twentyone Corporation (2373) - Financial and Strategic SWOT Analysis Review

Care Twentyone Corporation (Care Twentyone Corporation) is Japan based health care pharmaceutical organization. The company is mai
2011 250,00$

CEDAR Co., Ltd. (2435) - Financial and Strategic SWOT Analysis Review

CEDAR. Co., Ltd. (CEDAR. Co., Ltd) is a Japan based healthcare organization. The company is involved in providing nursing care ser
2011 250,00$

Indoco Remedies Limited (INDOCO) - Financial and Strategic SWOT Analysis Review

Indoco Remedies Limited (Indoco Remedies) is india based pharmaceutical health care organization. The company is involved in the d
2011 250,00$

United Envirotech Ltd. (U19) - Financial and Strategic SWOT Analysis Review

United Envirotech Ltd (United Envirotech) is a holding company. It is an environmental solution provider, which is focused on wate
2011 250,00$

Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review

Hovid Berhad (Hovid), formerly Ho Yan Hor, is a pharmaceutical company. It carries out the manufacture and commercialization of ph
2011 250,00$

Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic SWOT Analysis Review

Taiko Pharmaceutical Co.,Ltd. (Taiko) is a pharmaceutical company that is engaged in the manufacture, sale and export of gastroint
2011 250,00$

Swissmed Centrum Zdrowia S.A. (SWD) - Financial and Strategic SWOT Analysis Review

Swissmed Centrum Zdrowia SA (Swissmed) is a Poland based medical organization, engaged in offering a range of medical services fro
2011 250,00$

Neuca SA (TFM) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Neuca SA provides you an in-depth strategic analysis of the company’s businesses and operation
2011 125,00$

Essex Bio-Technology Limited (8151) - Financial and Strategic SWOT Analysis Review

Essex Bio-Technology Limited (Essex) is a Hong Kong based investment holding drug development company. It principally focuses on t
2011 250,00$

LifeVantage Corporation (LFVN) - Financial and Strategic SWOT Analysis Review

LifeVantage Corporation (LifeVantage) is a publicly traded company engaged in the manufacture, marketing and distribution of its d
2011 250,00$

Lipidviro Tech, Inc. (LPVO) - Financial and Strategic SWOT Analysis Review

LipidViro Tech, Inc. (LTI) was engaged in providing research and development for d-OSAB Therapy, a treatment specifically for card
2011 250,00$

PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic SWOT Analysis Review

PT. Pyridam Farma Tbk. (Pyridam) is a pharmaceutical company engaged in the manufacture of cosmetics, food supplements, over the c
2011 250,00$

SemBiosys Genetics Inc. (SBS) - Financial and Strategic SWOT Analysis Review

SemBioSys Genetics Inc. (SemBioSys) is a plant biotechnology company, that is engaged in the development of pharmaceutical and non
2011 250,00$

Pharmesis International Ltd. (P31) - Financial and Strategic SWOT Analysis Review

Pharmesis International Ltd. (Pharmesis) is a pharmaceutical company that manufactures western medicine and traditional Chinese me
2011 250,00$

Suven Life Sciences Ltd. (SUVEN) - Financial and Strategic SWOT Analysis Review

Suven Life Sciences Ltd. (Suven) is a biotechnology company engaged in the business of design, manufacture and supply of bulk acti
2011 250,00$

Galapagos NV (GLPG) - Financial and Strategic SWOT Analysis Review

Galapagos NV (Galapagos) is Belgium based health care pharmaceutical company. The company is involved in discovery and manufacture
2011 250,00$

EMC Instytut Medyczny SA (EMCINSMED) - Financial and Strategic SWOT Analysis Review

EMC Instytut Medyczny SA (EMC Instytut Medyczny SA) is a Poland based health care pharmaceutical organization. The company is invo
2011 250,00$

Uni-Bio Science Group Ltd. (0690) - Financial and Strategic SWOT Analysis Review

Uni-Bio Science Group Limited (Uni-Bio Science) is a publicly held pharmaceutical company. It is engaged in the development of nex
2011 250,00$

Ruyan Group (Holdings) Limited (329) - Financial and Strategic SWOT Analysis Review

Ruyan Group (Holdings) Limited (Ruyan), is formally the company was known as Golden Dragon Group (Holdings) Limited, the main boar
2011 250,00$

Thomson Medical Centre Limited (5FV) - Financial and Strategic SWOT Analysis Review

Thomson Medical Centre Limited (TMC) is a publicly held health care service provider company that is principally engaged in provid
2011 250,00$

Apollo Consolidated Limited (AOP) - Financial and Strategic SWOT Analysis Review

Apollo Consolidated Limited (Apollo Consolidated Limited) is an Australia based skin care organization. Apollo Consolidated Limite
2011 250,00$

Broad Intelligence International Pharmaceutical Holdings Limited (1149) - Financial and Strategic SWOT Analysis Review

Broad Intelligence International Pharmaceutical Holdings Limited (Broad Intelligence) is a pharmaceutical company that is engaged
2011 250,00$

Jiwa Bio-Pharm Holdings Limited (2327) - Financial and Strategic SWOT Analysis Review

Jiwa Bio-Pharm Holdings Limited (Jiwa) is a publicly held pharmaceutical company that is engaged in the producing, selling and dis
2011 250,00$

INS Bioscience Berhad (INSBIO) - Financial and Strategic SWOT Analysis Review

INS Bioscience Berhad (INSBio) is a publicly held healthcare company engaged in the research and development of food base health s
2011 250,00$

Hualan Biological Engineering, Inc. (002007) - Financial and Strategic SWOT Analysis Review

Hualan Biological Engineering, Inc. (Hualan Biological) is a publicly held bio-pharmaceutical company that is involved in the rese
2011 250,00$

MediPost Co., Ltd. (078160) - Financial and Strategic SWOT Analysis Review

Medipost Co, Ltd. (Medipost) is a South Korea based health care organization. The company is involved in the provision of cell rep
2011 250,00$

Byotrol Plc (BYOT) - Financial and Strategic SWOT Analysis Review

Byotrol plc (Byotrol) is a publicly held biotechnology company engaged in the development of biocides through hygiene technology.
2011 250,00$

Medi-Flex Limited (5FF) - Financial and Strategic SWOT Analysis Review

Medi-Flex Limited (Medi-Flex) is a publicly held cleanroom medical disposal glove manufacturer company is engaged in the business
2011 250,00$

Fuhua Group Co. Ltd. Zhuhai S.E.Z. (000507) - Financial and Strategic SWOT Analysis Review

Fuhua Group Co. Ltd. Zhuhai S.E.Z. (Fuhua Group Co. Ltd. Zhuhai S.E.Z.) is China based pharmaceutical industry. The company is eng
2011 125,00$

Carotech Bhd. (CAROTEC) - Financial and Strategic SWOT Analysis Review

Carotech Berhad (Carotech) publicly held company that is engaged in the extraction and processing of nutrients from virgin crude p
2011 250,00$

TMC Life Sciences Berhad (TMCLIFE) - Financial and Strategic SWOT Analysis Review

TMC Life Sciences Berhad (TMC Life) is a publicly held healthcare company engaged in the provision of specialist healthcare servic
2011 250,00$

Jiuzhitang Co.,Ltd. (000989) - Financial and Strategic SWOT Analysis Review

Jiuzhitang Co., Ltd. (Jiuzhitang) is a China based company which is engaged in the production of Chinese traditional medicines. Th
2011 125,00$

HENAN TALOPH PHARMACEUTICAL STOCK CO., LTD (600222) - Financial and Strategic SWOT Analysis Review

Henan Taloph Pharmaceutical Stock Co., Ltd (Henan Taloph Pharmaceutical Stock Co) is Chinese medicine based pharmaceutical company
2011 250,00$

Reyoung Pharmaceutical Holdings Limited (R12) - Financial and Strategic SWOT Analysis Review

Reyoung Pharmaceutical Holdings Limited (RPHL) is a publicly held manufacturer and distributor of personal hygiene and pharmaceuti
2011 250,00$

Topsun Science and Technology Co., Ltd. (600771) - Financial and Strategic SWOT Analysis Review

Topsun Science and Technology Co., Ltd. (Topsun) is a pharmaceutical company which is engaged in the production and sale of prescr
2011 250,00$

C & O Pharmaceutical Technology (Holdings) Limited (E92) - Financial and Strategic SWOT Analysis Review

C & O Pharmaceutical Technology (C & O Pharmaceutical Technology) is Hong Kong based health care pharmaceutical industry. The comp
2011 250,00$

CareTech Holdings PLC (CTH) - Financial and Strategic SWOT Analysis Review

CareTech Holdings PLC (CareTech) is a publicly held company that is engaged in providing a range of specialist care and housing s
2011 250,00$

Sichuan Joint-Wit Med. & Pharm. Ind. (000809) - Financial and Strategic SWOT Analysis Review

Sichuan Joint-Wit Med. & Pharm. Ind. (SJWMPI) is a pharmaceutical company engaged in the research, development, production and dis
2011 250,00$

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial and Strategic SWOT Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (Lingrui) is a china-based public shareholding company which is engaged in the production a
2011 250,00$

Guilinjiqi Pharmaceutical Co., Ltd. (000750) - Financial and Strategic SWOT Analysis Review

Guilinjiqi Pharmaceutical Co., Ltd. (Guilinjiqi) is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutic
2011 250,00$

Angel Biotechnology Holdings plc (ABH) - Financial and Strategic SWOT Analysis Review

Angel Biotechnology Holdings PLC (Angel Biotechnology) is a contract biomanufacturing company engaged in providing process develop
2011 250,00$

Sanitas AB (SAN1L) - Financial and Strategic SWOT Analysis Review

Sanitas AB (Sanitas) is a publicly held pharmaceutical company engaged in the manufacture, development, and sale of generic medici
2011 125,00$

Qinghai Gelatin Company Limited (000606) - Financial and Strategic SWOT Analysis Review

Qinghai Gelatin Company Limited (QGCL) is a publicly held pharmaceutical company which is principally engaged in the manufacturi
2011 250,00$

Beximco Pharmaceuticals Ltd. (BXP) - Financial and Strategic SWOT Analysis Review

Beximco Pharmaceuticals Ltd. (Beximco Pharmaceuticals) is a leading edge pharmaceutical company which is engaged in the supply of
2011 250,00$

S&P Pharmaceutical Co., Ltd. (600869) - Financial and Strategic SWOT Analysis Review

S&P Pharmaceutical Co., Ltd. (S&P Pharmaceutical) is a pharmaceutical company engaged in the development, manufacture and sale of
2011 250,00$

Mebix, Inc. (3780) - Financial and Strategic SWOT Analysis Review

Mebix, Inc. (Mebix) is a publicly held pharmaceutical company involved in four different business segments which include Evidence
2011 250,00$

Medicare Group QSC (MCGS) - Financial and Strategic SWOT Analysis Review

Medicare Group QSC (Medicare Group) is engaged in providing healthcare and hospital services. The company is principally involved
2011 250,00$

Sichuan Di Kang Sci&Tech Pharm. Ind. Co. (600466) - Financial and Strategic SWOT Analysis Review

Sichuan Dikang Sci&Tech Pharmaceutical Industry Co., Ltd. (Dikang) is a pharmaceutical company engaged in the research, manufactur
2011 250,00$

Clinica Las Condes S.A. (LASCONDES) - Financial and Strategic SWOT Analysis Review

Clinica Las Condes S.A. (CLC) operates Clinica Las Condes is a publicly held hospital that is engaged in providing health care ser
2011 125,00$

Summit Corporation plc (SUMM) - Financial and Strategic SWOT Analysis Review

Summit Corporation plc (Summit Corp) is a publicly held drug discovery company that is engaged in the discovery and development of
2011 250,00$

SeouLin Bioscience Co., Ltd. (038070) - Financial and Strategic SWOT Analysis Review

SeouLin Bioscience Co., Ltd. (SeouLin Bioscience) is a publicly held biotechnology company principally engaged in the research and
2011 250,00$

CrystalGenomics, Inc. (083790) - Financial and Strategic SWOT Analysis Review

CrystalGenomics, Inc. (CrystalGenomics) is a publicly held pharmaceutical company engaged in the structure-based drug discovery an
2011 250,00$

Gulf Pharmaceutical Industries PSC (JULPHUR) - Financial and Strategic SWOT Analysis Review

Gulf Pharmaceutical Industries PSC, also known as Julphar, is a publicly held pharmaceutical company focusing on the manufacture o
2011 125,00$

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) - Financial and Strategic SWOT Analysis Review

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (TRPHCL) is a publicly held pharmaceutical company engaged in the manufacture and
2011 250,00$

Ginwa Enterprise (Group) Inc. (600080) - Financial and Strategic SWOT Analysis Review

Ginwa Enterprise (Group) Inc. (Ginwa) is a well-diversified group engaged in the business of pharmaceuticals and property leasing.
2011 250,00$

Hainan Hai Pharmaceutical Co., Ltd. (000566) - Financial and Strategic SWOT Analysis Review

Hainan Haiyao Co., Ltd. (Haiyao) is a china-based public share holding company, engaged in the production and sale of traditional
2011 250,00$

Biofarm S.A. (BIO) - Financial and Strategic SWOT Analysis Review

Biofarm S.A. (Biofarm) is a specialty pharmaceutical company engaged in developing over-the-counter pharmaceuticals. The product p
2011 250,00$

Sanjiu Yigong Biopharmaceutical & Chem (000403) - Financial and Strategic SWOT Analysis Review

Sanjiu Yigong Biopharmaceutical & Chemical Inc. (Sanjiu Yigong) is engaged in the development, manufacture and sale of pharmaceuti
2011 250,00$

Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (000766) - Financial and Strategic SWOT Analysis Review

Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (Tonghua) is engaged in the manufacture and commercialization of pharmaceuti
2011 250,00$

Unisplendour Guhan Group Corporation Ltd (000590) - Financial and Strategic SWOT Analysis Review

Unisplendour Guhan Group Corporation Ltd. (Unisplendour) is a publicly held China based pharmaceutical company that is engaged in
2011 250,00$

Jiangzhong Pharmaceutical Co.,Ltd (600750) - Financial and Strategic SWOT Analysis Review

Jiangzhong Pharmaceutical Co., Ltd (JZJT) is a pharmaceutical company, engaged in the production and sale of pharmaceuticals produ
2011 125,00$

Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252) - Financial and Strategic SWOT Analysis Review

Guangxi Wuzhou Zhongheng Group Co., Ltd (Zhongheng Group) is a diversified company, principally engaged in research and developmen
2011 250,00$

Along Tibet Co., Ltd. PLC (600773) - Financial and Strategic SWOT Analysis Review

Along Tibet Co., Ltd. PLC (Along Tibet Co) is principally engaged in the production and sale of pharmaceuticals and agricultural c
2011 250,00$

Chang An Info Industry (Group) Co.,Ltd (600706) - Financial and Strategic SWOT Analysis Review

Chang An Info Industry (Group) Co., Ltd (Chang An) is engaged in manufacture and distribution of drugs and medical equipments. The
2011 250,00$

NextGen Group PLC (NGG) - Financial and Strategic SWOT Analysis Review

NextGen Group PLC (NextGen) is a biotechnology company which is engaged in providing protein biomarker services for pharmaceutical
2011 250,00$

Jilin Pharmaceutical Co., Ltd (000545) - Financial and Strategic SWOT Analysis Review

Jilin Pharmaceutical Co., Ltd. (Jilin) is a pharmaceutical manufacturing and commercialization company principally engaged in the
2011 250,00$

Renhe Pharmacy Co., Ltd. (000650) - Financial and Strategic SWOT Analysis Review

Renhe Pharmacy Co., Ltd. (RPCL) is a publicly held pharmaceutical company. It mainly focuses on the manufacturing and marketing of
2011 250,00$

Sihuan Pharmaceutical Co.,Ltd. (000605) - Financial and Strategic SWOT Analysis Review

Sihuan Pharmaceutical Co., Ltd. (Sihuan Pharmaceutical) engages in the production, marketing and commercial wholesaling of pharmac
2011 250,00$

DongGuan Fangda Renew Reso Indu Co., Ltd (600656) - Financial and Strategic SWOT Analysis Review

DongGuan Fangda Renew Reso Indu Co., Ltd (DongGuan Fangda) is engaged in manufacturing and distribution of bulk drugs, chemicals a
2011 250,00$

Anhui Koyo (Group) Co., Ltd. (000979) - Financial and Strategic SWOT Analysis Review

Anhui Koyo (Group) Co., Ltd. (Koyo) is a China-based diversified company. The company is principally engaged in providing high qua
2011 250,00$

Latvijas Juras medicinas centrs AS (LJM1R) - Financial and Strategic SWOT Analysis Review

Latvijas Juras medicinas centrs AS (LJMC) is a health care service provider based in Latvia. LJMC along with its subsidiary provid
2011 250,00$

Clinica de Marly S.A. (MARLY) - Financial and Strategic SWOT Analysis Review

Clinica de Marly S.A. (Clinica de Marly S.A.) is a Colombia based pharmaceutical industy. The company handles the Marly Clinic in
2011 250,00$

Hikal Limited (HIKAL) - Financial and Strategic SWOT Analysis Review

Hikal Limited (Hikal Limited) is an India based health care pharmaceutical Industry. The company is involved in the research and d
2011 125,00$

Adinotec AG (N1N) - Financial and Strategic SWOT Analysis Review

Adinotec AG (Adinotec AG) is Germany based engaged health care organization. The company is involved in the development, productio
2011 250,00$

Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial and Strategic SWOT Analysis Review

Rigas Farmaceitiska Fabrika AS (RFF) is a pharmaceutical company engaged in the manufacture and distribution of galenical preparat
2011 250,00$

Nectar Lifesciences Ltd. (NECLIFE) - Financial and Strategic SWOT Analysis Review

Nectar Lifesciences Ltd (NecLife) is engaged in the manufacture of cephalosporin active pharmaceutical ingredients and finished do
2011 250,00$

Celestial Labs Limited (CELESTIAL) - Financial and Strategic SWOT Analysis Review

Celestial Labs Limited (CLL) is a Hydrabad(india) based herbal product organization. The company is engaged in manufacturing, dist
2011 250,00$

Golden House Ltd. (GOHO) - Financial and Strategic SWOT Analysis Review

Golden House Ltd. (Golden House Ltd.) is Israel based Nursing care medical terminology organization. The company is involved in tw
2011 250,00$

GlaxoSmithKline S.A.E. (BIOC) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline S.A.E. is an Egypt based member of GlaxoSmithKline plc. The company principally engages in the manufacture, packa
2011 250,00$

AdCare Health Systems, Inc. (ADK) - Financial and Strategic SWOT Analysis Review

AdCare Health Systems, Inc. (AdCare) is a healthcare and medical services provider. AdCare is engaged in developing and managing h
2011 250,00$

STAR Pharmaceutical Limited (X64) - Financial and Strategic SWOT Analysis Review

STAR Pharmaceutical Limited (STAR Pharmaceutical) is a pharmaceutical company, engaged in the development, manufacturing and mark
2011 250,00$

Plethora Solutions Holdings plc (PLE) - Financial and Strategic SWOT Analysis Review

Plethora Solutions Holdings plc (Plethora) is a biotechnology company, engaged in the development and marketing of drugs and medic
2011 250,00$

Aqua Bounty Technologies, Inc. (ABTX) - Financial and Strategic SWOT Analysis Review

Aqua Bounty Technologies, Inc. (Aqua Bounty) is a publicly held biotechnology company, engaged in the research, development, and c
2011 250,00$

Millet Innovation SA (ALINN) - Financial and Strategic SWOT Analysis Review

Millet Innovation SA (Millet Innovation) is a pharmaceutical company based in France. Millet Innovation is engaged in developing,
2011 250,00$

Protalex, Inc. (PRTX) - Financial and Strategic SWOT Analysis Review

Protalex, Inc. (Protalex) is a publicly traded development stage bio pharmaceutical company, engaged in developing a novel, new cl
2011 250,00$

Plethico Pharmaceuticals Limited (532739) - Financial and Strategic SWOT Analysis Review

Plethico Pharmaceuticals Limited (Plethico) is a publicly held global healthcare and pharmaceutical company engaged in the manufac
2011 125,00$

PCB SA (PCBB) - Financial and Strategic SWOT Analysis Review

PCB SA (PCB) is a publicly held company that is engaged in the distribution of pharmaceutical products. The company’s activities a
2011 125,00$

Pharma Foods International Co., Ltd. (2929) - Financial and Strategic SWOT Analysis Review

Pharma Foods International Co., Ltd. (PFI) is a publicly held venture business company, focused on providing functional food ingre
2011 250,00$

Geneart AG (G6A) - Financial and Strategic SWOT Analysis Review

Geneart AG (Geneart) is a publicly held service provider that is engaged in providing solutions for DNA engineering and processing
2011 250,00$

atect corporation (4241) - Financial and Strategic SWOT Analysis Review

Atect Corporation (Atect Corporation) is biotechnology pharmaceutical organization in Japan. The company is involved in polymer, p
2011 250,00$

Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review

Oriola-KD Oyj (Oriola-KD) is a publicly held pharmaceutical company that is engaged in distribution of pharmaceuticals and healthc
2011 125,00$

MDxHealth SA (ONCOB) - Financial and Strategic SWOT Analysis Review

MDxHealth SA (MDxHealth) is a publicly held molecular diagnostics company that is engaged in developing gene methylation tests for
2011 250,00$

Le Noble Age S.A. (LNA) - Financial and Strategic SWOT Analysis Review

Le Noble Age S.A. (Le Noble Age) is a France-based, provider of retirement homes and complexes for elderly residents. The company
2011 125,00$

JVM Co., Ltd. (054950) - Financial and Strategic SWOT Analysis Review

JVM Co., Ltd. (JVM Co) is a publicly held health care IT company engaged in the development and manufacture of medical automation
2011 250,00$

Granules India Limited (532482) - Financial and Strategic SWOT Analysis Review

Granules India Ltd. (Granules) is a publicly held research based pharmaceutical manufacturing company that engaged in the producti
2011 250,00$

Starwin Products Limited (SPL) - Financial and Strategic SWOT Analysis Review

Starwin Products Limited (SPL) is a pharmaceutical manufacturing company, engaged in the manufacturing as well as in importing and
2011 250,00$

Microbio Co., Ltd. (4128) - Financial and Strategic SWOT Analysis Review

Microbio Co., Ltd. (Microbio) is a botanical and biotransformation drug development and manufacturing company, engaged in research
2011 250,00$

Marksans Pharma Limited (MARKSANS) - Financial and Strategic SWOT Analysis Review

Marksans Pharma Limited (Marksans Pharma) is engaged in the manufacture of prescription drugs for the oncology, gastroenterology,
2011 250,00$

Sucampo Pharmaceuticals, Inc. (SCMP) - Financial and Strategic SWOT Analysis Review

Sucampo Pharmaceuticals, Inc. (Sucampo) is a publicly held biopharmaceutical company engaged in the development and commercializat
2011 250,00$

Innate Pharma SA (IPH) - Financial and Strategic SWOT Analysis Review

Innate Pharma SA (Innate Pharma) is a biopharmaceutical company. It is engaged in developing drugs, principally targeting cancer i
2011 250,00$

HumanOptics AG (H9O) - Financial and Strategic SWOT Analysis Review

HumanOptics AG (HumanOptics) is a specialty pharmaceutical company engaged in developing, manufacturing and selling of intraocular
2011 250,00$

Phylogica Limited (PYC) - Financial and Strategic SWOT Analysis Review

Phylogica Limited (Phylogica) is an Australia-based pharmaceutical company, engaged in the discovery and development of therapeuti
2011 250,00$

Conpharm AB (CONP A) - Financial and Strategic SWOT Analysis Review

Conpharm AB (Conpharm AB) is a Sweden based pharmaceutical company. It markets, through licenses, pharmaceutical products based on
2011 250,00$

Oman Medical Projects Company SAOG (OMPS) - Financial and Strategic SWOT Analysis Review

Oman Medical Projects Company SAOG (OMPC) is principally engaged in establishing hospitals, clinics and medical centers to offer m
2011 250,00$

IDL Biotech AB (publ) (IDL B) - Financial and Strategic SWOT Analysis Review

IDL Biotech AB (IDL Biotech AB) is a Sweden based biotechnology company engaged in developing, manufacturing and marketing of in v
2011 250,00$

Creative Antibiotics Sweden AB (INPH) - Financial and Strategic SWOT Analysis Review

Creative Antibiotics Sweden AB (Creative Antibiotics) is a Sweden based biotechnogy company which develops anti-infective agents.
2011 250,00$

Proximagen Group plc (PRX) - Financial and Strategic SWOT Analysis Review

Proximagen Group plc, (Proximagen) formerly known as Proximagen Neuroscience plc, is a London-based neuroscience research company.
2011 250,00$

Immunotec Inc. (IMM) - Financial and Strategic SWOT Analysis Review

Immunotec Inc. (Immunotec) is engaged in the development, manufacturing and marketing of natural health products, dietary suppleme
2011 250,00$

Kamada Ltd. (KMDA) - Financial and Strategic SWOT Analysis Review

Kamada Ltd. (Kamada) is a publicly traded, biopharmaceutical company that is engaged in development, production and marketing of s
2011 250,00$

Affymax, Inc. (AFFY) - Financial and Strategic SWOT Analysis Review

Affymax, Inc.(Affymax) is a biopharmaceutical company, principally engaged in the development of novel drugs for the treatment of
2011 250,00$

Personalized Nursing Services SA (PNSB) - Financial and Strategic SWOT Analysis Review

Personalized Nursing Services SA (PNS) is a healthcare service provider that is focused on the provision of paramedical care at pa
2011 250,00$

Khimfarm AO (CHFM) - Financial and Strategic SWOT Analysis Review

Khimfarm AO (Khimfarm) is a publicly held pharmaceutical company, engaged in the production and marketing of pharmaceutical produc
2011 250,00$

Luis Cassanello SAICECA (CAS) - Financial and Strategic SWOT Analysis Review

Luis Cassanello SAICECA (Luis Cassanello) is a publicly traded Paraguay based company. The company is principally engaged in buyin
2011 250,00$

Al-Bilad Medical Services Co. (ABMS) - Financial and Strategic SWOT Analysis Review

Al-Bilad Medical Services Co. (Al-Bilad Medical) is an integrated health service offering company. The company owns and operates t
2011 250,00$

Arab Center for Pharmaceutical and Chemical Industries Co. (APHC) - Financial and Strategic SWOT Analysis Review

Arab Center for Pharmaceutical and Chemical Industries Co. (ACPC) is a pharmaceutical company principally engaged in the manufactu
2011 250,00$

Hayat Pharmaceutical Industries (HPIC) - Financial and Strategic SWOT Analysis Review

Hayat Pharmaceutical Industries (HPI) is a pharmaceutical company, engaged in manufacturing and distribution of general pharmaceut
2011 250,00$

Pinnacle Staffing Group plc (PCL) - Financial and Strategic SWOT Analysis Review

Pinnacle Staffing Group plc (Pinnacle Staffing) is a contract service provider engaged in providing recruitment services for the h
2011 250,00$

Tien Liang BioTech Co., Ltd. (4127) - Financial and Strategic SWOT Analysis Review

Tien Liang BioTech Co., Ltd. (Tien Liang BioTech) is a pharmaceutical company engaged in the production and marketing of chemicals
2011 250,00$

Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic SWOT Analysis Review

Nang Kuang Pharmaceutical Co., Ltd. (Nang Kuang) is focused on the manufacture, processing and trading of western medicines. The c
2011 250,00$

Avonova Sverige AB (AVON) - Financial and Strategic SWOT Analysis Review

Avonova Sverige AB (Avonova, formerly known as Curera Sverige AB) is a healthcare service provider company. The company is engaged
2011 250,00$

Biosensor Applications Sweden AB (BIAP A) - Financial and Strategic SWOT Analysis Review

Biosensor Applications Sweden AB (Biosensor Applications) is a biotechnology company engaged in developing, manufacturing and sell
2011 250,00$

Ocean Bright Co., Ltd. (3266) - Financial and Strategic SWOT Analysis Review

Ocean Bright Co., Ltd. (Ocean Bright) is a Taiwan based drug manufacturing company. The company is principally engaged in research
2011 250,00$

Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic SWOT Analysis Review

Genovate Biotechnology Co., Ltd. (GBL), a fully integrated biopharmaceutical company located in Taiwan. The company is engaged in
2011 250,00$

SCI Pharmtech, Inc. (4119) - Financial and Strategic SWOT Analysis Review

SCI Pharmtech, Inc. ( SCI) is a pharmaceutical manufacturing company. It is principally engaged in the research, development, manu
2011 250,00$

Syn-Tech Chem. & Pharm. Co., Ltd. (1777) - Financial and Strategic SWOT Analysis Review

Syn-Tech Chem. & Pharm. Co., Ltd. (Syn-Tech) is a pharmaceutical company, engaged in the manufacture of pharmaceutical raw materia
2011 250,00$

Panion & Bf Biotech Inc. (1760) - Financial and Strategic SWOT Analysis Review

Panion & Bf Biotech Inc. (Panion) is a public traded biotechnology and pharmaceutical company. The company focuses on development
2011 250,00$

Replek AD Skopje (REPL) - Financial and Strategic SWOT Analysis Review

Replek AD Skopje (Replek AD) is a healthcare company, engaged in the manufacture, marketing and distribution of pharmaceuticals, m
2011 250,00$

Sagittarius Life Science Corp. (3205) - Financial and Strategic SWOT Analysis Review

Sagittarius Life Science Corp. (SLSC) is a pharmaceutical company engaged in the discovery, development and production of herbal t
2011 250,00$

OctoPlus N.V. (OCTO) - Financial and Strategic SWOT Analysis Review

OctoPlus N.V. (OctoPlus) operates as a drug delivery company, engaged in the development of improved pharmaceutical products. The
2011 250,00$

Asiri Surgical Hospital PLC (AMSLN) - Financial and Strategic SWOT Analysis Review

Asiri Surgical Hospital PLC (Asiri Surgical) is principally engaged in providing a range of healthcare services related to surgica
2011 250,00$

Center Laboratories, Inc. (4123) - Financial and Strategic SWOT Analysis Review

Center Laboratories, Inc. (Center Laboratories) is a Tiwan based company, engaged in the manufacture and marketing of pastilles an
2011 250,00$

Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review

Level Biotechnology Inc., (LBI) is a biomedical products marketing and distribution company, based in Taiwan. The company engages
2011 250,00$

BIONET Corp. (1784) - Financial and Strategic SWOT Analysis Review

BIONET Corp. (BIONET) is a publicly held stem cell bank engaged in the collection, processing, storage and commercialization of ne
2011 250,00$

GenMont Biotech Inc. (3164) - Financial and Strategic SWOT Analysis Review

Genmont Biotech Inc. (Genmont Biotech) is principally engaged in to researching, developing, manufacturing and selling functional
2011 250,00$

Trident Medical Corp. (4116) - Financial and Strategic SWOT Analysis Review

Trident Medical Corp. (Trident Medical) is engaged in the manufacturing and commercialization of medical equipment. The company's
2011 250,00$

ChronTech Pharma AB (CTEC) - Financial and Strategic SWOT Analysis Review

ChronTech Pharma AB (ChronTech Pharma), formerly known as Tripep AB, is a publicly held biotechnology research company. The compan
2011 250,00$

NeutraHealth Plc (NUT) - Financial and Strategic SWOT Analysis Review

NeutraHealth Plc is a UK based holding company. The company is engaged in production, distribution and sale of nutraceutical produ
2011 250,00$

Probiotec Limited (PBP) - Financial and Strategic SWOT Analysis Review

Probiotec Limited (Probiotec) is engaged in the manufacture, market, and distribution of various prescription and over-the-counter
2011 250,00$

CytoTools AG (T5O) - Financial and Strategic SWOT Analysis Review

CytoTools AG (CytoTools) is an publicly held investment and holding company in the technology sector. The company holds its share
2011 250,00$

Advanta India Limited (ADVANTA) - Financial and Strategic SWOT Analysis Review

Advanta India Limited (AIL) is a research focused biotechnology company. The company is engaged in research and development, produ
2011 250,00$

Astek Group Plc (AKG) - Financial and Strategic SWOT Analysis Review

Astek Group plc (Astek) is engaged in the manufacture and supply of dental products and dental consumables. It also produces and s
2011 250,00$

China-Biotics, Inc. (CHBT) - Financial and Strategic SWOT Analysis Review

China-Biotics Inc. (China-Biotics) is engaged in the research, development, production, marketing and distribution of probiotic pr
2011 250,00$

Bosnalijek d.d. Sarajevo (BSNLR) - Financial and Strategic SWOT Analysis Review

Bosnalijek d.d. Sarajevo (Bosnalijek) is a pharmaceutical company engaged in the manufacture of drugs and disinfecting agents in t
2011 250,00$

Synopsis Ltd. (SYNO) - Financial and Strategic SWOT Analysis Review

Synopsis Ltd. (Synopsis) is an Israel-based health care services company. Synopsis provides services through its subsidiaries name
2011 250,00$

T.R.D. Instrum Ltd. (TRD) - Financial and Strategic SWOT Analysis Review

T.R.D. Instrum Ltd. (TRD) is engaged in developing, marketing and manufacture of dental products. Its main products include: OrbO,
2011 250,00$

InterCure Ltd. (INCR) - Financial and Strategic SWOT Analysis Review

InterCure Ltd. (InterCure) is a medical device company engaged in the manufacture and sale of RESPeRATE. The company’s product RES
2011 250,00$

Societe des Industries Pharmaceutiques de Tunisie S.A. (SIPHA) - Financial and Strategic SWOT Analysis Review

Societe des Industries Pharmaceutiques de Tunisie S.A. (SIPHAT) is a drug manufacturing company. The company is a subsidiary of th
2011 250,00$

Sothema (SOT) - Financial and Strategic SWOT Analysis Review

Sothema is a publicly traded pharmaceutical company that specializes in manufacturing and marketing of drugs. The company offers a
2011 250,00$

Oasmia Pharmaceutical AB (OASM) - Financial and Strategic SWOT Analysis Review

Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company engaged in the development of second and third genera
2011 250,00$

European Lifecare Group A/S (DLVS) - Financial and Strategic SWOT Analysis Review

European Lifecare Group A/S (European Lifecare) formerly known as Danske Laegers Vaccinations Service A/S, is one of the largest p
2011 250,00$

Taihua plc (TAIH) - Financial and Strategic SWOT Analysis Review

Taihua plc (Taihua) is an investment holding company, engaged in development, manufacture and commercialization of pharmaceutical
2011 250,00$

Cyclopharm Limited (CYC) - Financial and Strategic SWOT Analysis Review

Cyclopharm Limited (CL) is a medical and health care equipments manufacturing company. The company is engaged in the manufacturing
2011 250,00$

Imexpharm Pharmaceutical JSC (IMP) - Financial and Strategic SWOT Analysis Review

Imexpharm Pharmaceutical JSC (Imexpharm) is a publicly held pharmaceutical company engaged in manufacturing and distributing pharm
2011 250,00$

Ferozsons Laboratories Limited (FEROZ) - Financial and Strategic SWOT Analysis Review

Ferozsons Laboratories Limited (Ferozsons Laboratories) is a publicly held pharmaceutical company, engaged in the manufacturing an
2011 250,00$

Shifa International Hospitals Limited (SHFA) - Financial and Strategic SWOT Analysis Review

Shifa International Hospitals Ltd. (Shifa International) is publicly held company that is principally engaged in providing a broad
2011 250,00$

DiaMedica Inc. (DMA) - Financial and Strategic SWOT Analysis Review

DiaMedica Inc. (DiaMedica) is a publicly held biopharmaceutical company principally involved in the discovery and development of p
2011 250,00$

Nawaloka Hospitals Private Limited (NHL) - Financial and Strategic SWOT Analysis Review

Nawaloka Hospitals Private Limited (Nawaloka Hospitals) is principally engaged in providing a range of healthcare and hospital ser
2011 250,00$

New Nordic Healthbrands AB (NNH) - Financial and Strategic SWOT Analysis Review

New Nordic Healthbrands AB (New Nordic) is a Sweden based pharmaceutical company. The company is principally engaged in developmen
2011 250,00$

Oscotec Inc. (039200) - Financial and Strategic SWOT Analysis Review

Oscotec Inc. (Oscotec) is a publicly held pharmaceutical company that is engaged in manufacturing drug candidates for the treatmen
2011 250,00$

Cremer SA (CREM3) - Financial and Strategic SWOT Analysis Review

Cremer SA (Cremer) is a manufacturing and distribution company of disposable healthcare textile and adhesive products. The product
2011 125,00$

Hikari Heights-Varus Co., Ltd. (2137) - Financial and Strategic SWOT Analysis Review

Hikari Heights-Varus Co., Ltd. (Hikari Heights) is a public company that is engaged in the establishment, operation and management
2011 250,00$

OPC Pharmaceutical Joint Stock Company (OPC) - Financial and Strategic SWOT Analysis Review

OPC Pharmaceutical Joint Stock Company (OPC Pharmaceutical) is engaged in manufacturing pharmaceutical products from medicinal her
2011 250,00$

Immuno-Biological Laboratories Co., Ltd. (4570) - Financial and Strategic SWOT Analysis Review

Immuno-Biological Laboratories Co., Ltd. (IBL) is engaged in the research, development, manufacture and sale of pharmaceutical pro
2011 250,00$

Jilin Zixin Pharmaceutical Ind. Co., Ltd (002118) - Financial and Strategic SWOT Analysis Review

Jilin Zixin Pharmaceutical Industrial Co., Ltd (Jilin Zixin) is a publicly held company that is engaged in research, development,
2011 250,00$

Aptilon Corporation (APZ) - Financial and Strategic SWOT Analysis Review

Aptilon Corporation (Aptilon) is a Canada-based healthcare IT company. The company is principally engaged in providing a range of
2011 250,00$

Clinica Baviera SA (CBAV) - Financial and Strategic SWOT Analysis Review

Clinica Baviera SA (Clinica Baviera) is a Spain-based ophthalmic company. Clinica Baviera is engaged in providing laser surgery se
2011 250,00$

Servizi Italia S.p.A. (SRI) - Financial and Strategic SWOT Analysis Review

Servizi Italia S.p.A. (Servizi Italia) is a conglomerate company principally engaged in the operations of design, construction and
2011 125,00$

Simcere Pharmaceutical Group (SCR) - Financial and Strategic SWOT Analysis Review

Simcere Pharmaceutical Group (Simcere) is a publicly held company that is principally engaged in the manufacture and supply of gen
2011 125,00$

Ankur Drugs and Pharma Ltd. (ANKURDRUGS) - Financial and Strategic SWOT Analysis Review

Ankur Drugs and Pharma Ltd. (Ankur Drugs) is a publicly held pharmaceutical company principally engaged in contract manufacturing
2011 125,00$

Transgene Biotek Limited (526139) - Financial and Strategic SWOT Analysis Review

Transgene Biotek Limited. (TBL) is a biotechnology company that focused on the development of medical diagnostics products such as
2011 250,00$

Jupiter Bioscience Limited (524826) - Financial and Strategic SWOT Analysis Review

Jupiter Bioscience Limited. (Jupiter Bioscience) is a publicly held company that is engaged in the production and selling of pepti
2011 250,00$

Themis Medicare Ltd. (530199) - Financial and Strategic SWOT Analysis Review

Themis Medicare Ltd. (Themis Medicare) is a public traded pharmaceutical company engaged in the manufacture of active pharmaceutic
2011 125,00$

DHG Pharmaceutical JSC (DHG) - Financial and Strategic SWOT Analysis Review

DHG Pharmaceutical JSC (DHG) is a publicly held pharmaceutical company engaged in the production and trade of pharmaceutical produ
2011 250,00$

Protox Therapeutics Inc. (PRX) - Financial and Strategic SWOT Analysis Review

Protox Therapeutics Inc. (Protox) is a publicly held development stage bio-pharmaceutical company principally engaged in the resea
2011 250,00$

MetrioPharm AG (MP5) - Financial and Strategic SWOT Analysis Review

MetrioPharm AG (MetrioPharm) is a pharmaceutical company engaged in the development and marketing of therapies against bacterial a
2011 250,00$

Aureum Realwert AG (TRH) - Financial and Strategic SWOT Analysis Review

Aureum Realwert AG, (formerly known as HELIO Biotech AG) is a biotechnology company that mainly focuses on the development, manufa
2011 250,00$

Skilled Healthcare Group, Inc. (SKH) - Financial and Strategic SWOT Analysis Review

Skilled Healthcare Group, Inc. (Skilled Healthcare Group) is a holding company that owns subsidiaries and is engaged in providing
2011 125,00$

Domesco Medical Import-Export JS Corp (DMC) - Financial and Strategic SWOT Analysis Review

Domesco Medical Import-Export JS Corp (Domesco Medical) is a publicly held pharmaceutical company that is engaged in the manufactu
2011 250,00$

DONGKOOK Pharmaceutical Co., Ltd. (086450) - Financial and Strategic SWOT Analysis Review

DONGKOOK Pharmaceutical Co., Ltd. (Dongkook) is a publicly held pharmaceutical company engaged in the development and manufacturin
2011 250,00$

Medical Nutrition USA, Inc. (MDNU) - Financial and Strategic SWOT Analysis Review

Medical Nutrition USA, Inc. (MNI) is engaged in the manufacturing, marketing and distribution of nutritional and health care produ
2011 250,00$

Farmstandart OAO (PHST) - Financial and Strategic SWOT Analysis Review

Farmstandart OAO (Farmstandart) is a publicly held research focused biotechnology company that is principally engaged in research,
2011 125,00$

Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic SWOT Analysis Review

Avvaa World Health Care Products, Inc. (Avvaa) is a biotechnology company, based in Canada. The company focused on the manufacturi
2011 250,00$

Huifeng BioPharmaceutical Technology Inc. (HFGB) - Financial and Strategic SWOT Analysis Review

Huifeng BioPharmaceutical Technology Inc. (Huifeng) is a publicly held company that is principally engaged in development, product
2011 250,00$

Cord Blood America, Inc. (CBAI) - Financial and Strategic SWOT Analysis Review

Cord Blood America, Inc. (Cord Blood) is a biotechnology company engaged in providing private cord blood stem cell preservation se
2011 250,00$

Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic SWOT Analysis Review

Raptor Pharmaceuticals Corp. (Raptor) is a biotechnology company that is involved in the acquisition, development, and commerciali
2011 250,00$

Choongwae Holdings Co., Ltd (096760) - Financial and Strategic SWOT Analysis Review

Choongwae Holdings Co., Ltd (Choongwae) is a publicly held company that is principally engaged in the drug distribution and export
2011 125,00$

Ost Japan Group Inc. (2757) - Financial and Strategic SWOT Analysis Review

Ost Japan Group Inc. (Ost Japan) is a public holding company, engaged in wholesale pharmaceuticals business and real estate relate
2011 250,00$

Redpoint Bio Corporation (RPBC) - Financial and Strategic SWOT Analysis Review

Redpoint Bio Corporation (Redpoint) is a privately held biotechnology company engaged in the discovery of novel small molecules, w
2011 250,00$

Societe Adwya SA (ADWYA) - Financial and Strategic SWOT Analysis Review

Societe Adwya SA (Societe Adwya) is engaged in the manufacturing and commercialization of pharmaceutical products. The company foc
2011 250,00$

Sunway Global Inc. (SUWG) - Financial and Strategic SWOT Analysis Review

Sunway Global Inc. (Sunway Global) is a medical equipment company engaged in the development and manufacture of medicine dispensin
2011 250,00$

Guilin Layn Natural Ingredients Corp. (002166) - Financial and Strategic SWOT Analysis Review

Guilin Layn Natural Ingredients Corp. (Layn) is a publicly traded pharmaceutical company which is engaged in the research, develop
2011 250,00$

IPC The Hospitalist Company, Inc. (IPCM) - Financial and Strategic SWOT Analysis Review

IPC The Hospitalist Company, Inc. (IPC) is a national hospitalist physician group practice company, engaged in the delivery of hos
2011 125,00$

Aqua Bio Technology ASA (ATB) - Financial and Strategic SWOT Analysis Review

Aqua Bio Technology ASA (ABT) is a Norway based pharmaceutical company. The company is principally engaged in research and develop
2011 250,00$

Biotoxtech Co., Ltd (086040) - Financial and Strategic SWOT Analysis Review

Biotoxtech Co., Ltd (Biotoxtech) is a publicly held pharmaceutical company principally engaged in providing non-clinical drug tria
2011 250,00$

China Kangtai Cactus Bio-Tech Inc. (CKGT) - Financial and Strategic SWOT Analysis Review

China Kangtai Cactus Bio-Tech Inc. (China Kangtai) is a vertically integrated manufacturer and marketer of cactus based consumer p
2011 250,00$

Highnoon Laboratories Limited (HINOON) - Financial and Strategic SWOT Analysis Review

Highnoon Laboratories Limited (HNL) is a pharmaceutical company focused on the manufacture, import, sale, and marketing of pharmac
2011 250,00$

Sun Pharma Advanced Research Company (SPARC) - Financial and Strategic SWOT Analysis Review

Sun Pharma Advanced Research Company (SPARC) is a publicly held pharmaceutical research and drug discovery company engaged in the
2011 250,00$

Imuniti Holdings Limited (IMU) - Financial and Strategic SWOT Analysis Review

Imuniti Holdings Limited (Imuniti) is a publicly held pharmaceutical company that is engaged in the formulation and manufacturing
2011 250,00$

Stem Cell Therapeutics Corp. (SSS) - Financial and Strategic SWOT Analysis Review

Stem Cell Therapeutics Corp. (SCT) is a publicly held biotechnology company, based in Canada. The company is primarily focusing on
2011 250,00$

Neimeth International Pharmaceutical PLC (NEIMETH) - Financial and Strategic SWOT Analysis Review

Neimeth International Pharmaceutical PLC (Neimeth) is a Nigeria based drug manufacturing company. The company is principally engag
2011 250,00$

CPEX Pharmaceuticals, Inc. (CPEX) - Financial and Strategic SWOT Analysis Review

CPEX Pharmaceuticals, Inc. (CPEX) is a publicly held development stage specialty pharmaceutical company that is principally engage
2011 250,00$

MIC Medical Corporation (2166) - Financial and Strategic SWOT Analysis Review

MIC Medical Corporation (MIC Medical) is a publicly held company that is engaged in providing development support services to the
2011 250,00$

Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review

Galena Biopharma, Inc. (Galena), formerly known as RXi Pharmaceuticals Corporation, is a discovery-stage biotechnology company. It
2011 250,00$

ProMD Biotech Co., Ltd. (4731) - Financial and Strategic SWOT Analysis Review

ProMD Biotech Co., Ltd. (ProMD) is a pharmaceutical company engaged in the research, development and commercialization of probioti
2011 250,00$

Nattopharma ASA (NATTO) - Financial and Strategic SWOT Analysis Review

Nattopharma ASA (Nattopharma) is a publicly held company focusing primarily on research, developing and selling of vitamin K2. Its
2011 250,00$

Nepentes SA (NEP) - Financial and Strategic SWOT Analysis Review

Nepentes S.A. (Nepentes) is a publicly held pharmaceutical company that is engaged in manufacturing and marketing of dermocosmetic
2011 250,00$

Transdermal Cosmetics Plc (TRCP) - Financial and Strategic SWOT Analysis Review

Transdermal Cosmetics Plc (Transdermal Cosmetics) is a publicly held biopharmaceutical company engaged in the manufacture, distrib
2011 250,00$

Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review

Japan Tissue Engineering Co., Ltd. (J-TEC) is engaged in the development, manufacture and commercialization of tissue-engineered m
2011 250,00$

EastPharma Ltd. (EAST) - Financial and Strategic SWOT Analysis Review

EastPharma Ltd. (EastPharma) is a publicly held pharmaceutical company that is principally engaged in the manufacturing and market
2011 125,00$

B.M.P. Pharma Trading AG (BMP) - Financial and Strategic SWOT Analysis Review

B.M.P. Pharma Trading AG (B.M.P) is engaged in the trade of nutraceutical products and pharmaceutical raw materials. The company o
2011 250,00$

NatureWise Biotech & Medicals Corp (4732) - Financial and Strategic SWOT Analysis Review

NatureWise Biotech & Medicals Corp. (NBM) is principally engaged in drug discovery and development. Also, the company offers healt
2011 250,00$

InfuSystem Holdings, Inc. (INFU) - Financial and Strategic SWOT Analysis Review

InfuSystem Holdings, Inc. (InfuSystem) is one of the largest providers of ambulatory infusion pumps and related services for oncol
2011 250,00$

Aoxing Pharmaceutical Company, Inc (AXN) - Financial and Strategic SWOT Analysis Review

Aoxing Pharmaceutical Company Inc. (Aoxing) is a specialized pharmaceutical company engaged in the research, development, manufact
2011 250,00$

Skystar Bio-Pharmaceutical Company (SKBI) - Financial and Strategic SWOT Analysis Review

Skystar Bio-Pharmaceutical Company (Skystar Bio-Pharmaceutical) is a biopharmaceutical company that develops, manufactures and dis
2011 250,00$

China Health Resource, Inc. (CHRI) - Financial and Strategic SWOT Analysis Review

China Health Resource, Inc. (CHR) is a pharmaceutical company, engaged in the processing, manufacturing, development and commercia
2011 250,00$

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (002219) - Financial and Strategic SWOT Analysis Review

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (Gansu Duyiwei) is a traditional drug manufacturing company, based in China. The
2011 250,00$

NanoCarrier Co., Ltd. (4571) - Financial and Strategic SWOT Analysis Review

NanoCarrier Co., Ltd. (NanoCarrier) is a biotechnology company, engaged in the research, development and manufacturing of anticanc
2011 250,00$

Lotus Eye Care Hospital Limited (LOTUSEYE) - Financial and Strategic SWOT Analysis Review

Lotus Eye Care Hospital Limited (Lotus Eye Care) operates as an eye hospital, engaged in providing eye care facilities. In additio
2011 250,00$

Carna Biosciences, Inc. (4572) - Financial and Strategic SWOT Analysis Review

Carna Biosciences, Inc. (Carna Biosciences) is a biotechnology company, based in Japan. The company is principally engaged in the
2011 250,00$

Senzime AB (SEZI) - Financial and Strategic SWOT Analysis Review

Senzime AB (Senzime) is a Sweden-based biotechnology company. The company is principally engaged in the development, manufacture a
2011 250,00$

R-Tech Ueno, Ltd. (4573) - Financial and Strategic SWOT Analysis Review

R-Tech Ueno, Ltd. (R-Tech) is principally engaged in the research, development, manufacturing, selling, exporting and importing ph
2011 250,00$

Hartalega Holdings Berhad (HARTA) - Financial and Strategic SWOT Analysis Review

Hartalega Holdings Berhad (Hartalega) is a medical devices company, engaged in the manufacture of latex gloves and nitrile gloves.
2011 250,00$

G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic SWOT Analysis Review

G&E Herbal Biotechnology Co., Ltd. (G&E Herbal) is a Taiwan based biotechnology company, engaged in developing new botanic drugs.
2011 250,00$

Ambalal Sarabhai Enterprises Limited (500009) - Financial and Strategic SWOT Analysis Review

Ambalal Sarabhai Enterprises Limited (ASE) is a pharmaceutical company, principally engaged in the development of wide range of bu
2011 250,00$

Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic SWOT Analysis Review

Rexahn Pharmaceuticals, Inc., (Rexahn Pharmaceuticals) is a biopharmaceutical company that is engaged in the discovery, manufactur
2011 250,00$

Myungmoon pharmaceutical Co.,Ltd. (017180) - Financial and Strategic SWOT Analysis Review

Myungmoon pharmaceutical Co.,Ltd. (Myungmoon pharmaceutical) is engaged in the manufacture and marketing of pharmaceutical and che
2011 250,00$

NeuroVive Pharmaceutical AB (NVP) - Financial and Strategic SWOT Analysis Review

NeuroVive Pharmaceutical AB (NeuroVive) is a drug manufacturing company. The company is principally engaged in the development and
2011 250,00$

Piramal Life Sciences Limited (PIRLIFE) - Financial and Strategic SWOT Analysis Review

Piramal Life Sciences Limited (PLSL) is a research focused pharmaceutical company. The company is principally engaged in the drug
2011 250,00$

Abnova Corporation (4133) - Financial and Strategic SWOT Analysis Review

Abnova Corporation (Abnova) is a biotechnology company that is engaged in the manufacturing of antibodies and proteins. The compan
2011 250,00$

Unipharm AD (59X) - Financial and Strategic SWOT Analysis Review

Unipharm AD (Unipharm) is engaged in the manufacturing and commercialization of medicinal products for human healthcare. The compa
2011 250,00$

Ina Research Inc. (2176) - Financial and Strategic SWOT Analysis Review

Ina Research Inc. (INA) is a public traded, contract research laboratory. The company is principally engaged in the development of
2011 250,00$

Qualitas Medical Group Sdn Bhd. (5NN) - Financial and Strategic SWOT Analysis Review

Qualitas Medical Group Sdn Bhd. (Qualitas) is a contract service providing company engaged in providing well-integrated network of
2011 250,00$

Jiangsu Nhwa Pharma Corporation (002262) - Financial and Strategic SWOT Analysis Review

Jiangsu Nhwa Pharma Corporation (Jiangsu) is a pharmaceutical company that is engaged in the research, development and manufacture
2011 125,00$

Enervit S.p.A. (ENV) - Financial and Strategic SWOT Analysis Review

Enervit S.p.A. (Enervit) is a healthcare company engaged in the research, development, production and commercialization of product
2011 250,00$

Growell Holdings Co., Ltd. (3141) - Financial and Strategic SWOT Analysis Review

Growell Holdings Co., Ltd. (Growell) is a holding company, engaged in the management of subsidiaries as well as a group of compani
2011 125,00$

Gamma Pharmaceuticals Inc. (GMPM) - Financial and Strategic SWOT Analysis Review

Gamma Pharmaceuticals Inc. (Gamma Pharmaceuticals) is a US-based drug manufacturing company. The company is engaged in product for
2011 250,00$

PuraMed BioScience Inc. (PMBS) - Financial and Strategic SWOT Analysis Review

PuraMed BioScience Inc. (PuraMed) is a US-based pharmaceutical company. The company is specialized in the manufacture of over th
2011 250,00$

Fluorotechnics Limited (FLS) - Financial and Strategic SWOT Analysis Review

Fluorotechnics Limited (Fluorotechnics) is a Austraian-based pharmaceutical and healthcare company. The company is engaged in dev
2011 250,00$

Medizone International, Inc. (MZEI) - Financial and Strategic SWOT Analysis Review

Medizone International, Inc. (Medizone) is a US-based research and development company. The company is engaged in development of n
2011 250,00$

Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review

Merrion Pharmaceuticals Plc (Merrion) is a specialty pharmaceutical company engaged in developing oral dosage forms of drugs that
2011 250,00$

Scancell Holdings Plc (SCLP) - Financial and Strategic SWOT Analysis Review

Scancell Holdings plc (Scancell) is a biopharmaceutical company, engaged in developing novel therapeutic cancer vaccines for the t
2011 250,00$

Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic SWOT Analysis Review

Sunzen Biotech Berhad (Sunzen Biotech) is a healthcare company engaged in the development manufacture and marketing of animal heal
2011 250,00$

Clinique du Rond-Point des Champs Elysees SA (MLCRP) - Financial and Strategic SWOT Analysis Review

Clinique du Rond-Point des Champs Elysees SA (CRPCE) is engaged medical and surgical services. Its operations are focused on the a
2011 250,00$

Tiens Biotech Group (USA), Inc. (TBV) - Financial and Strategic SWOT Analysis Review

Tiens Biotech Group (USA), Inc. (Tiens) is a public traded biotechnology company engaged in the research, development, manufacturi
2011 250,00$

Kovai Medical Center & Hospital Limited (523323) - Financial and Strategic SWOT Analysis Review

Kovai Medical Center & Hospital Limited (Kovai Medical) is a medical and healthcare services provider that provides hospital facil
2011 250,00$

Indraprastha Medical Corporation Limited (INDRAMEDCO) - Financial and Strategic SWOT Analysis Review

Indraprastha Medical Corporation Limited (Indraprastha Medical) is a medical and healthcare services provider, based in India. Ind
2011 250,00$

Fortis Malar Hospitals Limited (523696) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Fortis Malar Hospitals Limited provides you an in-depth strategic analysis of the company’s bu
2011 250,00$

Sanacorp Pharmaholding AG (SNC3) - Financial and Strategic SWOT Analysis Review

Sanacorp Pharmaholding AG (Sanacorp Pharmaholding) formerly known as Sanacorp Pharmahandel AG, is engaged in the wholesale of phar
2011 250,00$

Gufic BioSciences Limited (GUFICBIO) - Financial and Strategic SWOT Analysis Review

Gufic BioSciences Limited (Gufic BioSciences) is a pharmaceutical company based in India. Gufic BioSciences is one of the leading
2011 250,00$

Aventis Pharma Limited (AVENTIS) - Financial and Strategic SWOT Analysis Review

Aventis Pharma Limited (Aventis) is an India based pharmaceuticals manufacturing company. The company provides medicines for the t
2011 125,00$

Prospect Medical Holdings Inc (PZZ) - Financial and Strategic SWOT Analysis Review

Prospect Medical Holdings, Inc. (Prospect) is a provider of healthcare services, based in the US. The company provides healthcare
2011 125,00$

MiMedx Group, Inc (MDXG) - Financial and Strategic SWOT Analysis Review

MiMedx Group, Inc.(MiMedx Group) is engaged in the development, manufacture and marketing of patent protected biomaterial-based pr
2011 250,00$

Hawkley Oil And Gas Limited (ICV) - Financial and Strategic SWOT Analysis Review

Hawkley Oil And Gas Limited (formerly known as Incitive Ltd.) is a research focused biotechnology company. The company is engaged
2011 250,00$

Genolier Swiss Medical Network SA (GSMN) - Financial and Strategic SWOT Analysis Review

Genolier Swiss Medical Network SA (Genolier Swiss) is the leading hospital network in the French speaking region of Switzerland (R
2011 250,00$

Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic SWOT Analysis Review

Cumberland Pharmaceuticals, Inc. (CPI) is a specialty pharmaceutical company, engaged in the acquisition, development and commerci
2011 250,00$

Logibec Groupe Informatique Ltd. (LGI) - Financial and Strategic SWOT Analysis Review

Logibec Groupe Informatique Ltd. (LGI) is engaged in the development, marketing, implementation and support of information systems
2011 125,00$

Zandu Realty Limited (506720) - Financial and Strategic SWOT Analysis Review

Zandu Realty Limited is formerly known as Zandu Pharmaceutical Works Ltd. (Zandu Pharma) is an India based pharmaceutical company.
2011 250,00$

HOV Services Limited (HOVS) - Financial and Strategic SWOT Analysis Review

HOV Services Limited is engaged in offering business process outsourcing services to various sectors including financial, telecom
2011 125,00$

Magic Software Enterprises Ltd. (MGIC) - Financial and Strategic SWOT Analysis Review

Magic Software Enterprises Ltd. (MSEL) is engaged in providing application platforms and business integration solutions. The compa
2011 125,00$

PCI Biotech Holding ASA (PCIB) - Financial and Strategic SWOT Analysis Review

PCI Biotech Holding ASA (PCI Biotech) is a Norway-based company focused on the commercialization of a patented photochemical drug
2011 250,00$

Grupo Estrella SA (QUES) - Financial and Strategic SWOT Analysis Review

Grupo Estrella SA (Estrella) is focused on the manufacture of consumer goods. The company is principally involved in production an
2011 250,00$

Instituto Rosenbusch S.A. (ROSE) - Financial and Strategic SWOT Analysis Review

Instituto Rosenbusch S.A. (Instituto Rosenbusch) is a healthcare institute engaged in the production and sale of veterinary produc
2011 250,00$

Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic SWOT Analysis Review

Medical Union Pharmaceuticals Company (MUP) is a pharmaceutical manufacturing facility, engaged in providing a wide range of produ
2011 250,00$

The Nile Co. for Pharm & Chemical Ind. (NIPH) - Financial and Strategic SWOT Analysis Review

The Nile Co. for Pharm & Chemical Ind. (EL-Nile) is a pharmaceutical company engaged in the manufacturing and trading of pharmaceu
2011 250,00$

Cairo Pharmaceuticals and Chemical Industries (CPCI) - Financial and Strategic SWOT Analysis Review

Cairo Pharmaceuticals and Chemical Industries (Cairo Pharmaceuticals), also known as Kahira Pharmaceuticals & Chemical Industries
2011 250,00$

Alexandria Pharmaceutical and Chemical Industries Company (AXPH) - Financial and Strategic SWOT Analysis Review

Alexandria Pharmaceutical and Chemical Industries Company (APCIC) is an Egyptian pharmaceutical company, engaged in the manufactur
2011 250,00$

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GSK) is a research-focused healthcare and pharmaceutical company. The company offers a di
2011 125,00$

Jagsonpal Pharmaceuticals Limited (507789) - Financial and Strategic SWOT Analysis Review

Jagsonpal Pharmaceuticals Limited (Jagsonpal) is an India based pharmaceutical company. It is engaged in the research, development
2011 250,00$

Affitech A/S (AFFI) - Financial and Strategic SWOT Analysis Review

Affitech A/S (Affitech) is a pharmaceutical company, based in Denmark. The company operates in the discovery and development of hu
2011 250,00$

Fresenius Kabi Oncology Limited (FKONCO) - Financial and Strategic SWOT Analysis Review

Fresenius Kabi Oncology Limited (Fresenius Kabi) is a drug developing and manufacturing company engages in cancer research and ant
2011 250,00$

Wyeth Limited (WYETH) - Financial and Strategic SWOT Analysis Review

Wyeth Limited is a pharmaceutical company, engaged in the development, manufacture, and sale of pharmaceutical products. It operat
2011 250,00$

Sharon Bio-Medicine Ltd. (590034) - Financial and Strategic SWOT Analysis Review

Sharon Bio-Medicine Ltd. (Sharon) is an India-based pharmaceutical company. The company is principally engaged in research & devel
2011 250,00$

Aarti Drugs Ltd. (AARTIDRUGS) - Financial and Strategic SWOT Analysis Review

Aarti Drugs Ltd. (Aarti Drugs) is an India based drugs manufacturing company. Aarti Drugs is a part of Aarti Group of Industries.
2011 250,00$

Astrazeneca Pharma India Limited (ASTRAZEN) - Financial and Strategic SWOT Analysis Review

AstraZeneca Pharma India Limited (AZPIL) is pharmaceutical company engaged in the research, production and commercialization of ph
2011 250,00$

The Lanka Hospitals Corporation PLC (LHCL) - Financial and Strategic SWOT Analysis Review

The Lanka Hospitals Corporation PLC (Lanka Hospitals Corporation) is a healthcare company engaged in the provision of healthcare s
2011 250,00$

EIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (ECILC) - Financial and Strategic SWOT Analysis Review

EIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (EIS Eczacibasi) is engaged in production, marketing and se
2011 125,00$

StemCells, Inc. (STEMD) - Financial and Strategic SWOT Analysis Review

StemCells, Inc. (StemCells) is a biopharmaceutical company engaged in the discovery and development of cell-based therapeutics to
2011 250,00$

Egyptian International Pharmaceutical Industries Company (PHAR) - Financial and Strategic SWOT Analysis Review

Egyptian International Pharmaceutical Industries Company (EIPIC) is a pharmaceutical company, engaged in the production, sale and
2011 125,00$

Cardica, Inc. (CRDC) - Financial and Strategic SWOT Analysis Review

Cardica, Inc. (Cardica) is a manufacturing company, engaged in the research and development of novel technologies in the field of
2011 250,00$

Deepak Nitrite Ltd. (506401) - Financial and Strategic SWOT Analysis Review

Deepak Nitrite Ltd. (DNL) is engaged in manufacturing inorganic, organic and fine & specialty chemicals that are used as intermedi
2011 250,00$

Halcygen Pharmaceuticals Limited (MYX) - Financial and Strategic SWOT Analysis Review

Halcygen Pharmaceuticals Limited (Halcygen) is focused on the improvement and reformulation of existing drugs. The company has two
2011 250,00$

Hadasit Bio-Holdings Ltd. (HDST) - Financial and Strategic SWOT Analysis Review

Hadasit Bio-Holdings Ltd. (HBL) is subsidiary of Hadasit Ltd. The company through its subsidiaries is engaged in serving the medic
2011 250,00$

Abbott Laboratories (Pakistan) Limited (ABOT) - Financial and Strategic SWOT Analysis Review

Abbott Laboratories (Pakistan) Limited (Abbott Pakistan) is a health care company. It is a subsidiary of Abbott Laboratories, the
2011 250,00$

ZhuZhou QianJin Pharmaceutical Co., Ltd (600479) - Financial and Strategic SWOT Analysis Review

ZhuZhou QianJin Pharmaceutical Co., Ltd (QianJin), a China-based public shareholding company is engaged in the production and sale
2011 250,00$

Maywufa Company Limited (1731) - Financial and Strategic SWOT Analysis Review

Maywufa Company Limited (Maywufa) is engaged in the manufacture and marketing of pharmaceuticals, hair and skin care products. It
2011 250,00$

Ham-Let (Israel-Canada) Ltd. (HAML) - Financial and Strategic SWOT Analysis Review

Ham-Let (Israel-Canada) Ltd. (Ham-Let) is an Israel-based company. Ham-Let is engaged in the development, manufacture and marketin
2011 250,00$

Znomics, Inc. (ZNOM) - Financial and Strategic SWOT Analysis Review

Znomics, Inc. is a biotechnology company engaged in drug discovery by combining medicinal chemistry with Zebrafish Technologies. I
2011 250,00$

Abl Biotechnologies Limited (526955) - Financial and Strategic SWOT Analysis Review

Abl biotechnologies Limited (ABL), is a public company involved in the production and research and development of bio-chemicals. T
2011 250,00$

Mavens Biotech Ltd (590083) - Financial and Strategic SWOT Analysis Review

Mavens Biotech Ltd. (Mavens) is a biotechnology company. It is principally engaged in the development, testing and validation of i
2011 250,00$

BioSyent Inc. (RX) - Financial and Strategic SWOT Analysis Review

BioSyent Inc. (BioSyent) is a specialty pharmaceutical company that is engaged in development, acquisition and marketing of pharma
2011 250,00$

Phosphagenics Limited (POH) - Financial and Strategic SWOT Analysis Review

Phosphagenics Limited (Phosphagenics), formerly known as Vital Capital Limited, is a biopharmaceutical company. It is principally
2011 250,00$

Mammatech Corporation (MAMM) - Financial and Strategic SWOT Analysis Review

Mammatech Corporation (MammaCare) is a company engaged in the sale of the breast examination systems. The systems are sold in the
2011 250,00$

Simulations Plus, Inc. (SLP) - Financial and Strategic SWOT Analysis Review

Simulations Plus, Inc. (Simulations Plus) is a public company that develops and produces software for use in pharmaceutical resear
2011 125,00$

HMS Holdings Corp. (HMSY) - Financial and Strategic SWOT Analysis Review

HMS Holdings Corp. (HMS) is a healthcare service company engaged in providing a variety of cost management services to government-
2011 125,00$

Viropro Inc. (VPRO) - Financial and Strategic SWOT Analysis Review

Viropro, Inc. (Viropro) is a publicaly held pharmaceutical company engaged in cell line and business development process. The comp
2011 250,00$

Vivalis SA (VLS) - Financial and Strategic SWOT Analysis Review

Vivalis SA (Vivalis) is a public bio-pharmaceutical company, engaged in the provision of cell based solutions for the industrial m
2011 250,00$

MOCON Inc. (MOCO) - Financial and Strategic SWOT Analysis Review

Mocon Inc (Mocon) is a publicly traded company engaged in providing innovative instruments, testing services and consulting for th
2011 250,00$

Natural Capsules Limited (524654) - Financial and Strategic SWOT Analysis Review

Natural Capsules Limited (Natural Capsules) is public limited company, principally engaged in the manufacturing of capsule shells
2011 250,00$

CordLife Pte. Ltd. (CBB) - Financial and Strategic SWOT Analysis Review

CordLife Pte. Ltd. (Cordlife) is a publicly held healthcare company engaged in collection, processing and storing cord blood stem
2011 250,00$

Kedem Pharmaceuticals Inc. (GHLV) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Kedem Pharmaceuticals Inc. provides you an in-depth strategic analysis of the company’s busine
2011 250,00$

Cellectis S.A. (ALCLS) - Financial and Strategic SWOT Analysis Review

Cellectis S.A. (Cellectis) is a biotechnology company, engaged in the development of high-precision, high-performance systems for
2011 250,00$

Protokinetix Inc. (PKTX) - Financial and Strategic SWOT Analysis Review

ProtoKinetix, Inc. (ProtoKinetix) is a biotechnology company, engaged in the development of patented synthetic anti-aging glycopep
2011 250,00$

Applied DNA Sciences, Inc. (APDN) - Financial and Strategic SWOT Analysis Review

Applied DNA Sciences, Inc. (APDN) is a biotechnology company, engaged in the commercialization of patented DNA security solutions
2011 250,00$

Tremont Fair, Inc. (VCAN) - Financial and Strategic SWOT Analysis Review

Tremont Fair, Inc. (Tremont) is the publicly held US based biotechnology company which is principally engaged in developing immuno
2011 250,00$

XenaCare Holdings, Inc. (XCHO) - Financial and Strategic SWOT Analysis Review

XenaCare Holdings, Inc. (XenaCare) is a publicly held pharmaceutical company. It engages in the formulation, marketing and distrib
2011 250,00$

Nkbio Co., Ltd. (019260) - Financial and Strategic SWOT Analysis Review

Nkbio Co., Ltd. (Nkbio) is a research focused biopharmaceuticals company, engaged in manufacturing and commercialization of fiber
2011 250,00$

ARCA biopharma, Inc. (ABIO) - Financial and Strategic SWOT Analysis Review

ARCA biopharma, Inc. (ARCA biopharma) is a bio pharmaceutical company, engaged in the development and commercializing genetically-
2011 250,00$

Smruthi Organics Limited (590046) - Financial and Strategic SWOT Analysis Review

Smruthi Organics Limited (Smruthi) is an API manufacturing company. It offers contract research, manufacturing and custom synthesi
2011 250,00$

MolMed S.p.A. (MLM) - Financial and Strategic SWOT Analysis Review

MolMed S.p.A. (Molmed) is a publicly traded medical biotechnology company engaged in research, development and the clinical valida
2011 250,00$

Sinovac Biotech Ltd. (SVA) - Financial and Strategic SWOT Analysis Review

Sinovac Biotech Ltd (Sinovac Biotech) is engaged in the research, development, manufacture and commercialization of vaccines that
2011 250,00$

Myrexis, Inc. (MYRX) - Financial and Strategic SWOT Analysis Review

Myrexis, Inc. (Myrexis) is a pharmaceutical company, engaged in the discovery, development, and commercialization of small molecul
2011 250,00$

Genexine Co., Ltd. (095700) - Financial and Strategic SWOT Analysis Review

Genexine Co., Ltd. (Genexine) is involved in the research and development of therapeutic vaccines for incurable diseases and next-
2011 250,00$

Giaconda Limited (GIA) - Financial and Strategic SWOT Analysis Review

Giaconda Limited (Giaconda) is a research focused biotechnology company, engaged in research, development and commercialization of
2011 250,00$

CytoDyn, Inc. (CYDY) - Financial and Strategic SWOT Analysis Review

CytoDyn, Inc. (CytoDyn ) is a biotechnology research company that is engaged in the development of drugs to treat HIV/AIDS. The co
2011 250,00$

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

Intellect Neurosciences, Inc. (Intellect Neuro) is a publicly held biopharmaceutical company. Intellect Neuro is in development st
2011 250,00$

QRxPharma Limited (QRX) - Financial and Strategic SWOT Analysis Review

QRxPharma Limited (QRxPharma) is clinical-stage specialty pharmaceutical company. The company is engaged in the development, manuf
2011 250,00$

Omeros Corporation (OMER) - Financial and Strategic SWOT Analysis Review

Omeros Corporation (Omeros) is the US based clinical-stage bio-pharmaceutical company. It is engaged in the discovery, development
2011 250,00$

Sosei Co. Ltd. (4565) - Financial and Strategic SWOT Analysis Review

Sosei Co. Ltd., (Sosei)is a privately held company that is engaged in the process of drug development. The product pipeline of the
2011 250,00$

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

China Medical System Holdings Limited (CMS) is an integrated pharmaceutical group that focuses on the research development, manufa
2011 250,00$

Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic SWOT Analysis Review

Laboratorios Farmaceuticos ROVI, S.A. (Laboratorios Farmaceuticos) is a chemical and pharmaceutical company. The company is engage
2011 125,00$

BioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic SWOT Analysis Review

BioStar Pharmaceuticals, Inc. (BioStar) is a pharmaceutical company engaged in development, manufacture, and marketing of pharmace
2011 250,00$

China Medicine Corporation (CHME) - Financial and Strategic SWOT Analysis Review

China Medicine Corporation (CMC) is involved in the discovery, development, distribution and manufacturing of pharmaceutical produ
2011 250,00$

Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic SWOT Analysis Review

Lijun International Pharmaceutical (Holding) Co., Ltd. (Lijun) is engaged in the research, development, manufacture and marketing
2011 125,00$

China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review

China Shineway Pharmaceutical Group Limited (China Shineway) is a pharmaceutical company that is focused in the research, developm
2011 125,00$

Cornerstone Therapeutics Inc. (CRTX) - Financial and Strategic SWOT Analysis Review

Cornerstone Therapeutics Inc. (Cornerstone Therapeutics) is a specialty pharmaceutical company. It is engaged in acquiring, develo
2011 250,00$

Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572) - Financial and Strategic SWOT Analysis Review

Zhejiang CONBA Pharmaceutical Co., Ltd. (Zhejiang) is principally engaged in providing medicine raw materials. The company offers
2011 125,00$

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic SWOT Analysis Review

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFP) is a pharmaceutical company primarily engaged in research, development, prod
2011 125,00$

Tongjitang Chinese Medicines Company (TCM) - Financial and Strategic SWOT Analysis Review

Tongjitang Chinese Medicines Company (Tongjitang) is a specialty pharmaceutical company that is engaged in the development, manufa
2011 250,00$

Guilin Sanjin Pharmaceutical Co., Ltd. (002275) - Financial and Strategic SWOT Analysis Review

Guilin Sanjin Pharmaceutical Co., Ltd. (Sanjin, formerly known as Guilin Traditional Chinese Medicine Factory) is a pharmaceutical
2011 125,00$

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) - Financial and Strategic SWOT Analysis Review

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (ZPP) is engaged in development and marketing of Chinese herbs mainly in the marke
2011 250,00$

Sanofi-aventis Pakistan limited (SAPL) - Financial and Strategic SWOT Analysis Review

Sanofi-aventis Pakistan limited (Sanofi-aventis Pakistan) is a pharmaceutical company engaged in the manufacture and sale of pharm
2011 250,00$

Vetoquinol S A (VETO) - Financial and Strategic SWOT Analysis Review

Vetoquinol S A (Vetoquinol) is a publicly traded company primarily engaged in the animal healthcare. The company is mainly involve
2011 125,00$

Shandong Lukang International Trading Co., Ltd (600789) - Financial and Strategic SWOT Analysis Review

Shandong Lukang International Trading Co., Ltd (Shandong Lukang), formerly Jining Antibiotic Factory is a publicly traded biotechn
2011 125,00$

Vital Pharmaceutical Holdings Limited (1164) - Financial and Strategic SWOT Analysis Review

Vital Pharmaceutical Holdings Limited (Vital Pharmaceutical) is a publicly traded investment holding company. The company engages
2011 250,00$

Shandong Luoxin Pharmacy Stock Co., Ltd. (8058) - Financial and Strategic SWOT Analysis Review

Shandong Luoxin Pharmacy Stock Co., Ltd. (Shandong Luoxin, formerly Shandong Luoxin Factory) is a pharmaceutical company engaged i
2011 250,00$

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic SWOT Analysis Review

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a Japan based company engaged in providing various drug development services t
2011 125,00$

Wai Yuen Tong Medicine Holdings Limited (897) - Financial and Strategic SWOT Analysis Review

Wai Yuen Tong Medicine Holdings Limited (Wai Yuen Tong) is a pharmaceutical company that is engaged in the production and sale of
2011 250,00$

Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic SWOT Analysis Review

Shanghai Jiao Da Onlly Co., Ltd. is a publicly held healthcare food company. It is involved in the production and sales of biologi
2011 250,00$

Jiangsu Sihuan Bioengineering Co., Ltd (000518) - Financial and Strategic SWOT Analysis Review

Jiangsu Sihuan Bioengineering Co., Ltd (Jiangsu Sihuan) is a biological medicine manufacturer and provider engaged in the biologic
2011 250,00$

Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic SWOT Analysis Review

Beijing Tiantan Biological Products Co., Ltd. (Tiantan Biological) is a publicly held biotechnology company that is principally en
2011 250,00$

Caplin Point Laboratories Ltd (524742) - Financial and Strategic SWOT Analysis Review

Caplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company engaged in contract manufacturing of several pharmaceutic
2011 250,00$

ImmunoVaccine Technologies Inc. (IMV) - Financial and Strategic SWOT Analysis Review

ImmunoVaccine Technologies Inc. (IMV, formerly Rhino Resources Inc.) is a biotechnology company engaged in the development of high
2011 250,00$

Mediscience Planning Inc. (2182) - Financial and Strategic SWOT Analysis Review

Mediscience Planning Inc. (Mediscience Planning) is engaged in providing contract research services to medical and pharmaceutical
2011 250,00$

Winteam Pharmaceutical Group Limited (570) - Financial and Strategic SWOT Analysis Review

Winteam Pharmaceutical Group Limited (Winteam) is a public traded company engaged in the manufacture and sale of Chinese medicine
2011 250,00$

Southwest Synthetic Pharmaceutical Corporation Ltd. (000788) - Financial and Strategic SWOT Analysis Review

Southwest Synthetic Pharmaceutical Corporation Ltd. (SSPCL) is a publicly held pharmaceutical company that is engaged in the manuf
2011 250,00$

Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (002019) - Financial and Strategic SWOT Analysis Review

Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (Xinfu), a public share holding company engaged in production and sale of fine chemical a
2011 250,00$

Zhejiang Hisoar Pharmaceutical Co.,LTD. (002099) - Financial and Strategic SWOT Analysis Review

Zhejiang Hisoar Pharmaceutical Co.,LTD. (Hisoar), a public share holding company engaged in the production and sale of drug substa
2011 250,00$

Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Financial and Strategic SWOT Analysis Review

Zhejiang Jingxin Pharmaceutical Co., Ltd (Jingxin Pharma), formerly known as Zhejiang Jingxin Pharmaceutical Factory is a public s
2011 250,00$

Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic SWOT Analysis Review

Tianjin Tasly Pharmaceutical Co. Ltd. (Tasly) is a public traded pharmaceutical company engaged in the development, manufacturing
2011 125,00$

Welichem Biotech Inc. (WBI) - Financial and Strategic SWOT Analysis Review

Welichem Biotech Inc. (Welichem, formerly known as Welichem Technology Corporation) is a public share holding company. It is princ
2011 250,00$

Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic SWOT Analysis Review

Adeona Pharmaceuticals, Inc. (Adeona), a public share holding company, is a development-stage specialty pharmaceutical company. Th
2011 250,00$

Tianjin Zhongxin Pharmaceutical Group Corporation Limited (600329) - Financial and Strategic SWOT Analysis Review

Tianjin Zhongxin Pharmaceutical Group Corporation Limited (TZPG) is a publicly traded pharmaceutical company, engaged in the produ
2011 125,00$

Pharmstandard (PHST) - Financial and Strategic SWOT Analysis Review

Pharmstandard is engaged in the manufacture and marketing of pharmaceuticals and medical products. It operates in two segments nam
2011 250,00$

The United Laboratories International Holdings Limited (3933) - Financial and Strategic SWOT Analysis Review

The United Laboratories International Holdings Limited (TUL) is a public traded pharmaceutical company engaged in the production a
2011 125,00$

Wuhan Humanwell Hi-Tech Industry Co., LTD. (600079) - Financial and Strategic SWOT Analysis Review

Wuhan Humanwell Hi-Tech Industry Co., LTD. (Wuhan Humanwell) is a pharmaceutical company, based in China. The company is specializ
2011 125,00$

Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic SWOT Analysis Review

Wuyi International Pharmaceutical Company Limited (Wuyi International) is a public traded company involved in the research and dev
2011 250,00$

GeneLink BioSciences, Inc. (GNLK) - Financial and Strategic SWOT Analysis Review

GeneLink BioSciences, Inc. (Genelink) is a public traded biosciences company. The company provides genetically guided health, beau
2011 250,00$

GENova Biotherapeutics, Inc. (GVBP) - Financial and Strategic SWOT Analysis Review

GENova Biotherapeutics, Inc. (GENova) is a publicly traded biotechnological drug development company, engaged in the identifying,
2011 250,00$

Shandong Jintai Group Co.,Ltd. (600385) - Financial and Strategic SWOT Analysis Review

Shandong Jintai Group Co., Ltd. (Shandong Jintai) is a pharmaceutical company principally engaged in the production and distributi
2011 250,00$

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic pr
2011 250,00$

Cellceutix Corporation (CTIX) - Financial and Strategic SWOT Analysis Review

Cellceutix Corporation (Cellceutix) is a publicly traded development stage bio-pharmaceutical company and is engaged in the develo
2011 250,00$

VIA Pharmaceuticals, Inc. (VIAP) - Financial and Strategic SWOT Analysis Review

VIA Pharmaceuticals, Inc. (VIA) is a public traded biotechnology company, based in the US. The company is engaged in discovery, de
2011 250,00$

Vanda Pharmaceuticals Inc. (VNDA) - Financial and Strategic SWOT Analysis Review

Vanda Pharmaceuticals Inc. (Vanda) is a biopharmaceutical company, engaged in developing and commercializing clinical-stage drug c
2011 250,00$

Virax Holdings Limited (VHL) - Financial and Strategic SWOT Analysis Review

Virax Holdings Limited (Virax) is a biopharmaceutical company, principally engaged in the discovery and development of novel immun
2011 250,00$

Intellipharmaceutics International Inc. (IPCI) - Financial and Strategic SWOT Analysis Review

Intellipharmaceutics International Inc. (formerly known as IntelliPharmaCeutics Corp.) is engaged in the design and development of
2011 250,00$

AB Science (AB) - Financial and Strategic SWOT Analysis Review

AB Science (ABS) is a privtely held biopharmaceutical company. It is principally engaged in the research, development and commerci
2011 250,00$

Tetragenex Pharmaceuticals, Inc. (TTRXQ) - Financial and Strategic SWOT Analysis Review

Tetragenex Pharmaceuticals, Inc. (Tetragenex) is a publicly held bio pharmaceutical company. It is principally engaged in developm
2011 250,00$

Anthera Pharmaceuticals‚ Inc. (ANTH) - Financial and Strategic SWOT Analysis Review

Anthera Pharmaceuticals, Inc. (Anthera) is a research based biopharmaceutical company targeting on development and commercializati
2011 250,00$

GNI, LTD. (2160) - Financial and Strategic SWOT Analysis Review

GNI, LTD. (GNI) is a publicly traded bio-pharmaceutical company, focused on the discovery and development and manufacturing of the
2011 250,00$

Adamis Pharmaceuticals Corporation (ADMP) - Financial and Strategic SWOT Analysis Review

Adamis Pharmaceuticals Corporation (Adamis), formerly known as Cellegy Pharmaceuticals, Inc., is a publicly traded specialty pharm
2011 250,00$

Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic SWOT Analysis Review

Tianyin Pharmaceutical Co., Inc. (Tianyin) formerly known as Viscorp, Inc. is a publicly held pharmaceutical company, engaged in d
2011 250,00$

Cannabis Science, Inc. (CBISE) - Financial and Strategic SWOT Analysis Review

Cannabis Science, Inc. (formerly, Gulf Onshore, Inc.) is a public traded, pharmaceutical company that is engaged in the developmen
2011 125,00$

Synergy Pharmaceuticals, Inc. (SGYP) - Financial and Strategic SWOT Analysis Review

Synergy Pharmaceuticals, Inc. (Synergy) is a development-stage biopharmaceutical company, based in the US. The company is engaged
2011 250,00$

AVEO Pharmaceuticals, Inc. (AVEO) - Financial and Strategic SWOT Analysis Review

AVEO Pharmaceuticals, Inc. (Aveo Pharmaceuticals) is a pharmaceutical company engaged in the discovery and development of therapeu
2011 250,00$

Winston Pharmaceuticals, Inc. (WPHM) - Financial and Strategic SWOT Analysis Review

Winston Pharmaceuticals, Inc. (Winston Pharmaceuticals, formerly known as Getting Ready Corporation) is a development stage, resea
2011 250,00$

Vitro Diagnostics, Inc. (VODG) - Financial and Strategic SWOT Analysis Review

Vitro Diagnostics, Inc. (Vitro Biopharma) is a bio-pharmaceutical company. The company is principally engaged in the research, dev
2011 250,00$

BioNeutral Group, Inc. (BONU) - Financial and Strategic SWOT Analysis Review

BioNeutral Group, Inc. (BioNeutral) is a public traded, specialty life science company. The company is principally engaged in the
2011 250,00$

ViroMed Co., Ltd. (084990) - Financial and Strategic SWOT Analysis Review

Viromed Co. Ltd. (Viromed) is a Korea based biotechnology company. The company is principally engaged in the research and developm
2011 250,00$

NasVax Ltd. (NSVX) - Financial and Strategic SWOT Analysis Review

NasVax Ltd. (NasVax) is bio-pharmaceutical company, principally engaged in developing advanced vaccines and immunotherapeutics. It
2011 250,00$

Afexa Life Sciences Inc. (FXA) - Financial and Strategic SWOT Analysis Review

Afexa Life Sciences Inc. (ALSI, formerly known as CV Technologies Inc.) is a health sciences and technology company. The company i
2011 250,00$

Ind-Swift Limited. (524652) - Financial and Strategic SWOT Analysis Review

Ind-Swift Limited. (Ind-Swift) is a public traded pharmaceutical company, engaged in the manufacturing and marketing of finished d
2011 250,00$

Anu's Laboratories Limited (532981) - Financial and Strategic SWOT Analysis Review

Anu's Laboratories Limited (Anu's Laboratories) is involved in the production of drug intermediates, based in India. The company i
2011 250,00$

Kawamura Cycle Co., Ltd. (7311) - Financial and Strategic SWOT Analysis Review

Kawamura Cycle Co., Ltd. (Kawamura Cycle) is a Japan based manufacturing company. The company is engaged in the manufacture and sa
2011 250,00$

IADELPA SAECA (IAD) - Financial and Strategic SWOT Analysis Review

IADELPA SAECA (IADELPA) also known as Andromaco Institute of Paraguay, is a publicly held company that is engaged in the manufactu
2011 250,00$

Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (600671) - Financial and Strategic SWOT Analysis Review

Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (Hangzhou) is a pharmaceutical company engaged in the production, distribution and trading
2011 250,00$

B.O.S. Better OnLine Solutions Ltd. (BOSC) - Financial and Strategic SWOT Analysis Review

B.O.S. Better OnLine Solutions Ltd. (B.O.S) is publicly held company focused on providing RFID, Mobile and Supply Chain Solutions
2011 125,00$

Bal Pharma Limited (524824) - Financial and Strategic SWOT Analysis Review

Bal Pharma Limited (Bal Pharma) is a pharmaceutical company, engaged in the manufacturing and marketing of pharmaceutical formulat
2011 250,00$

Fabryka Kosmetykow POLLENA-EWA SA (PLE) - Financial and Strategic SWOT Analysis Review

Fabryka Kosmetykow POLLENA-EWA SA (F.K. POLLENA-EWA) is a healthcare company, principally engaged in manufacturing of cosmetics. T
2011 250,00$

Harbin Pharm Group Sanjing Pharm Co Ltd (600829) - Financial and Strategic SWOT Analysis Review

Harbin Pharm Group Sanjing Pharm Co Ltd (Sanjing Pharmaceutical) is china based pharmaceutical company. The company is engaged in
2011 125,00$

Al Borg Laboratory (ALAB) - Financial and Strategic SWOT Analysis Review

Al Borg Laboratory (Al Borg) formerly known as Cairo Medical Tower Laboratory, is a publicly held pharmaceutical company engaged i
2011 250,00$

Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic SWOT Analysis Review

Ahlcon Parenterals (India) Ltd (APIL) is publicly held pharmaceutical company, based in India. The company is engaged in the manuf
2011 250,00$

Hatay Pharmaceutical JSC (DHT) - Financial and Strategic SWOT Analysis Review

Hatay Pharmaceutical JSC (Hatay Pharmaceutical) is a publicly held pharmaceutical company engaged in manufacturing, marketing and
2011 250,00$

Health Grades, Inc. (HGRD) - Financial and Strategic SWOT Analysis Review

Health Grades, Inc. (HGRD) is a healthcare ratings organization engaged in providing ratings and profiles of hospitals, nursing ho
2011 250,00$

HealthSport, Inc. (HSPO) - Financial and Strategic SWOT Analysis Review

HealthSport, Inc. (HealthSport) is a drug delivery company focused on the development, manufacture, distribution and sale of brand
2011 250,00$

Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

Surya Pharmaceutical Limited (Surya Pharmaceutical) is a publicly traded company engaged in the production of range of Active Phar
2011 250,00$

ImmunoBiotics, Inc. (IMBI) - Financial and Strategic SWOT Analysis Review

ImmunoBiotics, Inc. (ImmunoBiotics) is a bio-pharmaceutical company engaged in developing, testing, manufacturing, licensing of he
2011 250,00$

OdontoPrev S.A. (ODPV3) - Financial and Strategic SWOT Analysis Review

Odontoprev SA (Odontoprev) is a publicly held health services providing company. The company is engaged in providing dental health
2011 125,00$

Procognia Limited (PRCG) - Financial and Strategic SWOT Analysis Review

Procognia Limited (Procognia) is a public listed biotechnology company that is engaged in providing fast and accurate glycoanalysi
2011 250,00$

Alpa Laboratories Limited (ALPA) - Financial and Strategic SWOT Analysis Review

Alpa Laboratories Limited (Alpa) is publicly held company engaged in research, development and production of ethical drugs, over t
2011 250,00$

Merriman Curhan Ford Group, Inc. (MERR) - Financial and Strategic SWOT Analysis Review

Merriman Curhan Ford Group, Inc. (Merriman Curhan) is an US based financial services provider to various industries including Heal
2011 250,00$

Access Plans, Inc. (APNC) - Financial and Strategic SWOT Analysis Review

Access Plans, Inc. (Access Plans) formerly known as Alliance HealthCard, Inc., is a leading provider of health discount and lifest
2011 250,00$

Pacific Healthcare Holdings Ltd. (P47) - Financial and Strategic SWOT Analysis Review

Pacific Healthcare Holdings Ltd. (Pacific Healthcare) is a health care provider that is engaged in offering a range of health care
2011 250,00$

CardioGenics Holdings Inc. (CGNH) - Financial and Strategic SWOT Analysis Review

CardioGenics Holdings Inc. (CardioGenics) is a publicly held company engaged in the development of technology and products, which
2011 250,00$

Transax International Limited (TNSX) - Financial and Strategic SWOT Analysis Review

Transax International Limited (Transax) offers information network solutions to health care providers and health insurance compani
2011 125,00$

Bliss GVS Pharma Limited (BLISSGVS) - Financial and Strategic SWOT Analysis Review

Bliss GVS Pharma Limited (Bliss) is a publicly held pharmaceutical company that is engaged in manufacturing prescription drugs and
2011 250,00$

World Health Energy Holdings, Inc. (WHEN) - Financial and Strategic SWOT Analysis Review

World Health Energy Holdings, Inc (WHEN) engages in providing new innovative clean green energy and pioneering new food crops. The
2011 125,00$

The Advisory Board Company (ABCO) - Financial and Strategic SWOT Analysis Review

The Advisory Board Company (The Advisory Board) is engaged in providing best practices research and analysis services to the healt
2011 125,00$

Spectral Diagnostics Inc. (SDI) - Financial and Strategic SWOT Analysis Review

Spectral Diagnostics Inc. (Spectral) is a health care company, engaged in the development and commercialization of innovative diag
2011 250,00$

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (8329) - Financial and Strategic SWOT Analysis Review

Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. (Interlong) is a biological pharmaceutical manufacturer in China and a leading
2011 250,00$

Venturepharm Laboratories Limited (8225) - Financial and Strategic SWOT Analysis Review

Venturepharm Laboratories Limited (Venturepharm) is engaged in providing a range of pharmaceutical development services by bringin
2011 250,00$

Medika d.d. (MDKA-R-A) - Financial and Strategic SWOT Analysis Review

Medika d.d. (Medika) is a publicly held wholesale drug company that is engaged in supply and distribution of pharmaceutical and me
2011 125,00$

WuXi PharmaTech (Cayman), Inc. (WX) - Financial and Strategic SWOT Analysis Review

WuXi PharmaTech (Cayman), Inc. (WuXi PharmaTech) is a healthcare service company engaged in the providing various services for pha
2011 125,00$

Nano Dimensions, Inc. (NDSI) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Nano Dimensions, Inc. provides you an in-depth strategic analysis of the company’s businesses
2011 250,00$

Lee's Pharmaceutical Holdings Limited (950) - Financial and Strategic SWOT Analysis Review

Lee's Pharmaceutical Holdings Limited (Lee's Pharma) is a publicly held company that is engaged in research, development, manufact
2011 250,00$

Shrink Nanotechnologies, Inc. (INKN) - Financial and Strategic SWOT Analysis Review

Shrink Nanotechnologies, Inc. (Shrink) is engaged in developing technologies primarily for solar energy, medical and diagnostic se
2011 250,00$

China Biologic Products, Inc. (CBPO) - Financial and Strategic SWOT Analysis Review

China Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. It is engaged in the research, development, product
2011 250,00$

Burcon NutraScience Corporation (BU) - Financial and Strategic SWOT Analysis Review

Burcon NutraScience Corporation (Burcon) is a research and development company. The company is engaged in the development of novel
2011 250,00$

Total Nutraceutical Solutions, Inc. (TNUS) - Financial and Strategic SWOT Analysis Review

Total Nutraceutical Solutions, Inc. (TNS) is a nutraceutical company. The company is engaged in the discovery, formulation and mar
2011 250,00$

EPS Co., Ltd. (4282) - Financial and Strategic SWOT Analysis Review

EPS Co., Ltd. (EPS) is a contract research organization, engaged in providing services in clinical trials for drug development pri
2011 125,00$

Yomeishu Seizo Co. Ltd. (2540) - Financial and Strategic SWOT Analysis Review

Yomeishu Seizo Co. Ltd. (Yomeishu Seizo) is engaged in the development, manufacturing, production and sale of a therapeutic drug n
2011 250,00$

Addus HomeCare Corporation (ADUS) - Financial and Strategic SWOT Analysis Review

Addus HomeCare Corporation (Addus HomeCare) is a specialty service provider that operates through its subsidiary Addus HealthCare,
2011 125,00$

NuRx Pharmaceuticals, Inc. (NUXP) - Financial and Strategic SWOT Analysis Review

NuRx Pharmaceuticals, Inc. (NuRx Pharmaceuticals) is a development stage research and development biopharmaceutical company. The c
2011 250,00$

First Physicians Capital Group, Inc. (FPCG) - Financial and Strategic SWOT Analysis Review

First Physicians Capital Group, Inc. (formerly known as Tri-Isthmus Group, Inc.) provides financial and managerial services to phy
2011 250,00$

Dil Ltd. (506414) - Financial and Strategic SWOT Analysis Review

Dil Ltd. (DIL, formerly known as Duphar Interfran Ltd.) is specializes in contract research, custom synthesis and process research
2011 250,00$

Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis Review

Entest BioMedical Inc. (Entest), a majority owned subsidiary of Bio-Matrix Scientific Group Inc. The company is engaged in the dev
2011 250,00$

Sihuan Pharmaceutical Holdings Group Ltd. (460) - Financial and Strategic SWOT Analysis Review

Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan) is a publicly held pharmaceutical company that is engaged in the research and d
2011 250,00$

Freedom Eye Resources Limited (FYI) - Financial and Strategic SWOT Analysis Review

Freedom Eye Limited (Freedom Eye) is a publicly held company that is engaged in research and development of novel pharmaceutical p
2011 250,00$

China Baoan Group Co., Ltd. (000009) - Financial and Strategic SWOT Analysis Review

China Baoan Group Co., Ltd. (CBGC) is a bio-pharmaceutical industry. The company is principally engaged in the businesses of real
2011 125,00$

Vivakor, Inc. (VIVK) - Financial and Strategic SWOT Analysis Review

Vivakor, Inc. (Vivakor) is engaged in the research, development and acquisition of products in the area of biological handling, el
2011 250,00$

Reliv International, Inc. (RELV) - Financial and Strategic SWOT Analysis Review

Reliv International Inc. (Reliv) is engaged in the development, manufacturing and marketing of an array of innovative nutritional
2011 125,00$

Adventa Berhad (ADVENTA) - Financial and Strategic SWOT Analysis Review

Adventa Berhad (Adventa) is an investment holding company, based in Malaysia. The company is principally engaged in manufacture, d
2011 250,00$

Acuvax Ltd (ACU) - Financial and Strategic SWOT Analysis Review

Acuvax Ltd (Acuvax) is a publicly held holding company that is principally engaged in the development of cancer therapies and vacc
2011 250,00$

J-COM Holdings Co., Ltd. (2462) - Financial and Strategic SWOT Analysis Review

J-COM Holdings Co., Ltd. (J-COM Holdings) is Japan based company. It is formerly known as J-Com Co., Ltd. J-COM Holdings is princi
2011 250,00$

Ohr Pharmaceutical Inc. (OHRP) - Financial and Strategic SWOT Analysis Review

Ohr Pharmaceutical Inc. (Ohr) is a public listed biotechnology company. It is engaged in the research and development of first in
2011 250,00$

Shanghai Dingli Technology Development (Group) Co., Ltd. (900907) - Financial and Strategic SWOT Analysis Review

Shanghai Dingli Technology Development (Group) Co., Ltd. (Shanghai Dingli) is a publicly held company that operates its businesses
2011 250,00$

Centric Health Corporation (CHH) - Financial and Strategic SWOT Analysis Review

Centric Health Corporation (Centric Health) is a publicly held diversified healthcare investment company. It offers surgical proce
2011 250,00$

Synmosa Biopharma Corporation (4114) - Financial and Strategic SWOT Analysis Review

Synmosa Biopharma Corporation (Synmosa) is engaged in the development, manufacture, marketing and distribution of pharmaceutical a
2011 250,00$

Sunshine Biopharma, Inc. (SBFM) - Financial and Strategic SWOT Analysis Review

Sunshine BioPharma, Inc., (formerly known as Mountain West Business Solutions, Inc.) is a pharmaceutical company. It focuses on
2011 250,00$

ECI, Inc. (4567) - Financial and Strategic SWOT Analysis Review

ECI, Inc. (ECI) is a publicly traded bio-pharmaceutical company, engaged in the research and development of cell function analysis
2011 250,00$

The Westaim Corporation (WED) - Financial and Strategic SWOT Analysis Review

The Westaim Corporation (Westaim) is a publicly held investment company. The company invests, directly and indirectly, through acq
2011 250,00$

ISU ABXIS Co.,Ltd. (086890) - Financial and Strategic SWOT Analysis Review

ISU ABXIS Co., Ltd. (ISU ABXIS), a subsidiary company of ISU Chemical Co. Ltd., is a Korean biotechnology company. It involves i
2011 250,00$

Fem Care Pharma Ltd. (524608) - Financial and Strategic SWOT Analysis Review

Fem Care Pharma Ltd. (Fem Care Pharma) is engaged in manufacturing of consumer products and dermatological products. The company o
2011 250,00$

Baolingbao Biology Co., Ltd. (002286) - Financial and Strategic SWOT Analysis Review

Baolingbao Biology Co., Ltd. (Baolingbao) is a biotechnology company. It is principally engaged in the processing, manufacture and
2011 250,00$

Cardia Bioplastics Limited (CNN) - Financial and Strategic SWOT Analysis Review

Cardia Bioplastics Limited (Cardia Bioplastics) is a biotechnology company, engaged in the development, manufacture and supply of
2011 250,00$

Care Advantage, Inc. (CADV) - Financial and Strategic SWOT Analysis Review

Care Advantage, Inc. (CAI) is a public company that is engaged in providing healthcare consulting services, senior living services
2011 250,00$

La Positiva Seguros y Reaseguros S.A. (POSITIC1) - Financial and Strategic SWOT Analysis Review

La Positiva Seguros y Reaseguros S.A. (La Positiva) is an insurance company engaged in providing insurance for people, business in
2011 250,00$

Kangmei Pharmaceutical Co., Ltd. (600518) - Financial and Strategic SWOT Analysis Review

Kangmei Pharmaceutical Co., Ltd. (Kangmei) is a publicly held pharmaceutical company. It is principally engaged in the manufacture
2011 125,00$

BDH Industries Ltd. (524828) - Financial and Strategic SWOT Analysis Review

BDH Industries Ltd. (BDH) is a pharmaceutical company engaged in the manufacturing and marketing of therapeutic formulations cover
2011 250,00$

JCL Bioassay Corporation (2190) - Financial and Strategic SWOT Analysis Review

JCL Bioassay Corporation (JCL Bioassay) is a publically held company that is engaged in testing and contract research services for
2011 250,00$

EQUISnZAROO CO.,LTD (058530) - Financial and Strategic SWOT Analysis Review

EQUISnZAROO CO.,LTD (formerly known as EquisPharm Co., Ltd.) is a publicly held manufacturing company which was formed by merging
2011 250,00$

Modern Medical Modalities Corporation (MODM) - Financial and Strategic SWOT Analysis Review

Modern Medical Modalities, Inc., (MMMI) is a public listed specialty pharmaceutical company that is principally engaged in providi
2011 250,00$

General Biologicals Corporation (4117) - Financial and Strategic SWOT Analysis Review

General Biologicals Corporation (GBC) is a public traded in vitro diagnostic device manufacturer, engaged in research, development
2011 250,00$

General Medical Clinics PLC (GMCP) - Financial and Strategic SWOT Analysis Review

General Medical Clinics PLC (General Medical) is a medical and healthcare services providing company. It is engaged in providing g
2011 250,00$

Concord Medical Services Holdings Limited (CCM) - Financial and Strategic SWOT Analysis Review

Concord Medical Services Holdings Limited (CMS) is engaged in the provision of services such as cancer detection and therapy cente
2011 250,00$

Cell Biotech Co., Ltd. (049960) - Financial and Strategic SWOT Analysis Review

Cell Biotech Co., Ltd. (Cell Biotech) is a publicly traded biochemical company. It is principally engaged in the manufacturing of
2011 250,00$

Jiangbo Pharmaceuticals, Inc. (JGBO) - Financial and Strategic SWOT Analysis Review

Jiangbo Pharmaceuticals, Inc. (Jiangbo) is a pharmaceutical company, engaged in the research, development, production, marketing a
2011 250,00$

KDL Biotech Ltd (KOPDRUGS) - Financial and Strategic SWOT Analysis Review

KDL Biotech Ltd (KDL) is a publicly held healthcare company, based in India. The company is engaged in the development of various
2011 250,00$

Jiangsu Kanion Pharmaceutical Co., Ltd. (600557) - Financial and Strategic SWOT Analysis Review

Jiangsu Kanion Pharmaceutical Co., Ltd. (Jiangsu-Kanion) is a publicly held pharmaceutical company that is principally engaged in
2011 250,00$

Jiangsu Lianhuan Pharmaceutical Co. Ltd (600513) - Financial and Strategic SWOT Analysis Review

Jiangsu Lianhuan Pharmaceutical Co., Ltd. (Jiangsu Lianhuan) is an operational division of Jiangsu Lianhuan Pharmaceutical Group,
2011 250,00$

Genmed Holding Corp. (GENM) - Financial and Strategic SWOT Analysis Review

Genmed Holding Corp. (GHC) is a public traded an integrated generic pharmaceuticals company. The company operates through its whol
2011 250,00$

Kerala Ayurveda Limited (530163) - Financial and Strategic SWOT Analysis Review

Kerala Ayurveda Limited (KAL) is a health care company, focused on the development of new products for the treatment of various di
2011 250,00$

GFR Pharmaceuticals, Inc. (GFRP) - Financial and Strategic SWOT Analysis Review

GFR Pharmaceuticals, Inc.(GFR Pharmaceuticals) is a research focused pharmaceuticals and medical device company. The company opera
2011 250,00$

Beijing Tong Ren Tang Group Co., Ltd. (600085) - Financial and Strategic SWOT Analysis Review

Beijing Tong Ren Tang Group Co., Ltd. (Tongrentang) is a publicly held company engaged in supplying medicines for the royal pharma
2011 125,00$

Center for Wound Healing, Inc. (CFWH) - Financial and Strategic SWOT Analysis Review

Center for Wound Healing, Inc. (CFWH) is a publicly held company develops and manages hospital-based wound care centers that provi
2011 250,00$

Central Securities Corporation (CET) - Financial and Strategic SWOT Analysis Review

Central Securities Corporation (Central Securities) is a publicly held investment company that invests in various sectors namely h
2011 250,00$

Ayrton Drugs Manufacturing Company Ltd. (AYRTN) - Financial and Strategic SWOT Analysis Review

Ayrton Drug Manufacturing Limited (Ayrton) is a publicly held pharmaceutical company engaged in the manufacture, development, sale
2011 250,00$

C-Pharma, Inc. (COBI) - Financial and Strategic SWOT Analysis Review

C-Pharma, Inc. (C-Pharma), is a publicly held biotechnology company that is engaged in the development and commercialization of th
2011 250,00$

Ceylon Hospitals PLC (CHL) - Financial and Strategic SWOT Analysis Review

Ceylon Hospitals PLC (Ceylon Hospitals), a subsidiary of Durdans Management Services Ltd. is a healthcare institution, engaged in
2011 250,00$

CHA Bio & Diostech Co., Ltd. (085660) - Financial and Strategic SWOT Analysis Review

CHA Bio & Diostech Co., Ltd. (CHA Bio & Diostech), formerly known as CHA Biotech, Co., Ltd., is a a publicly traded Korean company
2011 125,00$

Changchun High & New Tech Industry Inc (000661) - Financial and Strategic SWOT Analysis Review

Changchun High & New Tech Industry Inc (Changchun High) is a biotechnology company. It is primarily engaged in the development, ma
2011 250,00$

ChemoMetec A/S (CHEMM) - Financial and Strategic SWOT Analysis Review

ChemoMetec A/S (ChemoMetec) is engaged in working with hospitals, research institutes and universities to focus on the development
2011 250,00$

Chennai Meenakshi Multispeciality Hospital Limited (523489) - Financial and Strategic SWOT Analysis Review

Chennai Meenakshi Multispeciality Hospital Limited (Chennai Meenakshi) is an Indian based company. The hospital is engaged in oper
2011 250,00$

Cherwell Capital PLC (CHEP) - Financial and Strategic SWOT Analysis Review

Cherwell Capital Plc (Cherwell Capital) is a publicly traded UK based investment company. It is a private equity and venture capit
2011 250,00$

Lotus Pharmaceutical Co., Ltd. (1795) - Financial and Strategic SWOT Analysis Review

Lotus Pharmaceutical Co., Ltd. (Lotus) is a public listed, specialty pharmaceutical company that is engaged in the development and
2011 250,00$

China Animal Husbandry Industry Co., Ltd (600195) - Financial and Strategic SWOT Analysis Review

China Animal Husbandry Industry Co., Ltd (CAHIC) is principally engaged in the manufacturing and distribution of animal feeds, vet
2011 125,00$

Life Nutrition Products, Inc. (LIPN) - Financial and Strategic SWOT Analysis Review

Life Nutrition Products, Inc., is a dietary supplement manufacturing company. The company has been into operation since 2005 and p
2011 250,00$

Hong Kong Health Check and Medical Diagnostic Centre (397) - Financial and Strategic SWOT Analysis Review

Hong Kong Health Check and Laboratory (HK Health Check) is a pharmaceutical holding company engaged in providing health checks and
2011 250,00$

Linical Co., Ltd. (2183) - Financial and Strategic SWOT Analysis Review

Linical Co., Ltd., (Lincal) is a contract research organization (CRO) based in Japan. The company along with its subsidiary engage
2011 250,00$

China Longyi Group International Holdings Limited (CGYG) - Financial and Strategic SWOT Analysis Review

China Longyi Group International Holdings Limited (China Longyi) is a pharmaceutical holding company operating through its subsidi
2011 250,00$

Syncom Formulations (India) Ltd (524470) - Financial and Strategic SWOT Analysis Review

Syncom Formulations (India) Ltd (Syncom) is a public company that is engaged in the manufacture of pharmaceutical formulations. It
2011 250,00$

China Shenghuo Pharmaceutical Holdings, Inc. (KUN) - Financial and Strategic SWOT Analysis Review

China Shenghuo Pharmaceutical Holdings, Inc. (China Shenghuo) is a specialty pharmaceutical company engaged in the research, devel
2011 250,00$

Hubei Biocause Pharmaceutical Co. , Ltd. (000627) - Financial and Strategic SWOT Analysis Review

Hubei Biocause Pharmaceutical Co. , Ltd. (Hubei Biocause) engages in manufacturing and exporting of metric tons of bulk Ibuprofen
2011 250,00$

Bharat Immunologicals and Biologicals Corporation Limited (524663) - Financial and Strategic SWOT Analysis Review

Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a pharmaceutical company. It is engaged in the development a
2011 250,00$

Longrun Tea Group Company Limited (2898) - Financial and Strategic SWOT Analysis Review

Longrun Tea Group Company Limited (LTG), formerly known as Long Far Pharmaceutical Holdings Ltd. is engaged in manufacturing, sell
2011 250,00$

China Organic Fertilizer Inc (CHOR) - Financial and Strategic SWOT Analysis Review

China Organic Fertilizer Inc (formerly known as China SXAN Biotech, Inc) is a holding company, engaged in the manufacturing and di
2011 250,00$

Wakefield Health Limited (WFD) - Financial and Strategic SWOT Analysis Review

Wakefield Health Limited (Wakefield Health) is a publicaly held health care company. The company is engaged in the provision of pr
2011 250,00$

Verisante Technology, Inc. (VRS) - Financial and Strategic SWOT Analysis Review

Verisante Technology, Inc. (Verisante), formerly known as (T-Ray Science, Inc.) is a public traded company that provides portable
2011 250,00$

Scientific Industries, Inc. (SCND) - Financial and Strategic SWOT Analysis Review

Scientific Industries, Inc. (Scientific Industries) is engaged in the design, manufacture and marketing of standard benchtop labor
2011 125,00$

Choong Ang Biotech Co., Ltd. (015170) - Financial and Strategic SWOT Analysis Review

Choong Ang Biotech Co., Ltd. (Choong Ang) is a publicly held pharmaceutical company. It is principally engaged in the manufacture
2011 250,00$

Cybrdi, Inc. (CYDI) - Financial and Strategic SWOT Analysis Review

Cybrdi, Inc., (Cybrdi) is a public traded tissue micro-array products manufacturing company that are used for drug discovery and d
2011 250,00$

China YCT International Group, Inc. (CYIG) - Financial and Strategic SWOT Analysis Review

China YCT International Group Inc. (China YCT) is a publicly held pharmaceutical manufacturing enterprise. The company through its
2011 250,00$

CNS Response, Inc. (CNSO) - Financial and Strategic SWOT Analysis Review

CNS Response, Inc. (CNS) is a life sciences company. It provides services through its subsidiaries, CNS California and CNS Colorad
2011 250,00$

Inergetics Inc (NRTI) - Financial and Strategic SWOT Analysis Review

Inergetics Inc (Formerly known as Millennium Biotechnologies Group, Inc) is a research-based bio-nutraceutical company, principall
2011 250,00$

Yung Shin Pharma Ind. Co. Ltd (1716) - Financial and Strategic SWOT Analysis Review

Yung Shin Pharma Ind. Co. Ltd (Yung Shin Pharma) is a pharmaceutical company engaged in principal activities like manufacturing an
2011 125,00$

Shandong Xinhua Pharmaceutical Company Limited (000756) - Financial and Strategic SWOT Analysis Review

Shandong Xinhua Pharmaceutical Company Limited (Xinhua Pharm) is engaged in the manufacturing and exporting of chemical products,
2011 125,00$

Vita Life Sciences Limited (VSC) - Financial and Strategic SWOT Analysis Review

Vita Life Sciences Limited (Vita Life Sciences) is a publicly traded life-science company. The company is engaged in formulation,
2011 250,00$

May & Baker Nigeria PLC (MAYBAKER) - Financial and Strategic SWOT Analysis Review

May & Baker Nigeria PLC. (May & Baker) is a specialty pharmaceutical company that provides quality and affordable medicines, food
2011 250,00$

Paradise Entertainment Limited (1180) - Financial and Strategic SWOT Analysis Review

Paradise Entertainment Limited (Paradise Entertainment) is an investment holding company and is formerly known as LifeTec Group Li
2011 250,00$

RNL BIO Co., Ltd. (003190) - Financial and Strategic SWOT Analysis Review

RNL BIO Co., Ltd. (RNL BIO) is a publically held biotechnology company. The company is principally engaged in the development and
2011 250,00$

Savoy Equities Limited (SVY) - Financial and Strategic SWOT Analysis Review

Savoy Equities Limited (Savoy Equities) operates as oil and resins extraction business. The company is also engaged in manufacturi
2011 250,00$

Enerland Corporation Co., Ltd. (045260) - Financial and Strategic SWOT Analysis Review

Enerland Corporation Co., Ltd. (Enerland) is a diversified company, involved in pharmaceutical, defense, energy and real estate se
2011 250,00$

North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review

North China Pharmaceutical Co., Ltd. (NCPC) is a publicaly held drug manufacturing company. The company is principally engaged in
2011 125,00$

J Communications Co., Ltd. (060750) - Financial and Strategic SWOT Analysis Review

J Communications Co., Ltd. (J Communications) is a Korea-based company that is engaged in the pharmaceutical and communication dev
2011 250,00$

Chongqing Taiji Industry(Group)Co., Ltd. (600129) - Financial and Strategic SWOT Analysis Review

Chongqing Taiji Industry(Group)Co., Ltd. (Chongqing Taiji), formerly Sichuan Taiji Industry (Group) Co., Ltd. is a pharmaceutical
2011 125,00$

Shanghai Wingsung Investment Management Co., Ltd. (900904) - Financial and Strategic SWOT Analysis Review

Shanghai Wingsung Investment Management Co., Ltd. (Shanghai Wingsung) is a publicly held company that is principally engaged in th
2011 250,00$

Shenzhen Neptunus Bioengineering Co. Ltd (000078) - Financial and Strategic SWOT Analysis Review

Shenzhen Neptunus Bioengineering Co. Ltd (Neptunus) is a publicly held company that is chiefly involved in the production and dist
2011 125,00$

Ams Life Science Co., Ltd. (2927) - Financial and Strategic SWOT Analysis Review

AMS Life Science Co.,Ltd. (AMS Life ) is an OEM manufacturer that delivers quality products which can correspond the lines of plan
2011 250,00$

Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review

Dottikon ES Holding AG (Dottikon ES) is a puclically held company engaged in producing hazardous chemistry and focuses on the excl
2011 250,00$

Phylaxia 1912 Holding Nyrt (PHYLAXIA) - Financial and Strategic SWOT Analysis Review

Phylaxia 1912 Holding Nyrt (Phylaxia) is engaged in the manufacture of pharmaceutical preparations. Also, the company manufactures
2011 250,00$

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (8231) - Financial and Strategic SWOT Analysis Review

Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co., Ltd. (FDZJ) is a publically held company engaged in the research, development, m
2011 250,00$

Shanghai Modern Pharmaceutical Co., Ltd. (600420) - Financial and Strategic SWOT Analysis Review

Shanghai Modern Pharmaceutical Co., Ltd. (SM Pharma) is publicly held pharmaceutical company. The company is principally engaged i
2011 125,00$

Shandong Shanda Wit Science & Tech Co (000915) - Financial and Strategic SWOT Analysis Review

Shandong Shanda Wit Science & Technology Co., Ltd., (Shandong Shanda ) is a publically held pharmaceutical company based in China.
2011 250,00$

Southwest Pharmaceutical Co., Ltd. (600666) - Financial and Strategic SWOT Analysis Review

Southwest Pharmaceutical Co., Ltd. (Southwest Pharmaceutical) is a publically held manufacturer of chemical preparations. The comp
2011 250,00$

Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic SWOT Analysis Review

Shanghai Furen Industrial (Group) Co., Ltd. (Shanghai Furen) is publicly held pharmaceutical company. The company is engaged in th
2011 250,00$

Yabao Pharmaceutical Group Co., Ltd (600351) - Financial and Strategic SWOT Analysis Review

Yabao Pharmaceutical Group Co.,Ltd, (Yabao Pharmaceutical) formerly known as Shanxi Yabao Pharmaceutical Group Co., Ltd. is a pub
2011 250,00$

Shenzhen Cau Technology Co., Ltd. (000004) - Financial and Strategic SWOT Analysis Review

Shenzhen Cau Technology Co., Ltd. (Cau Technology) is a China-based diversified company. The company is principally engaged in res
2011 250,00$

Institute of Applied Medicine, Inc. (2123) - Financial and Strategic SWOT Analysis Review

Institute of Applied Medicine,Inc. (IAM) is a publicaly held contract research organization engaged in the provision of outsourcin
2011 250,00$

Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (MPHA) - Financial and Strategic SWOT Analysis Review

Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (Midpharma) is a publicaly held drug development and m
2011 250,00$

Omega Diagnostics Group PLC (ODX) - Financial and Strategic SWOT Analysis Review

Omega Diagnostics Group PLC (ODG) is a publicaly held biotechnology company, engaged in manufacture, development and distribution
2011 250,00$

Wyeth Pakistan Limited (WYETH) - Financial and Strategic SWOT Analysis Review

Wyeth Pakistan Limited (Wyeth Pakistan) is a pubicaly held pharmaceutical company. The company is engaged in the manufacturing and
2011 250,00$

Shandong Wohua Pharmaceutical Co., Ltd. (002107) - Financial and Strategic SWOT Analysis Review

Shandong Wohua Pharmaceutical Co., Ltd., (Wohua Pharma) is a traditional chinese pharmaceutical company that is principally engage
2011 250,00$

Nuvilex, Inc. (NVLX) - Financial and Strategic SWOT Analysis Review

Nuvilex, Inc. (Nuvilex) is a US based holding company operates through its wholly-owned subsidiaries. The company is principally i
2011 250,00$

Worldwide Biotech & Pharmaceutical Co. (WWBP) - Financial and Strategic SWOT Analysis Review

Worldwide Biotech & Pharmaceutical Company (WWBP) is a pharmaceutical company engaged in developing and marketing of viruses and v
2011 250,00$

Woogene B&G Co, Ltd. (018620) - Financial and Strategic SWOT Analysis Review

Woogene B&G Co, Ltd. (Woogene B&G) is a Korea-based pharmaceutical company engaged in developing, manufacturing and marketing a wi
2011 250,00$

Ivy Medical Chemicals PLC (IVMP) - Financial and Strategic SWOT Analysis Review

Ivy Medical Chemicals PLC (Ivy Medical) is engaged in the development and marketing of medical products to oncology markets. The c
2011 250,00$

AquaSource Algae Group PLC (AAGP) - Financial and Strategic SWOT Analysis Review

AquaSource Algae Group PLC (AquaSource) is a pharmaceutical company. The company is principally engaged in providing a wide variet
2011 250,00$

Medical Developments International Limited (MVP) - Financial and Strategic SWOT Analysis Review

Medical Developments International Limited (MDI) is a healthcare company, engaged in manufacturing of pain relief and respiratory
2011 250,00$

AlumiFuel Power Corporation (AFPW) - Financial and Strategic SWOT Analysis Review

AlumiFuel Power Corporation (AlumiFuel Power)is a publicly held holding company. The company operates through its subsidiary Alumi
2011 250,00$

Newtime Infrastructure Ltd. (531959) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Newtime Infrastructure Ltd. provides you an in-depth strategic analysis of the company’s busin
2011 250,00$

Beijing Century Health Medical, Inc. (BCHM) - Financial and Strategic SWOT Analysis Review

Beijing Century Health Medical, Inc. (Formerly known as Super Luck, Inc. ) is a development stage pharmaceuticals company, engaged
2011 250,00$

Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic SWOT Analysis Review

Omnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company, engaged in providing diagnostic, prognostic and
2011 250,00$

Kun Run Biotechnology, Inc. (KURU) - Financial and Strategic SWOT Analysis Review

Kun Run Biotechnology, Inc. (Kun Run) is a pharmaceutical drug manufacturing company. The company is involved in drug development
2011 250,00$

Metabolic Research, Inc. (MTBR) - Financial and Strategic SWOT Analysis Review

Metabolic Research, Inc. (Metabolic Research) is a public traded biotechnology company. It is engaged in the development, manufact
2011 250,00$

Procyon Corporation (PCYN) - Financial and Strategic SWOT Analysis Review

Procyon Corporation (Procyon) is a publicly held pharmaceutical company engaged in manufacturing and marketing of wound and skin c
2011 250,00$

AmStem Corporation (AMST) - Financial and Strategic SWOT Analysis Review

AmStem Corporation is formerly known as Stem Cell Therapy International, Inc. (SCTI) is a biotechnology company, engaged in the fi
2011 250,00$

Tensall Bio-Tech Co., LTD. (4135) - Financial and Strategic SWOT Analysis Review

Tensall Bio-Tech Co.,Ltd (Tensall) is a biotechnology company, engaged in providing probiotics and cosmetics. It is principally en
2011 250,00$

The Sagemark Companies Ltd. (SKCO) - Financial and Strategic SWOT Analysis Review

The Sagemark Companies Ltd. (Sagemark) is a diagnostic imaging company. The company is engaged in the owning, operating and managi
2011 250,00$

China Healthcare Limited (592) - Financial and Strategic SWOT Analysis Review

China Healthcare Limited (CHL) is healthcare service providers . The company, along with its subsidiaries provides planning, desig
2011 250,00$

Supporta Plc (SOR) - Financial and Strategic SWOT Analysis Review

Supporta Plc (Supporta) is a publicly held holding company engaged in providing domiciliary care services. Supporta operates throu
2011 250,00$

Asiri Hospital PLC (ASIR.N0000) - Financial and Strategic SWOT Analysis Review

Asiri Hospital PLC (Asiri) is principally engaged in providing a wide range of healthcare and hospital services. It is an operatin
2011 250,00$

Corporacion Dermoestetica SA (DERM) - Financial and Strategic SWOT Analysis Review

Corporacion Dermoestetica SA (Corporacion) is specialized in aesthetic medicine, aesthetic surgery, dietetics, nutrition and odont
2011 250,00$

Nafais Holding Company (K.S.C.C.) (NAFAIS) - Financial and Strategic SWOT Analysis Review

Nafais Holding Company KSCC (Nafais Holding) is a Kuwait-based company, engaged in the provision of health care services, the esta
2011 250,00$

Topchoice Medical Invesment Co., Inc (600763) - Financial and Strategic SWOT Analysis Review

Topchoice Medical Investment Co., Inc (Topchoice Medical) is a provider of dental and oral health care services. Major services of
2011 250,00$

Thai Nakarin Hospital Public Company Limited (TNH) - Financial and Strategic SWOT Analysis Review

Thai Nakarin Hospital Public Company Limited (Thai Nakarin Hospital) operates as a general hospital. The company has state-of-the-
2011 250,00$

Sirona Biochem Corp (SBM) - Financial and Strategic SWOT Analysis Review

Sirona Biochem Corp (Sirona Biochem), is a biotech company which is engaged in discovery and development of drug compounds. It is
2011 250,00$

Biomm S.A. (BIOM4) - Financial and Strategic SWOT Analysis Review

Biomm S.A. (Biomm) is a publicly held Brazil-based biotechnology company that is principally engaged in the development of technol
2011 250,00$

Spine Pain Management, Inc. (SPIN) - Financial and Strategic SWOT Analysis Review

Spine Pain Management, Inc. (SPMI) focuses on the delivery of solutions to spine surgeons and orthopedic surgeons for necessary tr
2011 250,00$

Patient Portal Technologies, Inc. (PPRG) - Financial and Strategic SWOT Analysis Review

Patient Portal Technologies, Inc. (PPRG), formerly known as Gambino Apparel Group, Inc., is provider of innovative health care and
2011 250,00$

ONE Bio, Corp. (ONBI) - Financial and Strategic SWOT Analysis Review

ONE Bio, Corp. (ONE Bio), formerly known as One Holdings Corporation, is engaged in utilizing green processes to manufacture raw c
2011 250,00$

Jordanian Pharmaceutical Manufacturing Co. PLC (JPHM) - Financial and Strategic SWOT Analysis Review

Jordanian Pharmaceutical Manufacturing Co. PLC (JPM) is a pharmaceutical drug manufacturing company. The company develops, manufac
2011 250,00$

Twilight Litaka Pharma Ltd. (TWILITAKA) - Financial and Strategic SWOT Analysis Review

Twilight Litaka Pharma Ltd. (TL Pharma) is an Indian based pharmaceutical company principally engaged in the manufacture of drugs
2011 250,00$

PHARMENA SA (PHR) - Financial and Strategic SWOT Analysis Review

PHARMENA SA (PHARMENA) is a pharmaceutical company engaged in the production and commercialization of innovative pharmaceuticals a
2011 250,00$

Agennix AG (AGX) - Financial and Strategic SWOT Analysis Review

Agennix AG (Agennix) is a biopharmaceutical company resulting from the combination of GPC Biotech AG and Agennix. The company is e
2011 250,00$

Traphaco Joint Stock Company (TRA) - Financial and Strategic SWOT Analysis Review

Traphaco Joint Stock Company (Traphaco JSC) is a pharmaceutical manufacturing company. It is principally engaged in manufacturing,
2011 250,00$

Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic SWOT Analysis Review

Molecular Pharmacology (the US.) Ltd. (MPL) is a biotechnology company. It is principally engaged in the discovery, development an
2011 250,00$

Rekah Pharmaceutical Industry Ltd. (REKA) - Financial and Strategic SWOT Analysis Review

Rekah Pharmaceutical Industry Ltd. (Rekah) is a pharmaceutical company that is focuses on the development, manufacture, marketing,
2011 250,00$

Wintac Limited (524758) - Financial and Strategic SWOT Analysis Review

Wintac Limited (Wintac), formerly known as Recon Ltd., is engaged in the research, development, production and commercialization o
2011 250,00$

Luye Pharma Group Co., Ltd. (A61) - Financial and Strategic SWOT Analysis Review

Luye Pharma Group Ltd. (Luye Pharma), formerly known as AsiaPharm Group Ltd., is one of the leading biopharmaceutical company. It
2011 250,00$

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Financial and Strategic SWOT Analysis Review

Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a global integrated pharmaceutical company. It focuses on the research,
2011 250,00$

Kunming Pharmaceutical Group Co., Ltd. (600422) - Financial and Strategic SWOT Analysis Review

Kunming Pharmaceutical Group Co., Ltd. (KPC) is a pharmaceutical company engaged in drug manufacturing and marketing. The company
2011 250,00$

Sierra Health Services - Strategic SWOT Analysis Review

Sierra Health Services, Inc. is a diversified healthcare services company that operates health maintenance organizations, indemnit
2011 250,00$

Targanta Therapeutics Corporation - Strategic SWOT Analysis Review

Targanta Therapeutics Corporation (Targanta) is a privately held bio-pharmaceutical company. The company principally focused on de
2011 250,00$

Regent Assisted Living Inc. (RGNT) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Regent Assisted Living Inc. provides you with an in-depth strategic analysis of the company's b
2011 250,00$

BND Co., Ltd. (047940) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of BND Co., Ltd. provides you with an in-depth strategic analysis of the company's businesses and
2011 250,00$

Polymer Research Corp. of America (PROAQ) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Polymer Research Corp. of America provides you with an in-depth strategic analysis of the compa
2011 250,00$

Golden Pond Healthcare, Inc. (GPH) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Golden Pond Healthcare, Inc. provides you with an in-depth strategic analysis of the company's
2011 250,00$

Integrated Health Services - Strategic SWOT Analysis Review

Integrated Health Services (Integrated Health) is engaged in providing post-acute healthcare services. Post-acute care is the prov
2011 250,00$

Alert B&C Corporation (ACB) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Alert B&C Corporation provides you with an in-depth strategic analysis of the company's busines
2011 250,00$

IRI SEPARATION TECHNOLOGIES INC. (IRI) - Strategic SWOT Analysis Review

IRI Separation Technologies Inc is a biotechnology company specialized in the extraction, development and commercialization antibo
2011 125,00$

Astralis, Ltd. - Strategic SWOT Analysis Review

Astralis Ltd. (Astralis) is a development-stage pharmaceutical company that is principally enggaed in the development of treatment
2011 250,00$

Memory Pharmaceuticals Corp. - Strategic SWOT Analysis Review

Memory Pharmaceuticals Corp. (Memory Pharmaceutical) is a biopharmaceutical company, engaged in the discovery and development of d
2011 250,00$

China Healthcare Acquisition Corporation - Strategic SWOT Analysis Review

China Healthcare Acquisition Corporation (CHAC) is engaged in acquiring one or more operating businesses in the healthcare sector.
2011 250,00$

South Egypt Drug Industries Company - Strategic SWOT Analysis Review

This comprehensive SWOT profile of South Egypt Drug Industries Company provides you with an in-depth strategic analysis of the com
2011 250,00$

Global Napi Pharmaceuticals - Strategic SWOT Analysis Review

Global Napi Pharmaceuticals (Global Napi) is an Egypt based pharmaceutical company. Global Napi is engaged in developing and manuf
2011 250,00$

Egyptian International Medical Center - Strategic SWOT Analysis Review

Egyptian International Medical Center (EIMC) is a private pharma company, The company supplies cytotoxics, plasma derivatives and
2011 250,00$

APEX Pharma S.A.E. - Strategic SWOT Analysis Review

APEX Pharma S.A.E. (APEX) is an Egyptian based Joint Stock company, engaged in the production, marketing and sale and importation
2011 250,00$

Immune Network, Ltd. - Strategic SWOT Analysis Review

Immune Network, Ltd. (formerly Immune Network Research Ltd.) is a biotechnology company. It is involved in the development of immu
2011 250,00$

Keunwha Pharmaceutical Co.,Ltd. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Keunwha Pharmaceutical Co.,Ltd. provides you with an in-depth strategic analysis of the company
2011 250,00$

Caribbean American Health Resorts, Inc. (CAHR) - Strategic SWOT Analysis Review

Carribbean American Health Resorts, Inc, (CAHR) is a publicly held development-stage company that principally focuses on owning, d
2011 250,00$

Lexington Healthcare Group, Inc. - Strategic SWOT Analysis Review

Lexington Healthcare Group, Inc. (Lexington Healthcare) in engaged in providing a wide range of healthcare services, including nur
2011 250,00$

Sinovac Biotech Co., Ltd. - Strategic SWOT Analysis Review

Sinovac Biotech Co., Ltd.( Beijing Kexing Bioproducts.) engages in selling of human vaccines. It also engages in research and deve
2011 250,00$

D I L Limited - Strategic SWOT Analysis Review

This comprehensive SWOT profile of D I L Limited provides you with an in-depth strategic analysis of the company's businesses and
2011 250,00$

Harvard Scientific Corp. - Strategic SWOT Analysis Review

Harvard Scientific Corp. (Harvard Scientific) is a bio pharmaceutical company engaged in the development, manufacturing and distri
2011 250,00$

Health Sciences Group, Inc. (HESG) - Strategic SWOT Analysis Review

Health Sciences Group, Inc. (Health Sciences Group) is focused on the development and commercialization of products and functional
2011 250,00$

CANCOG Technologies Inc. - Strategic SWOT Analysis Review

CanCog Technologies, Inc. (CanCog Technologies) is a privately held contract research organization engaged in providing predictive
2011 250,00$

Flagship Global Health, Inc. (FGHH) - Strategic SWOT Analysis Review

Flagship Global Health, Inc. (formerly Patients & Physicians, Inc., ) is a health assurance organization providing prority access
2011 250,00$

Comvita New Zealand Limited - Strategic SWOT Analysis Review

Comvita is a natural health and wellness company with a strong heritage in innovating and manufacturing therapeutic apicultural pr
2011 125,00$

Terveystalo Healthcare Oyj - Strategic SWOT Analysis Review

Terveystalo Healthcare Oyj (Terveystalo) is a privately held health care service company and is principally engaged in providing h
2011 250,00$

Shanghai Fosun Medical Technology Development Co., Ltd. ( 600196) - Strategic SWOT Analysis Review

Shanghai Fosun Med-Tech Development Co., Ltd. (Shanghai Fosun) is a China based private company engaged in producuing in vitro dia
2011 250,00$

The University of Texas M. D. Anderson Cancer Center - Strategic SWOT Analysis Review

The University of Texas M. D. Anderson Cancer Center (M. D. Anderson Cancer Center) conducts research on cancer. Its programs inte
2011 250,00$

Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Millennium Pharmaceuticals, Inc. (Millennium) is a biopharmaceutical company which is engaged in the research, development, and co
2011 125,00$

Arkopharma SA - Strategic SWOT Analysis Review

Arkopharma SA (Arkopharma) is phytotherapy and nutritional supplements provider in Europe, engaged in the manufacture and distribu
2011 125,00$

Austin Health - Strategic SWOT Analysis Review

Austin Health (Austin) is the provider of tertiary health services, health professional education and research in the northeast of
2011 125,00$

Bay of Plenty District Health Board - Strategic SWOT Analysis Review

Bay of Plenty District Health Board (BOPDHB) operates as one of the 21 district health boards in New Zealand. It provides a range
2011 125,00$

Crucell Switzerland AG - Strategic SWOT Analysis Review

Crucell Switzerland AG (Crucell) is a private biopharmaceutical company engaged in producing vaccines and antibodies. The company
2011 125,00$

Capital & Coast District Health Board - Strategic SWOT Analysis Review

Capital & Coast District Health Board (C&C DHB) is a one of the specialist health services providers in the central region of New
2011 125,00$

Danbury Hospital - Strategic SWOT Analysis Review

Danbury Hospital is a US based health care centre, principally engaged in providing various treatments relating to cancer and card
2011 125,00$

DCH Health System - Strategic SWOT Analysis Review

DCH Health System (DCH Health) is a medical and healthcare services provider. DCH Health is a US government subdivision, operating
2011 125,00$

Ferrosan A/S - Strategic SWOT Analysis Review

Ferrosan A/S (Ferrosan) is an international consumer and healthcare company. The company offers various supplements and healthcare
2011 125,00$

Fisher Scientific International Inc. (FSH) - Strategic SWOT Analysis Review

Fisher Scientific International, Inc. (Fisher) is an US based public company that provides analytical instruments and services to
2011 250,00$

Health Protection Agency - Strategic SWOT Analysis Review

The Health Protection Agency (HPA) is a government organization that focuses on defending the public against health dangers in the
2011 125,00$

Jose de Mello, SGPS - Strategic SWOT Analysis Review

Jose de Mello, SGPS (Jose de Mello) is one of the Portugal’s biggest corporate groups. It is an economic group which concentrates
2011 125,00$

LEO Pharma A/S - Strategic SWOT Analysis Review

LEO Pharma A/S (LEO Pharma) is one of the leading pharmaceutical companies within Dermatology and Critical Care. The company maint
2011 125,00$

MDS Analytical Technologies - Strategic SWOT Analysis Review

MDS Analytical Technologies (MDS Analytical) is one of the leading global suppliers of analytical instruments and technology solut
2011 125,00$

Melbourne Health - Strategic SWOT Analysis Review

Melbourne Health is an Australia based health service provider. The company is principally engaged in providing acute, sub-acute a
2011 125,00$

Merz GmbH & Co. KGaA - Strategic SWOT Analysis Review

Merz GmbH & Co. KGaA is a Germany based healthcare company. The company is principally engaged in providing pharmaceuticals, consu
2011 125,00$

MidCentral District Health Board - Strategic SWOT Analysis Review

MidCentral District Health Board (MDHB) is a New Zealand based health and disability support service provider. The company princip
2011 250,00$

Norgine Limited - Strategic SWOT Analysis Review

Norgine Limited (Norgine) is engaged in the development, manufacturing and marketing of pharmaceutical products. The company also
2011 125,00$

Sandoz International GmbH - Strategic SWOT Analysis Review

Sandoz International GmbH (Sandoz) is one of the leading global generics companies. The company develops and markets off-patent me
2011 125,00$

Taiho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review

Taiho Pharmaceutical Co., Ltd. (Taiho Pharmaceutical) is a Japan-based pharmaceutical company engaged in the development, producti
2011 125,00$

Tamro Corporation - Strategic SWOT Analysis Review

Tamro Corporation is involved in the wholesale supply and distribution of pharmaceuticals principally in Northern Europe. It princ
2011 125,00$

Toyama Chemical Co. Ltd - Strategic SWOT Analysis Review

Toyama Chemical Co. Ltd. was acquired by Fujifilm Holdings Corporation and became a consolidated subsidiary during 2008. Toyama Ch
2011 125,00$

United Surgical Partners International - Strategic SWOT Analysis Review

United Surgical Partners International (United Surgical Partners) is one of the leaders in the ambulatory surgery center and short
2011 125,00$

Western Health - Strategic SWOT Analysis Review

Western Health (WH) is an Australian based health related service provider. The company is principally engaged in the field of off
2011 125,00$

Zambon Group S.p.A. - Strategic SWOT Analysis Review

Zambon Group S.p.A. is a major multinational pharmaceutical and chemical company. Zambon Company SpA is the holding company of the
2011 125,00$

Carl-Zeiss-Stiftung - Strategic SWOT Analysis Review

Carl-Zeiss-Stiftung, is a German based company. The company operates through its subsidiaries namely Carl Zeiss AG and SCHOTT AG a
2011 125,00$

Nelson Marlborough District Health Board - Strategic SWOT Analysis Review

Nelson Marlborough District Health Board (Nelson Marlborough) is a New Zealand based health board chiefly engaged in the planning
2011 250,00$

APS Healthcare Inc - Strategic SWOT Analysis Review

APS Healthcare Inc. (APS) is a privately held health care company. The company works in collaboration with Medicaid Agencies , sta
2011 125,00$

Groupe ORPEA (ORP) - Strategic SWOT Analysis Review

Groupe ORPEA (Orpea) is France based company engaged in offering long-term care and post-acute care. The company is primarily enga
2011 125,00$

PHOENIX Group - Strategic SWOT Analysis Review

PHOENIX Group is a leading pharmaceutical distribution company in Europe. It provides a range of pharmaceutical and healthcare pro
2011 125,00$

Universal Hospital Services Inc (UHS) - Strategic SWOT Analysis Review

Universal Hospital Services, Inc. (UHS) provides medical equipment management and service solutions to the health care industry in
2011 125,00$

Nova BioGenetics, Inc. (NVBG) - Strategic SWOT Analysis Review

Nova BioGenetics, Inc. (Nova) is a publicly held research focused biotechnology company, engaged in discovery, development, commer
2011 250,00$

ALIGN Pharmaceuticals, LLC. - Strategic SWOT Analysis Review

ALIGN Pharmaceuticals is a specialty pharmaceutical company principally engaged in providing supportive care solutions for symptom
2011 125,00$

Scandinavian Clinical Nutrition i Sverige AB (SCN) - Strategic SWOT Analysis Review

Scandinavian Clinical Nutrition i Sverige AB (SCN) is a Sweden based company is nutritional products developer and supplier. The
2011 250,00$

ReGenX Biosciences, LLC - Strategic SWOT Analysis Review

ReGenX Biosciences, LLC (ReGenX) is a bio pharmaceutical company that is engaged in research and development of therapeutics based
2011 125,00$

NeuroGenesis, Inc. (NEUN) - Strategic SWOT Analysis Review

NeuroGenesis, Inc. (Neurogenesis) is publicly held US based company. It is principally engaged in development of nutritional suppl
2011 250,00$

Medical & Biological Laboratories Co., Ltd. (4557) - Strategic SWOT Analysis Review

Medical & Biological Laboratories Co., Ltd.(MBL) is engaged in the research, development and manufacture of clinical reagents and
2011 250,00$

PCI Biotech AS - Strategic SWOT Analysis Review

PCI Biotech AS (PCI Biotech) is a drug delivery company, engaged in commercialization of photochemical drug delivery technology fo
2011 250,00$

InterSystems Corporation - Strategic SWOT Analysis Review

InterSystems Corporation (InterSystems) is a privately-held software company engaged in providing premier platform for connected h
2011 125,00$

Carolinas Hospital System - Strategic SWOT Analysis Review

Carolinas Hospital System (CHS) is a hospital providing acute health care services in Florence, South Carolina. CHS offers various
2011 125,00$

TMC HealthCare - Strategic SWOT Analysis Review

TMC HealthCare (TMC) is a nonprofit hospital. TMC is focused on supporting the communities’ health needs by supporting education a
2011 125,00$

University Medical Center Corporation - Strategic SWOT Analysis Review

University Medical Center Corporation (UMC) is a privately held, nonprofit hospital located in Tucson, Arizona. The organization o
2011 125,00$

D-Pharm Ltd. (DPRM) - Strategic SWOT Analysis Review

D-Pharm LTD.(D-Pharm) is a specialty bio-pharmaceutical company. It is engaged in the design and development of innovative drugs f
2011 250,00$

CepTor Corporation (CEPO) - Strategic SWOT Analysis Review

CepTor Corporation (CepTor) is a development-stage biopharmaceutical company that is engaged in the discovery, development and com
2011 250,00$

Axiogenesis AG (AI8) - Strategic SWOT Analysis Review

Axiogenesis AG (Axiogenesis) is an innovative biotechnology company that specializes in applied stem cell technology and molecular
2011 250,00$

The State University of New York - Strategic SWOT Analysis Review

The State University of New York (SUNY) is one of the largest and most comprehensive state university system in the US. The State
2011 125,00$

Artec, Inc. (ATKJ) - Strategic SWOT Analysis Review

Artec, Inc. (Artec) is a publicly held pharmaceutical company. It is principally engaged in the manufacture and distribution of a
2011 250,00$

Italfarmaco S.p.A. - Strategic SWOT Analysis Review

Italfarmaco S.p.A. (Italfarmaco) is an independently held private company based in Italy. The company along with its subsidiaries
2011 125,00$

LONGPORT, INC (LPTI) - Strategic SWOT Analysis Review

LONGPORT, INC (Longport) is a publicly-held Delaware corporation, which develops, manufactures, markets, and sells high resolution
2011 250,00$

Advik Laboratories Ltd. (ADVIKLA) - Strategic SWOT Analysis Review

Advik Laboratories Ltd. (Advik) is an India based company engaged in the manufacture and sale of ethical and generic pharmaceutica
2011 250,00$

Julphar (JULPHUR) - Strategic SWOT Analysis Review

Julphar (Julphar) is a publicly held company that is engaged in the manufacture of medicines, drugs and various other types of pha
2011 250,00$

Migami, Inc. (MIGA) - Strategic SWOT Analysis Review

Migami, Inc. (Migami) is a publicly held development stage pharmaceutical company. It is principally engaged in the distribution o
2011 250,00$

Cavit Sciences, Inc. (CVIT) - Strategic SWOT Analysis Review

Cavit Sciences, Inc. (Cavit Sciences) is a biotechnology company, based in the US. The company is engaged in the development of th
2011 250,00$

Renato Corporation (4OZ) - Strategic SWOT Analysis Review

Renato Corporation (Renato) is the publicly held US based biotechnology company which is principally engaged in providing health d
2011 250,00$

GenoMed, Inc. (GMED) - Strategic SWOT Analysis Review

GenoMed, Inc. (GenoMed) is a publicly held biotechnology company. It is principally engaged in medical genomics and disease manage
2011 250,00$

Laboratorios Liomont S.A. de C.V. - Strategic SWOT Analysis Review

Laboratorios Liomont S.A. de C.V. (Liomont) is a Mexico-based pharmaceutical company, engaged in offering a wide range of pharmace
2011 125,00$

Armstrong Laboratorios de Mexico S.A. de C.V. - Strategic SWOT Analysis Review

Armstrong Laboratorios de Mexico SA de C.V. (Armstrong Laboratorios) is a Mexican based company. It supplies quality medicines to
2011 125,00$

TranXenoGen, Inc. - Strategic SWOT Analysis Review

TranXenoGen, Inc. (TranXenoGen) is the US based privately held biotechnology company which is engaged in the development of new th
2011 250,00$

Canopus BioPharma Incorporated (CBIA) - Strategic SWOT Analysis Review

Canopus BioPharma Incorporated (Canopus BioPharma) is a publicly traded pharmaceutical company, engaged in the research and develo
2011 250,00$

BIOQUAL, Inc. (BIOQ) - Strategic SWOT Analysis Review

BIOQUAL, Inc. (Bioqual) is a public traded, research, development and consulting company and is engaged in providing quality resea
2011 250,00$

Caleco Pharma Corp. (CAEH) - Strategic SWOT Analysis Review

Caleco Pharma Corp. (Caleco) is a public company engaged in the development of products to treat moderate to severe liver maladies
2011 250,00$

Sinobiopharma Inc. (SNBP) - Strategic SWOT Analysis Review

Sinobiopharma Inc. (Sinobiopharma) is an integrated and innovative biotechnology company. The company is focused on the research a
2011 250,00$

Multiple Myeloma Research Foundation - Strategic SWOT Analysis Review

Multiple Myeloma Research Foundation (MMRF) is a bio-pharmaceutical company, based in the US. It is principally engaged in the dev
2011 250,00$

Amazon BioTech (AMZB) - Strategic SWOT Analysis Review

Amazon BioTech (Amazon) is a privately held pharmaceutical company. It is principally engaged in research and development of natur
2011 250,00$

China Health Management Corp. (CNHC) - Strategic SWOT Analysis Review

China Health Management Corp. (CHMC) engages in providing operations and management of hospitals in China. Its services include, h
2011 250,00$

Immune-tree International, Inc. (IMUT) - Strategic SWOT Analysis Review

Immune-tree International, Inc. (Immune tree)specializes in the development and manufacture of colostrum-based health food product
2011 250,00$

Cannasat Therapeutics, Inc. (CTH) - Strategic SWOT Analysis Review

Cannasat Therapeutics, Inc. (Cannasat) publicly held clinicla stage pharmaceutical company, that is engaged in the discovery and d
2011 250,00$

DelSite Biotechnologies, Inc. (DSII) - Strategic SWOT Analysis Review

DelSite Biotechnologies, Inc. is an early stage drug-delivery and biotechnology company established to provide the pharmaceutical
2011 250,00$

Milestone Biosciences, LLC (ACCP) - Strategic SWOT Analysis Review

Milestone Biosciences, LLC (Milestone) is a development-stage biotechnology company. It is principally focuses on in-licensing and
2011 250,00$

iDiS Limited - Strategic SWOT Analysis Review

iDiS Limited (IDIS), has created a tool of Mobile Asset Management which helps to take giant strides within the space. Mobile Asse
2011 250,00$

Shin Poong Pharm Co., Ltd. (019170) - Strategic SWOT Analysis Review

Shin Poong Pharm Co., Ltd.(Shin Poong) is a pharmaceutical company engaged in the development, marketing, and distribution of phar
2011 250,00$

Tularik, Inc. - Strategic SWOT Analysis Review

Tularik, Inc. (Tularik) is a pharmaceutical company, based in the US. The company is engaged in the discovery and development of o
2011 250,00$

SOHM Inc. (SOHM) - Strategic SWOT Analysis Review

SOHM Inc. (SOHM) is a pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals. The company ma
2011 250,00$

Vanguard Pharmaceutical Corporation (VGPH) - Strategic SWOT Analysis Review

Vanguard Pharmaceutical Corporation (Vanguard) is engaged in research, development, manufacture, and sale of generic and oncology
2011 250,00$

Islet Holdings, Inc. (ISHI) - Strategic SWOT Analysis Review

Islet Holdings, Inc. (formerly known as Biozhem Cosmeceuticals, Inc.) is a marketer of personal care products through a worldwide
2011 250,00$

Perrigo Israel Pharmaceuticals Ltd. (PRGO) - Strategic SWOT Analysis Review

Perrigo Israel Pharmaceuticals Ltd. (Perrigo Israel) is a privately held pharmaceutical company that is engaged in developing, man
2011 250,00$

Ventana Biotech Inc. (VNTA) - Strategic SWOT Analysis Review

Ventana Biotech Inc. (Ventana Biotech) is a bioscience company that is engaged in the development and marketing of products for th
2011 250,00$

Chemizon, Inc. (010170) - Strategic SWOT Analysis Review

Chemizon, Inc. (Chemizon) is a biotechnology company, engaged in the discovery and development of innovative therapeutics. The com
2011 250,00$

Cellceutix Pharmaceuticals, Inc. (CTIX) - Strategic SWOT Analysis Review

Cellceutix Pharmaceuticals, Inc. (Cellceutix) is a publicly traded start-up bio pharmaceutical company. It is principally engaged
2011 250,00$

Sinil Pharma Ltd. (012790) - Strategic SWOT Analysis Review

Sinil Pharma Co Ltd. (Sinil Pharma) is a pharmaceutical company. Sinil Pharma is engaged in the manufacture and distribution of ph
2011 250,00$

Ranaz Corporation (RNZ) - Strategic SWOT Analysis Review

Ranaz Corporation (Ranaz) is engaged in designing, producing, and marketing of nutritional, protein, and dietary supplements all a
2011 250,00$

Help at Home, Inc. (HAHI) - Strategic SWOT Analysis Review

Help at Home, Inc. (Help at Home) is a healthcare service provider that offers homemaker, custodial, and personal home care servic
2011 250,00$

NGL Fine-chem Ltd. (524774) - Strategic SWOT Analysis Review

NGL Fine-chem Ltd. (NGL) is a publicly held pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical
2011 250,00$

Piedmont Behavioral Healthcare - Strategic SWOT Analysis Review

Piedmont Behavioral Healthcare (PBH) is engaged in managing a system of care for children and adults with mental health, developme
2011 125,00$

Auro Laboratories Limited (530233) - Strategic SWOT Analysis Review

Auro Laboratories Limited (Auro Laboratories) is pharmaceutical company that is engaged in the manufacturing of active pharmaceuti
2011 250,00$

U.S NeuroSurgical, Inc. (USN) - Strategic SWOT Analysis Review

U.S NeuroSurgical, Inc. (U.S. Neurosurgical) is a publicly traded specialty service company that offers expertise in the field of
2011 250,00$

Ortin Laboratories Limited (590074) - Strategic SWOT Analysis Review

Ortin Laboratories Limited (Ortin Labs) is a privately held company focused on the manufacture and supply of drugs and medicines i
2011 250,00$

BioLife Remedies, Inc. (BLRS) - Strategic SWOT Analysis Review

BioLife Remedies, Inc. (BioLife) is a pharmaceutical company that combines traditional chinese medicine and western academic resea
2011 250,00$

DocPlanet.com Inc. (DOCP) - Strategic SWOT Analysis Review

DocPlanet.com Inc. (DPI) is a business-to-business e-commerce company that provides pharmaceuticals to office-based physicians. Th
2011 250,00$

Trinity Medical Group USA, Inc. (TMGU) - Strategic SWOT Analysis Review

Trinity Medical Group the US., Inc. (TMG the US.), is a development stage company operating in the healthcare sector. The group is
2011 250,00$

PharmChem, Inc. (PCHM) - Strategic SWOT Analysis Review

PharmChem, Inc. (PharmChem) is a laboratory that offers integrated drug testing services to government and corporate customers. Th
2011 250,00$

Physicians Adult Daycare Inc. - Strategic SWOT Analysis Review

Physicians Adult Daycare Inc. (Adult Daycare) is a managed healthcare organization engaged in providing senior living services. Th
2011 250,00$

Venkat Pharma Limited (VKTP) - Strategic SWOT Analysis Review

Venkat Pharma Limited (Venkat Pharma) is a publicly held Indian based pharmaceutic company. The company is principally engaged in
2011 250,00$

Promethean Corporation (PRMN) - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own
2011 250,00$

Searle Pakistan Limited (SEARL) - Strategic SWOT Analysis Review

Searle Pakistan Limited (SPL) is a Pakistan-based pharmaceutical company engaged in the manufacture, sale, and distribution of pha
2011 250,00$

Nigerian-German Chemicals Plc (NIG-GERMAN) - Strategic SWOT Analysis Review

Nigerian-German Chemicals Plc (NGC) is a biotechnology company engaged in manufacturing and distributing pharmaceutical, consumer
2011 250,00$

Brawn Pharmaceuticals Limited (530207) - Strategic SWOT Analysis Review

Brawn Pharmaceuticals Limited (BRAWN) is a public traded company engages in the marketing, trading and distribution of pharmaceuti
2011 250,00$

Renata Limited (RENATA) - Strategic SWOT Analysis Review

Renata Limited (Renata) is a public traded company specialized in the manufacture and marketing of pharmaceutical and nutritional
2011 250,00$

Scandimed International A.S - Strategic SWOT Analysis Review

Scandimed International A.S (Scandimed) is a Denmark-based company. It specializes in the production of surgical, endo-urological
2011 125,00$

Pine Rest Christian Mental Health Services - Strategic SWOT Analysis Review

Pine Rest Christian Mental Health Services (Pine Rest) is a non-profit health center engaged in providing comprehensive behavioral
2011 125,00$

Health Dialog Services Corporation - Strategic SWOT Analysis Review

Health Dialog Services Corporation (Health Dialog) is a health based support services provider. The company is engages in providin
2011 125,00$

Harvard Vanguard Medical Associates - Strategic SWOT Analysis Review

Harvard Vanguard Medical Associates (Harvard Vanguard) is a non-profit organization that provides healthcare services. It offers a
2011 125,00$

National Medical Development, Inc. - Strategic SWOT Analysis Review

National Medical Development, Inc. (NMDI) is a healthcare organization, engaged in developing, managing owning and operating outpa
2011 125,00$

Summit plc (SUMM) - Strategic SWOT Analysis Review

Summit plc (Summit) is engaged in the discovery and development of novel drugs. It develops new medicines using its proprietary im
2011 250,00$

PD-Rx Pharmaceuticals, Inc (PDRX) - Strategic SWOT Analysis Review

PD-Rx Pharmaceuticals, Inc (PD-Rx) is a provider of pharmaceutical services. It is engaged in distribution of pharmaceutical produ
2011 250,00$

TCP Reliable - Strategic SWOT Analysis Review

TCP Reliable is engaged in providing packaging solution in the field of temperature controlled packaging right from needs assessme
2011 250,00$

Cardio Incorporated - Strategic SWOT Analysis Review

Cardio Incorporated (Cardio) is engaged in health care company. The company is involved in maintaining and improving the life of p
2011 250,00$

Nventa Biopharmaceuticals Corp. (NVN) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Nventa Biopharmaceuticals Corp. provides you with an in-depth strategic analysis of the company
2011 250,00$

Miracor Diagnostics, Inc. (MRDG) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Miracor Diagnostics, Inc. provides you with an in-depth strategic analysis of the company's bus
2011 250,00$

MascoMid Co. - Strategic SWOT Analysis Review

MascoMid Co. (MascoMid) is a medical device company, principally engaged in manufacturing of high quality medical disposable healt
2011 125,00$

Nanjing Medical Co., Ltd. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Nanjing Medical Co., Ltd. provides you with an in-depth strategic analysis of the company's bus
2011 250,00$

Incomex Paraguay SAECA (ICO) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Incomex Paraguay SAECA provides you with an in-depth strategic analysis of the company's busine
2011 250,00$

Carematrix Corporation (CMDCQ) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Carematrix Corporation provides you with an in-depth strategic analysis of the company's busine
2011 250,00$

Karver International, Inc. (KRVR) - Strategic SWOT Analysis Review

Karver International, Inc. (Karver), formerly Medeorex, Inc. is a development stage pharmaceutical companyengaged in rendering hea
2011 250,00$

Dental Patient Care America Inc (DPAT) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Dental Patient Care America Inc provides you with an in-depth strategic analysis of the company
2011 250,00$

Chemeq Technologies Pty Ltd - Strategic SWOT Analysis Review

Chemeq Technologies Pty Ltd (Chemeq Technologies) is a privately held research company that is engaged in developing anti-microbia
2011 250,00$

Let''s Talk Recovery Inc. (LKRV) - Strategic SWOT Analysis Review

Let's Talk Recovery, Inc. is a publicly traded company offering dynamic, socially responsible solutions to the rapidly growing rec
2011 125,00$

China Dasheng Biotechnology Co (CDBT) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of China Dasheng Biotechnology Co provides you with an in-depth strategic analysis of the company'
2011 250,00$

Livewave Media Plc (LIVP) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Livewave Media Plc provides you with an in-depth strategic analysis of the company's businesses
2011 125,00$

Miravant Medical Technologies - Strategic SWOT Analysis Review

Miravant Medical Technologies (Miravant Medical) is a US based pharmaceutical company. Miravant Medical is engaged in research and
2011 250,00$

Combe Incorporated - Strategic SWOT Analysis Review

Combe Incorporated (Combe) is engaged in providing over-the-counter healthcare products, which are used in dermatology, male healt
2011 250,00$

Gliatech Inc. (GLIAQ) - Strategic SWOT Analysis Review

Gliatech Inc. (Gliatech) is principally engaged in the discovery and development of biosurgery and pharmaceutical products. The co
2011 250,00$

Compare Generiks, Inc. - Strategic SWOT Analysis Review

Compare Generiks, Inc. (CGI) is a pharmaceutical company engaged in marketing and distribution of dietary supplements and Over-the
2011 250,00$

BioTransplant Inc. - Strategic SWOT Analysis Review

BioTransplant Inc. (BioTransplant) is a specialty pharmaceutical company engaged in providing intellectual property rights that it
2011 250,00$

Entropin, Inc. (ETOP) - Strategic SWOT Analysis Review

Entropin, Inc. is engaged in the research and development of pharmaceutical products. The company is headquatered in Florida, the
2011 250,00$

MitoPharm Corporation - Strategic SWOT Analysis Review

Mitopharm Corporation (MTPM) is a pharmaceutical company. The company engages in the research, development, marketing and sales of
2011 250,00$

Select Therapeutics Inc. - Strategic SWOT Analysis Review

Select Therapeutics Inc. (Select Therapeutics) is a pharmaceutical company principally engaged in the research and development of
2011 250,00$

Pilot Therapeutics Holdings, Inc. - Strategic SWOT Analysis Review

Pilot Therapeutics Holdings, Inc. (Pilot Therapeutics), formerly Interallied Group, Inc. is a pharmaceutical company principally e
2011 250,00$

BHK Inc. - Strategic SWOT Analysis Review

BHK Inc. (BHK) is engaged in selling electric parts, including MP3 and related business activities. In addition, it is also engage
2011 250,00$

Avantogen Oncology, Inc. (AVTO) - Strategic SWOT Analysis Review

Avantogen Oncology, Inc. (Avantogen) is principally engaged in the development and commercialization of oncology drugs. It is form
2011 250,00$

Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis Review

Stem Cell Sciences plc is a provider of stem cells and associated technologies for drug discovery. The company is specialized in d
2011 250,00$

GlaxoSmithkline Consumer Nig PLC (GLAXOSMITH) - Strategic SWOT Analysis Review

GlaxoSmithKline Consumer Nigeria Plc company is engaged in manufacturing, distribution and marketing a range of consumer healthcar
2011 250,00$

Synova Healthcare Group, Inc. (SNVHQ) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Synova Healthcare Group, Inc. provides you with an in-depth strategic analysis of the company's
2011 250,00$

Span Diagnostics SARL - Strategic SWOT Analysis Review

Span Diagnostics SARL (Span Diagnostics) is a healthcare company, engaged in the development and manufacturing of novel products f
2011 250,00$

Transderm Laboratories Corporation (TLCC) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Transderm Laboratories Corporation provides you with an in-depth strategic analysis of the comp
2011 250,00$

CuraTech Industries, Inc. (CUTC) - Strategic SWOT Analysis Review

CuraTech Industries, Inc., (CII), is a pharmaceutical company. CII is engaged in development and marketing of a health supplements
2011 250,00$

Response Oncology, Inc. (ROIX) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Response Oncology, Inc. provides you with an in-depth strategic analysis of the company's busin
2011 250,00$

U.S. Homecare Corporation (USHO) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of U.S. Homecare Corporation provides you with an in-depth strategic analysis of the company's bus
2011 250,00$

Integra, Inc. (INGA) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Integra, Inc. provides you with an in-depth strategic analysis of the company's businesses and
2011 250,00$

Innovative Clinical Solutions, Ltd. - Strategic SWOT Analysis Review

Innovative Clinical Solutions, Ltd. (ICSL) is a contract research organization engaged in the management of investigative clinical
2011 250,00$

ProMedCo Management Co. - Strategic SWOT Analysis Review

ProMedCo Management Co. (ProMedCo) is a pharmaceutical company engaged in providing medical and healthcare services in the non-urb
2011 250,00$

RainTree Healthcare Corp. - Strategic SWOT Analysis Review

RainTree Healthcare Corp. (RainTree Healthcare), formerly known as Unison HealthCare Corp. is a privately held health care service
2011 250,00$

Diversified Senior Services, Inc. - Strategic SWOT Analysis Review

Diversified Senior Services, Inc. (DISS) is engaged in the development, acquisition and management of apartments, independent livi
2011 250,00$

Molecular Imaging Corporation - Strategic SWOT Analysis Review

Molecular Imaging Corporation (Molecular Imaging) is a diagnostic imaging company engaged in the provision of molecular imaging se
2011 250,00$

Catasys Health, Inc - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Catasys Health, Inc provides you with an in-depth strategic analysis of the company's businesse
2011 250,00$

NewBiotics, Inc. - Strategic SWOT Analysis Review

NewBiotics Inc. (NewBiotics) is a privately held pharmaceutical company engaged in the development of breakthrough drugs for the t
2011 250,00$

Aperture Health, Inc. (APRE) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Aperture Health, Inc. provides you with an in-depth strategic analysis of the company's busines
2011 250,00$

LifeWatch AG (LIFE) - Financial and Strategic SWOT Analysis Review

LifeWatch AG (LIFE) - Financial and Strategic SWOT Analysis Review / / Summary / / LifeWatch AG (LifeWatch), formerly known as C
2011 125,00$

Kensey Nash Corporation (KNSY) - Financial and Strategic SWOT Analysis Review

Kensey Nash Corporation (KNSY) - Financial and Strategic SWOT Analysis Review / / Summary / / Kensey Nash Corp (Kensey Nash) is
2011 125,00$

Given Imaging Ltd. (GIVN) - Financial and Strategic SWOT Analysis Review

Given Imaging Ltd. (GIVN) - Financial and Strategic SWOT Analysis Review / / Summary / / Given Imaging Ltd. (Given Imaging) is e
2011 125,00$

Nakanishi Inc. (7716) - Financial and Strategic SWOT Analysis Review

Nakanishi Inc. (7716) - Financial and Strategic SWOT Analysis Review / / Summary / / Nakanishi Inc. (Nakanishi) is engaged in th
2011 125,00$

TranS1 Inc. (TSON) - Financial and Strategic SWOT Analysis Review

TranS1 Inc. (TSON) - Financial and Strategic SWOT Analysis Review / / Summary / / TranS1 Inc. (TranS1) is a US-based medical dev
2011 125,00$

Positron Corporation (POSC) - Financial and Strategic SWOT Analysis Review

Positron Corporation (POSC) - Financial and Strategic SWOT Analysis Review / / Summary / / Positron Corporation (Positron) is a
2011 250,00$

Oridion Systems Ltd. (ORIDN) - Financial and Strategic SWOT Analysis Review

Oridion Systems Ltd. (ORIDN) - Financial and Strategic SWOT Analysis Review / / Summary / / Oridion Systems Ltd. (Oridion) is a
2011 125,00$

American Medical Alert Corp. (AMAC) - Financial and Strategic SWOT Analysis Review

American Medical Alert Corp. (AMAC) - Financial and Strategic SWOT Analysis Review / / Summary / / American Medical Alert Corp.
2011 125,00$

Lincare Holdings Inc. (LNCR) - Financial and Strategic SWOT Analysis Review

Lincare Holdings Inc. (LNCR) - Financial and Strategic SWOT Analysis Review / / Summary / / Lincare Holdings Inc. (Lincare) is e
2011 125,00$

Cambridge Heart, Inc. (CAMH) - Financial and Strategic SWOT Analysis Review

Cambridge Heart, Inc. (CAMH) - Financial and Strategic SWOT Analysis Review / / Summary / / Cambridge Heart, Inc. (Cambridge Hea
2011 250,00$

MELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis Review

MELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis Review / / Summary / / MELA Sciences, Inc. (MELA Sciences), f
2011 250,00$

Mediwatch Plc (MDW) - Financial and Strategic SWOT Analysis Review

Mediwatch Plc (MDW) - Financial and Strategic SWOT Analysis Review / / Summary / / Mediwatch Plc (Mediwatch) is a medical device
2011 125,00$

Bioheart, Inc. (BHRT) - Financial and Strategic SWOT Analysis Review

Bioheart, Inc. (BHRT) - Financial and Strategic SWOT Analysis Review / / Summary / / Bioheart, Inc. (Bioheart) is a biotechnolog
2011 125,00$

Bioneer Corporation (064550) - Financial and Strategic SWOT Analysis Review

Bioneer Corporation (064550) - Financial and Strategic SWOT Analysis Review / / Summary / / Bioneer Corporation (Bioneer) is a b
2011 250,00$

Insulet Corporation (PODD) - Financial and Strategic SWOT Analysis Review

Insulet Corporation (PODD) - Financial and Strategic SWOT Analysis Review / / Summary / / Insulet Corporation (Insulet) is engag
2011 125,00$

MedQuist Holdings Inc. (MEDH) - Financial and Strategic SWOT Analysis Review

MedQuist Holdings Inc. (MEDH) - Financial and Strategic SWOT Analysis Review / / Summary / / MedQuist Holdings Inc. (MedQuist),
2011 125,00$

Emdeon Inc. (EM) - Financial and Strategic SWOT Analysis Review

Emdeon Inc. (EM) - Financial and Strategic SWOT Analysis Review / / Summary / / Emdeon Inc. (Emdeon) is a provider of healthcare
2011 125,00$

curasan AG (CUR) - Financial and Strategic SWOT Analysis Review

curasan AG (CUR) - Financial and Strategic SWOT Analysis Review / / Summary / / curasan AG (curasan) is a medical device company
2011 125,00$

Pacific Edge Limited (PEB) - Financial and Strategic SWOT Analysis Review

Pacific Edge Limited (PEB) - Financial and Strategic SWOT Analysis Review / / Summary / / Pacific Edge Limited (PEB), formerly P
2011 125,00$

ImpediMed Limited (IPD) - Financial and Strategic SWOT Analysis Review

ImpediMed Limited (IPD) - Financial and Strategic SWOT Analysis Review / / Summary / / ImpediMed Limited (ImpediMed) is an Austr
2011 125,00$

ClearStream Technologies Group plc (CTN) - Financial and Strategic SWOT Analysis Review

ClearStream Technologies Group plc (CTN) - Financial and Strategic SWOT Analysis Review / / Summary / / ClearStream Technologies
2011 125,00$

Exalenz Bioscience Ltd. (EXEN) - Financial and Strategic SWOT Analysis Review

Exalenz Bioscience Ltd. (EXEN) - Financial and Strategic SWOT Analysis Review / / Summary / / Exalenz Bioscience Ltd (Exalenz),
2011 125,00$

WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic SWOT Analysis Review

WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic SWOT Analysis Review / / Summary / / WaferGen Biosystems, Inc. (Wafer
2011 250,00$

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review / / Summary / / Apex Biotechnology Corp. (ApexBio
2011 125,00$

TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review

TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review / / Summary / / TaiDoc Technology Corporatio
2011 125,00$

Shanghai Kehua Bio-engineering Co., Ltd. (002022) - Financial and Strategic SWOT Analysis Review

Shanghai Kehua Bio-engineering Co., Ltd. (002022) - Financial and Strategic SWOT Analysis Review / / Summary / / Shanghai Kehua
2011 125,00$

Versus Technology, Inc. (VSTI) - Financial and Strategic SWOT Analysis Review

Versus Technology, Inc. (VSTI) - Financial and Strategic SWOT Analysis Review / / Summary / / Versus Technology, Inc. (Versus Te
2011 250,00$

Comvita Limited (CVT) - Financial and Strategic SWOT Analysis Review

Comvita Limited (CVT) - Financial and Strategic SWOT Analysis Review / / Summary / / Comvita Limited (Comvita) is a healthcare c
2011 125,00$

Angelica Corporation - Strategic SWOT Analysis Review

Angelica Corporation - Strategic SWOT Analysis Review / / Summary / / Angelica Corporation (Angelica) is a provider of outsource
2011 125,00$

FUJIFILM Medical Systems USA, Inc. - Strategic SWOT Analysis Review

FUJIFILM Medical Systems USA, Inc. - Strategic SWOT Analysis Review / / Summary / / FUJIFILM Medical Systems USA, Inc. (Fujifilm
2011 125,00$

3DM Inc. - Strategic SWOT Analysis Review

3DM Inc. - Strategic SWOT Analysis Review / / Summary / / 3DM Inc. (3DM) is a privately held specialty biomaterials and medical
2011 125,00$

US Endoscopy - Strategic SWOT Analysis Review

US Endoscopy - Strategic SWOT Analysis Review / / Summary / / US Endoscopy is a medical devices company engaged in the design an
2011 125,00$

Ivoclar Vivadent AG - Strategic SWOT Analysis Review

Ivoclar Vivadent AG - Strategic SWOT Analysis Review / / Summary / / Ivoclar Vivadent AG (Ivoclar) is a medical device company e
2011 125,00$

Biotronik SE & Co. KG - Strategic SWOT Analysis Review

Biotronik SE & Co. KG - Strategic SWOT Analysis Review / / Summary / / Biotronik SE & Co. KG (Biotronik) is a leading biomedical
2011 125,00$

Schiller AG - Strategic SWOT Analysis Review

Schiller AG - Strategic SWOT Analysis Review / / Summary / / Schiller AG (Schiller) is a Switzerland-based global medical device
2011 125,00$

MAQUET GmbH & Co. KG - Strategic SWOT Analysis Review

MAQUET GmbH & Co. KG - Strategic SWOT Analysis Review / / Summary / / MAQUET GmbH & Co. KG (MAQUET) is engaged in the design, ma
2011 125,00$

TRACOE medical GmbH - Strategic SWOT Analysis Review

TRACOE medical GmbH - Strategic SWOT Analysis Review / / Summary / / TRACOE medical GmbH (TRACOE medical) is a medical device co
2011 125,00$

Molnlycke Health Care AB - Strategic SWOT Analysis Review

Molnlycke Health Care AB - Strategic SWOT Analysis Review / / Summary / / Molnlycke Health Care AB (Molnlycke) is engaged in the
2011 125,00$

MedSolutions - Strategic SWOT Analysis Review

MedSolutions - Strategic SWOT Analysis Review / / Summary / / MedSolutions (MedSolutions) is principally engaged in providing me
2011 125,00$

AlloSource - Strategic SWOT Analysis Review

AlloSource - Strategic SWOT Analysis Review / / Summary / / AlloSource is a non-profit medical device company engaged in the dev
2011 125,00$

Creganna-Tactx Medical - Strategic SWOT Analysis Review

Creganna-Tactx Medical - Strategic SWOT Analysis Review / / Summary / / Creganna-Tactx Medical (Creganna-Tactx) is a contract ma
2011 125,00$

Teleflex Medical - Strategic SWOT Analysis Review

Teleflex Medical - Strategic SWOT Analysis Review / / Summary / / Teleflex Medical, a business segment of Teleflex Incorporated,
2011 125,00$

BARRX Medical, Inc. - Strategic SWOT Analysis Review

BARRX Medical, Inc. - Strategic SWOT Analysis Review / / Summary / / BARRX Medical, Inc. (BARRX) is a medical device company eng
2011 125,00$

Cook Medical Incorporated - Strategic SWOT Analysis Review

Cook Medical Incorporated - Strategic SWOT Analysis Review / / Summary / / Cook Medical Incorporated (Cook Medical) is engaged i
2011 125,00$

Vygon SA - Strategic SWOT Analysis Review

Vygon SA - Strategic SWOT Analysis Review / / Summary / / Vygon SA (Vygon) is a medical device company engaged in the design, ma
2011 125,00$

Cardiva Medical, Inc. - Strategic SWOT Analysis Review

Cardiva Medical, Inc. - Strategic SWOT Analysis Review / / Summary / / Cardiva Medical, Inc. (Cardiva) is a medical device compa
2011 125,00$

SHPS, Inc. - Strategic SWOT Analysis Review

SHPS, Inc. - Strategic SWOT Analysis Review / / Summary / / SHPS, Inc. (SHPS) provides a broad range of health management progra
2011 125,00$

Medtronic CoreValve, LLC - Strategic SWOT Analysis Review

Medtronic CoreValve, LLC - Strategic SWOT Analysis Review / / Summary / / Medtronic CoreValve, LLC (CoreValve) is a medical tech
2011 125,00$

Lumenis Ltd. - Strategic SWOT Analysis Review

Lumenis Ltd. - Strategic SWOT Analysis Review / / Summary / / Lumenis Ltd. (Lumenis) is one of the leading medical and aesthetic
2011 125,00$

Abbott Diagnostics - Strategic SWOT Analysis Review

Abbott Diagnostics - Strategic SWOT Analysis Review / / Summary / / Abbott Diagnostics is one of the world’s leading in vitro di
2011 125,00$

OrthoHelix Surgical Designs, Inc. - Strategic SWOT Analysis Review

OrthoHelix Surgical Designs, Inc. - Strategic SWOT Analysis Review / / Summary / / OrthoHelix Surgical Designs, Inc. (OrthoHelix
2011 125,00$

Kreatech Holding B.V. - Strategic SWOT Analysis Review

Kreatech Holding B.V. - Strategic SWOT Analysis Review / / Summary / / Kreatech Holding B.V. (Kreatech Diagnostics) is a private
2011 125,00$

Samsung Medison Co.,Ltd. - Strategic SWOT Analysis Review

Samsung Medison Co.,Ltd. - Strategic SWOT Analysis Review / / Summary / / Samsung Medison Co., Ltd. (Samsung Medison) is a medic
2011 125,00$

HeartSine Technologies, Inc. - Strategic SWOT Analysis Review

HeartSine Technologies, Inc. - Strategic SWOT Analysis Review / / Summary / / HeartSine Technologies, Inc. (HeartSine) is a medi
2011 250,00$

Japan Medical Materials Corporation - Strategic SWOT Analysis Review

Japan Medical Materials Corporation - Strategic SWOT Analysis Review / / Summary / / Japan Medical Materials Corporation (JMM) i
2011 125,00$

Ferno-Washington, Inc. - Strategic SWOT Analysis Review

Ferno-Washington, Inc. - Strategic SWOT Analysis Review / / Summary / / Ferno-Washington, Inc. (Ferno) is engaged in the manufac
2011 125,00$

Oxford Nanopore Technologies Ltd. - Strategic SWOT Analysis Review

Oxford Nanopore Technologies Ltd. - Strategic SWOT Analysis Review / / Summary / / Oxford Nanopore Technologies Ltd. (Oxford Nan
2011 125,00$

iMDsoft Inc. - Strategic SWOT Analysis Review

iMDsoft Inc. - Strategic SWOT Analysis Review / / Summary / / iMDsoft Inc. (iMDsoft) is a privately-held medical software compan
2011 125,00$

Medicalis Corporation - Strategic SWOT Analysis Review

Medicalis Corporation - Strategic SWOT Analysis Review / / Summary / / Medicalis Corporation (Medicalis) is a health care IT com
2011 250,00$

ONTEX International N.V. - Strategic SWOT Analysis Review

ONTEX International N.V. - Strategic SWOT Analysis Review / / Summary / / ONTEX International N.V. (ONTEX) is a healthcare compa
2011 250,00$

Nypro, Inc. - Strategic SWOT Analysis Review

Nypro, Inc. - Strategic SWOT Analysis Review / / Summary / / Nypro, Incorporated (Nypro) is a leading plastics technology compan
2011 125,00$

Bracco S.p.A. - Strategic SWOT Analysis Review

Bracco S.p.A. - Strategic SWOT Analysis Review / / Summary / / Bracco S.p.A. (Bracco) is a holding company of Bracco Group, with
2011 125,00$

Advanced BioHealing, Inc. - Strategic SWOT Analysis Review

Advanced BioHealing, Inc. - Strategic SWOT Analysis Review / / Summary / / Advanced BioHealing, Inc. (ABH) is a privately held,
2011 125,00$

Medical Information Technology, Inc. - Strategic SWOT Analysis Review

Medical Information Technology, Inc. - Strategic SWOT Analysis Review / / Summary / / Medical Information Technology, Inc. (Medi
2011 125,00$

DMG America LLC - Strategic SWOT Analysis Review

DMG America LLC - Strategic SWOT Analysis Review / / Summary / / DMG America LLC (DMG America), formerly known as Zenith Dental,
2011 125,00$

Symphogen AS - Strategic SWOT Analysis Review

Symphogen AS - Strategic SWOT Analysis Review / / Summary / / Symphogen A/S (Symphogen) is a privately-held biopharmaceutical co
2011 125,00$

PEAK Surgical, Inc. - Strategic SWOT Analysis Review

PEAK Surgical, Inc. - Strategic SWOT Analysis Review / / Summary / / PEAK Surgical, Inc. (PEAK Surgical) is a medical device com
2011 125,00$

EOS imaging SA - Strategic SWOT Analysis Review

EOS imaging SA - Strategic SWOT Analysis Review / / Summary / / EOS imaging SA (EOS Imaging), formerly Biospace Med, is an ortho
2011 125,00$

KARL STORZ Endoscopy-America, Inc. - Strategic SWOT Analysis Review

KARL STORZ Endoscopy-America, Inc. - Strategic SWOT Analysis Review / / Summary / / KARL STORZ Endoscopy-America, Inc. (KSEA) is
2011 125,00$

Medtronic ENT - Strategic SWOT Analysis Review

Medtronic ENT - Strategic SWOT Analysis Review / / Summary / / Medtronic ENT, a division of Medtronic, Inc., is engaged in the d
2011 125,00$

Systagenix Wound Management - Strategic SWOT Analysis Review

Systagenix Wound Management - Strategic SWOT Analysis Review / / Summary / / Systagenix Wound Management (Systagenix) is a medic
2011 125,00$

Cardiocom, LLC - Strategic SWOT Analysis Review

Cardiocom, LLC - Strategic SWOT Analysis Review / / Summary / / Cardiocom, LLC (Cardiocom) is a leader in providing daily remote
2011 125,00$

In Veritas Medical Diagnostics Inc. (IVME) - Strategic SWOT Analysis Review

In Veritas Medical Diagnostics Inc. (IVME) - Strategic SWOT Analysis Review / / Summary / / In Veritas Medical Diagnostics Inc.
2011 125,00$

DSM Dyneema B.V. - Strategic SWOT Analysis Review

DSM Dyneema B.V. - Strategic SWOT Analysis Review / / Summary / / DSM Dyneema B.V. (DSM Dyneema) is engaged in the manufacture a
2011 125,00$

Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review

Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review / / Summary / / Illumina, Inc. (Illumina) is a molecular di
2011 125,00$

AlphaRx, Inc. (ALRX) - Financial and Strategic SWOT Analysis Review

AlphaRx, Inc. (ALRX) - Financial and Strategic SWOT Analysis Review / / Summary / / AlphaRX, Inc. (AlphaRX), formerly known as L
2011 125,00$

Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis Review

Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis Review / / Summary / / Valeant Pharmac
2011 125,00$

Neoprobe Corporation (NEOP) - Financial and Strategic SWOT Analysis Review

Neoprobe Corporation (NEOP) - Financial and Strategic SWOT Analysis Review / / Summary / / Neoprobe Corporation (Neoprobe) is a
2011 125,00$

Sanofi (SAN) - Financial and Strategic SWOT Analysis Review

Sanofi (SAN) - Financial and Strategic SWOT Analysis Review / / Summary / / Sanofi is a global pharmaceutical company engaged in
2011 125,00$

Agilent Technologies, Inc. (A) - Financial and Strategic SWOT Analysis Review

Agilent Technologies, Inc. (A) - Financial and Strategic SWOT Analysis Review / / Summary / / Agilent Technologies, Inc. (Agilen
2011 125,00$

Bioniche Life Sciences, Inc. (BNC) - Financial and Strategic SWOT Analysis Review

Bioniche Life Sciences, Inc. (BNC) - Financial and Strategic SWOT Analysis Review / / Summary / / Bioniche Life Sciences Inc. (B
2011 125,00$

Alkermes, Inc. (ALKS) - Financial and Strategic SWOT Analysis Review

Alkermes, Inc. (ALKS) - Financial and Strategic SWOT Analysis Review / / Summary / / Alkermes, Inc., (Alkermes) is a publicly tr
2011 125,00$

Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review

Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review / / Summary / / Myriad Genetics, Inc. (Myriad) is a
2011 125,00$

CK Life Sciences International (Holdings) Inc. (0775) - Financial and Strategic SWOT Analysis Review

CK Life Sciences International (Holdings) Inc. (0775) - Financial and Strategic SWOT Analysis Review / / Summary / / CK Life Sci
2011 125,00$

Healthscope Limited (HSP) - Financial and Strategic SWOT Analysis Review

Healthscope Limited (HSP) - Financial and Strategic SWOT Analysis Review / / Summary / / Healthscope Limited (Healthscope) is an
2011 125,00$

IMS Health Incorporated (RX) - Financial and Strategic SWOT Analysis Review

IMS Health Incorporated (RX) - Financial and Strategic SWOT Analysis Review / / Summary / / IMS Health (IMS) is engaged in provi
2011 125,00$

InterMune, Inc. (ITMN) - Financial and Strategic SWOT Analysis Review

InterMune, Inc. (ITMN) - Financial and Strategic SWOT Analysis Review / / Summary / / InterMune, Inc. (InterMune) is a biopharma
2011 125,00$

Kindred Healthcare, Inc. (KND) - Financial and Strategic SWOT Analysis Review

Kindred Healthcare, Inc. (KND) - Financial and Strategic SWOT Analysis Review / / Summary / / Kindred Healthcare Inc. (Kindred H
2011 125,00$

King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review

King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review / / Summary / / King Pharmaceuticals, Inc. (King)
2011 125,00$

KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review

KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review / / Summary / / KV Pharmaceutical Company (KV Ph
2011 125,00$

Magellan Health Services, Inc. (MGLN) - Financial and Strategic SWOT Analysis Review

Magellan Health Services, Inc. (MGLN) - Financial and Strategic SWOT Analysis Review / / Summary / / Magellan Health Services, I
2011 125,00$

Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review

Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review / / Summary / / Novavax, Inc. (Novavax) is a clinical-stage
2011 125,00$

Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review

Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review / / Summary / / Acura Pharmaceuticals, Inc. (A
2011 125,00$

Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review

Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review / / Summary / / Hikma Pharmaceuticals PLC (Hikma
2011 125,00$

Enzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis Review

Enzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis Review / / Summary / / Enzo Biochem, Inc. (Enzo Biochem) is a l
2011 125,00$

Imugene Limited (IMU) - Financial and Strategic SWOT Analysis Review

Imugene Limited (IMU) - Financial and Strategic SWOT Analysis Review / / Summary / / Imugene Limited (Imugene) is a biotechnolog
2011 125,00$

AEterna Zentaris Inc. (AEZ) - Financial and Strategic SWOT Analysis Review

AEterna Zentaris Inc. (AEZ) - Financial and Strategic SWOT Analysis Review / / Summary / / AEterna Zentaris Inc. (AEterna Zentar
2011 125,00$

Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review

Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review / / Summary / / Immtech Pharmaceuticals, Inc
2011 125,00$

Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review

Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review / / Summary / / Amicus Therapeutics, Inc. (Amicu
2011 125,00$

IMMUNOMEDICS, INC (IMMU) - Financial and Strategic SWOT Analysis Review

IMMUNOMEDICS, INC (IMMU) - Financial and Strategic SWOT Analysis Review / / Summary / / Immunomedics, Inc. (Immunomedics) is a N
2011 125,00$

Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review

Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review / / Summary / / Ardea Biosciences, Inc. (Ardea Bio
2011 125,00$

Insmed Incorporated (INSM) - Financial and Strategic SWOT Analysis Review

Insmed Incorporated (INSM) - Financial and Strategic SWOT Analysis Review / / Summary / / Insmed Incorporated (Insmed) is a biop
2011 125,00$

Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review

Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review / / Summary / / Takeda Pharmaceutica
2011 125,00$

Tsumura & co. (4540) - Financial and Strategic SWOT Analysis Review

Tsumura & co. (4540) - Financial and Strategic SWOT Analysis Review / / Summary / / Tsumura & Co (Tsumura) is a Japan based phar
2011 125,00$

EBOS Group Limited (EBO) - Financial and Strategic SWOT Analysis Review

EBOS Group Limited (EBO) - Financial and Strategic SWOT Analysis Review / / Summary / / EBOS Group Limited (EBOS) is New Zealand
2011 125,00$

Delcath Systems, Inc. (DCTH) - Financial and Strategic SWOT Analysis Review

Delcath Systems, Inc. (DCTH) - Financial and Strategic SWOT Analysis Review / / Summary / / Delcath Systems, Inc. (Delcath Syste
2011 125,00$

Celltrion, Inc. (068270) - Financial and Strategic SWOT Analysis Review

Celltrion, Inc. (068270) - Financial and Strategic SWOT Analysis Review / / Summary / / Celltrion Inc., (Celltrion) is a Korea-b
2011 250,00$

Lutronic Corporation (085370) - Financial and Strategic SWOT Analysis Review

Lutronic Corporation (085370) - Financial and Strategic SWOT Analysis Review / / Summary / / Lutronic Corporation (Lutronic) is
2011 250,00$

Air Methods Corporation (AIRM) - Financial and Strategic SWOT Analysis Review

Air Methods Corporation (AIRM) - Financial and Strategic SWOT Analysis Review / / Summary / / Air Methods Corporation (Air Metho
2011 125,00$

AMN Healthcare Services, Inc. (AHS) - Financial and Strategic SWOT Analysis Review

AMN Healthcare Services, Inc. (AHS) - Financial and Strategic SWOT Analysis Review / / Summary / / AMN Healthcare Services, Inc.
2011 125,00$

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review / / Summary / / Biocon Limited (Biocon) is a fully integr
2011 125,00$

Brookdale Senior Living Inc. (BKD) - Financial and Strategic SWOT Analysis Review

Brookdale Senior Living Inc. (BKD) - Financial and Strategic SWOT Analysis Review / / Summary / / Brookdale Senior Living Inc (B
2011 125,00$

Centene Corporation (CNC) - Financial and Strategic SWOT Analysis Review

Centene Corporation (CNC) - Financial and Strategic SWOT Analysis Review / / Summary / / Centene Corporation (Centene) is one of
2011 125,00$

Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review

Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review / / Summary / / Charles Rive
2011 125,00$

Cross Country Healthcare, Inc. (CCRN) - Financial and Strategic SWOT Analysis Review

Cross Country Healthcare, Inc. (CCRN) - Financial and Strategic SWOT Analysis Review / / Summary / / Cross Country Healthcare, I
2011 125,00$

FALCO SD Holdings Co., Ltd. (4671) - Financial and Strategic SWOT Analysis Review

FALCO SD Holdings Co., Ltd. (4671) - Financial and Strategic SWOT Analysis Review / / Summary / / FALCO SD Holdings Co., Ltd. (F
2011 125,00$

Guerbet Group (GBT) - Financial and Strategic SWOT Analysis Review

Guerbet Group (GBT) - Financial and Strategic SWOT Analysis Review / / Summary / / Guerbet Group (Guerbet) is a pharmaceutical c
2011 125,00$

The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review

The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review / / Summary / / The Medicines company a global pharm
2011 125,00$

Molina Healthcare, Inc. (MOH) - Financial and Strategic SWOT Analysis Review

Molina Healthcare, Inc. (MOH) - Financial and Strategic SWOT Analysis Review / / Summary / / Molina Healthcare, Inc (Molina) is
2011 125,00$

Parkway Holdings Limited (P27) - Financial and Strategic SWOT Analysis Review

Parkway Holdings Limited (P27) - Financial and Strategic SWOT Analysis Review / / Summary / / Parkway Holdings Limited (Parkway)
2011 125,00$

Phibro Animal Health Corporation (PAHC) - Financial and Strategic SWOT Analysis Review

Phibro Animal Health Corporation (PAHC) - Financial and Strategic SWOT Analysis Review / / Summary / / Phibro Animal Health Corp
2011 125,00$

Prestige Brands Holdings, Inc. (PBH) - Financial and Strategic SWOT Analysis Review

Prestige Brands Holdings, Inc. (PBH) - Financial and Strategic SWOT Analysis Review / / Summary / / Prestige Brands Holdings, In
2011 125,00$

Ranbaxy Laboratories Limited (500359) - Financial and Strategic SWOT Analysis Review

Ranbaxy Laboratories Limited (500359) - Financial and Strategic SWOT Analysis Review / / Summary / / Ranbaxy Laboratories Limite
2011 125,00$

RuralMetro Corporation (RURL) - Financial and Strategic SWOT Analysis Review

RuralMetro Corporation (RURL) - Financial and Strategic SWOT Analysis Review / / Summary / / Rural/Metro Corporation (Rural/Metr
2011 250,00$

Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and Strategic SWOT Analysis Review

Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and Strategic SWOT Analysis Review / / Summary / / Shasun Pharmaceutical
2011 125,00$

Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review

Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review / / Summary / / Siegfried Holding AG (Siegfried) is a
2011 250,00$

WebMD Health Corp. (WBMD) - Financial and Strategic SWOT Analysis Review

WebMD Health Corp. (WBMD) - Financial and Strategic SWOT Analysis Review / / Summary / / WebMD Health Corp. (WebMD) is a US base
2011 125,00$

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review / / Summary / / PT Kalbe Farma Tbk (Kalbe) is pharmaceu
2011 250,00$

Shilpa Medicare Limited (SHILPAMED) - Financial and Strategic SWOT Analysis Review

Shilpa Medicare Limited (SHILPAMED) - Financial and Strategic SWOT Analysis Review / / Summary / / Shilpa Medicare Limited (Shil
2011 250,00$

Blackmores Limited (BKL) - Financial and Strategic SWOT Analysis Review

Blackmores Limited (BKL) - Financial and Strategic SWOT Analysis Review / / Summary / / Blackmores Limited (Blackmores) is an Au
2011 125,00$

PAREXEL International Corporation (PRXL) - Financial and Strategic SWOT Analysis Review

PAREXEL International Corporation (PRXL) - Financial and Strategic SWOT Analysis Review / / Summary / / PAREXEL International Co
2011 125,00$

Suheung Capsule Co., Ltd. (008490) - Financial and Strategic SWOT Analysis Review

Suheung Capsule Co., Ltd. (008490) - Financial and Strategic SWOT Analysis Review / / Summary / / Suheung Capsule Co., Ltd. (Suh
2011 125,00$

Shanghai Pharmaceutical Co., Ltd. (601607) - Financial and Strategic SWOT Analysis Review

Shanghai Pharmaceutical Co., Ltd. (601607) - Financial and Strategic SWOT Analysis Review / / Summary / / Shanghai Pharmaceutica
2011 250,00$

Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review

Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review / / Summary / / Kolon Life Science Inc. (KLS) i
2011 125,00$

Zhejiang Medicine Co., Ltd. (600216) - Financial and Strategic SWOT Analysis Review

Zhejiang Medicine Co., Ltd. (600216) - Financial and Strategic SWOT Analysis Review / / Summary / / Zhejiang Medicine Co., Ltd.
2011 125,00$

Health Fitness Corporation - Financial and Strategic SWOT Analysis Review

Health Fitness Corporation - Financial and Strategic SWOT Analysis Review / / Summary / / Health Fitness Corporation (HealthFitn
2011 125,00$

Asterand plc (ATD) - Financial and Strategic SWOT Analysis Review

Asterand plc (ATD) - Financial and Strategic SWOT Analysis Review / / Summary / / Asterand plc (Asterand) is a biotechnology com
2011 125,00$

Starpharma Holdings Limited (SPL) - Financial and Strategic SWOT Analysis Review

Starpharma Holdings Limited (SPL) - Financial and Strategic SWOT Analysis Review / / Summary / / Starpharma Holdings Limited (St
2011 125,00$

Raffles Medical Group (R01) - Financial and Strategic SWOT Analysis Review

Raffles Medical Group (R01) - Financial and Strategic SWOT Analysis Review / / Summary / / Raffles Medical Group Ltd. (RMG) is a
2011 250,00$

Probiomics Ltd. (PCC) - Financial and Strategic SWOT Analysis Review

Probiomics Ltd. (PCC) - Financial and Strategic SWOT Analysis Review / / Summary / / Probiomics Ltd. (Probiomics), formerly know
2011 250,00$

Amrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis Review

Amrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis Review / / Summary / / Amrutanjan Health Care L
2011 125,00$

Dar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic SWOT Analysis Review

Dar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic SWOT Analysis Review / / Summary / / Dar Al Dawa
2011 125,00$

JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic SWOT Analysis Review

JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic SWOT Analysis Review / / Summary / / JCR Pharmaceuticals Co., Ltd
2011 250,00$

Acibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic SWOT Analysis Review

Acibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic SWOT Analysis Review / / Summary / / Acibadem Saglik
2011 125,00$

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis Review

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis Review / / Summary /
2011 125,00$

Jack Chia Industries (Thailand) Public Company Limited (JCT) - Financial and Strategic SWOT Analysis Review

Jack Chia Industries (Thailand) Public Company Limited (JCT) - Financial and Strategic SWOT Analysis Review / / Summary / / Jack
2011 125,00$

Adcock Ingram Holdings Limited (AIPJ) - Financial and Strategic SWOT Analysis Review

Adcock Ingram Holdings Limited (AIPJ) - Financial and Strategic SWOT Analysis Review / / Summary / / Adcock Ingram Holdings Limi
2011 125,00$

Bangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic SWOT Analysis Review

Bangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic SWOT Analysis Review / / Summary / / Bangkok Chain Hospita
2011 250,00$

Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review

Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review / / Summary / / Kotra Industries Berhad (Kotra) i
2011 250,00$

Renovo Group Plc (RNVO) - Financial and Strategic SWOT Analysis Review

Renovo Group Plc (RNVO) - Financial and Strategic SWOT Analysis Review / / Summary / / Renovo Group Plc (Renovo) is a biopharmac
2011 125,00$

Pierrel S.p.A. (PRL) - Financial and Strategic SWOT Analysis Review

Pierrel S.p.A. (PRL) - Financial and Strategic SWOT Analysis Review / / Summary / / Pierrel S.P.A. (Pierrel) is a publicly held
2011 125,00$

Clavis Pharma ASA (CLAVIS) - Financial and Strategic SWOT Analysis Review

Clavis Pharma ASA (CLAVIS) - Financial and Strategic SWOT Analysis Review / / Summary / / Clavis Pharma ASA (Clavis Pharma) is o
2011 250,00$

OraSolv AB (OS) - Financial and Strategic SWOT Analysis Review

OraSolv AB (OS) - Financial and Strategic SWOT Analysis Review / / Summary / / OraSolv AB (OraSolv) engages in the acquisition,
2011 250,00$

ThromboGenics NV (THR) - Financial and Strategic SWOT Analysis Review

ThromboGenics NV (THR) - Financial and Strategic SWOT Analysis Review / / Summary / / ThromboGenics NV (ThromboGenics) is a biop
2011 125,00$

Fortis Healthcare (India) Ltd. (FORTIS) - Financial and Strategic SWOT Analysis Review

Fortis Healthcare (India) Ltd. (FORTIS) - Financial and Strategic SWOT Analysis Review / / Summary / / Fortis Healthcare (India)
2011 125,00$

China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review

China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review / / Summary / / China Pharma Holdings, Inc. (C
2011 250,00$

Huons Co., Ltd. (084110) - Financial and Strategic SWOT Analysis Review

Huons Co., Ltd. (084110) - Financial and Strategic SWOT Analysis Review / / Summary / / Huons Co., Ltd. (Huons) is a specialty p
2011 250,00$

Orexigen Therapeutics, Inc. (OREX) - Financial and Strategic SWOT Analysis Review

Orexigen Therapeutics, Inc. (OREX) - Financial and Strategic SWOT Analysis Review / / Summary / / Orexigen Therapeutics, Inc. (O
2011 125,00$

Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review

Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review / / Summary / / Hybrigenics S.A. (Hybrigenics) is a Fran
2011 125,00$

Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review

Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review / / Summary / / Genomma Lab Internacio
2011 125,00$

Healthway Medical Corporation Limited (5NG) - Financial and Strategic SWOT Analysis Review

Healthway Medical Corporation Limited (5NG) - Financial and Strategic SWOT Analysis Review / / Summary / / Healthway Medical Cor
2011 250,00$

Medicamen Biotech Limited (531146) - Financial and Strategic SWOT Analysis Review

Medicamen Biotech Limited (531146) - Financial and Strategic SWOT Analysis Review / / Summary / / Medicamen Biotech Limited (Med
2011 125,00$

Hester Biosciences Limited (524669) - Financial and Strategic SWOT Analysis Review

Hester Biosciences Limited (524669) - Financial and Strategic SWOT Analysis Review / / Summary / / Hester Biosciences Limited fo
2011 125,00$

Verona Pharma Plc (VRP) - Financial and Strategic SWOT Analysis Review

Verona Pharma Plc (VRP) - Financial and Strategic SWOT Analysis Review / / Summary / / Verona Pharma Plc (Verona Pharma), former
2011 125,00$

Hypermarcas SA (HYPE3) - Financial and Strategic SWOT Analysis Review

Hypermarcas SA (HYPE3) - Financial and Strategic SWOT Analysis Review / / Summary / / Hypermarcas SA (Hypermarcas) is engaged in
2011 125,00$

Solagran Ltd. (SLA) - Financial and Strategic SWOT Analysis Review

Solagran Ltd. (SLA) - Financial and Strategic SWOT Analysis Review / / Summary / / Solagran Ltd. (Solagran) is a biotechnology c
2011 250,00$

Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic SWOT Analysis Review

Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic SWOT Analysis Review / / Summary / / Ironwood Pharmaceuticals, I
2011 125,00$

Orchid Cellmark Inc. (ORCH) - Financial and Strategic SWOT Analysis Review

Orchid Cellmark Inc. (ORCH) - Financial and Strategic SWOT Analysis Review / / Summary / / Orchid Cellmark Inc. (Orchid Cellmark
2011 125,00$

Mondobiotech Holding AG (RARE) - Financial and Strategic SWOT Analysis Review

Mondobiotech Holding AG (RARE) - Financial and Strategic SWOT Analysis Review / / Summary / / Mondobiotech Holding AG (Mondobiot
2011 125,00$

Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic SWOT Analysis Review

Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic SWOT Analysis Review / / Summary / / Zhejiang Hisun Ph
2011 125,00$

BPH Energy Limited (BPH) - Financial and Strategic SWOT Analysis Review

BPH Energy Limited (BPH) - Financial and Strategic SWOT Analysis Review / / Summary / / BPH Energy Limited (BPH), formerly BPH C
2011 250,00$

SMS Pharmaceuticals Ltd. (SMSPHARMA) - Financial and Strategic SWOT Analysis Review

SMS Pharmaceuticals Ltd. (SMSPHARMA) - Financial and Strategic SWOT Analysis Review / / Summary / / SMS Pharmaceuticals Ltd. (SM
2011 250,00$

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis Review

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis Review / / Summary / / Sinopharm Group Co. Ltd. (Sinopha
2011 125,00$

Amil Participacoes S.A. (AMIL3) - Financial and Strategic SWOT Analysis Review

Amil Participacoes S.A. (AMIL3) - Financial and Strategic SWOT Analysis Review / / Summary / / Amil Participacoes S.A. (Amil Par
2011 125,00$

RegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic SWOT Analysis Review

RegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic SWOT Analysis Review / / Summary / / RegenoCELL Therapeutics, Inc
2011 125,00$

Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review

Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review / / Summary / / Mycenax Biotech Inc. (Mycenax) is a b
2011 125,00$

Fibrocell Sciences, Inc. (ILEIQ) - Financial and Strategic SWOT Analysis Review

Fibrocell Sciences, Inc. (ILEIQ) - Financial and Strategic SWOT Analysis Review / / Summary / / Fibrocell Sciences, Inc. (Fibroc
2011 125,00$

EUGENE SCIENCE, INC. (EUSI) - Strategic SWOT Analysis Review

EUGENE SCIENCE, INC. (EUSI) - Strategic SWOT Analysis Review / / Summary / / Eugene Science, Inc. (Eugene) is a biotechnology co
2011 125,00$

Hexima Limited - Strategic SWOT Analysis Review

Hexima Limited - Strategic SWOT Analysis Review / / Summary / / Hexima Limited (Hexima) is an Australia-based ag-biotech company
2011 125,00$

Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review

Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review / / Summary / / Blue Cross and Blue Shield Association (
2011 125,00$

Stiefel Laboratories, Inc. - Strategic SWOT Analysis Review

Stiefel Laboratories, Inc. - Strategic SWOT Analysis Review / / Summary / / Stiefel Laboratories, Inc. (Stiefel Laboratories) is
2011 125,00$

Henry Ford Health System - Strategic SWOT Analysis Review

Henry Ford Health System - Strategic SWOT Analysis Review / / Summary / / Henry Ford Health System (HFHS) is one of the leading
2011 125,00$

Epic Systems Corporation - Strategic SWOT Analysis Review

Epic Systems Corporation - Strategic SWOT Analysis Review / / Summary / / Epic Systems Corporation (Epic) is a privately held he
2011 125,00$

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review / / Summary / / Chiesi Farmaceutici SpA (Chiesi) is a European pharmace
2011 250,00$

ESTEVE - Strategic SWOT Analysis Review

ESTEVE - Strategic SWOT Analysis Review / / Summary / / ESTEVE engages in the manufacture of pharmaceutical products. The compan
2011 125,00$

Galderma S.A. - Strategic SWOT Analysis Review

Galderma S.A. - Strategic SWOT Analysis Review / / Summary / / Galderma S.A. (Galderma) is one of the leading dermatology compan
2011 125,00$

General Nutrition Centers, Inc. - Strategic SWOT Analysis Review

General Nutrition Centers, Inc. - Strategic SWOT Analysis Review / / Summary / / General Nutrition Centers, Inc. (GNC) is a spec
2011 125,00$

Health Care Service Corporation - Strategic SWOT Analysis Review

Health Care Service Corporation - Strategic SWOT Analysis Review / / Summary / / Health Care Service Corporation (HCSC) is a cus
2011 125,00$

Laboratoires Urgo - Strategic SWOT Analysis Review

Laboratoires Urgo - Strategic SWOT Analysis Review / / Summary / / Laboratoires Urgo (Urgo Laboratoires) specializes in wound dr
2011 125,00$

Nuffield Health - Strategic SWOT Analysis Review

Nuffield Health - Strategic SWOT Analysis Review / / Summary / / Nuffield Health (Nuffield) is a non-profit organization engaged
2011 125,00$

Ingenix - Strategic SWOT Analysis Review

Ingenix - Strategic SWOT Analysis Review / / Summary / / Ingenix, Inc.(Ingenix), also known by OptumInsight is a health care da
2011 125,00$

SCIOinspire Corp. - Strategic SWOT Analysis Review

SCIOinspire Corp. - Strategic SWOT Analysis Review / / Summary / / SCIOinspire Corp. (SCIOinspire) is a healthcare technology se
2011 125,00$

Ecron Acunova - Strategic SWOT Analysis Review

Ecron Acunova - Strategic SWOT Analysis Review / / Summary / / Ecron Acunova (EA) is a full-service expert contract service orga
2011 125,00$

AccentCare, Inc. - Strategic SWOT Analysis Review

AccentCare, Inc. - Strategic SWOT Analysis Review / / Summary / / AccentCare, Inc. (AccentCare) is a healthcare service company
2011 125,00$

Stemgent, Inc. - Strategic SWOT Analysis Review

Stemgent, Inc. - Strategic SWOT Analysis Review / / Summary / / Stemgent, Inc. (Stemgent) is a stem cell research company which
2011 125,00$

Aurora Health Care, Inc. - Strategic SWOT Analysis Review

Aurora Health Care, Inc. - Strategic SWOT Analysis Review / / Summary / / Aurora Health Care, Inc. (AHC) is a not-for-profit hea
2011 250,00$

AIM Health Group Inc. (AHG) - Strategic SWOT Analysis Review

AIM Health Group Inc. (AHG) - Strategic SWOT Analysis Review / / Summary / / AIM Health Group Inc. (AIM), formerly Orior Technol
2011 125,00$

NaviNet, Inc. - Strategic SWOT Analysis Review

NaviNet, Inc. - Strategic SWOT Analysis Review / / Summary / / NaviNet, Inc. (NaviNet) is a real-time healthcare communications
2011 125,00$

OptumHealth, Inc. - Strategic SWOT Analysis Review

OptumHealth, Inc. - Strategic SWOT Analysis Review / / Summary / / OptumHealth, Inc. (OptumHealth) is a health, wealth and finan
2011 125,00$

American Academy of Ophthalmology (AAO) 2011 Annual Meeting - Review and Analysis

Introduction / / GlobalData’s report, “American Academy of Ophthalmology (AAO) 2011 Annual Meeting - Review and Analysis” provide
2011 1.000,00$

Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis

Introduction / / GlobalData’s report, “Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis” pro
2011 1.000,00$

Zimmer Acquires ExtraOrtho - To Increase Focus on the Non-Elective Trauma Business - Deal Analysis from GlobalData

Introduction / / GlobalData’s report, “Zimmer Acquires ExtraOrtho - To Increase Focus on the Non-Elective Trauma Business” provid
2011 500,00$

Samsung Electronics Acquires Nexus Division of ITC - A Move to Strengthen its Presence in the Medical Device Industry - Deal Analysis from GlobalData

Introduction / / GlobalData’s report “Samsung Electronics Acquires Nexus Division of ITC - A Move to Strengthen its Presence in t
2011 500,00$

Mammography Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Mammography Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Afr
2011 2.500,00$

Nuclear Imaging Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Nuclear Imaging Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

X-Ray Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “X-Ray Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to
2011 2.500,00$

Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Mar
2011 3.500,00$

Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems,
2011 3.500,00$

South and Central America Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “South and Central America Diagnostic Imaging Market Outlook to 2017 - Ultrasound Syste
2011 3.500,00$

North America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “North America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamet
2011 3.500,00$

Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 3.500,00$

Asia-Pacific Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Asia-Pacific Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamete
2011 3.500,00$

Craniomaxillofacial (CMF) Fixators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Craniomaxillofacial (CMF) Fixators - Global Pipeline Analysis, Competitive Landscape a
2011 3.500,00$

Middle East and Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Middle East and Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Mul
2011 3.500,00$

South and Central America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “South and Central America Patient Monitoring Market Outlook to 2017 - Fetal Monitors,
2011 3.500,00$

External Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “External Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market F
2011 3.500,00$

Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Mark
2011 3.500,00$

Computed Tomography (CT) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Computed Tomography (CT) Systems - Global Pipeline Analysis, Competitive Landscape and
2011 3.500,00$

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t
2011 3.500,00$

Canada Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Canada Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 2.500,00$

Netherlands Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Netherlands Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter
2011 2.500,00$

Mexico Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Mexico Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 2.500,00$

Israel Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Israel Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 2.500,00$

United Kingdom Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “United Kingdom Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparame
2011 2.500,00$

United States Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “United States Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory
2011 2.500,00$

United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory
2011 2.500,00$

Japan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Japan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices,
2011 2.500,00$

China Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “China Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices,
2011 2.500,00$

Canada Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Canada Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices
2011 2.500,00$

Germany Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Germany Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices
2011 2.500,00$

Spain Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices,
2011 2.500,00$

Australia Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Australia Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devi
2011 2.500,00$

Netherlands Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Netherlands Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Dev
2011 2.500,00$

Belgium Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Belgium Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Device
2011 2.500,00$

Austria Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Austria Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat
2011 2.500,00$

Russian Federation Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Russian Federation Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multipa
2011 2.500,00$

New Zealand Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “New Zealand Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter
2011 2.500,00$

Denmark Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Denmark Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat
2011 2.500,00$

Saudi Arabia Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Saudi Arabia Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamete
2011 2.500,00$

Portable/Disposable Negative Pressure Wound Therapy (NPWT) Systems - A Market Snapshot

Introduction / / GlobalData’s report, “Portable/Disposable Negative Pressure Wound Therapy (NPWT) Systems - A Market Snapshot” pr
2011 500,00$

Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2017 - Respira
2011 2.500,00$

Denmark Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

Introduction / / GlobalData’s new report, “Denmark Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Device
2011 2.500,00$

Tuberculosis Infection - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Tuberculosis Infection - Pipeline As
2011 3.500,00$

Muscular Dystrophy (MD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Muscular Dystrophy (MD) Therapeutics
2011 3.500,00$

Insomnia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Insomnia Therapeutics - Pipeline Ass
2011 3.500,00$

Brain Hemorrhage Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Brain Hemorrhage Therapeutics - Pipe
2011 3.500,00$

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Attention Deficit Hyperactivity Diso
2011 3.500,00$

Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011

Introduction / / GlobalData's “Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essentia
2011 500,00$

Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011

Introduction / / GlobalData's “Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential sourc
2011 500,00$

Gilead to Acquire Pharmasset for $11 Billion - Deal Analysis from GlobalData

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gilead to Acquire Pharmasset for $11
2011 500,00$

Abbott Laboratories Likely to Reap Benefits from Strategic Split - Deal Analysis from GlobalData

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Abbott Laboratories Likely to Reap B
2011 500,00$

Novartis’s Zelnorm Suspension - Impact On The Irritable Bowel Syndrome (IBS) Treatment Landscape

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Novartis’s Zelnorm Suspension - Impa
2011 500,00$

Irritable Bowel Syndrome Epidemiology by Sub-Type in G7 Countries

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Irritable Bowel Syndrome Epidemiolog
2011 500,00$

Personalized Medicine for Cancer

Introduction / / GlobalData, the industry analysis specialist, has released its new view point, “Personalized Medicine for Cancer
2011 500,00$

Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for Biosimilars

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Biologics Price Competition and Inno
2011 500,00$

FDA Reforms Fuel the Biotech Industry Growth

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “FDA Reforms Fuel the Biotech Industr
2011 500,00$

Sarcomas and their Subtypes

Introduction / / GlobalData, the industry analysis specialist, has released its new view point, “Sarcomas and their Subtypes”. Th
2011 500,00$

Provenge fails to Live up to Dendreon’s Expectations

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Provenge fails to Live up to Dendreo
2011 500,00$

MDV3100 Raises Hopes for Medivation

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “MDV3100 Raises Hopes for Medivation”
2011 500,00$

Jakafi (ruxolitinib) Gains US FDA Approval to Become the First Drug Ever to be Approved for Myelofibrosis

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Jakafi (ruxolitinib) Gains US FDA Ap
2011 500,00$

Future Technology Trends and Upcoming Players in Hemophilia Therapeutics Market

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Future Technology Trends and Upcomin
2011 500,00$

Celiac Disease - Pipeline Assessment and Market Forecasts to 2019

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Celiac Disease - Pipeline Assessment
2011 3.500,00$

Lennox-Gastaut Syndrome (LGS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Lennox-Gastaut Syndrome (LGS) Therap
2011 3.500,00$

Erectile Dysfunction Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Erectile Dysfunction Therapeutics -
2011 3.500,00$

Chemotherapy-Induced Neutropenia (CIN) Therapeutics -Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chemotherapy-Induced Neutropenia (CI
2011 3.500,00$

Peripheral Artery Disease (PAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peripheral Artery Disease (PAD) Ther
2011 3.500,00$

Gastrointestinal Bleeding Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Gastrointestinal Bleeding Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Aortic Valve Stenosis Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Asperger Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Asperger Syndrome Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Burkitt Lymphoma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Revie
2011 1.000,00$

Diastolic Heart Failure Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H2, 2011" provides d
2011 1.000,00$

Duodenal Ulcer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Duodenal Ulcer Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Enterovirus Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Enterovirus Infections Global Clinical Trials Review, H2, 2011" provides da
2011 1.000,00$

Epidermolysis Bullosa Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Filariasis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H2, 2011" provides data on the Fi
2011 1.000,00$

Fungemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2011" provides data on the Fung
2011 1.000,00$

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2011" prov
2011 1.000,00$

Hyponatremia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Nutritional Disorders Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2011" prov
2011 1.000,00$

Joint Pain Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Joint Pain Global Clinical Trials Review, H2, 2011" provides data on the Jo
2011 1.000,00$

Keratitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Keratitis Global Clinical Trials Review, H2, 2011" provides data on the Ker
2011 1.000,00$

Circadian Rhythm Sleep Disorders Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Circadian Rhythm Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Lymphedema Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Lymphedema Global Clinical Trials Review, H2, 2011" provides data on the Ly
2011 1.000,00$

Pompe Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Renal Pain Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Renal Pain Global Clinical Trials Review, H2, 2011" provides data on the Re
2011 1.000,00$

Respiratory Insufficiency Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Respiratory Insufficiency Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011
2011 1.000,00$

Uterine Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Vaginal Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Von Willebrand Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Von Willebrand Disease Global Clinical Trials Review, H2, 2011" provides da
2011 1.000,00$

West Nile Virus Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “West Nile Virus Infections Global Clinical Trials Review, H2, 2011" provide
2011 1.000,00$

Xerostomia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Xerostomia Global Clinical Trials Review, H2, 2011" provides data on the Xe
2011 1.000,00$

Anal Fissure Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Anal Fissure Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Blepharitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Blepharitis Global Clinical Trials Review, H2, 2011" provides data on the B
2011 1.000,00$

Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2011" pr
2011 1.000,00$

Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2
2011 1.000,00$

Gastric Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Hyperthyroidism Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperthyroidism Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Thalassemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, H2, 2011" provides data on the T
2011 1.000,00$

Chlamydia Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Hemiplegia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hemiplegia Global Clinical Trials Review, H2, 2011" provides data on the He
2011 1.000,00$

Pulmonary Edema Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Pulmonary Edema Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Streptococcal Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Hyperuricemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Tuberous Sclerosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Tuberous Sclerosis Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Biliary Cirrhosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Biliary Cirrhosis Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Mucositis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Mucositis Global Clinical Trials Review, H2, 2011" provides data on the Muc
2011 1.000,00$

Osteomyelitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Osteomyelitis Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Nasal Polyps Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Paralysis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, H2, 2011" provides data on the Par
2011 1.000,00$

Schistosomiasis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Schistosomiasis Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Seborrhea Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Seborrhea Global Clinical Trials Review, H2, 2011" provides data on the Seb
2011 1.000,00$

Syphilis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Syphilis Global Clinical Trials Review, H2, 2011" provides data on the Syph
2011 1.000,00$

Thymus Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Bacteriuria Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Bacteriuria Global Clinical Trials Review, H2, 2011" provides data on the B
2011 1.000,00$

Typhoid Fever Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Typhoid Fever Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Rabies Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Rabies Global Clinical Trials Review, H2, 2011" provides data on the Rabies
2011 1.000,00$

Cerebral Hypoxia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cerebral Hypoxia Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Angioedema Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H2, 2011" provides data on the An
2011 1.000,00$

Sleep Disorders Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Sleep Disorders Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Sleep Apnea Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Sleep Apnea Global Clinical Trials Review, H2, 2011" provides data on the S
2011 1.000,00$

Apnea Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Apnea Global Clinical Trials Review, H2, 2011" provides data on the Apnea c
2011 1.000,00$

Multiple Myeloma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Multiple Myeloma Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Liver Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Liver Cancer Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Venous Thromboembolism Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism Therapeutics
2011 3.500,00$

Myocardial Infarction Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myocardial Infarction Therapeutics -
2011 3.500,00$

Gaucher's Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gaucher's Disease Therapeutics - Pip
2011 3.500,00$

Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peptic Ulcer Therapeutics - Pipeline
2011 3.500,00$

Fabry's Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Fabry's Disease Therapeutics - Pipel
2011 3.500,00$

Unstable Angina Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Unstable Angina Therapeutics - Pipel
2011 3.500,00$

Germany Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Germany Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat
2011 2.500,00$

France Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “France Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 2.500,00$

Italy Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Italy Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie
2011 2.500,00$

Spain Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Spain Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie
2011 2.500,00$

Australia Patient Monitoring Market Outlook to 2017 – Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Australia Patient Monitoring Market Outlook to 2017 – Fetal Monitors, Multiparameter P
2011 2.500,00$

Brazil Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Brazil Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 2.500,00$

Belgium Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Belgium Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat
2011 2.500,00$

Argentina Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Argentina Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter P
2011 2.500,00$

Republic of Korea Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Republic of Korea Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multipar
2011 2.500,00$

Taiwan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Taiwan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 2.500,00$

South Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “South Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamete
2011 2.500,00$

Japan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Japan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie
2011 2.500,00$

India Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “India Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie
2011 2.500,00$

China Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “China Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie
2011 2.500,00$

Czech Republic Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Czech Republic Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparame
2011 2.500,00$

Sweden Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “Sweden Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati
2011 2.500,00$

SWOT Review of the Key Orthopedic Device Companies

Introduction / / GlobalData’s report, “SWOT Review of the Key Orthopedic Device Companies” provides information and analysis on t
2011 500,00$

United States Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others

Introduction / / GlobalData’s new report, “United States Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamet
2011 2.500,00$

Afinitor (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Breast Cancer) – Analysis and Forecasts to 2020” provides Afinit
2011 2.000,00$

Cardiovascular Inflammation Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, H2, 2011" provid
2011 1.000,00$

Abscess Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, H2, 2011" provides data on the Absce
2011 1.000,00$

Respiratory Depression Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Respiratory Depression Global Clinical Trials Review, H2, 2011" provides da
2011 1.000,00$

Friedreich Ataxia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Acute Heart Failure Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Vascular Dysfunction Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Vascular Dysfunction Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Sickle Cell Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Hemoglobinuria Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hemoglobinuria Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Osteonecrosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Osteonecrosis Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Myasthenia Gravis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2011" provides d
2011 1.000,00$

Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011
2011 1.000,00$

Pulmonary Embolism Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Pulmonary Embolism Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Type 2 Diabetes Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Type 2 Diabetes Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Warts Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Warts Global Clinical Trials Review, H2, 2011" provides data on the Warts c
2011 1.000,00$

Cervical Dysplasia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cervical Dysplasia Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Endocarditis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Endocarditis Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Hemophilia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hemophilia Global Clinical Trials Review, H2, 2011" provides data on the He
2011 1.000,00$

Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2011" provide
2011 1.000,00$

Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2011" provides da
2011 1.000,00$

Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2011" provi
2011 1.000,00$

Respiratory Tract Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Respiratory Tract Infections Global Clinical Trials Review, H2, 2011" provi
2011 1.000,00$

Urinary Retention Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Urinary Retention Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Influenza Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Influenza Global Clinical Trials Review, H2, 2011" provides data on the Inf
2011 1.000,00$

Narcolepsy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Narcolepsy Global Clinical Trials Review, H2, 2011" provides data on the Na
2011 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011”
2011 1.000,00$

CorAssist Cardiovascular Ltd. - Product Pipeline Analysis

CorAssist Cardiovascular Ltd. - Product Pipeline Analysis / / Summary / / CorAssist Cardiovascular Ltd. (CorAssist) is principal
2011 750,00$

Pathfinder Cell Therapy, Inc. (SYMD) - Product Pipeline Analysis

Pathfinder Cell Therapy, Inc. (SYMD) - Product Pipeline Analysis / / Summary / / Pathfinder Cell Therapy, Inc. (Pathfinder Cell
2011 750,00$

Diazyme Laboratories - Product Pipeline Analysis

Diazyme Laboratories - Product Pipeline Analysis / / Summary / / Diazyme Laboratories (Diazyme) is a medical device company is p
2011 750,00$

Optiscan Imaging Limited (OIL) - Product Pipeline Analysis

Optiscan Imaging Limited (OIL) - Product Pipeline Analysis / / Summary / / Optiscan Imaging Limited (Optiscan Imaging) is a medi
2011 750,00$

Predictive Biosciences, Inc. - Product Pipeline Analysis

Predictive Biosciences, Inc. - Product Pipeline Analysis / / Summary / / Predictive Biosciences, Inc. (Predictive Biosciences) i
2011 750,00$

A&G Pharmaceutical, Inc. - Product Pipeline Analysis

A&G Pharmaceutical, Inc. - Product Pipeline Analysis / / Summary / / A&G Pharmaceutical, Inc. (A&G) is a provider of personalize
2011 750,00$

Exonhit S.A. (ALEHT) - Product Pipeline Analysis

Exonhit S.A. (ALEHT) - Product Pipeline Analysis / / Summary / / Exonhit S.A. (Exonhit), formerly ExonHit Therapeutics SA, is a
2011 750,00$

MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to
2011 3.500,00$

Cardiovascular Devices - Emerging Countries (China, India, Brazil) Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Cardiovascular Devices - Emerging Countries (China, India, Brazil) Pipeline Analysis,
2011 3.500,00$

Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Marke
2011 3.500,00$

Nuclear Imaging Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Nuclear Imaging Equipment - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Marke
2011 3.500,00$

Electrophysiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Electrophysiology Devices - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline
2011 3.500,00$

Middle East and Africa and South and Central America Healthcare IT Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Healthcare IT Market Outlook to 2017” provides key market data
2011 3.500,00$

Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Competitiv
2011 3.500,00$

Asia-Pacific Healthcare IT Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Healthcare IT Market Outlook to 2017” provides key market data on the Asi
2011 3.500,00$

North America Healthcare IT Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Healthcare IT Market Outlook to 2017” provides key market data on the No
2011 3.500,00$

Medical Imaging Information Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Medical Imaging Information Systems Market Outlook in BRICS (Brazil, Russia, India, Ch
2011 2.500,00$

Ultrasound Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Ultrasound Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa
2011 2.500,00$

Computed Tomography Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Computed Tomography Systems Market Outlook in BRICS (Brazil, Russia, India, China, Sou
2011 2.500,00$

New Zealand Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “New Zealand Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI System
2011 2.500,00$

Sweden Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Sweden Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co
2011 2.500,00$

Russian Federation Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Russian Federation Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI
2011 2.500,00$

Czech Republic Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Czech Republic Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Sys
2011 2.500,00$

Austria Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Austria Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C
2011 2.500,00$

Israel Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Israel Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co
2011 2.500,00$

Taiwan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Taiwan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co
2011 2.500,00$

X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t
2011 3.500,00$

Belgium Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Belgium Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C
2011 2.500,00$

Argentina Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Argentina Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems,
2011 2.500,00$

Mexico Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Mexico Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co
2011 2.500,00$

North America Diagnostic Imaging Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Diagnostic Imaging Market Outlook to 2017” provides key market data on
2011 3.500,00$

Europe Diagnostic Imaging Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Diagnostic Imaging Market Outlook to 2017” provides key market data on the Eu
2011 3.500,00$

Asia-Pacific Diagnostic Imaging Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Diagnostic Imaging Market Outlook to 2017” provides key market data on t
2011 3.500,00$

Denmark Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Denmark Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C
2011 2.500,00$

Saudi Arabia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Saudi Arabia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Syste
2011 2.500,00$

Healthcare IT Market Outlook in Germany to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Germany to 2017 - Hospital Information Systems and Med
2011 2.500,00$

Healthcare IT Market Outlook in Japan to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Japan to 2017 - Hospital Information Systems and Medic
2011 2.500,00$

Healthcare IT Market Outlook in Spain to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Spain to 2017 - Hospital Information Systems and Medic
2011 2.500,00$

Healthcare IT Market Outlook in Denmark to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Denmark to 2017 - Hospital Information Systems and Med
2011 2.500,00$

Healthcare IT Market Outlook in Sweden to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Sweden to 2017 - Hospital Information Systems and Medi
2011 2.500,00$

Healthcare IT Market Outlook in New Zealand to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in New Zealand to 2017 - Hospital Information Systems and
2011 2.500,00$

Interstitial Cystitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Interstitial Cystitis Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2011" p
2011 1.000,00$

Acne Vulgaris Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Otitis Media Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Otitis Media Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Cystoid Macular Edema Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cystoid Macular Edema Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Encephalitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Gastroenteritis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Cerebral Aneurysms Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Hypercholesterolemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Gaucher’s Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Gaucher’s Disease (Gout) Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

The Seventh International Congress on Vascular Dementia - Post Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “The Seventh International
2011 1.000,00$

Urinary Incontinence (UI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Urinary Incontinence (UI) Therapeuti
2011 3.500,00$

Sarcopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Sarcopenia Therapeutics - Pipeline A
2011 3.500,00$

Pneumonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Pneumonia Therapeutics - Pipeline As
2011 3.500,00$

Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Polycystic Ovarian Syndrome (PCOS) T
2011 3.500,00$

Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Heart Failure (HF) Therapeutics - Pi
2011 3.500,00$

Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bipolar Disorder Therapeutics - Pipe
2011 3.500,00$

GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides GV10
2011 2.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011” report
2011 1.500,00$

21st European Meeting on Hypertension and Cardiovascular Prevention 2011 - Post-Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “21st European Meeting on
2011 1.000,00$

Periodontal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Periodontal Disease Therapeutics - P
2011 3.500,00$

Healthcare IT Market Outlook in Italy to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Italy to 2017 - Hospital Information Systems and Medic
2011 2.500,00$

Artificial Disc Replacement Devices - A Market Snapshot

Introduction / / GlobalData’s report, “Artificial Disc Replacement Devices - A Market Snapshot” provides information and analysis
2011 500,00$

South Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “South Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Syste
2011 2.500,00$

Australia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Australia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems,
2011 2.500,00$

Spain Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Spain Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com
2011 2.500,00$

Germany Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Germany Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C
2011 2.500,00$

Canada Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Canada Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co
2011 2.500,00$

China Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “China Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com
2011 2.500,00$

Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011” report is an ess
2011 1.500,00$

Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibril
2011 3.500,00$

Ophthalmic Diagnostic Equipments Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Ophthalmic Diagnostic Equipments Market Outlook in BRICS (Brazil, Russia, India, China
2011 2.500,00$

Vision Care Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Vision Care Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 20
2011 2.500,00$

Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, Sout
2011 2.500,00$

Global Healthcare IT Monthly Deals Analysis - M&A and Investment Trends, September 2011

Introduction / / GlobalData's “Global Healthcare IT Monthly Deals Analysis - M&A and Investment Trends, September 2011” report is
2011 1.000,00$

Netherlands Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Netherlands Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI System
2011 2.500,00$

Republic of Korea Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Republic of Korea Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI
2011 2.500,00$

Taiwan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Taiwan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Healthcare IT Market Outlook in Australia to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Australia to 2017 - Hospital Information Systems and M
2011 2.500,00$

Healthcare IT Market Outlook in United Kingdom to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in United Kingdom to 2017 - Hospital Information Systems
2011 2.500,00$

Healthcare IT Market Outlook in United States to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in United States to 2017 - Hospital Information Systems a
2011 2.500,00$

Healthcare IT Market Outlook in Brazil to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Brazil to 2017 - Hospital Information Systems and Medi
2011 2.500,00$

Healthcare IT Market Outlook in China to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in China to 2017 - Hospital Information Systems and Medic
2011 2.500,00$

Healthcare IT Market Outlook in France to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in France to 2017 - Hospital Information Systems and Medi
2011 2.500,00$

Healthcare IT Market Outlook in South Africa to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in South Africa to 2017 - Hospital Information Systems an
2011 2.500,00$

Healthcare IT Market Outlook in Belgium to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Belgium to 2017 - Hospital Information Systems and Med
2011 2.500,00$

Healthcare IT Market Outlook in Russian Federation to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Russian Federation to 2017 - Hospital Information Syst
2011 2.500,00$

Healthcare IT Market Outlook in Israel to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Israel to 2017 - Hospital Information Systems and Medi
2011 2.500,00$

Dementia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Dementia Global Clinical Trials Review, H2, 2011" provides data on the Deme
2011 1.000,00$

Epilepsy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Epilepsy Global Clinical Trials Review, H2, 2011" provides data on the Epil
2011 1.000,00$

Migraine Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Migraine Global Clinical Trials Review, H2, 2011" provides data on the Migr
2011 1.000,00$

Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2011" provid
2011 1.000,00$

Schizophrenia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2011" prov
2011 1.000,00$

Osteoporosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2011" provides d
2011 1.000,00$

Rhinosinusitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Rhinosinusitis Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Septic Shock Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Septic Shock Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Hepatitis C Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, H2, 2011" provides data on the H
2011 1.000,00$

Hepatitis A Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, H2, 2011" provides data on the H
2011 1.000,00$

Peptic Ulcers Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Peptic Ulcer Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Bronchitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, H2, 2011" provides data on the Br
2011 1.000,00$

Parkinson’s Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Alzheimer’s Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Diphtheria Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, H2, 2011" provides data on the Di
2011 1.000,00$

Emphysema Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Emphysema Global Clinical Trials Review, H2, 2011" provides data on the Emp
2011 1.000,00$

Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011" pr
2011 1.000,00$

Cerebral Palsy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cerebral Palsy Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Acute Lung Injury Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Non-Small Cell Lung Cancer (NSCLC) T
2011 3.500,00$

Major Depressive Disorder (MDD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Major Depressive Disorder (MDD) Ther
2011 3.500,00$

Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Benign Prostatic Hyperplasia (BPH) T
2011 3.500,00$

Anti-Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anti-Hypertension Therapeutics - Pip
2011 3.500,00$

Paclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, "Paclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Pac
2011 2.000,00$

Talactoferrin Alfa (NSCLC) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Talactoferrin Alfa (NSCLC) – Analysis and Forecasts to 2020” provides Tala
2011 2.000,00$

Victhom Human Bionics Inc. (VHB) - Product Pipeline Analysis

Victhom Human Bionics Inc. (VHB) - Product Pipeline Analysis / / Summary / / Victhom Human Bionics Inc. (Victhom) is a medical d
2011 750,00$

Micronics, Inc. - Product Pipeline Analysis

Micronics, Inc. - Product Pipeline Analysis / / Summary / / Micronics, Inc. (Micronics), a privately-held medical device company
2011 750,00$

Biomoda, Inc. (BMOD) - Product Pipeline Analysis

Biomoda, Inc. (BMOD) - Product Pipeline Analysis / / Summary / / Biomoda, Inc. (Biomoda) is a medical device manufacturing compa
2011 750,00$

Medispec LTD - Product Pipeline Analysis

Medispec LTD - Product Pipeline Analysis / / Summary / / Medispec LTD, (Medispec) is a privately-held medical device company. It
2011 750,00$

Ceragenix Pharmaceuticals, Inc. (CGXP) - Product Pipeline Analysis

Ceragenix Pharmaceuticals, Inc. (CGXP) - Product Pipeline Analysis / / Summary / / Ceragenix Pharmaceuticals, Inc. (Ceragenix) i
2011 750,00$

Fina Biotech - Product Pipeline Analysis

Fina Biotech - Product Pipeline Analysis / / Summary / / Fina Biotech, formerly known as Indas Biotech is a biotechnology compan
2011 750,00$

SANUWAVE Health, Inc. (SNWV) - Product Pipeline Analysis

SANUWAVE Health, Inc. (SNWV) - Product Pipeline Analysis / / Summary / / SANUWAVE, Inc. (SANUWAVE) is a medical technology compa
2011 750,00$

TcLand Expression - Product Pipeline Analysis

TcLand Expression - Product Pipeline Analysis / / Summary / / TcLand Expression (TcLand) is an privately held integrated biotech
2011 750,00$

AOI Medical, Inc. - Product Pipeline Analysis

AOI Medical, Inc. - Product Pipeline Analysis / / Summary / / AOI Medical, Inc. (AOI Medical) is a medical device company, engag
2011 750,00$

TherOx, Inc. - Product Pipeline Analysis

TherOx, Inc. - Product Pipeline Analysis / / Summary / / TherOx, Inc. (TherOx) is a privately held medical device company. It is
2011 750,00$

Spectros Corporation - Product Pipeline Analysis

Spectros Corporation - Product Pipeline Analysis / / Summary / / Spectros Corporation (Spectros) is a privately-held medical dev
2011 750,00$

Ascension Orthopedics, Inc. - Product Pipeline Analysis

Ascension Orthopedics, Inc. - Product Pipeline Analysis / / Summary / / Ascension Orthopedics Corporation (Ascension) is a priva
2011 750,00$

InSightec Ltd. - Product Pipeline Analysis

InSightec Ltd. - Product Pipeline Analysis / / Summary / / InSightec Ltd. (InSightec) is a privately held medical device company
2011 750,00$

Toscana Biomarkers Srl - Product Pipeline Analysis

Toscana Biomarkers Srl - Product Pipeline Analysis / / Summary / / Toscana Biomarkers Srl (Toscana Biomarkers) is a start up com
2011 750,00$

Xcorporeal, Inc. (XCRP) - Product Pipeline Analysis

Xcorporeal, Inc. (XCRP) - Product Pipeline Analysis / / Summary / / Xcorporeal, Inc. (Xcorporeal) is a medical device company pr
2011 750,00$

CorNova, Inc. - Product Pipeline Analysis

CorNova, Inc. - Product Pipeline Analysis / / Summary / / CorNova, Inc. (CorNova) is a medical device company engaged in the man
2011 750,00$

Epinex Diagnostics Incorporated - Product Pipeline Analysis

Epinex Diagnostics Incorporated - Product Pipeline Analysis / / Summary / / Epinex Diagnostics Inc.,(Epinex) is a medical diagno
2011 750,00$

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis / / Summary / / Cytograft Tissue Engineering, Inc. (Cytograft) is
2011 750,00$

XEPTAGEN SpA - Product Pipeline Analysis

XEPTAGEN SpA - Product Pipeline Analysis / / Summary / / XEPTAGEN SpA. (XEPTAGEN) is engaged in the development, production and
2011 750,00$

ValveXchange, Inc. - Product Pipeline Analysis

ValveXchange, Inc. - Product Pipeline Analysis / / Summary / / ValveXchange, Inc. (ValveXchange) is a medical device company eng
2011 750,00$

Orthox Ltd. - Product Pipeline Analysis

Orthox Ltd. - Product Pipeline Analysis / / Summary / / Orthox Ltd (Orthox) is a privately-held medical device company engaged i
2011 750,00$

MEDICREA INTERNATIONAL (ALMED) - Product Pipeline Analysis

MEDICREA INTERNATIONAL (ALMED) - Product Pipeline Analysis / / Summary / / MEDICREA INTERNATIONAL (Medicrea) is a medical device
2011 750,00$

Aeon Astron Corporation - Product Pipeline Analysis

Aeon Astron Corporation - Product Pipeline Analysis / / Summary / / Aeon Astron Corporation (AAC) is a corporate holding company
2011 750,00$

X-spine Systems, Inc. - Product Pipeline Analysis

X-spine Systems, Inc. - Product Pipeline Analysis / / Summary / / X-spine Systems, Inc. (X-spine) is a privately held medical de
2011 750,00$

Jemo Spine, LLC. - Product Pipeline Analysis

Jemo Spine, LLC. - Product Pipeline Analysis / / Summary / / Jemo Spine, LLC. (Jemo Spine) is a privately-held medical device co
2011 750,00$

Palmaz Scientific, Inc. - Product Pipeline Analysis

Palmaz Scientific, Inc. - Product Pipeline Analysis / / Summary / / Palmaz Scientific, Inc. (Palmaz) is a privately held medical
2011 750,00$

Abbott Vascular Inc. - Product Pipeline Analysis

Abbott Vascular Inc. - Product Pipeline Analysis / / Summary / / Abbott Vascular Inc. (Abbott Vascular) is engaged in the develo
2011 750,00$

Akonni Biosystems Inc - Product Pipeline Analysis

Akonni Biosystems Inc - Product Pipeline Analysis / / Summary / / Akonni Biosystems Inc (Akonni Biosystems) is a US based life s
2011 750,00$

BioQ Devices Pty Ltd - Product Pipeline Analysis

BioQ Devices Pty Ltd - Product Pipeline Analysis / / Summary / / BioQ Devices Pty Ltd (BioQ Devices) is a medical device company
2011 750,00$

BioTech One Inc - Product Pipeline Analysis

BioTech One Inc - Product Pipeline Analysis / / Summary / / BioTech One Inc (BioTech One) is a privately held medical device com
2011 750,00$

Bonovo Orthopedics, Inc. - Product Pipeline Analysis

Bonovo Orthopedics, Inc. - Product Pipeline Analysis / / Summary / / Bonovo Orthopedics, Inc. (Bonovo) is a privately held compa
2011 750,00$

MabCure Inc. (MBCI) - Product Pipeline Analysis

MabCure Inc. (MBCI) - Product Pipeline Analysis / / Summary / / MabCure Inc. (MabCure), formerly Smartec Holdings Inc. is a deve
2011 750,00$

BioHelix Corporation - Product Pipeline Analysis

BioHelix Corporation - Product Pipeline Analysis / / Summary / / BioHelix Corporation (Biohelix) is a privately held molecular d
2011 750,00$

TransMedics, Inc. - Product Pipeline Analysis

TransMedics, Inc. - Product Pipeline Analysis / / Summary / / TransMedics, Inc. (TransMedics) is a privately held medical device
2011 750,00$

Aurelium BioPharma Inc. - Product Pipeline Analysis

Aurelium BioPharma Inc. - Product Pipeline Analysis / / Summary / / Aurelium BioPharma Inc. (Aurelium) is a privately held medic
2011 750,00$

Control Medical Technology - Product Pipeline Analysis

Control Medical Technology - Product Pipeline Analysis / / Summary / / Control Medical Technology is a medical equipments compan
2011 750,00$

Sensile Medical AG - Product Pipeline Analysis

Sensile Medical AG - Product Pipeline Analysis / / Summary / / Sensile Medical AG (Sensile) is a privately held medical device c
2011 750,00$

Debiotech S.A. - Product Pipeline Analysis

Debiotech S.A. - Product Pipeline Analysis / / Summary / / Debiotech S.A. (Debiotech) is engaged in the development of innovativ
2011 750,00$

AbaStar MDx - Product Pipeline Analysis

AbaStar MDx - Product Pipeline Analysis / / Summary / / AbaStar MDx, Inc. (AbaStar) is a healthcare medical device company princ
2011 750,00$

AutoGenomics, Inc. - Product Pipeline Analysis

AutoGenomics, Inc. - Product Pipeline Analysis / / Summary / / AutoGenomics, Inc. (AutoGenomics) is engaged in the design, devel
2011 750,00$

China Medical Technologies, Inc. (CMED) - Product Pipeline Analysis

China Medical Technologies, Inc. (CMED) - Product Pipeline Analysis / / Summary / / China Medical Technologies, (China Medical)
2011 750,00$

Cardima, Inc. (CADM) - Product Pipeline Analysis

Cardima, Inc. (CADM) - Product Pipeline Analysis / / Summary / / Cardima, Inc. (Cardima) designs, develops, manufactures and mar
2011 750,00$

Bone Solutions, Inc. - Product Pipeline Analysis

Bone Solutions, Inc. - Product Pipeline Analysis / / Summary / / Bone Solutions, Inc. (Bone Solutions) is a bone adhesive techno
2011 750,00$

LifeBond Ltd. - Product Pipeline Analysis

LifeBond Ltd. - Product Pipeline Analysis / / Summary / / LifeBond Ltd. (LifeBond) is a medical device company principally engag
2011 750,00$

Axial Biotech, Inc. - Product Pipeline Analysis

Axial Biotech, Inc. - Product Pipeline Analysis / / Summary / / Axial Biotech, Inc. (Axial Biotech) is medical technology compan
2011 750,00$

Pluromed, Inc. - Product Pipeline Analysis

Pluromed, Inc. - Product Pipeline Analysis / / Summary / / Pluromed, Inc. (Pluromed) is an early-stage medical technology compan
2011 750,00$

Bioretec Ltd. - Product Pipeline Analysis

Bioretec Ltd. - Product Pipeline Analysis / / Summary / / Bioretec Ltd. (Bioretec) is a medical device company engaged in the de
2011 750,00$

Xylos Corporation - Product Pipeline Analysis

Xylos Corporation - Product Pipeline Analysis / / Summary / / Xylos Corporation (Xylos), a privately-held biotechnology company
2011 750,00$

Xhale Diagnostics, Inc. - Product Pipeline Analysis

Xhale Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / Xhale Diagnostics, Inc. (Xhale) is a privately-held medical
2011 750,00$

NewCardio, Inc. (NWCI) - Product Pipeline Analysis

NewCardio, Inc. (NWCI) - Product Pipeline Analysis / / Summary / / NewCardio, Inc. (NewCardio) is a medical technology company.
2011 750,00$

GeneEx, Inc - Product Pipeline Analysis

GeneEx, Inc - Product Pipeline Analysis / / Summary / / GeneEx, Inc. (GenEx), a privately-held medical device service provider c
2011 750,00$

DiagnoCure Inc. (CUR) - Product Pipeline Analysis

DiagnoCure Inc. (CUR) - Product Pipeline Analysis / / Summary / / DiagnoCure Inc. (DiagnoCure) is engaged in the development, pr
2011 750,00$

Glycominds Ltd. - Product Pipeline Analysis

Glycominds Ltd. - Product Pipeline Analysis / / Summary / / Glycominds Ltd. (GML), a privately-held medical device provider, is
2011 750,00$

Disc Motion Technologies - Product Pipeline Analysis

Disc Motion Technologies - Product Pipeline Analysis / / Summary / / Disc Motion Technologies (DMT) is a privately-held spine te
2011 750,00$

Instrumentation Laboratory - Product Pipeline Analysis

Instrumentation Laboratory - Product Pipeline Analysis / / Summary / / Instrumentation Laboratory is a subsidiary of Werfen Grou
2011 750,00$

Mystic Pharmaceuticals, Inc. - Product Pipeline Analysis

Mystic Pharmaceuticals, Inc. - Product Pipeline Analysis / / Summary / / Mystic Pharmaceuticals, Inc. (Mystic) is a specialty ph
2011 750,00$

Target Discovery, Inc. - Product Pipeline Analysis

Target Discovery, Inc. - Product Pipeline Analysis / / Summary / / Target Discovery, Inc. (TDI) is a medical equipment company,
2011 750,00$

Innocoll Technologies Ltd - Product Pipeline Analysis

Innocoll Technologies Ltd - Product Pipeline Analysis / / Summary / / Innocoll Technologies Ltd (Innocoll Technologies) is a med
2011 750,00$

FMI Technologies, Inc. - Product Pipeline Analysis

FMI Technologies, Inc. - Product Pipeline Analysis / / Summary / / FMI Technologies, Inc. (FMI Technologies) is a medical device
2011 750,00$

Tepha, Inc. - Product Pipeline Analysis

Tepha, Inc. - Product Pipeline Analysis / / Summary / / Tepha, Inc. (Tepha) is a privately-held medical device company engaged i
2011 750,00$

Marvel Medtech, LLC - Product Pipeline Analysis

Marvel Medtech, LLC - Product Pipeline Analysis / / Summary / / Marvel Medtech, LLC (Marvel Medtech) is principally engaged in t
2011 750,00$

Apaxis Medical, Inc. - Product Pipeline Analysis

Apaxis Medical, Inc. - Product Pipeline Analysis / / Summary / / Apaxis Medical, Inc. (formerly known as SEMMT, Inc.) is a priva
2011 750,00$

Source MDx - Product Pipeline Analysis

Source MDx - Product Pipeline Analysis / / Summary / / Source MDx (Source) is a privately held medical device company. It is pri
2011 750,00$

Tigran Technologies AB (TIGR) - Product Pipeline Analysis

Tigran Technologies AB (TIGR) - Product Pipeline Analysis / / Summary / / Tigran Technologies AB (Tigran Technologies) is a medi
2011 750,00$

B1 Medical Ltd - Product Pipeline Analysis

B1 Medical Ltd - Product Pipeline Analysis / / Summary / / B1 Medical Ltd (B1 Medical) is a medical device company, principally
2011 750,00$

KISCO International - Product Pipeline Analysis

KISCO International - Product Pipeline Analysis / / Summary / / KISCO International is formerly known as Kiscomedica, it is prin
2011 750,00$

HyperBranch Medical Technology, Inc. - Product Pipeline Analysis

HyperBranch Medical Technology, Inc. - Product Pipeline Analysis / / Summary / / Hyperbranch Medical Technology, Inc. (Hyperbran
2011 750,00$

JetGuide Ltd. - Product Pipeline Analysis

JetGuide Ltd. - Product Pipeline Analysis / / Summary / / JetGuide Ltd. (JetGuide) is a medical device company, principally enga
2011 750,00$

BioCure, Inc. - Product Pipeline Analysis

BioCure, Inc. - Product Pipeline Analysis / / Summary / / BioCure, Inc. (BioCure) is medical device company, engaged in the deve
2011 750,00$

Minos Medical Inc. - Product Pipeline Analysis

Minos Medical Inc. - Product Pipeline Analysis / / Summary / / Minos Medical Inc. (Minos Medical) is a medical device company pr
2011 750,00$

AGA Medical Holdings, Inc. - Product Pipeline Analysis

AGA Medical Holdings, Inc. - Product Pipeline Analysis / / Summary / / AGA Medical Holdings, Inc. (AGA Medical), a medical devic
2011 750,00$

Integrated Diagnostics - Product Pipeline Analysis

Integrated Diagnostics - Product Pipeline Analysis / / Summary / / Integrated Diagnostics is engaged in developing diagnostic pr
2011 750,00$

Milagen, Inc. - Product Pipeline Analysis

Milagen, Inc. - Product Pipeline Analysis / / Summary / / Milagen, Inc. (Milagen) is a medical device company is principally eng
2011 750,00$

CollPlant Ltd. - Product Pipeline Analysis

CollPlant Ltd. - Product Pipeline Analysis / / Summary / / CollPlant Ltd. (CollPlant) is a biotechnology company. It is engaged
2011 750,00$

Prediction Sciences - Product Pipeline Analysis

Prediction Sciences - Product Pipeline Analysis / / Summary / / Prediction Sciences is a medical device company is principally e
2011 750,00$

Cohera Medical, Inc. - Product Pipeline Analysis

Cohera Medical, Inc. - Product Pipeline Analysis / / Summary / / Cohera Medical, Inc. (Cohera), a privately-held medical device
2011 750,00$

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis / / Summary / / Rosetta Genomics, Ltd. (RGL) is a medical device compa
2011 750,00$

Innova Biotechnology Co., Ltd. - Product Pipeline Analysis

Innova Biotechnology Co., Ltd. - Product Pipeline Analysis / / Summary / / Innova Biotechnology Co., Ltd. (Innova Biotechnology)
2011 750,00$

Spring Health Solutions Ltd. - Product Pipeline Analysis

Spring Health Solutions Ltd. - Product Pipeline Analysis / / Summary / / Spring Health Solutions Ltd. (Spring Health) is a medic
2011 750,00$

MND Diagnostic LTD - Product Pipeline Analysis

MND Diagnostic LTD - Product Pipeline Analysis / / Summary / / MND Diagnostic LTD (MND Diagnostic) is engaged in the development
2011 750,00$

Biosign Technologies Inc. (BIO) - Product Pipeline Analysis

Biosign Technologies Inc. (BIO) - Product Pipeline Analysis / / Summary / / Biosign Technologies Inc. (Biosign) is a medical dev
2011 750,00$

EndoChoice Inc. - Product Pipeline Analysis

EndoChoice Inc. - Product Pipeline Analysis / / Summary / / EndoChoice Inc. (EndoChoice) is one of the leading gastrointestinal
2011 750,00$

Quanterix Corporation - Product Pipeline Analysis

Quanterix Corporation - Product Pipeline Analysis / / Summary / / Quanterix Corporation is engaged in developing a platform for
2011 750,00$

GT Urological, LLC - Product Pipeline Analysis

GT Urological, LLC - Product Pipeline Analysis / / Summary / / GT Urological, LLC (GTU) is a medical device company principally
2011 750,00$

CW Optics, Inc. - Product Pipeline Analysis

CW Optics, Inc. - Product Pipeline Analysis / / Summary / / CW Optics, Inc. (CW Optics) is a medical technology company principa
2011 750,00$

AMPLITUDE SAS - Product Pipeline Analysis

AMPLITUDE SAS - Product Pipeline Analysis / / Summary / / AMPLITUDE SAS (Amplitude) is a medical device company, which is engage
2011 750,00$

SQI Diagnostics Inc. (SQD) - Product Pipeline Analysis

SQI Diagnostics Inc. (SQD) - Product Pipeline Analysis / / Summary / / SQI Diagnostics Inc. (SQI) is a privately-held medical de
2011 750,00$

Corgenix, Inc. - Product Pipeline Analysis

Corgenix, Inc. - Product Pipeline Analysis / / Summary / / Corgenix, Inc. (Corgenix) is a medical device company engaged in the
2011 750,00$

Scil Technology Gmbh - Product Pipeline Analysis

Scil Technology Gmbh - Product Pipeline Analysis / / Summary / / Scil Technology Gmbh (Scil) is a biopharmaceutical drug develop
2011 750,00$

Bolton Medical, Inc. - Product Pipeline Analysis

Bolton Medical, Inc. - Product Pipeline Analysis / / Summary / / Bolton Medical, Inc. (Bolton Medical) is a privately-held medic
2011 750,00$

Mentor Worldwide LLC - Product Pipeline Analysis

Mentor Worldwide LLC - Product Pipeline Analysis / / Summary / / Mentor Worldwide LLC (Mentor) is a medical device company engag
2011 750,00$

Elixir Medical Corporation - Product Pipeline Analysis

Elixir Medical Corporation - Product Pipeline Analysis / / Summary / / Elixir Medical Corporation (Elixir Medical) is a privatel
2011 750,00$

BG Medicine, Inc. (BGMD) - Product Pipeline Analysis

BG Medicine, Inc. (BGMD) - Product Pipeline Analysis / / Summary / / BG Medicine, Inc. (BG Medicine) is life sciences company, p
2011 750,00$

Kytogenics Pharmaceuticals, Inc. - Product Pipeline Analysis

Kytogenics Pharmaceuticals, Inc. - Product Pipeline Analysis / / Summary / / Kytogenics Pharmaceuticals, Inc. (Kytogenics) is a
2011 750,00$

MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Product Pipeline Analysis

MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Product Pipeline Analysis / / Summary / / MCS Medical Compression Systems (D
2011 750,00$

Covalon Technologies Ltd. (COV) - Product Pipeline Analysis

Covalon Technologies Ltd. (COV) - Product Pipeline Analysis / / Summary / / Covalon Technologies, Ltd. (Covalon) is a publicly h
2011 750,00$

Cytokine PharmaSciences, Inc. - Product Pipeline Analysis

Cytokine PharmaSciences, Inc. - Product Pipeline Analysis / / Summary / / Cytokine PharmaSciences, Inc. (CPSI) is engaged in the
2011 750,00$

Atlas Genetics Ltd. - Product Pipeline Analysis

Atlas Genetics Ltd. - Product Pipeline Analysis / / Summary / / Atlas Genetics Ltd. (Atlas Genetics) is a medical diagnostic com
2011 750,00$

Medical Bionics Inc. - Product Pipeline Analysis

Medical Bionics Inc. - Product Pipeline Analysis / / Summary / / Medical Bionics Inc (Medical Bionics) is a privately-held compa
2011 750,00$

EXINI Diagnostics AB - Product Pipeline Analysis

EXINI Diagnostics AB - Product Pipeline Analysis / / Summary / / EXINI Diagnostics AB (EXINI Diagnostics) is a privately-held me
2011 750,00$

Eurocor GmbH - Product Pipeline Analysis

Eurocor GmbH - Product Pipeline Analysis / / Summary / / Eurocor GmbH (Eurocor) is a medical device company which is principally
2011 750,00$

Brazil Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Brazil Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co
2011 2.500,00$

Italy Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Italy Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com
2011 2.500,00$

France Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “France Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co
2011 2.500,00$

India Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “India Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com
2011 2.500,00$

Private Equity and Venture Capital Investments in Medical Equipment Industry - Q3 2011

Introduction / / GlobalData's “Private Equity and Venture Capital Investments in Medical Equipment Industry - Q3 2011” report is
2011 1.500,00$

Healthcare IT Market Outlook in Netherlands to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Netherlands to 2017 - Hospital Information Systems and
2011 2.500,00$

Healthcare IT Market Outlook in Canada to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Canada to 2017 - Hospital Information Systems and Medi
2011 2.500,00$

Saudi Arabia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Saudi Arabia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagn
2011 2.500,00$

Denmark Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Denmark Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Israel Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Israel Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Japan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “Japan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com
2011 2.500,00$

United Kingdom Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “United Kingdom Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Sys
2011 2.500,00$

Middle East and Africa Ophthalmic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Ophthalmic Devices Market Outlook to 2017” provides key market
2011 3.500,00$

Vitreo Retinal Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Vitreo Retinal Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China,
2011 2.500,00$

Cataract Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Cataract Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Heart Failure Society of America (HFSA) 15th Annual Scientific Meeting - Review and Analysis

Introduction / / GlobalData’s report, “Heart Failure Society of America (HFSA) 15th Annual Scientific Meeting - Review and Analys
2011 1.000,00$

Periodontal Disease - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist’s new report, “Periodontal Disease - Pipeline Assessment and Market
2011 3.500,00$

Osteoarthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis Therapeutics - Pipeli
2011 3.500,00$

Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the Industry analysis specialist, has released its new report, “Growth Hormone Deficiency (GHD) Ther
2011 3.500,00$

Atherosclerosis or Coronary Artery Disease Therapeutics (CAD) - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Atherosclerosis or Coronary Artery D
2011 3.500,00$

Chemotherapy-Induced Neutropenia (CIN) Therapeutics –Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chemotherapy-Induced Neutropenia (CI
2011 3.500,00$

Bronchitis Therapeutics- Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bronchitis Therapeutics- Pipeline As
2011 3.500,00$

Angina Pectoris Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Angina Pectoris Therapeutics - Pipel
2011 3.500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011”
2011 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011” r
2011 1.000,00$

Waldenstrom Macroglobulinemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, H2, 2011" prov
2011 1.000,00$

Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Uveitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H2, 2011" provides data on the Uveit
2011 1.000,00$

Glaucoma Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Glaucoma Global Clinical Trials Review, H2, 2011" provides data on the Glau
2011 1.000,00$

Hernia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hernia Global Clinical Trials Review, H2, 2011" provides data on the Hernia
2011 1.000,00$

Leprosy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Leprosy Global Clinical Trials Review, H2, 2011" provides data on the Lepro
2011 1.000,00$

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 201
2011 1.000,00$

Hemophilia A Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hemophilia A Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Valstar (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Valstar (Bladder Cancer) - Analysis and Forecasts to 2020” provides Valsta
2011 2.000,00$

Urocidin (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Urocidin (Bladder Cancer) - Analysis and Forecasts to 2020” provides Uroci
2011 2.000,00$

Thiotepa (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Thiotepa (Bladder Cancer) - Analysis and Forecasts to 2020” provides Thiot
2011 2.000,00$

Gemzar (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Bladder Cancer) - Analysis and Forecasts to 2020” provides Gemzar
2011 2.000,00$

BCG (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “BCG (Bladder Cancer) - Analysis and Forecasts to 2020” provides BCG global
2011 2.000,00$

MVAC (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “MVAC (Bladder Cancer) - Analysis and Forecasts to 2020” provides MVAC glob
2011 2.000,00$

Mitomycin (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Mitomycin (Bladder Cancer) - Analysis and Forecasts to 2020” provides Javl
2011 2.000,00$

Javlor (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Javlor (Bladder Cancer) - Analysis and Forecasts to 2020” provides Javlor
2011 2.000,00$

Eoquin (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Eoquin (Bladder Cancer) - Analysis and Forecasts to 2020” provides Eoquin
2011 2.000,00$

Tykerb (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tykerb (Bladder Cancer) - Analysis and Forecasts to 2020” provides Tykerb
2011 2.000,00$

Ellence (Bladder Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Ellence (Bladder Cancer) - Analysis and Forecasts to 2020” provides Ellenc
2011 2.000,00$

Iressa (Bladder Cancer) - Analysis and Forecast to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Iressa (Bladder Cancer) - Analysis and Forecast to 2020” provides Iressa g
2011 2.000,00$

Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides Vect
2011 2.000,00$

Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020” provides Taxot
2011 2.000,00$

Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides Mit
2011 2.000,00$

Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020” provides Erbitux
2011 2.000,00$

Ellence (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Ellence (Gastric Cancer) - Analysis and Forecasts to 2020” provides Ellenc
2011 2.000,00$

Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Actos s
2011 2.000,00$

Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides A
2011 2.000,00$

Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Amaryl
2011 2.000,00$

Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Apidra
2011 2.000,00$

ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides ASP19
2011 2.000,00$

Avandia (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avandia (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Avand
2011 2.000,00$

Basen (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Basen (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Basen s
2011 2.000,00$

BI 10773 (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “BI 10773 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides BI10
2011 2.000,00$

Bydureon (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Bydureon (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Bydu
2011 2.000,00$

Byetta (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Byetta (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Byetta
2011 2.000,00$

Canagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Canagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides
2011 2.000,00$

Cycloset (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Cycloset (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Cycl
2011 2.000,00$

Dapagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Dapagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides
2011 2.000,00$

Galvus (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Galvus (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Galvus
2011 2.000,00$

Glipizide (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Glipizide (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Gal
2011 2.000,00$

Glyburide (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Glyburide (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Gly
2011 2.000,00$

Glyset (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Glyset (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Glyset
2011 2.000,00$

Humalog (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Humalog (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Humal
2011 2.000,00$

Humulin (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Humulin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Humul
2011 2.000,00$

Insulin Degludec (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Insulin Degludec (Type 2 Diabetes) – Analysis and Forecasts to 2020” provi
2011 2.000,00$

Janumet (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Janumet (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Janum
2011 2.000,00$

Januvia (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Januvia (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Januv
2011 2.000,00$

Kombiglyze XR (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Kombiglyze XR (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides
2011 2.000,00$

Lantus (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Lantus (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Lantus
2011 2.000,00$

Levemir (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Levemir (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Levem
2011 2.000,00$

LY2189265 (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “LY2189265 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides LY2
2011 2.000,00$

Lyxumia (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Lyxumia (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Lyxum
2011 2.000,00$

Naturlose (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Naturlose (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Nat
2011 2.000,00$

Nesina (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Nesina (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Nesina
2011 2.000,00$

Onglyza (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Onglyza (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Ongly
2011 2.000,00$

Prandin (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Prandin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Prand
2011 2.000,00$

Precose (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Precose (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Preco
2011 2.000,00$

Starlix (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Starlix (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Starl
2011 2.000,00$

Symlin (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Symlin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Nesina
2011 2.000,00$

Syncria (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Syncria (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Syncr
2011 2.000,00$

Tradjenta (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tradjenta (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Tra
2011 2.000,00$

Victoza (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Victoza (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Victo
2011 2.000,00$

Welchol (Type 2 Diabetes) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Welchol (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Welch
2011 2.000,00$

Avastin (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Avasti
2011 2.000,00$

Gemzar (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Gemzar
2011 2.000,00$

Farletuzumab (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Farletuzumab (Ovarian Cancer) - Analysis and Forecasts to 2020” provides F
2011 2.000,00$

Votrient (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Votrient (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Votri
2011 2.000,00$

Hycamtin (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Hycamtin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Hycam
2011 2.000,00$

Opaxio (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Opaxio (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Opaxio
2011 2.000,00$

Doxil/Caelyx (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020” provides D
2011 2.000,00$

Vargatef (Ovarian Cancer) – Analysis and Forecats to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Vargatef (Ovarian Cancer) - Analysis and Forecats to 2020” provides Vargat
2011 2.000,00$

Karenitecin (Ovarian Cancer) – Analysis and Forecast to 2020

Introduction / / GlobalData’s pharmaceuticals report, "Karenitecin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Ka
2011 2.000,00$

Paclical (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, "Paclical (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Pacli
2011 2.000,00$

Cisplatin (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, "Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Cisp
2011 2.000,00$

AMG 386 (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, "AMG 386 (Ovarian Cancer) - Analysis and Forecasts to 2020” provides AMG 38
2011 2.000,00$

Carboplatin (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, "Carboplatin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Ca
2011 2.000,00$

Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Yonde
2011 2.000,00$

Recentin (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Recentin (Ovarian Cancer) – Analysis and Forecasts to 2020” provides Recen
2011 2.000,00$

Olaparib (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Olaparib (Ovarian Cancer) – Analysis and Forecasts to 2020” provides Olapa
2011 2.000,00$

EC145 (Ovarian Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020” provides EC145 sa
2011 2.000,00$

Taxol (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Taxol (Breast Cancer) – Analysis and Forecasts to 2020” provides Taxol sal
2011 2.000,00$

Avastin (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Breast Cancer) – Analysis and Forecasts to 2020” provides Avastin
2011 2.000,00$

Taxotere (Breast Cancer) – Analysis and Forecats to 2017

Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Breast Cancer) – Analysis and Forecasts to 2017” provides Taxote
2011 2.000,00$

Afatinib (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Afatinib (Breast Cancer) – Analysis and Forecasts to 2020” provides Afatin
2011 2.000,00$

Femara (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Femara (Breast Cancer) – Analysis and Forecasts to 2020” provides Femara s
2011 2.000,00$

Herceptin (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Herceptin (Breast Cancer) – Analysis and Forecasts to 2020” provides Herce
2011 2.000,00$

Omnitarg (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Omnitarg (Breast Cancer) – Analysis and Forecasts to 2020” provides Omnita
2011 2.000,00$

Trastuzumab-DM1 (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Trastuzumab-DM1 (Breast Cancer) – Analysis and Forecasts to 2020” provides
2011 2.000,00$

Gemzar (Breast Cancer) – Analysis and Forecasts to 2015

Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Breast Cancer) – Analysis and Forecasts to 2015” provides Gemzar s
2011 2.000,00$

Ixempra (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Ixempra (Breast Cancer) – Analysis and Forecasts to 2020” provides Ixempra
2011 2.000,00$

Arimidex (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Arimidex (Breast cancer) - Analysis and Forecasts to 2020” provides Arimid
2011 2.000,00$

Aromasin (Breast Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Aromasin (Breast cancer) - Analysis and Forecasts to 2020” provides Aromas
2011 2.000,00$

Faslodex (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Faslodex (Breast cancer) - Analysis and Forecasts to 2020” provides Faslod
2011 2.000,00$

Neratinib (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Neratinib (Breast cancer) - Analysis and Forecasts to 2020” provides Nerat
2011 2.000,00$

Nolvadex (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Nolvadex (Breast cancer) - Analysis and Forecasts to 2020” provides Nolvad
2011 2.000,00$

Tykerb (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tykerb (Breast cancer) - Analysis and Forecasts to 2020” provides Tykerb s
2011 2.000,00$

Xeloda (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Xeloda (Breast cancer) - Analysis and Forecasts to 2020” provides Xeloda s
2011 2.000,00$

Zoladex (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Zoladex (Breast cancer) - Analysis and Forecasts to 2020” provides Zoladex
2011 2.000,00$

Ellence (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Ellence (Breast cancer) - Analysis and Forecasts to 2020” provides Ellence
2011 2.000,00$

Halaven (Breast cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Halaven (Breast cancer) - Analysis and Forecasts to 2020” provides Halaven
2011 2.000,00$

Tarceva (Pancreatic cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tarceva (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Tar
2011 2.000,00$

Afinitor (Pancreatic cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Af
2011 2.000,00$

Gemzar (Pancreatic cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Gemz
2011 2.000,00$

Abraxane (Pancreatic cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Abraxane (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Ab
2011 2.000,00$

Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides Sute
2011 2.000,00$

S-1 (Pancreatic Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “S-1 (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides S-1 sal
2011 2.000,00$

AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides AMG4
2011 2.000,00$

Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020”
2011 2.000,00$

Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides M
2011 2.000,00$

GVAX (Pancreatic Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “GVAX (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides GVAX s
2011 2.000,00$

Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020” provides Cis
2011 2.000,00$

Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020” provides Cerv
2011 2.000,00$

V503 (Cervical Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “V503 (Cervical Cancer) - Analysis and Forecasts to 2020” provides V503 sal
2011 2.000,00$

Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020” provides Gard
2011 2.000,00$

Hycamtin (Cervical Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Hycamtin (Cervical Cancer) - Analysis and Forecasts to 2020” provides Hyca
2011 2.000,00$

Avastin (Cervical Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Cervical Cancer) - Analysis and Forecasts to 2020 ” provides Avas
2011 2.000,00$

Tirazone (Cervical Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Tirazone ( Cervical Cancer) - Analysis and Forecasts to 2020” provides Ti
2011 2.000,00$

S-1 (Cervical Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ S-1 ( Cervical Cancer) - Analysis and Forecasts to 2020” provides S-1 sal
2011 2.000,00$

Gemzar (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2015

Introduction / / GlobalData’s pharmaceuticals report, “ Gemzar (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2015” pro
2011 2.000,00$

Tarceva (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2015

Introduction / / GlobalData’s pharmaceuticals report, “ Tarceva (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” pr
2011 2.000,00$

Vargatef (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Vargatef (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” p
2011 2.000,00$

Cisplatin (Non Small Cell Lung Cancer) – Analysis and forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Cisplatin (Non Small Cell Lung Cancer) - Analysis and Estimates from 2002
2011 2.000,00$

Abraxane (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Abraxane (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 ”
2011 2.000,00$

ARQ 197 (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ ARQ 197 (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” pr
2011 2.000,00$

Opaxio (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Opaxio (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” pro
2011 2.000,00$

Etoposide (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Etoposide (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” p
2011 2.000,00$

Alimta (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Alimta (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” prov
2011 2.000,00$

Stimuvax (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Stimuvax (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” pr
2011 2.000,00$

Taxol (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ Taxol (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” provi
2011 2.000,00$

Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” pro
2011 2.000,00$

Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” pro
2011 2.000,00$

Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” prov
2011 2.000,00$

Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” p
2011 2.000,00$

Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” provi
2011 2.000,00$

Erbitux (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Erbitux (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” pro
2011 2.000,00$

Navelbine (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Navelbine (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” p
2011 2.000,00$

Tykerb (Head and Neck Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tykerb(Head and Neck Cancer )-Analysis and Forecasts to 2020” provides Ze
2011 2.000,00$

Reolysin (Head and Neck Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Reolysin(Head and Neck Cancer )-Analysis and Forecasts to 2020” provides
2011 2.000,00$

Methotrexate (Head and Neck Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Methotrexate (Head and Neck Cancer )-Analysis and Forecasts to 2020” prov
2011 2.000,00$

Bleomycin (Head and Neck Cancer) –Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Bleomycin (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides
2011 2.000,00$

Iressa (Head and Neck Cancer) –Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Iressa (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides Ir
2011 2.000,00$

Avastin (Head and Neck Cancer) –Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides
2011 2.000,00$

Cisplatin (Head and Neck Cancer) –Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Cisplatin (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides
2011 2.000,00$

Erbitux (Head and Neck Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Erbitux (Head and Neck cancer)- Analysis and Forecasts to 2020” provides E
2011 2.000,00$

Nimotuzumab (Head and Neck Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Nimotuzumab (Head and Neck Cancer) - Analysis and Forecasts to 2020” provi
2011 2.000,00$

Taxotere (Head and Neck Cancer) – Analysis and Forecasts to 2017

Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Head and Neck cancer)- Analysis and Forecasts to 2017” provides
2011 2.000,00$

Axitinib (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Axitinib (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides
2011 2.000,00$

Dovitinib (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Dovitinib (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides
2011 2.000,00$

Avastin (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides A
2011 2.000,00$

Rencarex (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides
2011 2.000,00$

Anyara (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Anyara (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides An
2011 2.000,00$

Nexavar (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Nexavar (Renal Cell Carcinoma)- Analysis and Forecasts to 2020 ” provides
2011 2.000,00$

Sutent (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Sutent (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides Su
2011 2.000,00$

Torisel (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Torisel (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides T
2011 2.000,00$

Afinitor (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Renal Cell Carcinoma) Analysis and Forecasts to 2020” provides A
2011 2.000,00$

Tivozanib (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tivozanib (Renal Cell Carcinoma) Analysis and Forecasts to 2020” provides
2011 2.000,00$

Votrient (Renal Cell Carcinoma) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Votrient (Renal Cell Carcinoma) Analysis and Forecasts to 2020 ” provides
2011 2.000,00$

Tesetaxel (Gastric Cancer) – Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020 ” provides Teset
2011 2.000,00$

Herceptin (Gastric Cancer) -Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Herceptin (Gastric Cancer)-Analysis and Forecasts to 2020” provides Hercep
2011 2.000,00$

Tykerb (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tykerb (Gastric Cancer) - Analysis and Forecasts from 2012 to 2020” provid
2011 2.000,00$

S-1 (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “S-1 (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides S-1 sales
2011 2.000,00$

Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020 ” provides Xeloda
2011 2.000,00$

Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020” provides Etop
2011 2.000,00$

Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides Afin
2011 2.000,00$

Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020” provides Ram
2011 2.000,00$

Cisplatin (Gastric Cancer) - Analysis and Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Cisplatin (Gastric Cancer) – Analysis and Forecasts to 2020” provides Cis
2011 2.000,00$

Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020” provides Dox
2011 2.000,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, October 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, October 2011” report is an e
2011 1.000,00$

Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and
2011 3.500,00$

Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market F
2011 3.500,00$

Ventricular Assist Devices (VAD) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Ventricular Assist Devices (VAD) - Global Pipeline Analysis, Competitive Landscape and
2011 3.500,00$

Bioabsorbable Stents - A Future Outlook

Introduction / / GlobalData’s report, “Bioabsorbable Stents - A Future Outlook” provides key information on bioabsorbable stents
2011 500,00$

Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines Therapeutics - Pi
2011 3.500,00$

Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cancer Vaccines - Pipeline Assessmen
2011 3.500,00$

Systemic Lupus Erythematosus Therapeutics (SLE) - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Systemic Lupus Erythematosus Therape
2011 3.500,00$

Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Depression Therapeutics - Pipeline A
2011 3.500,00$

Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glioblastoma Multiforme (GBM) Therap
2011 3.500,00$

Uterine Fibroids Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Uterine Fibroids Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" p
2011 1.000,00$

Osteopenia Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H2, 2011" provides data on the Os
2011 1.000,00$

Growth Hormone Deficiency Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2011" provides
2011 1.000,00$

Hyperglycemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperglycemia Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Hepatitis B Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2011" provides data on the H
2011 1.000,00$

Barrett’s Esophagus Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Barrett’s Esophagus Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gastroesophageal Reflux Disease (GER
2011 3.500,00$

Polycystic Ovarian Syndrome Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Global Clinical Trials Review, H2, 2011" provid
2011 1.000,00$

Choroidal Neovascularization Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Choroidal Neovascularization Global Clinical Trials Review, H2, 2011" provi
2011 1.000,00$

Cerus Corporation (CERS) - Product Pipeline Analysis

Cerus Corporation (CERS) - Product Pipeline Analysis / / Summary / / Cerus Corporation (Cerus) is a biomedical products manufact
2011 750,00$

IRIS International, Inc. (IRIS) - Product Pipeline Analysis

IRIS International, Inc. (IRIS) - Product Pipeline Analysis / / Summary / / IRIS International, Inc. (IRIS) designs, develops, m
2011 750,00$

W. L. Gore & Associates, Inc. - Product Pipeline Analysis

W. L. Gore & Associates, Inc. - Product Pipeline Analysis / / Summary / / W. L. Gore & Associates, Inc. (Gore) is engaged in the
2011 750,00$

China Sky One Medical, Inc. (CSKI) - Product Pipeline Analysis

China Sky One Medical, Inc. (CSKI) - Product Pipeline Analysis / / Summary / / China Sky One Medical, Inc. formerly Comet Techno
2011 750,00$

Visualase, Inc. - Product Pipeline Analysis

Visualase, Inc. - Product Pipeline Analysis / / Summary / / Visualase, Inc. (Visualase) is a US based privately-held company eng
2011 750,00$

CathRx Ltd (CXD) - Product Pipeline Analysis

CathRx Ltd (CXD) - Product Pipeline Analysis / / Summary / / CathRx Ltd (CathRx) is a medical device company engaged in the rese
2011 750,00$

SensiVida Medical Technologies, Inc (SVMT) - Product Pipeline Analysis

SensiVida Medical Technologies, Inc (SVMT) - Product Pipeline Analysis / / Summary / / SensiVida Medical Technologies Inc.(Sensi
2011 750,00$

SynCardia Systems, Inc. - Product Pipeline Analysis

SynCardia Systems, Inc. - Product Pipeline Analysis / / Summary / / SynCardia Systems, Inc. (SynCardia Systems) is engaged in th
2011 750,00$

Echo Therapeutics, Inc. (ECTE) - Product Pipeline Analysis

Echo Therapeutics, Inc. (ECTE) - Product Pipeline Analysis / / Summary / / Echo Therapeutics, Inc. (Echo Therapeutics) is a medi
2011 750,00$

Hai Kang Life Corporation Limited - Product Pipeline Analysis

Hai Kang Life Corporation Limited - Product Pipeline Analysis / / Summary / / Hai Kang Life Corporation Limited (Hai Kang Life)
2011 750,00$

Terumo Corporation (4543) - Product Pipeline Analysis

Terumo Corporation (4543) - Product Pipeline Analysis / / Summary / / Terumo Corporation (Terumo) is a medical technology compan
2011 750,00$

New Zealand Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “New Zealand Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagno
2011 2.500,00$

Sweden Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Sweden Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Russian Federation Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Russian Federation Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic
2011 2.500,00$

Czech Republic Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Czech Republic Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Dia
2011 2.500,00$

Austria Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Austria Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Disposable Insulin Pumps - A Market Snapshot

Introduction / / GlobalData’s report, “Disposable Insulin Pumps - A Market Snapshot” provides information and analysis on the glo
2011 500,00$

Kyphoplasty and Vertebroplasty Market - Favourable Clinical Evidence and Penetration into New Markets to Drive Growth

Introduction / / GlobalData’s report, “Kyphoplasty and Vertebroplasty Market - Favourable Clinical Evidence and Penetration into
2011 500,00$

Automated Dispensing Machines - A Market Snapshot

Introduction / / GlobalData’s report, “Automated Dispensing Machines - A Market Snapshot” provides key information and analysis o
2011 500,00$

South Africa Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “South Africa Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagn
2011 2.500,00$

Republic of Korea Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Republic of Korea Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic
2011 2.500,00$

Mexico Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Mexico Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Argentina Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Argentina Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnost
2011 2.500,00$

Belgium Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Belgium Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Netherlands Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Netherlands Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagno
2011 2.500,00$

Brazil Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Brazil Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Italy Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Italy Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E
2011 2.500,00$

France Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “France Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Germany Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Germany Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

China Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “China Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E
2011 2.500,00$

Bayer HealthCare AG Market Share Analysis

Introduction / / GlobalData’s new report, “Bayer HealthCare AG Market Share Analysis” provides in-depth information on Bayer Heal
2011 1.000,00$

Fujitsu Limited Market Share Analysis

Introduction / / GlobalData’s new report, “Fujitsu Limited Market Share Analysis” provides in-depth information on Fujitsu Limite
2011 1.000,00$

McKesson Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “McKesson Corporation Market Share Analysis” provides in-depth information on McKesson
2011 1.000,00$

Quantel Medical SA Market Share Analysis

Introduction / / GlobalData’s new report, “Quantel Medical SA Market Share Analysis” provides in-depth information on Quantel Med
2011 1.000,00$

STAAR Surgical Company Market Share Analysis

Introduction / / GlobalData’s new report, “STAAR Surgical Company Market Share Analysis” provides in-depth information on STAAR S
2011 1.000,00$

Vascular Concepts Limited Market Share Analysis

Introduction / / GlobalData’s new report, “Vascular Concepts Limited Market Share Analysis” provides in-depth information on Vasc
2011 1.000,00$

United States Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

Introduction / / GlobalData’s new report, “United States Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Syst
2011 2.500,00$

Europe Healthcare IT Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Healthcare IT Market Outlook to 2017” provides key market data on the Europe
2011 3.500,00$

South and Central America Ophthalmic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Ophthalmic Devices Market Outlook to 2017” provides key mar
2011 3.500,00$

Asia-Pacific Ophthalmic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Ophthalmic Devices Market Outlook to 2017” provides key market data on t
2011 3.500,00$

Interventional Cardiology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Interventional Cardiology Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, Sou
2011 2.500,00$

Europe Ophthalmic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Ophthalmic Devices Market Outlook to 2017” provides key market data on the Eu
2011 3.500,00$

KW-6002– Analysis and Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “KW-6002– Analysis and Forecasts from 2013 to 2020” provides KW-6002 sales
2011 2.000,00$

Neupro - Analysis and Estimates from 2006 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Neupro - Analysis and Estimates from 2006 to 2020” provides Neupro sales e
2011 2.000,00$

Atrial Septal Defect Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Atrial Septal Defect Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Diabetic Nephropathy Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Glucose Intolerance Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Glucose Intolerance Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Type 1 Diabetes Therapeutics - Pipel
2011 3.500,00$

Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Psoriasis Therapeutics - Pipeline As
2011 3.500,00$

Azilect – Analysis and Estimates from 2005 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Azilect – Analysis and Estimates from 2005 to 2020” provides Azilect sales
2011 2.000,00$

Requip (ropinirole) – Analysis and Estimates from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Requip (ropinirole) – Analysis and Estimates from 2002 to 2020” provides R
2011 2.000,00$

Apokyn – Analysis and Estimates from 2004 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Apokyn – Analysis and Estimates from 2004 to 2020” provides Apokyn sales e
2011 2.000,00$

Stalevo – Analysis and Estimates from 2003 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Stalevo – Analysis and Estimates from 2003 to 2020” provides Stalevo sales
2011 2.000,00$

Mirapex – Analysis and Estimates from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Mirapex – Analysis and Estimates from 2002 to 2020” provides Mirapex sales
2011 2.000,00$

Comtan - Analysis and Estimates from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Comtan - Analysis and Estimates from 2002 to 2020” provides Comtan sales e
2011 2.000,00$

Zelapar – Analysis and Estimates from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Zelapar – Analysis and Estimates from 2002 to 2020” provides Zelapar sales
2011 2.000,00$

Eldepryl – Analysis and Estimates from 2002 to 2012

Introduction / / GlobalData’s pharmaceuticals report, “Eldepryl – Analysis and Estimates from 2002 to 2012” provides Eldepryl sal
2011 2.000,00$

Tasmar – Analysis and Estimates from 2004 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tasmar – Analysis and Estimates from 2004 to 2020” provides Tasmarsales es
2011 2.000,00$

Requip XL – Analysis and Estimates from 2007 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Requip XL – Analysis and Estimates from 2007 to 2020” provides Requip XL
2011 2.000,00$

Mirapex ER – Analysis and Estimates from 2009 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Mirapex ER – Analysis and Estimates from 2009 to 2020” provides Mirapex ER
2011 2.000,00$

Trerief – Analysis and Estimates from 2009 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Trerief – Analysis and Estimates from 2009 to 2020” provides Trerief sales
2011 2.000,00$

Safinamide – Analysis and Estimates from 2012 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Safinamide – Analysis and Estimates from 2012 to 2020” provides Safinamide
2011 2.000,00$

IPX066 – Analysis and Estimates from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “IPX066 – Analysis and Estimates from 2013 to 2020” provides IPX066 sales
2011 2.000,00$

Preladenant– Analysis and Estimates from 2014 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Preladenant– Analysis and Estimates from 2014 to 2020” provides Preladenan
2011 2.000,00$

Pardoprunox – Analysis and Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Pardoprunox – Analysis and Forecasts from 2013 to 2020” provides Pardoprun
2011 2.000,00$

Abilify – Analysis and Estimates from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Abilify – Analysis and Estimates from 2002 to 2020” provides Abilify sale
2011 2.000,00$

Clozapine – Analysis and Forecasts from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Clozapine – Analysis and Forecasts from 2002 to 2020” provides Clozapines
2011 2.000,00$

Geodon – Analysis and Forecasts from 2002 to 2017

Introduction / / GlobalData’s pharmaceuticals report, “Geodon – Analysis and Forecasts from 2002 to 2017” provides Geodon sales
2011 2.000,00$

Invega – Analysis and Forecasts from 2007 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Invega – Analysis and Forecasts from 2007 to 2020” provides Invega sales
2011 2.000,00$

Latuda – Analysis and Forecasts from 2011 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Latuda – Analysis and Forecasts from 2011 to 2020” provides Latuda sales
2011 2.000,00$

Risperdal Consta – Analysis and Forecasts from 2003 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Risperdal Consta – Analysis and Forecasts from 2003 to 2020” provides Risp
2011 2.000,00$

Saphris – Analysis and Estimates from 2009 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Saphris – Analysis and Estimates from 2009 to 2020” provides Saphris sale
2011 2.000,00$

Seroquel – Analysis and Estimates from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Seroquel – Analysis and Estimates from 2002 to 2020” provides Seroquel sal
2011 2.000,00$

Zyprexa – Analysis and Forecasts from 2002 to 2018

Introduction / / GlobalData’s pharmaceuticals report, “Zyprexa – Analysis and Forecasts from 2002 to 2018” provides Zyprexa sal
2011 2.000,00$

Seroquel XR – Analysis and Estimates from 2007 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Seroquel XR – Analysis and Estimates from 2007 to 2020” provides Seroquel
2011 2.000,00$

Invega Sustenna – Analysis and Forecasts from 2009 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Invega Sustenna – Analysis and Forecasts from 2009 to 2020” provides Inv
2011 2.000,00$

Cariprazine – Analysis and Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Cariprazine – Analysis and Forecasts from 2013 to 2020” provides Caripra
2011 2.000,00$

Zicronapine – Analysis and Forecasts from 2014 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Zicronapine – Analysis and Forecasts from 2014 to 2020” provides Zicrona
2011 2.000,00$

RG1678 – Analysis and Forecasts from 2014 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “RG1678 – Analysis and Forecasts from 2014 to 2020” provides RG1678  sale
2011 2.000,00$

Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020” provides T
2011 2.000,00$

Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020” provides R
2011 2.000,00$

Remodulin - Analysis and Forecasts from 2002 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Remodulin - Analysis and Forecasts from 2002 to 2020” provides Remodulin s
2011 2.000,00$

Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020
2011 2.000,00$

Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017

Introduction / / GlobalData’s pharmaceuticals report, “Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017” provides V
2011 2.000,00$

Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020” provides A
2011 2.000,00$

Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020” provides
2011 2.000,00$

Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020” provide
2011 2.000,00$

Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020” provid
2011 2.000,00$

Riociguat - Analysis and Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Riociguat - Analysis and Forecasts from 2013 to 2020” provides Riociguat s
2011 2.000,00$

Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020”
2011 2.000,00$

Gleevec - Analysis and Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Gleevec - Analysis and Forecasts from 2013 to 2020” provides Gleevec sales
2011 2.000,00$

Doxorubicin – Analysis and Market Forecasts from 2011 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Doxorubicin – Analysis and Market Forecasts from 2011 to 2020” provides Do
2011 2.000,00$

Miripla – Analysis and Market Forecasts from 2010 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Miripla – Analysis and Market Forecasts from 2010 to 2020” provides Miripl
2011 2.000,00$

PrevOnco – Analysis and Market Forecasts from 2014 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “PrevOnco – Analysis and Market Forecasts from 2014 to 2020” provides PrevO
2011 2.000,00$

Ramucirumab – Analysis and Market Forecasts from 2014 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Ramucirumab – Analysis and Market Forecasts from 2014 to 2020” provides Ra
2011 2.000,00$

Tarceva – Analysis and Market Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Tarceva – Analysis and Market Forecasts from 2013 to 2020” provides Tarcev
2011 2.000,00$

Thalidomide – Analysis and Market Forecasts from 2015 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Thalidomide – Analysis and Market Forecasts from 2015 to 2020” provides Th
2011 2.000,00$

Muparfostat – Analysis and Market Forecasts from 2017 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Muparfostat – Analysis and Market Forecasts from 2017 to 2020” provides Mu
2011 2.000,00$

Nexavar – Analysis and Market Forecasts from 2007 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Nexavar – Analysis and Market Forecasts from 2007 to 2020” provides Nexava
2011 2.000,00$

ThermoDox – Analysis and Market Forecasts from 2012 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “ThermoDox – Analysis and Market Forecasts from 2012 to 2020” provides Ther
2011 2.000,00$

Avastin (bevacizumab) – Analysis and Market Forecasts from 2016 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Avastin (bevacizumab) – Analysis and Market Forecasts from 2016 to 2020” p
2011 2.000,00$

Brivanib – Analysis and Market Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Brivanib – Analysis and Market Forecasts from 2013 to 2020” provides Briva
2011 2.000,00$

Linifanib – Assessment and Market Forecasts from 2013 to 2020

Introduction / / GlobalData’s pharmaceuticals report, “Linifanib – Analysis and Market Forecasts from 2013 to 2020” provides Lini
2011 2.000,00$

European Society of Cardiology Congress 2011 - Post-Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “European Society of Cardi
2011 1.000,00$

Development of New Antibiotics Hits a Road Block

Introduction / / GlobalData, the industry analysis specialist, has released its new viewpoint, “Development of New Antibiotics Hi
2011 500,00$

Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Autistic Disorder Therapeutics - Pip
2011 3.500,00$

Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Multiple Myeloma Therapeutics - Pipe
2011 3.500,00$

Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Non-Hodgkin's Lymphoma (NHL) Therape
2011 3.500,00$

Aortic Valve Diseases Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Aortic Valve Diseases Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Melanoma Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H2, 2011" provides data on the Mela
2011 1.000,00$

Hemorrhagic Shock Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Sick Sinus Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Sick Sinus Syndrome Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Hypoplastic Left Heart Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hypoplastic Left Heart Syndrome Global Clinical Trials Review, H2, 2011" pr
2011 1.000,00$

Raynauds Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Coronary Thrombosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Thrombosis Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Bone Metastasis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Shock Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Shock Global Clinical Trials Review, H2, 2011" provides data on the Shock c
2011 1.000,00$

Hemorrhage Global Clinical Trials Review, H2 2011

Introduction / / GlobalData's clinical trial report, “Hemorrhage Global Clinical Trials Review, H2, 2011" provides data on the He
2011 1.000,00$

Tetralogy Of Fallot Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Tetralogy Of Fallot Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Malignant Mesothelioma Therapeutics
2011 2.000,00$

Hyperparathyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hyperparathyroidism Therapeutics - P
2011 2.000,00$

Hyperthyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hyperthyroidism Therapeutics - Pipel
2011 2.000,00$

Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Alopecia Therapeutics - Pipeline Ass
2011 2.000,00$

Restless Leg Syndrome (RLS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Restless Leg Syndrome (RLS) Therapeu
2011 2.000,00$

Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Ischemic Stroke (AIS) Therapeu
2011 3.500,00$

Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Amyotrophic Lateral Sclerosis (ALS)
2011 3.500,00$

Endometriosis Therapeutics- Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Endometriosis Therapeutics- Pipeline
2011 3.500,00$

Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Rheumatoid Arthritis Therapeutics -
2011 3.500,00$

Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Kidney Disease (CKD) Therape
2011 3.500,00$

Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Atopic Dermatitis Therapeutics - Pip
2011 3.500,00$

Dyslipidemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dyslipidemia Therapeutics - Pipeline
2011 3.500,00$

Cardiovascular Monitoring and Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Cardiovascular Monitoring and Diagnostic Devices Market Outlook in BRICS (Brazil, Russ
2011 2.500,00$

North America Ophthalmic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Ophthalmic Devices Market Outlook to 2017” provides key market data on t
2011 3.500,00$

Netherlands Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Netherlands Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management,
2011 2.500,00$

Taiwan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Taiwan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte
2011 2.500,00$

United States Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “United States Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diag
2011 2.500,00$

United Kingdom Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “United Kingdom Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Dia
2011 2.500,00$

Japan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Japan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E
2011 2.500,00$

India Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “India Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E
2011 2.500,00$

Canada Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Canada Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic
2011 2.500,00$

Spain Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Spain Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E
2011 2.500,00$

Australia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices

Introduction / / GlobalData’s new report, “Australia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnost
2011 2.500,00$

Abdominal Aortic Stent Grafts - A Market Snapshot

Introduction / / GlobalData’s report “Abdominal Aortic Stent Grafts - A Market Snapshot” provides key insights on the abdominal a
2011 500,00$

Liver Cirrhosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Ventricular Arrhythmia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Ventricular Arrhythmia Global Clinical Trials Review, H2, 2011" provides da
2011 1.000,00$

Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2011" provid
2011 1.000,00$

Bleeding and Clotting Disorders Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Bleeding and Clotting Disorders Global Clinical Trials Review, H2, 2011" pr
2011 1.000,00$

Menopausal Disorders Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Menopausal Disorders Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Coronary Vasospasm Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Vasospasm Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Pre-Eclampsia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Pre-Eclampsia Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

High Triglyceridemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “High Triglyceridemia Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2011" provi
2011 1.000,00$

American Medical Technologies, Inc. (ADLI) - Financial and Strategic SWOT Analysis Review

American Medical Technologies, Inc (AMT) is a dental medical device company engaged in development, manufacture and marketing of h
2011 125,00$

Biocompatibles International Ltd. - Financial and Strategic SWOT Analysis Review

Biocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used fo
2011 125,00$

Biophan Technologies, Inc. - Financial and Strategic SWOT Analysis Review

Biophan Technologies, Inc. (Biophan Technologies) is a technology development and holding company, engaged in the development and
2011 125,00$

Atrion Corporation (ATRI) - Financial and Strategic SWOT Analysis Review

Atrion Corporation (Atrion), is engaged in the design, development, manufacture, sale and distribution of products and components
2011 250,00$

NMT Medical, Inc. (NMTI) - Financial and Strategic SWOT Analysis Review

NMT Medical, Inc. (NMT Medical) designs, develops and markets innovative medical devices for the non-surgical treatment of patient
2011 250,00$

CMT Medical Technologies Ltd (CMD) - Financial and Strategic SWOT Analysis Review

CMT Medical Technologies Ltd (CMT) is a medical device company engaged in the design, development, manufacture and marketing of hi
2011 250,00$

Merz Aesthetics, Inc. - Financial and Strategic SWOT Analysis Review

Merz Aesthetics, Inc. (Merz Aesthetics) formely known as BioForm Medical, Inc. is a medical aesthetics company specialized in the
2011 125,00$

Zygo Corporation (ZIGO) - Financial and Strategic SWOT Analysis Review

ZYGO Corporation (ZYGO) is engaged in the design, manufacture and marketing of high-end optical systems and components for metrolo
2011 250,00$

Samyang Corporation (000070) - Financial and Strategic SWOT Analysis Review

Samyang Corporation (Samyang), through its subsidiaries, provides various products and services in the areas of food, chemicals, p
2011 125,00$

BioMedical Enterprises, Inc. - Strategic SWOT Analysis Review

BioMedical Enterprises, Inc. (BME) is a medical device company, engaged in the development, manufacture and marketing of orthopedi
2011 125,00$

Maximus Medical Products, Inc. - Strategic SWOT Analysis Review

Maximus Medical Products, Inc. (Maximus Medical) is engaged in the manufacture and distribution of specialty intravenous (I.V.) th
2011 125,00$

LifeMasters Supported SelfCare, Inc. - Strategic SWOT Analysis Review

LifeMasters Supported SelfCare, Inc. (LifeMasters) is a US based disease management company. The company is engaged in the provisi
2011 125,00$

Goold Health Systems, Inc. - Strategic SWOT Analysis Review

Goold Health Systems, Inc. (GHS) is a privately-held healthcare management company that focuses on providing pharmacy benefit serv
2011 125,00$

Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review

Jubilant Life Sciences Limited (formerly Jubilant Organosys Limited) is engaged in the research and development of advanced and in
2011 125,00$

Campbell Brothers Limited (CPB) - Financial and Strategic SWOT Analysis Review

Campbell Brothers Limited (Campbell) is an Australia-based commercial services company. The company operates its business through
2011 125,00$

Animal Health International, Inc. - Financial and Strategic SWOT Analysis Review

Animal Health International, Inc. (Animal Health) is one of the leading distributors of animal health products in the US and Canad
2011 125,00$

Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic SWOT Analysis Review

Polydex Pharmaceuticals Limited (PPL) is a biotechnology company, engaged in the development and manufacturing of products based o
2011 250,00$

VaxGen, Inc. (VXGN) - Financial and Strategic SWOT Analysis Review

VaxGen, Inc., (VaxGen) is a biopharmaceutical company, engaged in the development, manufacture and marketing of biologic products
2011 250,00$

Microfluidics International Corporation (MFLU) - Financial and Strategic SWOT Analysis Review

Microfluidics International Corporation (Microfluidics) is engaged in manufacturing and marketing a range of materials processing
2011 250,00$

Synthetech, Inc. (NZYM) - Financial and Strategic SWOT Analysis Review

Synthetech, Inc. (Synthetech) is a publicly held pharmaceutical company specializing in organic synthesis, bio catalysis and chira
2011 250,00$

LecTec Corporation (LECT) - Financial and Strategic SWOT Analysis Review

LecTec Corporation (LecTec) is an intellectual property licensing and holding company. The company principally earns royalties by
2011 250,00$

O.I. Corporation (OICO) - Financial and Strategic SWOT Analysis Review

O.I. Corporation (OI) is a medical device company and it is engaged in providing and supplying the products for chemical analysi
2011 250,00$

Minapharm Pharmaceuticals & Chemical Industries - Strategic SWOT Analysis Review

Minapharm Pharmaceuticals & Chemical Industries (Minapharm) is a privately held specialty pharmaceutical company engaged in the ma
2011 250,00$

RegeneRx Biopharmaceuticals, Inc. (RGN) - Strategic SWOT Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is publicly held US based biopharmaceutical company. The company i
2011 250,00$

Binex Co., Ltd. (053030) - Strategic SWOT Analysis Review

Binex Co., Ltd. (Binex) is a pharmaceutical company engaged in manufacturing over-the-counter (OTC) drugs and bulk pharmaceuticals
2011 250,00$

First Health Services Corporation - Strategic SWOT Analysis Review

First Health Services Corporation (First Health Services) is a leading provider of integrated clinical management services for pub
2011 125,00$

Chemaphor Inc. (CFR) - Strategic SWOT Analysis Review

Chemaphor Inc. (Chemaphor) is a publicly held biotechnology company that is engaged in the development and commercialization of sm
2011 250,00$

China Pediatric Pharmaceuticals, Inc. (CPDU) - Strategic SWOT Analysis Review

China Pediatric Pharmaceuticals, Inc.(China Pediatric Pharmaceuticals) is a pharmaceutical company principally engaged in the deve
2011 250,00$

Beluga Composites Corp. (BGCC) - Strategic SWOT Analysis Review

Beluga Composites Corp. (Beluga) is engaged in the development of immunodiagnostic testing systems. The company performs immunodia
2011 250,00$

Vivimed Labs Limited (532660 ) - Strategic SWOT Analysis Review

Vivimed Labs (Vivimed) is an publicly held India based pharma company. It is engaged in the manufacture of ingredients used in the
2011 250,00$

Middle East and Africa Cardiovascular Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Cardiovascular Devices Market Outlook to 2017” provides key mar
2011 3.500,00$

South and Central America Cardiovascular Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Cardiovascular Devices Market Outlook to 2017” provides key
2011 3.500,00$

Dental Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Dental Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts
2011 3.500,00$

Spinal Fusion - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Spinal Fusion - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t
2011 3.500,00$

Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market F
2011 3.500,00$

Aortic Stent Grafts - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Aortic Stent Grafts - Global Pipeline Analysis, Competitive Landscape and Market Forec
2011 3.500,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, September 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, September 2011” report is an
2011 1.000,00$

Belgium Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Belgium Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int
2011 2.500,00$

Mexico Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Mexico Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte
2011 2.500,00$

Republic of Korea Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Republic of Korea Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Manag
2011 2.500,00$

South Africa Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “South Africa Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management
2011 2.500,00$

Israel Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Israel Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte
2011 2.500,00$

US Cloud Computing Market for Medical Imaging - Exponential Growth in the Volume of Medical Imaging Data to Drive Market

Introduction / / GlobalData’s report, “US Cloud Computing Market for Medical Imaging - Exponential Growth in the Volume of Medica
2011 500,00$

Austria Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Austria Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int
2011 2.500,00$

Czech Republic Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Czech Republic Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Manageme
2011 2.500,00$

Russian Federation Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Russian Federation Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Mana
2011 2.500,00$

Sweden Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Sweden Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte
2011 2.500,00$

New Zealand Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “New Zealand Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management,
2011 2.500,00$

Denmark Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Denmark Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int
2011 2.500,00$

Saudi Arabia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Saudi Arabia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management
2011 2.500,00$

Gilead’s newly approved drug Complera, the Second Triple Combination Once-a-Day Pill Intended for Untreated HIV Patients is unlikely to displace its own market-leading drug, Atripla

Introduction / / GlobalData’s viewpoint, “Gilead’s newly approved drug Complera, the Second Triple Combination Once-a-Day Pill In
2011 500,00$

Increasing Collaboration Between Big Pharma and Academia to Counter R&D, Patent and Approval Issues in the Industry

Introduction / / GlobalData’s viewpoint, “Increasing Collaboration Between Big Pharma and Academia to Counter R&D, Patent and App
2011 500,00$

Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Lymphocytic Leukemia (ALL) The
2011 2.000,00$

Nocturnal Enuresis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Nocturnal Enuresis Therapeutics - Pi
2011 2.000,00$

HIV-Associated Lipodystrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / Industry analysis specialist, GlobalData, has released its new report, “HIV-Associated Lipodystrophy Therapeutic
2011 2.000,00$

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cytomegalovirus (CMV) Infections - P
2011 3.500,00$

Small Cell Lung Cancer (SCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Small Cell Lung Cancer (SCLC) Therap
2011 3.500,00$

Asthma Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Asthma Therapeutics - Pipeline Asses
2011 3.500,00$

Glaucoma Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glaucoma Therapeutics - Pipeline Ass
2011 3.500,00$

Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Post-Menopausal Hormone Replacement
2011 3.500,00$

Macular Edema Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Macular Edema Therapeutics - Pipelin
2011 3.500,00$

Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Neuropathic Pain Therapeutics - Pipe
2011 3.500,00$

Macular Degeneration Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Macular Degeneration Therapeutics -
2011 3.500,00$

Allergic Conjunctivitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData's report, “Allergic Conjunctivitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”,
2011 3.500,00$

Irritable Bowel Syndrome (IBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Irritable Bowel Syndrome (IBS) Thera
2011 3.500,00$

Hemophilia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hemophilia Therapeutics - Pipeline A
2011 3.500,00$

Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ulcerative Colitis Therapeutics - Pi
2011 3.500,00$

Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Herpes Simplex Therapeutics - Pipeli
2011 3.500,00$

Meningitis - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Meningitis - Pipeline Assessment and
2011 3.500,00$

Cataract Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H2, 2011" provides data on the Cata
2011 1.000,00$

Liver Fibrosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Fatty Liver Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Malaria Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, H2, 2011" provides data on the Malar
2011 1.000,00$

CryoLife, Inc. (CRY) - Product Pipeline Analysis

CryoLife, Inc. (CRY) - Product Pipeline Analysis / / Summary / / CryoLife, Inc. (CryoLife) is a biological medical device compan
2011 750,00$

Sequenom, Inc. (SQNM) - Product Pipeline Analysis

Sequenom, Inc. (SQNM) - Product Pipeline Analysis / / Summary / / Sequenom, Inc. (Sequenom) is a molecular diagnostic testing an
2011 750,00$

Qiagen N.V. (QIA) - Product Pipeline Analysis

Qiagen N.V. (QIA) - Product Pipeline Analysis / / Summary / / Qiagen N.V. (Qiagen) is engaged in providing innovative technologi
2011 750,00$

BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis

BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis / / Summary / / BioMimetic Therapeutics, Inc. (BioMimetic) is a
2011 750,00$

CytoCore, Inc. (CYOE) - Product Pipeline Analysis

CytoCore, Inc. (CYOE) - Product Pipeline Analysis / / Summary / / CytoCore, Inc. (CCI), formerly known as Molecular Diagnostics,
2011 750,00$

Toshiba America Medical Systems, Inc. - Product Pipeline Analysis

Toshiba America Medical Systems, Inc. - Product Pipeline Analysis / / Summary / / Toshiba America Medical Systems, Inc. (TAMS) i
2011 750,00$

Genomic Health, Inc. (GHDX) - Product Pipeline Analysis

Genomic Health, Inc. (GHDX) - Product Pipeline Analysis / / Summary / / Genomic Health, Inc. (Genomic Health) is a life science
2011 750,00$

Exiqon AS (EXQ) - Product Pipeline Analysis

Exiqon AS (EXQ) - Product Pipeline Analysis / / Summary / / Exiqon A/S (Exiqon) is a biotechnology company principally engaged i
2011 750,00$

Interleukin Genetics, Inc. (ILIU) - Product Pipeline Analysis

Interleukin Genetics, Inc. (ILIU) - Product Pipeline Analysis / / Summary / / Interleukin Genetics, Inc. (Interleukin) is a gene
2011 750,00$

Pacific Edge Limited (PEB) - Product Pipeline Analysis

Pacific Edge Limited (PEB) - Product Pipeline Analysis / / Summary / / Pacific Edge Limited (PEB), formerly Pacific Edge Biotech
2011 750,00$

Merit Medical Systems, Inc. (MMSI) - Product Pipeline Analysis

Merit Medical Systems, Inc. (MMSI) - Product Pipeline Analysis / / Summary / / Merit Medical Systems, Inc. (Merit Medical) is a
2011 750,00$

Luminex Corporation (LMNX) - Product Pipeline Analysis

Luminex Corporation (LMNX) - Product Pipeline Analysis / / Summary / / Luminex Corporation (Luminex) engages in the development,
2011 750,00$

Artimplant AB (ARTI B) - Product Pipeline Analysis

Artimplant AB (ARTI B) - Product Pipeline Analysis / / Summary / / Artimplant AB (Artimplant) is a biomaterials company providin
2011 750,00$

Biomerica, Inc. (BMRA) - Product Pipeline Analysis

Biomerica, Inc. (BMRA) - Product Pipeline Analysis / / Summary / / Biomerica, Inc. (Biomerica) is engaged in the development, ma
2011 750,00$

SpectraScience, Inc. (SCIE) - Product Pipeline Analysis

SpectraScience, Inc. (SCIE) - Product Pipeline Analysis / / Summary / / SpectraScience, Inc. (SpectraScience) is a medical devic
2011 750,00$

Cyberonics, Inc. (CYBX) - Product Pipeline Analysis

Cyberonics, Inc. (CYBX) - Product Pipeline Analysis / / Summary / / Cyberonics, Inc. (Cyberonics) is a neuromodulation company.
2011 750,00$

Quidel Corporation (QDEL) - Product Pipeline Analysis

Quidel Corporation (QDEL) - Product Pipeline Analysis / / Summary / / Quidel Corporation (Quidel) is a medical device company en
2011 750,00$

Thoratec Corporation (THOR) - Product Pipeline Analysis

Thoratec Corporation (THOR) - Product Pipeline Analysis / / Summary / / Thoratec Corporation (Thoratec) is a medical device comp
2011 750,00$

Spire Corporation (SPIR) - Product Pipeline Analysis

Spire Corporation (SPIR) - Product Pipeline Analysis / / Summary / / Spire Corporation (Spire) is engaged in the development, ma
2011 750,00$

Akers Biosciences, Inc. (AKR) - Product Pipeline Analysis

Akers Biosciences, Inc. (AKR) - Product Pipeline Analysis / / Summary / / Akers Biosciences, Inc. (ABI) is engaged in the develo
2011 750,00$

DiaGenic ASA (DIAG) - Product Pipeline Analysis

DiaGenic ASA (DIAG) - Product Pipeline Analysis / / Summary / / DiaGenic ASA (DiaGenic) is a life sciences company, primarily en
2011 750,00$

Nephros, Inc. (NEPH) - Product Pipeline Analysis

Nephros, Inc. (NEPH) - Product Pipeline Analysis / / Summary / / Nephros, Inc. (Nephros) is US-based medical device company that
2011 750,00$

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis / / Summary / / Calypte Biomedical Corporation (Calypte) is a
2011 750,00$

Misonix, Inc. (MSON) - Product Pipeline Analysis

Misonix, Inc. (MSON) - Product Pipeline Analysis / / Summary / / Misonix, Inc. (Misonix) is engaged in the design, development,
2011 750,00$

Antares Pharma, Inc. (AIS) - Product Pipeline Analysis

Antares Pharma, Inc. (AIS) - Product Pipeline Analysis / / Summary / / Antares Pharma, Inc. (Antares Pharma) is a specialty phar
2011 750,00$

Clarient, Inc. - Product Pipeline Analysis

Clarient, Inc. - Product Pipeline Analysis / / Summary / / Clarient, Inc. (Clarient) is an oncology diagnostics services company
2011 750,00$

Cardium Therapeutics, Inc. (CXM) - Product Pipeline Analysis

Cardium Therapeutics, Inc. (CXM) - Product Pipeline Analysis / / Summary / / Cardium Therapeutics, Inc. (Cardium) is a medical t
2011 750,00$

LeMaitre Vascular, Inc. (LMAT) - Product Pipeline Analysis

LeMaitre Vascular, Inc. (LMAT) - Product Pipeline Analysis / / Summary / / LeMaitre Vascular, Inc. (LeMaitre Vascular) is a medi
2011 750,00$

Cytori Therapeutics, Inc. (XMP) - Product Pipeline Analysis

Cytori Therapeutics, Inc. (XMP) - Product Pipeline Analysis / / Summary / / Cytori Therapeutics, Inc. (Cytori) is a medical devi
2011 750,00$

NuVasive, Inc. (NUVA) - Product Pipeline Analysis

NuVasive, Inc. (NUVA) - Product Pipeline Analysis / / Summary / / NuVasive, Inc. (NuVasive) is a medical device company engaged
2011 750,00$

Ethicon Endo-Surgery, Inc. - Product Pipeline Analysis

Ethicon Endo-Surgery, Inc. - Product Pipeline Analysis / / Summary / / Ethicon Endo-Surgery, Inc. (EES) is a US-based medical de
2011 750,00$

Abbott Diagnostics - Product Pipeline Analysis

Abbott Diagnostics - Product Pipeline Analysis / / Summary / / Abbott Diagnostics, one of the world’s leading in vitro diagnosti
2011 750,00$

Integra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis

Integra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis / / Summary / / Integra LifeSciences Holdings Corpo
2011 750,00$

Kinetic Concepts, Inc. (KCI) - Product Pipeline Analysis

Kinetic Concepts, Inc. (KCI) - Product Pipeline Analysis / / Summary / / Kinetic Concepts, Inc. (KCI) is a global medical techno
2011 750,00$

Cepheid (CPHD) - Product Pipeline Analysis

Cepheid (CPHD) - Product Pipeline Analysis / / Summary / / Cepheid is a molecular diagnostic company, engaged in the development
2011 750,00$

Alphatec Holdings, Inc. (ATEC) - Product Pipeline Analysis

Alphatec Holdings, Inc. (ATEC) - Product Pipeline Analysis / / Summary / / Alphatec Holdings, Inc. (Alphatec) is a medical techn
2011 750,00$

Epigenomics AG (ECX) - Product Pipeline Analysis

Epigenomics AG (ECX) - Product Pipeline Analysis / / Summary / / Epigenomics AG (Epigenomics) is a molecular diagnostics company
2011 750,00$

Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis

Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis / / Summary / / Anika Therapeutics, Inc. (Anika) is engaged in the d
2011 750,00$

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis / / Summary / / Nanosphere, Inc. (Nanosphere) is a nanotechnology-based mole
2011 750,00$

Endologix, Inc. (ELGX) - Product Pipeline Analysis

Endologix, Inc. (ELGX) - Product Pipeline Analysis / / Summary / / Endologix, Inc. (Endologix) is a medical device company engag
2011 750,00$

Cardiac Assist Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Cardiac Assist Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Af
2011 2.500,00$

Cardiac Rhythm Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Cardiac Rhythm Management Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Cardiovascular Prosthetic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Cardiovascular Prosthetic Devices Market Outlook in BRICS (Brazil, Russia, India, Chin
2011 2.500,00$

Cardiovascular Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Cardiovascular Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Af
2011 2.500,00$

Prosthetic Heart Valves Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Prosthetic Heart Valves Market Outlook in BRICS (Brazil, Russia, India, China, South A
2011 2.500,00$

Electrophysiology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Electrophysiology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa)
2011 2.500,00$

External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Af
2011 2.500,00$

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to
2011 2.500,00$

Merge Healthcare Completes Acquisition of Ophthalmic Imaging Systems (OIS) - A Move to Expand into New Markets through Strategic Acquisition - Deal Analysis from GlobalData

Introduction / / GlobalData’s “Merge Healthcare Completes Acquisition of Ophthalmic Imaging Systems (OIS): A Move to Expand Throu
2011 500,00$

Orthopedic Joint Reconstruction Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Orthopedic Joint Reconstruction Market Outlook in BRICS (Brazil, Russia, India, China,
2011 2.500,00$

Spinal Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Spinal Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to
2011 2.500,00$

Trauma Fixation Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Trauma Fixation Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) t
2011 2.500,00$

Arthroscopy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Arthroscopy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 20
2011 2.500,00$

Orthopedic Accessories Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Orthopedic Accessories Market Outlook in BRICS (Brazil, Russia, India, China, South Af
2011 2.500,00$

Orthopedic Braces and Supports Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Orthopedic Braces and Supports Market Outlook in BRICS (Brazil, Russia, India, China,
2011 2.500,00$

Cranio Maxillofacial Fixation (CMF) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Cranio Maxillofacial Fixation (CMF) Market Outlook in BRICS (Brazil, Russia, India, Ch
2011 2.500,00$

Orthopedic Prosthetics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Orthopedic Prosthetics Market Outlook in BRICS (Brazil, Russia, India, China, South Af
2011 2.500,00$

Operating Room Equipment - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Operating Room Equipment - Global Opportunity Assessment, Competitive Landscape and Ma
2011 3.500,00$

North America Cardiovascular Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Cardiovascular Devices Market Outlook to 2017” provides key market data
2011 3.500,00$

Europe Cardiovascular Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Cardiovascular Devices Market Outlook to 2017” provides key market data on the
2011 3.500,00$

Asia-Pacific Cardiovascular Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Cardiovascular Devices Market Outlook to 2017” provides key market data
2011 3.500,00$

Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts
2011 3.500,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends - August 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends - August 2011” report is an e
2011 1.000,00$

United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Managemen
2011 2.500,00$

United Kingdom Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “United Kingdom Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Manageme
2011 2.500,00$

Japan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Japan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter
2011 2.500,00$

India Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “India Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter
2011 2.500,00$

China Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “China Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter
2011 2.500,00$

Canada Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Canada Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte
2011 2.500,00$

Germany Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Germany Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int
2011 2.500,00$

France Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “France Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte
2011 2.500,00$

Italy Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Italy Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter
2011 2.500,00$

Spain Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Spain Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter
2011 2.500,00$

Australia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Australia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, I
2011 2.500,00$

Brazil Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Brazil Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte
2011 2.500,00$

Argentina Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Introduction / / GlobalData’s new report, “Argentina Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, I
2011 2.500,00$

Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Postmenopausal Osteoporosis Therapeu
2011 2.000,00$

Pneumococcal Infections - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Pneumococcal Infections - Pipeline A
2011 2.000,00$

Uterine Fibroids Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Uterine Fibroids Therapeutics - Pipe
2011 2.000,00$

Acromegaly and Gigantism Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acromegaly and Gigantism Therapeutic
2011 2.000,00$

Staphylococcal Infections Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Staphylococcal Infections Therapeuti
2011 2.000,00$

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Idiopathic Pulmonary Fibrosis (IPF)
2011 3.500,00$

Nonalcoholic Steatohepatitis (NASH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Nonalcoholic Steatohepatitis (NASH)
2011 3.500,00$

Women’s Infertility Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Women’s Infertility Therapeutics - P
2011 3.500,00$

Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anemia Therapeutics - Pipeline Asses
2011 3.500,00$

Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Obstructive Pulmonary Diseas
2011 3.500,00$

Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acne Therapeutics - Pipeline Assessm
2011 3.500,00$

Cystic Fibrosis (CF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cystic Fibrosis (CF) Therapeutics -
2011 3.500,00$

Breast Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Breast Cancer Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, H2, 2011" p
2011 1.000,00$

Acute Myelocytic Leukemia (AML) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML) Global Clinical Trials Review, H2, 2011" pr
2011 1.000,00$

Bile Duct Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Bile Duct Cancer Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Bladder Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Bone Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Bone Cancer Global Clinical Trials Review, H2, 2011" provides data on the B
2011 1.000,00$

Brain Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Cervical Cancer Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2011" provides data on t
2011 1.000,00$

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2011"
2011 1.000,00$

Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011"
2011 1.000,00$

Hemophilia B Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hemophilia B Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Liver Transplantation Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Heart Transplantation Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Heart Transplantation Global Clinical Trials Review, H2, 2011" provides dat
2011 1.000,00$

Endometriosis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Endometriosis Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Shigella Infections Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Shigella Infections Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Cardiogenic Shock Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Cardiogenic Shock Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Colon Cancers Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Colon Cancers Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Hyperlipidemia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Hyperparathyroidism Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Inflammation Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Inflammation Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Myopia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, H2, 2011" provides data on the Myopia
2011 1.000,00$

Sepsis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2011" provides data on the Sepsis
2011 1.000,00$

Ulcerative Colitis Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2011" provides data o
2011 1.000,00$

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2011" provide
2011 1.000,00$

Hypothyroidism Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Hypothyroidism Global Clinical Trials Review, H2, 2011" provides data on th
2011 1.000,00$

Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011" provi
2011 1.000,00$

Peritoneal Tumor Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Peritoneal Tumor Global Clinical Trials Review, H2, 2011" provides data on
2011 1.000,00$

Malnutrition Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Malnutrition Global Clinical Trials Review, H2, 2011" provides data on the
2011 1.000,00$

Vitamin D Deficiency Global Clinical Trials Review, H2, 2011

Introduction / / GlobalData's clinical trial report, “Vitamin D Deficiency Global Clinical Trials Review, H2, 2011" provides data
2011 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - August 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2011” re
2011 1.000,00$

Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Compet
2011 3.500,00$

Hospital Supplies Market Outlook in United States to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in United States to 2017 - Disposable Hospital Suppli
2011 2.500,00$

Covidien Set to Become a Pure-play Medical Devices Company - Expected to sell its Pharmaceutical Business Unit

Introduction / / GlobalData’s medical equipment report “Covidien Set to Become a Pure-play Medical Devices Company - Expected to
2011 500,00$

Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts
2010 3.500,00$

Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData has released its new report, “Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2
2011 2.000,00$

Chronic Lymphocytic Leukemia (CLL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Lymphocytic Leukemia (CLL) T
2011 2.000,00$

Liver Cirrhosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Liver Cirrhosis Therapeutics - Pipel
2011 2.000,00$

Diabetic Retinopathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Retinopathy Therapeutics -
2011 2.000,00$

Diabetic Neuropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Neuropathy Therapeutics - P
2011 2.000,00$

Lupus Nephritis Therapeutics - Pipeline Assessment and Market Forecast to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Lupus Nephritis Therapeutics - Pipel
2011 2.000,00$

Glomerulonephritis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glomerulonephritis Therapeutics - Pi
2011 2.000,00$

Methicillin-Resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Methicillin-Resistant Staphylococcus
2011 2.000,00$

Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis A Preventive Vaccines - Pi
2011 2.000,00$

Gout Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gout Therapeutics - Pipeline Assessm
2011 2.000,00$

Herpes Zoster - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Herpes Zoster - Pipeline Assessment
2011 2.000,00$

Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dry Eye Syndrome Therapeutics - Pipe
2011 2.000,00$

H1N1 (Swine Influenza) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “H1N1 (Swine Influenza) - Pipeline As
2011 2.000,00$

Ascites Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, Q1, 2011" provides data on the Ascit
2011 1.000,00$

Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gastrointestinal Stromal Tumors (GIS
2011 2.000,00$

Thyroid Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Thyroid Cancer Therapeutics - Pipeli
2011 2.000,00$

Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Endometrial Cancer Therapeutics - Pi
2011 2.000,00$

Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bone Metastases Therapeutics - Pipel
2011 2.000,00$

Chronic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Pain Therapeutics - Pipeline
2011 2.000,00$

Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Juvenile Rheumatoid Arthritis (JRA)
2011 2.000,00$

Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Foot Ulcer (DFU) Therapeuti
2011 2.000,00$

Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Uveitis Therapeutics - Pipeline Asse
2011 2.000,00$

Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Traumatic Brain Injury (TBI) Therape
2011 2.000,00$

Mucopolysaccharidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Mucopolysaccharidosis Therapeutics -
2011 2.000,00$

Osteoarthritis Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis Pain Therapeutics - P
2011 2.000,00$

Dermatophytic Onychomycosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dermatophytic Onychomycosis Therapeu
2011 2.000,00$

Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hypercholesterolemia Therapeutics -
2011 2.000,00$

Acute Upper Respiratory Infections (AURI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData has released its new report, “Acute Upper Respiratory Infections (AURI) Therapeutics - Pipeline Asses
2011 2.000,00$

Dementia Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dementia Therapeutics - Pipeline Ass
2011 2.000,00$

Cytomegalovirus (CMV) Retinitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cytomegalovirus (CMV) Retinitis Ther
2011 2.000,00$

Guillain Barre Syndrome (GBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Guillain Barre Syndrome (GBS) Therap
2011 2.000,00$

Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion (RVO) Therape
2011 2.000,00$

HIV/AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData has released its new report, “HIV/AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 201
2011 2.000,00$

Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myelodysplastic Syndrome Therapeutic
2011 2.000,00$

Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cancer Pain Therapeutics - Pipeline
2011 2.000,00$

Human Papillomavirus (HPV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Human Papillomavirus (HPV) Therapeut
2011 2.000,00$

Testicular Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Testicular Cancer Therapeutics - Pip
2011 2.000,00$

Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteosarcoma Therapeutics - Pipeline
2011 2.000,00$

Anxiety Disorders Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anxiety Disorders Therapeutics - Pip
2011 2.000,00$

Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Spinal Cord Injury (ASCI) Ther
2011 2.000,00$

Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Obsessive Compulsive Disorder (OCD)
2011 2.000,00$

AIDS-Related Kaposi’s Sarcoma (ARKS) Therapeutics -Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “AIDS-Related Kaposi’s Sarcoma (ARKS)
2011 2.000,00$

Diabetic Nephropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Nephropathy Therapeutics -
2011 2.000,00$

Genital Herpes Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Genital Herpes Therapeutics - Pipeli
2011 2.000,00$

Chronic Myelogenous Leukemia (CML) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Myelogenous Leukemia (CML) T
2011 2.000,00$

Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Respiratory Distress Syndrome
2011 2.000,00$

Choroidal Neovascularization (CNV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Choroidal Neovascularization (CNV) T
2011 2.000,00$

Premature Ejaculation (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Premature Ejaculation (PE) Therapeut
2011 2.000,00$

Shigella Infections Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Shigella Infections Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Primary Biliary Cirrhosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Primary Biliary Cirrhosis Therapeuti
2011 2.000,00$

Trigeminal Neuralgia (TN) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Trigeminal Neuralgia (TN) Therapeuti
2011 2.000,00$

Peripheral Ulcerative Keratitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peripheral Ulcerative Keratitis Ther
2011 2.000,00$

Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Oropharyngeal Cancer Therapeutics -
2011 2.000,00$

Postherpetic Neuralgia (PHN) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Postherpetic Neuralgia (PHN) Therape
2011 2.000,00$

Post-Traumatic Stress Disorder (PTSD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Post-Traumatic Stress Disorder (PTSD
2011 2.000,00$

Sepsis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Sepsis Therapeutics - Pipeline Asses
2011 2.000,00$

Ewing’s Sarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ewing’s Sarcoma Therapeutics - Pipel
2011 2.000,00$

Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Neuroendocrine Carcinoma Therapeutic
2011 2.000,00$

Critical Limb Ischemia (CLI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Critical Limb Ischemia (CLI) Therape
2011 2.000,00$

Oral Mucositis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Oral Mucositis Therapeutics - Pipeli
2011 2.000,00$

Healthcare IT Market Outlook in Brazil to 2016- Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Brazil to 2016- Hospital Information Sys
2010 2.500,00$

Dental Radiology Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Dental Radiology Equipment - Global Pipeline Analysis, Competitive Landscape and Marke
2011 3.500,00$

Gentium S.p.A’s Defibrotide Set to Become the First Treatment Option for Veno-occlusive Disease (VOD)

Introduction / / GlobalData’s report “Gentium S.p.A’s Defibrotide Set to Become the First Treatment Option for Veno-occlusive Dis
2011 500,00$

FDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent VTE in Joint Replacement Surgeries in the US

Introduction / / GlobalData’s report “FDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent V
2011 500,00$

Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the US

Introduction / / GlobalData’s report “Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemi
2011 500,00$

Esophageal Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Esophageal Cancer Therapeutics - Pip
2011 2.000,00$

Hodgkin Lymphoma (HL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hodgkin Lymphoma (HL) Therapeutics -
2011 2.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011” report
2011 1.500,00$

KW 6002 (Parkinson's Disease) - Analysis and Sales Forecasts to 2020

Introduction / / GlobalData’s pharmaceuticals report, “KW-6002(Parkinson's Disease) - Analysis and Sales Forecasts to 2020” provi
2011 2.000,00$

IS Pharma plc (ISPH) - Financial and Strategic SWOT Analysis Review

IS Pharma plc (ISPH) - Financial and Strategic SWOT Analysis Review / / Summary / / IS Pharma plc (Previously known as Maelor pl
2011 125,00$

bioMD Limited (BOD) - Financial and Strategic SWOT Analysis Review

bioMD Limited (BOD) - Financial and Strategic SWOT Analysis Review / / Summary / / bioMD Limited (bioMD) is a Western Australia-
2011 125,00$

Gaymar Industries, Inc. - Strategic SWOT Analysis Review

Gaymar Industries, Inc. - Strategic SWOT Analysis Review / / Summary / / Gaymar Industries, Inc. (Gaymar) is a provider of produ
2011 125,00$

Oberg Industries, Inc. - Strategic SWOT Analysis Review

Oberg Industries, Inc. - Strategic SWOT Analysis Review / / Summary / / Oberg Industries, Inc. (Oberg) is engaged in providing p
2011 125,00$

Drug Eluting Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Drug Eluting Stents - Global Pipeline Analysis, Competitive Landscape and Market Forec
2011 3.500,00$

North America Orthopedic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Orthopedic Devices Market Outlook to 2017” provides key market data on
2011 3.500,00$

Europe Orthopedic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Orthopedic Devices Market Outlook to 2017” provides key market data on the Eu
2011 3.500,00$

Asia Pacific Orthopedic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Orthopedic Devices Market Outlook to 2017” provides key market data on t
2011 3.500,00$

Middle East and Africa Orthopedic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Orthopedic Devices Market Outlook to 2017” provides key market
2011 3.500,00$

South and Central America Orthopedic Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Orthopedic Devices Market Outlook to 2017” provides key mar
2011 3.500,00$

Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape an
2011 3.500,00$

Respiratory Measurement Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Respiratory Measurement Devices - Global Pipeline Analysis, Competitive Landscape and
2011 3.500,00$

Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape an
2011 3.500,00$

Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011” report is an esse
2011 1.500,00$

United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spina
2011 2.500,00$

Germany Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Germany Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge
2011 2.500,00$

France Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “France Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger
2011 2.500,00$

Italy Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Italy Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery
2011 2.500,00$

Spain Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Spain Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery
2011 2.500,00$

Brazil Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Brazil Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger
2011 2.500,00$

Netherlands Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Netherlands Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal S
2011 2.500,00$

Belgium Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Belgium Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge
2011 2.500,00$

Mexico Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Mexico Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger
2011 2.500,00$

Republic of Korea Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Republic of Korea Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Sp
2011 2.500,00$

Taiwan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Taiwan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger
2011 2.500,00$

South Africa Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “South Africa Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal
2011 2.500,00$

Austria Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Austria Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge
2011 2.500,00$

New Zealand Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “New Zealand Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal S
2011 2.500,00$

Denmark Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Denmark Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge
2011 2.500,00$

Saudi Arabia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Saudi Arabia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal
2011 2.500,00$

United States Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “United States Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal
2011 2.500,00$

Japan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Japan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery
2011 2.500,00$

India Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “India Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery
2011 2.500,00$

China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery
2011 2.500,00$

Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger
2011 2.500,00$

Australia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Australia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Sur
2011 2.500,00$

Argentina Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Argentina Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Sur
2011 2.500,00$

Israel Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Israel Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger
2011 2.500,00$

Czech Republic Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Czech Republic Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spina
2011 2.500,00$

Russian Federation Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Russian Federation Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, S
2011 2.500,00$

Sweden Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Introduction / / GlobalData’s new report, “Sweden Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger
2011 2.500,00$

Neurostimulation Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Neurostimulation Devices Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa)
2011 2.500,00$

Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Mark
2011 3.500,00$

Aesthetic Lasers and Energy Devices - Global Market Briefing to 2017

Introduction / / GlobalData’s new report, “Aesthetic Lasers and Energy Devices - Global Market Briefing to 2017” provides key dat
2011 3.500,00$

Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forec
2011 3.500,00$

Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

Introduction / / GlobalData’s new report, “Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Fo
2011 3.500,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, July 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, July 2011” report is an esse
2011 1.000,00$

Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the Future

Introduction / / GlobalData’s viewpoint, “Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the Future” provides k
2011 500,00$

The 43rd Meeting 2011 of the European Pancreatic Club – Post Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alert, “The 43rd Meeting 2011 of t
2011 1.000,00$

71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “71st Scientific sessions
2011 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, July 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, July 2011” repor
2011 1.000,00$

Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South A
2011 2.500,00$

Dental Chairs and Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Dental Chairs and Equipment Market Outlook in BRICS (Brazil, Russia, India, China, Sou
2011 2.500,00$

Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to
2011 2.500,00$

Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russian, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russia, India, China, Sou
2011 2.500,00$

Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa
2011 2.500,00$

Hearing Aid Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Hearing Aid Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Afric
2011 2.500,00$

Hearing Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Hearing Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa)
2011 2.500,00$

Central Venous Catheters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Central Venous Catheters Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Disposable Hospital Supplies Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Disposable Hospital Supplies Market Outlook in BRICS (Brazil, Russia, India, China, So
2011 2.500,00$

Patient Examination Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Patient Examination Devices Market Outlook in BRICS (Brazil, Russia, India, China, Sou
2011 2.500,00$

Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, Indi
2011 2.500,00$

Medical Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Medical Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, So
2011 2.500,00$

CAD/CAM Dental Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

Introduction / / GlobalData’s new report, “CAD/CAM Dental Systems – Global Pipeline Analysis, Competitive Landscape and Market Fo
2011 3.500,00$

Flexible Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Flexible Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forec
2011 3.500,00$

Capsule Endoscope Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Capsule Endoscope Systems – Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Global Food Microbiology Diagnostics Market - Tighter Food Safety Regulations to Drive Market

Introduction / / GlobalData’s report, “Global Food Microbiology Diagnostics Market - Tighter Food Safety Regulations to Drive Mar
2011 500,00$

Renal Dialysis Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Renal Dialysis Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Neurological Diagnostic Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Neurological Diagnostic Equipment Market Outlook in BRICS (Brazil, Russia, India, Chin
2011 2.500,00$

Crowns and Bridges Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Crowns and Bridges Market Outlook in BRICS (Brazil, Russia, India, China, South Africa
2011 2.500,00$

CAD/CAM Dental Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “CAD/CAM Dental Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Af
2011 2.500,00$

Waldenstrom Macroglobulinemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, Q2, 2011" prov
2011 1.000,00$

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, Q2, 201
2011 1.000,00$

Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Mark
2011 3.500,00$

Japanese Medical Device Industry - An Overview

Introduction / / GlobalData’s medical equipment report, “Japanese Medical Device Industry - An Overview” provides the medical equ
2011 500,00$

Dental Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Dental Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) t
2011 2.500,00$

Dental Biomaterials Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Dental Biomaterials Market Outlook in BRICS (Brazil, Russia, India, China, South Afric
2011 2.500,00$

Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, In
2011 2.500,00$

Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South
2011 2.500,00$

Incontinence Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Introduction / / GlobalData’s new report, “Incontinence Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Afri
2011 2.500,00$

Hypothyroidism Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hypothyroidism Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Peritoneal Tumor Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Peritoneal Tumor Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Vitamin D Deficiency Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Vitamin D Deficiency Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Polycystic Ovarian Syndrome Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Global Clinical Trials Review, Q2, 2011" provid
2011 1.000,00$

Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011" p
2011 1.000,00$

Hyperparathyroidism Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Bone Metastasis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Allergic Conjunctivitis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Allergic Conjunctivitis Global Clinical Trials Review, Q2, 2011" provides d
2011 1.000,00$

Chronic Plaque Psoriasis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Plaque Psoriasis Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Heart Transplantation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Heart Transplantation Global Clinical Trials Review, Q2, 2011" provides dat
2011 1.000,00$

Osteopenia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, Q2, 2011" provides data on the Os
2011 1.000,00$

Choroidal Neovascularization Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Choroidal Neovascularization Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Uterine Fibroids Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Uterine Fibroids Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Cachexia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, Q2, 2011" provides data on the Cach
2011 1.000,00$

Alcon, Inc. (ACL) - Product Pipeline Analysis

Alcon, Inc. (ACL) - Product Pipeline Analysis / / Summary / / Alcon, Inc. (Alcon) is one of the leading eye care providers in th
2011 750,00$

Exactech, Inc. (EXAC) - Product Pipeline Analysis

Exactech, Inc. (EXAC) - Product Pipeline Analysis / / Summary / / Exactech, Inc. (Exactech) is engaged in the development, manuf
2011 750,00$

Vermillion, Inc. (VRML) - Product Pipeline Analysis

Vermillion, Inc. (VRML) - Product Pipeline Analysis / / Summary / / Vermillion, Inc. (VRML) is a pharmaceutical company that dis
2011 750,00$

Volcano Corporation (VOLC) - Product Pipeline Analysis

Volcano Corporation (VOLC) - Product Pipeline Analysis / / Summary / / Volcano Corporation (Volcano) is a medical device company
2011 750,00$

Aachen Resonance GmbH - Product Pipeline Analysis

Aachen Resonance GmbH - Product Pipeline Analysis / / Summary / / Aachen Resonance GmbH (Aachen Resonance) is engaged in the dev
2011 750,00$

Nobel Biocare Holding AG (NOBN) - Product Pipeline Analysis

Nobel Biocare Holding AG (NOBN) - Product Pipeline Analysis / / Summary / / Nobel Biocare Holding AG (Nobel Biocare) is a medica
2011 750,00$

Globus Medical, Inc. - Product Pipeline Analysis

Globus Medical, Inc. - Product Pipeline Analysis / / Summary / / Globus Medical, Inc. (Globus Medical) is a privately-held medic
2011 750,00$

TrovaGene, Inc. (TROV) - Product Pipeline Analysis

TrovaGene, Inc. (TROV) - Product Pipeline Analysis / / Summary / / TrovaGene, Inc. (TrovaGene), formally, Xenomics, Inc. is a de
2011 750,00$

aap Implantate AG (AAQ) - Product Pipeline Analysis

aap Implantate AG (AAQ) - Product Pipeline Analysis / / Summary / / aap Implantate AG (aap) is a medical technology company prin
2011 750,00$

DiaSorin S.p.A (DIA) - Product Pipeline Analysis

DiaSorin S.p.A (DIA) - Product Pipeline Analysis / / Summary / / DiaSorin S.p.A. (DiaSorin) is a medical device company, engaged
2011 750,00$

Kuros Biosurgery AG - Product Pipeline Analysis

Kuros Biosurgery AG - Product Pipeline Analysis / / Summary / / Kuros Biosurgery AG (Kuros) is a biomedical company engaged in t
2011 750,00$

Smith & Nephew Plc (SN.) - Product Pipeline Analysis

Smith & Nephew Plc (SN.) - Product Pipeline Analysis / / Summary / / Smith & Nephew Plc (Smith & Nephew) is a global medical dev
2011 750,00$

BIOLASE Technology, Inc. (BLTI) - Product Pipeline Analysis

BIOLASE Technology, Inc. (BLTI) - Product Pipeline Analysis / / Summary / / BIOLASE Technology, Inc. (BIOLASE) is a medical tech
2011 750,00$

BioTex, Inc. - Product Pipeline Analysis

BioTex, Inc. - Product Pipeline Analysis / / Summary / / BioTex, Inc. (BioTex) is engaged in the research, development and marke
2011 750,00$

The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting - Post Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “The 2011 ASCO (American S
2011 1.000,00$

Kidney Transplantation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Kidney Transplantation Global Clinical Trials Review, Q2, 2011" provides da
2011 1.000,00$

Pregnancy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Pregnancy Global Clinical Trials Review, Q2, 2011" provides data on the Pre
2011 1.000,00$

Smoking Addiction Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Smoking Addiction Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Inflammation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Inflammation Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Ocular Hypertension Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ocular Hypertension Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Infertility Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Infertility Global Clinical Trials Review, Q2, 2011" provides data on the I
2011 1.000,00$

Nausea and Vomiting Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Nausea and Vomiting Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Open-Angle Glaucoma Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Urinary Incontinence Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Urinary Incontinence Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Systemic Lupus Erythematosus Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Erectile Dysfunction Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Erectile Dysfunction Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Overactive Bladder Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Overactive Bladder Global Clinical Trials Review, Q2, 2011" provides data o
2011 1.000,00$

HIV-1 Infection Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “HIV-1 Infection Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Revi
2011 1.000,00$

Transplantation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Transplantation Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review,
2011 1.000,00$

Acne Vulgaris Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Liver Transplantation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, Q2, 2011" provides dat
2011 1.000,00$

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, Q2, 2011"
2011 1.000,00$

Pertussis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Pertussis Global Clinical Trials Review, Q2, 2011" provides data on thePert
2011 1.000,00$

Macular Degeneration Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Macular Degeneration Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Myeloproliferative Disorders Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Myeloproliferative Disorders Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Hemorrhage Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hemorrhage Global Clinical Trials Review, Q2, 2011" provides data on theHem
2011 1.000,00$

Arrhythmias Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Arrhythmias Global Clinical Trials Review, Q2, 2011" provides data on theAr
2011 1.000,00$

Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011" provide
2011 1.000,00$

Sjogren’s Syndrome Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Sjogren’s Syndrome Global Clinical Trials Review, Q2, 2011" provides data o
2011 1.000,00$

Varicose Veins Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Varicose Veins Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Celiac Disease Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Celiac Disease Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Presbyopia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Presbyopia Global Clinical Trials Review, Q2, 2011" provides data on the Pr
2011 1.000,00$

Stryker to Acquire Memometal Technologies - To Increase Presence in the Fast Growing Extremities Market - Deal Analysis from GlobalData

Introduction / / GlobalData’s report, “Stryker to Acquire Memometal Technologies – To Increase Presence in the Fast Growing Extre
2011 500,00$

Knee Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Knee Replacement Implants – Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Hypercholesterolemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Hepatitis B Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, Q2, 2011" provides data on the H
2011 1.000,00$

Hepatitis C Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, Q2, 2011" provides data on the H
2011 1.000,00$

Ulcerative Colitis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, Q2, 2011" provides data o
2011 1.000,00$

Sepsis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, Q2, 2011" provides data on the Sepsis
2011 1.000,00$

Hyperlipidemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Myopia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, Q2, 2011" provides data on the Myopia
2011 1.000,00$

Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 201
2011 1.000,00$

Male Hypogonadism Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Hyperphosphatemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hyperphosphatemia Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Inguinal Hernia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Inguinal Hernia Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Hepatitis A Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, Q2, 2011" provides data on the H
2011 1.000,00$

Rhinosinusitis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Rhinosinusitis Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, June 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, June 2011” report is an es
2011 1.000,00$

Germany Nephrology Biomarkers - A Market Snapshot

Introduction / / GlobalData’s report, “Germany Nephrology Biomarkers - A Market Snapshot” provides key information and analysis
2011 500,00$

Heart Failure Congress 2011 - Post - Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “Heart Failure Congress
2011 1.000,00$

20th European Stroke Conference - Post Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “20th European Stroke Co
2011 1.000,00$

Pharmaceuticals Monthly Deal Analysis - Partnerships, Licensing, Investments and M&A Trends, June 2011

Introduction / / GlobalData's “Pharmaceuticals Monthly Deal Analysis - Partnerships, Licensing, Investments and M&A Trends, Jun
2011 1.000,00$

North America Drug Delivery Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Drug Delivery Devices Market Outlook to 2017” provides key market data
2011 3.500,00$

Europe Drug Delivery Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Drug Delivery Devices Market Outlook to 2017” provides key market data on the
2011 3.500,00$

Asia-Pacific Drug Delivery Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Drug Delivery Devices Market Outlook to 2017” provides key market data on
2011 3.500,00$

South and Central America Drug Delivery Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Drug Delivery Devices Market Outlook to 2017” provides key
2011 3.500,00$

Middle East and Africa Drug Delivery Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Drug Delivery Devices Market Outlook to 2017” provides key mark
2011 3.500,00$

South and Central America Nephrology and Urology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Nephrology and Urology Devices Market Outlook to 2017” prov
2011 3.500,00$

Middle East and Africa Nephrology & Urology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Nephrology & Urology Devices Market Outlook to 2017” provides k
2011 3.500,00$

South and Central America Neurology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Neurology Devices Market Outlook to 2017” provides key mark
2011 3.500,00$

Middle East And Africa Neurology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Neurology Devices Market Outlook to 2017” provides key market
2011 3.500,00$

South and Central America Dental Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Dental Devices Market Outlook to 2017” provides key market
2011 3.500,00$

Middle East and Africa Dental Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Dental Devices Market Outlook to 2017” provides key market dat
2011 3.500,00$

Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Hip Replacement Implants – Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

South and Central America ENT Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America ENT Devices Market Outlook to 2017” provides key market dat
2011 3.500,00$

Middle East and Africa ENT Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa ENT Devices Market Outlook to 2017” provides key market data o
2011 3.500,00$

South and Central America Hospital Supplies Market Outlook to 2017

Introduction / / GlobalData’s new report, “South and Central America Hospital Supplies Market Outlook to 2017” provides key mark
2011 3.500,00$

Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Middle East and Africa Hospital Supplies Market Outlook to 2017

Introduction / / GlobalData’s new report, “Middle East and Africa Hospital Supplies Market Outlook to 2017” provides key market
2011 3.500,00$

China Medical Devices Industry - A Market Snapshot and Key Company Profiles

Introduction / / GlobalData’s new report, “China Medical Devices Industry - A Market Snapshot and Key Company Profiles” provides
2011 3.500,00$

India Medical Device Industry - Key Company Profiles

Introduction / / GlobalData’s report, “India Medical Device Industry - Key Company Profiles” provides detailed information and an
2011 500,00$

Tradjenta (linagliptin) - First Member of DPP - 4 Inhibitor Class to Be Approved by US FDA at One Dosage Strength

Introduction / / GlobalData’s report “Tradjenta (linagliptin) - First Member of DPP - 4 Inhibitor Class to Be Approved by US FDA
2011 500,00$

Hypoalbuminemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hypoalbuminemia Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Thrombophilia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Thrombophilia Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Adenovirus Infection Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Adenovirus Infection Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, Q2, 20
2011 1.000,00$

Gastrointestinal Bleeding Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Gastrointestinal Bleeding Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Gastrointestinal Hemorrhage Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Gastrointestinal Hemorrhage Global Clinical Trials Review, Q2, 2011" provid
2011 1.000,00$

Hepatic Encephalopathy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, Q2, 2011" provides da
2011 1.000,00$

Hepatic Insufficiency Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, Q2, 2011" provides dat
2011 1.000,00$

Hepatic Lesion Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hepatic Lesion Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Indigestion Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Indigestion Global Clinical Trials Review, Q2, 2011" provides data on the I
2011 1.000,00$

Other Metabolic Disorders Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Other Metabolic Disorders Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Spondylitis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Spondylitis Global Clinical Trials Review, Q2, 2011" provides data on the S
2011 1.000,00$

Arterial Obstructive Disease Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Arterial Obstructive Disease Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Abdominal Aortic Aneurysms Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, Q2, 2011" provide
2011 1.000,00$

Aorto-Iliac Aneurysms Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Aorto-Iliac Aneurysms Global Clinical Trials Review, Q2, 2011" provides dat
2011 1.000,00$

Cerebral Aneurysms Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, Q2, 2011" provides data o
2011 1.000,00$

Iliac Aneurysms Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Iliac Aneurysms Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Chronic Stable Angina Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, Q2, 2011" provides dat
2011 1.000,00$

Ventricular Arrhythmia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ventricular Arrhythmia Global Clinical Trials Review, Q2, 2011" provides da
2011 1.000,00$

Atrial Flutter Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Chagas Cardiomyopathy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Chagas Cardiomyopathy Global Clinical Trials Review, Q2, 2011" provides dat
2011 1.000,00$

Dilated Cardiomyopathy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Dilated Cardiomyopathy Global Clinical Trials Review, Q2, 2011" provides da
2011 1.000,00$

Ischemic Cardiomyopathy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, Q2, 2011" provides d
2011 1.000,00$

Aortic Aneurysm Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Aortic Aneurysm Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Sick Sinus Syndrome Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Sick Sinus Syndromes Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Congenital Heart Disease Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Congenital Heart Disease Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Hypoplastic Left Heart Syndrome Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hypoplastic Left Heart Syndrome Global Clinical Trials Review, Q2, 2011" pr
2011 1.000,00$

Atrial Septal Defect Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Atrial Septal Defect Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Tetralogy Of Fallot Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Tetralogy Of Fallot Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Congestive Heart Failure Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Congestive Heart Failure Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Diastolic Heart Failure Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, Q2, 2011" provides d
2011 1.000,00$

Coronary Arteriosclerosis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Arteriosclerosis Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Coronary Disease Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Disease Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Heart Failure Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Heart Failure Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Acute Heart Failure Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Hypotension Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hypotension Global Clinical Trials Review, Q2, 2011" provides data on the H
2011 1.000,00$

Orthostatic Hypotension Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Orthostatic Hypotension Global Clinical Trials Review, Q2, 2011" provides d
2011 1.000,00$

Ischemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, Q2, 2011" provides data on the Isch
2011 1.000,00$

Critical Limb Ischemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, Q2, 2011" provides da
2011 1.000,00$

Left Ventricular Dysfunction Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Left Ventricular Hypertrophy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, Q2, 2011" provi
2011 1.000,00$

Low Cardiac Output Syndrome Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, Q2, 2011" provid
2011 1.000,00$

Shock Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Shock Global Clinical Trials Review, Q2, 2011" provides data on the Shock c
2011 1.000,00$

Cardiogenic Shock Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cardiogenic Shock Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Hemorrhagic Shock Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Coronary Thrombosis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Thrombosis Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Thromboembolism Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Deep Vein Thrombosis (DVT) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, Q2, 2011" provide
2011 1.000,00$

Vascular Dysfunction Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Vascular Dysfunction Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Ventricular Fibrillation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ventricular Fibrillation Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Cardiovascular Inflammation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, Q2, 2011" provid
2011 1.000,00$

Arteritis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Arteritis Global Clinical Trials Review, Q2, 2011" provides data on the Art
2011 1.000,00$

Coronary Vasospasm Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Vasospasm Global Clinical Trials Review, Q2, 2011" provides data o
2011 1.000,00$

Bradycardia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Bradycardia Global Clinical Trials Review, Q2, 2011" provides data on the B
2011 1.000,00$

High Triglyceridemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “High Triglyceridemia Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Portal Hypertension Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Pre-Eclampsia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Pre-Eclampsia Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Restenosis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Restenosis Global Clinical Trials Review, Q2, 2011" provides data on the Re
2011 1.000,00$

Ventricular Tachycardia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, Q2, 2011" provides d
2011 1.000,00$

Aortic Valve Diseases Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Aortic Valve Diseases Global Clinical Trials Review, Q2, 2011" provides dat
2011 1.000,00$

Hypoxemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hypoxemia Global Clinical Trials Review, Q2, 2011" provides data on the Hyp
2011 1.000,00$

Other Cardiovascular Disorders Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Other Cardiovascular Disorders Global Clinical Trials Review, Q2, 2011" pro
2011 1.000,00$

Raynauds Disease Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Regurgitation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Regurgitation Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Mitral Regurgitation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Mitral Regurgitation Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Reperfusion Injury Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, Q2, 2011" provides data o
2011 1.000,00$

Telangiectasis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Telangiectasis Global Clinical Trials Review, Q2, 2011" provides data on th
2011 1.000,00$

Ulcers Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Ulcers Global Clinical Trials Review, Q2, 2011" provides data on the Ulcers
2011 1.000,00$

Varicosis Ulcer Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Varicosis Ulcer Global Clinical Trials Review, Q2, 2011" provides data on t
2011 1.000,00$

Venous Ulcers Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Venous Ulcers Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Louis-Bar Syndrome Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “ Louis-Bar Syndrome Global Clinical Trials Review, Q2, 2011"” provides data
2011 1.000,00$

Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Revi
2011 1.000,00$

Cerebellar Ataxia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cerebellar Ataxia Global Clinical Trials Review, Q2, 2011" provides data on
2011 1.000,00$

Cognitive Disorders Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cognitive Disorders Global Clinical Trials Review, Q2, 2011" provides data
2011 1.000,00$

Encephalitis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Hernia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Hernia Global Clinical Trials Review, Q2, 2011" provides data on the Hernia
2011 1.000,00$

Diabetic Retinopathy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Paralysis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, Q2, 2011" provides data on the Par
2011 1.000,00$

Sedation Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Sedation Global Clinical Trials Review, Q2, 2011" provides data on the Seda
2011 1.000,00$

Renal Pain Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Renal Pain Global Clinical Trials Review, Q2, 2011" provides data on the Re
2011 1.000,00$

General Anxiety Disorder Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “General Anxiety Disorder Global Clinical Trials Review, Q2, 2011" provides
2011 1.000,00$

Child Abuse Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Child Abuse Global Clinical Trials Review, Q2, 2011" provides data on the
2011 1.000,00$

Diabetic Neuropathy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Revi
2011 1.000,00$

Alcohol Addiction Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Alcohol Addiction Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Cystic Fibrosis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Crohn’s Disease Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Crohn’s Disease Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Atopic Dermatitis (Eczema) Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Atopic Dermatitis (Eczema) Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Dyslipidemia Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Age Related Macular Degeneration Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Age Related Macular Degeneration Global Clinical Trials Review, Q1, 2011" p
2011 1.000,00$

Arthritis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Arthritis Global Clinical Trials Review, Q1, 2011" provides data on the Art
2011 1.000,00$

Septic Shock Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Septic Shock Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Endometriosis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Endometriosis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Interstitial Cystitis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Interstitial Cystitis Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Duchenne Muscular Dystrophy Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, Q1, 2011" provid
2011 1.000,00$

Retinitis Pigmentosa Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Retinitis Pigmentosa Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Gaucher's Disease Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Gaucher’s Disease Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

LifeScan, Inc. - Product Pipeline Analysis

LifeScan, Inc. - Product Pipeline Analysis / / Summary / / LifeScan, Inc. (LifeScan) is a medical device company engaged in the
2011 750,00$

Allergan, Inc. (AGN) - Product Pipeline Analysis

Allergan, Inc. (AGN) - Product Pipeline Analysis / / Summary / / Allergan, Inc. (Allergan) is a global healthcare company engage
2011 750,00$

Varian Medical Systems, Inc. (VAR) - Product Pipeline Analysis

Varian Medical Systems, Inc. (VAR) - Product Pipeline Analysis / / Summary / / Varian Medical Systems, Inc. (Varian) is a leadin
2011 750,00$

DePuy, Inc. - Product Pipeline Analysis

DePuy, Inc. - Product Pipeline Analysis / / Summary / / DePuy, Inc. (DePuy) is a subsidiary of Johnson & Johnson, which principa
2011 750,00$

Berlin Heart GmbH - Product Pipeline Analysis

Berlin Heart GmbH - Product Pipeline Analysis / / Summary / / Berlin Heart GmbH (Berlin Heart) is engaged in development, manufa
2011 750,00$

Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis

Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis / / Summary / / Ortho-Clinical Diagnostics, Inc., (Ortho-Clinical) i
2011 750,00$

TORNIER, Inc. - Product Pipeline Analysis

TORNIER, Inc. - Product Pipeline Analysis / / Summary / / TORNIER, Inc. (Tornier) is a medical device company, principally engag
2011 750,00$

Roche Diagnostics Limited - Product Pipeline Analysis

Roche Diagnostics Limited - Product Pipeline Analysis / / Summary / / Roche Diagnostics Limited (Roche Diagnostics), a division
2011 750,00$

Pioneer Surgical Technology, Inc. - Product Pipeline Analysis

Pioneer Surgical Technology, Inc. - Product Pipeline Analysis / / Summary / / Pioneer Surgical Technology, Inc. (Pioneer Surgica
2011 750,00$

Stryker Corporation (SYK) - Product Pipeline Analysis

Stryker Corporation (SYK) - Product Pipeline Analysis / / Summary / / Stryker Corporation (Stryker) is one of the leading manufa
2011 750,00$

Alere Inc. (ALR) - Product Pipeline Analysis

Alere Inc. (ALR) - Product Pipeline Analysis / / Summary / / Alere Inc. (formerly Inverness Medical Innovations, Inc.) is a prov
2011 750,00$

Beckman Coulter, Inc. (BEC) - Product Pipeline Analysis

Beckman Coulter, Inc. (BEC) - Product Pipeline Analysis / / Summary / / Beckman Coulter, Inc. (Beckman) is principally engaged i
2011 750,00$

SurModics, Inc. (SRDX) - Product Pipeline Analysis

SurModics, Inc. (SRDX) - Product Pipeline Analysis / / Summary / / SurModics, Inc. (SurModics) is a healthcare company engaged i
2011 750,00$

Biomet, Inc. - Product Pipeline Analysis

Biomet, Inc. - Product Pipeline Analysis / / Summary / / Biomet, Inc. (Biomet) is engaged in the design, manufacture and marketi
2011 750,00$

Baxter International Inc. (BAX) - Product Pipeline Analysis

Baxter International Inc. (BAX) - Product Pipeline Analysis / / Summary / / Baxter International Inc. (Baxter) is a globally div
2011 750,00$

Becton, Dickinson and Company (BDX) - Product Pipeline Analysis

Becton, Dickinson and Company (BDX) - Product Pipeline Analysis / / Summary / / Becton, Dickinson and Company (BD) is a medical
2011 750,00$

Boston Scientific Corporation (BSX) - Product Pipeline Analysis

Boston Scientific Corporation (BSX) - Product Pipeline Analysis / / Summary / / Boston Scientific Corporation (Boston Scientific
2011 750,00$

C. R. Bard, Inc. (BCR) - Product Pipeline Analysis

C. R. Bard, Inc. (BCR) - Product Pipeline Analysis / / Summary / / C. R. Bard, Inc. (Bard) is a multinational company engaged in
2011 750,00$

Gen-Probe Incorporated (GPRO) - Product Pipeline Analysis

Gen-Probe Incorporated (GPRO) - Product Pipeline Analysis / / Summary / / Gen-Probe Incorporated (Gen-Probe) is engaged in the d
2011 750,00$

Philips Healthcare - Product Pipeline Analysis

Philips Healthcare - Product Pipeline Analysis / / Summary / / Philips Healthcare (formerly known as Philips Medical Systems) is
2011 750,00$

Synthes, Inc. (SYST) - Product Pipeline Analysis

Synthes, Inc. (SYST) - Product Pipeline Analysis / / Summary / / Synthes, Inc. (Synthes) is a medical device company specializin
2011 750,00$

Edwards Lifesciences Corporation (EW) - Product Pipeline Analysis

Edwards Lifesciences Corporation (EW) - Product Pipeline Analysis / / Summary / / Edwards Lifesciences Corporation (Edwards) pro
2011 750,00$

Ethicon, Inc. - Product Pipeline Analysis

Ethicon, Inc. - Product Pipeline Analysis / / Summary / / Ethicon, Inc. (Ethicon) is a global surgical products company engaged
2011 750,00$

Zimmer Holdings, Inc. (ZMH) - Product Pipeline Analysis

Zimmer Holdings, Inc. (ZMH) - Product Pipeline Analysis / / Summary / / Zimmer Holdings, Inc. (Zimmer) engages in the design, de
2011 750,00$

St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis

St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis / / Summary / / St. Jude Medical, Inc. (SJM) is a medical device compan
2011 750,00$

Covidien plc (COV) - Product Pipeline Analysis

Covidien plc (COV) - Product Pipeline Analysis / / Summary / / Covidien plc (Covidien) is a leading global healthcare company. I
2011 750,00$

AtriCure, Inc. (ATRC) - Product Pipeline Analysis

AtriCure, Inc. (ATRC) - Product Pipeline Analysis / / Summary / / AtriCure, Inc. (AtriCure) is a medical device company principa
2011 750,00$

Cordis Corporation - Product Pipeline Analysis

Cordis Corporation - Product Pipeline Analysis / / Summary / / Cordis Corporation (Cordis) is a medical device corporation, whic
2011 750,00$

Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Cardiovascular Monitoring and Diagnostic Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Cardiovascular Monitoring and Diagnostic Devices – Global Pipeline Analysis, Competiti
2011 3.500,00$

Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fore
2011 3.500,00$

Hearing Aid Devices - A Market Snapshot

Introduction / / GlobalData’s report, “Hearing Aid Devices – A Market Sanpshot” provides key data, information and analysis on th
2011 500,00$

Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer

Introduction / / This year another endothelin A receptor antagonist failed to demonstrate an advantage for advanced prostate canc
2011 500,00$

Healthcare Reform in the US - Impact on Pricing and Reimbursement

Introduction / / On 23 March, 2010, the Obama administration brought into effect the Patient Protection and Affordable Care Act (
2011 500,00$

Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market

Introduction / / Avastin (bevacizumab) is a vascular endothelial growth factor (VEGF) receptor inhibitor. It was first approved i
2011 500,00$

FDA Approves Zytiga (Abiraterone Acetate) for the Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer

Introduction / / It has been an exciting year for prostate cancer therapeutics. On April 28, 2011, the US Food and Drug Administr
2011 500,00$

US FDA Approval of Afinitor Ends a Three Decade Long Wait for Pancreatic Neuroendocrine Tumor (PNET) Patients

Introduction / / On May 5, 2011, the US Food and Drug Association (FDA) approved Afinitor (everolimus) for the treatment of progr
2011 500,00$

Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)

Introduction / / The group of cancers that originate in the lymphatic system are known as lymphoma. Lymphoma is broadly classifie
2011 500,00$

Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to Follow

Introduction / / Hepatitis C is caused by a type of virus called hepatitis C virus (HCV). The virus infects the liver, causing se
2011 500,00$

Sanofi - Aventis seals Licensing Deal with Glenmark for $613m - Deal Analysis from GlobalData

Introduction / / May 16, 2011 witnessed the commencement of the licensing deal between Glenmark Pharmaceuticals S.A (GPSA), a who
2011 500,00$

Osmetech plc (OMH) - Financial and Strategic SWOT Analysis Review

Osmetech plc (Osmetech) is engaged in the manufacturing, development, design and distribution of molecular diagnostic technologies
2011 125,00$

Orthomimetics Limited - Strategic SWOT Analysis Review

OrthoMimetics Limited (OrthoMimetics) is a medical technology company engaged in the design, development and manufacturing of biol
2011 125,00$

Mead Johnson Nutrition Company (MJN) - Financial and Strategic SWOT Analysis Review

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company engaged in the production, distribution and sale of
2011 125,00$

NascaCell Technologies AG (N7C) - Financial and Strategic SWOT Analysis Review

Nascacell Technologies AG (Nascacell) is a publicly held company specialized in the development of products and drug development c
2011 250,00$

Unigene Laboratories, Inc. (UGNE) - Strategic SWOT Analysis Review

Unigene Laboratories, Inc. (Unigene) is publicly held US based biopharmaceutical company provides peptide related products. It is
2011 250,00$

1st Dental Laboratories plc (FDT) - Financial and Strategic SWOT Analysis Review

1st Dental Laboratories PLC (1st Dental) is one of the leading provider of dental laboratory products and services in the UK. The
2011 125,00$

Black Ridge Mining Limited (BRD) - Financial and Strategic SWOT Analysis Review

Black Ridge Mining Limited (formerly Genesis Biomedical Ltd.) was formally a medical technology company and was engaged in the de
2011 125,00$

Acri Tec Gmbh - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Acri Tec Gmbh provides you with an in-depth strategic analysis of the company's businesses and
2011 250,00$

Gen-Probe Prodesse, Inc. - Strategic SWOT Analysis Review

Gen-Probe Prodesse, Inc. (Prodesse), a biotechnology company engaged in the manufacture, development and distribution of molecular
2011 125,00$

Fujinon Corporation - Strategic SWOT Analysis Review

Fujinon Corporation (Fujinon), formerly Fuji Photo Optical Co., Ltd. is a conglomerate principally engaged in the development, man
2011 125,00$

Kane Biotech Inc. (KNE) - Strategic SWOT Analysis Review

Kane Biotech Inc. (Kane Biotech) is a developmental stage biotechnology company. It is engaged in the research and development o
2011 125,00$

Alere LLC - Strategic SWOT Analysis Review

Alere LLC (Alere) is a healthcare company. It provides the most comprehensive and patient-centric health management services, rang
2011 125,00$

Gentex Corporation (GNTX) - Strategic SWOT Analysis Review

Gentex Corporation (Gentex) is principally engaged in designing, developing, manufacturing and marketing integrated military life
2011 250,00$

Bradmer Pharmaceuticals Inc. (BMR) - Financial and Strategic SWOT Analysis Review

Bradmer Pharmaceuticals Inc. (Bradmer) is a publicly held life sciences company that is engaged in the development and marketing o
2011 250,00$

Dhanuka Agritech Ltd (507717) - Financial and Strategic SWOT Analysis Review

Dhanuka Agritech Ltd (DAL) is engaged in the development of agro-chemicals, fertilizers, and seeds. The company provides numerous
2011 250,00$

Bering Exploration, Inc. (OCOL) - Strategic SWOT Analysis Review

Bering Exploration, Inc (Bering Exploration) is a company engaged in the exploration, development, production, acquisition and mar
2011 250,00$

Biolight AB (BIOL) - Strategic SWOT Analysis Review

Biolight AB (Biolight) is a Sweden-based medical technology company. It is principally engaged in the development and sale of mach
2011 250,00$

Saudi Arabia Medical Equipment Market Analysis and Forecasts to 2017

Introduction / / GlobalData’s new report, “Saudi Arabia Medical Equipment Market Analysis and Forecasts to 2017” provides key dat
2011 3.500,00$

Neurostimulation Devices - A Market Snapshot

Introduction / / GlobalData’s report, “Neurostimulation Devices - A Market Snapshot” provides information and analysis on the glo
2011 500,00$

The 2011 Tsunami and Earthquake in Japan - A Medical Devices Industry Perspective

Introduction / / GlobalData’s medical equipment viewpoint, “The 2011 Tsunami and Earthquake in Japan - A Medical Devices Industry
2011 500,00$

Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler D
2011 2.500,00$

Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler
2011 2.500,00$

Drug Delivery Devices Market Outlook in Japan to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Japan to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Canada to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Canada to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Germany to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Germany to 2017 - Metered Dose Inhaler Devices
2011 2.500,00$

Drug Delivery Devices Market Outlook in France to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in France to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Italy to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Italy to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Spain to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Spain to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devic
2011 2.500,00$

Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Netherlands to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Netherlands to 2017 - Metered Dose Inhaler Dev
2011 2.500,00$

Drug Delivery Devices Market Outlook in Belgium to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Belgium to 2017 - Metered Dose Inhaler Devices
2011 2.500,00$

Drug Delivery Devices Market Outlook in Argentina to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Argentina to 2017 - Metered Dose Inhaler Devic
2011 2.500,00$

Drug Delivery Devices Market Outlook in Mexico to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Mexico to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Republic of Korea to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Republic of Korea to 2017 - Metered Dose Inhal
2011 2.500,00$

Drug Delivery Devices Market Outlook in Taiwan to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Taiwan to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in South Africa to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in South Africa to 2017 - Metered Dose Inhaler De
2011 2.500,00$

Drug Delivery Devices Market Outlook in Israel to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Israel to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in Austria to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Austria to 2017 - Metered Dose Inhaler Devices
2011 2.500,00$

Drug Delivery Devices Market Outlook in Czech Republic to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Czech Republic to 2017 - Metered Dose Inhaler
2011 2.500,00$

Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inha
2011 2.500,00$

Drug Delivery Devices Market Outlook in Sweden to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Sweden to 2017 - Metered Dose Inhaler Devices,
2011 2.500,00$

Drug Delivery Devices Market Outlook in New Zealand to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in New Zealand to 2017 - Metered Dose Inhaler Dev
2011 2.500,00$

Drug Delivery Devices Market Outlook in Denmark to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Denmark to 2017 - Metered Dose Inhaler Devices
2011 2.500,00$

Drug Delivery Devices Market Outlook in Saudi Arabia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Saudi Arabia to 2017 - Metered Dose Inhaler De
2011 2.500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2011” repor
2011 1.000,00$

Nordion Inc. - Strategic SWOT Analysis Review

Nordion Inc. - Strategic SWOT Analysis Review / / Summary / / Nordion Inc. (formerly known as MDS Inc.) is a global specialty he
2011 125,00$

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review / / Summary / / Novozymes A/S (Novozymes) is a Denmark base
2011 125,00$

Hospital Supplies Market Outlook in Australia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Australia to 2017 - Disposable Hospital Supplies,
2011 2.500,00$

Hospital Supplies Market Outlook in Spain to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Spain to 2017 - Disposable Hospital Supplies, Ster
2011 2.500,00$

Hospital Supplies Market Outlook in Germany to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Germany to 2017 - Disposable Hospital Supplies, St
2011 2.500,00$

Hospital Supplies Market Outlook in South Africa to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in South Africa to 2017 - Disposable Hospital Supplie
2011 2.500,00$

Hospital Supplies Market Outlook in Italy to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Italy to 2017 - Disposable Hospital Supplies, Ster
2011 2.500,00$

Hospital Supplies Market Outlook in Brazil to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Brazil to 2017 - Disposable Hospital Supplies, Ste
2011 2.500,00$

Hospital Supplies Market Outlook in Mexico to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Mexico to 2017 - Disposable Hospital Supplies, Ste
2011 2.500,00$

Hospital Supplies Market Outlook in Republic of Korea to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Republic of Korea to 2017 - Disposable Hospital Su
2011 2.500,00$

Hospital Supplies Market Outlook in Netherlands to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Netherlands to 2017 - Disposable Hospital Supplies
2011 2.500,00$

Hospital Supplies Market Outlook in Czech Republic to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Czech Republic to 2017 - Disposable Hospital Suppl
2011 2.500,00$

Hospital Supplies Market Outlook in Sweden to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Sweden to 2017 - Disposable Hospital Supplies, Ste
2011 2.500,00$

Hospital Supplies Market Outlook in Belgium to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Belgium to 2017 - Disposable Hospital Supplies, St
2011 2.500,00$

Hospital Supplies Market Outlook in Austria to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Austria to 2017 - Disposable Hospital Supplies, St
2011 2.500,00$

Hospital Supplies Market Outlook in Denmark to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Denmark to 2017 - Disposable Hospital Supplies, St
2011 2.500,00$

Hospital Supplies Market Outlook in Saudi Arabia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Saudi Arabia to 2017 - Disposable Hospital Supplie
2011 2.500,00$

Hospital Supplies Market Outlook in New Zealand to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in New Zealand to 2017 - Disposable Hospital Supplies
2011 2.500,00$

Hospital Supplies Market Outlook in Argentina to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Argentina to 2017 - Disposable Hospital Supplies,
2011 2.500,00$

Hospital Supplies Market Outlook in Israel to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Israel to 2017 - Disposable Hospital Supplies, Ste
2011 2.500,00$

Hospital Supplies Market Outlook in Taiwan to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Taiwan to 2017 - Disposable Hospital Supplies, Ste
2011 2.500,00$

Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion - Deal Analysis from GlobalData

Introduction / / GlobalData’s medical equipment report, “Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion” p
2011 500,00$

North America Hospital Supplies Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Hospital Supplies Market Outlook to 2017” provides key market data on t
2011 3.500,00$

Europe Hospital Supplies Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Hospital Supplies Market Outlook to 2017” provides key market data on the Eur
2011 3.500,00$

Asia Pacific Hospital Supplies Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia Pacific Hospital Supplies Market Outlook to 2017” provides key market data on the
2011 3.500,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, May 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, May 2011” report is an essen
2011 1.000,00$

Johnson & Johnson to Acquire Synthes – Betting Big on the Orthopedic Devices Market Opportunity

Introduction / / GlobalData’s medical equipment report, “Johnson & Johnson to Acquire Synthes - Betting Big on the Orthopedic Dev
2011 500,00$

Clinical Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Clinical Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Compe
2011 3.500,00$

Radiation Therapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s medical equipment report, “Radiation Therapy Devices - Global Opportunity Assessment, Competitive L
2011 3.500,00$

Hip Resurfacing Implants - Global Pipeline Analysis,Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t
2011 3.500,00$

Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q1 2011

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q1 2011” report is an esse
2011 1.500,00$

Dental Devices Market Outlook in Argentina to 2017 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Argentina to 2017 - Dental Chairs and Equipment, Dent
2011 2.500,00$

Dental Devices Market Outlook in Taiwan to 2017 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Taiwan to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Hospital Supplies Market Outlook in United Kingdom to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in United Kingdom to 2017 - Disposable Hospital Suppl
2011 2.500,00$

Hospital Supplies Market Outlook in Japan to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Japan to 2017 - Disposable Hospital Supplies, Ster
2011 2.500,00$

Hospital Supplies Market Outlook in India to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in India to 2017 - Disposable Hospital Supplies, Ster
2011 2.500,00$

Hospital Supplies Market Outlook in China to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in China to 2017 - Disposable Hospital Supplies, Ster
2011 2.500,00$

Hospital Supplies Market Outlook in Canada to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Canada to 2017 - Disposable Hospital Supplies, Ste
2011 2.500,00$

Hospital Supplies Market Outlook in France to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in France to 2017 - Disposable Hospital Supplies, Ste
2011 2.500,00$

Hospital Supplies Market Outlook in Russian Federation to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Russian Federation to 2017 - Disposable Hospital S
2011 2.500,00$

Lymphangioleiomyomatosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Lymphangioleiomyomatosis Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, Q1, 2011" pr
2011 1.000,00$

Hemostasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, Q1, 2011" provides data on the He
2011 1.000,00$

Pancytopenia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pancytopenia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Thrombocytopenia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Thrombocytopenia Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Lymphedema Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Lymphedema Global Clinical Trials Review, Q1, 2011" provides data on the Ly
2011 1.000,00$

Hyponatremia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hyponatremia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Hyperuricemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Hemoglobinuria Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hemoglobinuria Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Von Willebrand Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Von Willebrand Disease Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Hemophilia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hemophilia Global Clinical Trials Review, Q1, 2011" provides data on the He
2011 1.000,00$

Thalassemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, Q1, 2011" provides data on the T
2011 1.000,00$

Sickle Cell Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

West Nile Virus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “West Nile Virus Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Warts Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Warts Global Clinical Trials Review, Q1, 2011" provides data on the Warts c
2011 1.000,00$

Herpes Zoster Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Herpes Zoster Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Herpes Simplex Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Herpes Simplex Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Herpes Labialis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Herpes Labialis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Genital Herpes Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Enterovirus Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Enterovirus Infections Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Cytomegalovirus Infection Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cytomegalovirus Infection Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Condyloma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Condyloma Global Clinical Trials Review, Q1, 2011" provides data on the Con
2011 1.000,00$

Periodontal Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Periodontal Disease Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Gingivitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gingivitis Global Clinical Trials Review, Q1, 2011" provides data on the Gi
2011 1.000,00$

Dental Plaque Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dental Plaque Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Trypanosomiasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Glaucoma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Glaucoma Global Clinical Trials Review, Q1, 2011" provides data on the Glau
2011 1.000,00$

Osteoporosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Pancreatic Fistula Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pancreatic Fistula Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Cellulitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cellulitis Global Clinical Trials Review, Q1, 2011" provides data on the Ce
2011 1.000,00$

Gonorrhea Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gonorrhea Global Clinical Trials Review, Q1, 2011" provides data on the Gon
2011 1.000,00$

Impetigo Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, Q1, 2011" provides data on the Impe
2011 1.000,00$

Pelvic Infection Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pelvic Infection Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Surgical Wound Infection Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Surgical Wound Infection Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Fungemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, Q1, 2011" provides data on the Fung
2011 1.000,00$

Cryptococcosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Onychomycosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Onychomycosis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Alopecia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Alopecia Global Clinical Trials Review, Q1, 2011" provides data on the Alop
2011 1.000,00$

Rosacea Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, Q1, 2011" provides data on the Rosac
2011 1.000,00$

Vitiligo Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Vitiligo Global Clinical Trials Review, Q1, 2011" provides data on the Viti
2011 1.000,00$

Epistaxis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Epistaxis Global Clinical Trials Review, Q1, 2011" provides data on the Epi
2011 1.000,00$

Nasal Obstruction Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Nasal Obstruction Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Vestibular Diseases Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Vestibular Diseases Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Vocal Cord Paralysis Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Vocal Cord Paralysis Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Voice Disorders Global Clinical Trials Review, Q2, 2011

Introduction / / GlobalData's clinical trial report, “Voice Disorders Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Strabismus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Strabismus Global Clinical Trials Review, Q1, 2011" provides data on the St
2011 1.000,00$

Blepharitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Blepharitis Global Clinical Trials Review, Q1, 2011" provides data on the B
2011 1.000,00$

Presbyopia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Presbyopia Global Clinical Trials Review, Q1, 2011" provides data on the Pr
2011 1.000,00$

Retinal Vein Occlusion Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Retinal Vein Occlusion Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Retinoblastoma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Retinoblastoma Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Cryptosporidiosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cryptosporidiosis Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Cognition Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cognition Global Clinical Trials Review, Q1, 2011" provides data on the Cog
2011 1.000,00$

Skin and Soft Tissue Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Skin and Soft Tissue Infections Global Clinical Trials Review, Q1, 2011" pr
2011 1.000,00$

Hemorrhoids Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, Q1, 2011" provides data on the H
2011 1.000,00$

Hepatobiliary Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hepatobiliary Disease Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Hepatorenal Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Intussusception Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Intussusception Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Inflammatory Bowel Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Biliary Atresia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Biliary Atresia Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Chronic Liver Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Liver Disease Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Fatty Liver Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Hepatic Injury Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Liver Cirrhosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Liver Failure Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Liver Failure Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Liver Fibrosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Malabsorption Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Malabsorption Syndrome Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, Q1, 2011" prov
2011 1.000,00$

Fabry Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Fabry Disease Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Bacterial Vaginosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Bacterial Vaginosis Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Allergic Corneal Marginal Ulcers Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Allergic Corneal Marginal Ulcers Global Clinical Trials Review, Q1, 2011" p
2011 1.000,00$

Enterobacteriaceae Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Enterobacteriaceae Infections Global Clinical Trials Review, Q1, 2011" prov
2011 1.000,00$

Mycobacterium Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Mycobacterium Infections Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, Q1, 2011" prov
2011 1.000,00$

Q Fever Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Q Fever Global Clinical Trials Review, Q1, 2011" provides data on the Q Fev
2011 1.000,00$

Deglutition Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Deglutition Disorders Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Hemophilia A Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hemophilia A Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Hemophilia B Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hemophilia B Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Cognitive Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cognitive Disorders Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011” report
2011 1.500,00$

Hit by the Infamous Patent Cliff, Big Pharma Strategize Counter Measures for the Future

Introduction / / GlobalData’s report, “Hit by the Infamous Patent Cliff, Big Pharma Strategize Counter Measures for the Future” p
2011 500,00$

AutoGenomics and PGXL Laboratories to Partner to Expand Molecular Testing in Pharmacogenetics - Deal Analysis from GlobalData

Introduction / / GlobalData’s medical equipment report, “AutoGenomics and PGXL Laboratories to Partner to Expand Molecular Testin
2011 500,00$

Medical Action Industries Acquires AVID Medical - To Gain a Stronghold in the Custom Procedure Tray Market - Deal Analysis from GlobalData

Introduction / / GlobalData’s medical equipment report, “Medical Action Industries Acquires AVID Medical - To Gain a Stronghold i
2011 500,00$

FDA Changes Suggested in 510(k) Process - Impact and Opportunities

Introduction / / GlobalData’s report, “FDA Changes Suggested in 510(k) Process- Impact and Opportunities” provides key informatio
2011 500,00$

Europe Dental Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Dental Devices Market Outlook to 2017” provides key market data on the Europe
2011 3.500,00$

Asia-Pacific Dental Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Dental Devices Market Outlook to 2017” provides key market data on the
2011 3.500,00$

Europe ENT Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe ENT Devices Market Outlook to 2017” provides key market data on the Europe EN
2011 3.500,00$

Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s medical equipment report, “Brachytherapy Devices - Global Opportunity Assessment, Competitive Lands
2011 3.500,00$

Asia-Pacific ENT Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific ENT Devices Market Outlook to 2017” provides key market data on the Asi
2011 3.500,00$

Medical Equipment Annual Deals Analysis 2011

Introduction / / GlobalData's “Medical Equipment Annual Deals Analysis 2011” report is an essential source of data and trend anal
2011 3.500,00$

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011” report is an ess
2011 1.000,00$

ENT Devices Market Outlook in Republic of Korea to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Republic of Korea to 2017 - Hearing Aid Devices and Impl
2011 2.500,00$

ENT Devices Market Outlook in Sweden to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Sweden to 2017 - Hearing Aid Devices and Implants and Di
2011 2.500,00$

ENT Devices Market Outlook in New Zealand to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in New Zealand to 2017 - Hearing Aid Devices and Implants a
2011 2.500,00$

ENT Devices Market Outlook in Denmark to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Denmark to 2017 - Hearing Aid Devices and Implants and D
2011 2.500,00$

ENT Devices Market Outlook in Saudi Arabia to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Saudi Arabia to 2017 - Hearing Aid Devices and Implants
2011 2.500,00$

Brazil Medical Device Industry – Key Company Profiles

Introduction / / GlobalData’s report, “Brazil Medical Device Industry - Key Company Profiles” provides information and analysis o
2011 500,00$

Dental Devices Market Outlook in Austria to 2017 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Austria to 2017 – Dental Chairs and Equipment, Dental
2011 2.500,00$

Healthcare IT Market Outlook in India to 2017 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s new report, “Healthcare IT Market Outlook in India to 2017 - Hospital Information Systems and Medic
2011 2.500,00$

Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market F
2011 3.500,00$

Dental Devices Market Outlook in Israel to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Israel to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

ENT Devices Market Outlook in Taiwan to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Taiwan to 2017 - Hearing Aid Devices and Implants and Di
2011 2.500,00$

ENT Devices Market Outlook in Austria to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Austria to 2017 - Hearing Aid Devices and Implants and D
2011 2.500,00$

Dental Devices Market Outlook in Czech Republic to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Czech Republic to 2017 - Dental Chairs and Equipment,
2011 2.500,00$

Dental Devices Market Outlook in Sweden to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Sweden to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in New Zealand to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in New Zealand to 2017 - Dental Chairs and Equipment, De
2011 2.500,00$

Dental Devices Market Outlook in Denmark to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Denmark to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in Saudi Arabia to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Saudi Arabia to 2017 - Dental Chairs and Equipment, D
2011 2.500,00$

BioDelivery Sciences International Prices Private Placement of $15m - Deal Analysis from GlobalData

Introduction / / The drug discovery process has become more complex, time consuming and quite expensive leading to big rise in R&
2011 500,00$

Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalData

Introduction / / In March 2011, Cephalon announced that it had signed an agreement to acquire the outstanding stock of Gemin X Ph
2011 500,00$

FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

Introduction / / GlobalData’s report, “FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade” provi
2011 500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011” repo
2011 1.000,00$

Schistosomiasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Schistosomiasis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

United Kingdom Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “United Kingdom Diagnostic Imaging Market Outlook to 2016” provides key m
2010 2.500,00$

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity As
2011 3.500,00$

American Academy of Orthopaedic Surgeons Annual Meeting 2011 - Review and Analysis

Introduction / / GlobalData’s report, “American Academy of Orthopaedic Surgeons Annual Meeting 2011: Review and Analysis” provide
2011 1.000,00$

Healthcare Information and Management Systems Society (HIMSS) Conference 2011: Review and Analysis

Introduction / / GlobalData’s report, “Healthcare Information and Management Systems Society (HIMSS) Conference 2011: Review and
2011 1.000,00$

Accuray to Acquire Tomotherapy: To Become Third Largest Player in Global Radiation Therapy Market – Deal Analysis from GlobalData

Introduction / / GlobalData’s medical equipment report, “Accuray to Acquire Tomotherapy: To Become Third Largest Player in Global
2011 500,00$

Terumo to Buy Blood Transfusion Business from Gambro: To become the Largest Player in the Blood Transfusion Market - Deal Analysis From GlobalData

Introduction / / GlobalData’s “Terumo to Buy Blood Transfusion Business from Gambro to become the Largest Player in Blood Transfu
2011 500,00$

Aramark Healthcare Buys ReMedPar, MasterPlan and MESA to Become End-to-End Clinical Technology Service Provider - Deal Analysis From GlobalData

Introduction / / GlobalData’s medical equipment report, “Aramark Healthcare Buys ReMedPar, MasterPlan and MESA to Become End-to-E
2011 500,00$

North America Nephrology and Urology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Nephrology and Urology Devices Market Outlook to 2017” provides key mar
2011 3.500,00$

Europe Nephrology and Urology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Nephrology and Urology Devices Market Outlook to 2017” provides key market dat
2011 3.500,00$

Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017” provides key mark
2011 3.500,00$

North America Neurology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Neurology Devices Market Outlook to 2017” provides key market data on th
2011 3.500,00$

Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis,
2011 3.500,00$

Europe Neurology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Europe Neurology Devices Market Outlook to 2017” provides key market data on the Eur
2011 3.500,00$

Asia-Pacific Neurology Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “Asia-Pacific Neurology Devices Market Outlook to 2017” provides key market data on th
2011 3.500,00$

Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competi
2011 3.500,00$

Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape an
2011 3.500,00$

North America ENT Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America ENT Devices Market Outlook to 2017” provides key market data on the Nort
2011 3.500,00$

Orthotics and Prosthetics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Orthotics and Prosthetics - Global Pipeline Analysis, Competitive Landscape and Market
2011 3.500,00$

India X-Ray Systems and Mammography Equipment Market Briefing to 2017

Introduction / / GlobalData’s new report, “India X-Ray Systems and Mammography Equipment Market Briefing to 2017” provides key da
2011 2.000,00$

Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

Introduction / / GlobalData’s new report, “Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts
2011 3.500,00$

Nephrology and Urology Devices Market Outlook in South Africa to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in South Africa to 2017 - Incontinence D
2011 2.500,00$

Dental Devices Market Outlook in United States to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in United States to 2017 - Dental Chairs and Equipment,
2011 2.500,00$

Dental Devices Market Outlook in United Kingdom to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in United Kingdom to 2017 - Dental Chairs and Equipment,
2011 2.500,00$

Dental Devices Market Outlook in Japan to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Japan to 2017 - Dental Chairs and Equipment, Dental I
2011 2.500,00$

Dental Devices Market Outlook in India to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in India to 2017 - Dental Chairs and Equipment, Dental I
2011 2.500,00$

Dental Devices Market Outlook in China to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in China to 2017 - Dental Chairs and Equipment, Dental I
2011 2.500,00$

Dental Devices Market Outlook in Canada to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Canada to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in Germany to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Germany to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in France to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in France to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in Italy to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Italy to 2017 - Dental Chairs and Equipment, Dental I
2011 2.500,00$

Dental Devices Market Outlook in Spain to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Spain to 2017 - Dental Chairs and Equipment, Dental I
2011 2.500,00$

Dental Devices Market Outlook in Australia to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Australia to 2017 - Dental Chairs and Equipment, Dent
2011 2.500,00$

Dental Devices Market Outlook in Brazil to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Brazil to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in Netherlands to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Netherlands to 2017 - Dental Chairs and Equipment, De
2011 2.500,00$

Dental Devices Market Outlook in Belgium to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Belgium to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in Mexico to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Mexico to 2017 - Dental Chairs and Equipment, Dental
2011 2.500,00$

Dental Devices Market Outlook in Republic of Korea to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Republic of Korea to 2017 - Dental Chairs and Equipme
2011 2.500,00$

Dental Devices Market Outlook in South Africa to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in South Africa to 2017 - Dental Chairs and Equipment, D
2011 2.500,00$

Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices,
2011 2.500,00$

Neurology Devices Market Outlook in United Kingdom to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in United Kingdom to 2017 – Neurostimulation Devices,
2011 2.500,00$

North America Dental Devices Market Outlook to 2017

Introduction / / GlobalData’s new report, “North America Dental Devices Market Outlook to 2017” provides key market data on the
2011 3.500,00$

Neurology Devices Market Outlook in Japan to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Japan to 2017 – Neurostimulation Devices, Interven
2011 2.500,00$

Neurology Devices Market Outlook in India to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in India to 2017 - Neurostimulation Devices, Interven
2011 2.500,00$

Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interven
2011 2.500,00$

Neurology Devices Market Outlook in Canada to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Canada to 2017 - Neurostimulation Devices, Interve
2011 2.500,00$

Neurology Devices Market Outlook in Germany to 2017 – Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Germany to 2017 – Neurostimulation Devices, Interv
2011 2.500,00$

Neurology Devices Market Outlook in France to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in France to 2017 - Neurostimulation Devices, Interve
2011 2.500,00$

Neurology Devices Market Outlook in Italy to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Italy to 2017 - Neurostimulation Devices, Interven
2011 2.500,00$

Neurology Devices Market Outlook in Spain to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Spain to 2017 - Neurostimulation Devices, Interven
2011 2.500,00$

Neurology Devices Market Outlook in Australia to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Australia to 2017 - Neurostimulation Devices, Inte
2011 2.500,00$

Neurology Devices Market Outlook in Brazil to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Brazil to 2017 – Neurostimulation Devices, Interve
2011 2.500,00$

Neurology Devices Market Outlook in Netherlands to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Netherlands to 2017 - Neurostimulation Devices, In
2011 2.500,00$

Neurology Devices Market Outlook in Belgium to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Belgium to 2017 - Neurostimulation Devices, Interv
2011 2.500,00$

Neurology Devices Market Outlook in Argentina to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Argentina to 2017 - Neurostimulation Devices, Inte
2011 2.500,00$

Neurology Devices Market Outlook in Mexico to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Mexico to 2017 – Neurostimulation Devices, Interve
2011 2.500,00$

Neurology Devices Market Outlook in Republic of Korea to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Republic of Korea to 2017 - Neurostimulation Devic
2011 2.500,00$

Neurology Devices Market Outlook in Taiwan to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Taiwan to 2017 – Neurostimulation Devices, Interve
2011 2.500,00$

Neurology Devices Market Outlook in South Africa to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in South Africa to 2017 - Neurostimulation Devices, I
2011 2.500,00$

Neurology Devices Market Outlook in Israel to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Israel to 2017 - Neurostimulation Devices, Interve
2011 2.500,00$

Neurology Devices Market Outlook in Austria to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Austria to 2017 - Neurostimulation Devices, Interv
2011 2.500,00$

Neurology Devices Market Outlook in Czech Republic to 2017 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Czech Republic to 2017 - Neurostimulation Devices,
2011 2.500,00$

Neurology Devices Market Outlook in Russian Federation to 2017 – Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Russian Federation to 2017 – Neurostimulation Devi
2011 2.500,00$

Neurology Devices Market Outlook in Sweden to 2017 – Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Sweden to 2017 – Neurostimulation Devices, Interve
2011 2.500,00$

Neurology Devices Market Outlook in New Zealand to 2017 – Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in New Zealand to 2017 – Neurostimulation Devices, In
2011 2.500,00$

Neurology Devices Market Outlook in Denmark, to 2017 – Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Denmark, to 2017 – Neurostimulation Devices, Inter
2011 2.500,00$

Neurology Devices Market Outlook in Saudi Arabia to 2017 – Neurostimulation Devices, Interventional Neurology and Other

Introduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Saudi Arabia to 2017 – Neurostimulation Devices, I
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Czech Republic to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Czech Republic to 2017 - Incontinence
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Russian Federation to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Russian Federation to 2017 - Incontin
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Sweden to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Sweden to 2017 - Incontinence Devices
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in New Zealand to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in New Zealand to 2017 - Incontinence De
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Denmark to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Denmark to 2017 - Incontinence Device
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Saudi Arabia to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Saudi Arabia to 2017 - Incontinence D
2011 2.500,00$

ENT Devices Market Outlook in United States to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in United States to 2017 - Hearing Aid Devices and Implants
2011 2.500,00$

ENT Devices Market Outlook in United Kingdom to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in United Kingdom to 2017 - Hearing Aid Devices and Implant
2011 2.500,00$

ENT Devices Market Outlook in Japan to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Japan to 2017 - Hearing Aid Devices and Implants and Dia
2011 2.500,00$

ENT Devices Market Outlook in India to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in India to 2017 - Hearing Aid Devices and Implants and Dia
2011 2.500,00$

ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Dia
2011 2.500,00$

ENT Devices Market Outlook in Canada to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Canada to 2017 - Hearing Aid Devices and Implants and Di
2011 2.500,00$

ENT Devices Market Outlook in Germany to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Germany to 2017 - Hearing Aid Devices and Implants and D
2011 2.500,00$

ENT Devices Market Outlook in France to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in France to 2017 - Hearing Aid Devices and Implants and Di
2011 2.500,00$

ENT Devices Market Outlook in Italy to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Italy to 2017 - Hearing Aid Devices and Implants and Dia
2011 2.500,00$

ENT Devices Market Outlook in Spain to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Spain to 2017 - Hearing Aid Devices and Implants and Dia
2011 2.500,00$

ENT Devices Market Outlook in Australia to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Australia to 2017 - Hearing Aid Devices and Implants and
2011 2.500,00$

ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Di
2011 2.500,00$

ENT Devices Market Outlook in Netherlands to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Netherlands to 2017 - Hearing Aid Devices and Implants a
2011 2.500,00$

ENT Devices Market Outlook in Belgium to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Belgium to 2017 - Hearing Aid Devices and Implants and D
2011 2.500,00$

ENT Devices Market Outlook in Argentina to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Argentina to 2017 - Hearing Aid Devices and Implants and
2011 2.500,00$

ENT Devices Market Outlook in Mexico to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Mexico to 2017 - Hearing Aid Devices and Implants and Di
2011 2.500,00$

ENT Devices Market Outlook in South Africa to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in South Africa to 2017 - Hearing Aid Devices and Implants
2011 2.500,00$

ENT Devices Market Outlook in Israel to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Israel to 2017 - Hearing Aid Devices and Implants and Di
2011 2.500,00$

ENT Devices Market Outlook in Czech Republic to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Czech Republic to 2017 - Hearing Aid Devices and Implant
2011 2.500,00$

ENT Devices Market Outlook in Russian Federation to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s new report, “ENT Devices Market Outlook in Russian Federation to 2017 - Hearing Aid Devices and Imp
2011 2.500,00$

Critical Care Settings: An Impact Analysis of Ongoing and Expected Trends

Introduction / / GlobalData’s report, “Critical Care Settings -An Impact Analysis of Ongoing and Expected Trends” provides key in
2011 500,00$

Biomaterials that Deliver Antimicrobials: An Overview

Introduction / / GlobalData’s report, “Biomaterials that Deliver Antimicrobials: An Overview” provides key information, products
2011 500,00$

Dental Devices Market Outlook in Russian Federation to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s new report, “Dental Devices Market Outlook in Russian Federation to 2017 - Dental Chairs and Equipm
2011 2.500,00$

Uveitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, Q1, 2011" provides data on the Uveit
2011 1.000,00$

Urinary Tract Cancer Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Urinary Tract Cancer Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Epidermolysis Bullosa Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Xerostomia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Xerostomia Global Clinical Trials Review, Q1, 2011" provides data on the Xe
2011 1.000,00$

Respiratory Insufficiency Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Respiratory Insufficiency Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Tinnitus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, Q1, 2011" provides data on the Tinn
2011 1.000,00$

Pulmonary Hypertension Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Filariasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, Q1, 2011" provides data on the Fi
2011 1.000,00$

Anemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Anemia Global Clinical Trials Review, Q1, 2011" provides data on the Anemia
2011 1.000,00$

Leishmaniasis (Kala-Azar) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Schizophrenia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Depression Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Depression Global Clinical Trials Review, Q1, 2011" provides data on the De
2011 1.000,00$

Arrythmia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Arrhythmia Global Clinical Trials Review, Q1, 2011" provides data on the Ar
2011 1.000,00$

Coronary Artery Disease (CAD) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Artery Disease Global Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Heart Valve Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Heart Valve Disease Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Respiration Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Respiration Disorders Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pain Global Clinical Trials Review, Q1, 2011" provides data on the Pain cli
2011 1.000,00$

Retinitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Retinitis Global Clinical Trials Review, Q1, 2011" provides data on the Ret
2011 1.000,00$

Helminthiasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Helminthiasis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Hypertension Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hypertension Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Other Psychiatric Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Other Psychiatric Disorders Global Clinical Trials Review, Q1, 2011" provid
2011 1.000,00$

Other Neurologic Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Other Neurologic Disorders Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Mental Illness Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Mental Illness Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Spinal Cord Injury Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Neuroblastoma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Neuroblastoma Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Tropical Spastic Paraparesis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Tropical Spastic Paraparesis Global Clinical Trials Review, Q1, 2011" provi
2011 1.000,00$

Back Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Back Pain Global Clinical Trials Review, Q1, 2011" provides data on the Bac
2011 1.000,00$

Anorexia Nervosa Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Aphasia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Aphasia Global Clinical Trials Review, Q1, 2011" provides data on the Aphas
2011 1.000,00$

Delirium Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Delirium Global Clinical Trials Review, Q1, 2011" provides data on the Deli
2011 1.000,00$

Brain Infarction Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Brain Infarction Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Ataxia-Telangiectasia [Louis-Bar syndrome] Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Ataxia-Telangiectasia [Louis-Bar Syndrome] Global Clinical Trials Review, Q
2011 1.000,00$

Diabetes Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diabetes Global Clinical Trials Review, Q1, 2011" provides data on the Diab
2011 1.000,00$

Diabetic Foot Ulcers Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Foot Ulcers Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Diabetic Foot Infection (DFI) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, Q1, 2011" prov
2011 1.000,00$

Diabetic Gastroparesis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Gastroparesis Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Diabetic Ketoacidosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Drug Abuse Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Drug Abuse Global Clinical Trials Review, Q1, 2011" provides data on the Dr
2011 1.000,00$

Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2
2011 1.000,00$

Neurotoxicity Syndromes Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Neurotoxicity Syndromes Global Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, Q1, 2011" prov
2011 1.000,00$

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Tr
2011 1.000,00$

Carotid Sinus Syncope Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Carotid Sinus Syncope Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Cerebellar Ataxia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cerebellar Ataxia Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Brain Injury Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Other Pain Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Other Pain Disorders Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Cancer Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, Q1, 2011" provides data on the C
2011 1.000,00$

Brain Hemorrhage Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Amblyopia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Amblyopia Global Clinical Trials Review, Q1, 2011" provides data on the Amb
2011 1.000,00$

Asperger Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Asperger Syndrome Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Cerebral Hypoxia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cerebral Hypoxia Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Cerebrovascular Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cerebrovascular Disease Global Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Brain Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Brain Disease Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Constipation Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Cardiac Arrest Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cardiac Arrest Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Candidiasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, Q1, 2011" provides data on the C
2011 1.000,00$

Cluster Headache Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cluster Headache Syndrome Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Complex Regional Pain Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Complex Regional Pain Syndrome Global Clinical Trials Review, Q1, 2011" pro
2011 1.000,00$

Anesthetic Effect Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Anesthetic Effect Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Fragile X Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Fragile X Syndrome Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Anthrax Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, Q1, 2011" provides data on the Anth
2011 1.000,00$

Attention Deficit Disorder Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Attention Deficit Disorder Global Clinical Trials Review, Q1, 2011" provid
2011 1.000,00$

Panic Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Panic Disorders Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Subarachnoid Hemorrhage Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Subarachnoid Hemorrhage Global Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Movement Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Movement Disorders Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Nevus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Nevus Global Clinical Trials Review, Q1, 2011" provides data on the Nevus
2011 1.000,00$

Skin Rash Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Skin Rash Global Clinical Trials Review, Q1, 2011" provides data on the Ski
2011 1.000,00$

Hidradenitis Suppurativa Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Tinea Pedis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Tinea Pedis Global Clinical Trials Review, Q1, 2011" provides data on the T
2011 1.000,00$

Ankylosing Spondylitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Ankylosing Spondylitis Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Lupus Nephritis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

International Stroke Conference 2011: Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “International Stroke Conf
2011 1.000,00$

2nd World Congress on Controversies in Ophthalmology 2011: Post-Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “2nd World Congress on Con
2011 1.000,00$

The 10th International Conference on Alzheimer’s and Parkinson’s Diseases: Post-Conference Review and Analysis

Introduction / / GlobalData, the industry analysis specialist, has released its new conference alert, “The 10th International Con
2011 1.000,00$

Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bladder Cancer - Global Drug Forecas
2011 5.000,00$

Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gastric Cancer - Global Drug Forecas
2011 5.000,00$

Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C Treatment

Introduction / / Global Data“Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standar
2011 500,00$

Cypress Bioscience Announces the Discontinuation of Co-Promotion Agreement with Forest Laboratories for Savella (Milnacipran)

Introduction / / GlobalData’s report, “Cypress Bioscience Announces the Discontinuation of Co-Promotion Agreement with Forest Lab
2011 500,00$

Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resistant Prostate Cancer

Introduction / / GlobalData’s report, “Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resist
2011 500,00$

Gilenya (Fingolimod), Laquinimod and Cladribine - Impact on the Multiple Sclerosis (MS) Treatment Landscape

Introduction / / GlobalData’s report, “Gilenya (Fingolimod), Laquinimod and Cladribine - Impact on the Multiple Sclerosis (MS) Tr
2011 500,00$

Increasing Disease Burden of Alzheimer’s Disease - Is There a Solution in Sight?

Introduction / / GlobalData’s report, “Increasing Disease Burden of Alzheimer’s Disease - Is There a Solution in Sight? ” provide
2011 500,00$

Iniparib Failure: Highlights the Uncertainty in Late Stage Breast Cancer Pipeline

Introduction / / GlobalData’s report, “Iniparib Failure - Highlights the Uncertainty in Late Stage Breast Cancer Pipeline” provid
2011 500,00$

FDA ends the 50-year long wait for Lupus patients - Benlysta set to become the next blockbuster

Introduction / / GlobalData’s report, “FDA ends the 50-year long wait for Lupus patients - Benlysta set to become the next blockb
2011 500,00$

Early Diagnosis of Alzheimer’s Disease - Benefits, Challenges and Recent Developments

Introduction / / GlobalData’s report, “Early Diagnosis of Alzheimer’s Disease - Benefits, Challenges and Recent Developments” pro
2011 500,00$

Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logistics Infrastructure

Introduction / / GlobalData’s report, “Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logist
2011 500,00$

Erosive Oral Lichen Planus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Erosive Oral Lichen Planus Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Enamel Carious Lesions Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Enamel Carious Lesions Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Cholera Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cholera Global Clinical Trials Review, Q1, 2011" provides data on the Chole
2011 1.000,00$

Hairy Cell Leukemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Partial Seizure Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Addiction Control Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Addiction Control Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Acidity Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Acidity Global Clinical Trials Review, Q1, 2011" provides data on the Acidi
2011 1.000,00$

Appetite Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Appetite Global Clinical Trials Review, Q1, 2011" provides data on the Appe
2011 1.000,00$

Biliary Tract Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Billary Tract Disease Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Duodenitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Duodenitis Global Clinical Trials Review, Q1, 2011" provides data on the Du
2011 1.000,00$

Burns Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Burns Global Clinical Trials Review, Q1, 2011" provides data on the Burns c
2011 1.000,00$

Cellulite Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cellulite Global Clinical Trials Review, Q1, 2011" provides data on the Cel
2011 1.000,00$

Chronic Urticaria or Hives Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Urticaria or Hives Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Cutaneous Mastocytosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cutaneous Mastocytosis Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Dental Caries Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dental Caries Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Dental Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dental Pain Global Clinical Trials Review, Q1, 2011" provides data on the D
2011 1.000,00$

Dermatitis Herpetiformis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dermatitis Herpetiformis Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Inflammatory Skin Diseases Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Inflammatory Skin Diseases Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Leg Ulcer Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Leg Ulcer Global Clinical Trials Review, Q1, 2011" provides data on the Leg
2011 1.000,00$

Mouth Ulcers Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Mouth Ulcers Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Muckle-Wells Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Muckle-Wells Syndrome Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Pressure Ulcer Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pressure Ulcer Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Psoriasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, Q1, 2011" provides data on the Pso
2011 1.000,00$

Psoriatic Arthritis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Scar Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Scar Global Clinical Trials Review, Q1, 2011" provides data on the Scar cli
2011 1.000,00$

Skin Ulcers Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Skin Ulcers Global Clinical Trials Review, Q1, 2011" provides data on the S
2011 1.000,00$

Wounds Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Wounds Global Clinical Trials Review, Q1, 2011" provides data on the Wounds
2011 1.000,00$

Wrinkles Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Wrinkles Global Clinical Trials Review, Q1, 2011" provides data on the Wrin
2011 1.000,00$

Sarcopenia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Sarcopenia Global Clinical Trials Review, Q1, 2011" provides data on the Sa
2011 1.000,00$

Enteritis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Enteritis Global Clinical Trials Review, Q1, 2011" provides data on the Ent
2011 1.000,00$

Barrett’s Esophagus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Barrett’s Esophagus Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Eosinophilic Esophagitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Fistula Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Fistula Global Clinical Trials Review, Q1, 2011" provides data on the Fistu
2011 1.000,00$

Choledocholithiasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Choledocholithiasis Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Cholelithiasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cholelithiasis Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Gastric Motility Disorder Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gastric Motility Disorder Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Gastroesophageal Reflux Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gastroesophageal Reflux Disease Global Clinical Trials Review, Q1, 2011" pr
2011 1.000,00$

Dyspepsia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, Q1, 2011" provides data on the Dys
2011 1.000,00$

Dry Eye Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dry Eye Global Clinical Trials Review, Q1, 2011" provides data on the Dry E
2011 1.000,00$

Varicella-Zoster Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Varicella-Zoster Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Orthomyxoviridae Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Orthomyxoviridae Infections Global Clinical Trials Review, Q1, 2011" provid
2011 1.000,00$

Croup Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Croup Global Clinical Trials Review, Q1, 2011" provides data on the Croup c
2011 1.000,00$

Human Papillomavirus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Human Papillomavirus Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Genital Warts Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Genital Warts Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Graft Versus Host Disease (GVHD) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, Q1, 2011" p
2011 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – March 2011” rep
2011 1.000,00$

Gall Stone Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gall Stone Global Clinical Trials Review, Q1, 2011" provides data on the Ga
2011 1.000,00$

DURECT Corporation (DRRX) - Product Pipeline Analysis

DURECT Corporation (DRRX) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2011 750,00$

EKOS Corporation - Product Pipeline Analysis

EKOS Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige
2011 750,00$

Medlogics Device Corporation - Product Pipeline Analysis

Medlogics Device Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2011 750,00$

Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis

Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti
2011 750,00$

NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis

NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i
2011 750,00$

Arterial Remodeling Technologies - Product Pipeline Analysis

Arterial Remodeling Technologies - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti
2011 750,00$

LifeWave, Inc. - Product Pipeline Analysis

LifeWave, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2011 750,00$

Gene Express, Inc. - Product Pipeline Analysis

Gene Express, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelli
2011 750,00$

TYRX, Inc. - Product Pipeline Analysis

TYRX, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on
2011 750,00$

Doxa AB - Product Pipeline Analysis

Doxa AB - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on th
2011 750,00$

Scient'x USA - Product Pipeline Analysis

Scient'x USA - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2011 750,00$

Korea Bone Bank Inc. - Product Pipeline Analysis

Korea Bone Bank Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel
2011 750,00$

Japan Medical Materials Corporation - Product Pipeline Analysis

Japan Medical Materials Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and a
2011 750,00$

SomaLogic, Inc. - Product Pipeline Analysis

SomaLogic, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2011 750,00$

Raymedica, LLC - Product Pipeline Analysis

Raymedica, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2011 750,00$

Small Bone Innovations, Inc. - Product Pipeline Analysis

Small Bone Innovations, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2011 750,00$

Onconome, Inc. - Product Pipeline Analysis

Onconome, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2011 750,00$

Micrus Endovascular Corporation (MEND) - Product Pipeline Analysis

Micrus Endovascular Corporation (MEND) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis an
2011 750,00$

OrSense Ltd. - Product Pipeline Analysis

OrSense Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2011 750,00$

Lithotech Medical Ltd. - Product Pipeline Analysis

Lithotech Medical Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2011 750,00$

LDR Holding Corporation - Product Pipeline Analysis

LDR Holding Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2011 750,00$

Heart Tronics, Inc. (HRTT) - Product Pipeline Analysis

Heart Tronics, Inc. (HRTT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2011 750,00$

ITGI Medical Ltd. - Product Pipeline Analysis

ITGI Medical Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig
2011 750,00$

Medicsight PLC (MDST) - Product Pipeline Analysis

Medicsight PLC (MDST) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte
2011 750,00$

Nerites Corporation - Product Pipeline Analysis

Nerites Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2011 750,00$

Nanomix, Inc. - Product Pipeline Analysis

Nanomix, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2011 750,00$

Palomar Medical Technologies, Inc. (PMTI) - Product Pipeline Analysis

Palomar Medical Technologies, Inc. (PMTI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis
2011 750,00$

Infopia Co., Ltd. (036220) - Product Pipeline Analysis

Infopia Co., Ltd. (036220) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2011 750,00$

HEXACATH - Product Pipeline Analysis

HEXACATH - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on t
2011 750,00$

Wet Nose Technologies, LLC - Product Pipeline Analysis

Wet Nose Technologies, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2011 750,00$

Eden Spine, LLC - Product Pipeline Analysis

Eden Spine, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2011 750,00$

Nesstent Ltd. - Product Pipeline Analysis

Nesstent Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2011 750,00$

Amedica Corporation - Product Pipeline Analysis

Amedica Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2011 750,00$

Alfa Scientific Designs, Inc. - Product Pipeline Analysis

Alfa Scientific Designs, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actiona
2011 750,00$

VentriPoint, Inc. - Product Pipeline Analysis

VentriPoint, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig
2011 750,00$

Satoris, Inc. - Product Pipeline Analysis

Satoris, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2011 750,00$

Dynatomics Ltd. - Product Pipeline Analysis

Dynatomics Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2011 750,00$

Sphere Medical Limited - Product Pipeline Analysis

Sphere Medical Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2011 750,00$

BioCardia, Inc. - Product Pipeline Analysis

BioCardia, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2011 750,00$

Angiotech Pharmaceuticals, Inc. (ANP) - Product Pipeline Analysis

Angiotech Pharmaceuticals, Inc. (ANP) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and
2011 750,00$

University of Tampere - Product Pipeline Analysis

University of Tampere - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte
2011 750,00$

Sahajanand Medical Technologies Pvt. Ltd. - Product Pipeline Analysis

Sahajanand Medical Technologies Pvt. Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis
2011 750,00$

Danaher Signs an Agreement to Acquire Beckman Coulter: A Move to Leverage its Position in the Life Sciences Market in View of the Increasing Demand - Deal Analysis From GlobalData

Introduction / / GlobalData’s report, “Danaher Corp. Acquires Beckman Coulter Inc.: Move to Leverage its Position in the Life Sci
2011 500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - March 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – March 2011” report is an ess
2011 1.000,00$

Nephrology and Urology Devices Market Outlook in United States to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in United States to 2017 - Incontinence
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in United Kingdom to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in United Kingdom to 2017 - Incontinence
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Japan to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Japan to 2017 - Incontinence Devices,
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in India to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in India to 2017 - Incontinence Devices,
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in China to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in China to 2017 - Incontinence Devices,
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Canada to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Canada to 2017 - Incontinence Devices
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Germany to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Germany to 2017 - Incontinence Device
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in France to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in France to 2017 - Incontinence Devices
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Italy to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Italy to 2017 - Incontinence Devices,
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Spain to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Spain to 2017 - Incontinence Devices,
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Australia to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Australia to 2017 - Incontinence Devi
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Brazil to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Brazil to 2017 - Incontinence Devices
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Netherlands to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Netherlands to 2017 - Incontinence De
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Belgium to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Belgium to 2017 - Incontinence Device
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Argentina to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Argentina to 2017 - Incontinence Devi
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Mexico to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Mexico to 2017 - Incontinence Devices
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Republic of Korea to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Republic of Korea to 2017 - Incontine
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Taiwan to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2017 - Incontinence Devices
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Israel to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Israel to 2017 - Incontinence Devices
2011 2.500,00$

Nephrology and Urology Devices Market Outlook in Austria to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Austria to 2017 - Incontinence Device
2011 2.500,00$

Strong Pipeline Characterized with Novel Therapies will Drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market

Introduction / / GlobalData’s report, “Strong Pipeline Characterized with Novel Therapies will drive the Methicillin-Resistant St
2011 500,00$

Novel Targeted Therapies Hold the Promise of Cure for Parkinson’s Disease (PD)

Introduction / / GlobalData’s report, “Novel Targeted Therapies Hold the Promise of Cure for Parkinson’s Disease (PD) ” provides
2011 500,00$

Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy

Introduction / / GlobalData’s report, “Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therap
2011 500,00$

Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis

Introduction / / GlobalData’s report, “Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fib
2011 500,00$

Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?

Introduction / / GlobalData’s report, “Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?” provides information on
2011 500,00$

Cerebral Infarction Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cerebral Infarction Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1,
2011 1.000,00$

Motor Neurone Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Motor Neurone Disease Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Hyperalgesia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hyperalgesia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Radiculopathy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Brain Ischemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Brain Ischemia Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Craniocerebral Trauma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Craniocerebral Trauma Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Circadian Rhythm Sleep Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Circadian Rhythm Sleep Disorders Global Clinical Trials Review, Q1, 2011" p
2011 1.000,00$

Inflammatory Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Anal Fissure Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Anal Fissure Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Biliary Cirrhosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Biliary Cirrhosis Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Colitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Colitis Global Clinical Trials Review, Q1, 2011" provides data on the Colit
2011 1.000,00$

Diverticulitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diverticulitis Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Dysphagia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, Q1, 2011" provides data on the Dys
2011 1.000,00$

Angioedema Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, Q1, 2011" provides data on the An
2011 1.000,00$

Chlamydia Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Clostridium Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Clostridium Infections Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Endophthalmitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Endophthalmitis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Escherichia coli Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Escherichia coli Infections Global Clinical Trials Review, Q1, 2011" provid
2011 1.000,00$

Histoplasmosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Histoplasmosis Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Pneumococcal Infections Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pneumococcal Infections Global Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Trauma Fixation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Introduction / / GlobalData’s new report, “Trauma Fixation Devices - Global Pipeline Analysis, Competitive Landscape and Market F
2011 3.500,00$

Wireless Medical Devices - A Market Snapshot

Introduction / / GlobalData’s report, “Wireless Medical Devices - A Market Snapshot” provides information and analysis on the glo
2011 500,00$

Generalized Seizures Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Memory Impairment Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Memory Impairment Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Tardive Dyskinesia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Seborrhea Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Seborrhea Global Clinical Trials Review, Q1, 2011" provides data on the Seb
2011 1.000,00$

Syphilis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Syphilis Global Clinical Trials Review, Q1, 2011" provides data on the Syph
2011 1.000,00$

Pharmaceutical & Healthcare Annual Deals Analysis 2011

Analysis of the market trends for the pharmaceutical industry in the global arena. / Review of deal trends in the cardiovascular
2011 3.500,00$

Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines - Pipeline Assessment and Market For
2010 2.000,00$

CHAD Therapeutics, Inc. (CHADQ) - Financial and Strategic SWOT Analysis Review

CHAD Therapeutics (CHAD ) is engaged in the development, production and distribution of respiratory care products for hospital and
2011 250,00$

VNUS Medical Technologies, Inc. (VNUS) - Financial and Strategic SWOT Analysis Review

VNUS Medical Technologies, Inc. (VNUS Medical) develops, manufactures and licenses VNUS Closure system of products used in the min
2011 250,00$

LMS Medical Systems Inc. (LMZ) - Financial and Strategic SWOT Analysis Review

LMS Medical Systems Inc. (LMS), a healthcare technology service provider company. The company is principally engaged in the develo
2011 250,00$

SSL International plc (Inactive) (SSL) - Financial and Strategic SWOT Analysis Review

SSL International plc (SSL) is engaged in manufacturing and distributing healthcare products to the consumer markets worldwide. Th
2011 125,00$

Tepnel Life Sciences PLC (TED) - Financial and Strategic SWOT Analysis Review

Tepnel Life Sciences PLC is engaged in offering products and services in healthcare market. The company operates through its subsi
2011 250,00$

Xcorporeal, Inc. (XCRP) - Financial and Strategic SWOT Analysis Review

Xcorporeal, Inc. (Xcorporeal) is a medical device company principally engaged in the development of an extra-corporeal platform t
2011 250,00$

KOKEN CO., LTD (7963) - Financial and Strategic SWOT Analysis Review

KOKEN CO., LTD. (KOKEN) is engaged in the development, manufacture and marketing of medical devices and products for the healthcar
2011 250,00$

US Spine, Inc. - Strategic SWOT Analysis Review

US Spine, Inc. (US Spine) is a privately-held medical technology company, engaged in the design, development, manufacture and mark
2011 125,00$

Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - February 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – February 2011” report is an
2011 1.000,00$

Changing Regulatory and Health Economics Scenarios in Europe - An Orthopedic Devices Industry Perspective

Introduction / / GlobalData’s report, “Changing Regulatory and Health Economics Scenarios in Europe - An Orthopedic Devices Indus
2011 500,00$

Hospital Hygiene - How to Improve

Introduction / / GlobalData’s report, “Hospital Hygiene – How to Improve” provides comprehensive information on hospital hygiene
2011 500,00$

STEN Corporation (STEN) - Financial and Strategic SWOT Analysis Review

STEN Corporation (STEN) is a diversified company that is engaged in offering contract manufacturing and financial services to its
2011 250,00$

TLC Vision Corporation (TLC) - Financial and Strategic SWOT Analysis Review

TLC Vision Corporation (TLC Vision) is an eye care services company based in Canada. TLC Vision is principally engaged in providin
2011 125,00$

Zentiva NV (BAAZEN) - Financial and Strategic SWOT Analysis Review

Zentiva NV is a leading pharmaceutical company in Czech Republic, Turkey, Romania, Poland, Slovakia and Russia. Its business opera
2011 125,00$

Jerini AG (JI4) - Financial and Strategic SWOT Analysis Review

Jerini AG (Jerini) is a publicly held pharmaceutical company that is engaged in the discovery, development, and commercialization
2011 250,00$

MedCom USA, Inc. (EMED) - Financial and Strategic SWOT Analysis Review

MedCom USA, Inc. (MedCom USA) a publicly held company is engaged in providing technology solutions for the healthcare industry in
2011 250,00$

Synovics Pharmaceuticals, Inc. (SYVC) - Financial and Strategic SWOT Analysis Review

Synovics Pharmaceuticals, Inc. (Synovics) is a US based Pharmaceutical company. It is engaged in developing, manufacturing and dis
2011 250,00$

MIV Therapeutics Inc (MIVI) - Financial and Strategic SWOT Analysis Review

MIV Therapeutics Inc. (MIVT) is an advanced stage, research and development company, that is engaged in the development of biocomp
2011 250,00$

China Biopharma, Inc. (CHBO) - Financial and Strategic SWOT Analysis Review

China Biopharma Inc. (CBI) is a biopharmaceutical company, that is engaged in introduction and marketing of human vaccines and oth
2011 250,00$

Clearant, Inc. (CLRA) - Financial and Strategic SWOT Analysis Review

Clearant, Inc. (Clearant) is a publicly trading pharmaceutical company engaged in developing and marketing of pathogen inactivatio
2011 250,00$

MedCap AB (MCAP) - Financial and Strategic SWOT Analysis Review

MedCap AB (MedCap), formerly New Science Svenska AB, is a investment company that invests in research companies within the life sc
2011 250,00$

Upstream Biosciences Inc. (UPBS) - Financial and Strategic SWOT Analysis Review

Upstream Biosciences Inc. (Upstream Biosciences) is a biotechnology company, engaged in the discovery, design, development and mar
2011 250,00$

Zorka Pharma A.D. Sabac (ZOPH) - Financial and Strategic SWOT Analysis Review

Zorka Pharma A.D. Sabac (Zorka Pharma), a Hemofarm Group company is a serbia-based public shareholding company. It is engaged in m
2011 250,00$

Toxin Alert Inc. (TOX) - Financial and Strategic SWOT Analysis Review

Toxin Alert Inc. (Toxin Alert) is a development stage company operating in the food safety business. The company is primarily enga
2011 250,00$

Cordex Pharma, Inc. (CDXP) - Financial and Strategic SWOT Analysis Review

Cordex Pharma, Inc. (Cordex Pharma) is a pharmaceutical company that develops therapeutic and diagnostic products. It also develop
2011 250,00$

Shanghai Industrial Pharmaceutical Investment Co. Ltd. (600607) - Financial and Strategic SWOT Analysis Review

Shanghai Industrial Pharmaceutical Investment Co. Ltd. (Shanghai Industrial Pharmaceutical) is a China based company which is invo
2011 125,00$

Zdravlje A.D. Leskovac (ZDRV) - Financial and Strategic SWOT Analysis Review

Zdravlje A.D. Leskovac (Actavis Serbia) is a research based pharmaceutical company, engaged in the development and commercializati
2011 250,00$

Daewoong Bio, Inc. (016890) - Financial and Strategic SWOT Analysis Review

Daewoong Bio, Inc. (DBI), is a leading pharmaceutical raw materials manufacturer. DBI is engaged in research and development; manu
2011 125,00$

Chuounyu Co., Ltd. (9053) - Financial and Strategic SWOT Analysis Review

Chuounyu Co., Ltd. (Chuounyu) is a Japan-based company engaged in the transportation of pharmaceuticals and warehousing. The compa
2011 250,00$

LensWista AG (LZVB) - Financial and Strategic SWOT Analysis Review

LensWista AG (LensWista) is a privately held pharmaceutical company that is engaged in the production and distribution of contact
2011 250,00$

Shanghai Zhongxi Pharmaceutical Co., Ltd. (600842) - Financial and Strategic SWOT Analysis Review

Shanghai Zhongxi Pharmaceutical Co., Ltd. (Zhongxi Pharmaceutical) is a publicly held China-based drug manufacturing company. The
2011 250,00$

Tissera, Inc. (TSSR) - Financial and Strategic SWOT Analysis Review

Tissera, Inc. (Tissera) is a developmental stage company engaged in the development, testing and commercializing solid organ trans
2011 250,00$

VYTA Corp. (VYTC) - Financial and Strategic SWOT Analysis Review

Vyta Corp. (Vyta), formerly known as NanoPierce Technologies, Inc., is a pharmaceutical company. The company is principally engage
2011 250,00$

Thomas Pharmaceuticals, Ltd. (TPHM) - Financial and Strategic SWOT Analysis Review

Thomas Pharmaceuticals, Ltd. is a public traded company focuses on relaunching products with proven effectiveness and usefulness s
2011 250,00$

UCB S.A. (UCB) - Strategic SWOT Analysis Review

UCB S.A (UCB) is a publicly held bio-pharmaceutical company. UCB is engaged in developing treatments for severe diseases. It focus
2011 250,00$

Therapeutic Cancer Vaccines - A New Paradigm in Cancer Therapy

Introduction / / GlobalData’s report, “Therapeutic Cancer Vaccines - A New Paradigm in Cancer Therapy” provides key information o
2011 500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - February 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – February 2011”
2011 1.000,00$

Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Revi
2011 1.000,00$

Post-Operative Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Post-Operative Pain Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, Q1, 2011"
2011 1.000,00$

Peripheral Neuropathy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Peripheral Neuropathy Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Mania Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Mania Global Clinical Trials Review, Q1, 2011" provides data on the Mania c
2011 1.000,00$

Neuralgia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Neuralgia Global Clinical Trials Review, Q1, 2011" provides data on the Neu
2011 1.000,00$

Postherpetic Neuralgia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Postherpetic Neuralgia Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Spasticity Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Spasticity Global Clinical Trials Review, Q1, 2011" provides data on the Sp
2011 1.000,00$

Hemiplegia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hemiplegia Global Clinical Trials Review, Q1, 2011" provides data on the He
2011 1.000,00$

Narcolepsy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Narcolepsy Global Clinical Trials Review, Q1, 2011" provides data on the Na
2011 1.000,00$

Osteoarthritis Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Joint Pains Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Joint Pains Global Clinical Trials Review, Q1, 2011" provides data on the J
2011 1.000,00$

Polyneuropathies Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Polyneuropathies Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Tension–Type Headache Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Tension–Type Headache Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Status Epilepticus Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Status Epilepticus Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Dyslexia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dyslexia Global Clinical Trials Review, Q1, 2011" provides data on the Dysl
2011 1.000,00$

Diarrhea Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, Q1, 2011" provides data on the Diar
2011 1.000,00$

Metabolic Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Metabolic Syndrome Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Insulin Resistance Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Diabetes Global Clinical Trials Review, Q1, 2011" provides data on the Diab
2011 1.000,00$

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, Q1,
2011 1.000,00$

Keratoconjunctivitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Keratoconjunctivitis Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Endotoxemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Endotoxemia Global Clinical Trials Review, Q1, 2011" provides data on the E
2011 1.000,00$

Helicobacter Pylori Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Helicobacter Pylori Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Leprosy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Leprosy Global Clinical Trials Review, Q1, 2011" provides data on the Lepro
2011 1.000,00$

Lyme Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Lyme Disease Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Typhoid Fever Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Typhoid Fever Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Dysentery Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dysentery Global Clinical Trials Review, Q1, 2011" provides data on the Dys
2011 1.000,00$

ImageWorks (AFPC) - Financial and Strategic SWOT Analysis Review

ImageWorks (formerly known as AFP Imaging Corporation) is a privately held medical device company. The company is engaged in the d
2011 250,00$

Elron Electronic Industries, Ltd. (ELRN) - Financial and Strategic SWOT Analysis Review

Elron Electronic Industries, Ltd. (Elron) is a medical devices company. It is operating through its group of companies in the fiel
2011 250,00$

I-Flow Corporation (IFLO) - Financial and Strategic SWOT Analysis Review

I-Flow Corporation (I-Flow) is a medical device company engaged in the design, development, manufacture and marketing of technical
2011 250,00$

Inion Oy (IIN) - Financial and Strategic SWOT Analysis Review

Inion Oy, (Inion) is engaged in the development of biodegradable medical implants for the orthopedics market. The company manufact
2011 125,00$

Genetix Group plc (GTX) - Financial and Strategic SWOT Analysis Review

Genetix Group plc (Genetix) is a Medical Diagnostic company engaged in designing, development, manufacturing and marketing of auto
2011 125,00$

Northstar Neuroscience, Inc. (NSTR) - Financial and Strategic SWOT Analysis Review

Northstar Neuroscience, Inc. (Northstar) is principally engaged in the manufacture and development of novel neurostimulation thera
2011 125,00$

Power Medical Interventions, Inc. (PMII) - Financial and Strategic SWOT Analysis Review

Power Medical Interventions, Inc. (PMII) is engaged in the development and commercialization of medical equipments for surgical ma
2011 250,00$

Intercytex Group plc (ICX) - Financial and Strategic SWOT Analysis Review

Intercytex Group plc (Intercytex) is engaged in the development of cell therapy products for the wound care markets. It develops w
2011 250,00$

Protein Polymer Technologies, Inc. (PPTI) - Financial and Strategic SWOT Analysis Review

Protein Polymer Technologies, Inc., (PPTI) is a biotechnology company engaged in the research, development and production of bio-a
2011 125,00$

Genexel-Sein Inc. (034660) - Financial and Strategic SWOT Analysis Review

Genexel-Sein Inc. (Genexel-Sein) is one of the world’s largest manufacturers of blood pressure measuring equipment and nerve stimu
2011 250,00$

Point Blank Solutions, Inc. (PBSO) - Financial and Strategic SWOT Analysis Review

Point Blank Solutions, Inc. (Point Blank Solutions) is engaged in designing, manufacturing and distribution of stab, bullet and fr
2011 125,00$

IOMED, Inc. (Inactive) - Strategic SWOT Analysis Review

IOMED, Inc. (IOMED) is a medical devices company. It is engaged in the development, manufacturing and marketing of active drug del
2011 125,00$

Everest Biomedical Instruments Company - Strategic SWOT Analysis Review

Everest Biomedical Instruments Company (Everest Biomedical) is principally engaged in the design and development of advanced, stat
2011 125,00$

ProRhythm Inc. (Inactive) - Strategic SWOT Analysis Review

ProRhythm, Inc. (ProRhythm) is a medical device company, engaged in the development, manufacture and marketing of high intensity f
2011 125,00$

PLC Medical Systems, Inc. (PLCSF) - Financial and Strategic SWOT Analysis Review

PLC Medical Systems, Inc., is engaged in providing process control programming and control tasks. The company's Diagnostics Syste
2011 250,00$

Nordion Inc. (NDN) - Financial and Strategic SWOT Analysis Review

Nordion Inc. (formerly MDS Inc.) is a health science company. It is engaged in developing, manufacturing and commercializing of sp
2011 125,00$

HLTH Corporation (HLTH) - Financial and Strategic SWOT Analysis Review

HLTH Corporation, through its principal subsidiary, WebMD Health Corp., provides health information services to consumers, healthc
2011 125,00$

Global Clean Energy Holdings, LLC (GCEH) - Financial and Strategic SWOT Analysis Review

Global Clean Energy Holdings, LLC (GCEH) is a publicly held company engaged in the research and development of biofuel feedstock d
2011 250,00$

NORTHFIELD LABORATORIES INC (NFLD) - Financial and Strategic SWOT Analysis Review

Northfield Laboratories Inc. is principally engaged in research, development, testing, manufacturing, marketing, and distributing
2011 250,00$

Orbus Pharma Inc. (ORB) - Financial and Strategic SWOT Analysis Review

Orbus Pharma Inc. (Orbus Pharma), formerly known as BOVAR Inc, is a publicly held pharmaceutical company. It is engaged in the dev
2011 250,00$

GeneThera, Inc. (GTHR) - Financial and Strategic SWOT Analysis Review

GeneThera, Inc. (GeneThera) is a biotechnology company. It is engaged in the development molecular diagnostic testing and vaccines
2011 250,00$

MWG-Biotech AG (NWU) - Financial and Strategic SWOT Analysis Review

MWG-Biotech AG (MWG) is a biotechnology company engaged in the manufacture and marketing of biomolecules and apparatuses for use i
2011 250,00$

GeneScan Europe AG (GEP1) - Financial and Strategic SWOT Analysis Review

GeneScan Europe AG (GeneScan) is a German company, engaged in the molecular biology sector. The company offers complete solutions
2011 250,00$

NitroMed, Inc. (NTMD) - Financial and Strategic SWOT Analysis Review

NitroMed, Inc. (NitroMed) is a pharmaceutical company that is engaged in discovery, development and commercialization of proprieta
2011 250,00$

Praxitelio Hospital S.A. (PRAXC) - Financial and Strategic SWOT Analysis Review

Praxitelio Hospital S.A. (Praxitelio) is engaged in providing healthcare services. Praxitelio operates two clinics namely, Gallin
2011 250,00$

Pharco Pharmaceuticals (PHPC) - Financial and Strategic SWOT Analysis Review

Pharco Pharmaceuticals (Pharco Pharma) is a subsidiary of Pharco Corporation, the biggest pharmaceutical organization in North Afr
2011 125,00$

Phynova Group Ltd (PYN) - Financial and Strategic SWOT Analysis Review

Phynova Group Ltd (Phynova) is a publicly held pharmaceutical company engaged in the development of drugs to satisfy unmet therape
2011 250,00$

RayClinic AB (RCLN B) - Financial and Strategic SWOT Analysis Review

RayClinic AB (RayClinic) is a pharmaceutical company that provides treatment for cancer related diseases. It focuses on treating c
2011 250,00$

Hebi Health Care AB (HEBI B) - Financial and Strategic SWOT Analysis Review

Hebi Health Care AB (Hebi Health Care), through its subsidiaries is focused on offering products for the life science and healthca
2011 250,00$

Norwood Immunology Limited (AIM) - Financial and Strategic SWOT Analysis Review

Norwood Immunology Ltd. (Norwood) is a publicly held research focused biotechnology company. The company is principally engaged in
2011 250,00$

ReSearch Pharmaceutical Services, Inc. (RPSE) - Financial and Strategic SWOT Analysis Review

ReSearch Pharmaceutical Services, Inc. (RPS) is a contract research organization, providing phase I-IV clinical development servic
2011 125,00$

HC Innovations, Inc. (HCNV) - Financial and Strategic SWOT Analysis Review

HC Innovations, Inc. (HC Innovations) is a specialty disease and care management company. It is engaged in providing specialty car
2011 250,00$

Fountain Healthy Aging Inc. (FHAIE) - Financial and Strategic SWOT Analysis Review

Fountain Healthy Aging, Inc. (FHAI) is a health care product distributor that is principally engaged in licensing and distributing
2011 250,00$

QSound Labs, Inc. (QSND) - Financial and Strategic SWOT Analysis Review

QSound Labs, Inc. (QSound Labs) is an audio technology company. It is engaged in the development of proprietary audio solutions fo
2011 250,00$

Sepracor Inc. (SEPR) - Financial and Strategic SWOT Analysis Review

Sepracor Inc. (SEPR) - Financial and Strategic SWOT Analysis Review / / Sepracor Inc. (Sepracor) is a research oriented pharmaceu
2011 125,00$

BSML, Inc. (BSML) - Financial and Strategic SWOT Analysis Review

BSML, Inc. ( BSML ) is a medical devices company. It is engaged in development, distribution, marketing and selling of advanced t
2011 250,00$

ALUS Liquidation Corp. (ALUS) - Financial and Strategic SWOT Analysis Review

ALUS Liquidation Corp. (previously known as Alsius Corporation) is a medical device company engaged in the development, manufactur
2011 250,00$

BodyTel Scientific Inc. (BDYT) - Financial and Strategic SWOT Analysis Review

BodyTel Scientific Inc. (BodyTel) is a medical equipment company engaged in the development and marketing of monitoring and manage
2011 125,00$

AOI Medical, Inc. (AOI) - Financial and Strategic SWOT Analysis Review

AOI Medical, Inc. (AOI Medical) is a medical device company, engaged in the development and marketing of innovative medical device
2011 250,00$

Ascribe plc (ASP) - Financial and Strategic SWOT Analysis Review

Ascribe plc (Ascribe) is a healthcare company that is engaged in the development and marketing of software solutions. The company
2011 125,00$

American CryoStem Corporation (AMCY) - Strategic SWOT Analysis Review

This comprehensive SWOT profile of American CryoStem Corporation provides you with an in-depth strategic analysis of the company's
2011 250,00$

Allion Healthcare, Inc. (ALLI) - Financial and Strategic SWOT Analysis Review

Allion Healthcare, Inc. (Allion) is one of US’s leading providers of specialty pharmacy and disease management services. The compa
2011 125,00$

AIDA Pharmaceuticals, Inc. (AIDA) - Financial and Strategic SWOT Analysis Review

Aida Pharmaceuticals (AIDA) is a pharmaceuticals company focused on formulation, development, clinical testing, registration, manu
2011 125,00$

Avastra Sleep Centres Limited (AVS) - Financial and Strategic SWOT Analysis Review

Avastra Sleep Centres Limited (Avastra ) is a publicly held Australia based company that operates diagnostic sleep centers. It is
2011 250,00$

Amoun Pharmaceutical Co. SAE (BOARD (ORDERS MARKET)) - Financial and Strategic SWOT Analysis Review

Amoun Pharmaceutical Co. SAE (BOARD (ORDERS MARKET)) - Financial and Strategic SWOT Analysis Review / / Amoun Pharmaceutical Co.
2011 125,00$

Amreyah Pharmaceuticals Company (ARPP) - Financial and Strategic SWOT Analysis Review

Amreyah Pharmaceuticals Company (Amreyah) is engaged in the manufacturing and distribution of pharmaceutical and veterinary produc
2011 250,00$

AngioGenex, Inc. (AGGX) - Financial and Strategic SWOT Analysis Review

AngioGenex, Inc. (AngioGenex) is a development stage, publicly held bio-pharmaceutical company engaged in the discovery and develo
2011 250,00$

Cairo Radiology Center Co. (RADI) - Financial and Strategic SWOT Analysis Review

Cairo Radiology Center Co. (Cairo Scan) is a pharmaceutical company offering diagnostic imaging services. The company’s services c
2011 250,00$

Cell Kinetics Ltd. (CKNTF) - Financial and Strategic SWOT Analysis Review

Cell Kinetics Ltd. (Cell Kinetics) is engaged in the design, development, manufacture and marketing of life science and medical de
2011 250,00$

Austria Medical Equipment Market Profile

Introduction / / GlobalData’s medical equipment report, “Austria Medical Equipment Market Profile” provides the medical equipment
2011 500,00$

Myocardial Ischemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Migraine Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Migraine Global Clinical Trials Review, Q1, 2011" provides data on the Migr
2011 1.000,00$

Sleep Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Sleep Disorders Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Fatigue Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Fatigue Global Clinical Trials Review, Q1, 2011" provides data on the Fatig
2011 1.000,00$

Mild Cognitive Impairment Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Restless Legs Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Friedreich Ataxia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Psychogenic Movement Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Psychogenic Movement Disorders Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Non Erosive Reflux Disease (NERD) Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Non Erosive Reflux Disease (NERD)Global Clinical Trials Review, Q1, 2011" p
2011 1.000,00$

Obesity Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Obesity Global Clinical Trials Review, Q1, 2011" provides data on the obesi
2011 1.000,00$

Gestational Diabetes Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Hyperglycemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hyperglycemia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Glucose Intolerance Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Glucose Intolerance Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Hypoglycemia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hypoglycemia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Texas Instruments Incorporated (TXN) - Financial and Strategic SWOT Analysis Review

Texas Instruments Incorporated (TXN) - Financial and Strategic SWOT Analysis Review / / Summary / / Texas Instruments Incorporat
2011 125,00$

Electronic Medical Records (EMR) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Electronic Medical Records (EMR) - Global Opportunity Assessment, Competitive Landscap
2011 3.500,00$

Wound Care Management - Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Wound Care Management - Emerging Countries (China, India, Brazil) Opport
2011 3.500,00$

European Medical Devices Industry: An Impact Analysis of the Changing Regulatory and Health Economics Scenarios

Introduction / / GlobalData’s report, “European Medical Devices Industry: An Impact Analysis of the Changing Regulatory and Healt
2011 500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2010” report
2011 1.500,00$

FDA Withdraws Approval of Avastin in Breast Cancer

Introduction / / GlobalData’s report, “FFDA Withdraws Approval of Avastin in Breast Cancer” provides key data, information on Bre
2011 500,00$

Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market

Introduction / / GlobalData’s report, “Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market” provide
2010 500,00$

Novel Targeted Therapies Hold Promise of Reversing the Progress of Alzheimer’s Disease (AD)

Introduction / / GlobalData’s report, “Novel Targeted Therapies Hold Promise of Reversing the Progress of Alzheimer’s Disease (AD
2011 500,00$

Pharmacy Benefit Managers (PBMs) are Critical for Ensuring Quality of Pharmaceutical Care and Controlling Drug Expenditures

Introduction / / GlobalData’s report, “Pharmacy Benefit Managers (PBMs) are Critical for Ensuring Quality of Pharmaceutical Care
2011 500,00$

Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hypertension (PAH) Market

Introduction / / GlobalData’s report, “Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hype
2011 500,00$

Pituitary Neoplasms Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pituitary Neoplasms Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Achlorhydria Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Achlorhydria Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Acute Ischemic Stroke Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Acute Ischemic Stroke Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Chronic Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Chronic Pain Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Nicotine Addiction Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Nicotine Addiction Global Clinical Trials Review, Q1, 2011" provides data o
2011 1.000,00$

Sleep Apnea Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Sleep Apnea Global Clinical Trials Review, Q1, 2011" provides data on the S
2011 1.000,00$

Dystonia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, Q1, 2011" provides data on the Dyst
2011 1.000,00$

Huntington’s Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Huntington’s Disease Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Tourette Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Tourette Syndrome Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Acute Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Acute Pain Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Down syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Down Syndrome Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Dyskinesia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Radiological Society of North America Conference 2010: Review and Analysis

Introduction / / GlobalData’s report, “Radiological Society of North America Conference 2010: Review and Analysis” provides key d
2011 1.000,00$

Medline Industries Acquires O'Mara Scientific: A Strategy to Expand Inorganically - Deal Analysis From GlobalData

Introduction / / GlobalData’s report, “Medline Industries Acquires O'Mara Scientific: A Strategy to Expand Inorganically” provide
2011 500,00$

Ultrasound Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Ultrasound Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forec
2011 3.500,00$

Wound Closure Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Wound Closure Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fo
2011 3.500,00$

Advanced Wound Management - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Advanced Wound Management - Global Pipeline Analysis, Opportunity Assessment and Marke
2011 3.500,00$

Cranio Maxillofacial Fixation (CMF) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Cranio Maxillofacial Fixation (CMF) Devices - Global Pipeline Analysis, Opportunity As
2011 3.500,00$

Patient Monitoring - Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Patient Monitoring - Emerging Countries (China, India, Brazil) Opportunity Assessment,
2011 3.500,00$

Remote Patient Monitoring - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Remote Patient Monitoring - Global Pipeline Analysis, Opportunity Assessment and Marke
2011 3.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - January 2011

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – January 2011” report is an e
2011 1.000,00$

Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q4 2010

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q4 2010” report is an ess
2011 1.500,00$

Global In-Vitro Diagnostics Market Trends

Introduction / / GlobalData’s medical equipment report, “Global In-Vitro Diagnostics Market Trends” provides key market data on t
2011 500,00$

Peripheral Intravenous Catheters: A Market Snapshot

Introduction / / GlobalData’s report, “Peripheral Intravenous Catheters: A Market Snapshot” provides key data, information and an
2011 500,00$

Canada Medical Equipment Market Analysis and Forecasts to 2016

Introduction / / This report is an essential source for in-depth information and data relating to the Canada medical equipment ma
2010 3.500,00$

The Proton-Deuterium Swap – Will the Heavy Strategy Work?

Introduction / / GlobalData’s report, “The Proton-Deuterium Swap – Will the Heavy Strategy Work?” provides key information on the
2011 500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - January 2011

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – January 2011” r
2011 1.000,00$

Schistosomiasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Schistosomiasis Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Gastritis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gastritis Global Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Carcinoma of the Bile Duct Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Carcinoma Of The Bile Duct Global Clinical Trials Review, Q4, 2010" provide
2010 1.000,00$

Stroke Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Stroke Global Clinical Trials Review, Q1, 2011" provides data on the Stroke
2011 1.000,00$

Aortic Valve Stenosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Aortic Valve Stenosis Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Atrial Fibrillation Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Coronary Stenosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Coronary Stenosis Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Cardiomyopathy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cardiomyopathy Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Appendicitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Appendicitis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Cholangitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cholangitis Global Clinical Trials Review, Q1, 2011" provides data on the C
2011 1.000,00$

Cholecystitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cholecystitis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Gall Stone Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gall Stone Global Clinical Trials Review, Q1, 2011" provides data on the Ga
2011 1.000,00$

Gastroparesis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Peritonitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Peritonitis Global Clinical Trials Review, Q1, 2011" provides data on the P
2011 1.000,00$

Pancreatitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pancreatitis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Duodenal Ulcer Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Duodenal Ulcer Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Zollinger-Ellison Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Zollinger-Ellison Syndrome Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Abscess Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, Q1, 2011" provides data on the Absce
2011 1.000,00$

Bacteremia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Bacteremia Global Clinical Trials Review, Q1, 2011" provides data on the Ba
2011 1.000,00$

Bacteriuria Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Bacteriuria Global Clinical Trials Review, Q1, 2011" provides data on the B
2011 1.000,00$

Brucellosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, Q1, 2011" provides data on the B
2011 1.000,00$

Osteomyelitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Osteomyelitis Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Nasal Polyps Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Left Ventricular Dysfunction Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, Q1, 2011" provi
2011 1.000,00$

Tachycardia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Tachycardia Global Clinical Trials Review, Q1, 2011" provides data on the T
2011 1.000,00$

Other Respiratory Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Other Respiratory Disorders Global Clinical Trials Review, Q1, 2011" provid
2011 1.000,00$

Congenital Lung Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Congenital Lung Disease Global Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Bronchiectasis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Bronchiectasis Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Obstructive Pulmonary Disease Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, Q1, 2011" prov
2011 1.000,00$

Haemophilus Influenzae Infection Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Haemophilus Influenzae Infection Global Clinical Trials Review, Q1, 2011" p
2011 1.000,00$

Interstitial Lung Diseases Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Interstitial Lung Diseases Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Lung Injury Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, Q1, 2011" provides data on the L
2011 1.000,00$

Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, Q1, 2
2011 1.000,00$

Bronchopulmonary Dysplasia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, Q1, 2011" provide
2011 1.000,00$

Bronchospasm Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Respiratory Depression Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Respiratory Depression Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Nasal Congestion Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Nasal Congestion Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Viral Respiratory Tract Infection Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, Q1, 2011"
2011 1.000,00$

Anxiety Disorders Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Anxiety Disorders Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Nonhematologic Malignancy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Nonhematologic Malignancy Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Stomatitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Stomatitis Global Clinical Trials Review, Q1, 2011" provides data on the St
2011 1.000,00$

Hypopharyngeal Cancer Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Hypopharyngeal Cancer Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Indolent Lymphoma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Salivary Gland Cancer Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, Q1, 2011" provides dat
2011 1.000,00$

Medullary Thyroid Cancer Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Glo
2011 1.000,00$

Lymphoma Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Lymphoma Global Clinical Trials Review, Q1, 2011" provides data on the Lymp
2011 1.000,00$

Skin Neoplasms Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Skin Neoplasms Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Neuropathic Pain Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

Major Depressive Disorder Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Major Depressive Disorder Global Clinical Trials Review, Q1, 2011" provides
2011 1.000,00$

Substance Abuse Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Substance Abuse Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Dementia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dementia Global Clinical Trials Review, Q1, 2011" provides data on the Deme
2011 1.000,00$

Obsessive-Compulsive Disorder Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Obsessive-Compulsive Disorder Global Clinical Trials Review, Q1, 2011" prov
2011 1.000,00$

Psychosis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Psychosis Global Clinical Trials Review, Q1, 2011" provides data on the Psy
2011 1.000,00$

Alcoholism Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Alcoholism Global Clinical Trials Review, Q1, 2011" provides data on the Al
2011 1.000,00$

Pharyngeal Neoplasms Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Pharyngeal Neoplasms Global Clinical Trials Review, Q1, 2011" provides data
2011 1.000,00$

Traumatic Brain Injury Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Traumatic Brain Injury Global Clinical Trials Review, Q1, 2011" provides da
2011 1.000,00$

Vasculitis Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Vasculitis Global Clinical Trials Review, Q1, 2011" provides data on the Va
2011 1.000,00$

Lennox-Gastaut Syndrome Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Lennox-Gastaut Syndrome Global Clinical Trials Review, Q1, 2011" provides d
2011 1.000,00$

Autism Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Autism Global Clinical Trials Review, Q1, 2011" provides data on the Autism
2011 1.000,00$

Dysmorphophobia Trichotillomania Eating Disorder Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Dysmorphophobia Trichotillomania Eating Disorder Global Clinical Trials Rev
2011 1.000,00$

Fibromyalgia Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Fibromyalgia Global Clinical Trials Review, Q1, 2011" provides data on the
2011 1.000,00$

Cerebral Palsy Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Cerebral Palsy Global Clinical Trials Review, Q1, 2011" provides data on th
2011 1.000,00$

Opium Addiction Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Opium Addiction Global Clinical Trials Review, Q1, 2011" provides data on t
2011 1.000,00$

Smoking Cessation Global Clinical Trials Review, Q1, 2011

Introduction / / GlobalData's clinical trial report, “Smoking Cessation Global Clinical Trials Review, Q1, 2011" provides data on
2011 1.000,00$

India Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “India Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Co
2010 3.500,00$

Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assess
2011 3.500,00$

Vision Care (Contact Lenses and Spectacle Lenses) - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Vision Care (Contact Lenses and Spectacle Lenses) - Global Pipeline Analysis, Opportun
2011 3.500,00$

Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Fo
2011 3.500,00$

Magnetic Resonance Imaging (MRI) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Magnetic Resonance Imaging (MRI) Systems - Global Pipeline Analysis, Opportunity Asses
2011 3.500,00$

Insulin Delivery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Insulin Delivery Devices - Global Pipeline Analysis, Opportunity Assessment and Market
2011 3.500,00$

Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment an
2011 3.500,00$

Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Mark
2011 3.500,00$

Clinical Chemistry Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Clinical Chemistry Global Market Briefing to 2016” provides key data, information and
2011 2.000,00$

Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Opportunity Assessm
2011 3.500,00$

Nuclear Imaging Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Nuclear Imaging Equipment - Global Pipeline Analysis, Opportunity Assessment and Marke
2011 3.500,00$

Dental Lasers - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Dental Lasers - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts
2011 3.500,00$

Diagnostic Imaging Equipment - Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Diagnostic Imaging Equipment - Emerging Countries (China, India, Brazil) Opportunity
2011 3.500,00$

Haematology Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Haematology Global Market Briefing to 2016” provides key data, information and analysi
2011 2.000,00$

Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market F
2010 3.500,00$

Breast Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Breast Cancer Clinical Trials Review, Q4, 2010"” provides data on the Breas
2010 1.000,00$

Acute Lymphocytic Leukemia (ALL) Clinical Trials Review Q4, 2010

Introduction / / GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, Q4, 2010"”
2010 1.000,00$

Acute Myelogenous Leukemia Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Acute Myelocytic Leukemia (AML)Global Clinical Trials Review, Q4, 2010"” p
2010 1.000,00$

Bile Duct Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Bile Duct Cancer Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Bladder Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, Q4, 2010" provides data on th
2010 1.000,00$

Bone Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Bone Cancer Global Clinical Trials Review, Q4, 2010" provides data on the B
2010 1.000,00$

Brain Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Cervical Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, Q4, 2010"
2010 1.000,00$

Chronic Myelocytic Leukemia(CML) Global Clinical Trial Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, Q4, 2010"
2010 1.000,00$

Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Central Nervous System Tumors Global Clinical Trials Review, Q4, 2010" prov
2010 1.000,00$

Colon Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Colon Cancer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Colorectal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Colorectal Cancer Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Endometrial Cancer Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, Q4, 2010" provides data o
2010 1.000,00$

Esophageal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Eosophageal Cancer Global Clinical Trials Review, Q4, 2010" provides data o
2010 1.000,00$

Fallopian Tube Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, Q4, 2010" provides dat
2010 1.000,00$

Gastric Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, Q4, 2010" provides data on th
2010 1.000,00$

Gastrointestinal Stromal Tumors (GIST) Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Gastrointestinal Stromal Tumors (GIST) Global Clinical Trials Review, Q4,
2010 1.000,00$

Germ Cell Tumors Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Germ Cell Tumors Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Glioblastoma (GBM) Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Glioblastoma (GBM) Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Glioma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Glioma Global Clinical Trials Review, Q4, 2010" provides data on the Gliom
2010 1.000,00$

Head and Neck Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Head and Neck Cancer Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Hematological Cancers Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Hematological Cancers Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Hepatic Tumor Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Hepatic Tumor Clinical Trials Review, Q4, 2010""” provides data on the Hepa
2010 1.000,00$

Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Kidney Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Kidney Cancer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Larynx Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Larynx Cancer Global Clinical Trials Review, Q4, 2010" provides data on th
2010 1.000,00$

Leukemia Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Leukemia Global Clinical Trials Review, Q4, 2010" provides data on the Leuk
2010 1.000,00$

Liver Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Liver Cancer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Lung Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Lung Cancer Global Clinical Trials Review, Q4, 2010"” provides data on the
2010 1.000,00$

Melanoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, Q4, 2010"” provides data on the Mel
2010 1.000,00$

Multiple Myeloma Therapeutics Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Multiple Myeloma Global Clinical Trials Review, Q4, 2010"” provides data on
2010 1.000,00$

Myelodysplastic Syndrome Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Myelodsplastic Syndrome Global Clinical Trials Review, Q4, 2010"” provides
2010 1.000,00$

Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Post-Traumatic Stress Disorder Global Clinical Trials Review, Q4, 2010"” pr
2010 1.000,00$

Non-Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010"” provides dat
2010 1.000,00$

Non-Small Cell Lung Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, Q4, 2010"” provid
2010 1.000,00$

Oral Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Oral Cancer Global Clinical Trials Review, Q4, 2010"” provides data on the
2010 1.000,00$

Ovarian Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t
2010 1.000,00$

Pancreatic cancer Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, Q4, 2010"” provides data o
2010 1.000,00$

Peritoneal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, Q4, 2010"” provides data o
2010 1.000,00$

Precancerous Condition Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Precancerous Condition Global Clinical Trials Review, Q4, 2010"” provides d
2010 1.000,00$

Prostate Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Prostate Cancer Global Clinical Trials Review, Q4, 2010"” provides data on
2010 1.000,00$

Rectal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, Q4, 2010"” provides data on th
2010 1.000,00$

Small-Cell Lung Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Small Cell Lung Cancer Global Clinical Trials Review, Q4, 2010"” provides d
2010 1.000,00$

Soft Tissue Sarcoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Soft Tissue Sarcoma Global Clinical Trials Review, Q4, 2010"” provides data
2010 1.000,00$

Solid Tumors Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Solid Tumors Global Clinical Trials Review, Q4, 2010"” provides data on the
2010 1.000,00$

Testicular Cancer Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, Q4, 2010"” provides data o
2010 1.000,00$

Thymus Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, Q4, 2010"” provides data on th
2010 1.000,00$

Thyroid Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t
2010 1.000,00$

Uterine Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t
2010 1.000,00$

Vaginal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t
2010 1.000,00$

Burkitt Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, Q4, 2010"” provides data on
2010 1.000,00$

Osteosarcoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Osteosarcoma Global Clinical Trials Review, Q4, 2010"” provides data on the
2010 1.000,00$

Hepatocellular Carcinoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, Q4, 2010"” provides
2010 1.000,00$

Gallbladder Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, Q4, 2010"” provides data
2010 1.000,00$

Brain Metastasis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Brain Metastasis Global Clinical Trials Review, Q4, 2010"” provides data on
2010 1.000,00$

Basal Cell Carcinoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Basal Cell Carcinoma Global Clinical Trials Review, Q4, 2010"” provides dat
2010 1.000,00$

Astrocytoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Astrocytoma Global Clinical Trials Review, Q4, 2010"” provides data on the
2010 1.000,00$

Anal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, Q4, 2010"” provides data on the
2010 1.000,00$

Adenomas Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Adenomas Global Clinical Trials Review, Q4, 2010"” provides data on the Ade
2010 1.000,00$

Insomnia Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, Q4, 2010"” provides data on the Ins
2010 1.000,00$

Parkinson’s Disease Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, Q4, 2010"” provides data
2010 1.000,00$

Alzheimer's Disease Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, Q4, 2010"” provides data
2010 1.000,00$

Aneurysm Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Aneurysm Global Clinical Trials Review, Q4, 2010"” provides data on the Ane
2010 1.000,00$

Angina Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Angina Global Clinical Trials Review, Q4, 2010"” provides data on the Angin
2010 1.000,00$

Phlebitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Phlebitis Global Clinical Trials Review, Q4, 2010"” provides data on the Ph
2010 1.000,00$

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “COPD Global Clinical Trials Review, Q4, 2010"” provides data on the COPD cl
2010 1.000,00$

Apnea Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Apnea Global Clinical Trials Review, Q4, 2010"” provides data on the Apnea
2010 1.000,00$

Bronchitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, Q4, 2010"” provides data on the B
2010 1.000,00$

Allergic Rhinitis Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, Q4, 2010"” provides data o
2010 1.000,00$

Asthma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, Q4, 2010"” provides data on the Asthm
2010 1.000,00$

Polio Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Polio Global Clinical Trials Review, Q4, 2010"” provides data on the Polio
2010 1.000,00$

Dengue Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Dengue Global Clinical Trials Review, Q4, 2010"” provides data on the Dengu
2010 1.000,00$

Pompe Disease Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Smallpox Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Small Pox Global Global Clinical Trials Review, Q4, 2010"” provides data on
2010 1.000,00$

Meningitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Meningitis Global Global Clinical Trials Review, Q4, 2010"” provides data o
2010 1.000,00$

Chicken Pox Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Chicken Pox Global Global Clinical Trials Review, Q4, 2010"” provides data
2010 1.000,00$

Irritable Bowel Syndrome Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Irritable bowel syndrome Global Global Clinical Trials Review, Q4, 2010"” p
2010 1.000,00$

Tetanus Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Tetanus Global Global Clinical Trials Review, Q4, 2010"” provides data on t
2010 1.000,00$

Equine Encephalitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Equine Encephalitis Global Global Clinical Trials Review, Q4, 2010"” provid
2010 1.000,00$

Tuberculosis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Tuberculosis Global Global Clinical Trials Review, Q4, 2010"” provides data
2010 1.000,00$

Enterocolitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Enterocolitis Global Global Clinical Trials Review, Q4, 2010"” provides dat
2010 1.000,00$

Esophagitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Esophagitis Global Global Clinical Trials Review, Q4, 2010"” provides data
2010 1.000,00$

Arteriosclerosis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Arteriosclerosis Global Global Clinical Trials Review, Q4, 2010"” provides
2010 1.000,00$

Venous Thromboembolism Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Venous Thromboembolism Global Global Clinical Trials Review, Q4, 2010"” pro
2010 1.000,00$

Peripheral Arterial Disease Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Peripheral Arterial Disease Global Global Clinical Trials Review, Q4, 2010"
2010 1.000,00$

Myocardial Infarction Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Myocardial Infarction Global Global Clinical Trials Review, Q4, 2010"” prov
2010 1.000,00$

Upper Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Upper Respiratory Tract Infections Global Global Clinical Trials Review, Q4
2010 1.000,00$

Pneumonia Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pneumonia Global Global Clinical Trials Review, Q4, 2010"” provides data on
2010 1.000,00$

Aspergillosis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Plasma Cell Neoplasm Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Plasma Cell Neoplasm Global Global Clinical Trials Review, Q4, 2010"” provi
2010 1.000,00$

Rhabdomyosarcoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Rhabdomyosarcoma Global Global Clinical Trials Review, Q4, 2010"” provides
2010 1.000,00$

Squamous Cell Carcinoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Squamous Cell Carcinoma Global Global Clinical Trials Review, Q4, 2010"” pr
2010 1.000,00$

Vulvar Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Vulvar Cancer Global Global Clinical Trials Review, Q4, 2010"” provides dat
2010 1.000,00$

Epilepsy Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Epilepsy Global Global Clinical Trials Review, Q4, 2010"” provides data on
2010 1.000,00$

Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Attention-Deficit Hyperactivity Disorder (ADHD) Global Global Clinical Tria
2010 1.000,00$

Bipolar Depression Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Bipolar Depression Global Global Clinical Trials Review, Q4, 2010"” provide
2010 1.000,00$

Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Catarac
2010 2.500,00$

Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, "Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Car
2010 2.500,00$

Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Visio
2010 2.500,00$

Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and Accessories

Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical S
2010 2.500,00$

Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and Accessories

Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Han
2010 2.500,00$

Refractive Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Refractive Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Mark
2010 3.500,00$

Remote Patient Monitoring: A Global Industry Overview

Introduction / / GlobalData’s new report, “Remote Patient Monitoring: A Global Industry Overview” provides an overview of the mar
2010 500,00$

Medical Device Industry Regains PE/VC Investor Attention

Introduction / / GlobalData’s new report, “Medical Device Industry Regains PEVC Investor Attention” provides key information and
2010 500,00$

Malaria Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, Q4, 2010" provides data on the Malar
2010 1.000,00$

Tonsillitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Sarcomas Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Sarcomas Global Clinical Trials Review, Q4, 2010" provides data on the Sarc
2010 1.000,00$

Carcinomas Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Carcinomas Global Clinical Trials Review, Q4, 2010" provides data on the Ca
2010 1.000,00$

Metastatic Breast Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

Metastatic Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Metastatic Cancer Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Metastatic Melanoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Metastatic Melanoma Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Glioblastoma Multiforme Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Glioblastoma Multiforme Global Clinical Trials Review, Q4, 2010" provides d
2010 1.000,00$

Pediatric Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Renal Cell Carcinoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Diffuse Large B-cell Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, Q4, 2010" prov
2010 1.000,00$

Gynecological Cancers Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gynecological Cancers Global Clinical Trials Review, Q4, 2010" provides dat
2010 1.000,00$

Malignant Mesothelioma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Hepatocellular Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Hepatocellualar Cancer Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010" provides d
2010 1.000,00$

Hormone Refractory Prostate Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Hormone Refractory Prostate Cancer Global Clinical Trials Review, Q4, 2010"
2010 1.000,00$

Neutropenia Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, Q4, 2010" provides data on the N
2010 1.000,00$

Bone Metastasis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Metastatic Pancreatic Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, Q4, 2010" provi
2010 1.000,00$

Neuroendocrine Carcinoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

B-cell Lymphomas Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

T-cell Lymphomas Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Mantle Cell Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Follicular Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Cutaneous T-cell Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

Oropharynx Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Oropharynx Cancer Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Anaplastic Astrocytoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Metastatic Brain Tumors Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “ Metastatic Brain Tumors Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

Nonmelanomatous Skin Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Nonmelanomatous Skin Cancer Global Clinical Trials Review, Q4, 2010" provid
2010 1.000,00$

Medulloblastoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Medulloblastoma Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

T-Cell Leukemia Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Carcinoid Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Carcinoid Cancer Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Adrenocortical Carcinoma Adrenal Tumor Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Adrenocortical Carcinoma Adrenal Tumor Global Clinical Trials Review, Q4, 2
2010 1.000,00$

Metastatic Lung Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Metastatic Lung Cancer Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Ewing Sarcoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Oligodendroglioma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

AIDS - Related Cancers Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Aids - Related Cancers Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Nasopharyngeal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, Q4, 2010" provides dat
2010 1.000,00$

Meningioma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Meningioma Global Clinical Trials Review, Q4, 2010" provides data on the Me
2010 1.000,00$

Ependymoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Ependymoma Global Clinical Trials Review, Q4, 2010" provides data on the Ep
2010 1.000,00$

Hypopharynx Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Hypopharynx Cancer Global Clinical Trials Review, Q4, 2010" provides data o
2010 1.000,00$

Other Brain-Related Conditions Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Other Brain-Related Conditions Global Clinical Trials Review, Q4, 2010" pro
2010 1.000,00$

Gliosarcoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gliosarcoma Global Clinical Trials Review, Q4, 2010" provides data on the G
2010 1.000,00$

Transitional Cell Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Transitional Cell Cancer Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Rev
2010 1.000,00$

Laryngeal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Adrenocortical Carcinoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Adrenocortical Carcinoma Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

Wilms’ Tumor Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Wilms’ Tumor Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Oropharyngeal Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Gastrointestinal Tract Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gastrointestinal Tract Cancer Global Clinical Trials Review, Q4, 2010" prov
2010 1.000,00$

Chordoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, Q4, 2010" provides data on the Chor
2010 1.000,00$

Penile Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Penile Cancer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Sezary Syndrome Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Pituitary Tumors Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pituitary Tumors Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Cervical Dysplasia Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cervical Dysplasia Global Clinical Trials Review, Q4, 2010" provides data o
2010 1.000,00$

Cancer Cachexia Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cancer Cachexia Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Throat Cancer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Throat Cancer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Lymphoblastic Lymphoma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Malignant Pleural Effusion Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Malignant Pleural Effusion Global Clinical Trials Review, Q4, 2010" provide
2010 1.000,00$

Thrombosis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Thrombosis Global Clinical Trials Review, Q4, 2010" provides data on the Th
2010 1.000,00$

Obstructive Sleep Apnea Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Obstructive Sleep Apnea Global Clinical Trials Review, Q4, 2010" provides d
2010 1.000,00$

Sinusitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Sinusitis Global Clinical Trials Review, Q4, 2010" provides data on the Sin
2010 1.000,00$

Rabies Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Rabies Global Clinical Trials Review, Q4, 2010" provides data on the Rabies
2010 1.000,00$

HIV / AIDS Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “HIV Global Clinical Trials Review, Q4, 2010" provides data on the HIV clini
2010 1.000,00$

Pulmonary Edema Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pulmonary Edema Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Adult Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010
2010 1.000,00$

Pharyngitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pharyngitis Global Clinical Trials Review, Q4, 2010" provides data on the P
2010 1.000,00$

Common Cold Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Common Cold Global Clinical Trials Review, Q4, 2010" provides data on the C
2010 1.000,00$

Respiratory Syncytial Virus (RSV) Infection Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Respiratory Syncytial Virus (Rsv) Global Clinical Trials Review, Q4, 2010"
2010 1.000,00$

Dyspnea Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, Q4, 2010" provides data on the Dyspn
2010 1.000,00$

Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010" prov
2010 1.000,00$

Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010" provides data o
2010 1.000,00$

Cough Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cough Global Clinical Trials Review, Q4, 2010" provides data on the Cough c
2010 1.000,00$

Acute Lung Injury Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010" prov
2010 1.000,00$

Emphysema Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Emphysema Global Clinical Trials Review, Q4, 2010" provides data on the Emp
2010 1.000,00$

Pulmonary Arterial Hypertension Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pulmonary Arterial Hypertension Global Clinical Trials Review, Q4, 2010" pr
2010 1.000,00$

Acute Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010
2010 1.000,00$

Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010" provi
2010 1.000,00$

Pulmonary Embolism Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pulmonary Embolism Global Clinical Trials Review, Q4, 2010" provides data o
2010 1.000,00$

Diphtheria Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, Q4, 2010" provides data on the Di
2010 1.000,00$

Diabetic Macular Edema Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Diabetic Macular Edema Global Clinical Trials Review, Q4, 2010" provides da
2010 1.000,00$

Bronchiolitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Bronchiolitis Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Cystic Fibrosis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cystic fibrosis Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Staphylococcal Infections Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Staphylococcal Infection Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

Streptococcal Infections Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, Q4, 2010" provides
2010 1.000,00$

Otitis Media Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Otitis Media Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Cataract Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, Q4, 2010" provides data on the Cata
2010 1.000,00$

Cystoid Macular Edema Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Cystoid Macular Edema Global Clinical Trials Review, Q4, 2010" provides dat
2010 1.000,00$

Gastroenteritis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Peptic Ulcer Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Peptic ulcer Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Encephalitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Influenza Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Influenza Global Clinical Trials Review, Q4, 2010" provides data on the Inf
2010 1.000,00$

Acne Vulgaris Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Acne Vulgari Global Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Dermatitis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, Q4, 2010" provides data on the De
2010 1.000,00$

Mucositis Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Mucositis Global Clinical Trials Review, Q4, 2010" provides data on the Muc
2010 1.000,00$

Gout Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Gout Global Clinical Trials Review, Q4, 2010" provides data on the Gout cli
2010 1.000,00$

Type 1 Diabetes Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Type I Diabetes Global Clinical Trials Review, Q4, 2010" provides data on t
2010 1.000,00$

Type 2 Diabetes Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Type II Diabetes Global Clinical Trials Review, Q4, 2010" provides data on
2010 1.000,00$

Diabetic Nephropathy Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, Q4, 2010" provides data
2010 1.000,00$

Neuroma Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Neuroma Global Clinical Trials Review, Q4, 2010" provides data on the Neuro
2010 1.000,00$

Pruritus Global Clinical Trials Review, Q4, 2010

Introduction / / GlobalData's clinical trial report, “Pruritus Global Clinical Trials Review, Q4, 2010" provides data on the Prur
2010 1.000,00$

Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes

Introduction / / GlobalData’s report, “Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challen
2010 500,00$

Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients

Introduction / / GlobalData’s report, “Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients” provides key data, in
2010 500,00$

FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market

Introduction / / GlobalData’s report, “FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy M
2010 500,00$

Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bronchitis Therapeutics - Pipeline A
2010 2.000,00$

Glaucoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glaucoma Therapeutics - Pipeline Ass
2010 2.000,00$

Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cervical Cancer - Pipeline Assessmen
2010 2.000,00$

Tuberculosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Annualized global tuberculosis therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017. / The pipe
2010 2.000,00$

Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anti-Obesity - Pipeline Assessment a
2010 2.000,00$

Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Melanoma Therapeutics - Pipeline Ass
2010 2.000,00$

Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Multiple Myeloma Therapeutics - Pipe
2010 2.000,00$

Atrial Fibrillation Therapeutics – Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Atrial Fibrillation Therapeutics - Pip
2010 2.000,00$

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Multiple Sclerosis Therapeutics - Pi
2010 2.000,00$

Bladder Cancer - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bladder Cancer - Pipeline Assessment
2010 2.000,00$

Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Pipeli
2010 2.000,00$

Non-Small Cell Lung Cancer (NSCLC) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Non-Small Cell Lung Cancer (NSCLC) -
2010 2.000,00$

Macular Degeneration - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Macular Degeneration - Pipeline As
2010 2.000,00$

Atherosclerosis or Coronary Artery Disease (CAD) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Atherosclerosis or Coronary Artery Disease (CAD) - P
2010 2.000,00$

Renal Cell Carcinoma (RCC) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Renal Cell Carcinoma (RCC) Therapeut
2010 2.000,00$

North America Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Wound Care Management Market Outlook to 2016” provides key market data o
2010 3.500,00$

Europe Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Wound Care Management Market Outlook to 2016” provides key market data on the E
2010 3.500,00$

Asia-Pacific Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Wound Care Management Market Outlook to 2016” provides key market data on
2010 3.500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – December 2010”
2010 1.000,00$

Crohn’s Disease - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Crohn’s Disease –Pipeline Assessment and Market Fore
2010 2.000,00$

Liver Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Liver Cancer Therapeutics - Pipeline
2010 2.000,00$

Brain Tumor - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Brain tumor- Pipeline Assessment and
2010 2.000,00$

Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Addiction Control Therapeutics - Pip
2010 2.000,00$

Breast Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Breast Cancer Therapeutics - Pipelin
2010 2.000,00$

Healthcare IT Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Healthcare IT Services - Global Opportunity Assessment, Competitive Landscape and Mark
2010 3.500,00$

Vehicle-to-Grid (V2G) - Global Market Analysis and Forecasts to 2020

Introduction / / GlobalData’s “Vehicle-to-Grid (V2G) - Global Market Analysis and Forecasts to 2020” provides information on mark
2010 3.500,00$

Hemophilia - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hemophilia - Pipeline Assessment a
2010 2.000,00$

Schizophrenia - Pipeline Assessment and Market Forecast to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Schizophrenia - Pipeline Assessmen
2010 2.000,00$

Macular Edema Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Macular Edema Therapeutics - Pipeline Assessment a
2010 2.000,00$

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Obstructive Pulmonary Dise
2010 2.000,00$

Endometriosis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Endometriosis - Pipeline Assessmen
2010 2.000,00$

Dystonia - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dystonia - Pipeline Assessment and
2010 2.000,00$

Venous Thromboembolism – Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism - Pipeline
2010 2.000,00$

Lyme Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Lyme Disease Therapeutics - Pipelin
2010 2.000,00$

Nonalcoholic Steatohepatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Non-alcoholic Steatohepatitis (NAS
2010 2.000,00$

Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Coronary Syndrome - Pipeline A
2010 2.000,00$

Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Prostate Cancer - Pipeline Assessmen
2010 3.500,00$

Irritable Bowel Syndrome - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Irritaable Bowel Syndrome (IBS) - Pi
2010 2.000,00$

Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Gastroesophageal Reflux Disease (GERD)
2010 2.000,00$

Celsis International Ltd. - Financial and Strategic SWOT Analysis Review

Celsis International Ltd. (Celsis) provides innovative life science products and laboratory services to pharmaceutical, biopharmac
2010 125,00$

Concateno plc - Financial and Strategic SWOT Analysis Review

Concateno plc (Concateno) is a provider of drug and alcohol testing services. The company operates as a subsidiary of Inverness Me
2010 125,00$

Asthma - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Asthma - Pipeline Assessment and Mar
2010 2.000,00$

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020” is a
2010 3.000,00$

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020”. The
2010 3.000,00$

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020”. The
2010 3.000,00$

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020” is
2010 3.000,00$

Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020” is an e
2010 3.000,00$

Anti-Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Anti-Hypertension Therapeutics - Pipeline Assessme
2010 2.000,00$

Candidiasis Therapeutics Market - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Candidiasis Therapeutics Market - Pi
2010 2.000,00$

Acute Ischemic Stroke Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Acute Ischemic Stroke (AIS) Therapeutics Market -
2010 2.000,00$

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Attention Deficit Hyperactivity Di
2010 2.000,00$

Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Ulcerative Colitis Therapeutics - Pi
2010 2.000,00$

Angina Pectoris - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Angina pectoris - Pipeline Assessment and Market F
2010 2.000,00$

Europe Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Patient Monitoring Market Outlook to 2016” provides key market data on the Euro
2010 3.500,00$

Asia-Pacific Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Orthopedic Devices” Market Outlook to 2016” provides key market data on t
2010 3.500,00$

North America Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Anesthesia and Respiratory Devices Market Outlook to 2016” provides key
2010 3.500,00$

External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Mar
2010 3.500,00$

North America Endoscopy Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Endoscopy Devices Market Outlook to 2016” provides key market data on th
2010 3.500,00$

Europe Endoscopy Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Endoscopy Devices Market Outlook to 2016” provides key market data on the Europ
2010 3.500,00$

Asia-Pacific Endoscopy Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Endoscopy Devices Market Outlook to 2016” provides key market data on the
2010 3.500,00$

North America Neurology Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Neurology Devices Market Outlook to 2016” provides key market data on th
2010 3.500,00$

Asia-Pacific Hospital Supplies Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Hospital Supplies Market Outlook to 2016” provides key market data on the
2010 3.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - November 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – November 2010” report is an
2010 1.000,00$

Europe Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Orthopedic Devices Market Outlook to 2016” provides key market data on the Euro
2010 3.500,00$

Europe Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 3.500,00$

Asia Pacific Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia Pacific Cardiovascular Devices Market Outlook to 2016” provides key market data o
2010 3.500,00$

Asia-Pacific Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Anesthesia and Respiratory Devices” Market Outlook to 2016” provides key
2010 3.500,00$

Asia-Pacific Dental Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Dental Devices Market Outlook to 2016” provides key market data on the As
2010 3.500,00$

Europe Neurology Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Neurology Devices Market Outlook to 2016” provides key market data on the Europ
2010 3.500,00$

Asia-Pacific Neurology Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Neurology Devices Market Outlook to 2016” provides key market data on the
2010 3.500,00$

Europe Hospital Supplies Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Hospital Supplies” Market Outlook to 2016” provides key market data on the Euro
2010 3.500,00$

North America Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Diagnostic Imaging Market Outlook to 2016” provides key market data on t
2010 3.500,00$

Europe Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Diagnostic Imaging Market Outlook to 2016” provides key market data on the Euro
2010 3.500,00$

Asia-Pacific Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Diagnostic Imaging Market Outlook to 2016” provides key market data on th
2010 3.500,00$

Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants with Superior Safety Profile will Drive the Market

Introduction / / GlobalData’s report, “Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulan
2010 500,00$

Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Benign Prostatic Hyperplasia (BPH) T
2010 2.000,00$

Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Fibromyalgia Therapeutics - Pipeline Assessment and
2010 2.000,00$

Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Allergic Conjunctivitis - Pipeline A
2010 2.000,00$

Asia-Pacific Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Patient Monitoring Market Outlook to 2016” provides key market data on th
2010 3.500,00$

North America Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Cardiovascular Devices Market Outlook to 2016” provides key market data
2010 3.500,00$

American Academy of Ophthalmology Joint Meeting 2010: Review and Analysis

Introduction / / GlobalData’s report, “American Academy of Ophthalmology (AAO) Joint Meeting 2010 - Conference Review and Analysi
2010 1.000,00$

Europe Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Diabetes Care Devices” Market Outlook to 2016” provides key market data on the
2010 3.500,00$

North America In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America In Vitro Diagnostics Market Outlook to 2016” provides key market data on
2010 3.500,00$

North America Ophthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Ophthalmic Devices Market Outlook to 2016” provides key market data on t
2010 3.500,00$

Europe Ophthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Ophthalmic Devices” Market Outlook to 2016” provides key market data on the Eur
2010 3.500,00$

Asia-Pacific Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Opthalmic Devices” Market Outlook to 2016” provides key market data on th
2010 3.500,00$

Cataract Surgery - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Cataract Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market
2010 3.500,00$

North America Drug Delivery Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Drug Delivery Devices Market Outlook to 2016” provides key market data o
2010 3.500,00$

Europe Drug Delivery Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Drug Delivery Devices Market Outlook to 2016” provides key market data on the E
2010 3.500,00$

Asia-Pacific Drug Delivery Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Drug Delivery Devices Market Outlook to 2016” provides key market data on
2010 3.500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – November 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – November 2010”
2010 1.000,00$

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and
2010 3.000,00$

North America ENT Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America ENT Devices Market Outlook to 2016” provides key market data on the Nort
2010 3.500,00$

North America Dental Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Dental Devices Market Outlook to 2016” provides key market data on the N
2010 3.500,00$

Asia-Pacific HealthCare IT Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific HealthCare IT Market Outlook to 2016” provides key market data on the Asi
2010 3.500,00$

Europe HealthCare IT Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe HealthCare IT Market Outlook to 2016” provides key market data on the Europe He
2010 3.500,00$

North America HealthCare IT Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America HealthCare IT Market Outlook to 2016” provides key market data on the No
2010 3.500,00$

North America Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Diabetes Care Devices Market Outlook to 2016” provides key market data o
2010 3.500,00$

Europe ENT Devices Market Outlook to 2016`

Introduction / / GlobalData’s new report, “Europe ENT Devices Market Outlook to 2016” provides key market data on the Europe ENT
2010 3.500,00$

North America Hospital Supplies Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Hospital Supplies Market Outlook to 2016” provides key market data on th
2010 3.500,00$

Europe Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Surgical Equipment Market Outlook to 2016” provides key market data on the Euro
2010 3.500,00$

Asia-Pacific ENT Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific ENT Devices Market Outlook to 2016” provides key market data on the Asia-
2010 3.500,00$

North America Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Patient Monitoring Market Outlook to 2016” provides key market data on t
2010 3.500,00$

North America Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Orthopedic Devices Market Outlook to 2016” provides key market data on t
2010 3.500,00$

Asia Pacific Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia Pacific Diabetes Care Devices” Market Outlook to 2016” provides key market data o
2010 3.500,00$

North America Nephrology and Urology Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Nephrology and Urology Devices Market Outlook to 2016” provides key mark
2010 3.500,00$

Europe Nephrology and Urology Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Nephrology and Urology Devices Market Outlook to 2016” provides key market data
2010 3.500,00$

Asia Pacific Nephrology and Urology Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia-Pacific Nephrology and Urology Devices Market Outlook to 2016” provides key marke
2010 3.500,00$

Europe Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Anesthesia and Respiratory Devices Market Outlook to 2016” provides key market
2010 3.500,00$

Europe Dental Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe Dental Devices Market Outlook to 2016” provides key market data on the Europe D
2010 3.500,00$

Asia-Pacific Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia Pacific Surgical Equipment Market Outlook to 2016” provides key market data on th
2010 3.500,00$

North America Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “North America Surgical Equipment Market Outlook to 2016” provides key market data on t
2010 3.500,00$

Asia-Pacific In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Asia Pacific In Vitro Diagnostics Market Outlook to 2016” provides key market data on
2010 3.500,00$

Europe In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Europe In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Eu
2010 3.500,00$

Huntington’s Disease - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Huntington’s Disease - Pipeline Asse
2010 2.000,00$

Brain Hemorrhage Therapeutics – Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Brain Hemorrhage Therapeutics - Pipe
2010 2.000,00$

Paget’s disease of Bone - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Paget’s disease of Bone – Pipeline A
2010 2.000,00$

Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Osteoarthritis - Pipeline Assessment and Market Fore
2010 2.000,00$

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020” is an
2010 3.000,00$

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020”.
2010 3.000,00$

Acute Heart Failure - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Heart Failure - Pipeline Ass
2010 2.000,00$

Psoriasis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Psoriasis - Pipeline Assessment and
2010 2.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – October 2010” r
2010 1.000,00$

Pneumonia - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Pneumonia - Pipeline Assessment an
2010 2.000,00$

Dysmenorrhea - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Dysmenorrhea –Pipeline Assessment and Market Forec
2010 2.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2010” report
2010 1.500,00$

Orthopedic Joint Reconstruction - A Global Market Snapshot

Introduction / / GlobalData’s new report, “Orthopedic Joint Reconstruction – A Global Market Snapshot” provides key data, informa
2010 500,00$

Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Epilepsy - Pipeline Assessment and M
2010 2.000,00$

Urinary Tract Infections (UTI) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s report, “Urinary Tract Infections - Pipeline Assessment and Market Forecasts to 2017”, is an essent
2010 2.000,00$

Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Rheumatoid Arthritis - Pipeline Asse
2010 2.000,00$

Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Systemic Lupus Erythematosus - Pipeline Assessment
2010 2.000,00$

Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Head and Neck Cancer – Pipeline Assessment and Mar
2010 2.000,00$

Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines - Pipeline Asse
2010 2.000,00$

Anemia - Pipeline Assessment and Market Forecasts to 2017

GlobalData, the industry analysis specialist, has released its new report, “Anemia - Pipeline Assessment and Market Forecasts to 2
2010 2.000,00$

Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData has released its pharmaceutical report, “Acute Myeloid Leukemia (AML) - Pipeline Assessment and Marke
2010 2.000,00$

Alzheimer’s Disease - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Alzheimer’s Disease - Pipeline As
2010 2.000,00$

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Amyotrophic Lateral Sclerosis (ALS
2010 2.000,00$

Major Depressive Disorder (MDD) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Major Depressive Disorder - Pipeli
2010 2.000,00$

Non-Hodgkin’s Lymphoma (NHL) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist has released a new report, “Non-Hodgkin’s Lymphoma (NHL) - Pipeline
2010 2.000,00$

Medical Devices: A Global Industry Overview

Introduction / / GlobalData’s report, “Medical Devices: A Global Industry Overview” provides key data, information and analysis o
2010 500,00$

Global Diagnostic Imaging Market - Emerging Economies Hold the Key to Growth and Profitability

Introduction / / GlobalData’s new report, “Global Diagnostic Imaging Market – Emerging Economies Hold the Key to Growth and Profi
2010 500,00$

Vitreoretinal Surgery: A Market Snapshot

Introduction / / GlobalData’s report, “Vitreoretinal Surgery: A Market Snapshot” provides key data, information and analysis on t
2010 500,00$

Femtosecond Lasers: A Market Snapshot

Introduction / / GlobalData’s report, “Femtosecond Lasers: A Market Snapshot” provides key data, information and analysis on the
2010 500,00$

Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4
2010 5.000,00$

Pancreatic Cancer - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Pancreatic Cancer - Pipeline Assessment and Market F
2010 2.000,00$

Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B - Pipeline Assessment an
2010 2.000,00$

Bipolar Disorder - Drug Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bipolar Disorder - Drug Pipeline Ass
2010 2.000,00$

Muscular Dystrophy - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Muscular Dystrophy – Pipeline Assess
2010 2.000,00$

Insomnia - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Insomnia - Pipeline Assessment and M
2010 2.000,00$

Neutropenia - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Neutropenia - Pipeline Assessment and
2010 2.000,00$

Advanced Malignancy Clinical Trials Review, Q4 2010

Introduction / / GlobalData's clinical trial report, “Advancer Malignancy Clinical Trials Review, Q4, 2010" provides data on the
2010 1.000,00$

Gastritis Clinical Trials Review, Q4 2010

Introduction / / GlobalData's clinical trial report, “Gastritis Clinical Trials Review, Q4, 2010" provides data on the Gastritis
2010 1.000,00$

Waldenstrom Macroglobulinemia (WM) Clinical Trials Review, Q4 2010

Introduction / / GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Clinical Trials Review, Q4, 2010” provides da
2010 1.000,00$

Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016

Annualized global chronic kidney disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline
2010 2.000,00$

Med BioGene Inc. (MBI) - Product Pipeline Analysis

Med BioGene Inc. (MBI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

ATS Medical, Inc. (ATSI) - Product Pipeline Analysis

ATS Medical, Inc. (ATSI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

DNAPrint Genomics, Inc. (DNAG) - Product Pipeline Analysis

DNAPrint Genomics, Inc. (DNAG) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio
2010 750,00$

The Magstim Company Limited - Product Pipeline Analysis

The Magstim Company Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2010 750,00$

Candela Corporation - Product Pipeline Analysis

Candela Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel
2010 750,00$

Phosphagenics Limited (POH) - Product Pipeline Analysis

Phosphagenics Limited (POH) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2010 750,00$

Neovasc Inc. (NVC) - Product Pipeline Analysis

Neovasc Inc. (NVC) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2010 750,00$

InDevR Inc. - Product Pipeline Analysis

InDevR Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2010 750,00$

Serica Technologies, Inc. - Product Pipeline Analysis

Serica Technologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Osteotech, Inc. (OSTE) - Product Pipeline Analysis

Osteotech, Inc. (OSTE) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

Orthofix International N.V. (OFIX) - Product Pipeline Analysis

Orthofix International N.V. (OFIX) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and a
2010 750,00$

Foster-Miller, Inc. - Product Pipeline Analysis

Foster-Miller, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel
2010 750,00$

Kensey Nash Corporation (KNSY) - Product Pipeline Analysis

Kensey Nash Corporation (KNSY) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio
2010 750,00$

Sutura, Inc. - Product Pipeline Analysis

Sutura, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2010 750,00$

Spine Smith, LP - Product Pipeline Analysis

Spine Smith, LP - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige
2010 750,00$

Divya Laboratories - Product Pipeline Analysis

Divya Laboratories - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2010 750,00$

TheraGenetics Inc. - Product Pipeline Analysis

TheraGenetics Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2010 750,00$

Corin Group PLC (CRG) - Product Pipeline Analysis

Corin Group PLC (CRG) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

Nicast Ltd. - Product Pipeline Analysis

Nicast Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2010 750,00$

ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

ABIOMED, Inc. (ABMD) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte
2010 750,00$

Siemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis

Siemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and
2010 750,00$

Levitronix LLC - Product Pipeline Analysis

Levitronix LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

FIT Biotech Oyj Plc. - Product Pipeline Analysis

FIT Biotech Oyj Plc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte
2010 750,00$

BIOTRONIK SE & Co. KG - Product Pipeline Analysis

BIOTRONIK SE & Co. KG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

InspireMD Ltd. - Product Pipeline Analysis

InspireMD Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

FemSuite LLC. - Product Pipeline Analysis

FemSuite LLC. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2010 750,00$

Teikoku Seiyaku Co., Ltd. - Product Pipeline Analysis

Teikoku Seiyaku Co., Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Corium International, Inc. Product Pipeline Analysis

Corium International, Inc. Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Minvasys - Product Pipeline Analysis

Minvasys - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on
2010 750,00$

InterGenetics Incorporated - Product Pipeline Analysis

InterGenetics Incorporated - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl
2010 750,00$

Innovent Medical Solutions, Ltd. - Product Pipeline Analysis

Innovent Medical Solutions, Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act
2010 750,00$

Impliant Ltd. - Product Pipeline Analysis

Impliant Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2010 750,00$

VeinAid, LLC - Product Pipeline Analysis

VeinAid, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2010 750,00$

ECI Biotech Inc. - Product Pipeline Analysis

ECI Biotech Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig
2010 750,00$

Remon Medical Technologies, Inc. - Product Pipeline Analysis

Remon Medical Technologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act
2010 750,00$

Bioheart, Inc. (BHRT) - Product Pipeline Analysis

Bioheart, Inc. (BHRT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

Visual Pathways, Inc. - Product Pipeline Analysis

Visual Pathways, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

Medtronic, Inc. (MDT) - Product Pipeline Analysis

Medtronic, Inc. (MDT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

Proteus Biomedical, Inc. - Product Pipeline Analysis

Proteus Biomedical, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Power Medical Interventions, Inc. (PMII) - Product Pipeline Analysis

Power Medical Interventions, Inc. (PMII) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis
2010 750,00$

Osmetech plc (OMH) - Product Pipeline Analysis

Osmetech plc (OMH) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2010 750,00$

Universal Biosensors, Inc. (UBI) - Product Pipeline Analysis

Universal Biosensors, Inc. (UBI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act
2010 750,00$

VertiFlex - Product Pipeline Analysis

VertiFlex - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on
2010 750,00$

Gray Surgical - Product Pipeline Analysis

Gray Surgical - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2010 750,00$

Advanced Brain Monitoring, Inc. - Product Pipeline Analysis

Advanced Brain Monitoring, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti
2010 750,00$

NuOrtho Surgical, Inc. - Product Pipeline Analysis

NuOrtho Surgical, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

KeraCure, Inc. - Product Pipeline Analysis

KeraCure, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

GE Healthcare - Product Pipeline Analysis

GE Healthcare - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2010 750,00$

Malaysian Bio-Diagnostics Research Sdn Bhd - Product Pipeline Analysis

Malaysian Bio-Diagnostics Research Sdn Bhd - Product Pipeline Analysis / / Summary / / This report is a source for data, analys
2010 750,00$

Ayanda Biosystems S.A. - Product Pipeline Analysis

Ayanda Biosystems S.A. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

Planmed Oy - Product Pipeline Analysis

Planmed Oy - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o
2010 750,00$

Sybaritic, Inc. - Product Pipeline Analysis

Sybaritic, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige
2010 750,00$

Tristan Technologies, Inc. - Product Pipeline Analysis

Tristan Technologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl
2010 750,00$

Simbex - Product Pipeline Analysis

Simbex - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on th
2010 750,00$

NIPRO CORPORATION (8086) - Product Pipeline Analysis

NIPRO CORPORATION (8086) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Bioring SA - Product Pipeline Analysis

Bioring SA - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o
2010 750,00$

Protagen AG - Product Pipeline Analysis

Protagen AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2010 750,00$

STAAR Surgical Company (STAA) - Product Pipeline Analysis

STAAR Surgical Company (STAA) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and action
2010 750,00$

SenoRx, Inc. (SENO) - Product Pipeline Analysis

SenoRx, Inc. (SENO) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel
2010 750,00$

Q-Med AB (QMED) - Product Pipeline Analysis

Q-Med AB (QMED) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige
2010 750,00$

NMT Medical, Inc. (NMTI) - Product Pipeline Analysis

NMT Medical, Inc. (NMTI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Miraculins Inc. (MOM) - Product Pipeline Analysis

Miraculins Inc. (MOM) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

Anaxsys Technology - Product Pipeline Analysis

Anaxsys Technology - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2010 750,00$

Acoustic MedSystems, Inc. - Product Pipeline Analysis

Acoustic MedSystems, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Nano Interface Technology, Inc. - Product Pipeline Analysis

Nano Interface Technology, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti
2010 750,00$

EP Limited - Product Pipeline Analysis

EP Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o
2010 750,00$

Axis-Shield plc (ASD) - Product Pipeline Analysis

Axis-Shield plc (ASD) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

BioSciCon, Inc. - Product Pipeline Analysis

BioSciCon, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig
2010 750,00$

Bayer HealthCare AG - Product Pipeline Analysis

Bayer HealthCare AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel
2010 750,00$

Lifeline Biotechnologies, Inc. - Product Pipeline Analysis

Lifeline Biotechnologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio
2010 750,00$

CeMines, Inc. - Product Pipeline Analysis

CeMines, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2010 750,00$

XCounter AB (XCT) - Product Pipeline Analysis

XCounter AB (XCT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelli
2010 750,00$

Access Bio, Inc. - Product Pipeline Analysis

Access Bio, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig
2010 750,00$

Inion Oy (IIN) - Product Pipeline Analysis

Inion Oy (IIN) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

pSivida Corp. (PSDV) - Product Pipeline Analysis

pSivida Corp. (PSDV) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte
2010 750,00$

Dako Denmark AS - Product Pipeline Analysis

Dako Denmark AS - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige
2010 750,00$

Bioscan Technologies Inc. - Product Pipeline Analysis

Bioscan Technologies Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

XTENT, Inc. (XTNT) - Product Pipeline Analysis

XTENT, Inc. (XTNT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2010 750,00$

Clear Catheter Systems - Product Pipeline Analysis

Clear Catheter Systems - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

Core Essence Orthopaedics, LLC - Product Pipeline Analysis

Core Essence Orthopaedics, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio
2010 750,00$

Biomagnetics Diagnostics Corporation (BMGP) - Product Pipeline Analysis

Biomagnetics Diagnostics Corporation (BMGP) - Product Pipeline Analysis / / Summary / / This report is a source for data, analy
2010 750,00$

Ani Biotech Oy - Product Pipeline Analysis

Ani Biotech Oy - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

Infinite Biomedical Technologies, LLC - Product Pipeline Analysis

Infinite Biomedical Technologies, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis an
2010 750,00$

LightLab Imaging, Inc. - Product Pipeline Analysis

LightLab Imaging, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

CarpoNovum AB - Product Pipeline Analysis

CarpoNovum AB - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc
2010 750,00$

The Acrobot Company Limited - Product Pipeline Analysis

The Acrobot Company Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2010 750,00$

AsiaGen Corporation - Product Pipeline Analysis

AsiaGen Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel
2010 750,00$

Biocompatibles International plc (BII) - Product Pipeline Analysis

Biocompatibles International plc (BII) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis a
2010 750,00$

Arthro Kinetics plc (AKI) - Product Pipeline Analysis

Arthro Kinetics plc (AKI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

A-Spine Holding Group Corp. - Product Pipeline Analysis

A-Spine Holding Group Corp. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2010 750,00$

Ikonisys, Inc. - Product Pipeline Analysis

Ikonisys, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

Hansen Medical, Inc. (HNSN) - Product Pipeline Analysis

Hansen Medical, Inc. (HNSN) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2010 750,00$

HandyLab, Inc. - Product Pipeline Analysis

HandyLab, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

DISA Vascular (Pty) Ltd. - Product Pipeline Analysis

DISA Vascular (Pty) Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Correlogic Systems, Inc. - Product Pipeline Analysis

Correlogic Systems, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Ash Access Technology, Inc. - Product Pipeline Analysis

Ash Access Technology, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab
2010 750,00$

AdnaGen AG - Product Pipeline Analysis

AdnaGen AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o
2010 750,00$

Randox Laboratories Ltd. - Product Pipeline Analysis

Randox Laboratories Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Vascular Concepts Limited - Product Pipeline Analysis

Vascular Concepts Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

TriReme Medical Inc. - Product Pipeline Analysis

TriReme Medical Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte
2010 750,00$

Exagen Diagnostics, Inc. - Product Pipeline Analysis

Exagen Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Foundation for Innovative New Diagnostics - Product Pipeline Analysis

Foundation for Innovative New Diagnostics - Product Pipeline Analysis / / Summary / / This report is a source for data, analysi
2010 750,00$

Protein Polymer Technologies, Inc. (PPTI) - Product Pipeline Analysis

Protein Polymer Technologies, Inc. (PPTI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysi
2010 750,00$

GRANT Life Sciences, Inc. (GLIF) - Product Pipeline Analysis

GRANT Life Sciences, Inc. (GLIF) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act
2010 750,00$

Tomophase Corporation - Product Pipeline Analysis

Tomophase Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

CleveX, Inc. - Product Pipeline Analysis

CleveX, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2010 750,00$

Intelect Medical Inc. - Product Pipeline Analysis

Intelect Medical Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

Carestream Health, Inc. - Product Pipeline Analysis

Carestream Health, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i
2010 750,00$

Oryzon Genomics - Product Pipeline Analysis

Oryzon Genomics - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige
2010 750,00$

SONOWAND AS - Product Pipeline Analysis

SONOWAND AS - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence
2010 750,00$

IMEXCO General Ltd. - Product Pipeline Analysis

IMEXCO General Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel
2010 750,00$

BSD Medical Corporation (BSDM) - Product Pipeline Analysis

BSD Medical Corporation (BSDM) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio
2010 750,00$

Biosensors International Group, Ltd. (B20) - Product Pipeline Analysis

Biosensors International Group, Ltd. (B20) - Product Pipeline Analysis / / Summary / / This report is a source for data, analys
2010 750,00$

diaDexus, Inc. - Product Pipeline Analysis

diaDexus, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen
2010 750,00$

Advanced Diagnostics, Inc. - Product Pipeline Analysis

Advanced Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl
2010 750,00$

Lux Biosciences, Inc. - Product Pipeline Analysis

Lux Biosciences, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

8sens.biognostic GmbH - Product Pipeline Analysis

8sens.biognostic GmbH - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

Orion Genomics LLC - Product Pipeline Analysis

Orion Genomics LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell
2010 750,00$

World Heart Corporation (WHRT) - Product Pipeline Analysis

World Heart Corporation (WHRT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio
2010 750,00$

Zetiq Technologies Ltd. - Product Pipeline Analysis

Zetiq Technologies Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i
2010 750,00$

Cook Medical Incorporated - Product Pipeline Analysis

Cook Medical Incorporated - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

Perceptronix Medical Inc. - Product Pipeline Analysis

Perceptronix Medical Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable
2010 750,00$

BIOCRATES Life Sciences AG - Product Pipeline Analysis

BIOCRATES Life Sciences AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl
2010 750,00$

ev3 Inc. - Product Pipeline Analysis

ev3 Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on
2010 750,00$

HeartWare International, Inc. (HTWR) - Product Pipeline Analysis

HeartWare International, Inc. (HTWR) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and
2010 750,00$

B. Braun Melsungen AG - Product Pipeline Analysis

B. Braun Melsungen AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int
2010 750,00$

PhotoMedex, Inc. (PHMD) - Product Pipeline Analysis

PhotoMedex, Inc. (PHMD) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i
2010 750,00$

Nektar Therapeutics (NKTR) - Product Pipeline Analysis

Nektar Therapeutics (NKTR) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl
2010 750,00$

Translumina GmbH - Product Pipeline Analysis

Translumina GmbH - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig
2010 750,00$

Biosite Incorporated - Product Pipeline Analysis

Biosite Incorporated - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte
2010 750,00$

BioForm Medical, Inc. (BFRM) - Product Pipeline Analysis

BioForm Medical, Inc. (BFRM) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actiona
2010 750,00$

ZOLL Medical Corporation (ZOLL) - Product Pipeline Analysis

ZOLL Medical Corporation (ZOLL) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti
2010 750,00$

BioSyntech, Inc. (BSY) - Product Pipeline Analysis

BioSyntech, Inc. (BSY) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

Micro Medical Technologies - Product Pipeline Analysis

Micro Medical Technologies - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl
2010 750,00$

Biosense Webster, Inc. - Product Pipeline Analysis

Biosense Webster, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in
2010 750,00$

ProCure Treatment Centers, Inc. - Product Pipeline Analysis

ProCure Treatment Centers, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti
2010 750,00$

Transcatheter Cardiovascular Therapeutics (TCT) Conference 2010: Review and Analysis

Introduction / / GlobalData’s “Transcatheter Cardiovascular Therapeutics (TCT) 2010: Conference Review and Analysis” report is an
2010 1.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - July 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – July 2010” repo
2010 1.000,00$

Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualizati
2010 2.500,00$

Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2010” re
2010 1.000,00$

Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2016

Introduction / / GlobalData’s new report, “Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fore
2010 3.500,00$

Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Spinal Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market F
2010 3.500,00$

Ophthalmic Devices: Current Trends and Developments

Introduction / / GlobalData’s report, “Ophthalmic Devices: Current Trends and Developments” provides key data, information and an
2010 500,00$

Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook

Introduction / / GlobalData’s report, “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” provides key data, in
2010 500,00$

Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Meningitis Preventive Vaccines – Pip
2010 2.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - June 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – June 2010” repo
2010 1.000,00$

Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peripheral Arterial Disease (PAD) -
2010 2.000,00$

Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s report, “Growth Hormone Deficiency - Pipeline Assessment and Market Forecasts to 2017”, is an essen
2010 2.000,00$

Hitachi Medical Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “Hitachi Medical Corporation Market Share Analysis” provides in-depth information on Hi
2010 1.000,00$

China Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “China Cardiovascular Devices Market Outlook to 2016” provides key
2010 2.500,00$

Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualiza
2010 2.500,00$

Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualiza
2010 2.500,00$

Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualizati
2010 2.500,00$

Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visuali
2010 2.500,00$

Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visual
2010 2.500,00$

Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in United Kingdom to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the UK to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in United States to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the US to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Koninklijke Philips Electronics N.V. (PHIA) - Financial and Strategic Analysis Review

Koninklijke Philips Electronics N.V. (Philips Electronics) is a diversified company. The company principally engages in manufactur
2010 125,00$

Dental Devices Market Outlook in Argentina to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Argentina to 2016 - Dental Chairs and Equi
2010 2.500,00$

Dental Devices Market Outlook in Belgium to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Belgium to 2016 - Dental Chairs and Equipm
2010 2.500,00$

Dental Devices Market Outlook in Brazil to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Brazil to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in China to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in China to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in France to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in France to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Germany to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Germany to 2016 - Dental Chairs and Equipm
2010 2.500,00$

Dental Devices Market Outlook in India to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in India to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in Israel to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Israel to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Japan to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Japan to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in Mexico to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Mexico to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Netherlands to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Netherlands to 2016 - Dental Chairs and Eq
2010 2.500,00$

Dental Devices Market Outlook in Republic of Korea to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Republic of Korea to 2016 - Dental Chairs
2010 2.500,00$

Dental Devices Market Outlook in South Africa to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in South Africa to 2016 - Dental Chairs and E
2010 2.500,00$

Dental Devices Market Outlook in Taiwan to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Taiwan to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in United Kingdom to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the UK to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in United States to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the US to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization
2010 2.500,00$

ENT Devices Market Outlook in United Kingdom to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the UK to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospi
2010 2.500,00$

Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Su
2010 2.500,00$

Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation De
2010 2.500,00$

Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation De
2010 2.500,00$

Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devi
2010 2.500,00$

Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in China to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in China to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devi
2010 2.500,00$

Neurology Devices Market Outlook in India to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in India to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation
2010 2.500,00$

Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimul
2010 2.500,00$

Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation
2010 2.500,00$

Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in United Kingdom to 2016 – Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the UK to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in United States to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devic
2010 2.500,00$

Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Japan Drug Forec
2010 3.000,00$

Colorectal Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Italy Drug Forec
2010 3.000,00$

Colorectal Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Germany Drug For
2010 3.000,00$

Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - US Drug Forecast
2010 3.000,00$

Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Global Drug Fore
2010 5.000,00$

Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - France Drug Fore
2010 3.000,00$

Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Brazil, China, I
2010 3.000,00$

Colorectal Cancer - Spain Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Spain Drug Forec
2010 3.000,00$

Colorectal Cancer - UK Drug Forecasts and Treatment Analysis to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - UK Drug Forecast
2010 3.000,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – May 2010” repor
2010 1.000,00$

Healthcare IT Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Healthcare IT Global Market Briefing to 2016” provides key data, information and analy
2010 2.000,00$

Diabetes Care Devices Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Diabetes Care Devices Global Market Briefing to 2016” provides key data, information a
2010 2.000,00$

Respiratory Devices Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Respiratory Devices Global Market Briefing to 2016” provides key data, information and
2010 2.000,00$

Interventional Cardiology Devices Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Interventional Cardiology Devices Global Market Briefing to 2016” provides key data, i
2010 2.000,00$

Genetic Testing Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Genetic Testing Global Market Briefing to 2016” provides key data, information and ana
2010 2.000,00$

In Vitro Diagnostics (Immunochemistry and Infectious Immunology) Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “In Vitro Diagnostics (Immuno Chemistry, Infectious Immunology) Global Market Briefing
2010 2.000,00$

Spinal Surgery Devices Global Market Briefing to 2016

Introduction / / GlobalData’s new report, “Spinal Surgery Devices Global Market Briefing to 2016” provides key data, information
2010 2.000,00$

Trauma Fixation - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Trauma Fixation - Global Pipeline Analysis, Opportunity Assessment and Market Forecast
2010 3.500,00$

Extremities (Shoulder and Small Joint Implants) – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Opportunit
2010 3.500,00$

Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Pipeline Asses
2010 3.500,00$

Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s report, “Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017”, is an essential source
2010 2.000,00$

Osteoporosis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoporosis - Pipeline Assessment a
2010 2.000,00$

Medtronic Acquires Glucose Monitoring Assets from PreciSense: A Move to Develop New Platform for Closed Loop System – Deal Analysis from GlobalData

Introduction / / GlobalData’s report, “Medtronic Acquires Glucose Monitoring Assets from PreciSense: A Move to Develop New Platfo
2010 500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - September 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – September 2010” report is a
2010 1.000,00$

Computer Assisted Radiology and Surgery (CARS) 2010: Conference Review and Analysis

Introduction / / GlobalData’s “Computer Assisted Radiology and Surgery (CARS) 2010 – Conference Review and Analysis” report is an
2010 1.000,00$

Atopic Dermatitis - Pipeline Assessment and Market Forecasts to 2017

Annualized global Atopic Dermatitis therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. / Geog
2010 2.000,00$

Wound Care Management Market Outlook in Republic of Korea to 2016 - Advanced Wound Management, Negative Pressure Wound Therapy (NPWT), Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s medical device report, “Wound Care Management Market Outlook in Republic of Korea to 2016 - Advance
2010 2.500,00$

Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData's medical device report, “Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract
2010 2.500,00$

Healthcare IT Market Outlook in United States to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the US to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in United Kingdom to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in China to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in Germany to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Germany to 2016 - Hospital Information S
2010 2.500,00$

Healthcare IT Market Outlook in Australia to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Australia to 2016 - Hospital Information
2010 2.500,00$

Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Sy
2010 2.500,00$

Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract
2010 2.500,00$

Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Sy
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in United States to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in United Kingdom to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in France to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in France to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontinence Devices, Renal Dialysis Equipmentand Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Inc
2010 2.500,00$

Drug Delivery Devices Market Outlook in the United States to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in the United Kingdom to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation System
2010 2.500,00$

Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Syst
2010 2.500,00$

Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Sy
2010 2.500,00$

Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation System
2010 2.500,00$

Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Syst
2010 2.500,00$

Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalat
2010 2.500,00$

Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation S
2010 2.500,00$

Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems
2010 2.500,00$

Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital
2010 2.500,00$

Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospit
2010 2.500,00$

Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital
2010 2.500,00$

Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Catar
2010 2.500,00$

Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Catar
2010 2.500,00$

Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Ca
2010 2.500,00$

Healthcare IT Market Outlook in India to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in India to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in France to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in France to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information S
2010 2.500,00$

Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Informati
2010 2.500,00$

Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy V
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontin
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incont
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Inco
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontin
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incont
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontine
2010 2.500,00$

Dental Devices Market Outlook in Canada to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Italy to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical devices report, “Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Australia to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equi
2010 2.500,00$

ENT Devices Market Outlook in United States to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Imp
2010 2.500,00$

ENT Devices Market Outlook in France to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in France to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and I
2010 2.500,00$

ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Imp
2010 2.500,00$

ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and I
2010 2.500,00$

ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devic
2010 2.500,00$

ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices an
2010 2.500,00$

ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

Hospital Supplies Market Outlook in United States to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in United Kingdom to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital S
2010 2.500,00$

Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital S
2010 2.500,00$

Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable
2010 2.500,00$

Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical device report offering, “Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Ass
2010 3.500,00$

Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessme
2010 3.500,00$

Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Respiratory Devices – Global Pipeline Analysis, Opportunity Assessment a
2010 3.500,00$

Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Insulin Pumps – Global Pipeline Analysis, Opportunity Assessment and Mar
2010 3.500,00$

Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment a
2010 3.500,00$

Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Periodontal Disease - Pipeline Assessment and Market
2010 2.000,00$

Cardiovascular Devices – Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Cardiovascular Devices - Emerging Countries (China, India, Brazil) Oppor
2010 3.500,00$

Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Marke
2010 3.500,00$

Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and
2010 3.500,00$

Peripheral Vascular Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Peripheral Vascular Devices - Global Pipeline Analysis, Opportunity Asse
2010 3.500,00$

Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market
2010 3.500,00$

Netherlands Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Netherlands to 2016 - Surgical Sutures
2010 2.500,00$

Mexico Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Mexico to 2016 - Surgical Sutures, Han
2010 2.500,00$

Acteon, Inc. Market Share Analysis

Introduction / / GlobalData’s new report, “Acteon, Inc. Market Share Analysis” provides in-depth information on Acteon’s market p
2010 1.000,00$

Advanced Bionics Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “Advanced Bionics Corporation Market Share Analysis” provides in-depth information on A
2010 1.000,00$

ALCARE Co., Ltd. Market Share Analysis

Introduction / / GlobalData’s new report, “ALCARE Co., Ltd. Market Share Analysis” provides in-depth information on ALCARE’s mark
2010 1.000,00$

AlloSource Market Share Analysis

Introduction / / GlobalData’s new report, “AlloSource Market Share Analysis” provides in-depth information on Allosource’s market
2010 1.000,00$

Central Venous Catheters: Market Growth to be Driven by Increasing Demand for Catheters with Antimicrobial Coatings

Introduction / / GlobalData’s report, “Central Venous Catheters Market Growth to be Driven by Increasing Demand for Catheters wit
2010 500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010

Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010” report
2010 1.500,00$

Polycystic Ovarian Syndrome - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Polycystic Ovarian Syndrome - Pipeli
2010 2.000,00$

Hepatitis B - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B - Pipeline Assessment an
2010 2.000,00$

Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Autistic Disorder – Pipeline Assessm
2010 2.000,00$

India Orthopedic Devices Market Outlook to 2016

Market size and company share data for seven orthopedic devices market categories – Orthobiologics, Joint Reconstruction, Spinal S
2010 2.500,00$

Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017

Annualized global type 2 diabetes therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. / Geogra
2010 2.000,00$

Women’s Infertility - Pipeline Assessment and Market Forecasts to 2017

Annualized global women’s infertility therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. / Ge
2010 2.000,00$

Urinary Incontinence - Pipeline Assessment and Market Forecasts to 2017

Annualized global UI therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017. / Geographies covered
2010 2.000,00$

Hologic Acquires Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market

Introduction / / GlobalData’s report, “Hologic to Acquire Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market
2010 500,00$

Peripheral Vascular Devices Market in Japan

Introduction / / GlobalData’s report, “Peripheral Vascular Devices Market in Japan” provides key data, information and analysis o
2010 500,00$

Dental Lasers: A Market Snapshot

Introduction / / GlobalData’s report, “Dental Lasers: A Market Snapshot” provides key data, information and analysis on the globa
2010 500,00$

Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Neurostimulation Devices – Global Pipeline Analysis, Opportunity Assessment and Market
2010 3.500,00$

Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market Penetration

Introduction / / GlobalData’s report, “Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market
2010 500,00$

Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology

Introduction / / GlobalData’s report, “Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology”” provides
2010 500,00$

Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit from Huge Market Opportunity in Structural Heart Defects and Vascular Abnormalities

Introduction / / GlobalData’s report, “Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit fro
2010 500,00$

Brazil Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Brazil Orthopedic Devices Market Outlook to 2016” provides key market data
2010 2.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - August 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – August 2010” report is an e
2010 1.000,00$

Germany Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData's medical devices report, “Germany Opthalmic Devices Market Outlook to 2016” provides key market data
2010 2.500,00$

France Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData's medical devices report, “France Opthalmic Devices Market Outlook to 2016” provides key market data
2010 2.500,00$

Italy Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Italy Opthalmic Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

Spain Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Spain Opthalmic Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

Netherlands Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Netherlands Opthalmic Devices Market Outlook to 2016” provides key market
2010 2.500,00$

United Kingdom Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “United Kingdom Surgical Equipment Market Outlook to 2016” provides key mar
2010 2.500,00$

Japan Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Japan Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

India Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “India Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

Spain Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Spain Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

Belgium Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Belgium Surgical Equipment Market Outlook to 2016” provides key market dat
2010 2.500,00$

Argentina Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Argentina Surgical Equipment Market Outlook to 2016” provides key market d
2010 2.500,00$

Taiwan Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Taiwan Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

South Africa Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “South Africa Surgical Equipment Market Outlook to 2016” provides key marke
2010 2.500,00$

Israel Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Israel Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

Wound Care Management: Innovations and Trends

Introduction / / GlobalData’s report, “Wound Care Management: Innovations and Trends” provides key data, information and analysis
2010 500,00$

Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s pharmaceutical and healthcare report, “Erectile Dysfunction - Pipeline Assessment and Market Foreca
2010 2.000,00$

Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017

Annualized global cystic fibrosis market revenues data from 2001 to 2009, forecast forward for eight years to 2017. / Pipeline a
2010 2.000,00$

Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equi
2010 2.500,00$

Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical devices report, “Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems
2010 2.500,00$

ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and
2010 2.500,00$

ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Su
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontine
2010 2.500,00$

Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in the US to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the US to 2016 - Hospital Information Sy
2010 2.500,00$

Ambu A/S Market Share Analysis

Introduction / / GlobalData’s new report, “Ambu A/S Market Share Analysis” provides in-depth information on Ambu’s market posit
2010 1.000,00$

Boston Scientific Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “Boston Scientific Corporation Market Share Analysis” provides in-depth information o
2010 1.000,00$

Baxter International Inc. Market Share Analysis

Introduction / / GlobalData’s new report, “Baxter International Inc. Market Share Analysis” provides in-depth information on Ba
2010 1.000,00$

Rossmax International Ltd. Market Share Analysis

Introduction / / GlobalData’s new report, “Rossmax International Ltd. Market Share Analysis” provides in-depth information on Ros
2010 1.000,00$

BPL Healthcare Business Group Market Share Analysis

Introduction / / GlobalData’s new report, “BPL Healthcare Business Group Market Share Analysis” provides in-depth information o
2010 1.000,00$

TOSHIBA Medical Systems Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “TOSHIBA Medical Systems Corporation Market Share Analysis” provides in-depth informati
2010 1.000,00$

SonoSite, Inc. Market Share Analysis

Introduction / / GlobalData’s new report, “SonoSite, Inc. Market Share Analysis” provides in-depth information on SonoSite’s mark
2010 1.000,00$

Nihon Kohden Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “Nihon Kohden Corporation Market Share Analysis” provides in-depth information on Nihon
2010 1.000,00$

Fukuda Denshi Co., Ltd. Market Share Analysis

Introduction / / GlobalData’s new report, “Fukuda Denshi Co., Ltd. Market Share Analysis” provides in-depth information on Fukuda
2010 1.000,00$

Beijing Wandong Medical Equipment Co., Ltd. Market Share Analysis

Introduction / / GlobalData’s new report, “Beijing Wandong Medical Equipment Co., Ltd. Market Share Analysis” provides in-depth
2010 1.000,00$

Philips Respironics, Inc. Market Share Analysis

Introduction / / GlobalData’s new report, “Philips Respironics, Inc. Market Share Analysis” provides in-depth information on Phil
2010 1.000,00$

Canada Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Orthopedic Devices Market Outlook to 2016” provides key market
2010 2.500,00$

Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s Orthopedic Devices report, “Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessmen
2010 3.500,00$

Germany Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Orthopedic Devices Market Outlook to 2016” provides key market d
2010 2.500,00$

France Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “France Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

Italy Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

Spain Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

Australia Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Australia Orthopedic Devices Market Outlook to 2016” provides key mark
2010 2.500,00$

Netherlands Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Orthopedic Devices Market Outlook to 2016” provides key mark
2010 2.500,00$

Belgium Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Belgium Orthopedic Devices Market Outlook to 2016” provides key market
2010 2.500,00$

Argentina Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Argentina Orthopedic Devices Market Outlook to 2016” provides key mark
2010 2.500,00$

Mexico Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

Republic of Korea Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Republic of Korea Orthopedic Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Taiwan Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

South Africa Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “South Africa Orthopedic Devices Market Outlook to 2016” provides key mar
2010 2.500,00$

Israel Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

United Kingdom Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “The UK Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

Japan Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Japan Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

China Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

United States Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “US Orthopedic Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

Argentina Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Argentina Wound Care Management Market Outlook to 2016” provides key market data on
2010 2.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - July 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – July 2010” report is an ess
2010 1.000,00$

Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010” report is an ess
2010 1.500,00$

United States In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “US In Vitro Diagnostics Market Outlook to 2016” provides key market data on the US In
2010 2.500,00$

United Kingdom In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “UK In Vitro Diagnostics Market Outlook to 2016” provides key market data on the UK In
2010 2.500,00$

Canada In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Italy In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Italy In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ita
2010 2.500,00$

Spain In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, "Spain In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Spa
2010 2.500,00$

Brazil In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Brazil In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Netherlands In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Netherlands In Vitro Diagnostics Market Outlook to 2016” provides key market data on t
2010 2.500,00$

Belgium In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Republic of Korea In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Republic of Korea In Vitro Diagnostics Market Outlook to 2016” provides key market dat
2010 2.500,00$

Israel Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Israel Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Israel Wound Care Management Market Outlook to 2016” provides key market data on the I
2010 2.500,00$

Israel In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Israel In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Is
2010 2.500,00$

China Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “China Surgical Equipment Market Outlook to 2016” provides key market data on the China
2010 2.500,00$

Canada Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada Surgical Equipment Market Outlook to 2016” provides key market data on the Cana
2010 2.500,00$

Germany Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Germany Surgical Equipment Market Outlook to 2016” provides key market data on the Ger
2010 2.500,00$

France Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “France Surgical Equipment Market Outlook to 2016” provides key market data on the Fran
2010 2.500,00$

Italy Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Italy Surgical Equipment Market Outlook to 2016” provides key market data on the Italy
2010 2.500,00$

Australia Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia Surgical Equipment Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Brazil Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Brazil Surgical Equipment Market Outlook to 2016” provides key market data on the Br
2010 2.500,00$

Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData's has released its pharmaceutical and healthcare report, “Hormone Replacement Therapy in Menopause -
2010 2.000,00$

3M Health Care Market Share Analysis

Introduction / / GlobalData’s medical devices report, “3M Healthcare Market Share Analysis” provides in-depth information on 3M H
2010 1.000,00$

Draegerwerk AG & Co. KGaA Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Draegerwerk AG & Co. KGaA Market Share Analysis” provides in-depth informa
2010 1.000,00$

Coloplast A/S Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Coloplast A/S Market Share Analysis” provides in-depth information on Colo
2010 1.000,00$

Cordis Corporation Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Cordis Corporation Market Share Analysis” provides in-depth information on
2010 1.000,00$

Larsen & Toubro Medical Equipment & Systems Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Larsen & Toubro Medical Equipment & Systems (L&T Medical) Market Share Ana
2010 1.000,00$

Spain Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Spain Patient Monitoring Market Outlook to 2016” provides key market data on the Spain
2010 2.500,00$

Abbott Laboratories Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Abbott Laboratories Market Share Analysis” provides in-depth information o
2010 1.000,00$

Molnlycke Health Care AB Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Molnlycke Health Care AB Market Share Analysis” provides in-depth informat
2010 1.000,00$

BSN medical GmbH Market Share Analysis

Introduction / / GlobalData’s medical devices report, “BSN medical GmbH Market Share Analysis” provides in-depth information on B
2010 1.000,00$

Sectra AB Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Spectra AB. Market Share Analysis” provides in-depth information on Spectr
2010 1.000,00$

Animas Corporation Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Animas Corporation Market Share Analysis” provides in-depth information on
2010 1.000,00$

OSI Systems, Inc. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “OSI Systems, Inc. Market Share Analysis” provides in-depth information on
2010 1.000,00$

Medison Co., Ltd. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Medison Co., Ltd. Market Share Analysis” provides in-depth information on
2010 1.000,00$

CooperVision, Inc. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “CooperVision, Inc. Market Share Analysis” provides in-depth information on
2010 1.000,00$

Anthogyr S.A. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Anthogyr S.A. Market Share Analysis” provides in-depth information on Anth
2010 1.000,00$

Covidien plc Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Covidien plc Market Share Analysis” provides in-depth information on Covid
2010 1.000,00$

Mindray Medical International Limited Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Mindray Medical International Market Share Analysis” provides in-depth inf
2010 1.000,00$

Dameca a/s Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Dameca a/s Market Share Analysis” provides in-depth information on Dameca’
2010 1.000,00$

United States Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “US Wound Care Management Market Outlook to 2016” provides key market data on the US wo
2010 2.500,00$

United Kingdom Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “UK Wound Care Management Market Outlook to 2016” provides key market data on the UK wo
2010 2.500,00$

Japan Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan Wound Care Management Market Outlook to 2016” provides key market data on the Ja
2010 2.500,00$

India Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “India Wound Care Management Market Outlook to 2016” provides key market data on the In
2010 2.500,00$

France Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “France Wound Care Management Market Outlook to 2016” provides key market data on the F
2010 2.500,00$

Australia Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia Wound Care Management Market Outlook to 2016” provides key market data on th
2010 2.500,00$

South Africa Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “South Africa Wound Care Management Market Outlook to 2016” provides key market data on
2010 2.500,00$

Japan In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Jap
2010 3.500,00$

India In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ind
2010 3.500,00$

China In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Chi
2010 3.500,00$

Germany In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Germany In Vitro Diagnostics Market Outlook to 2016” provides key market data on the G
2010 3.500,00$

France In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “France In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Fr
2010 3.500,00$

Australia In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 3.500,00$

Argentina In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 3.500,00$

Mexico In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Mexico In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Me
2010 3.500,00$

Taiwan In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ta
2010 3.500,00$

South Africa In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2016” provides key market data on
2010 3.500,00$

Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Diabetes Care Devices - Emerging Countries Opportunity Assessment, Competitive Landsca
2010 3.500,00$

Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Allergic Rhinitis - Pipeline Assessm
2010 2.000,00$

Migraine - Pipeline Assessment and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Migraine - Pipeline Assessment and Market Forecast
2010 2.000,00$

Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s pharmaceutical and healthcare report, “Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Ma
2010 2.000,00$

Acne - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Acne - Pipeline Assessment and Marke
2010 2.000,00$

US Patient Monitoring Devices Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “US Patient Monitoring Pipeline Analysis, Opportunity Assessment and Ma
2010 3.500,00$

Mergers, Acquisitions and Partnerships in the Medical Devices Industry - Inorganic Growth Driven by the Strategic Need to Hold a Diversified Portfolio

Introduction / / Investments in the global medical devices industry exceeded $73 billion in 2009. In the same year, $18.7 billi
2010 3.500,00$

United States Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “US Anesthesia and Respiratory Devices Market Outlook to 2016” provides
2010 2.500,00$

Japan Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Japan Anesthesia and Respiratory Devices Market Outlook to 2016” provi
2010 2.500,00$

China Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Anesthesia and Respiratory Devices Market Outlook to 2016” provi
2010 2.500,00$

Australia Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Australia Anesthesia and Respiratory Devices Market Outlook to 2016” p
2010 2.500,00$

Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016”
2010 2.500,00$

Belgium Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Belgium Anesthesia and Respiratory Devices Market Outlook to 2016” pro
2010 2.500,00$

Mexico Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Anesthesia and Respiratory Devices Market Outlook to 2016” prov
2010 2.500,00$

South Africa Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “South Africa Anesthesia and Respiratory Devices Market Outlook to 2016
2010 2.500,00$

China Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Wound Care Management Market Outlook to 2016” provides key marke
2010 2.500,00$

Canada Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Germany Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Wound Care Management Market Outlook to 2016” provides key mar
2010 2.500,00$

Italy Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Wound Care Management Market Outlook to 2016” provides key marke
2010 2.500,00$

Spain Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Wound Care Management Market Outlook to 2016” provides key marke
2010 2.500,00$

Brazil Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Netherlands Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Wound Care Management Market Outlook to 2016” provides key
2010 2.500,00$

Belgium Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Belgium Wound Care Management Market Outlook to 2016” provides key mar
2010 2.500,00$

Mexico Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Taiwan Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Viscosupplementation - A European Market Snapshot

Introduction / / GlobalData’s report, “Viscosupplementation: A European Market Snapshot” provides key data, information and ana
2010 500,00$

Antimicrobial Coatings for Medical Devices: An Overview

Introduction / / GlobalData’s report, “Antimicrobial Coatings for Medical Devices” provides key data, information and analysis
2010 500,00$

Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Neuropathic Pain - Pipeline Assessment and Market
2010 2.000,00$

Herpes Simplex - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Herpes Simplex - Pipeline Assessment and Market Fo
2010 2.000,00$

HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016

Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016. / Pipeline analysis data pr
2010 2.000,00$

Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016

Annualized global hepatitis C market revenues data from 2000 to 2009, forecast for seven years to 2016. / Pipeline analysis data
2010 2.000,00$

Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016

Annualized global dyslipidemia market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline analysis
2010 2.000,00$

Pulmonary Arterial Hypertension (PAH) - Pipeline Assessment and Market Forecasts to 2016

Annualized global PAH market revenues data from 2005 to 2009, forecast forward for seven years to 2016. / Geographic markets cov
2010 2.000,00$

Parkinson's Disease – Pipeline Assessment and Market Forecasts to 2016

Annualized global Parkinson’s disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline a
2010 2.000,00$

Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017

Annualized global type 1 diabetes market revenues data from data from 2001 to 2009, forecast for eight years to 2017. / Pipeline
2010 2.000,00$

Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product Offerings

Introduction / / GlobalData’s report, “Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand
2010 500,00$

Japan Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Japan Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Germany Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Diagnostic Imaging Market Outlook to 2016” provides key market d
2010 2.500,00$

France Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “France Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Spain Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Australia Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Australia Diagnostic Imaging Market Outlook to 2016” provides key market
2010 2.500,00$

Belgium Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Argentina Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Argentina Diagnostic Imaging Market Outlook to 2016” provides key market
2010 2.500,00$

Republic of Korea Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Republic of Korea Diagnostic Imaging Market Outlook to 2016” provides ke
2010 2.500,00$

South Africa Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “South Africa Diagnostic Imaging Market Outlook to 2016” provides key mar
2010 2.500,00$

Israel Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “UK Anesthesia and Respiratory Devices Market Outlook to 2016” provides k
2010 2.500,00$

India Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “India Anesthesia and Respiratory Devices Market Outlook to 2016” provide
2010 2.500,00$

Canada Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Germany Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Anesthesia and Respiratory Devices Market Outlook to 2016” provi
2010 2.500,00$

France Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “France Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Italy Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Anesthesia and Respiratory Devices Market Outlook to 2016” provide
2010 2.500,00$

Spain Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2016” provide
2010 2.500,00$

Brazil Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Argentina Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Argentina Anesthesia and Respiratory Devices Market Outlook to 2016” pro
2010 2.500,00$

Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2
2010 2.500,00$

Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - June 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – June 2010” report is an ess
2010 1.000,00$

Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing

Introduction / / GlobalData’s report, “Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing” pr
2010 500,00$

Arigene Co., Ltd. (67850) - Strategic Analysis Review

This comprehensive SWOT profile of Arigene Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

DALTON CORPORATION - Strategic Analysis Review

This comprehensive SWOT profile of DALTON CORPORATION provides you an in-depth strategic analysis of the company’s businesses and
2010 125,00$

Attwell Capital Inc. (AT.H) - Strategic Analysis Review

This comprehensive SWOT profile of Attwell Capital Inc. provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Chemipal Ltd. (CMPL) - Strategic Analysis Review

This comprehensive SWOT profile of Chemipal Ltd. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

DIO Corporation (39840) - Strategic Analysis Review

This comprehensive SWOT profile of DIO Corporation provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

Lilama 69-1 JSC (L61) - Strategic Analysis Review

This comprehensive SWOT profile of Lilama 69-1 JSC provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

HOSHI IRYO-SANKI CO., LTD (7634) - Strategic Analysis Review

This comprehensive SWOT profile of HOSHI IRYO-SANKI CO., LTD provides you an in-depth strategic analysis of the company’s business
2010 250,00$

PositiveID Corporation (PSID) - Strategic Analysis Review

PositiveID Corporation is a company which operates in two main divisions: HealthID and ID Security. The company's HealthID busines
2010 250,00$

New Mexico Software Inc. - Strategic Analysis Review

This comprehensive SWOT profile of New Mexico Software Inc. provides you an in-depth strategic analysis of the company’s businesse
2010 125,00$

PT. Millennium Pharmacon International TBK (SDPC) - Strategic Analysis Review

This comprehensive SWOT profile of PT. Millennium Pharmacon International TBK provides you an in-depth strategic analysis of the c
2010 125,00$

J.L.Morison, Sons & Jones (Ceylon) PLC (MORI) - Strategic Analysis Review

This comprehensive SWOT profile of J.L.Morison, Sons & Jones (Ceylon) PLC provides you an in-depth strategic analysis of the compa
2010 250,00$

In House Productions Limited (526610) - Strategic Analysis Review

This comprehensive SWOT profile of In House Productions Limited provides you an in-depth strategic analysis of the company’s busin
2010 250,00$

Jacques Bogart SA (JBOG) - Strategic Analysis Review

This comprehensive SWOT profile of Jacques Bogart SA provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Indbank Merchant Banking Services Ltd (511473) - Strategic Analysis Review

This comprehensive SWOT profile of Indbank Merchant Banking Services Ltd provides you an in-depth strategic analysis of the compan
2010 250,00$

Audiotech Healthcare Corporation (AUD) - Strategic Analysis Review

This comprehensive SWOT profile of Audiotech Healthcare Corporation provides you an in-depth strategic analysis of the company’s b
2010 250,00$

Cassius Ventures Ltd. (CZ.P) - Strategic Analysis Review

This comprehensive SWOT profile of Cassius Ventures Ltd. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Bellmore Corp (BLMR) - Strategic Analysis Review

This comprehensive SWOT profile of Bellmore Corp provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Latvijas Zoovetapgade AS (ZOV1R) - Strategic Analysis Review

Latvijas Zoovetapgade AS (Latvijas Zoovetapgade JSC) is a veterinary preparations provider based in Latvia. The company is princip
2010 250,00$

Chengdu Huasun Group Inc.,Ltd. (790) - Strategic Analysis Review

This comprehensive SWOT profile of Chengdu Huasun Group Inc.,Ltd. provides you an in-depth strategic analysis of the company’s bus
2010 250,00$

Mangalam Drugs and Organics Limited (532637) - Strategic Analysis Review

This comprehensive SWOT profile of Mangalam Drugs and Organics Limited provides you an in-depth strategic analysis of the company’
2010 250,00$

Manitex Capital Inc. (MNX) - Strategic Analysis Review

Manitex Capital Inc. (Manitex) is a diversified technology investment company which invest in the life science industry. The compa
2010 250,00$

China Health Industries Holdings Inc (CHHE) - Strategic Analysis Review

This comprehensive SWOT profile of China Health Industries Holdings Inc provides you an in-depth strategic analysis of the company
2010 250,00$

Schiff Nutrition International Inc. (WNI) - Strategic Analysis Review

This comprehensive SWOT profile of Schiff Nutrition International Inc. provides you an in-depth strategic analysis of the company’
2010 250,00$

CHUO BUSSAN CORPORATION (9852) - Strategic Analysis Review

This comprehensive SWOT profile of CHUO BUSSAN CORPORATION provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

CTD Holdings Inc. - Strategic Analysis Review

CTD Holdings, Inc., (CHI) is a Florida based manufacturing and distribution company. CHI is principally engages in the distributio
2010 250,00$

Inner Mongolia Jinyu Group Co Ltd (600201) - Strategic Analysis Review

This comprehensive SWOT profile of Inner Mongolia Jinyu Group Co Ltd provides you an in-depth strategic analysis of the company’s
2010 250,00$

Procognia Israel Ltd - Strategic Analysis Review

This comprehensive SWOT profile of Procognia Israel Ltd provides you an in-depth strategic analysis of the company’s businesses an
2010 125,00$

BITComputer (32850) - Strategic Analysis Review

This comprehensive SWOT profile of BITComputer provides you an in-depth strategic analysis of the company’s businesses and operati
2010 125,00$

Instituto de Diagnostico S.A. (INDISA) - Strategic Analysis Review

This comprehensive SWOT profile of Instituto de Diagnostico S.A. provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

Northstar Healthcare, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Northstar Healthcare, Inc. provides you an in-depth strategic analysis of the company’s busines
2010 125,00$

Siemens Medical Solutions Diagnostics (506559) - Strategic Analysis Review

This comprehensive SWOT profile of Siemens Medical Solutions Diagnostics provides you an in-depth strategic analysis of the compan
2010 125,00$

MedTech Global Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of MedTech Global Ltd. provides you an in-depth strategic analysis of the company’s businesses and
2010 125,00$

PT Multi Indocitra Tbk (MICE) - Strategic Analysis Review

This comprehensive SWOT profile of PT Multi Indocitra Tbk provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Advanced Technology Company (ATC) - Strategic Analysis Review

This comprehensive SWOT profile of Advanced Technology Company provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Alta Natural Herbs & Supplements Ltd. (AHS) - Strategic Analysis Review

This comprehensive SWOT profile of Alta Natural Herbs & Supplements Ltd. provides you an in-depth strategic analysis of the compan
2010 250,00$

American Surgical Holdings Inc (ASRG) - Strategic Analysis Review

This comprehensive SWOT profile of American Surgical Holdings Inc provides you an in-depth strategic analysis of the company’s bus
2010 250,00$

American Vietnamese Biotech Inc (AMV) - Strategic Analysis Review

This comprehensive SWOT profile of American Vietnamese Biotech Inc provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Animalcare Group Plc (ANCR) - Strategic Analysis Review

This comprehensive SWOT profile of Animalcare Group Plc provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Aquamer Medical Corp (AQUM) - Strategic Analysis Review

This comprehensive SWOT profile of Aquamer Medical Corp provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

AXS-One Inc. (AXSO) - Financial and Strategic Analysis Review

AXS-One Inc. (AXSO) - Financial and Strategic Analysis Review / / Summary / / AXS-One Inc. (AXA-One) is engaged in providing con
2010 125,00$

TZ Limited (TZL) - Financial and Strategic Analysis Review

TZ Limited (TZL) - Financial and Strategic Analysis Review / / Summary / / TZ Limited is engaged in providing fuse environmental
2010 125,00$

Global Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis Review

Global Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis Review / / Summary / / Global Med Technologies, Inc., (G
2010 125,00$

Pro Medicus Limited (PME) - Financial and Strategic Analysis Review

Pro Medicus Limited (PME) - Financial and Strategic Analysis Review / / Summary / / Pro Medicus Limited (Pro Medicus) is an Aust
2010 125,00$

System C Healthcare plc (SYS) - Financial and Strategic Analysis Review

System C Healthcare plc (SYS) - Financial and Strategic Analysis Review / / Summary / / System C Healthcare plc (SCH) is a UK ba
2010 125,00$

SensiVida Medical Technologies, Inc - Strategic Analysis Review

SensiVida Medical Systems, Inc. is a minimally-invasive diagnostic device company. The company's technology addresses a number of
2010 250,00$

ZEVEX International, Inc. - Strategic Analysis Review

ZEVEX International, Inc. (ZEVEX) is a medical device company engaged in the design, manufacture, development and distribution of
2010 250,00$

Heraeus Holding GmbH - Strategic Analysis Review

Heraeus Holding GmbH (Heraeus) is a precious metals and technology group. It is engaged in the production and trading of high-qual
2010 125,00$

1-800 Contacts, Inc. - Strategic Analysis Review

1-800 Contacts, Inc (1-800 Contacts) is one of the worlds largest contact lens store. The company is involved in manufacturing, de
2010 250,00$

Burkhart Dental, Inc. - Strategic Analysis Review

Burkhart Dental, Inc. (Burkhart), is a dental supplier company principally engaged in the supply, distribution and marketing of de
2010 250,00$

IDS plc - Strategic Analysis Review

IDS plc formally known as IDS Nordic a/s is a biotechnology company, which is principally engaged in the manufacture, development
2010 125,00$

Spectrum Surgical Instruments Corporation - Strategic Analysis Review

Spectrum Surgical Instruments Corporation (Spectrum Surgical) is a medical device supplier, principally involved in providing a br
2010 250,00$

Jebsen & Jessen (SEA) Pte Ltd - Strategic Analysis Review

The Jebsen & Jessen (SEA) Pte Ltd (Jebsen & Jessen) is a group company and principally operates in seven core businesses namely Ch
2010 250,00$

National Distribution & Contracting, Inc. - Strategic Analysis Review

National Distribution & Contracting, Inc. (NDC) is a distributor company of medical, surgical, dental and laboratory equipments. T
2010 250,00$

QHR Technologies Inc. (QHR) - Strategic Analysis Review

QHR Technologies Inc. (QHR) is a healthcare IT company, which is specialized in the design of software to improve the efficiency o
2010 125,00$

PLC Medical Systems, Inc. (PLCSF) - Strategic Analysis Review

PLC Medical Systems, Inc. (PLC) is engaged in the development and marketing of innovative cardiac and vascular medical device-base
2010 250,00$

Biomoda, Inc. (BMOD) - Strategic Analysis Review

Biomoda, Inc. (Biomoda) is a medical device manufacturing company principally engaged in the development of disease specific test
2010 250,00$

Theken - Strategic Analysis Review

Theken family of companies are medical device companies, that are principally engaged in the research, development, manufacture an
2010 125,00$

Pan Probe Biotech, Inc. - Strategic Analysis Review

Pan Probe Biotech, Inc. is a medical device manufacturing company in the rapid diagnostic kit industry. It is very useful to detec
2010 250,00$

Span Diagnostics Ltd. (524727) - Strategic Analysis Review

Span Diagnostics Ltd. (Span Diagnostics) is an Indian based company. It is principally engaged in the manufacture and marketing of
2010 125,00$

Sanrad International Pvt Ltd - Strategic Analysis Review

Sanrad International Pvt Ltd (Sanrad) is a medical equipment supplier. Sanrad is engaged in the business of import, export, and sa
2010 250,00$

Ascent Healthcare Solutions, Inc. - Strategic Analysis Review

Ascent Healthcare Solutions, Inc. (Ascent) is a privately held medical device company engaged in medical device reprocessing and r
2010 250,00$

CBaySystems Holdings Ltd. (CBAY) - Strategic Analysis Review

CBaySystems Holdings Ltd. (CBaySystems) is a privately-held healthcare IT company engaged in providing software solutions for hea
2010 250,00$

Marshall Products Limited - Strategic Analysis Review

Marshall Products Limited (Marshall) is a medical equipment supplier company engaged in the importing, marketing and distribution
2010 250,00$

Asyah Haavot Ltd. - Strategic Analysis Review

Asyah Haavot Ltd. (Asyah) is a privately-held wholesale medical supplier company. The company focuses on marketing and distributio
2010 250,00$

Eldan Electronic Instruments Co. Ltd - Strategic Analysis Review

Eldan Electronic Instruments Co. Ltd (Eldan) is a privately-held supplier of equipment and consumables in the areas of Healthcare,
2010 250,00$

Futuremed Healthcare Income Fund (FMD.UN) - Strategic Analysis Review

Futuremed Healthcare Income Fund (Futuremed) is engaged in the manufacture and distribution of innovative healthcare products. The
2010 250,00$

A&T Corporation (6722) - Strategic Analysis Review

This comprehensive SWOT profile of A&T Corporation provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

American Shared Hospital Services - Strategic Analysis Review

This comprehensive SWOT profile of American Shared Hospital Services provides you an in-depth strategic analysis of the company’s
2010 250,00$

Topcon Corporation - Strategic Analysis Review

This comprehensive SWOT profile of Topcon Corporation provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Rockeby Biomed Limiteds - Strategic Analysis Review

Rockeby biomed Limited (Rockeby), is bio-technology service provider company. The company is principally engaged in the research a
2010 125,00$

Baumer S.A.s - Strategic Analysis Review

Baumer S.A. (Baumer) is a medical device manufacturing company principally engaged in the development, manufacturing and marketing
2010 250,00$

Safety Medical Products Limited (SFP) - Strategic Analysis Review

This comprehensive SWOT profile of Safety Medical Products Limited provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Integrated Surgical Systems, Inc. (ISSM) - Strategic Analysis Review

This comprehensive SWOT profile of Integrated Surgical Systems, Inc. provides you an in-depth strategic analysis of the company’s
2010 250,00$

SMC Ventures Inc. - Strategic Analysis Review

This comprehensive SWOT profile of SMC Ventures Inc. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Glycorex Transplantation AB - Strategic Analysis Review

This comprehensive SWOT profile of Glycorex Transplantation AB provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Morishita Jintan Co., Ltd. - Strategic Analysis Review

Morishita Jintan Co., Ltd. is a Japan based company that engages in offering product and services in the OTC market. The company o
2010 250,00$

Nadex Co., Ltd. - Strategic Analysis Review

Nadex Co., Ltd. is a Japan-based company that engages in offering product and services in the Opthalmic device market. The company
2010 250,00$

OKAMOTO INDUSTRIES, INC. - Strategic Analysis Review

This comprehensive SWOT profile of OKAMOTO INDUSTRIES, INC. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Hartest Holdings plc (HTH) - Strategic Analysis Review

Hartest Holdings plc is a medical device company engaged in the manufacture and sale of specialist scientific instrumentation toge
2010 250,00$

Cardio Vascular Medical Device Corp. - Strategic Analysis Review

This comprehensive SWOT profile of Cardio Vascular Medical Device Corp. provides you an in-depth strategic analysis of the company
2010 250,00$

Sagentia Group AG (SAG) - Strategic Analysis Review

This comprehensive SWOT profile of Sagentia Group AG provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Medigus Ltd. (MDGS) - Strategic Analysis Review

This comprehensive SWOT profile of Medigus Ltd. provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

Ingen Technologies, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Ingen Technologies, Inc. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Acceleware Corp. (AXE) - Strategic Analysis Review

This comprehensive SWOT profile of Acceleware Corp. provides you an in-depth strategic analysis of the company’s businesses and op
2010 250,00$

A&D Company, Limited. - Strategic Analysis Review

This comprehensive SWOT profile of A&D Company, Limited. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

American Science & Engineering Inc (ASEI) - Strategic Analysis Review

American Science & Engineering Inc is engaged in manufacturing of X-ray inspection products that can be used to inspect parcels, b
2010 250,00$

Atos Wellness Ltd - Strategic Analysis Review

This comprehensive SWOT profile of Atos Wellness Ltd provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Bio-Gate Ag (BIG) - Strategic Analysis Review

This comprehensive SWOT profile of Bio-Gate Ag provides you an in-depth strategic analysis of the company’s businesses and operati
2010 250,00$

Capitol Health Limited - Strategic Analysis Review

This comprehensive SWOT profile of Capitol Health Limited provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

China Asean Resources Limited - Strategic Analysis Review

This comprehensive SWOT profile of China Asean Resources Limited provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

Corem Property Group Ab - Strategic Analysis Review

Corem Property Group AB (publ) is a real estate company that owns and manages properties in central and southern Sweden and Denmar
2010 250,00$

Ellen Ab - Strategic Analysis Review

This comprehensive SWOT profile of Ellen Ab provides you an in-depth strategic analysis of the company’s businesses and operations
2010 250,00$

Euromedis Groupe Sa (EMG) - Strategic Analysis Review

Euromedis Groupe Sa is a medical device company which provides products in five different categories. They are parenteral access,
2010 250,00$

Fenwal Controls Of Japan Ltd - Strategic Analysis Review

This comprehensive SWOT profile of Fenwal Controls Of Japan Ltd provides you an in-depth strategic analysis of the company’s busin
2010 250,00$

Kel Corporation - Strategic Analysis Review

This comprehensive SWOT profile of Kel Corporation provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

Mani, Inc. (7730) - Strategic Analysis Review

This comprehensive SWOT profile of Mani, Inc. provides you an in-depth strategic analysis of the company’s businesses and operatio
2010 250,00$

Medic Vision Limited - Strategic Analysis Review

Medic Vision Limited is an Australia based provider of healthcare training solutions. The company engages in providing training se
2010 250,00$

Photon Control Inc - Strategic Analysis Review

This comprehensive SWOT profile of Photon Control Inc provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Poly Medicure Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Poly Medicure Ltd. provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Simtronics Asa - Strategic Analysis Review

This comprehensive SWOT profile of Simtronics Asa provides you an in-depth strategic analysis of the company’s businesses and oper
2010 250,00$

Somnomed Limited - Strategic Analysis Review

This comprehensive SWOT profile of Somnomed Limited provides you an in-depth strategic analysis of the company’s businesses and op
2010 125,00$

Sunray Holdings Limited - Strategic Analysis Review

This comprehensive SWOT profile of Sunray Holdings Limited provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Trestle Holdings, Inc. - Strategic Analysis Review

Trestle Holdings, Inc. is engaged in the development and selling of digital tissue imaging products and solutions for improved wor
2010 250,00$

Tso3 Inc (TOS) - Strategic Analysis Review

This comprehensive SWOT profile of Tso3 Inc provides you an in-depth strategic analysis of the company’s businesses and operations
2010 125,00$

Viscom Ag - Strategic Analysis Review

This comprehensive SWOT profile of Viscom Ag provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

Yagami Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Yagami Inc. provides you an in-depth strategic analysis of the company’s businesses and operati
2010 250,00$

Immersion Corporation - Strategic Analysis Review

Immersion Corporation is engaged in developing touch technology for automotive, consumer electronics, gaming, industrial, commerci
2010 250,00$

Emerging Vision, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Emerging Vision, Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Oncologix Tech, Inc. (OCLG) - Strategic Analysis Review

Oncologix Tech, Inc. (OCLG) is engaged in the research and development of medical devices for the treatment of soft tissue cancers
2010 250,00$

co.don AG - Strategic Analysis Review

This comprehensive SWOT profile of co.don AG provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

HepaLife Technologies Inc. (HPLF) - Strategic Analysis Review

HepaLife Technologies, Inc. (HepaLife) is Bioartificial Liver System Developer in United States. The company was principally engag
2010 250,00$

INDUS Holding AG - Strategic Analysis Review

This comprehensive SWOT profile of INDUS Holding AG provides you an in-depth strategic analysis of the company’s businesses and op
2010 250,00$

Acrongenomics Inc. (AGNM) - Strategic Analysis Review

Acrongenomics, Inc. is engaged in developing and commercializing novel technology platforms concerning the life sciences sector. A
2010 250,00$

addVise inredning skyddsventilation AB (ADDV) - Strategic Analysis Review

This comprehensive SWOT profile of addVise inredning skyddsventilation AB provides you an in-depth strategic analysis of the compa
2010 250,00$

Applisonix Ltd. (APLS) - Strategic Analysis Review

This comprehensive SWOT profile of Applisonix Ltd. provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

Austofix Group Limited (AYX) - Strategic Analysis Review

This comprehensive SWOT profile of Austofix Group Limited provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

Bilcare Limited (526853) - Strategic Analysis Review

Bilcare Limited is engaged in pharma packaging research solutions. It is a solutions provider that partners with the global pharma
2010 250,00$

MeVis Medical Solutions AG - Strategic Analysis Review

This comprehensive SWOT profile of MeVis Medical Solutions AG provides you an in-depth strategic analysis of the company’s busines
2010 125,00$

GENESIS BIOMEDICAL LTD - Strategic Analysis Review

This comprehensive SWOT profile of GENESIS BIOMEDICAL LTD provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

Allied Motion Technologies, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Allied Motion Technologies, Inc. provides you an in-depth strategic analysis of the company’s b
2010 250,00$

Bio-Cell Ltd. - Strategic Analysis Review

Bio-Cell Ltd. focuses on the development and manufacturing of protein-based medicines, using genetically engineered vegetal cultur
2010 250,00$

Allan International Holdings Ltd. (684) - Strategic Analysis Review

This comprehensive SWOT profile of Allan International Holdings Ltd. provides you an in-depth strategic analysis of the company’s
2010 250,00$

Bio-Matrix Scientific Group, Inc. - Strategic Analysis Review

Bio-Matrix Scientific Group, Inc. is a biotechnology research and development company engaged in inventing, developing, acquiring
2010 250,00$

Lifeline Scientific, Inc. (LSI) - Strategic Analysis Review

This comprehensive SWOT profile of Lifeline Scientific, Inc. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Raysearch Laboratories AB - Strategic Analysis Review

Raysearch Laboratories AB is a medical technology company that develops software for radiation therapy of cancer. The company's pr
2010 250,00$

Polylite Taiwan Co., Ltd. (1813) - Strategic Analysis Review

This comprehensive SWOT profile of Polylite Taiwan Co., Ltd. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Guidant Corp. - Strategic Analysis Review

This comprehensive SWOT profile of Guidant Corp. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Caprius, Inc. (CAPI) - Strategic Analysis Review

This comprehensive SWOT profile of Caprius, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

PJ Electronics Co., Ltd. (6140) - Strategic Analysis Review

This comprehensive SWOT profile of PJ Electronics Co., Ltd. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

CUREXO INC. - Strategic Analysis Review

This comprehensive SWOT profile of CUREXO INC. provides you an in-depth strategic analysis of the company’s businesses and operati
2010 250,00$

Theralase Technologies Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Theralase Technologies Inc. provides you an in-depth strategic analysis of the company’s busine
2010 125,00$

C-Rad AB (CRAD B) - Strategic Analysis Review

This comprehensive SWOT profile of C-Rad AB provides you an in-depth strategic analysis of the company’s businesses and operations
2010 250,00$

Universal Detection Technology - Strategic Analysis Review

Universal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices.presently the
2010 250,00$

ANGLE plc (AGL) - Strategic Analysis Review

This comprehensive SWOT profile of ANGLE plc provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

3M India Limited (523395) - Strategic Analysis Review

This comprehensive SWOT profile of 3M India Limited provides you an in-depth strategic analysis of the company’s businesses and op
2010 250,00$

IntriCon Corporation (IIN) - Strategic Analysis Review

This comprehensive SWOT profile of IntriCon Corporation provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Oclaro, Inc. (OCLR) - Strategic Analysis Review

Oclaro, Inc. is a engaged in providing optical and laser components and solutions for a broad range of diverse markets, including
2010 250,00$

1300 Smiles Limited (ONT) - Strategic Analysis Review

This comprehensive SWOT profile of 1300 Smiles Limited provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

athenahealth, Inc. (ATHN) - Strategic Analysis Review

athenahealth, Inc. offers the revenue cycle management solution to the healthcare industry. The company provides services related
2010 250,00$

HealthStream, Inc. (HSTM) - Strategic Analysis Review

This comprehensive SWOT profile of HealthStream, Inc. provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Chemel AB - Strategic Analysis Review

This comprehensive SWOT profile of Chemel AB provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

ZMAY Holdings Limited (8085) - Strategic Analysis Review

This comprehensive SWOT profile of ZMAY Holdings Limited provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Techtran Polylenses Limited (523455) - Strategic Analysis Review

This comprehensive SWOT profile of Techtran Polylenses Limited provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Omnisystem Co., Ltd (57540) - Strategic Analysis Review

This comprehensive SWOT profile of Omnisystem Co., Ltd provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Memory & Testing Inc. (65150) - Strategic Analysis Review

This comprehensive SWOT profile of Memory & Testing Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

3S Korea Co., Ltd. (60310) - Strategic Analysis Review

This comprehensive SWOT profile of 3S Korea Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Universal Vision Biotechnology Co., Ltd (3218) - Strategic Analysis Review

This comprehensive SWOT profile of Universal Vision Biotechnology Co., Ltd provides you an in-depth strategic analysis of the comp
2010 250,00$

Berli Jucker Public Company Limited (BJC) - Strategic Analysis Review

This comprehensive SWOT profile of Berli Jucker Public Company Limited provides you an in-depth strategic analysis of the company’
2010 125,00$

3D Diagnostic Imaging plc (3DDP) - Strategic Analysis Review

This comprehensive SWOT profile of 3D Diagnostic Imaging plc provides you an in-depth strategic analysis of the company’s business
2010 250,00$

CANTRONIC Systems Inc. - Strategic Analysis Review

This comprehensive SWOT profile of CANTRONIC Systems Inc. provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Dignitana AB (DIGN) - Strategic Analysis Review

This comprehensive SWOT profile of Dignitana AB provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

Resonance Health Limited (RHT) - Strategic Analysis Review

This comprehensive SWOT profile of Resonance Health Limited provides you an in-depth strategic analysis of the company’s businesse
2010 125,00$

Toumaz Holdings Limited - Strategic Analysis Review

This comprehensive SWOT profile of Toumaz Holdings Limited provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

HeartWare International, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of HeartWare International, Inc. provides you an in-depth strategic analysis of the company’s busi
2010 125,00$

ACTHERM INC. - Strategic Analysis Review

This comprehensive SWOT profile of ACTHERM INC. provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

Advanced BioMedical Technologies, Inc. (ABMT) - Strategic Analysis Review

This comprehensive SWOT profile of Advanced BioMedical Technologies, Inc. provides you an in-depth strategic analysis of the compa
2010 250,00$

Avisio, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Avisio, Inc. provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

B2 Health Inc. (BTWO) - Strategic Analysis Review

This comprehensive SWOT profile of B2 Health Inc. provides you an in-depth strategic analysis of the company’s businesses and oper
2010 250,00$

D.Western Therapeutics Institute, Inc. (4576) - Strategic Analysis Review

This comprehensive SWOT profile of D.Western Therapeutics Institute, Inc. provides you an in-depth strategic analysis of the compa
2010 250,00$

HANS BIOMED CORPORATION (42520) - Strategic Analysis Review

This comprehensive SWOT profile of HANS BIOMED CORPORATION provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Healthcare Enterprise Group PLC (HCEG) - Strategic Analysis Review

This comprehensive SWOT profile of Healthcare Enterprise Group PLC provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Microvision, Inc. (MVIS) - Strategic Analysis Review

This comprehensive SWOT profile of Microvision, Inc. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Alexandria Medical Services Company (AMES) - Strategic Analysis Review

Alexandria Medical Services Company is a company engaged in providing medical diagnostic and treatment services. Its facilities in
2010 250,00$

biOasis Technologies Inc. (BTI.V) - Strategic Analysis Review

biOasis Technologies Inc. (formerly W.R. Partners Ltd.) is a biotechnology company engaged in the development of biomarkers for di
2010 125,00$

Sun Life Corporation - Strategic Analysis Review

This comprehensive SWOT profile of Sun Life Corporation provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Eldav Investments Ltd. (ELDAV) - Strategic Analysis Review

Eldav Investments Ltd. is a public investment company. It is seeking to invest in high potential industrial, service and commercia
2010 250,00$

Aphton Corporation (APHTQ) - Financial and Strategic Analysis Review

Aphton Corporation (APHTQ) - Financial and Strategic Analysis Review / / Summary / / Aphton Corporation (Aphton) is a pennsylvan
2010 125,00$

Ads Media Group Inc (AMGU) - Financial and Strategic Analysis Review

Ads Media Group Inc (AMGU) - Financial and Strategic Analysis Review / / Summary / / ADS Media Group (ADSMG) is principally enga
2010 125,00$

CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review

CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review / / Summary / / CellMetrix, Inc. (CellMetrix) is a medical tec
2010 125,00$

Hi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis Review

Hi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis Review / / Summary / / Hi-Tech Pharmacal Co., Inc. (Hi-Tec
2010 250,00$

OptimumCare Corporation (OPMC) - Financial and Strategic Analysis Review

OptimumCare Corporation (OPMC) - Financial and Strategic Analysis Review / / Summary / / OptimumCare Corporation (OptimumCare) i
2010 125,00$

IVI Communications, Inc. (IVII) - Financial and Strategic Analysis Review

IVI Communications, Inc. (IVII) - Financial and Strategic Analysis Review / / Summary / / IVI Communications, Inc., (IVI) is an
2010 125,00$

Sitestar Corporation (SYTE) - Financial and Strategic Analysis Review

Sitestar Corporation (SYTE) - Financial and Strategic Analysis Review / / Summary / / Sitestar Corporation operates is an Intern
2010 125,00$

Orion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis Review

Orion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis Review / / Summary / / Orion HealthCorp, Inc. (Orion HealthCorp
2010 125,00$

Protide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis Review

Protide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis Review / / Summary / / Protide Pharmaceuticals, Inc. (Pr
2010 125,00$

Kalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis Review

Kalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis Review / / Summary / / Kalahari Greentech, Inc.(KGI) is a res
2010 125,00$

Velcera, Inc. (VLCR) - Financial and Strategic Analysis Review

Velcera, Inc. (VLCR) - Financial and Strategic Analysis Review / / Summary / / Velcera, Inc. (Velcera) is a is a development sta
2010 125,00$

Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review

Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review / / Summary / / Viral Genetics, Inc. (Viral Genetics) is a
2010 125,00$

Vital Living, Inc. (VTLV) - Financial and Strategic Analysis Review

Vital Living, Inc. (VTLV) - Financial and Strategic Analysis Review / / Summary / / Vital Living, Inc. (Vital Living) is a publi
2010 125,00$

Millenia Hope Inc. (MLF) - Financial and Strategic Analysis Review

Millenia Hope Inc. (MLF) - Financial and Strategic Analysis Review / / Summary / / Millenia Hope, Inc. (Millenia) is a research
2010 125,00$

BioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis Review

BioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis Review / / Summary / / BioChem Solutions Inc. (BioChem Solution
2010 125,00$

Stem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis Review

Stem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Innovations, Inc. (SCI) i
2010 125,00$

SinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis Review

SinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis Review / / Summary / / SinoFresh HealthCare, Inc. (SinoFres
2010 125,00$

Medistem, Inc. (MEDS) - Financial and Strategic Analysis Review

Medistem, Inc. (MEDS) - Financial and Strategic Analysis Review / / Summary / / Medistem, Inc. (Medistem) is a research focused
2010 125,00$

Swiss Medica, Inc. (SWME) - Financial and Strategic Analysis Review

Swiss Medica, Inc. (SWME) - Financial and Strategic Analysis Review / / Summary / / Swiss Medica, Inc. (Swiss Medica) is a speci
2010 125,00$

VasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis Review

VasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis Review / / Summary / / VasoActive Pharmaceuticals, I
2010 125,00$

AURELIUS AG (AR4) - Financial and Strategic Analysis Review

AURELIUS AG (AR4) - Financial and Strategic Analysis Review / / Summary / / Aurelius AG (Aurelius) is a private equity firm that
2010 125,00$

BackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis Review

BackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis Review / / Summary / / BackWeb Technologies Ltd. (BackWeb)
2010 125,00$

Healthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis Review

Healthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis Review / / Summary / / Healthcare Providers Direct,
2010 125,00$

Immunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis Review

Immunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis Review / / Summary / / Immunotech Laboratories, Inc. (Im
2010 125,00$

SSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis Review

SSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis Review / / Summary / / SSI Surgical Services, Inc. (SSI) i
2010 125,00$

RX for Africa, Inc. (RXAF) - Financial and Strategic Analysis Review

RX for Africa, Inc. (RXAF) - Financial and Strategic Analysis Review / / Summary / / RX for Africa, Inc. (RXoA) is an investment
2010 125,00$

Landela Pharmaceutical (RXEI) - Financial and Strategic Analysis Review

Landela Pharmaceutical (RXEI) - Financial and Strategic Analysis Review / / Summary / / Landela Pharmaceutical (Landela) is a ph
2010 125,00$

Omni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis Review

Omni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis Review / / Summary / / Omni Medical Holdings Inc. (Omni) i
2010 125,00$

The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis Review

The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis Review / / Summary / / The Arab Pharmac
2010 125,00$

Select Medical Holdings Corporation (SEM) - Financial and Strategic Analysis Review

Select Medical Holdings Corporation (SEM) - Financial and Strategic Analysis Review / / Summary / / Select Medical Holdings Corp
2010 125,00$

Optigenex Inc. (OPGX) - Financial and Strategic Analysis Review

Optigenex Inc. (OPGX) - Financial and Strategic Analysis Review / / Summary / / Optigenex Inc. (Optigenex) is an applied life sc
2010 125,00$

Biosynergy, Inc. (BSYN) - Financial and Strategic Analysis Review

Biosynergy, Inc. (BSYN) - Financial and Strategic Analysis Review / / Summary / / Biosynergy, Inc.(Biosynergy) is publicly held
2010 125,00$

Impreglon AG (I3M) - Financial and Strategic Analysis Review

Impreglon AG (I3M) - Financial and Strategic Analysis Review / / Summary / / Impreglon AG (Impreglon) is a technology based comp
2010 250,00$

Henley Healthcare, Inc. (HENL) - Financial and Strategic Analysis Review

Henley Healthcare, Inc. (HENL) - Financial and Strategic Analysis Review / / Summary / / Henley Healthcare, Inc. (Henley), forme
2010 125,00$

Auriga International SA (AURI) - Financial and Strategic Analysis Review

Auriga International SA (AURI) - Financial and Strategic Analysis Review / / Summary / / Auriga International S.A. (Auriga) is a
2010 125,00$

Easton Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis Review

Easton Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis Review / / Summary / / Easton Pharmaceuticals Inc. (Easton
2010 125,00$

Larrea Biosciences Corp (LRRA) - Financial and Strategic Analysis Review

Larrea Biosciences Corp (LRRA) - Financial and Strategic Analysis Review / / Summary / / Larrea Biosciences Corp (Larrea Bioscie
2010 125,00$

Jordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis Review

Jordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis Review / / Summary / / Jordan Emirates Insurance Co P
2010 250,00$

Activar Technical Products Group (MGSR) - Financial and Strategic Analysis Review

Activar Technical Products Group (MGSR) - Financial and Strategic Analysis Review / / Summary / / Activar Technical Products Gro
2010 125,00$

China Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis Review

China Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis Review / / Summary / / China Bio-Immunity Corporation (
2010 125,00$

Orchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis Review

Orchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis Review / / Summary / / Orchestra Therapeutics, Inc. (OCHT
2010 125,00$

VitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis Review

VitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis Review / / Summary / / VitalCare Diabetes T
2010 250,00$

Xechem International, Inc (XKEMQ) - Financial and Strategic Analysis Review

Xechem International, Inc (XKEMQ) - Financial and Strategic Analysis Review / / Summary / / Xechem International, Inc. (Xechem)
2010 125,00$

GlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis Review

GlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis Review / / Summary / / GlycoGenesys, Inc. (formerly known as SafeS
2010 125,00$

Micro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis Review

Micro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis Review / / Summary / / Micro Laboratories, Inc. (Micro Lab) i
2010 125,00$

Argonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis Review

Argonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis Review / / Summary / / Argonaut Technologies, Inc. (Argona
2010 125,00$

Kaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis Review

Kaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis Review / / Summary / / Kaken Pharmaceutical Co., Ltd. (
2010 125,00$

Egis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis Review

Egis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis Review / / Summary / / Egis Gyogyszergyar Nyrt (Egis) is enga
2010 125,00$

Hillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis Review

Hillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis Review / / Summary / / Hillestad Pharmaceuticals Inc. (H
2010 125,00$

Xeno Transplants Corporation (XENO) - Financial and Strategic Analysis Review

Xeno Transplants Corporation (XENO) - Financial and Strategic Analysis Review / / Summary / / Xeno Transplants Corporation, (Xen
2010 125,00$

Integrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis Review

Integrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis Review / / Summary / / Integrated Pharmaceuticals, In
2010 125,00$

Naturade, Inc. (NRDCQ) - Financial and Strategic Analysis Review

Naturade, Inc. (NRDCQ) - Financial and Strategic Analysis Review / / Summary / / Naturade, Inc. (Naturade) markets scientificall
2010 125,00$

NanoRepro AG (NN6) - Financial and Strategic Analysis Review

NanoRepro AG (NN6) - Financial and Strategic Analysis Review / / Summary / / NanoRepro AG (NanoRepro), a pan-European company fo
2010 125,00$

Comprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis Review

Comprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis Review / / Summary / / Comprehensive Healthca
2010 125,00$

Maxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis Review

Maxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis Review / / Summary / / Maxicare Health Plans, Inc. (MHP) i
2010 125,00$

Mednax, Inc. (MD) - Financial and Strategic Analysis Review

Mednax, Inc. (MD) - Financial and Strategic Analysis Review / / Summary / / Mednax, Inc. (Mednax) is a publicly held healthcare
2010 125,00$

MedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis Review

MedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis Review / / Summary / / MedTech Holdings Limited (MedTech)
2010 125,00$

Union Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis Review

Union Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis Review / / Summary / / Union Dental Holdings, Inc. (Union
2010 125,00$

VivoMedica plc - Financial and Strategic Analysis Review

VivoMedica plc - Financial and Strategic Analysis Review / / Summary / / VivoMedica plc (VivoMedica) is engaged in research, dev
2010 250,00$

InMedica Development Corporation (IMDD) - Financial and Strategic Analysis Review

InMedica Development Corporation(IMDD) - Financial and Strategic Analysis Review / / Summary / / InMedica Development Corporatio
2010 250,00$

Lady Drug Store Co., Ltd. (3027) - Strategic Analysis Review

This comprehensive SWOT profile of Lady Drug Store Co., Ltd. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Familymeds Group Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Familymeds Group Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Skinwell Holdings Limited (SKW) - Strategic Analysis Review

This comprehensive SWOT profile of Skinwell Holdings Limited provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Actinogen LIMITED - Strategic Analysis Review

Actinogen Limited is a broad based biotechnology company engaged in the detection and isolation of soil actinomycetes found in Wes
2010 250,00$

Aevum Limited (AVE) - Strategic Analysis Review

Aevum Limited (Aveum) is principally engaged in the development, operation and management of retirement villages and aged care fac
2010 250,00$

Eyecare Partners Limited (EPL) - Strategic Analysis Review

Eyecare Partners Limited is healthcare company principally engaged in the operations of optometry practices providing optometric h
2010 250,00$

Helicon Group Limited - Strategic Analysis Review

Helicon Group Limited is a pharma company engaged in finding and providing oppopportunities for advanced western Biomedical produc
2010 250,00$

Assura Group Limited - Strategic Analysis Review

Assura Group Limited runs it business through 4 segments: Medical, Pharmacy, Property and Property Development. The medical depart
2010 125,00$

American Biogenetic Sciences, Inc. (MABAA) - Strategic Analysis Review

American Biogenetic Sciences, Inc. (ABS) is a biopharmaceutical company focused in researching, developing and marketing cardiovas
2010 250,00$

Anhui Fengyuan Pharmaceutical Co., Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Anhui Fengyuan Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the comp
2010 125,00$

Apeloa Company Limited (739) - Strategic Analysis Review

This comprehensive SWOT profile of Apeloa Company Limited provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

IDT Australia Limited (IDT) - Strategic Analysis Review

IDT Australia Limited (IDT), formerly Institute of Drug Technology Australia Limited, is an Australia-based pharmaceutical manufac
2010 250,00$

Kiotech International plc (KIO) - Strategic Analysis Review

Kiotech International Plc is principally engaged in the development and marketing of biochemical stimulants. The company's mainly
2010 250,00$

Life Therapeutics Limited (LFE) - Strategic Analysis Review

Life Therapeutics Limited (Life Therapeutics) is a biotechnology company engaged in providing therapeutics products and diagnostic
2010 250,00$

Lifebank Corp. (LBK) - Strategic Analysis Review

Lifebank Corp.(Lifebank) is a healthcare services company principally engaged in the business of processing and cryo-preservation
2010 250,00$

BioProspect Limited (BPO) - Strategic Analysis Review

BioProspect Limited, a brisbane based natural compound and product development company, engages in research and commercialization
2010 250,00$

National Research Corporation (NRCI) - Strategic Analysis Review

National Research Corporation is a healthcare company principally engaged in providing ongoing survey-based performance measuremen
2010 250,00$

OBJ LIMITED - Strategic Analysis Review

OBJ LIMITED is formed with the compabination of medical, scientific and commercial specialists to deliver medical technology solut
2010 125,00$

Clover Corporation Limited (CLV) - Strategic Analysis Review

This comprehensive SWOT profile of Clover Corporation Limited provides you an in-depth strategic analysis of the company’s busines
2010 125,00$

PEARL HEALTHCARE LIMITED (PHL) - Strategic Analysis Review

Pearl Healthcare Limited is an Australia-based company which is principally engaged in the management, acquisition, consolidation
2010 250,00$

Advanced Medical Institute Inc. (AVMD) - Strategic Analysis Review

This comprehensive SWOT profile of Advanced Medical Institute Inc. provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

NightHawk Radiology Holdings, Inc. (NHWK) - Strategic Analysis Review

This comprehensive SWOT profile of NightHawk Radiology Holdings, Inc. provides you an in-depth strategic analysis of the company’s
2010 250,00$

Setiba Participacoes SA (SETI3B) - Strategic Analysis Review

This comprehensive SWOT profile of Setiba Participacoes SA provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Krebs Biochemicals & Industries Ltd - Strategic Analysis Review

Krebs Biochemicals & Industries Limited is a pharmaceutical company engaged in the manufacture and sale of API. The company manufa
2010 250,00$

Insas Berhad (INSAS) - Strategic Analysis Review

This comprehensive SWOT profile of Insas Berhad provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

NuRx Pharmaceuticals Inc - Strategic Analysis Review

This comprehensive SWOT profile of NuRx Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesse
2010 125,00$

NL Industries, Inc. (NL) - Strategic Analysis Review

NL Industries, Inc. (NL Industries) is primarily a holding company that operates through its subsidiaries namely, CompX Internatio
2010 250,00$

Dimed S.A Distribuidora de Medicamentos (PNVL3) - Strategic Analysis Review

This comprehensive SWOT profile of Dimed S.A Distribuidora de Medicamentos provides you an in-depth strategic analysis of the comp
2010 250,00$

Soprocal, Calerias e Industrias S.A. (SOPROCAL) - Strategic Analysis Review

This comprehensive SWOT profile of Soprocal, Calerias e Industrias S.A. provides you an in-depth strategic analysis of the company
2010 250,00$

Arab Pharmaceuticals (ADCI) - Strategic Analysis Review

This comprehensive SWOT profile of Arab Pharmaceuticals provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Divis Laboratories Limited - Strategic Analysis Review

Divis Laboratories Limited (Divis), formerly known as Divi’s Research Center is a biotechnology company. It is engaged in the prod
2010 125,00$

Anand Electric Supply Company Limited (501630) - Strategic Analysis Review

This comprehensive SWOT profile of Anand Electric Supply Company Limited provides you an in-depth strategic analysis of the compan
2010 250,00$

Beijing SL Pharmaceutical Co., Ltd (2038) - Strategic Analysis Review

Beijing SL Pharmaceutical Co., Ltd (SL Pharm) is a biotechnology-pharmaceutical company, engaged in developing and marketing of ge
2010 250,00$

Adinath Bio-Labs Limited (590088) - Strategic Analysis Review

This comprehensive SWOT profile of Adinath Bio-Labs Limited provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Origio AS - Strategic Analysis Review

Origio A/S (Origio) operates through three companies, namely, MediCult, Humagen Fertility Diagnostics and MidAtlantic Diagnostics.
2010 250,00$

Huadong Medicine Co., Ltd. (963) - Strategic Analysis Review

Huadong Medicine Co., Ltd. is engaged in manufacture and sale of medical products. It provides provides Chinese medicine products,
2010 125,00$

GreaterChina Technology Group Limited (8032) - Strategic Analysis Review

This comprehensive SWOT profile of GreaterChina Technology Group Limited provides you an in-depth strategic analysis of the compan
2010 250,00$

Select Vaccines Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Select Vaccines Ltd. provides you an in-depth strategic analysis of the company’s businesses an
2010 125,00$

Dr. Reddy's Laboratories Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Dr. Reddy's Laboratories Ltd. provides you an in-depth strategic analysis of the company’s busi
2010 125,00$

I''rom Holdings Co. Ltd. (2372) - Strategic Analysis Review

This comprehensive SWOT profile of I''rom Holdings Co. Ltd. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Bafna Pharmaceuticals Limited - Strategic Analysis Review

This comprehensive SWOT profile of Bafna Pharmaceuticals Limited provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

Daebong LS Co., Ltd. (78140) - Strategic Analysis Review

This comprehensive SWOT profile of Daebong LS Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Bridgetech Holdings International, Inc. (BGTH) - Strategic Analysis Review

Bridgetech Holdings International, Inc. is an early-stage company focused primarily on the business of facilitating the transfer o
2010 250,00$

Vivimed Labs Ltd (532660) - Strategic Analysis Review

Vivimed Labs (Vivimed) is an publicly held India based pharma company. It is engaged in the manufacture of ingredients used in the
2010 125,00$

Chong Kun Dang Pharmaceutical - Strategic Analysis Review

Chong Kun Dang Pharmaceutical (CKD) is a Korean company, engaged in the manufacturing, distribution, import and export of pharmace
2010 125,00$

Five Star Quality Care, Inc - Strategic Analysis Review

FIVE STAR QUALITY CARE, INC. (FSQC) is basically a health care services company. It offers communities where it provides its guest
2010 250,00$

Metropolitan Ambulance Services - Strategic Analysis Review

Metropolitan Ambulance Service (MAS) is an Australia based emergency medical service provider. The company principally engaged in
2010 250,00$

Select Medical Corporation - Strategic Analysis Review

Select Medical Corporation (Select Medical) is a US based company which provides specialty health care services in the US. Select
2010 250,00$

Kaken Pharmaceutical Co.,Ltd. (4521) - Strategic Analysis Review

Kaken Pharmaceutical Co., Ltd. (Kaken Pharmaceutical) is a Japan based pharmaceutical company, which is engaged in the development
2010 125,00$

KARMELSONIX LIMITED (KSX) - Strategic Analysis Review

Karmel Sonix Limited (Karmel Sonix) is an Australian based company engaged in research, development and commercialization of medic
2010 125,00$

Medicago Inc. (MDG) - Strategic Analysis Review

Medicago Inc. (Medicago) is a publicly held Canada based biotechnology company. It is engaged in the development of vaccines based
2010 250,00$

Mesoblast Ltd (MSB) - Strategic Analysis Review

Mesoblast Limited is an Australian biotechnology company which is committed to the development of novel treatments for orthopaedic
2010 250,00$

Mednax, Inc - Strategic Analysis Review

Mednax, Inc (Mednax) is an US based health service provider. The company principally engages in providing of physician services wh
2010 250,00$

Biovet JSC (53B) - Strategic Analysis Review

BIOVET JSC (BIOVET) is a privately held biotechnology company that is engaged in the manufacture and marketing of medicated and n
2010 250,00$

Movetis NV (MOVE ) - Strategic Analysis Review

Movetis NV (Movetis) is a public traded pharmaceutical company engaged in the discovery, development and marketing of innovative d
2010 250,00$

Kiwa Bio-Tech Products Group Corporation (KWBT) - Strategic Analysis Review

Kiwa Bio-Tech Products Group Corporation (Kiwa Bio-Tech) develops, manufactures, distributes and markets environmentally safe bio-
2010 250,00$

Mach One Corporation (MNCN) - Strategic Analysis Review

Mach One Corporation (Mach One) is a veterinary services company that offers a variety of services ranging from improving the immu
2010 250,00$

CellSeed Inc. (7776) - Strategic Analysis Review

CellSeed Inc. (CellSeed) is a publicly held company that is engaged in developing, supplying and commercialization of cell culture
2010 250,00$

Cellmid Ltd (CDY) - Strategic Analysis Review

Cellmid Ltd (Cellmid) is a privately held biotechnology company. It is principally engaged in the development of therapeutic and d
2010 250,00$

London Pacific & Partners, Inc. (LDPP) - Strategic Analysis Review

London Pacific & Partners, Inc. (London Pacific) is engaged in providing various services in the health care, hospitality, and fin
2010 250,00$

ResCare, Inc (RSCR) - Strategic Analysis Review

ResCare, Inc (ResCare) is a healthcare services company involved in providing job training and educational supports to people disa
2010 250,00$

The Medipattern Corporation (MKI) - Strategic Analysis Review

The Medipattern Corporation (Medipattern) is a medical technology company specializing in computer-aided detection (CAD) solutions
2010 250,00$

Brain Resources Company Limited (The) - Strategic Analysis Review

This comprehensive SWOT profile of Brain Resources Company Limited (The) provides you an in-depth strategic analysis of the compan
2010 250,00$

Summer Infant, Inc. - Strategic Analysis Review

Summer Infant, Inc. is a consumer goods and baby care products manufacturing company. The company products includes nursery audio/
2010 250,00$

Allied Hearts Holdings Co., Ltd. - Strategic Analysis Review

Allied Hearts Holdings Co., Ltd. is a pharmaceutical products, cosmetics and miscellaneous daily goods retailer. It is also engage
2010 250,00$

BioScrip, Inc - Strategic Analysis Review

BioScrip, Inc. is a provider of specialty pharmaceutical and pharmacy benefit management (PBM) services in the United States. It o
2010 250,00$

China National Medicines Corp Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of China National Medicines Corp Ltd. provides you an in-depth strategic analysis of the company’s
2010 250,00$

Chongqing Tongjunge Co., Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Chongqing Tongjunge Co., Ltd. provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

CNTIC Trading Co. Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of CNTIC Trading Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Kirindo Co Ltd - Strategic Analysis Review

Kirindo Co., Ltd. a drug store chains and dispensing pharmacies company. It offers medical products, healthcare products, cosmetic
2010 250,00$

Medca Japan Co. Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Medca Japan Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Orpea SA - Strategic Analysis Review

This comprehensive SWOT profile of Orpea SA provides you an in-depth strategic analysis of the company’s businesses and operations
2010 250,00$

Dermisonics, Inc. (DMSI) - Financial and Strategic Analysis Review

Dermisonics, Inc. (DMSI) - Financial and Strategic Analysis Review / / Summary / / Dermisonics, Inc. (Dermisonics) is a drug del
2010 125,00$

DiaSys Corporation (DYXC) - Financial and Strategic Analysis Review

DiaSys Corporation (DYXC) - Financial and Strategic Analysis Review / / Summary / / DiaSys Corporation ( DiaSys ) is a medical d
2010 125,00$

Diomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis Review

Diomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis Review / / Summary / / Diomed Holdings, Inc. (Diomed) is engage
2010 125,00$

Immunicon Corporation (IMMCQ) - Financial and Strategic Analysis Review

Immunicon Corporation (IMMCQ) - Financial and Strategic Analysis Review / / Summary / / Immunicon Corporation (Immunicon) is eng
2010 125,00$

Medwave, Inc. (MDWV) - Financial and Strategic Analysis Review

Medwave, Inc. (MDWV) - Financial and Strategic Analysis Review / / Summary / / Medwave, Inc . ( Medwave ) is a medical devices c
2010 125,00$

Forticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis Review

Forticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis Review / / Summary / / Forticell Bioscience, Inc. ( Fortic
2010 125,00$

Cyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis Review

Cyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis Review / / Summary / / Cyberkinetics Neuro
2010 125,00$

CareCentric, Inc. (CREC) - Financial and Strategic Analysis Review

CareCentric, Inc. (CREC) - Financial and Strategic Analysis Review / / Summary / / CareCentric, Inc. (CareCentric) is engaged in
2010 125,00$

Planar Systems, Inc. (PLNR) - Financial and Strategic Analysis Review

Planar Systems, Inc. (PLNR) - Financial and Strategic Analysis Review / / Summary / / Planar Systems, Inc. (Planar Systems) is e
2010 125,00$

GRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis Review

GRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis Review / / Summary / / Grant Life Sciences, Inc. (GLS) is a
2010 125,00$

StatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis Review

StatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis Review / / Summary / / StatSure Diagnostic Systems,
2010 125,00$

DelSite, Inc. (CARN) - Financial and Strategic Analysis Review

DelSite, Inc. (CARN) - Financial and Strategic Analysis Review / / Summary / / DelSite, Inc. (DelSite) is a global provider of m
2010 125,00$

XTENT, Inc. (XTNT) - Financial and Strategic Analysis Review

XTENT, Inc. (XTNT) - Financial and Strategic Analysis Review / / Summary / / XTENT, Inc. (XTENT), a development stage medical de
2010 250,00$

Heart Tronics, Inc. (HRTT) - Financial and Strategic Analysis Review

Heart Tronics, Inc. (HRTT) - Financial and Strategic Analysis Review / / Summary / / Heart Tronics, Inc. (Heart Tronics), former
2010 125,00$

MedicalCV, Inc. (MCVI) - Financial and Strategic Analysis Review

MedicalCV, Inc. (MCVI) - Financial and Strategic Analysis Review / / Summary / / MedicalCV, Inc. (MedicalCV) is engaged in the d
2010 125,00$

Dmatek Ltd. (DTK) - Financial and Strategic Analysis Review

Dmatek Ltd. (DTK) - Financial and Strategic Analysis Review / / Summary / / Dmatek Ltd. (Dmatek) is principally engaged in the m
2010 125,00$

Advanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis Review

Advanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis Review / / Summary / / Advanced Refractive Tech
2010 125,00$

Obagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis Review

Obagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis Review / / Summary / / Obagi Medical Products, Inc. (Obag
2010 250,00$

Lancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis Review

Lancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis Review / / Summary / / Lancer Orthodontics, Inc. (Lancer Ort
2010 125,00$

Carpenter Technology Corporation (CRS) - Financial and Strategic Analysis Review

Carpenter Technology Corporation (CRS) - Financial and Strategic Analysis Review / / Summary / / Carpenter Technology Corporatio
2010 125,00$

QuadraMed Corporation (QDHC) - Financial and Strategic Analysis Review

QuadraMed Corporation (QDHC) - Financial and Strategic Analysis Review / / Summary / / Quadramed Corporation (Quadramed) is a pu
2010 125,00$

Telzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis Review

Telzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis Review / / Summary / / Telzuit Medical Technologies
2010 125,00$

Andover Medical, Inc. (ADOV) - Financial and Strategic Analysis Review

Andover Medical, Inc. (ADOV) - Financial and Strategic Analysis Review / / Summary / / Andover Medical, Inc. (AMI) is engaged in
2010 125,00$

Computerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis Review

Computerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis Review / / Summary / / Computerized Thermal Imaging
2010 125,00$

Exploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis Review

Exploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis Review / / Summary / / Exploit Technologies Pte Ltd (Expl
2010 125,00$

Nano Mask, Inc. (NANM) - Financial and Strategic Analysis Review

Nano Mask, Inc. (NANM) - Financial and Strategic Analysis Review / / Summary / / Nano Mask, Inc. (formerly known as Emergency Fi
2010 125,00$

E Med Future, Inc. (EMDF) - Financial and Strategic Analysis Review

E Med Future, Inc. (EMDF) - Financial and Strategic Analysis Review / / Summary / / E Med Future, Inc. (E Med Future) is engaged
2010 125,00$

Refocus Group, Inc. (RFCS) - Financial and Strategic Analysis Review

Refocus Group, Inc. (RFCS) - Financial and Strategic Analysis Review / / Summary / / Refocus Group, Inc. is a medical device com
2010 125,00$

Banyan International Corp. (BNYN) - Financial and Strategic Analysis Review

Banyan International Corp. (BNYN) - Financial and Strategic Analysis Review / / Summary / / Banyan International Corp. (Banyan I
2010 125,00$

ReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis Review

ReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis Review / / Summary / / ReGen Biologics, Inc. (ReGen) is a public
2010 250,00$

ATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis Review

ATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis Review / / Summary / / ATS Automation Tooling Syste
2010 250,00$

CSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis Review

CSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis Review / / Summary / / CSMG Technologies, Inc. (CSMG Technolog
2010 125,00$

Celera Corporation (CRA) - Financial and Strategic Analysis Review

Celera Corporation (CRA) - Financial and Strategic Analysis Review / / Summary / / Celera Corporation (Celera) is a publicly hel
2010 125,00$

Abviva, Inc. (ABVV) - Financial and Strategic Analysis Review

Abviva, Inc. (ABVV) - Financial and Strategic Analysis Review / / Summary / / Abviva, Inc. (Abviva) is a biomedical company enga
2010 125,00$

PreMD Inc. (PMD) - Financial and Strategic Analysis Review

PreMD Inc. (PMD) - Financial and Strategic Analysis Review / / Summary / / PreMD Inc. (PreMD) a medical device company that is p
2010 125,00$

DNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis Review

DNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis Review / / Summary / / DNAPrint Genomics, Inc. (DNAPrint Genom
2010 125,00$

Immunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis Review

Immunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis Review / / Summary / / Immunodiagnostic Systems H
2010 125,00$

Central Uni Co Ltd (7706) - Financial and Strategic Analysis Review

Central Uni Co Ltd (7706) - Financial and Strategic Analysis Review / / Summary / / Central Uni Co., Ltd. (C&U) is engaged in de
2010 250,00$

Pace Medical, Inc. (PMDL) - Financial and Strategic Analysis Review

Pace Medical, Inc. (PMDL) - Financial and Strategic Analysis Review / / Summary / / Pace Medical, Inc. is a medical device compa
2010 125,00$

Pacific Safety Products Inc (PSP) - Financial and Strategic Analysis Review

Pacific Safety Products Inc (PSP) - Financial and Strategic Analysis Review / / Summary / / Pacific Safety Products Inc. (Pacifi
2010 250,00$

Simrad Optronics Asa (SIT) - Financial and Strategic Analysis Review

Simrad Optronics Asa (SIT) - Financial and Strategic Analysis Review / / Summary / / Simrad Optronics ASA is one of the leading
2010 250,00$

Universal Technology Systems Inc (5206) - Financial and Strategic Analysis Review

Universal Technology Systems Inc (5206) - Financial and Strategic Analysis Review / / Summary / / Universal Technology Systems I
2010 125,00$

Telanetix Inc. (TNXI) - Financial and Strategic Analysis Review

Telanetix Inc. (TNXI) - Financial and Strategic Analysis Review / / Summary / / Telanetix Inc. is a communications solutions pro
2010 250,00$

Nuance Communications, Inc. (NUAN) - Financial and Strategic Analysis Review

Nuance Communications, Inc. (NUAN) - Financial and Strategic Analysis Review / / Summary / / Nuance Communications, Inc. (Nuance
2010 125,00$

ALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis Review

ALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis Review / / Summary / / ALAPIS S.A. (ALAPIS) is a US based pharmaceutical
2010 250,00$

Dialysis Corporation of America (DCAI) - Financial and Strategic Analysis Review

Dialysis Corporation of America (DCAI) - Financial and Strategic Analysis Review / / Summary / / Dialysis Corporation of America
2010 250,00$

RCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis Review

RCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis Review / / Summary / / RCM Technologies, Inc. (RCM) is a US bas
2010 125,00$

Cimatron Ltd. (CIMT) - Financial and Strategic Analysis Review

Cimatron Ltd. (CIMT) - Financial and Strategic Analysis Review / / Summary / / Cimatron Ltd. (Cimatron) is a software tools prov
2010 125,00$

The Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis Review

The Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis Review / / Summary / / The Quantum Group, Inc. (Quantum) is a
2010 250,00$

IMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis Review

IMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis Review / / Summary / / IMPATH Bankruptcy Liquidat
2010 125,00$

Univec, Inc. (UNVC) - Financial and Strategic Analysis Review

Univec, Inc. (UNVC) - Financial and Strategic Analysis Review / / Summary / / Univec, Inc. (Univec) is a publicly held pharmaceu
2010 125,00$

Clean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis Review

Clean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis Review / / Summary / / Clean Diesel Technologies, Inc.
2010 250,00$

Curon Medical, Inc. (CRNM) - Financial and Strategic Analysis Review

Curon Medical, Inc. (CRNM) - Financial and Strategic Analysis Review / / Summary / / Curon Medical, Inc. (Curon) is a publicly h
2010 125,00$

Aksys, Ltd. (AKSY) - Financial and Strategic Analysis Review

Aksys, Ltd. (AKSY) - Financial and Strategic Analysis Review / / Summary / / Aksys, Ltd., (Aksys) is a publicly held pharmaceuti
2010 125,00$

Ardana Plc (ARA) - Financial and Strategic Analysis Review

Ardana Plc (ARA) - Financial and Strategic Analysis Review / / Summary / / Ardana Plc (Ardana) is a publicly held UK based pharm
2010 125,00$

Arterium Corporation (KMED) - Financial and Strategic Analysis Review

Arterium Corporation (KMED) - Financial and Strategic Analysis Review / / Summary / / Arterium Corporation (Arterium) is a publi
2010 125,00$

Panacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis Review

Panacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis Review / / Summary / / Panacos Pharmaceuticals, Inc. (Pa
2010 125,00$

Rad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis Review

Rad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis Review / / Summary / / Rad Source Technologies, Inc (Rad
2010 125,00$

Synvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis Review

Synvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis Review / / Summary / / Synvista Therapeutics, Inc. (Synvis
2010 125,00$

Extendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis Review

Extendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis Review / / Summary / / Extendicare Real Est
2010 125,00$

Life Sciences Research, Inc. (LSR) - Financial and Strategic Analysis Review

Life Sciences Research, Inc. (LSR) - Financial and Strategic Analysis Review / / Summary / / Life Sciences Research, Inc. (Life
2010 125,00$

PLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis Review

PLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis Review / / Summary / / PLIVA d.d.( PLIVA), is a joint stock company, wh
2010 125,00$

Symbion Health Limited (SYHTY) - Financial and Strategic Analysis Review

Symbion Health Limited (SYHTY) - Financial and Strategic Analysis Review / / Summary / / Symbion Health Limited (Symbion Health)
2010 125,00$

Tapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis Review

Tapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis Review / / Summary / / Tapestry Pharmaceuticals, Inc.,
2010 125,00$

GelStat Corporation (GSAC) - Financial and Strategic Analysis Review

GelStat Corporation (GSAC) - Financial and Strategic Analysis Review / / Summary / / GelStat Corporation (GelStat) is a publicly
2010 125,00$

Genitope Corporation (GTOP) - Financial and Strategic Analysis Review

Genitope Corporation (GTOP) - Financial and Strategic Analysis Review / / Summary / / Genitope Corporation (Genitope) is a publi
2010 125,00$

ICSGlobal Limited (ICS) - Financial and Strategic Analysis Review

ICSGlobal Limited (ICS) - Financial and Strategic Analysis Review / / Summary / / ICSGlobal Limited (ICSGlobal) is a medical ban
2010 125,00$

AVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis Review

AVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis Review / / Summary / / AVAX Technologies, Inc. (AVAX) is a pub
2010 125,00$

Medical Therapies Limited (CDY) - Financial and Strategic Analysis Review

Medical Therapies Limited (CDY) - Financial and Strategic Analysis Review / / Summary / / Medical Therapies Limited (Medical The
2010 250,00$

MediSolution Ltd. (MSH) - Financial and Strategic Analysis Review

MediSolution Ltd. (MSH) - Financial and Strategic Analysis Review / / Summary / / MediSolution Ltd. is a healthcare and public s
2010 125,00$

BioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis Review

BioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis Review / / Summary / / BioForce Nanosciences Hold
2010 125,00$

MIGENIX Inc. (MGI) - Financial and Strategic Analysis Review

MIGENIX Inc. (MGI) - Financial and Strategic Analysis Review / / Summary / / MIGENIX Inc. (MIGENIX) is a publicly held bio-pharm
2010 125,00$

Chemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis Review

Chemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis Review / / Summary / / Chemokine Therapeutics Corp. (Chemo
2010 125,00$

Peplin, Inc. (PLI) - Financial and Strategic Analysis Review

Peplin, Inc. (PLI) - Financial and Strategic Analysis Review / / Summary / / Peplin, Inc. (Peplin) is a pharmaceutical company p
2010 250,00$

VioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis Review

VioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis Review / / Summary / / VioQuest Pharmaceuticals is a pu
2010 125,00$

ACI Global Corp. (ACGJ) - Financial and Strategic Analysis Review

ACI Global Corp. (ACGJ) - Financial and Strategic Analysis Review / / Summary / / ACI Global Corp. (ACI Global) is a publicly he
2010 125,00$

ADL plc (AD.) - Financial and Strategic Analysis Review

ADL plc (AD.) - Financial and Strategic Analysis Review / / Summary / / ADL plc (ADL) is a publicly held UK based company, that
2010 250,00$

PharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis Review

PharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis Review / / Summary / / PharmaNet Development Group In
2010 125,00$

Davi Skin, Inc. (DAVN) - Financial and Strategic Analysis Review

Davi Skin, Inc. (DAVN) - Financial and Strategic Analysis Review / / Summary / / Davi Skin, Inc. (Davi Skin) is a publicly held
2010 125,00$

ATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis Review

ATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis Review / / Summary / / ATC Healthcare Services Inc. (ATC)
2010 125,00$

Nanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis Review

Nanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis Review / / Summary / / Nanobac Pharmaceuticals, Inc (Nan
2010 125,00$

Orthometrix, Inc. (OMRX) - Financial and Strategic Analysis Review

Orthometrix, Inc. (OMRX) - Financial and Strategic Analysis Review / / Summary / / Orthometrix, Inc. (Orthometrix) is a pharmace
2010 125,00$

Diapulse Corporation of America (DIAC) - Financial and Strategic Analysis Review

Diapulse Corporation of America (DIAC) - Financial and Strategic Analysis Review / / Summary / / Diapulse Corporation of America
2010 125,00$

Herborium Group, Inc. (HBRM) - Financial and Strategic Analysis Review

Herborium Group, Inc. (HBRM) - Financial and Strategic Analysis Review / / Summary / / Herborium Group, Inc. (Herborium) is a no
2010 125,00$

DOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis Review

DOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis Review / / Summary / / DOV Pharmaceutical, Inc. (DOV) is a ph
2010 125,00$

PainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis Review

PainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis Review / / Summary / / PainCare Holdings, Inc. (PainCare), is
2010 125,00$

Chongkundang Corp. (1630) - Financial and Strategic Analysis Review

Chongkundang Corp. (1630) - Financial and Strategic Analysis Review / / Summary / / Chong Kun Dang Pharmaceutical Corp. (Chong K
2010 125,00$

New York Health Care, Inc. (BBAL) - Financial and Strategic Analysis Review

New York Health Care, Inc. (BBAL) - Financial and Strategic Analysis Review / / Summary / / wNew York Health Care, Inc. (New Yor
2010 125,00$

ICP Biotechnology Limited (BIO) - Financial and Strategic Analysis Review

ICP Biotechnology Limited (BIO) - Financial and Strategic Analysis Review / / Summary / / ICP Biotechnology Limited (ICP) is a b
2010 125,00$

Entelos, Inc. (ENTL) - Financial and Strategic Analysis Review

Entelos, Inc. (ENTL) - Financial and Strategic Analysis Review / / Summary / / Entelos, Inc. (Entelos) is the US based life scie
2010 125,00$

Pharco SA (PHAR) - Financial and Strategic Analysis Review

Pharco SA (PHAR) - Financial and Strategic Analysis Review / / Summary / / Pharco SA (Pharco) is principally engaged in the area
2010 125,00$

CAPS Holdings Limited (CAPS) - Financial and Strategic Analysis Review

CAPS Holdings Limited (CAPS) - Financial and Strategic Analysis Review / / Summary / / CAPS Holdings Limited (CAPS) is one of Af
2010 125,00$

COLTENE Holding AG (CLTN) - Financial and Strategic Analysis Review

COLTENE Holding AG (CLTN) - Financial and Strategic Analysis Review / / Summary / / COLTENE Holding AG (COLTENE) is specialized
2010 250,00$

BioXell S.p.A. (BXLN) - Financial and Strategic Analysis Review

BioXell S.p.A. (BXLN) - Financial and Strategic Analysis Review / / Summary / / BioXell S.p.A. is a biopharmaceutical company fo
2010 125,00$

Curidium Medica plc (CUR) - Financial and Strategic Analysis Review

Curidium Medica plc (CUR) - Financial and Strategic Analysis Review / / Summary / / Curidium Medica plc (Curidium) is a personal
2010 125,00$

Eternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis Review

Eternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis Review / / Summary / / Eternal Technologies Group, In
2010 125,00$

Genex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis Review

Genex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis Review / / Summary / / Genex Pharmaceutical, Inc. (Genex Ph
2010 125,00$

Sinobiomed, Inc. (SOBM) - Financial and Strategic Analysis Review

Sinobiomed, Inc. (SOBM) - Financial and Strategic Analysis Review / / Summary / / Sinobiomed, Inc. (Sinobiomed) is a biotechnolo
2010 125,00$

Pacer Health Corporation (PHLH) - Financial and Strategic Analysis Review

Pacer Health Corporation (PHLH) - Financial and Strategic Analysis Review / / Summary / / Pacer Health Corporation (Pacer Health
2010 125,00$

PharmaFarm SA (NAFA) - Financial and Strategic Analysis Review

PharmaFarm SA (NAFA) - Financial and Strategic Analysis Review / / Summary / / PharmaFarm SA is a pharmaceutical distribution co
2010 125,00$

Global Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis Review

Global Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis Review / / Summary / / Global Pharmatech, Inc. (Global Pharmat
2010 125,00$

ER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis Review

ER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis Review / / Summary / / ER Urgent Care Holdings, Inc. (ER
2010 125,00$

Skin Health Spa PLC (SHS) - Financial and Strategic Analysis Review

Skin Health Spa PLC (SHS) - Financial and Strategic Analysis Review / / Summary / / Skin Health Spa PLC (Skin Health Spa) is an
2010 125,00$

Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review

Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review / / Summary / / Accura Animal Health Plc (Accura) is a
2010 250,00$

The Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis Review

The Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis Review / / Summary / / The Avicena Group, Inc. (Avicena) is a
2010 125,00$

Global Advanced Wound Management: Market Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Global Advanced Wound Management: Market Analysis and Opportunity Assessment” report is an essen
2009 3.500,00$

Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Global Endoscopes Equipment Pipeline Analysis, Opportunity Assessment an
2010 3.500,00$

Global Hospital Information Systems (HIS) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Global Hospital Information Systems (HIS) Opportunity Assessment, Compet
2010 3.500,00$

Medtronic to Acquire ATS Medical

Introduction / / Medtronic, Inc., a medical device company, signed a definitive agreement to acquire ATS Medical, Inc., a cardiov
2010 500,00$

Brazil Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Cardiovascular Devices Market Outlook to 2016” provides key marke
2010 2.500,00$

Mexico Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Cardiovascular Devices Market Outlook to 2016” provides key marke
2010 2.500,00$

Israel Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Cardiovascular Devices Market Outlook to 2016” provides key marke
2010 2.500,00$

United States Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “US Diagnostic Imaging Market Outlook to 2016” provides key market data o
2010 2.500,00$

China Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Canada Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Italy Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Brazil Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Netherlands Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Diagnostic Imaging Market Outlook to 2016” provides key mark
2010 2.500,00$

Mexico Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Taiwan Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving Growth

Introduction / / GlobalData’s report, “The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving Growt
2010 500,00$

Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed Expected to Expand Market for Insulin Pump Therapy

Introduction / / Insulet is a start up company in the insulin delivery market. The company’s product, the Omnipod, which is a dis
2010 500,00$

Canada Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Germany Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Germany Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Spain Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Spain Cardiovascular Devices Market Outlook to 2016” provides key market data on the S
2010 2.500,00$

Netherlands Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Netherlands Cardiovascular Devices Market Outlook to 2016” provides key market data on
2010 2.500,00$

Belgium Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Belgium Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

South Africa Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “South Africa Cardiovascular Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

United Kingdom Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “The UK Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Japan Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan Cardiovascular Devices Market Outlook to 2016” provides key market data on the J
2010 2.500,00$

United States Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “US Diabetes Care Devices Market Outlook to 2016” provides key market data on the US di
2010 2.500,00$

United States Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “US Cardiovascular Devices Market Outlook to 2016” provides key market data on the US c
2010 2.500,00$

Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010” report is an ess
2010 1.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - May 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – May 2010” report is an esse
2010 1.000,00$

Vacuum Assisted Breast Biopsy Systems: A Market Snapshot

Introduction / / GlobalData’s report, “Vacuum Assisted Breast Biopsy Systems: A Market Snapshot” provides key data, information a
2010 500,00$

Healthcare Reform: Impact on Medical Device Industry

Introduction / / GlobalData’s report, “Healthcare Reform: Impact on Medical Device Industry” provides key insights, information a
2010 500,00$

European Union (EU) Medical Device Directive (MDD) Changes: Industry Impact Analysis

Introduction / / Medical devices are primarily used for a physical effect on the body and are overseen by regulatory systems for
2010 500,00$

Arteriotomy Closure Devices: A Market Snapshot

Introduction / / GlobalData’s report, “Arteriotomy Closure Devices: A Market Snapshot” provides key data, information and analysi
2010 500,00$

Platelet Rich Plasma: A Market Snapshot

Introduction / / GlobalData’s report, “Platelet Rich Plasma (PRP): Market Snapshot” provides key data, information on the US plat
2010 500,00$

Rigid Video Laryngoscopes: A Market Snapshot

Introduction / / GlobalData’s report, “Rigid Video Laryngoscopes: A Market Snapshot” provides key data, information and analysis
2010 500,00$

Israel Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Israel Patient Monitoring Market Outlook to 2016” provides key m
2010 2.500,00$

France Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “France Cardiovascular Devices Market Outlook to 2016” provides k
2010 2.500,00$

Italy Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Italy Cardiovascular Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Australia Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Australia Cardiovascular Devices Market Outlook to 2016” provide
2010 2.500,00$

Argentina Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Argentina Cardiovascular Devices Market Outlook to 2016” provide
2010 2.500,00$

Republic of Korea Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Republic of Korea Cardiovascular Devices Market Outlook to 2016”
2010 2.500,00$

Taiwan Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Taiwan Cardiovascular Devices Market Outlook to 2016” provides k
2010 2.500,00$

India Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “India Cardiovascular Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Spain Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Spain Diabetes Care Devices Market Outlook to 2016” provides key
2010 2.500,00$

Argentina Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Argentina Diabetes Care Devices Market Outlook to 2016” provides
2010 2.500,00$

Israel Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Israel Diabetes Care Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecas
2010 3.500,00$

Angiotech Pharma Acquires Product Candidates and Technology Assets from Haemacure Corporation

Introduction / / Angiotech Pharmaceuticals, Inc. a specialty pharmaceutical and medical device company, announced the closing o
2010 500,00$

United Kingdom Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData's medical equipment offering - “The UK Diabetes Care Devices Market Outlook to 2016” provides key m
2010 2.500,00$

Canada Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Canada Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

Germany Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Germany Diabetes Care Devices Market Outlook to 2016” provides key m
2010 2.500,00$

France Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “France Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

Italy Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Italy Diabetes Care Devices Market Outlook to 2016” provides key mar
2010 2.500,00$

Australia Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Australia Diabetes Care Devices Market Outlook to 2016” provides key
2010 2.500,00$

Brazil Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Brazil Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

Netherlands Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Netherlands Diabetes Care Devices Market Outlook to 2016” provides k
2010 2.500,00$

Belgium Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Belgium Diabetes Care Devices Market Outlook to 2016” provides key m
2010 2.500,00$

Mexico Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Mexico Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

South Africa Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “South Africa Diabetes Care Devices Market Outlook to 2016” provides
2010 2.500,00$

Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData has released a pharmaceutical and healthcare report, “hepatitis C – Drug Pipeline Analysis and Mark
2010 2.000,00$

Germany Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Belgium Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Republic of Korea Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Taiwan Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

South Africa Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Japan Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

India Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

China Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

Republic of Korea Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

Taiwan Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

Canada Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada Patient Monitoring Market Outlook to 2016” provides key market data on the Ca
2010 2.500,00$

France Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “France Patient Monitoring Market Outlook to 2016” provides key market data on the Fr
2010 2.500,00$

Italy Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Italy Patient Monitoring Market Outlook to 2016” provides key market data on the Ita
2010 2.500,00$

Australia Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia Patient Monitoring Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Brazil Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Brazil Patient Monitoring Market Outlook to 2016” provides key market data on the Br
2010 2.500,00$

Netherlands Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Netherlands Patient Monitoring Market Outlook to 2016” provides key market data on t
2010 2.500,00$

Argentina Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Argentina Patient Monitoring Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Mexico Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Mexico Patient Monitoring Market Outlook to 2016” provides key market data on the Me
2010 2.500,00$

Healthcare Information and Management Systems Society (HIMSS) 2010 - Conference Review and Analysis

Introduction / / GlobalData’s “Healthcare Information and Management Systems Society (HIMSS) 2010: Conference Review and Analys
2010 1.000,00$

United Kingdom Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “The UK Patient Monitoring Market Outlook to 2016” provides key market data on the Un
2010 2.500,00$

Japan Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan Patient Monitoring Market Outlook to 2016” provides key market data on the Jap
2010 2.500,00$

India Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “India Patient Monitoring Market Outlook to 2016” provides key market data on the Ind
2010 2.500,00$

China Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “China Patient Monitoring Market Outlook to 2016” provides key market data on the Chi
2010 2.500,00$

Global Orthopedic Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies

Introduction / / While the leading orthopedic device manufacturers continue to be impacted by economic and regulatory challenge
2010 3.500,00$

Hepatitis B - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData\'s report, “Hepatitis B – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential sour
2010 2.000,00$

Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016”, provides an essentia
2010 2.000,00$

Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market
2010 3.500,00$

American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and Analysis

Introduction / / GlobalData’s “American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and Analysis” report is a
2010 1.000,00$

HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016

Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016. / Geographies covered in th
2010 2.000,00$

E. I. du Pont de Nemours and Company (DD) SWOT Profile

E. I. du Pont de Nemours and Company (DD) SWOT Profile / / Summary / / GlobalData’s E. I. du Pont de Nemours and Company (DD) SW
2010 150,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – April 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – April 2010” report is an e
2010 1.000,00$

Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Liver Cancer - Drug Pipeline Analysis and Market F
2010 2.000,00$

Cyanoacrylates Tissue Adhesives - A Market Snapshot

Introduction / / GlobalData’s report, “Cyanoacrylates Tissue Adhesives: A Market Snapshot” provides key data, information and a
2010 500,00$

Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Gastroesophageal Reflux Disease (GERD) – Drug Pipe
2010 2.000,00$

Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Polycystic Ovarian Syndrome– Drug Pipeline Analysi
2010 2.000,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - March 2010

Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – March 2010” report is an es
2010 1.000,00$

Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report on the pharmaceutical and healthcare industry - “Huntington’s disease – Drug Pipeline Analys
2010 2.000,00$

Global Spinal Surgery Devices: Market Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Global Spinal Surgery Devices: Market Analysis and Opportunity Assessment report is an essential s
2009 3.500,00$

Healthcare IT: A Market Poised for Strong Growth in the Future

Introduction / / GlobalData’s report, “Healthcare IT: A Market Poised for Strong Growth in the Future” provides key data, informa
2010 500,00$

Investment Opportunities in the Medical Devices Sector

Introduction / / GlobalData’s report, “Investment Opportunities in the Medical Device Sector” provides key insights, information
2010 500,00$

Sterilization Wraps: A Market Snapshot

Introduction / / GlobalData’s report, “Sterilization Wraps: A Market Snapshot” provides key data, information and analysis on the
2010 500,00$

Meningitis - Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Meningitis – Pipeline Analysis and Market Forecasts to 2016” is an essential source of inf
2010 2.000,00$

Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Amyotrophic lateral sclerosis (Lou Gehrigs) - Drug Pipeline Analysis and Market Forecasts
2010 2.000,00$

Medical Equipment Annual Deals Analysis 2010

Introduction / / "GlobalData's “Medical Equipment Annual Deals Analysis 2010” report is an essential source of data and trend ana
2010 3.500,00$

Medical Equipment Monthly Deals Analysis - February 2010

Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – February 2010” report is an essential source of data a
2010 1.000,00$

Asian Oil Companies Looking To Capitalize On the Opportunity in the Canadian Oil Sands Industry

Introduction / / The decline in oil reserves worldwide is challenging oil and gas companies to seek new fields in order to mainta
2010 500,00$

Medical Equipment Quarterly Deals Analysis Q4 2009

Introduction / / GlobalData's “Medical Equipment Quarterly Deal Analysis Q4 2009” report is an essential source of data and tre
2010 1.500,00$

Dyslipidemia - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Dyslipidemia - Drug Pipeline Analysis and Market F
2010 2.000,00$

Pulmonary Arterial Hypertension (PAH) - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Pulmonary Arterial Hypertension (PAH) - Drug Pipel
2010 2.000,00$

Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Anti-Hypertension - Drug Pipeline Analysis and Mar
2010 2.000,00$

Autism - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Autism - Drug Pipeline Analysis and Market Forecas
2010 2.000,00$

Bone Morphogenic Proteins: Future Therapeutic Applications

Introduction / / Stimulating the human body to generate and repair bone, reliably and quickly has been one of the greatest challe
2010 500,00$

Diagnostic Imaging in Developing Economies: A Closer Look at Accessibility

Introduction / / Patient access to diagnostic imaging in emerging economies varies across different economic regions within the s
2010 500,00$

Global Cardiovascular Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies

Introduction / / While the leading cardiovascular device manufacturers continue to be impacted by economic and regulatory challen
2010 2.000,00$

Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register High Growth in the Future

Introduction / / GlobalData’s new report, “Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register
2010 3.500,00$

Global Peritoneal Dialysis Market: Strategic Analysis and Opportunity Assessment

The report provides market size data and information on the global peritoneal dialysis market. / - Annualized market revenues data
2010 3.500,00$

US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015

Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Hip
2009 3.500,00$

UK Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “UK Orthopedic Devices Market Analysis and Forecasts to 2015” report provides key data, information
2010 3.500,00$

Medical Equipment Monthly Deals Analysis – January 2010

Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – January 2010” report is an essential source of data an
2010 1.000,00$

US Computed Tomography (CT) Systems Market: Strategic Analysis and Opportunity Assessment to 2015

Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Comp
2009 3.500,00$

Europe Nuclear Imaging Equipment: Market Analysis and Opportunity Assessment

Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “Europe
2009 3.500,00$

Flexible Endoscope Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Flexible Endoscope Pipeline Technology and Market Forecasts to 2015” report is an essential source
2009 2.000,00$

US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand

Introduction / / GlobalData’s “US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand” report is an essential sou
2009 3.500,00$

Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Europe Picture Archiving and Communication Systems (PACS) Market: Increasing Adoption to Drive Gro
2009 3.500,00$

Contrast Media: A Market Snapshot

Introduction / / The global contrast media market was valued at $5.4 billion in 2008, and is expected to grow to $7.9 billion in
2009 500,00$

Small Medium Enterprises: The Powerhouse of Innovation for Medical Device Industry

Introduction / / Rapid innovation is a pre-condition for survival of medical device companies, given the quick turnaround time of
2009 500,00$

Trocars: A Market Snapshot

Introduction / / The global market for trocars was valued at $800m in 2008. Increasing use of trocars in laparoscopic surgeries i
2009 500,00$

The US Cardiac Resynchronization Therapy Market: Positive Clinical Trial Results to Boost Growth

Introduction / / Cardiac Resynchronization Therapy (CRT) devices have been studied clinically since 1998, and have been on the US
2009 500,00$

The US Neurology Devices Market to Present Opportunities for Growth

Introduction / / Some of the major markets like cardiovascular and orthopedic devices have witnessed immense innovation over the
2009 500,00$

Australia Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Australia Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, infor
2009 3.500,00$

Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Anesthesia
2009 4.000,00$

Global Cardiovascular Devices Market Analysis & Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Cardiovasc
2009 4.000,00$

Global Dental Devices Market Analysis and Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global dental dev
2009 4.000,00$

Global Orthopedic Devices Market Analysis & Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Orthopedic
2009 4.000,00$

Global Wound Care Management Market Analysis and Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Wound Care
2009 4.000,00$

Brazil Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Brazil Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informat
2009 3.500,00$

US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place

Introduction / / GlobalData’s “US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place” report is an essent
2009 3.500,00$

India Ultrasound Systems Market: Strategic Market Analysis and Insight

Introduction / / GlobalData’s “India Ultrasound Systems Market: Strategic Market Analysis and Insight” report is an essential sou
2009 3.500,00$

Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016

Introduction / / GlobalData’s “Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016” report is an essential
2009 2.000,00$

Medical Equipment Monthly Deals Analysis – December 2009

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – December 2009 ” report is an essential source of data a
2009 1.000,00$

US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth

Introduction / / GlobalData’s “US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth” report is an essential
2009 3.500,00$

Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016

Introduction / / GlobalData’s “Negative Pressure Wound Therapy (NPWT)Pipeline Technology and Market Forecasts to 2016” report i
2009 2.000,00$

23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review and Analysis

Introduction / / GlobalData’s “23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review a
2009 1.000,00$

Glucose Monitoring Systems Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Glucose monitoring systems Pipeline Technology and Market Forecasts to 2015” report is an essentia
2009 2.000,00$

Attention Deficit Hyperactivity Disorder (ADHD) - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Attention Deficit Hyperactivity Disorder – Drug Pipe
2009 2.000,00$

Major Depressive Disorder (MDD) - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Major Depressive Disorder – Drug Pipeline Analysis a
2009 2.000,00$

Crohn's Disease - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Crohn’s Disease – Drug Pipeline Analysis and Marke
2009 2.000,00$

Alzheimer’s Disease - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Alzheimer’s Disease – Drug Pipeline Analysis and Mar
2009 2.000,00$

Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Parkinson’s Disease – Drug Pipeline Analysis and Mar
2009 2.000,00$

Insomnia - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Insomnia – Drug Pipeline Analysis and Market Forecas
2009 2.000,00$

Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Bipolar Disorder – Drug Pipeline Analysis and Market
2009 2.000,00$

Addiction Control - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist, has released a new report “Addiction Control – Drug Pipeline Analy
2009 2.000,00$

Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Acute Ischemic Stroke – Drug Pipeline Analysis and M
2009 2.000,00$

Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Non-Hodgkin's Lymphoma – Drug Pipeline Analysis and
2010 2.000,00$

Ulcerative Colitis - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Ulcerative Colitis – Drug Pipeline Analysis and Mark
2010 2.000,00$

Angina Pectoris - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Angina Pectoris – Drug Pipeline Analysis and Market
2010 2.000,00$

Renal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Renal Cancer – Drug Pipeline Analysis and Market For
2010 2.000,00$

Breast Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Breast Cancer – Drug Pipeline Analysis and Market Fo
2010 2.000,00$

Brain Tumor - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Brain Tumour – Drug Pipeline Analysis and Market For
2010 2.000,00$

Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Analysis and Market Forec
2010 2.000,00$

Type 1 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Type 1 Diabetes – Drug Pipeline Analysis and Market
2010 2.000,00$

North American Spine Society Annual Meeting 2009 – Post Conference Review

Introduction / / GlobalData’s “North American Spine Society (NASS) 24th Annual Meeting: Conference Review and Analysis” report is
2009 1.000,00$

American Society of Anesthesiologists Annual Meeting 2009 – Post Conference Review

Introduction / / GlobalData’s “American Society of Anesthesiologists (2009 Annual Meeting): Conference Review and Analysis” repor
2009 1.000,00$

A&D Medical Lifesource Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment busines
2009 1.000,00$

Abbott Medical Optics, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ABIOMED, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Accuray Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ACUTRONIC Medical Systems AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Advanced Bionics Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Advanced Medical Solutions Group plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Aerogen (Ireland) Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Agfa-Gevaert N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

AIR LIQUIDE Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ALCARE Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Allengers Medical Systems Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Allosource Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Aloka Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Alpha Bio GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Animas Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ansell Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Anthogyr S.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Apex Biotechnology Corp. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ARKRAY, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Arthrex, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Arthrocare Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ASAHI ROENTGEN IND.CO., LTD. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Asia Pacific Microsystems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Astro-Med, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Atricure, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

AViTA Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

B. Braun Melsungen AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BASKO HEALTHCARE Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bauerfeind AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Baxter International Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bayer HealthCare AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Becton, Dickinson and Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Beijing Aerospace Changfeng Co., Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bioject Medical Technologies Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Biomet, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BIONIME Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BIOTRONIK GmbH & Co. KG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Boehringer Ingelheim GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Boss Instruments, Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Boston Scientific Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bovie Medical Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BREG Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BSN medical GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CAMLOG Biotechnologies AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Card Guard AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cardiac Science Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cardinal Health, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Carestream Health, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Carl Zeiss AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cerner Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CIBA Vision Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CLINICARE Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cochlear Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Codman & Shurtleff, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Coloplast A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CompuGROUP Holding AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Compumedics Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Computer Programs and Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Conexao Sistemas de Protese Ltda. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CONMED Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Consort Medical plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ConvaTec Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CooperVision, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cordis Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Criticare Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cryolife, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Custom Ultrasonics Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cyberonics, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DEKA M.E.L.A. s.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DePuy, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DeRoyal Industries, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DiaSorin S.p.A Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Digene Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Digene Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Dornier MedTech GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Edwards Lifesciences Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Elekta AB Medical Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Eli Lilly and Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Embla Systems Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ERBE Elektromedizin GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ESAOTE S.p.A Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Essilor International Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ethicon, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ev3 Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

F. Hoffmann-La Roche Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fanem Ltda Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fleming Medical Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

FUJIFILM Medical Systems USA, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fujinon Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fujitsu Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Gambro AB Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GE Healthcare Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GE Sensing & Inspection Technologies Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Geistlich Pharma AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Gendex Dental Systems Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Gen-Probe Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Genzyme Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Getinge AB Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ginevri s.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GN ReSound A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

HAMILTON MEDICAL AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hanger Orthopedic Group, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Healthphone Solutions Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

HealthTronics, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hindustan Syringes & Medical Devices Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hitachi Medical Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hologic, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hospira, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

HOYA ConBio Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hoya Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

iMDsoft Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

IMECO S.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Instrumentarium Dental Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Intersurgical Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Invacare Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Invatec S.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

iSOFT Group PLC Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ivens S.A Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ivoclar Vivadent AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Jackson Allison Medical & Surgical Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Japan Medical Materials Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Johnson & Johnson Vision Care, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

K. Takaoka Industria e Comercio Ltda. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

KARL STORZ GmbH & Co. KG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Kimberly-Clark Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Kinetic Concepts, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

King Systems Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Klockner Implant System Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

KLS Martin, L.P. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Lamprecht AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Larsen & Turbo Medical Equipment & Systems Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

LifeScan, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

LMA International N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

MAQUET GmbH & Co. KG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Masimo Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Matrix I.T. Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

McKesson Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

MED-EL Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medical Information Technology, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

MEDICON eG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medline Industries, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medtronic CryoCath, LP. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medtronic, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Mennen Medical Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Metaltronica S.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Microlife Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Midmark Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Minntech Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Misys Healthcare Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Morepen Laboratories Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nakanishi Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Natus Medical Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

NEC Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Neodent S.A. Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Neurelec Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nightingale Informatix Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nihon Kohden Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

NIPRO CORPORATION Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nobel Biocare Holding AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Noritake Co., Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Novartis Medical Nutrition Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Novo Nordisk A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

NxStage Medical, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OLYMPUS CORPORATION Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OMRON HEALTHCARE Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ONTEX International N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Oridion Systems Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ortho-Clinical Diagnostics Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OSI Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OSSTEM IMPLANT Co., Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ossur hf. Medical Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Owandy S.A.S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Parker Healthcare Pty Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Pelton & Crane Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Penlon Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Perlong Medical Equipment Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Philips Healthcare Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Planmeca Oy Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Planmed Oy Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

PRAXIM medivision Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Profdoc ASA Market Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

PSP Corporation Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

QHR Technologies Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Qiagen N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ResMed Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Rossmax International Co.Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Rothacher & Partner Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

San Meditech(Huzhou)Co.,Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sanofi- Aventis Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Scanlan International, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Schick Technologies, Inc. Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Schiller AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sectra AB Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

SEIKO OPTICAL PRODUCTS CO., LTD. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sepracor Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shanghai Medical Instruments Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shaoxing Haitian Medical Device Co.,Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shimadzu Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shree Pacetronix Ltd., Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Siemens Healthcare Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sklar Instruments Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Smith & Nephew Plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Smiths Medical Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sonic Innovations, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

SonoSite, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sorin S.p.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Spectrum Surgical Instruments Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

SSM Sterile Health Products Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

St. Jude Medical, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

STAAR Surgical Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Starkey Laboratories, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

STERIS Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

STORZ MEDICAL AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Stryker Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sunrise Medical Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sutures India Private Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Svenska Cellulosa Aktiebolaget SCA Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sweden & Martina S.P.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Synergetics USA, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Synthes, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Taema Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Teleflex Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Terumo Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Thoratec Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Thuasne Cr, S.R.O. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TietoEnator Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TOSHIBA Medical Systems Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TRACOE medical GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TrakHealth Pty Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Transasia Bio-Medicals Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

VEPRO AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Vissco Rehabilitation Aids Pvt. Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

VITA In-Ceram Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Widex A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

William Demant Holding A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Wright Medical Group, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Zimmer Holdings, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Heinen + Löwenstein GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ambu A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

dbMotion Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Given Imaging Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shinhung Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Orthofix International N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Mindray Medical International Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GlaxoSmithKline plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Draegerwerk AG & Co. KGaA Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Global Health Pty Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Abbott Laboratories Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Alcon, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

All Pro Oxygen Masks Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

bioMerieux S.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Biosense Webster, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

C. R. Bard, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fresenius Medical Care AG & Co. KGaA Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Spain Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Spain orthopedic devices ma
2009 3.500,00$

South and Central America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the South and Central Ameri
2009 3.500,00$

China Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the China anesthesia & resp
2009 3.500,00$

Japan Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Japan anesthesia & resp
2009 3.500,00$

France Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the France anesthesia & res
2009 3.500,00$

North America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the North America anesthesi
2009 3.500,00$

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015” report provides key data,
2009 4.000,00$

US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest Segment

Introduction / / GlobalData’s “US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest Segment” report is an es
2009 3.500,00$

Medical Weekly Deals Summaries 27 July 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

Medical Weekly Deals Summaries 03 August 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth

Introduction / / GlobalData’s “Global Self Monitoring Blood Glucose (SMBG) Market: Increasing Adoption to Drive Growth” report is
2009 3.500,00$

Global Automated External Defibrillators (AED) Market: Demand to Drive Growth

Introduction / / GlobalData’s “Global Automated External Defibrillators (AED) Market: Demand to Drive Growth” report is an essent
2009 3.500,00$

Germany Diabetes Care Devices Market Analysis & Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Germany diabetes care devic
2009 3.500,00$

Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Intra Ocular Lens (IOL) Pipeline Technology and Market Forecasts to 2015” report is an essential s
2009 2.000,00$

Global Diagnostic Imaging Market Analysis & Forecasts to 2015

Key Companies GE Healthcare, Philips Healthcare, Siemens Medical Solutions, TOSHIBA Medical Systems Corporation, and Hitachi Medic
2009 4.000,00$

Italy Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Italy orthopedic devices ma
2009 3.500,00$

Japan Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Japan orthopedic devices ma
2009 3.500,00$

Italy Cardiovascular Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Italy Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info
2009 3.500,00$

Mergers & Acquisitions and Financing Trends in Medical Equipment Q2 2009

Introduction / / GlobalData's Medical Equipment Quarterly M&A and Financing Trends Report Q2 2009 is an excellent source providin
2009 1.500,00$

Spain Cardiovascular Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Spain Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info
2009 3.500,00$

Infusion Systems Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Infusion Systems Pipeline Technology and Market Forecasts to 2015” report is an essential source o
2009 2.000,00$

Medical Equipment Monthly Deals Analysis – November 2009

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – November 2009 ” report is an essential source of data a
2009 1.000,00$

Transcatheter Cardiovascular Therapeutics (TCT) 2009: Conference Review and Analysis

Introduction / / GlobalData’s “Transcatheter Therapeutics (TCT) 2009: Conference Review and Analysis” report is an essentially so
2009 1.000,00$

Cardiac Markers Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Cardiac Markers Pipeline Technology and Market Forecasts to 2015” report is an essential source of
2009 2.000,00$

India Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “India Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati
2009 3.500,00$

Medical Equipment Quarterly Deals Analysis Q3 2009

Introduction / / GlobalData's “Medical Equipment Quarterly Deal Analysis Q3 2009” report is an essential source of data and trend
2009 1.500,00$

Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015”
2009 2.000,00$

Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015” report is an essential
2009 2.000,00$

Japan Interventional Cardiology Devices: Coronary Stents to Drive Growth

Introduction / / GlobalData’s “Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth” report is an esse
2009 3.500,00$

Global Medical Devices Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery

Introduction / / “Global Medical Devices Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and R
2009 2.000,00$

Germany Wound Care Management Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Germany Wound Care Management Market Analysis and Forecasts to 2015” report provides key data, inf
2009 3.500,00$

China Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “China Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati
2009 3.500,00$

US Mammography Equipment Market: Product Innovations to Drive Growth

Introduction / / GlobalData’s “US Mammography Equipment Market: Product Innovations to Drive Growth” report is an essential sourc
2009 3.500,00$

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Brazil anesthesia &
2009 3.500,00$

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Canada anesthesia &
2009 3.500,00$

Germany Diagnostic Imaging Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Germany Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, inform
2009 3.500,00$

Italy Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Italy anesthesia &
2009 3.500,00$

Medical Equipment Industry Deals Analysis – September 2009

Introduction / / GlobalData's “Medical Equipment Industry Deals Analysis – September 2009” report is an essential source of data
2009 1.000,00$

Spain Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Spain anesthesia &
2009 3.500,00$

Spain Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Spain Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati
2009 3.500,00$

UK Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the UK anesthesia & res
2009 3.500,00$

Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment” report is
2009 3.500,00$

Global Diabetes Care Devices Market Analysis and Forecasts to 2015

Key Companies F. Hoffmann-La Roche, LifeScan, Bayer HealthCare, Abbott Laboratories, and Medtronic / It gives key company share i
2009 3.500,00$

Japan Dental Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Japan Dental Devices Market Analysis and Forecasts to 2015” report provides key data, information
2009 3.500,00$

Medical Weekly Deals Summaries 17 August 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

Medical Weekly Deals Summaries 24 August 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

UK Diagnostic Imaging Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “UK Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, information
2009 3.500,00$

Areva in a Global Expansion Mode

GlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our in-dept
2009 500,00$

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Forecasts & Analysis of the Canada diabetes care devices market to 2015. Market segmentation by glucose monitoring and insulin del
2009 3.500,00$

Canada Orthopedic Devices Market Analysis and Forecasts to 2015

and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke
2009 3.500,00$

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

Annualized global cardiac assist devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated com
2009 2.000,00$

China Orthopedic Devices Market Analysis and Forecasts to 2015

and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke
2009 3.500,00$

Computer Assisted Radiology and Surgery (CARS) 2009 Conference Review and Analysis

The report covers information and analysis on product and technology launched at the conference. The report provides market size d
2009 1.000,00$

Intra Ocular Lens Pipeline Technology and Market Forecasts to 2015

Annualized global IOLs market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data f
2009 2.000,00$

Medical Weekly Deals Summaries 20 July 2009

Summary of Medical Equipment deals by segment during the week Information on rumored and upcoming deals before they occur Any upd
2009 125,00$

Merger & Acquisition Deal Analysis - Bonavista Energy Trust To Acquire Non-Core Alberta Properties From EnCana Corporation

In depth analysis of the latest and the most important Mergers and Acquisitions deal
2009 500,00$

International Society of Arthroscopy, Knee Surgery & Orthopedic Sports Medicine 2009 – Conference Review And Analysis

The report covers information and analysis on product and technology launched at the conference. / The report provides market size
2009 1.000,00$

The Dawn Of Consolidation In The Spinal Surgery Market: Nuvasive To Acquire Cervitech

In depth analysis of the latest and the most important Mergers and Acquisitions deal; / Analysis of the operations of the companie
2009 500,00$

Japan Diabetes Care Devices Market Analysis and Forecasts to 2015

The report provides Diabetes care devices market information broken down into detailed categories and segments in Japan. / Total
2009 3.500,00$

United States Diabetes Care Devices Market Analysis & Forecasts to 2015

The report provides Diabetes care devices market information broken down into detailed categories and segments in the US. / Total
2009 3.500,00$

Dental Implants Pipeline Technology and Market Forecasts to 2015

Annualized global dental implants market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and rev
2009 2.000,00$

Medical Weekly Deals Summaries 27 April 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / Any
2009 125,00$

Medical Device Clinical Trials: Destination India

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue Regeneration

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Bioject Medical Technologies Inc. - Healthcare - Medical Equipment SWOT Report

Critical appraisal of the company’s positioning using SWOT analysis. / Company information, including business descriptions, com
2008 125,00$

Biliary Stents: Off – Label Use to Drive Growth

Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma
2009 500,00$

Medical Weekly Deals Summaries 01 June 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A
2009 125,00$

Medical Weekly Deals Summaries 25 May 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A
2009 125,00$

The Medical Device Reprocessing Industry: Increasing Hospital Sustainability

Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma
2009 500,00$

US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015

The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab
2009 3.500,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U
2009 3.500,00$

SWOT Review of the Key Orthopedic Device Companies

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Transcatheter Cardiovascular Therapeutics 2008 – Post Conference Review

The report covers information and analysis on product and technology launched at the conference / The report provides market size
2009 1.000,00$

Medtronic to Acquire Ablation Frontiers: A Move to Strengthen Stake in the Atrial Fibrillation Market

In depth profiling of the latest and the most important Mergers & Acquisitions deal; / Historical deal analysis of the compani
2009 500,00$

Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015

Annualized global cardiovascular surgery market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis
2009 2.000,00$

Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2012

This report provides detailed global, regional countries (United States, Germany, United Kingdom, France, Italy, Spain, Japan, Can
2009 3.500,00$

United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

The report provides patient monitoring devices information broken down into detailed categories and segments in United States. /
2009 3.500,00$

Aesthetics Devices Pipeline Product and Technology Analysis Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis
2009 2.000,00$

Neurostimulation Devices Pipeline Product and Technology Analysis Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis
2009 2.000,00$

Digital Mammography Pipeline Technology and Market Forecasts To 2015

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis
2009 2.000,00$

Mergers & Acquisitions and Financing Trends in Medical Equipment Industry Q4 2008

Comprehensive summary of Medical Equipment deals globally in the last four quarters / Trend analysis of deals by segments, region,
2009 1.500,00$

Cell Therapy - A New Lease of Life for the Heart

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Combination Products - Evolution of the Medical Equipment Industry

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Small Joints - Big Innovations

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Key M&A Events in the Spinal Surgery Market in 2008

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Orthopedic Devices Pipeline Product Analysis and Technology Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi
2008 2.000,00$

Peripheral Vascular Devices Pipeline Product Analysis and Technology Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi
2008 2.000,00$

Wound Care Management Pipeline Product Analysis and Technology Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi
2008 2.000,00$

Medical Equipment Mergers & Acquisitions Trends – April 2009

Comprehensive summary of Medical Equipment deals globally in the last six months / Trend analysis of deals by sector and type /
2009 1.000,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the xray systems market in the leading geographies of the world – United States, Canada, UK
2009 3.500,00$

Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth

The report provides market size data and information on two global Self Monitoring Blood Glucose (SMBG) market categories – blood
2009 3.500,00$

US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015

The report provides market size data and information on three US cardiac rhythm management devices market categories – Cardiac Res
2009 3.500,00$

Ultrasound Systems Pipeline Technology and Market Forecasts to 2015

Annualized global ultrasound systems market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and
2009 2.000,00$

Electrosurgical Devices Pipeline Technology and Market Forecasts to 2015

Develop business strategies by understanding the trends shaping and driving the global electrosurgical devices market. / Identify
2009 2.000,00$

Mergers & Acquisitions and Financing Trends in Medical Equipment, 2008

Comprehensive summary of Medical Equipment deals globally in the last four years / Trend analysis of deals by segments, region, an
2009 3.500,00$

Italy’s nuclear renaissance helps the country to meet the electricity demand

GlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our indepth
2009 500,00$

Middle East Will Drive Growth in the Global Refining Industry in the Next Five Years

GlobalData viewpoints cover the latest events or important trends in the global oil and gas industry and provide our in-depth anal
2009 500,00$

US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015

The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab
2009 3.500,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U
2009 3.500,00$

SWOT Review of the Key Orthopedic Device Companies

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

United States Medical Equipment Market Analysis & Forecasts to 2015

The report provides an overview of the medical equipment industry in the US and provides data and information on each of the key i
2009 4.000,00$

Mexico Orthopedic Devices Market Analysis & Forecasts to 2015

The report provides orthopedic devices information broken down into detailed categories and segments in Mexico. / Total revenues,
2009 3.500,00$

Global Patient Monitoring Market Analysis & Forecasts to 2015

Key Companies Philips Healthcare, GE Healthcare, OMRON HEALTHCARE, Draegerwerk Aktiengesellschaft, and OSI Systems. / It gives ke
2009 4.000,00$

United States Patient Monitoring Market Analysis & Forecasts to 2015

The report provides patient monitoring devices information broken down into detailed categories and segments in United States. /
2009 3.500,00$

United Kingdom Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in UK. / Total re
2009 3.500,00$

US Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015

The report provides canesthesia & respiratory devices market information broken down into detailed categories and segments in
2009 3.500,00$

United States Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in the US. / Tota
2009 3.500,00$

United States Diagnostic Imaging Market Analysis & Forecasts to 2015

The report provides diagnostic imaging market information broken down into detailed categories and segments in the US. / Total re
2009 3.500,00$

Japan Patient Monitoring Market Analysis & Forecasts to 2015

The report provides patient monitoring market information broken down into detailed categories and segments in Japan. / Total rev
2009 3.500,00$

Germany Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in Germany. / Tot
2009 3.500,00$

United States Orthopedic Devices Market Analysis & Forecasts to 2015

The report provides orthopedic devices market information broken down into detailed categories and segments in the US. / Total re
2009 3.500,00$

Japan Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in Japan. / Total
2009 3.500,00$

Dynamic Stabilization Pipeline Technology and Market Forecasts to 2015

Annualized global dynamic stabilization market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis a
2009 2.000,00$

India Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in India. / Total
2009 3.500,00$

Capsule Endoscopy: Small is Effective

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Kyphoplasty: Driving Growth in the Vertebral Compression Fracture Treatment Market in the US

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Medical Equipment M&A Trends - October 2008

Comprehensive summary of Medical Equipment deals globally in the last six months / Trend analysis of deals by sector and type /
2008 1.000,00$

US Electrophysiology Devices Market: Strategic Market Analysis and Insight to 2015

The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab
2009 3.500,00$

US Dental Implants Market: Growth Driver for the Dental Equipment Sector

The report provides market size data and information on two US dental implants market categories – Titanium Dental Implants, Zirco
2009 3.500,00$

Dental Aesthetics Pipeline Technology and Market Forecasts to 2015

Annualized global dental aesthetics market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and
2009 2.000,00$

Wound Closure Devices Pipeline Technology and Market Forecasts to 2015

Annualized global wound closure devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis
2009 2.000,00$

Medical Weekly Deals Summaries 06 April 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A
2009 125,00$

In Vitro Diagnostics Market - A Hotspot For Venture Capital Funding

Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma
2009 500,00$

US Ophthalmic Devices Market Analysis & Forecasts to 2015

The report provides ophthalmic devices market information broken down into detailed categories and segments in the US. / Total r
2009 3.500,00$

Knee Replacement Pipeline Technology and Market Forecasts to 2015

Annualized global knee replacement market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and r
2009 2.000,00$

Global Respiratory Devices Market: The Home and Self Care Products to Drive Growth

The report provides market size data and information on six respiratory devices market categories – Anesthesia Disposables, Anesth
2009 3.500,00$

Germany Diabetes Care Devices Market Analysis & Forecasts to 2015

The report provides Diabetes care devices market information broken down into detailed categories and segments in Germany. / Tot
2009 3.500,00$

China Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in China. / Tota
2009 3.500,00$

Europe Electrophysiology Devices Market: Increasing Demand to Drive Growth

The report provides market size data and information on four Europe electrophysiology devices market categories – electrophysiolog
2009 3.500,00$

Global Electrocardiogram (ECG) Data Management Systems Market: Increasing Demand to Drive Growth

The report covers data and analysis on the ECG data management systems market in the leading geographies of the world – US, Canada
2009 3.500,00$

Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015

The report covers data and analysis on the cardiopulmonary stress testing systems market in the leading geographies of the world –
2009 3.500,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U
2009 3.500,00$

markt-studie.de ist ein unabhängiges Verkaufsportal für Marktstudien, Marktanalysen und Marktforschung. Unser Angebot umfasst weit über 130.000 Studien mit aktuellen Marktdaten (Marktinformationen, Marktpotentiale, Marktentwicklung, etc.) für Tausende Segmente deutschland-, europa- und weltweit. Alle Markt-Studien und Branchenreports können bequem online oder per Fax bestellt werden.


reports-research.com : Market surveys globaldata pharmaceuticals health